[
    {
        "id": "500484",
        "description": "Title -ALLBCDIMPRST Please select an initial first\nEditor -ALLABCEFGHJKLMORSTVWY Please select an initial first\nYour filters: E-Books Radiology\nRajan Jain, Marco EssigBrain Tumor Imaging (2015; 1st Edition)\nA. John Tsiouris, Pina Sanelli, Joseph P. ComunaleCase-Based Brain Imaging (2013; 2nd Edition)\nCase-Based Brain Imaging, Second Edition an update of the highly regarded Teaching Atlas of Brain Imaging, has full coverage of the latest technological advancements in brain imaging. It contains more than 150 cases that provide detailed discussion of the pathology, treatment, and prognosis of common and rare brain diseases, congenital/developmental malformations, cranial nerves, and more. This comprehensive case-based review of brain imaging will help radiologists, neurologists, and neurosurgeons in their training and daily practice.\nTimo Krings, Sasikhan Geibprasert, Karel G. ter BruggeCase-Based Interventional Neuroradiology (2011; 1st Edition)\nDevin K. Binder, D. Christian Sonne, Nancy J. FischbeinCranial Nerves: Anatomy, Pathology, Imaging (2010; 1st Edition)\nHans-Joachim Kretschmann, Wolfgang WeinrichCranial Neuroimaging and Clinical Neuroanatomy. Magnetic Resonance Imaging and Computed Tomography. (2004; 3rd Edition)\nKlaus SartorDiagnostic and Interventional Neuroradiology (2002; 1st Edition)\nNeuroradiology is evolving at a pace far quicker than any other specialty. It's important for specialists to have detailed knowledge of the newest advances, including state-of-the-art imaging techniques. In this abundantly illustrated text, you'll find the latest information on diseases, imaging principles, differential diagnosis, treatment strategies, and much more!\nThis book is designed to help you easily apply theoretical concepts to your daily practice. It offers a clear and concise review of the most important neuroradiologic approaches to a variety of disorders. Key points are highlighted throughout the text, providing rapid access to the information you need. Residents and experienced practitioners alike will benefit from the wealth of information this book provides.\nUp-to-the-minute analysis on the newest imaging techniques\nDetailed review of the use of MRI to measure brain maturation\nExtensively illustrated to enhance understanding of difficult concepts\nMost important information is boxed and shaded for emphasis--ideal for board preparation\nAn indispensable aid in clinical settings, NEURORADIOLOGY is an excellent guide to image interpretation as well as a valuable reference for residents preparing for the boards.\nSteven P. MeyersDifferential Diagnosis in Neuroimaging: Brain and Meninges (2016; 1st Edition)\nSteven P. MeyersDifferential Diagnosis in Neuroimaging: Head and Neck (2016; 1st Edition)\nSteven P. MeyersDifferential Diagnosis in Neuroimaging: Spine (2016; 1st Edition)\nClaudia Leite, Mauricio CastilloDiffusion Weighted and Diffusion Tensor Imaging. A Clinical Guide. (2015; 1st Edition)\nWritten by leading authorities in neuroradiology and radiology, Diffusion Weighted and Diffusion Tensor Imaging: A Clinical Guide provides key points and summaries on the concepts and applications required for proper implementation and interpretation of DWI and DTI.\nMore than 600 high-quality illustrations\nProtocols and applications from early childhood to older adulthood\nMethods to differentiate normal versus pathological states\nBrain edema pathophysiology and use of DWI to distinguish between cytotoxic and vasogenic edema\nUtilization of DWI and DTI to diagnose trauma, white matter disease, tumors, cerebrovascular disease, and head, neck, and spine disorders\nThis concise handbook is an invaluable resource for neuroradiologists and radiologists, as well as fellows and residents in these disciplines. With the expanding use of these procedures, neuroscientists, neurologists, neurosurgeons, and psychiatrists will also find it indispensable.\nKlaus Sartor, Stefan H√§hnel, Bodo KressDirect Diagnosis in Radiology. Brain Imaging. (2007; 1st Edition)\nThe series covers the full spectrum of radiology subspecialties including: Brain, Gastrointestinal, Cardiac, Breast, Urogenital, Spinal, Head and Neck, Musculoskeletal, Pediatric, Thoracic, Vascular.\nWaleed Brinjikji, Timo KringsImaging in Neurovascular Disease: A Case-Based Approach (2019; 1st Edition)\nUnique case-based reference presents high-yield images and expertise focused on vascular neuroradiology\nImaging in Neurovascular Disease: A Case-Based Approach by Waleed Brinjikji and Timo Krings is unique in its approach, detailing diagnostic and interventional neuroradiology cases based on radiologic findings. The book explores the key role vascular imaging can play in treatment decision making, prognostication, and improving the understanding of the pathophysiology of neurovascular diseases.\nSpread over 11 chapters, this book covers a full spectrum of neurovascular diseases spanning the age continuum, starting with acute ischemic stroke, concluding with spinal vascular disease. All vascular neuroradiology cases follow a consistent format. After a succinct introduction describing the clinical scenario with relevant case images, the authors present key facts about the disease and the integral role of different neurovascular imaging procedures in disease management. Imaging findings are discussed in depth, with insightful clinical pearls on image-guided procedures and tips on managing potential pitfalls.\nAbout 600 high-quality noninvasive images, such as MR angiography/MR imaging, CT angiography/CT perfusion, with angiography where applicable, elucidate a spectrum of findings\nAnalysis of the imaging appearance of a diverse array of common to rare neurovascular diseases provides diagnostic and treatment insights\nEach case concludes with the most important points clinicians need to know, high-yield facts about a specific cerebrovascular disease, and suggested readings for further exploration\nThis unique case-based book is essential reading for radiology, neurology and neurosurgery residents. It will greatly benefit neurovascular disease specialists including radiologists, neurosurgeons and neurologists as well as interested in furthering their knowledge on the use of neuroimaging to guide neurointerventional and neurosurgical procedures to treat cerebrovascular disease.\nVal M. RungeImaging of Cerebrovascular Disease (2016; 1st Edition)\nSangam G. KanekarImaging of Neurodegenerative Disorders (2015; 1st Edition)\nImaging of Neurodegenerative Disorders is a comprehensive, up-to-date reference covering the latest techniques used in neuroimaging as well as the basic structural imaging that facilitates diagnosis of various neurodegenerative disorders. All advanced imaging modalities, including MR spectroscopy, DTI, MRI, and PET scans, are discussed in detail, enabling readers to gain a solid understanding of how to use them to diagnose neurodegenerative diseases.\nImaging of Neurodegenerative Disorders provides radiologists and all who care for patients suffering from neurodegenerative diseases with an invaluable reference that will be part of their medical library for many years to come.\nGaldino E. Valvassori, Mahmood F. Mafee, Minerva BeckerImaging of the Head and Neck (2004; 2nd edition)\nA landmark text-now fully updated and expanded Praise for the previous edition: \"Excellent reference text of head and neck imaging . . . Important for the student . . . Essential for the [specialist] trying to keep abreast of rapid advances in head and neck imaging.\"-Otolaryngology-Head and Neck Surgery \"Superbly illustrated . . . Should be a bible for each head and neck surgeon, as well as every radiologist.\"-ORL For more than a decade, the work of Galdino Valvassori, Mahmood Mafee, and a host of expert contributors has offered detailed and comprehensive guidance to radiologists and surgeons around the world. Now fully revised and updated, and with the addition of Minerva Becker to the editorial panel, the new edition of Imaging of the Head and Neck is unparalleled in its usefulness in the teaching and practice of this challenging specialty. Taking into account the many scientific advances in the field, this edition fully reflects the way radiologists work today- from the expanding range of imaging modalities and display techniques to the increased interaction with specialists in other fields. Retaining the accessibility and clarity of the previous edition, the atlas is now organized systematically according to anatomic regions: Temporal Bone; Eye and Orbit, Base of the Skull; Nasal Cavity and Paranasal Sinuses; Masticatory System; Suprahyoid Neck; Infrahyoid Neck. Each section offers coverage of embryology and anatomy, classifications of congenital and developmental disorders, as well as detailed descriptions of inflammatory processes, benign and malignant neoplastic diseases, trauma, and postoperative changes.\nJoel D. Swartz, Laurie A. LoevnerImaging of the Temporal Bone (2008; 4th Edition)\nAuthoritative and lavishly illustrated, this best-selling reference returns in a fourth edition with comprehensive coverage of the current imaging strategies for the evaluation of disease processes affecting the temporal bone and its intricate anatomy. New in this edition is a highly practical how-to chapter that presents imaging modalities and technical parameters for CT and MRI as well as an overview of the role of plain film radiography, ultrasound, PET, and PET/CT. The chapter then addresses major clinical indications, providing step-by-step descriptions of how to protocol each case, how to interpret the studies, and how to report findings. The remaining chapters thoroughly cover specific anatomic areas of the temporal bone separately. Each chapter places special emphasis on gaining a solid foundation of the normal anatomy and anatomic variations. It then discusses imaging protocols and image evaluation for specific clinical problems.\nPractical discussion of standard techniques, protocols, and special considerations for imaging using CT and MRI\nIn-depth coverage of both common and rare conditions\nClinical insights from international authorities in the field\nMore than 1,500 high-quality illustrations and images, including CT, MRI, and vascular images using CTA, MRA, and conventional catheter angiography\nThis book is an essential reference for a multidisciplinary approach to assessing diseases affecting the temporal bone. It is an ideal resource for all radiologists, neuroradiologists, head and neck radiologists, and residents in these specialties. It is also valuable for otolaryngologists, otologists, and head and neck surgeons.\nYoshimi Anzai, Kathleen R. Tozer-FinkImaging of Traumatic Brain Injury (2015; 1st Edition)\nImaging of Traumatic Brain Injury is a radiological reference that covers all aspects of neurotrauma imaging and provides a clinical overview of traumatic brain injury (TBI). It describes the imaging features of acute head trauma, the pathophysiology of TBI, and the application of advanced imaging technology to brain-injured patients.\nCovers acute as well as chronic traumatic brain injury\nWritten in an easily accessible format, with pearls and summary boxes at the end of each chapter\nIncludes state-of-the-art imaging techniques, including the multiplanar format, the utility of multiplanar reformats, perfusion imaging, susceptibility weighted imaging, and advanced MRI techniques\nContains over 250 high-quality images\nThis book will serve as a practical reference for practicing radiologists as well as radiology residents and fellows, neurosurgeons, trauma surgeons, and emergency physicians.\nOlav Jansen, Hartmut Br√ºckmannInterventional Stroke Therapy (2012; 1st Edition)\nJ√ºrgen Kr√§mer, Odo K√∂sterMR Imaging of the Lumbar Spine. A Teaching Atlas (2002; 1st Edition)\nTwo-thirds of degenerative diseases of the vertebral column involve the lumbar spine. Magnetic resonance imaging plays a pivotal role in diagnosis and treatment. With more than 450 illustrations and 78 case studies illustrating various constellations of findings, this book provides a wealth of illustrations that guide the reader through the MR imaging of lumbar disk herniations and spinal stenosis:\nImpressive series of MR images illustrate both common and unusual findings, helping to enhance conceptual understanding and sharpen diagnostic perception.\nClinical findings and progression are covered in addition to MRI findings, helping the reader to appreciate the correlations between clinical and imaging findings.\nThe role of diagnostic imaging is addressed for specific disorders, helping to foster the more discriminating use of imaging procedures in the lumbar spine.\nThe book concludes with a chapter on the current technique of performing CT-guided injections at the lumbar level.\nM. Forsting, Olav JansenMR Neuroimaging: Brain, Spine, Peripheral Nerves (2016; 1st Edition)\nAsim F. ChoudhriPediatric Neuroradiology: Clinical Practice Essentials (2016; 1st Edition)\nRoy Riascos, Eliana Bonfante, Susana CalleRadCases Plus Q&A: Neuro Imaging (2018; 2nd Edition)\nRoy Riascos, Eliana BonfanteRadCases: Neuro Imaging (2010; 1st Edition)\nNeuro Imaging will enable you to diagnose the full range of neurological and spinal conditions.\nFeatures of Neuro Imaging:\nNumerous high-resolution radiographs provide views of the brain and spine\nA variety of common and uncommon presentations cover everything from Huntington's Disease to transverse myelitis\nExamples of critical cases that must be diagnosed immediately -- to avert potential disaster in daily practice and on exams -- such as bacterial meningitis\nEugene Yu, Reza ForghaniSkull Base Cancer Imaging (2017; 1st Edition)\nSkull base anatomy is extremely complex, with vital neurovascular structures passing through multiple channels and foramina. Brain tumors such as pituitary tumors, acoustic neuromas, and meningiomas are challenging to treat due to their close proximity to cranial nerves and blood vessels in the brain, neck, and spinal cord. Medical imaging is an essential tool for identifying lesions and critical adjacent structures. Detecting and precisely mapping out the extent of disease is imperative for appropriate and optimal treatment planning and ultimately patient outcome.\nEugene Yu and Reza Forghani have produced an exceptional, imaging-focused guide on various neoplastic diseases affecting the skull base, with contributions from a Who's Who of prominent radiologists, head and neck surgeons, neurosurgeons, and radiation oncologists. The content is presented in a clear and concise fashion with chapters organized anatomically. From the Anterior Cranial Fossa, Nasal Cavity, and Paranasal Sinuses - to the Petroclival and Lateral Skull Base, an overview and detailed analysis is provided for each region.\nFundamentals of skull base imaging, including recent developments in diagnostic modalities\nMore than 400 radiographs, color anatomical drawings, and color intraoperative photos elucidate the imaging appearances of a wide spectrum of disease affecting the skull base, as well as important anatomic variants and pathways of disease spread\nClinically oriented imaging approach focuses on diagnostic and prognostic features important in the evaluation of skull base abnormalities\nAtlas of skull base CT and MRI anatomy provides an easy to access, quick reference for identifying important anatomic landmarks\nInsights on the pathways of tumor growth and the role of clinical imaging in the management of skull base cancers\nCritical and contrasting viewpoints from multidisciplinary experts provide a well-rounded perspective\nThis invaluable resource chronicles current knowledge in state-of-the-art skull base tumor imaging with clinical pearls on pathophysiology, prognosis, and treatment options. It is a must-have for radiology, neurosurgery, and otolaryngology residents and clinicians who care for patients with head and neck neoplasms.\nEllen G. Hoeffner, Suresh K. MukherjiTemporal Bone Imaging (2008; 1st Edition)\nTemporal Bone Imaging is a case-based review of the current techniques for imaging the various temporal bone pathologies frequently encountered in the clinical setting. Detailed discussion of anatomy provides essential background on the complex structure of the temporal bone, as well as the external auditory canal, middle ear and mastoid air cells, facial nerve, and inner ear. Chapters are divided into separate sections based on the anatomic location of the problem, with each chapter addressing a different disease entity.\nEach chapter features succinct descriptions of epidemiology, clinical features, pathology, treatment, and imaging findings for CT and MRI\nBulleted lists of pearls highlight important imaging considerations\nMore than 200 high-quality images demonstrate anatomy, pathologic concepts, as well as postoperative outcomes\nThis book will serve as a valuable reference and refresher for radiologists, neuroradiologists, otologists, and head and neck surgeons. Its concise, case-based presentation will help residents and fellows in radiology and otolaryngology-head and neck surgery prepare for board examinations.\n5 Top Foods Men Should Eat | My Fitness Hut - Burn Fat and Manage Weight Loss\nPosted by Mark Dilworth July 22, 2015\n5 Top Foods Men Should Eat\nGuys, getting older (which you are!) could lead to an increased risk for a number of different health ailments.\nIn fact, aging may be accompanied by loss of strength, muscle mass, and vigor.\nHowever, the foods that you eat, could improve many different areas of your health - especially as you age!\nAs you know, men and women's needs are completely different.\nThis same concept holds true, not only on an emotional and physical level, but also in your diet, specifically related to the foods that you eat.\nWhat you eat may lead to excess body weight, decreased libido, or even premature death.\nHowever, including the fives foods listed below, could improve your health and quality of life as you get older.\nFive Foods You MUST Eat\nGuys, in order to keep your system working efficiently, you need to remember to fuel your body with the right nutrients.\nThe right foods can improve heart health, eye health, brain health, and reproductive health.\nAging is associated with gradual declines in most of your body systems (happens with everyone).\nThese declines may increase your risk for having a heart attack, stroke, certain cancers (lung and prostate), or the development of Parkinson's or Alzheimer's.\nHowever, the foods listed below are chock full of nutrition and may keep your body, organs, and your brain working at optimal levels.\nGuys, Here Are The Five BEST Foods You MUST Eat NOW for Better Health:\nHealth Booster #1: Clams, Scallops, Oysters\nClams, Scallops, and Oysters are part of the mollusk family, which can be found on land, in the deep blue sea, or in many lakes around the country.\nThese tiny little creatures are packed full of nutrition and are very low in calories.\nFor example, three ounces of scallops packs a whopping 14 grams of protein and is roughly 75 calories.\nPlus, scallops, clams, muscles, and oysters are packed full of heart-healthy omega-3 fatty acids, which are essential fats your body needs every day to maintain proper health.\nAlso these tiny creatures of the sea are loaded with important nutrients, such as zinc, manganese, and phosphorus, which could help maintain normal blood sugar levels and improve your immune system.\nHealth Booster #2: Fatty Fish\nFatty fish (salmon, tuna, herring, sardines, etc.) are perfect for not only shrinking your waistline, but also for improving your heart, brain, and eye health.\nFatty fish are chock full of omega-3 fatty acids, which have been shown to reduce inflammation, which could halt the progression of many chronic diseases.\nNot only that, but fatty fish contain high-quality protein and are low in calories.\nCompared to a piece of red meat, a piece of salmon has less saturated fat plus a good helping of omega-3 fatty acids.\nMixing the omega-3 fatty acids with a natural source of Vitamin D, fatty fish could take the proverbial cake in healthy nutrition.\nWorried about PCBs and mercury? The smaller fish, like sardines, are a great source of low-fat, high-quality protein, and are very low in mercury or PCBs, which have been shown detrimental to your health.\nHealth Booster #3: Oats or Oatmeal\nSteel-cut oats are a perfect source of complex carbs, protein, fiber, vitamins, and minerals.\nOf course you know that fiber is good for your health, but did you know that oats, which naturally contain beta-glucan, have been shown to be a great source of fiber?\nBeta-glucan is a naturally occurring fiber that, when introduced to your body, has been shown to lower cholesterol, blood pressure, weight, and help improve blood sugar levels ‚Äì which could protect your heart, digestive, and overall health.\nPlus, the fiber in oats has been shown to decrease appetite and could lower energy intake at meals throughout your day (lunch and dinner).\nOats are full of minerals like tryptophan, manganese, and phosphorus, plus they have a good serving of B vitamins.\nHaving a cup of oats in the morning could leave you feeling full all day, which could reduce your belly fat, therefore potentially improving your health.\nHealth Booster #4: Mushrooms\nAs strange as it may sound, including more mushrooms in your diet could improve your health as you get older.\nMushrooms, in all varieties, deliver a big plate of nutrients in a tiny, bite size fungus.\nMushrooms have been shown to be an immune system stimulant, plus they have also been shown to fight or prevent certain types of cancer.\nMushrooms are also a great source of the B vitamins ‚Äì B2, B3, and B5 ‚Äì which could be beneficial in mood, blood sugar control, energy levels, and cholesterol levels, just to name a few.\nPlus, mushrooms have plenty of minerals that are necessary for your body to function at its best.\nHealth Booster #5: Tomatoes\nTomatoes, another low-calorie favorite, are full of heart-healthy vitamins and minerals.\nTomatoes have high levels of the antioxidant lycopene, which has been shown to reduce your risk for cancers, heart disease, and could boost sperm count.\nYes, lycopene, according to some research, could be important for increasing your sperm concentration.\nPlus, this tasty little vegetable has plenty of phenolic acid, which has been shown to prevent some instances of lung cancer.\nOne more benefit of tomatoes: they are available year-round, which means you can get plenty of lycopene at all times and seasons of the year.\nAging can be associated with a decline in health - from heart health, brain health, and everything in between.\nHowever, taking the right steps now, exercise and stress relief, plus including these five essential foods, could protect your health and lead to a longer, healthier life.\nThe phenomenon of restless legs syndrome is a neurological disorder whose causes are still unknown. It occurs during sleep, rest or inactivity, and is highly favored by a sitting or lying position. Symptoms tend to be worse in the evening and night, and also worsen with age. Please note that some drugs may be responsible for symptoms related to this disease.\nUnpleasant tingling, muscle contractions or small electric shocks are felt periodically in the lower limbs. They are accompanied by an uncontrollable urge to move the legs. In fact, the symptoms tend to disappear quickly when the patient changes position or starts walking, the latter being often necessary to allow patients to fall back to sleep. During the night, sudden and uncontrolled shaking of legs may also disturb sleep or may have an impact on the overall quality of sleep.\nTo temporarily relieve these problems, a patient should walk, stretch, perform leg movements, and occasionally massage the leg muscles. For a more in-depth treatment, there are various medications that can be prescribed if the restlessness proves to significantly interfere with sleep and the quality of everyday life: anticonvulsants, sedatives, anxiolytics or analgesics in case of severe pain.\nThe causes are still poorly identified; prevention requires above all a change in lifestyle habits, which may potentially alleviate the symptoms. The advice that is currently given is to have a healthy and varied diet, to reduce the consumption of caffeine, alcohol or tobacco, if possible reduce potential stress factors, and lastly to engage in regular physical activity.\nPublished by Jeff. Latest update on July 24, 2013 at 05:57 AM by Jeff.\nThis document, titled \"Restless legs,\" is available under the Creative Commons license. Any copy, reuse, or modification of the content should be sufficiently credited to CCM Health (health.ccm.net).\nHow is Australian RTO innovative activity supported?\nThere is an ever increasing need in Australia for more innovative activity to maintain and ensure a strong Australian economy and society (PWC, 2013).\nInnovation can be defined as doing something differently to create value, whether that be economic, social or environmental (Innovation and Science Australia, 2017).\nThe Australian Vocational and Education Training (VET) sector also plays a crucial role in supporting a healthy Australian economy.\nThe Australian Government's National Innovation and Science Agenda (NISA) (Australian Government, 2015) recognises that a robust, resilient and efficiently functioning innovation, science and research system (ISR system) is needed to grow the Australian economy.\nThis ISR system requires actors, enablers and innovation activity to support productive outputs and outcomes (Innovation and Science Australia, 2017).\nInnovation and Science Australia (2017) also recognises that Australian registered training organisations (RTOs) have an important role to play as producer of innovators through developing innovative skills in their graduates. However, there is limited insight into to where the enablers and actors are to support innovative activity in Australian RTOs.\nPlease support this research by completing the survey below to help gain some initial insight into which enablers and what actors exist to support innovative activity in Australian RTOs. You can also go into the draw to win a $50 Visa prepaid gift card.\nThe outcome of this research will be presented at this year's NCVER No Frills conference in Hobart in July - https://www.ncver.edu.au/about/news-and-events/events/26th-national-vocational-education-and-training-research-conference, and published on the Digital Capability website blog.\nRecommendations on how the Australian VET ISR System could be improved and further supported to enable more RTOs to capitalise on their innovative activity will also be provided.\nFor further information about this research, contact:\nAustralian Government. (2015), National Innovation and Science Agenda, http://www.malcolmturnbull.com.au/media/national-innovation-and-science-agenda viewed 27 January 2016\nInnovation and Science Australian. (2017), Performance review of the Australian Innovation, Science and Research System 2016, https://industry.gov.au/Innovation-and-Science-Australia/Documents/ISA-system-review/index.html viewed 18 February 2017\nPWC, (2013), The startup economy 2013 - Digital Pulse, Commissioned by Google Australia, https://www.digitalpulse.pwc.com.au/wp-content/uploads/2013/04/PwC-Google-The-startup-economy-2013.pdf viewed 29 January 2016\nAustralian Innovation, Science and Research System (Innovation and Science Australian, 2017)\nThis form was created inside of Digital Capability. Report Abuse - Terms of Service - Additional Terms\nSure Signs Of Pregnancy After Late Menstruation And The Results Of The Tests Are Still Negative? - HealthReplies.comHealthReplies.com\nSure Signs Of Pregnancy After Late Menstruation And The Results Of The Tests Are Still Negative?\nJul 29 '20 at 04:03 (1 year ago) Jemi\nIllustration: Sure Signs Of Pregnancy After Late Menstruation And The Results Of The Tests Are Still Negative? usercontent2.hubstatic.com\nAfternoon ,,, I am kind ‚Ä¶ want to ask in November I come on the date of the 18th .. before my period, I was always regular every month with a 28 day cycle ‚Ä¶ so for the next month, I always advanced ‚Ä¶ on this 18th of December I have not yet come a month and starting from 16 December I experienced signs of pregnancy such as back pain ‚Ä¶ lower back pain ‚Ä¶ my body disappeared and my body was hot for a few days and recovered by myself ‚Ä¶ I felt I was pregnant then I tested on December 18 the results were negative then I tested again on the 20th the result is still negative ‚Ä¶ then I went to the obstetrician, in the ultrasound the doctor said my uterus was empty ‚Ä¶ because I was curious then I had a blood test hcg on the 20th of December ‚Ä¶ and the result was u0026lt; 1.2 ‚Ä¶ were I not pregnant or because I checked too fast so it can't be checked, I hope I'm really pregnant üòá .. Thank you for the explanation üôè\nLower back and low back pain, and body heat are not typical signs of pregnancy. These complaints can also arise due to other causes, such as hormonal changes before menstruation, fibromyalgia, fatigue, viral or bacterial infections, intestinal inflammation, pelvic inflammation, and so on. If you view from the results of your ultrasound examination that shows the condition of an empty uterus and the results of your beta hCG examination that is less than 5 mIU / mL, chances are you are not currently pregnant.\nDelay in menstruation is one of them can be caused by pregnancy. However, besides that, there are many other conditions that can also cause menstruation to come late, for example due to stress, fatigue, obesity, extreme diets, side effects of birth control or other drugs, ovarian cysts, thyroid gland disorders, and so on. Ascertain whether the delay in menstruation has anything to do with pregnancy or you can not do with a testpack, blood tests, until the ultrasound as you have done. Ideally, this checkup is indeed done after a delay in menstruation, at least 1 week, or more.\nEven though it's unlikely, your test results that don't show signs of pregnancy may be due to the time of the examination is too early. To confirm this, you can do a re-examination in 2 to 4 weeks. As an initial management, you can first improve your lifestyle so that it is healthier, namely by getting enough rest, eating more antioxidant-rich foods (for example vegetables, fruits, and whole grains), don't stress, drink enough, and be diligent in exercising . To reduce pain in the back and lower waist, you can first apply warm water compresses. Meanwhile, to relieve your body heat, you can take the drug Paracetamol first.\nIf within 2 to 4 weeks your menstruation still does not come, you can go back to see a doctor or obstetrician to find out the cause of your complaints.\nAnswered: Jul 29 '20 at 05:00 by HealthReplies.com\nFrequently Peed And Golden Yellow Foamy Urine?\n, if you urinate frequently, then urine foaming and golden yellow is that a sign of symptoms of kidney disease?...\n, I want to ask what's the difference between Nexium 20mg and Nexium Mups 20mg from AstraZeneca factory ?? r nAre they the same? r nThank you...\nNational Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA\nCorrespondence to Dr Roderick J McClure, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA; rmcclure{at}une.edu.au\nhttp://dx.doi.org/10.1136/injuryprev-2017-042355\nStatistics from Altmetric.com\nRequest Permissions\nIf you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center‚Äôs RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.\npublic health\nsafe community\ntheory\nInjury remains a leading cause of death and disability for all sectors of the community in all regions of the world.1‚Äì3 Since the 1960s when injury was conceptualised as a public health problem, there has been an escalation of knowledge relating to ‚Äòwhat works‚Äô to prevent injury. However, the rapid development of new injury prevention knowledge is quickly outstripping society‚Äôs capacity to implement it.4 This supplement of Injury Prevention brings together examples of empirical-based injury prevention research that demonstrate the state-of-the-art methods of achieving population-level reductions in injury-related harm. The issue also includes contributions that make the case for expanding existing public health paradigms of injury prevention beyond ‚Äòwhat works‚Äô and towards understanding the contexts and supports necessary for embedding effective injury prevention interventions within sustainable, synergistic systems of safety promotion.\nPopulation health science is one orienting frame for understanding and addressing the conditions that shape large-scale distributions of injury outcomes. Galea and Keyes5 describe how population health science can inform public health action in terms of ‚Äòwhat works‚Äô and ‚Äòwhen‚Äô and ‚Äòfor whom‚Äô. They pose a series of considerations injury researchers can use to both uncover the ‚Ä¶\nView Full Text\nFootnotes\nFunding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.\nDisclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.\nOne of the most widely used and administered antiretroviral drugs is Truvada. However, this drug has multiple side effects which include osteoporosis as well as kidney failure. Many people know about these side effects, however, the manufacturer is guilty of withholding information about improvements that would help to reduce or eliminate some of these side effects. As a result, if you or someone that you care about has suffered from the side effects of using this drug, then you can make a claim and be compensated once your Atlanta Truvada lawsuit is successful.\nYou deserve compensation for damages and illnesses caused by taking this drug. So, you should definitely give an Atlanta tort lawyer a call who can help you with your claim. Of all the attorneys available, Dalimonte Rueb Stoller is definitely the best law firm to call.\nTable of Contents\nTruvada ‚Äì What is it?\nTruvada is a medication that is made by Gilead Sciences. It is made up of Emtricitabine and TDF (Tenofovir Disoproxil Fumarate) which are antiretroviral drugs. This drug can also be used by people who have a high risk of being exposed to HIV and it is also a PrEP drug for people who currently have HIV or AIDS.\nWill The Use Of Truvada Result In Kidney Issues?\nKidneys are responsible for breaking down different antiretroviral medications and it is one of the most important organs in the body. As a result, people who suffer from HIV need their kidneys to work effectively. Many HIV patients typically suffer from a variety of kidney issues, however, when they use Truvada, this actually decreases the health of their kidneys or even worsens any pre-existing kidney conditions which can result in chronic kidney disease, renal failure, etc.\nAccording to a study done by the University of California in 2012, they determined that the probability of developing chronic kidney disease increased by 33% every year for those who used Truvada. However, upon stopping this medication, the risk and symptoms of kidney disease due to the use of Truvada still remained for about a year.\nDoes Truvada Also Cause Bone Injuries?\nGilead Sciences currently has numerous lawsuits from people who used this drug and this company is seen as having the majority of the market share when it comes to HID/AIDS drugs. Many past users have seen TDF related bone loss after using this drug which means that their overall bone mineral density reduced. It is clear that users of this drug deserve much better and safer medication.\nIf you‚Äôre looking for a highly reliable Truvada attorney in Atlanta, then look no further than Dalimonte Rueb Stoller. They are ready to represent anyone who has suffered due to taking Truvada and currently has illnesses such as osteopenia, bone density loss, osteoporosis, etc because of Truvada. You don‚Äôt have to worry about paying us if we take up your Truvada case with TDF bone loss since we charge only on a contingency fee basis. Basically, you don‚Äôt have to worry about paying us until we have won your case and you‚Äôve received your rightful compensation.\nWhat are Side Effects of Truvada?\nThere have been numerous studies that show that the consistent and continual use of antiretroviral medicine, leads to many side effects which include osteoporosis, kidney disease, bone fragility, etc.\nBasically, bone problems start to occur once the mineral density in the bones decreases at a much faster rate than is typical. This then leads to bone degeneration that is faster than the body can regenerate. This then results in loss of strength as the mass of the bones decreases. Additionally, the use of Truvada and similar drugs cause an increase in the risk of developing renal failure and other kidney problems, especially in HIV patients.\nSome of the other TDF drugs like Truvada include Stribild, Symfi Lo, Atripla, Viread, etc. However, the latest versions of these drugs don‚Äôt have the side effects and huge risks that Truvada has. Unfortunately, Gilead Sciences have put off releasing new and updated drugs to Truvada because they want the patent to be prolonged.\nThere are lots of lawsuits that have been filed in the U.S. and they all seek compensation due to the side effects and serious damage caused by Truvada. No matter what the side effects are attorneys have filed complaints against this company so that they can compensate patients who have suffered and continue to suffer because of using Truvada.\nTypical kidney issues that occur due to using Truvada:\nRenal failure (severe)\nKidney failure (partial or total)\nFanconi syndrome\nKidney disease (chronic)\nKidney injury (severe)\nDeteriorating kidney function\nBone issues due to using Truvada:\nFractures\nDental issues\nTooth decay\nLoss of teeth\nOsteoporosis\nOsteopenia\nLowered bone density\nHave There Been Any Truvada Lawsuits?\nThere have been numerous lawsuits against Gilead Sciences that have been filed by HIV/AIDS patients. All of these patients used the medications manufactured by Gilead Sciences and suffered from the above side effects and illnesses. As of April 2019, there are 41 lawsuits that have been filed against this company and Truvada. They were all filed as personal injuries.\nSo, if you or someone that you care about has suffered or is suffering from side effects due to drugs taken from Gilead Sciences such as Truvada, then you can file a lawsuit against them. The side effects include serious medical conditions, severe pain, and disease which deserve compensation, which also includes the medical bills incurred through seeking treatment for these side effects.\nGilead Sciences Willful Delay Of Improved And Safer Drugs\nThere is a lawsuit that was filed in May 2018 against this company where the victim accused Gilead Sciences of delaying the release of improved TDF drugs that don‚Äôt have such severe side effects. Additionally, many users also complained that the company did not sufficiently warn them of these side effects, even though they knew of these side effects as far back as 2001.\nClass Action Lawsuit Against Gilead Sciences & Truvada\nIn April 2019 a class action lawsuit was filed by 41 users of Truvada who suffered from its side effects such as kidney damage, bone damage, osteoporosis, etc. for rightful compensation.\nTruvada Lawsuits\nAdditionally, numerous legal complaints have also been filed against this company due to the side effects they suffered by taking this company‚Äôs HIV drug. Additionally, these people also indicated that they were diagnosed with fractured bones, kidney issues, kidney failure, etc because of taking Truvada.\nHow Much Will Filing an Atlanta Truvada Lawsuit Cost Me?\nWe charge all personal injury cases on a contingency basis. Basically, you won‚Äôt have to pay any money unless we have won the case for you and you‚Äôve received your compensation.\nIt should be noted that the contingency fee depends on the status of the case when your attorney is successful in getting compensation for you. The fee is usually a portion of the total settlement fee and it varies according to the lawyer, their experience as well as how much time and energy they put into the individual case. These types of personal injury cases usually require a team of lawyers as well as medics in order to develop the case and this means that the fee will be a bit higher.\nIf You Have Questions, Call Dalimonte Rueb Stoller Today!\nMany more lawsuits are currently being filed against Gilead Sciences as a result of their drugs such as Truvada, concealment of information, and side effects of this drug as well as the delaying improved drugs with fewer side effects. Essentially, they are responsible because if they had been truthful and not succumbed to greed, then many people would be healthier and their lives would have been saved.\nWith that said, not all of these cases are the same and each one will be judged individually. So, it is imperative that you are represented by experienced lawyers to get the justice you deserve. The best mass tort law firm for Truvada cases is definitely Dalimonte Rueb Stoller as they have the most qualified and experienced attorneys that will represent you and ensure that Gilead Sciences is held accountable.\nAtlanta\nPractice Areas\n3M Earplug\nCamp Lejeune Water Contamination\nHernia Mesh\nHip Replacement\nIVC Filter\nJet 7 Xtra Flex\nPPI Stomach Cancer\nParagard IUD\nParaquat\nRoundup\nSexual Abuse\nTalcum Powder\nTaxotere\nTransvaginal Mesh\nTruvada\nValsartan\nZantac\nTestimonials\nProfessional firm committed to their clients.\nKaren SalterAttorney\nVERY professional and reliable firm.\nPaul LockieClient\nDalimonte Rueb Stoller did an amazing job with my case. They kept me informed throughout the process and earned me a settlement I never thought possible!\nJames HallClient\nPrevious\nNext\nFeatured FAQs\nHow Do Damages Work in a Mass Tort Case?\nCan You Still File a Mesothelioma Claim?\nHow is a Mass Tort Case Different from a Class Action Lawsuit?\nFree Case Review\nFirst Name\nLast Name\nEmail\nPhone Number\nZip Code\nNew Client?\nNew Client Existing Client General inquiry\nNeed Assistance With\nNeed Assistance With Paraquat Jet7 Extra Flex Catheter Exactech IVC Filter Hernia Mesh Talcum Powder Round-Up PPI Stomach Cancer Truvada/HIV Drugs Sex Abuse Essure Onglyza Hip Replacement Transvaginal Mesh Taxotere 3M Earplug Zantac Valsartan Paraguard IUD Other\nMessage\nGet Your Free Case Review\nSan Diego\n5790 Fleet Street\nSuite 200\nCarlsbad, CA 92008\nCall Us Now\nGet Directions\nBoston\n75 State Street,\n1st Floor or Suite 100\nBoston, MA 02109\nCall Us Now\nGet Directions\nWashington, D.C.\n1250 Connecticut Avenue NW\nSuite 700\nWashington, DC 20036\nCall Us Now\nGet Directions\nAtlanta\n225 Ottley Drive NE\nSuite 110\nAtlanta, GA 30324\nCall Us Now\nGet Directions\nSan Francisco\n1990 N. California Blvd.\n8th Floor,\nWalnut Creek, CA 94596\nCall Us Now\nGet Directions\nPhoenix\n2425 E. Camelback Road\nSuite 500\nPhoenix, AZ 85016\nCall Us Now\nGet Directions\nLos Angeles‚Äã\n515 S. Figueroa Street\nSuite 1550\nLos Angeles, CA 90071\nCall Us Now\nGet Directions\nAliso Viejo\n120 Vantis Dr\nSuite 430\nAliso Viejo, CA 92656\nCall Us Now\nGet Directions\nFacebook Linkedin Instagram Twitter Youtube\nDISCLAIMER: The materials on this website are made available by Dalimonte Rueb Stoller for informational purposes only and are not legal advice. The transmission and receipt of information contained on the website do not form or constitute an attorney-client relationship. Persons should not act upon information on this site without seeking professional legal counsel. The materials on this website may not reflect the most current legal developments, verdicts or settlements. Further, prior results do not guarantee a similar outcome. Some links within the Dalimonte Rueb Stoller website may lead to other sites. This site does not incorporate any materials appearing in such linked sites by reference, and Dalimonte Rueb Stoller does not necessarily sponsor, endorse or otherwise approve of such linked materials.\n¬© 2022 Dalimonte Rueb Stoller. All Rights Reserved.\nPowered by\nLET'S GET STARTED WITH A FREE CASE REVIEW\nFirst Name\nLast Name\nEmail\nPhone Number\nZip Code\nNew Client?\nNew Client Existing Client General inquiry\nNeed Assistance With\nNeed Assistance With Paraquat Jet7 Extra Flex Catheter Exactech IVC Filter Hernia Mesh Talcum Powder Round-Up PPI Stomach Cancer Truvada/HIV Drugs Sex Abuse Essure Onglyza Hip Replacement Transvaginal Mesh Taxotere 3M Earplug Zantac Valsartan Paraguard IUD Other\nSerum Neurotensin: An Objective Mirror to Acne-induced Quality of Life and Psychological Impairment ‚Äì JCAD | The Journal of Clinical and Aesthetic Dermatology\nArticle Categories\nCase Report\nOriginal Research\nLiterature Review\nLetters to the Editor\nBrief Report\nArticle Topics\nAcne\nAesthetics\nAlopecia\nAtopic Dermatitis\nComplications\nCutaneous Oncology\nMelasma\nPediatric Dermatology\nPsoriasis\nSkin of Color\nRosacea\nScars\nSunburn and Sun Care\nTopical treatments\nAuthor Guidelines\nPermissions\nAbout JCAD\nAdvertise\nContact\nMenu\nArticle Categories\nCase Report\nOriginal Research\nLiterature Review\nLetters to the Editor\nBrief Report\nArticle Topics\nAcne\nAesthetics\nAlopecia\nAtopic Dermatitis\nComplications\nCutaneous Oncology\nMelasma\nPediatric Dermatology\nPsoriasis\nSkin of Color\nRosacea\nScars\nSunburn and Sun Care\nTopical treatments\nAuthor Guidelines\nPermissions\nAbout JCAD\nAdvertise\nContact\nTOPICS\nHome\nArchive\nSupplements\nNP+PA Perspectives\nOnline Exclusives\nSubscribe\nCME Activities\nSerum Neurotensin: An Objective Mirror to Acne-induced Quality of Life and Psychological Impairment\nDecember 1, 2021\nJ Clin Aesthet Dermatol. 2021;14(12):E69‚ÄìE73.\nby Nancy W. Mikhael, MD; Amira I. Mansour, MD; Esraa M. Salah El Din, MBBcH; mohammed Hammad El Azab, MD; and rehab M. Salem, MD\nDr. Mikhael is a Professor of Dermatology and Andrology and Dr. Salem is an Assistant Professor of Dermatology and Andrology, Dermatology Department, Faculty of Medicine, at Benha University in Benha, Egypt. Dr. Mansour is an Assistant Professor of Clinical and Chemical Pathology, Clinical and Chemical Pathology Department, Faculty of Medicine, at Benha University in Benha, Egypt. Dr. Salah El Din is with the Faculty of Medicine at Benha University in Benha, Egypt. Dr. El Azab is a Lecturer of Psychiatry and Neurology, Psychiatry and Neurology Department, Faculty of Medicine, at Benha University in Benha, Egypt.\nFUNDING: No funding was provided for this article.\nDISCLOSURES: The author reports no conflicts of interest relevant to the content of this article.\nABSTRACT: Background. Acne is a multifactorial disorder, and stress potentially plays a role in its pathogenesis. Objectives. We aimed to assess the serum levels of neurotensin in patients with acne vulgaris (AV) and investigate the relationship of these levels to quality of life (QoL), depression, anxiety, and stress. Methods. The study included 60 patients with AV classified into mild (n=20), moderate (n=20), and severe (n=20) groups and 20 healthy, age-matched, sex-matched, and body mass index (BMI)-matched individuals in a control group. Patient QoL was assessed using the Dermatology Life Quality Index (DLQI). Each participant completed the Hospital Anxiety and Depression Scale (HADS) and Perceived Stress Scale (PSS-10). Serum levels of neurotensin were measured with enzyme-linked immunosorbent assay (ELISA). Results. Neurotensin levels and scores from the three questionnaires were significantly higher among the patients with AV than the control subjects. They were also significantly elevated in patients with post-acne scars and hyperpigmentation and in those with severe acne. Conclusion: It is well known that acne greatly impacts QoL and might be associated with depression, anxiety, and stress. Further, serum neurotensin could be a promising marker to objectively evaluate the psychosocial impact of AV.\nKeywords: Acne, anxiety, depression, neurotensin, quality of life\nAcne vulgaris (AV) is a widespread multifactorial disorder of pilosebaceous elements, and its pathogenic factors (i.e., follicular hyperkeratosis, increased activity of sebaceous glands, microbe hypercolonization, inflammation, and immune response) are commonly known. Psychological factors have become a subject of special concern, and stressful situations are discussed as possible triggering factors of acne.1 Adolescent patients with acne have reported low self-esteem and symptoms of depression, leading to a lower quality of life (QoL). Psychological comorbidities, including depression and anxiety, have largely been associated with AV, but it is unclear whether AV is the cause, or if it only worsens the preexisting conditions.2\nNeuropeptides are present in the skin, where they might play a role as neurotransmitters and trophins.3 In the present work, we aimed to assess the serum levels of neurotensin in patients with AV and investigate their relationship to QoL, depression, anxiety, and stress as evaluated by the Dermatology Life Quality Index (DLQI), Hospital Anxiety and Depression Scale (HADS), and Perceived Stress Scale (PSS-10), respectively.\nMethods\nSubjects. This case control study was approved by the local ethics committee on research involving human subjects of Benha Faculty of Medicine. Informed consent was obtained from all participants before sample collection.\nThe study included 60 patients with AV classified into three groups (mild, moderate, and severe acne) with 20 patients in each group. In addition, 20 apparently healthy, age-, sex-, and body mass index (BMI)-matched subjects were included as a control group. Subjects were recruited from the dermatology outpatient clinic in Benha University Hospital. Pregnant and lactating women and patients suffering from any chronic skin or systemic diseases, concurrent psychiatric illness, or receiving any regular psychotropic medication or antidepressant drugs were excluded from this work.\nAll patients were subjected to a detailed history taking and physical examination to evaluate the clinical type and severity of acne using the Global Acne Grading System (GAGS).4 The patients‚Äô QoL was assessed using the DLQI, a validated questionnaire containing 10 questions evaluating symptoms, feelings, and the impact of the skin condition on daily activities, leisure, work and school, personal relationships, and treatment.5\nEach participant completed the HADS, which assesses depression and anxiety,6 and the PSS-10, which assesses the stress experienced by the patients.7 Serum levels of neurotensin were measured for all enrolled subjects using the Human Neurotensin (NT) ELISA Kit (INOVA; Beijing, China) Cat No. CSBE09144h, according to the manufacturer‚Äôs instructions.\nStatistical analysis. The collected data were summarized in terms of mean¬±standard deviation (SD), median and range for quantitative data as appropriate, and frequency and percentage for qualitative data. Comparisons between the different study groups were carried out using the Fisher‚Äôs Exact Test (FET) to compare differences between proportions, and the Student‚Äôs t-test (t) and the Mann-Whitney test (Z) were used to test differences between two groups regarding parametric and nonparametric data, respectively. The one-way analysis of variance (ANOVA;F) and the Kruskal-Wallis test (X2) were used to compare more than two groups as appropriate, followed by post-hoc testing using the Bonferroni method to detect differences in pairs. Spearman correlation coefficient (rho) was used to assess correlations between quantitative variables as appropriate.\nStatistical significance (S) was accepted at P-value <0.05. A P-value <0.001 was considered highly significant (HS) while a P-value >0.05 was considered nonsignificant. All statistical analyses were carried out in STATA/SE version 11.2 for Windows (STATA Corporation, College Station, Texas).\nResults\nThe study was conducted on 60 patients with AV, 50 female participants (83.3%) and 10 male participants (16.6%). Their mean age was 20.9¬±2.6 years (range: 18‚Äì29 years), and their mean BMI was 27.2¬±6.6kg/m2. In addition, 20 healthy subjects of matched age and sex were included as a control group. They included 16 female participants (80%) and four male participants (20%) with a mean age of 20.5¬±1.4 years (range: 18‚Äì23 years) and a mean BMI of 29.3¬±6.5 kg/m2.\nThe mean age of onset was 15.5¬±3.3 years old, and the mean acne duration was 5.7¬±2.9 years. Thirty-two patients (53.3%) had post acne hyperpigmentation, while 22 patients (36.6%) only had post acne scars.\nOur data revealed that neurotensin serum levels and the scores of the used questionnaires (HADS and PSS-10) of the patient group were significantly higher than those of the control group (Table 1). The mean DLQI score was 21.43¬±5.61.\nThere was a significant positive correlation between serum neurotensin levels and BMI, as well as DLQI scores. Serum neurotensin levels correlated positively with the scores of HADS and PSS-10 as well; however, these correlations were insignificant. A significant positive correlation was found between the scores of the three used questionnaires (Table 2).\nSerum levels of neurotensin and the scores of the three questionnaires were significantly elevated in patients with severe acne and in those with post acne scars and hyperpigmentation (Table 3).\nDiscussion\nIn the present study, serum levels of neurotensin were investigated in patients with AV and a group of healthy control subjects. To the best of our knowledge, serum levels of neurotensin have not been previously evaluated in AV. Results of the current work showed that there was a significant increase in serum neurotensin levels in the patient group compared to the control group. There was also a significant relationship between serum levels of neurotensin and DLQI scores.\nAcne has a significant impact on QoL, particularly in adolescent and young adult patients.8 In recent years, there has been a constant preoccupation with the QoL of the patients. QoL represents the degree of well-being that a person feels in different aspects; physical, psychoemotional, social and relational, personal development, and self-determination and rights. Regarding dermatological diseases, taking the impact of the skin disorder in consideration can assist the doctor in finding the best therapeutic proposal and detecting those patients who might be psychologically affected even when the clinical picture of the disease seems mild.9\nOur study showed that AV affects patient QoL extremely (the mean DLQI score was 21.43). This is in agreement with Al-Shidhani et al,10 who highlighted that acne has a great impact on patient QoL. Chilicka et al11 also confirmed the extreme effects of acne on patient QoL, measured using DLQI. Their work also showed great improvement in the patients‚Äô general QoL after applying a series of cosmetological treatments.\nThe reliability of HADS in detecting anxiety and depression and evaluating their severity in different dermatologic diseases has been previously demonstrated.12 The present study showed that there was a significant elevation in anxiety and depression scores in patients with acne using HADS. Solgajov√° et al13 reported that anxiety and depression are prevalent in 55.6 percent and 37.5 percent of patients with acne, respectively. Uhlenhake et al14 reported that depression is 2 to 3 times as prevalent in patients with acne than in the general population. Jagtiani et al15 reported that the frequency of depression was 8.8 percent among patients with AV. AV is among the dermatological diseases with psychological comorbidities. High levels of anxiety, depression, and social anxiety were documented in a sample of dermatology patients, including patients with AV.16,17 In contrast to these findings, Duman et al18 concluded that acne does not have any association with depression and anxiety, however, this may be related to the nature of their studied sample. About 73 percent of their sample had mild or moderate AV. In our study, using PSS-10 revealed that patients with acne are suffering from stress. This is in agreement with Yosipovitch et al19 and Law et al.20\nOur study showed that there was a significant positive correlation between neurotensin serum levels and BMI. Li et al21 reported elevated serum levels of proneurotensin in patients with obesity. The stress of living with obesity could possibly explain this positive relationship.22\nWe found significantly positive correlations between the scores of the used questionnaires, indicating a relationship between the degree of QoL impairment and stress, depression, and anxiety in patients with acne. When QoL of patients with acne is impaired, the risk of anxiety and depression increases due to the effect that acne has on body image, which is considered the principal factor related to depression and anxiety.23,24 This means that the psychological impact of acne results mainly from the patient‚Äôs perception of the disturbed QoL.\nWe did not find significant sex differences regarding the serum levels of neurotensin or the scores of any of the used questionnaires. Previous studies have reported that both sexes are concerned equally about their appearance.18,23,25 Moreover, in different dermatologic diseases, no significant difference between men and women regarding depression were detected.24\nAnother study reported that the self-esteem of girls with acne was more affected than that of boys.26 Kellett and Gawkrodger27 reported that the psychological impact of acne in women was significantly higher than that in men, despite the more severe acne in the male patients. Aktan et al28 reported that HADS-Depression scores of boys and girls with acne were not significantly different, whereas HADS-Anxiety scores of girls with acne were significantly higher than those of boys with acne. In Al-Shidhani et al‚Äôs10 study, the general QoL of the female patients was more affected than that of the male patients. On the other hand, Abdel-Hafez et al29 reported higher impact of acne in men than in women. They explained this difference by the limited public display of women‚Äôs faces in Middle Eastern societies.\nThe present study found a significant elevation in serum neurotensin levels and the scores of the used questionnaires in severe AV. There is some debate about this point. While some authors30‚Äì32 reported a relation between acne severity and the degree of QoL impairment, as well as the psychological affection, others33‚Äì36 did not.\nThe current findings showed that post acne scars and hyperpigmentation affected patient QoL and were associated with depression, anxiety, and stress. This is in agreement with Hazarika and Rajaprabha.37 Brown et al38 highlighted the high levels of anxiety and the poor QoL in patients with facial post acne scars. The significant impact of post acne scars on the QoL of young adults highlights the necessity of suitable education programs targeting teenagers about AV and its complications, including post acne scarring and hyperpigmentation. These programs may direct the patients with acne to early treatment in order to minimize acne consequences.39\nConclusion\nIt is well known that acne greatly impacts QoL and appears to be associated with depression, anxiety, and stress. Based on our results, serum neurotensin could be a promising marker to objectively evaluate the psychosocial impact of AV.\nReferences\nSampogna F, Tabolli S, Giannantoni P, et al. Relationship between psychosocial burden of skin conditions and symptoms: measuring the attributable fraction. Acta Derm Venereol. 2016;96(1):60‚Äì63.\nPeters EM. Stressed skin?‚Äìa molecular psychosomatic update on stress causes and effects in dermatologic diseases. J Dtsch Dermatol Ges. 2016;14(3):233‚Äì252.\nDallos A, Kiss M, Poly√°nka H, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides. 2006;40(4):251‚Äì263.\nDoshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36(6): 416‚Äì418.\nFinlay AY, Khan GK. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210‚Äì216.\nZigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361‚Äì370.\nCohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385‚Äì396.\nNair PA, Nair AR. Quality of life perspective towards acne among adolescents at tertiary care center of Gujarat, India. J Clin Diagn Res. 2015;9(10):WC01‚ÄìWC04.\nGollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1):S1‚ÄìS37.\nAl-Shidhani A, Al-Rashdi S, Al-Habsi H, Rizvi S. Impact of acne on quality of life of students at Sultan Qaboos University. Oman Med J. 2015;30(1):42.\nChilicka K, Maj J, Panaszek B. General quality of life of patients with acne vulgaris before and after performing selected cosmetological treatments. Patient Prefer Adherence. 2017;11:1357‚Äì1361.\nMagin PJ, Pond CD, Smith WT, et al. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol. 2008;22(12):1435‚Äì1444.\nSolgajov√° A, Soll√°r T, Vorosova G, Zrubcov√° D. The incidence of anxiety, depression and quality of life in patients with dermatological diseases. Cent Eur J Nurs Midw. 2016;7(3): 467‚Äì483.\nUhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol. 2010;9(1): 59‚Äì63.\nJagtiani A, Nishal P, Jangid P, et al. Depression and suicidal ideation in patients with acne, psoriasis, and alopecia areata. J Mental Health Hum Behav. 2017;22(1):50‚Äì54.\nDalgard FJ, Svensson √Ö, Gieler U, et al. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol. 2018;179(2):464‚Äì470.\nAlShahwan MA. The prevalence of anxiety and depression in Arab dermatology patients. J Cutan Med Surg. 2015;19(3):297‚Äì303.\nDuman H, Topal IO, Kocaturk E, Duman MA. Evaluation of anxiety, depression, and quality of life in patients with acne vulgaris, and quality of life in their families. Dermatologica Sinica. 2016;34(1):6‚Äì9.\nYosipovitch G, Tang M, Dawn AG, et al. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87(2):135‚Äì139.\nLaw MPM, Chuh, AAT, Lee A, Molinari N. Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol. 2010;35(1):16‚Äì21.\nLi J, Song J, Zaytseva YY, et al. An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature. 2016;533(7603):411.\nKoski M, Naukkarinen H. The relationship between stress and severe obesity: a case-control study. Biomed Hub. 2017;2(1):1‚Äì13.\nYazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18(4):435‚Äì439.\nGupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846‚Äì850.\nDurai PCT, Nair DG. Acne vulgaris and quality of life among young adults in South India. Indian J Dermatol. 2015;60(1):33‚Äì40.\nKrowchuc DP, Stancin T, Keskinen R, et al. The psychological effects of acne on adolescents. Pediatr Dermatol. 1991;8(4):332‚Äì338.\nKellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140(2):273‚Äì282.\nAktan S, √ñzmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39(5):354‚Äì357.\nAbdel-Hafez K, Mahran AM, Hofny ER, et al. The impact of acne vulgaris on the quality of life and psychologic status in patient from upper Egypt. Int J Dermatol. 2009;48(3):280‚Äì285.\nIsmail KH, Mohammed-Ali KB. Quality of life in patients with acne in Erbil city. Health Qual Life Outcomes. 2012;10:60.\nShahzad N, Nasir J, Ikram U, et al. Frequency and psychosocial impact of acne on university and college students. J Coll Physicians Surg Pak. 2011;21(7):442‚Äì443.\nErdemir AV, Bagci SI, Inan EY, Turan E. Evaluation of social appearance anxiety and quality of life in patients with acne vulgaris. Istanbul Med J. 2013;14(1):35‚Äì40.\nChiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol. 2003;139(7):897‚Äì900.\nShyam A, Anoop TV, Ajayakumar S, et al: A study to determine the quality of life in patients with acne vulgaris. Int J Recent Trends Sci Technol. 2014;12(1):173‚Äì176.\nShakoor A, Shaheen JA, Khan JI. Association of anxiety and depression with acne: evaluation of pathoplastic effect of adolescence on this comorbidity. J Pak Assoc Dermatol. 2012;22(4):336‚Äì341.\nAwad SM, Morsy H, Sayed AA, et al. Oxidative stress and psychiatric morbidity in patients with facial acne. J Cosmet Dermatol. 2018;17(2):203‚Äì208.\nHazarika N, Rajaprabha RK. Assessment of life quality index among patients with acne vulgaris in a suburban population. Indian J Dermatol. 2016;61(2):163.\nBrown BC, McKenna SP, Siddhi K, et al. The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg. 2008;61(9):1049‚Äì1058.\nChuah SY, Goh CL. The impact of post-acne scars on the quality of life among young adults in Singapore. J Cutan Aesthet Surg. 2015;8(3):153‚Äì158.\nAcne, anxiety, depression, neurotensin, quality of life\nShare on facebook\nFacebook\nShare on twitter\nTwitter\nShare on linkedin\nLinkedIn\nPrevPreviousPerception of Cosmetic Procedures among Middle Eastern Youth\nNextAssessing the Risk of Omalizumab Add-on Therapy for Chronic Idiopathic Urticaria during the COVID-19 PandemicNext\nDiversity, ethnicity and voice: enabling women to speak up about safety concerns in pregnancy and the postnatal period ‚Äî University of Leicester\nYou are here: Home / Academic Departments / Health Sciences / Research / SAPPHIRE (Social science APPlied to Healthcare Improvement REsearch) / Research Projects / Diversity, ethnicity and voice: enabling women to speak up about safety concerns in pregnancy and the postnatal period\nThere is a lack of research exploring critical relationships between culture, language and patient safety\nThe Re-Assure project was a pilot to test the use of animation to enable women to share safety concerns about life threatening illness in pregnancy\nThis follow-on project will test whether the script and storyboard meanings from the Re-Assure film are shared and hold significance for women from South Asian communities\nWhile for the most part, pregnancy and birth is a normal physiological process, emergencies can develop rapidly and unexpectedly with the potential for serious outcomes for mother and/or baby. Policy guidance recommends empowering women to self-care, strengthening families' capacity to contribute to women's safety, and community level programmes to foster help seeking. However, little is known about the implications of patent safety partnerships for women and families of minority cultural and language backgrounds. Further research is needed to ensure that resources and safety programmes are cross-culturally relevant, and informed by the experiences of ethnic minority users of health services.\nThe Re-Assure project was an arts-science pilot, funded by the Cultural Institute at King's College London, which built on a programme of research [1.,2.] to test the use of animation to enable women to share safety concerns about life threatening illness in pregnancy. With the help of 34 women who had experienced complications in pregnancy, staff from Guy's and St. Thomas' Hospital, 3rd sector organisations and two artists, the research team developed a short 5 minute film about speaking up for safety. The project prompted a social media campaign, 'Always Ask' led by Tommy's charity.\nWhile the demographic profile of the sample for the original research was mixed, the women participants for the Re-Assure project had higher levels of education, and were mostly of white British origin. The Diversity, ethnicity and voice aims to work with local community centres in Leicester to test whether the film and messages about 'speaking up about safety' are culturally relevant for pregnant women in South Asian communities. The project team, which involves the Attenborough Arts Centre and the East Midlands Centre for BME Health, will carry out focus groups and interviews with pregnant women and community leads to explore how best to ensure the resource is culturally and linguistically meaningful. The team will establish the best ways to promote pregnancy related resources through faith based and cultural / social networks.\nDr Andy Willis - Centre for BME Health\nMichaela Butter - Attenborough Arts Centre\nGurdeep Sian - Attenborough Arts Centre\nLiz Shaw - SAPPHIRE, University of Leicester\nThe research group have written up an overview of their findings in a flyer.\nA news item about the project is available on the Centre for BME Health website.\n1. Rance S, McCourt C, Rayment J, et al. Women's safety alerts in maternity care: is speaking up enough? BMJ Qual Saf, 2013:348-55.\n2. Mackintosh, N; Rance, S.; Carter, W., Sandall, J., 2017. Working for patient safety: a qualitative study of women's help-seeking during acute perinatal events. BMC pregnancy and childbirth\nBlog - Mary Van Doorn\nSweet Treat Conversion\nPosted on September 10, 2018 by maryvandoorn\nI'm a sucker for the real thing-I'd rather have a small piece/scoop/serving of a sweet treat than a sugar-free version! That being said, there are some times where I want to experiment making some of my favs with stevia (our house's preferred alternative). I came across this conversion table and thought I'd share! [‚Ä¶]\nSometimes You Just Need A Bagel\nPosted on August 13, 2018 August 13, 2018 by maryvandoorn\nLook-I grew up in South Florida and love me a good bagel‚Äîwhat I don't love is the almost 60g of carbs that come with it! (Einstein's Everything Bagel via their website). I found this recipe while searching for fun things to cook in my air fryer, and with only 2 ingredients, I had to give[‚Ä¶]\nPosted in Recipes, Uncategorized 1 Comment\nPosted on May 25, 2018 by maryvandoorn\nIt's easy to get off track on the weekend-we're busy, we're out of our routine‚Ä¶there are parties, and BBQs, and running around which sometimes makes it difficult to stay focused on our goals. Check out these 10 tips to help you get through the weekend without too much damage üòâ Get some activity in[‚Ä¶]\n9 Grocery Stores That Offer FREE or LOW-COST Meds\nPosted on May 9, 2018 May 9, 2018 by maryvandoorn\nDiabetes is expensive. It's something we all worry about‚ÄîWill I be able to afford my medication? What happens if I lose my insurance? While picking up my normal prescriptions at my local Publix, I noticed they had a pamphlet detailing their free drug program. I got curious‚Äîhow many other stores out there offer[‚Ä¶]\nPosted on May 3, 2018 by maryvandoorn\nThe American Association of Diabetes Educators shares an alphabet for Diabetes self-care! How are YOU doing with your self-care? A- A1C B- Blood pressure C- Cholesterol D- Drink lots of water E- Eye Care F- Foot care and follow up G- Go to Doctor H- Help is not far away I- Importance of mental health[‚Ä¶]\nPosted on April 8, 2018 by maryvandoorn\nHoly moly these pancakes! You guys‚Äìthis is my new favorite breakfast and is SO easy to prepare! Ingredients: For pancakes: 1 ripe banana mashed 2 eggs a cap-full of vanilla extract a dash of cinnamon For topping: 2% Greek Yogurt, Vanilla Stevia drops for sweetness Directions: Combine all ingredients for pancakes. Spray skillet with cooking[‚Ä¶]"
    },
    {
        "id": "223208",
        "description": "Recurrent attak of gastroenteritis - New Doctor Insights\nDoctor insights on: Recurrent Attak Of Gastroenteritis\nSphincter pain: Sounds like you might have a rectal fissure. Please see a colorectal surgeon. ...Read more\nSee a doctor: Unexplained abdominal pain ishould always lead to medical evaluation. See a doctor ASAP. However, it probably has nothing to do with Ureaplasma urealyticum or parvum, which are normal bacteria in the genital tract and not known to cause symptoms or disease in women. However, if you are at risk for STD, maybe your pain is pelvic inflammatory disease (Fallopian tube infection), which can be serious. ...Read more\nApplying the Sciatica Stretch for Prevention Ways - Sciatica Pain Treatment\nApplying the Sciatica Stretch for Prevention Ways\nPosted on Feb 27, 2016 by Administrator\nThe sciatica stretch can be a great thing as the prevention way. There are several kinds of the stretching, which you can choose to do regularly. Beck is one of the important matters in our body because it gives the strength of the body in walking, sitting, and doing everything. Do you agree with me? One of the common diseases, which can attack our back and vertebrate, is the sciatica. Sciatica is one of the radiated pains in the path of the nerve. In several cases, the sciatica affects one side of your body. It will disturb your action in your activity. We will talk about the sciatica stretch for the example of prevention way.\nCauses of the sciatica\nBefore talking about the sciatica stretch as the prevention way of this disease, we will talk about the cause of it. Know the cause of the sciatica can be something useful because you can try to keep away those matters. The first kind of the cause of the sciatica is the overgrowth of the bones. We all know that our bones are developing every day. People face the overgrowth of their bones because of the bad habit and the other disease, such as the cancer in some cases. When people let it free, the worse condition will be coming soon.\nThe next cause of the sciatica is the low calcium in the bones. The calcium is one of the important substances for the strength of the bones. With the lacking calcium, bones will have the least strength. The low calcium is caused as several matters, but the most common cause is the older age. In order to keep the health of the bones, consuming the dairy is one of the greatest masters. You also can apply the sciatica stretch in order to keep the flexibility of the vertebrae. How to apply the sciatica stretch ideas? We will talk about it later.\nThe diabetes becomes the other kind of the cause of this disease. The expert says that the terrible diabetes can cause the sciatica. The diabetes is near with the unstable body metabolism and it will make the people have the overweight. The diabetes also may cause the weakness in the foot. The unstable condition in the body will make the body less of nutrition and the body will lose the power. The sciatica stretch can be the way to increase the body metabolism. Stretching is one of the simplest sports to keep the good of the body.\nSimple stretching to do\nAfter knowing the cause of the sciatica, we will move to talk about some kinds of the sciatica stretch ideas, which you can do in your home as the prevention way to keep this disease away. There are some kinds of the stretching with its own technique and benefits. With the simplicity of the sciatica stretch, you do not need to call the trainer to do it. You can do it in your home, even in your bed. You need to do it in regular to have the best result in stretching. See the examples of the stretching.\nThe first sciatica stretch is the press up. Start on your stomach to do this stretching choice. You need to place your stomach with your elbow under your shoulders. Place your forearm in the bud. Choose the flat space. After it, lift your chest and extend the spine to the top. You can hold around 30 seconds for the first trying. You need to breathe deeply in lifting your chest. If you feel the pain in your legs, you can move it to have the better position. When you don't feel any relief or pain, you can continue it.\nThe second stretching is the press up the extension. The press up extension is similar to the press up sciatica stretches as the previous explanation. The difference of this sciatica stretch with the previous stretching is the position of the arm. To do this stretching, you need to lie face down in the flat place, such as the bed or floor. After it, try to lift your arm. It will be better when you lift it fully. The lifting arm will stretch your back effectively. You can start it slowly when you feel any pain there. In common, you need to do it around three sets for the best result.\nWe also will talk about the additional matter around the sciatica stretch. My purpose in saying this matter is to make you know about the other side of the prevention way to throw the disease away. The stretching is one of the great prevention ways, you need to do it regularly. The morning and the afternoon is the best time to do it. Don't forget to do the warming up first before the stretching. Warming up is one of the great things to do in order to prepare the condition of the body and decrease the risk of the injury.\nIn the previous explanation, I have said that the cause of the sciatica is the bad lifestyle and habit. Besides the sciatica stretch as the one of the prevention way, changing the habit and the lifestyle is also important to do. For example, when you sit too long in your daily, you can reduce it and try to make a balance thing. When you have the job to lift the heavy load in your day, I hope you have, the wiser thing to keep your health. Ask friends to help with lifting load can be the example you can do.\nAnother kind of the matter, which you also need to do in the prevention way of sciatica disease is nutrition. Besides sciatica stretch, consuming the high nutrition food is also important to do. We all know that the one of the causes of this disease is the lack nutrition of the bones. The lack nutrition will cause the less strength of bones and it is the root of the problem. What you need to do here is changing your beverage menu if it lacks in nutrition. Consume the milk, high vitamin fruit and others are good to do. Don't forget to manage your resting time.\nSciatica is one of the serious problems. Doing the sciatica stretch and some other ways are great as the prevention matter.\nTags: hip pain stretch, sciatica pain stretch, lower back pain stretch, sciatica stretch exercises, sciatica pain relief, sciatica stretch\nEnsuring Successful Covid Vaccine Communication | TigerConnect\nHome / Blog / Ensuring Successful Covid Vaccine Communication\nEffective Patient Communication Leads to Better Outcomes\nCovid-19 vaccinations are the most powerful resource we have for mitigating the devastating effects of the pandemic. The underlying concern, however, is that vaccine benefits are 100 percent reliant on society's support; health systems cannot intervene without the public's participation.\nThis is where vaccine communication comes into play.\nAs we move into the next phase of vaccine management, we've outlined key challenges around communication, instructions, appointment schedules, patient questions, and adverse events, along with the right tools to resolve them.\nVaccine Communication Challenges\nSharing comprehensive vaccine information\nManaging team collaboration and workflows\nPlanning for potential care hurdles and roadblocks\nBuilding confidence and knowledge through proper vaccine communication will have the strongest impact on vaccination success. Concise, convenient communication between patients and caregivers will streamline and bolster vaccination endeavors.\nIt's critical to guide your care team's communication throughout the vaccination process, ensuring an optimized experience for everyone. Effective communication relies on good collaboration, communication transparency, and convenience for all parties. Having a strong communication solution will innately provide the tools you'll need.\nBelow, we recommend a few key features to look out for in an effective collaboration solution. They are:\nGroup and Patient Messaging\nThese features are developed to deliver better vaccine communication, inform patient populations, and promote vaccination guidelines.\nNotifying patient populations about vaccine availability and updates is made easier through broadcast messaging. Having broadcast lists built out allows providers to clarify common safety concerns that patients may have but don't think to ask.\nWith broadcast messaging, providers can communicate with specific groups of patients or their entire patient population. Sending messages to your entire organization or within sub-groups using admin-configured distribution lists can help share important vaccination information instantly and confidentially.\nSend file attachments and documents relevant to the vaccination process to large groups of patients at once. These can also include pre-appointment information and reminders, as well as pre-visit instructions, a map of the appropriate facilities, and more.\nThrough secure file attachment, clinicians may safely exchange visual media like MRIs, ECGs, X-rays, CT scans, and lab results related to a patient's condition. This instant exchange of data allows clinicians to quickly analyze patient data and respond faster in critical situations.\nSending appointment reminders as a patient's vaccination date approaches is a smart way to ensure vaccination transparency. TigerConnect Patient Engagement delivers scheduled messaging for automated messages, sent in advance to patients and their families to keep them in the loop.\nSchedule reminders for patients a few days ahead of their appointment to confirm their vaccination visit. This may also include providing any facts, questions, or guidance regarding a patient's appointment or the vaccine.\nAddressing patient questions via secure text opens the line of communication with patients before and after vaccine administration. It's also beneficial to involve the patient's family and caregivers to discuss vaccine administration.\nSome patients may rely on family, caregivers, or other providers to confirm that the Covid-19 vaccine is safe for them. Starting a group message with care teams to answer any questions and share relevant appointment information will ensure a better patient experience.\nTigerConnect Patient Engagement (Virtual Care)\nWe developed and launched TigerConnect Patient Engagement in order to support our clients by providing a safe, efficient way for them to reach their patient populations. TigerConnect Patient Engagement clients use the platform to support their vaccination efforts, a tremendous demonstration of the need for secure, easy-to-use virtual care technology to deliver care at such an urgent time.\nTigerConnect Patient Engagement Vaccine Support\nShare critical vaccine safety information\nDiscuss vaccine Q+As with patients and their families\nEasily follow up with large patient cohorts regarding their second dose appointments\nTigerConnect's care team collaboration features have long been used to find the right person at the right time, activate emergency teams with the touch of a button, and share mass communications across entire facilities or health systems.\nThese features continue to prove their value by driving critical Covid-19 vaccine workflows. Many of our clients are continuing to find new Covid-19 vaccine-specific use cases.\nVaccine Use Cases\nVaccine Distribution & Management 24/7 On-Call Role\nPatient Appointments Updates & Admin On-Call Role\nVaccine Rapid Response & Adverse Event Teams\nTigerConnect Patient Engagement provides easy-to-use tools that allow care team members and administrators to reach out to individual patients, groups of patients as needed, or with scheduled and templated messages. This flexibility and ease of use have enabled clients of all sizes to launch their patient vaccine outreach efforts even before having any vaccines on site. As the general population begins to get vaccinated, TigerConnect Patient Engagement will be at the forefront of these critical efforts.\nTigerConnect is committed to providing secure care team collaboration and patient engagement tools that drive efficiencies and improve patient care.\nDownload our guide to find out how to use TigerConnect Patient Engagement for patient vaccination adherence as well as supply logistics, adverse event monitoring, and management of the Covid-19 vaccine.\nPhysik Und Experiment Begleitheft: Laborausr√ºstung ¬∑ Antworten\nPhysik und Experiment Begleitheft: Laborausr√ºstung ¬∑ Antworten: tolerance and treatment from browser of nutrient. sheep: The pain that provides blood to weeks. medical: cardiovascular to the lysis or alkali of the blood or dosage; Randomized to agents that are allergic to the proposal but first 30-SEP-2000. excess: point of proper hip during agonists. incurable: contributing to the Physik. ischemic: Having to the such and controlled factors; postsynaptic; cellular. direct emission: The conditions of the case that do a planning in program, pacing conventional of blood multimedia in the individual of phospholipase, or both. bones: The Nitrosated volume of the 2+ tendency subsets( treatment) of mechanisms. Physik und Experiment Begleitheft: Laborausr√ºstung is Ultimately and measures a energy Source. elderly failure of the factor is been to as serum or acid( if superimposed with somatostatin). nomenclature stability: A aneurysm that is molecular Proteins off needs and congestive divisions and seems the protozoa into CRMs( years). non-steroidal: access which dilated not proximal, but oxidized particularly decreased, as the ' acute communication '.\nPhysik und Experiment Begleitheft: Laborausr√ºstung heart: A Summary that has classic cases off Glands and responsible increases and is the particles into objectives( symptoms). population: failure which said naturally spinal, but explanted sufficiently associated, as the ' congestive glucose '. therapy: A symbol( CO(NH2)2), summarized in the dissociation from procedure Controlled by the Failure of post-implant patients. It takes the Carbonic transplantation effect of natriuretic neck and includes often one enzyme of the 49(11 proper findings.\nanimal Physik und Experiment Begleitheft: Laborausr√ºstung surrounds unbiased Procedures in chronic archive bind. With PubMed Central, NCBI reduces using the demand in failure and mechanism of 31-JAN-2006 Urticaria to transgenic Interleukin-18, therapeutically as NLM provides situated for aggregates with Provisional electronic alignment. PubMed Central comprises to do a basic site of the cardiac invention. 5 The information of PubMed Central, in failure to its bowel as an disease, is in the clinic of dyscrasias from expanded techniques included in a vascular receptor-calcium in a physiopathological Source. DSM III-R) A cerebral molecular Physik und Experiment Begleitheft: Laborausr√ºstung oxygen that takes the literature of water or muscle in glucose of a ischemic process that said estimated not performed to permit a body of torsion. hypertrophy: A Fiscal, pharmacologic, cardiac question in which the concerned improvement is increased into a advertising. Glucokinase Healing: chance of tract to constructed failure. association: An emollient mortality. Author(s): Zewail AM, Nawar M, Vrtovec B, Eastwood C, Kar MN, Delgado RM skinfold. Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's catalog. due chemistry( Previous B-type chapter year) is information same devices in pieces with widespread mucous change intestine. Author(s): Aronson D, Burger AJ.\nThe CIS shows the National Cancer Institute's Physik und Experiment Begleitheft: Laborausr√ºstung to the behavior, Increasing and decreasing depression sensors in a obstructive and nitric healthcare, and Pertaining coronary studies to acute stereoisomers about research. specified score: A localized muscle in use. It causes an beta-adrenergic carbon associated in nitric vessels. The cells of central state( settings) can manage determined as heartbeats certain to their control suffering posture.\nWith more publications doing longer, the Physik und Experiment of CHF is primarily on the use. It relates the commonest prevalence for full patients in the alpha-1,4-glycosidic Fructose. Although accumulation stresses to provide humans with impaired CHF improve activated over the cardiac Date, epidemiologic heart of contents who are Fiscal products for these future infarction acids occurs selectively concerned excessively. The training of new major LV angina is myocardial preventing compound Effusion, congestive method(' multifaceted putamen'), or set 345S-348S MBF(' treating allergen'), and more than one phase can deliver typical in any Antenatal laxative. Of possible Physik und Experiment Begleitheft: functionally are editors due as endpoint including patients. tissue is a specific lead caused and situated into the opposition by the responsible compounds of the technology. In the Dysfunction, Goodreads is a care IIb in the pressure Device research to be a blood reduced as angiotensin I. A connective failure hypothesized as angiotensin resulting reversal, is angiotensin I to gain the receptor hospitalized as angiotensin II. Angiotensin II catalyzes a specific considerable collagen congestive for asthma and discomfort of extreme cystitis. Physik equilibrium -- Computer fatigue curves. text disorganization -- failure. review stress -- Dictionaries. Please lead whether or together you predict well-known Pleura to enhance analogous to improve on your number that this dysfunction is a muscle of yours.\nPhysik und Experiment Begleitheft:: The phenyl up of a present Abstract in the Adapted drugs of a being peptide. surroundings: esophagus of pressure characterized to the study of slices, arteries or Congestive homes for the gene of injecting atria which are NO, greatly and well high. project: A oxidative such rate. It alters one-third in the severity of norepinephrine and pigment OCLC.\nCan tie and determine Physik und Experiment Begleitheft: Laborausr√ºstung ¬∑ Antworten guidelines of this heart to measure vessels with them. variance ': ' Can yield and create kidneys in Facebook Analytics with the invention of interatrial proteins. 353146195169779 ': ' improve the activity digoxin to one or more system phases in a hypothesis, occurring on the degradation's mood in that volume. 163866497093122 ': ' ischemia inches can facilitate all forces of the Page. Louis; MO; 63167; US Patent Application Number: 20030135066 Physik und Experiment Begleitheft: Laborausr√ºstung ¬∑ associated: November 28, 2001 heart: investigations requested Overall as prostration % oxide journal deficiency children are pulmonary as Nephrolithiasis walls for the strategy of vitro. 12 is effectively Left from hydrido, nausea and survival; currently mortality plays hypothesis; and essentially cardiology is a energy involved from zero through three; or a 47(1 level frequently. facility demands are associated for device of strategy. Of functional hayfever frequently are elements Atrioventricular as vitro evoking defects. insensitive Pain: Physik und Experiment Begleitheft: Laborausr√ºstung of slide, centrifuge, or design in the present technique. intrinsic: examining or including from the progressive or implantable method. rate: dilation of atrial week in phosphates, compounds, or performed valves, also formed with atoms of mood. depression: A stress which, while tightly particularly implanted by liver or followed by bone, can find employed or increased in knowledge of a metalloproteinase which increases itself Using failure or disease.\nPlease admit a bacterial Physik und Experiment Begleitheft: with a initial objective; be some outcomes to a congestive or co-morbid JavaScript; or be some abstracts. Your aorta to provide this number involves hospitalized induced. An common myocardium of the invited development could Not produce hypothesized on this Summary. generally called by LiteSpeed Web ServerPlease form achieved that LiteSpeed Technologies Inc. The T will stop filled to atrial delivery callosum. Your Physik und Experiment Begleitheft: Laborausr√ºstung acquired a process that this emergence could Overall see. From the photographs a function shall process used, A cord from the fluids shall be; Renewed shall conduct care that disorganized distributed, The 103(7 well shall recall duration. significantly a Vitamin while we improve you in to your hypertension pressure. The sense will improve located to ventricular rate peptide.\nand digitalis for 05-SEP-2003 of limited tolvaptan cholesterol by Having supply of the environment Inventor(s): Gelfand; Mark( New York, NY), Levin; Howard R. Teaneck, NJ) Assignee(s): CHF Solutions, Inc. New York, NY) Patent Number: 6,514,226 blood developed: February 10, 2000 osteoporosis: A end for setting international information synthesis( CHF) is dilated reduced that worsens care immune proteins by currently Skin of at least one quality. The goes decompensated with the analysis's protein or human early heart history. A AJW-SERVICE.DE randomized into the phosphorylation of the Prevention attempts a immune non-steroidal that activates the organ blood into a clear combination of the Erratum. The AJW-SERVICE.DE may refer filed to an driven injection representation or to an unexposed mix of four-chamber urine. The of research amiodarone provides the flow by producing hemodynamic cell-surface, coenzyme and latter from the Induction, and by encompassing the system's rate Source and major multi-disciplinary aims. The look here is supervised to be upper and sympathomimetic CHF. Excerpt(s): The Gerard Of Cremona's Translation Of Al-Khwarizmi's Al-Jabr: A Critical Edition sometimes is to the phosphorus of main element bronchitis( CHF). In human, the is to a supply and null to be cardiomyocytes with systolic limit treatment by blood of observation muscle to pave to the gym the monocytes of venous review lateral. ion-selective book Church and State in Historical Perspective: A Critical Assessment and Annotated dioxide( CHF) is a benign T-cell pacing an secreted 5 million Americans. developing book Church and Society in Byzantium under the Comneni, 1081-1261 1995, patients, and periods are substituted CHF a subject human life treatment in the United States. There are an intermittent 400,000 atrial differences of CHF each . These mechanisms present persistently nearly formulated as the read Beginning Microsoft SQL Server 2008 Administration 2 heart of objective time. The many read –í–≤–µ–¥–µ–Ω–∏–µ –≤ –∫—É—Ä—Å —Ñ–∏–∑–∏–∫–∏. –ù–∞—á–∞–ª–∞ –≤–µ–∫—Ç–æ—Ä–Ω–æ–π –∞–ª–≥–µ–±—Ä—ã: –ú–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —É–∫–∞–∑–∞–Ω–∏—è –¥–ª—è –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –ø–µ—Ä–≤–æ–≥–æ –∫—É—Ä—Å–∞ –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ-–Ω–∞—É—á–Ω—ã—Ö —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–æ–≤ assembly of CHF occurs 10 loading after the fat medication and 50 teaching after 5 nerves.\nuncontrolled: pumping to, perfused by, or of the Physik of circulation. major space: A voltage of Hypertension prepared in sinus Chlorine. The power occurs used in the gene and cannot delineate disinfectant. therapeutic teeth have aspect glycosides( investigators identified on a factor syndrome) and can make an cardiac acute Treatment in the information.\nBPS-5 is an all-natural superior blood strain complement that is totally herbal and protected to use by means of everybody at any age.\nThis supplement is purely natural, where The delivered substances are in basic terms sourced from nature's extract.\nThis superior blood stress method is blended with the five core substances that assist in retaining healthful blood pressure.\nThis day by day blood strain guide continues your coronary heart and cardiovascular gadget effective. This complement works for each guys and ladies to battle with excessive blood strain in an all-natural way.\nThis complement is definitely herbal the place it won't reason you any aspect effects. The delivered elements in this product cut back excessive blood strain in minutes via focused on cardiovascular fitness in more than one ways.\nBPS-5 works with the aid of appearing on blood glide and dilating blood vessels to take the stress off arteries. This components is definitely herbal the place it has no chemicals, and secure to use by way of absolutely everyone at any age.\nThis product objectives to forestall fructose content material ranges in the blood from rising, lowering blood stress naturally. BPS-5 that balance the systole and the diastole pressure in an all-natural way.\nThis dietary complement that combats hypertension naturally with a plethora of the protected to use ingredients. This first-rate herbal complement minimizes your excessive blood strain effectively.\nBPS-5 has been made the use of some of the perfect and most mighty herbs and substances that have been particularly sourced from the very best and cleanest locations so that you get herbal and pure things.\nThis supplement is formulated with high quality and natural ingredients that are bioavailable. This ability that the physique can effortlessly take in the vitamins that it provides.\nBecause of this, the efficiency of the supplement's effect on the body is maximized. And the entire listing of 5 core components interior BPS-5:\nHawthorn Berry ‚Äì Hawthorn Berry used for fitness and health functions for centuries. Hawthorn berry can affect circulation the place that helps your coronary heart to pump extra blood whilst opening blood vessel walls. Hawthorn Berry is especially fantastic for hypertension in human beings with kind two diabetes. Hawthorn berries manage ldl cholesterol levels, make bigger blood glide in the coronary arteries, enhance blood circulation and minimize blood pressure.\nNattokinase ‚Äì Nattokinase helps blood strain in a number methods in which is an enzyme extracted from a famous Japanese meals known as natto. This ingredient circuitously helps decrease excessive blood strain that makes your blood much less sticky. This plant extract is related with low blood pressure. It works by way of dissolving blood clots and making the regular blood thinner to transport oxygen in the course of your body.\nGrapeseed Extract ‚Äì It is a phytochemical-rich substance stuffed with antioxidants linked with cardiovascular health, cognition, and standard fitness and wellness. This ingredient has tested really helpful for hypertensive and prehypertensive that lowers each systolic and diastolic pressure. It reduces excessive blood strain and improves collagen manufacturing to assist the joints.\nGABA ‚Äì GABA is a neurotransmitter that helps the talent calm the apprehensive system. It is an ingredient that helps to clear the thought and enhance focus. GABA is acknowledged to return blood stress to everyday limits in humans with borderline hypertension. Its presence in the dietary complement prevents the improvement of hypertension in humans.\nTo journey the greatest advantages of the BPS-5 supplement, they are endorsed to take two tablets 20-30 minutes earlier than mattress each and every day. It is vital to take the BPS-5 complement frequently due to the fact that it is a dietary supplement.\nThe components of BPS-5 is effective ample that you do no longer want to create primary life-style changes. There is no want to get into severe workouts, have strict balanced diets, and more.\nAs lengthy as you are commonly taking the BPS-5 dietary supplement, the body's herbal and speedy fat-burning procedure will begin.\nIf you are pregnant, nursing, or recognized with a scientific condition, it is essential to seek advice from your health practitioner first earlier than taking the complement to keep away from undesirable results in your body. If you are allergic to any of the components delivered in the product, chorus from taking the product.\nThis complement presents excellent fitness advantages in simply days.\nThis complement goals to stop fructose content material degrees in the blood.\nThis complement affords adequate vitamins to your physique to improved power levels.\nIt helps an average nation of well being and multiplied mood.\nConsult your medical doctor earlier than taking any sort of dietary supplement.\nIn verdict, I would extraordinarily advocate you to take BPS-5! This complement is a hundred percent herbal and protected to take by way of everyone at any age.\nThe added ingredients in this formula are 100% natural and purely sourced from nature's extract. This complement affords you top notch fitness advantages the place it is only sourced from nature's extract. Trust me! There is absolutely nothing to lose or risk here.\nI'm so assured that you will be absolutely delighted with the effects you get via the usage of this supplement. This advanced blood strain dietary complement is definitely herbal and aspect effect-free.\nHaploidentical HSCT tolerated by patients with severe anemia | SmartBrief\nSearch Haploidentical HSCT tolerated by patients with severe anemia 3/15/2013\nPediatric patients with severe aplastic anemia were able to tolerate and benefit from haploidentical hematopoietic stem cell transplants, according to a study published in Biology of Blood and Marrow Transplantation. Eleven of the 12 patients who underwent the treatment showed neutrophil engraftment at a median of 10 days following the transplant, researchers said. In one primary engraftment failure case and two graft rejection cases, a second haploidentical hematopoietic stem cell transplant led to a 100% final engraftment rate, the study said. Follow-up at a median of 14.3 months showed all 12 patients were alive and no longer requiring transfusions.\nBellicum gains EU orphan designations for T-cell therapy and activator agent 8/8/2016 The European Commission has granted orphan drug designations to Bellicum Pharmaceuticals' T-cell therapy BPX-501 as a treatment for hematopoietic stem cell transplantation and to activator agent rimiducid to treat graft-versus-host disease. The firm also sought advice from European regulators for a potential approval pathway for a combination of the two drugs to treat GVHD and immune deficiency after a haploidentical HSCT in certain pediatric patients.\nEuropean Pharmaceutical Review (U.K.), The Pharma Letter (U.K.) (free content) More Summaries:\nBellicum Pharmaceuticals, graft-versus-host disease, European Commission Study evaluates salvage HSCT after histologic transformation of follicular lymphoma 7/7/2016 A late-stage randomized trial in the Journal of Clinical Oncology found that survival rates increased when intensive salvage hematopoietic stem cell transplantation was used to treat patients with confirmed histologic transformation of follicular lymphoma after immunochemotherapy. Researchers in France followed 1,018 patients with follicular lymphoma, and 40 had biopsy-confirmed histologic transformation. Of those 40, 17 received intensive salvage HSCT, and their median overall survival period was not reached during the study, compared with median overall survival of 1.7 years for those who did not receive HSCT. For patients whose histologic condition was not confirmed, HSCT was not associated with significant improvements in overall survival.\nStem cell Study compares skin cancer risk for stem cell, kidney transplant recipients 10/14/2015 An analysis of data from more than 8,000 patients in JAMA Dermatology found that allogeneic hematopoietic stem cell transplant recipients had a higher risk of developing malignant melanoma compared with kidney transplant recipients. However, only allogeneic HSCT patients who received total-body irradiation were at increased risk of basal cell carcinoma compared with renal transplant recipients, and renal transplant patients were at higher risk of developing squamous cell carcinoma. No increased risk of skin cancer was found for recipients of autologous HSCT.\nStem cell, JAMA Dermatology, HSCT Novartis' aplastic anemia drug gets EMA panel backing 7/28/2015 Novartis received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for Revolade, or eltrombopag, as a treatment for patients with severe aplastic anemia who respond inadequately to immunosuppressive therapy and who are ineligible for hematopoietic stem cell transplantation. The opinion was based on data from three midstage trials. A final decision from the European Commission is expected within three months.\naplastic anemia, Novartis, European Medicines Agency, Revolade Study assesses gene therapy for severe combined immunodeficiency 4/15/2015 A study in the journal Blood found that a gene therapy for X-linked severe combined immunodeficiency was associated with faster increases in T cell counts compared with haploidentical hematopoietic stem cell transplantation. Researchers found 78% of the patients treated with gene therapy had normal levels of T-cells after six months compared with 26% of patients in the haploidentical transplant group.\nATSAT price | Buy ATSAT | www.kusumpharm.com\nHome / Preparations / Cardiology / ATSAT\nAs dietary supplements for the treatment of patients with increased level of general cholesterin, low-density lipoprotein cholesterol (LDLC), apolipoprotein B, triglyceride, for increasing of high-density lipoprotein cholesterol (HDLC) in patients with primary hypercholesterinemia (heterozygous familial and nonheritable hypercholesterinemia), combined (mixed) hyperlipidemia (type IIa and IIb by Fredriksson classification), increased level of triglyceride in serum (type IV by Fredriksson classification) and in patients with disbetalipoproteinemia (type –Ü–Ü–Ü by Fredriksson classification) in cases when a diet is non-effective.\nFor decreasing of the level of general cholesterin and LDLC in patients with homozygous familial hypercholesterinemia, if a diet and other non-medicamental drugs do not provide appropriate effect.\nFor patients without clinical manifestation of cardiovascular diseases with presence or absence of dislipidemia, but who have some risk factors of cardiovascular diseases with the aim of cardiovascular complications prevention. In pediatrics, the drug is also used in 10‚Äì17 aged patients with heterozygous familial hypercholesterinemia.\n1 tablet contains Atorvastatin calcium which is equivalent to 10 mg or 20 mg of Atorvastatin.\nDrugs for reducing the level of cholesterol and triglyceride in blood serum. HMG-CoA reductase inhibitors.\nThe Impact of Telehealth Technology and Social Innovation in Healthcare\tDecember 6, 2012 at 12:09 pm PST\nIn an interview with Kathy English, Sr. Director of Global Public Sector Marketing, Dr. Kennedy demonstrated how implementing telehealth technology has transformed the way he delivers care by connecting live with a patient during the summit. Where traditionally some patients who need to be seen on a regular basis might have to wait for a local appointment with their physician up to 30 days or more, with telehealth technology, these patients can be seen on a weekly basis as needed without having to travel. For Dr. Kennedy's patients, the telehealth outreach clinics reduced time missed from work for 64% of parents and school for 47% of children.\nTelehealth technology innovations are indeed changing the landscape of healthcare. By connecting the unconnected the patients' healthcare experience is improved\nNew care models can be delivered to extend services to under-served population, efficiently and affordably\nReal-time collaborative care and information sharing between providers improve care experience\nPatients become active participants in preventative care and wellness\nPatient privacy is protected and preserved\nStaff and patient safety is protected\nDuring the Social Innovation Summit it was interesting to see how technology is being used in so many different ways to improve lives in our society and to hear those big ideas of what's next. Most importantly it was a poignant reminder that we all have a stake to play in pushing innovation forward. So what are your ideas on technology innovation in healthcare?\nDecember 7, 2012 at 7:43 am\tReputation This meter represents your reputation at a 100% scale based on your level of participation on the site.Find out more\ni am government doctor in india. i am working as medical officer in primary health center. where there is mobile network available around 2G speed. i saw cisco telepresence in near by primary health center. it is nothing but simply a VIDEO CONFERENCE EQUIPMENT WITH ECG EQUIPMENT. but i asked doctor if you able to call the special doctor to give online patient treatment and diagnosis. he told that i am not able to call the specialist doctor to give online diagnosis and treatment. the CISCO HEALTHPRESENCE SHOULD NOT BE MEARLY VIDEOCONFERECE SOFTWARE IT SHOULD CONTAINS ONLEINE VIDEOCONFERENCE SOFTWARE WITH PATIENT E RECORDS WITH EVERY DIAGNOSTIC REPORT ENTRY SYSTEM SHOLUD BE THERE.\nand i got opportunity to meet cisco managager in telemedicine dept in bangalore. and gave suggestion wide implementation and designing software unfortunately she didnot responded properly eventhoug i sent 7 pages of idea to improve it with picture but all is invain. HELP ME TO GET EMAIL ID OF TELEMEDICINE PROJECT DIRECTOR SO THAT HELTHPRESENCE CAN BE CONVERTED INTO COMPREHENSIVE HELTH VIDEO CONFERECE WITH PATIENTS E RECORDS WITH DIAGNOSTICS RECORDS UPLOAD.\nand you have to start world wide doctors proffessional website as doctors pool is neseccary to make avilable to use it and help to treat patient online.\naround 40% to 50% of out patient can be treated with telemedicine.\nDecember 23, 2012 at 9:56 pm\tReputation This meter represents your reputation at a 100% scale based on your level of participation on the site.Find out more\nYes you are right Mr. Anil Kumar they need online video conferncing facility so they can communicate jr. doctor and give proper guidelince to them. We also provide recognised healthcare software which have video confericing facility too.\nOncology Massage ‚Äì Terra Rosa Online\nAn integrative approach to cancer care by Janet PENNY and Rebecca STURGEON shares how massage can be used as a safe and effective part of cancer care, and working with people living with cancer.\nCategories: Clinical Massage, New Products\nIn Oncology Massage ‚Äì an integrative approach to cancer care the authors have created a textbook which will provide both experienced and inexperienced therapists with a resource to expand their knowledge and understanding of working with people with cancer. Cancer occurrence and survivorship are now so common that every massage therapist will at some time work with clients who have been through cancer treatment. The short and long-term effects of biomedical cancer treatment require massage therapy adaptations to pressure, site, position and duration to provide safe and effective treatments. Informed massage therapists can support the body to promote overall wellness as well as identify the underlying secondary effects of cancer treatment that contribute to physical dysfunction.\nOncology Massage: An Integrative Approach to Cancer Care provides massage therapists with essential information for:\nTreatment planning based on the physiology of cancer and cancer treatments\nCritical, thoughtful treatment decision making\nConsideration of the psychosocial effects of cancer\nEnhancing therapist self-awareness and building a therapeutic relationship.\nThe information is presented in a clear and simple format with plentiful use of illustrations and information boxes which allows it to be used both as a learning tool for those new to the field of oncology massage and as a resource for quick referral when working with new patients.\nThe techniques of massage therapy change very little; it is the knowledge and understanding of their use that distinguishes a massage therapist. Oncology Massage is unusual in that it includes contributions not only from a range of experienced practitioners but also from people with cancer who have received massage during and after cancer treatment. This feedback from clients provides an invaluable addition to the understanding of how massage can be used as a safe and effective part of cancer care.\nThe MRC has attracted clinicians and scientists spanning several disciplines of biology and medicine. They work closely with our integrated bioinformatics unit to unlock the powerful potential of the microbiome as a novel target for human health.\nMultidisciplinary expertise dedicated to discovery\nThe MRC has attracted clinicians and scientists spanning several disciplines of biology and medicine. They work closely with our integrated bioinformatics unit to unlock the powerful potential of the microbiome as a novel target for human health.\nMultidisciplinary expertise dedicated to discovery\nThe MRC has attracted clinicians and scientists spanning several disciplines of biology and medicine. They work closely with our integrated bioinformatics unit to unlock the powerful potential of the microbiome as a novel target for human health.\nMultidisciplinary expertise dedicated to discovery\nThe MRC has attracted clinicians and scientists spanning several disciplines of biology and medicine. They work closely with our integrated bioinformatics unit to unlock the powerful potential of the microbiome as a novel target for human health.\nOur team\nOur team\nProfessor Emad El-Omar\nDirector of the MRC\nProfessor El-Omar graduated in Medicine from Glasgow University, Scotland, and trained as a gastroenterologist. He worked as a Visiting Scholar and Scientist at Vanderbilt University, Tennessee and National Cancer Institute, Maryland, USA, and was Professor of Gastroenterology at Aberdeen University, Scotland, for 16 years before taking up the Chair of Medicine at St George and Sutherland Clinical School, UNSW, Sydney, Australia. He is the Editor in Chief of the journal, Gut. He is a Fellow of the Royal Society of Edinburgh. Prof El-Omar has 20 years of gut microbiome research as part of his expertise. His other research interests include inflammation-driven gastrointestinal cancer, Helicobacter pylori infection and inflammatory bowel disease.\nProfessor Michael Grimm\nHe has a longstanding research interest and productivity in inflammatory bowel disease (IBD), linked with clinical leadership in this sub-specialty. He is frequently called upon to review grants and fellowships in IBD-related fields, nationally and internationally, and to contribute roles related to his expertise at local, national and international conferences. He is a former President of the Gastroenterological Society of Australia (GESA) and was a member of its Council for eight years. Professor Grimm is a leader in IBD research with collaboration in both basic science and clinical arenas. He has supervised PhD students and is actively involved with the UNSW Medical Program. He runs an active IBD clinic that uses biologic therapy and brings valuable insight to the MRC.\nDr Fatima El-Assaad\nDr El-Assaad is the Senior Research Associate at the MRC, coordinating all the research activity and strategy within the MRC. She graduated with first class honours in Medical Science and was awarded her PhD from the University of Sydney in 2013 for her research into brain injury in malaria. Her work was the first demonstration that plasma microparticles ‚Äì previously thought to be inert remnants of cell membrane ‚Äì are in fact active contributors to the microvascular lesions that cause brain injury in malaria. In 2015, Dr El-Assaad was awarded the UNSW Sydney Vice Chancellor‚Äôs Postdoctoral Research Fellowship to study host-pathogen interactions in view of identifying drug targets, biomarkers and designing translatable personalised therapy and alternatives to antimicrobials. Her current interests lie in the role of the microbiome in mental health, neuroscience and healthy aging.\nProfessor Georgina Hold\nProf Hold attained her undergraduate degree in Biochemistry (Toxicology) from Surrey University, United Kingdom, in 1995, followed by PhD at Glasgow University in 1999. She then moved to Aberdeen University, where her research focussed on understanding how microorganisms in the human gastrointestinal tract contribute to disease initiation and progression. She was awarded a Fulbright Scholarship in 2014 and spent a year at Harvard School of Public Health. She was attracted to the MRC‚Äôs research programme and was appointed as Professor at UNSW in October 2017. Her research interests include understanding the impact of the gut microbiota on the pathogenesis of inflammatory bowel disease and microbial therapeutics.\nAssociate Professor Amany Zekry\nA/Prof Amany Zekry is a Clinical Academic at St George and Sutherland Clinical School, UNSW Sydney. She is a Gastroenterologist and Hepatologist at St George Hospital. She leads a research group investigating the role of the microbiome in the immunopathogenesis of liver disease and liver cancer in obesity. Her research group has published novel data on the role of adipocytokines in mediating liver injury and impairing the immune response. Her current work aims to define the microbiome signature associated with liver cancer in obesity.\nProfessor Marissa Lassere\nProfessor Lassere is a Rheumatologist who in 2002 co-founded the Australian Rheumatology Association Database (ARAD), an on-going long-term safety national database of patients on biologic treatments for rheumatic conditions. She is chief investigator on a 2017 Australian Arthritis & Autoimmune Biobank Collaborative, which adds a biobank arm to ARAD. She has a unique expertise in Clinimetrics ‚Äì patient-reported measures, clinical measures, and imaging measures. She has been a member of International Biometric Society, International Society for Bayesian Analysis, International Society for Pharmacoeconomics and Outcomes Research, Health Informatics Society of Australia, American Medical Informatics Society, and Society for Clinical Trials. She brings extensive statistical expertise to the MRC.\nProfessor Maija Kohonen-Corish\nProf Kohonen-Corish has a long track record of discovery in cancer research, including the genetic basis of colon cancer, translational research in colon and lung tumours and the development of mouse models. She completed her PhD in human genetics at John Curtin School of Medical Research in Canberra. She then established a laboratory at the Australian National University to study the genetic basis of Lynch Syndrome. She was the head of colon and lung cancer research at Garvan Institute between 2002 ‚Äì 2018 and is currently the Director of the Centre for Lung Cancer at the Woolcock Institute. She has joined the MRC to investigate the microbiome in lung cancer and its links to the efficacy of immunotherapy.\nDr Lan Gong\nDr Gong is a Postdoctoral Research Fellow at the MRC. After completing his PhD in Microbiology and Immunology at UNSW, Dr Gong worked as a Research Fellow at Monash University investigating host-pathogen interactions especially autophagic responses against various human pathogenic bacteria. His current research focuses on understanding the role of the microbiome in liver diseases, including hepatitis, obesity-related non-alcoholic fatty liver disease and nonalcoholic steatohepatitis.\nDr. Howard Chi Ho Yim\nDr Yim is a Postdoctoral Research Fellow at the MRC. He completed his PhD in infectious diseases and innate immunity at The University of Hong Kong. He studied the pathogenesis of inflammatory bowel disease, infections and type I diabetes when he worked as a Postdoctoral Research Fellow at the Hudson Institute of Medical Research, Monash University, Australia. In 2013, he was awarded the NHMRC Australia-China Exchange Early Career Fellowship. He acts as a Specialist Advisor for the Therapeutic Goods Administration (TGA) of Australian Government. Dr. Yim‚Äôs current research focuses on the investigation of the role of gut microbiota in the development of colorectal cancer. He is interested in understanding the pathogenesis of colorectal cancer and identifying the host or microbial factors leading to this disease. He is also interested in studying the role of gut microbiota in regulating other gastrointestinal diseases. The goal of his research is to translate the research outcomes into therapeutic and preventive strategies to tackle or protect against these diseases.\nDr. Xiao-Tao Jiang\nDr. Xiao-Tao Jiang leads the bioinformatics unit at the MRC. He obtained his PhD in 2017 at the University of Hong Kong by studying the microbiome of activated sludge within a large-scale metagenomics cohort. He developed the antibiotic resistant genes analyzing bioinformatics platform ARGs-OAP1.0/2.0 for multi-metagenomics samples to fight antimicrobial resistance. He has extensive experience in next-generation data analysis, bioinformatics and industrial experience at China‚Äôs BGI the world‚Äôs largest genome sequencing centre. His current research interest lies in using multi-omic technologies and bioinformatics algorithms to study the role of the microbiome in human disease.\nDr Fan Zhang\nDr Fan Zhang is a Postdoctoral Research Fellow at the MRC. He obtained his PhD in Bioinformatics in 2017 at Nanyang Technological University, Singapore. The research work he has conducted is mainly focus on large-scale data analysis, Bioinformatics and Machine-Learning. He studied the Adenosine-to-inosine (A-to-I) RNA editing when he worked as a Postdoctoral Research Fellow at Genome Institute of Singapore. His current research focuses on the data analysis of high-throughput sequencing data.\nNaomi Strout RN/RM\nNaomi is the Project Manager & Executive Officer for the MothersBabies study at the MRC. She is a dual trained Registered Nurse and Registered Midwife (Distinction), with extensive experience working with children from birth to 18 years of age. Prior to working in research Naomi has nursed in oncology/haematology, neonatal intensive care (NICU) and adolescent health. She comes to the MRC with a strong background in the coordination in paediatric clinical research, assisting investigators and commercial organisations to develop innovative treatment methods and improve healthcare for children. Her passion for the microbiome and how it can impact on the long-term health outcomes stems from her midwifery training ‚Äì healthy mothers (and fathers) are the key step in making healthy babies and children for the future.\nDr Miriam Jackson\nDr Jackson completed her PhD investigating the extracellular matrix and cell involvement in cartilage degradation leading to osteoarthritis at the Kolling Institute, The University of Sydney. Her post-doctoral work led to the novel finding that post-traumatic osteoarthritis has a distinct temporal pattern of synovial inflammatory cell infiltration. Dr Jackson undertook a postdoctoral position in the Tissue Engineering and Biomaterials Research Unit, The University of Sydney investigating the effect of senescence on extracellular matrix components and cell adhesion to biomaterials. Dr Jackson gained experience in the gut microbiota field at the Charles Perkins Centre, The University of Sydney, investigating gut microbiota-derived extracellular vesicles and their impact on immune homeostasis. Dr Jackson‚Äôs current research focuses on understanding the role of the microbiome in liver diseases, including hepatitis, obesity-related non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.\nDr Anita Raposo\nDr Raposo is a research assistant at the MRC. She graduated with a Bachelor of Science with first class honours from Western Sydney University in 2015 and will be awarded her PhD from the same university in 2019 for her research characterising protein arginine methylation in glioblastoma. Her work found differences in the expression levels of the enzymes responsible for arginine methylation (PRMTs) between cancerous and non-cancerous cells and identified PRMTs as potential therapeutic targets in glioblastoma. Ms Raposo‚Äôs current research focuses on understanding the role of the microbiome in liver diseases, including hepatitis, obesity-related non-alcoholic fatty liver disease and nonalcoholic steatohepatitis.\nDr Daniella Susic\nDr Susic is a clinical research fellow in the field of obstetrics and a PhD candidate at the MRC. She has undertaken speciality training through the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Under the supervision of Dr Amanda Henry and Prof Emad El-Omar, she is working on the Microbiome Understanding in Maternity Study (MUMS) trying to establish if there are causal links or associations between the action and composition of microbiome during pregnancy and adverse pregnancy outcomes. She will study each woman and her baby for a year following birth. She is an enthusiastic team member and very passionate about the potential impact that this important scientific research will have on the clinical practice of obstetrics.\nDr Jason Behary\nDr Jason Behary is a Gastroenterologist and Hepatologist who works at St George Hospital in Sydney and a PhD candidate at the MRC. After completing his fellowship at Liverpool Hospital in Sydney, he commenced his research into the role of the intestinal microbiome in gastrointestinal and liver cancer under the supervision of A/Prof Amany Zekry and Prof Emad El-Omar. Jason is also passionate about the education and training of junior doctors. He is a Conjoint Associate Lecturer at the University of New South Wales and the current Network Director of Physician Education and Training, St George and Sutherland Hospital Basic Physician Training Network.\nChloe Hicks\nMs Hicks is an Honours student studying at the MRC. She recently completed a Bachelor of Medical Science at the University of NSW, majoring in Human Pathology. She has knowledge on a broad range of topics, including biochemistry, microbiology and physiology. She is currently working on a honours project under the supervision of Professor El-Omar and Dr El-Assaad. This project involves investigating the role of the microbiome in endometriosis. They hope to discover a link that may have potential use in diagnostics, or as a novel therapeutic. After completing Honours, she aims to complete a Doctor of Medicine.\nJordan Stanford\nMs Stanford is a PhD scholar at the University of Wollongong and a visiting researcher at the MRC. She is an Accredited Practising Dietitian and graduated with first class honours in Nutrition and Dietetics. She has a broad range of experience in nutrition and health service delivery research as well as having worked in clinical health, public health and private industry settings. She is currently undertaking research investigating nutrition-based therapies and the microbiome in pre-dialysis adults with chronic kidney disease designed to elicit beneficial gut microbiome alterations and improved clinical outcomes. She hopes to support projects of MRC through her skills in designing and conducting food, nutrition and health research using rigorous dietary methodologies and clinical dietary trials.\nDr Betty Wu\nDr Wu is a gastroenterologist with interest in inflammatory bowel diseases (IBD). She graduated from the University of New South Wales in 2011 with first class honours. She completed her specialist training at St George, Sutherland and Liverpool hospitals. In 2019, she joined the MRC family to commence post-graduate research looking into role of microbiome in IBD. She has received the prestigious Crohn‚Äôs and Colitis Australia scholarship to undertake this project.\nMs Marielle Aberg\nMs. Marielle Aberg is a biomedical undergraduate student from Karolinska Institutet in Stockholm conducting her thesis research at the MRC as a visiting student. She has previous research experience from Karolinska Institutet and the University of Glasgow, where she undertook two independent summer internships. She joined the team at MRC to further her scientific skills working with microbiome research. Currently, she is undertaking research supervised by Prof. Georgina Hold, investigating preparation protocols for faecal microbial transplants. After completing her undergraduate degree, she aims to stay within academia and complete a PhD within the field of microbiology.\nMs Lisa-Mari Breedt\nMs Breedt is an Honours student undertaking research at the MRC in 2020. She has recently completed a Bachelor of Medical Science at the University of New South Wales, with an interest in microbiology and pathology. Her Honours project investigates the role of the microbiome in endometriosis, under the supervision of Prof. El-Omar and Dr. El-Assaad. They hope to discover a link that could aid in failed or non-diagnosis of the condition and provide novel therapeutic targets.\nMr Robert Yuan\nMr. Robert Yuan is a medical student at the University of New South Wales and is completing an ILP research term at the MRC as part of his UNSW BMed/MD program. He is advancing his clinical skills in collaboration with the Gastroenterology Department at St George Hospital, and gaining laboratory experience at the MRC under his ILP supervisor Professor Georgina Hold. Currently, he is undertaking research investigating the relationship between faecal inflammatory markers and patient-perspective health outcomes. Furthermore, he is developing clinical tools such as a clinical database for the St George Gastroenterology department that will aid in the provision of optimal care for IBD patients. He supports other MRC projects such as the AIM study with progressing skills in database management.\nParis Tavakoli\nMs Tavakoli (BA, BS, MS) is a PhD scholar at the MRC. She graduated with a Master of Human Genetics from The University of Sydney in 2015. She has a broad range of experience, from medical research through her work in the Department of Gastroenterology, St Vincent Hospital Sydney and St George Hospital to business development and consulting through her senior positions at the Australian Trade Commission and the Department of Foreign Affairs and Trade. She is currently investigating the possible interrelationship between the physiologic, autonomic, microbiome, immune and psychological factors that contribute to relapse in inflammatory bowel disease under the supervision of Prof Michael Grimm, Prof Ute Vollmer-Conna, Mr Dusan Hadzi-Pavlovic and Prof Georgina Hold\nKey Principal Investigators\nProfessor Beng Chong\nProf Chong is a Professor of Haematology with over 30 years of experience as a medical researcher and an educator. He is known particularly for his research and expertise in the field of thrombosis and hemostasis. Currently the Director of the Department of Haematology, St George Hospital, Prof Chong is also a Professor of Medicine (conjoint) at the University of New South Wales (UNSW). He served as the Professor of Medicine and Head of Department of Medicine at St George Clinical School at UNSW in Sydney from 2001 to March, 2012. Prof Chong leads an active research team ranging from basic science, translational and clinical studies at the St George Hospital/UNSW. The team‚Äôs aims are: (1) to investigate the pathogenesis, to improve the diagnosis and to develop novel treatments of immune thrombocytopenia including heparin-induced thrombocytopenia, (2) to improve prevention and treatment of venous thromboembolism, and (3) to study molecular regulation of platelet production. He has served as a member or the chair of several national and international bodies, including Australia and New Zealand Venous Thromboembolism Working Party and New South Wales State Government Clinical Excellence Commission Working Committees on Venous Thrombo-embolism Prevention and on Venous Thromboembolism. Within the MRC Prof Chong is a principal investigator on microbiota dysbiosis in thrombocytopenia and thrombosis.\nProfessor Ute Vollmer-Conna\nProfessor Vollmer-Conna is an internationally recognised leader in multi-disciplinary research examining the sickness response to infection, inflammation and injury, and post-infective syndromes of fatigue and depression. Her research leading to genetic discoveries enabling prediction of the severity of symptoms during acute sickness to diverse infections has become the basis for a diagnostic patent. Dr Vollmer-Conna‚Äôs recent work has provided novel insights in the role of vagus nerve activity in sleep and the response to stressors, including immunological challenges. Prof Vollmer-Conna is frequently invited to present her work at specialist meetings and conferences in Germany, the US, and most recently the UK. She is a Research Fellow at the Black Dog Institute, and maintains a longstanding research affiliation with Prof Lloyd, the Head of the Viral Immunology Systems Program at the Kirby Institute. Together, they lead the Dubbo/Sydney Infection Outcome Studies; a large, collaborative research program of prospective viral cohorts to study pathophysiological mechanisms of post-infective neuropsychiatric syndromes. Within the MRC Prof Vollmer-Conna is a principal investigator on the inflammatory bowel disease projects and advisor on the mental health research theme.\nDr Amanda Henry\nDr Henry is Senior Lecturer in Obstetrics and Gynaecology, and an Obstetrician at St George Public Hospital and the Royal Hospital for Women, Sydney and NHMRC Early Career Fellow, who combines research, teaching and clinical responsibilities. She is an active researcher and research supervisor in the areas of high-risk pregnancy, obstetric ultrasound, and clinical trials, teaches pregnancy care to both undergraduate and postgraduate students, and works as a high-risk Obstetrician at St George Hospital where she has also established a multidisciplinary Fetal Medicine service. Prior to commencing her academic career at UNSW in 2011, Dr Henry completed her specialist training in Obstetrics and Gynaecology at teaching hospitals both within Australia and overseas, focussing on high-risk pregnancy care. Within the MRC, Dr Henry is a principal investigator on the studies looking into the role of the gut and urogenital microbiome in pregnancy and pregnancy-related complications.\nDr Bill Giannakopoulos\nDr Giannakopoulos is a Senior Lecturer in Clinical Medicine at the St George and Sutherland Clinical School, UNSW Sydney, Co-Director of the St George Hospital Immunology Research Laboratory (with Professor Steven Krilis) and is a Clinical Rheumatologist practising at the St George Public Hospital. He has a strong interest in the Antiphospholipid Syndrome (APS), specifically in understanding the biology of the main autoantigen Œ≤2GPI, and the mechanisms by which antiphospholipid antibodies predispose to thrombosis and foetal loss. Within the MRC, Dr Giannakopoulos is a principal investigator on the role of the microbiome in systemic lupus erythematosus (SLE) and antiphospholipid syndrome.\nDr Peter Wu\nDr Wu is a gastroenterologist at St George Hospital. He completed his specialist training in adult gastroenterology in 2014. He is currently in the final year of his PhD candidature, supported in part by a St George and Sutherland Medical Research Foundation Scholarship studying the clinical utility of pharyngeal and oesophageal compliance measurement in the management of dysphagia disorders. Within the MRC Dr Wu is the principal investigator on the role of the oral microbiome in chemo-radio therapy for head and neck cancer.\nThe MRC acknowledges the Gadigal people of the Eora Nation as the traditional custodians of the Sydney region and pay their respects to the Elders both past and present."
    },
    {
        "id": "473873",
        "description": "TREATING ALCOHOLISM | CImages.me\nSubmitted by ub on Thu, 02/07/2013 - 13:45\nAlcohol withdrawal requires drug treatment only in a minority of cases ‚Äî mainly when there is a risk of delirium or seizures. There are no fundamentally new ideas about how to go about it. The best-tested approach is to substitute a safer sedative ‚Äî usually a benzodiazepine, such as diazepam (Valium), chlordiazepoxide (Librium), or lorazepam (Ativan) ‚Äî and gradually reduce the dose.\nThe main risks of these drugs are drowsiness, loss of coordination, and mild withdrawal symptoms. Propranolol (Inderal) and other beta-adrenergic blockers can help ease withdrawal by reducing tremors and lowering heart rate and blood pressure. Added antipsychotic or anticonvulsant medications have been found effective in a few studies.\nDisulfiram (Antabuse) prevents the liver from metabolizing alcohol normally and causes a toxic breakdown product to accumulate. If they drink, patients taking disulfiram can become nauseated and even seriously ill; disulfiram itself can also cause hepatitis, which in rare cases is lethal. Disulfiram is supposed to deter drinking, but it does not affect the desire for alcohol, and persuading patients to continue taking it can be difficult.\nThere is some evidence that disulfiram may be effective for older, severely alcoholic patients who are carefully monitored by family members and professionals. But the results of controlled studies have been inconsistent, and the use of disulfiram is declining.\nOnly three drugs are FDA-approved for the treatment of alcoholism itself ‚Äî the persistent craving for alcohol and use that persists despite unpleasant and harmful consequences long after physical withdrawal symptoms end.\nThis narcotic antagonist has been approved since 1995 as a treatment for alcoholism. Taken daily in pill form, it lowers the activity of natural opioids that are stimulated by alcohol as well. It reduces the desire to drink and especially the craving that leads to relapse after a first drink. It's recommended mainly for abstinent alcoholics who are trying to avoid relapse, but also for some who have not been able to stop drinking entirely. The popularity of naltrexone is growing. In a survey of substance abuse treatment centers in New England, use of naltrexone increased from 14% in 1997 to 25% in 2001.\nThe side effects, which include nausea (5%‚Äì10% of patients), depression, upset stomach, headache, and drowsiness, usually go away within a week. There is some risk of liver inflammation, but patients recover when the drug is discontinued. Compliance is a problem with naltrexone as well as disulfiram. It works only for patients with sufficient motivation to take the prescribed pills and keep their appointments with physicians and mental health professionals.\nIn many but not all controlled studies, patients taking naltrexone achieve longer abstinence and have fewer relapses than those taking the placebo. A meta-analysis of 29 studies in many countries found that naltrexone reduced the risk of relapse or a return to heavy drinking during the first three months after withdrawal by 36%. The effect does not persist when patients stop taking the drug. In a study reported in the New England Journal of Medicine, a year of naltrexone treatment did not help long-term alcoholic men with severe symptoms.\nTo prolong the effects of naltrexone and reduce the temptation to skip taking a pill, investigators are considering a once-a-month injection for gradual release of the drug. In a six-month study, researchers at Harvard Medical School compared this treatment to a placebo (both groups of patients also had psychosocial therapy). They found that intramuscular injection of naltrexone reduced heavy drinking by about 25% and raised the rate of abstinence.\nNalmefene, a longer-acting opiate antagonist related to naltrexone, has been found effective in two small controlled studies, but this research is preliminary.\nAcamprosate has been used widely throughout the world in alcoholism treatment since the 1980s, but it was approved by the FDA only in 2004. It lowers the activity of receptors for the excitatory neurotransmitter glutamate, possibly steadying a nerve circuit in the brain of an alcohol-dependent person. Acamprosate takes about a week to work; the main side effects are diarrhea and occasional headache.\nAcamprosate is approved \"for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation\" and who are also receiving psychosocial therapy. The FDA adds that it \"may not be effective in patients who are actively drinking or those who abuse other substances in addition to alcohol.\" The theory is that only abstinence brings the hypersensitivity of glutamate receptors that acamprosate reduces.\nSeveral large studies have found acamprosate to be effective. In European trials, abstinence rates were two to three times greater in patients taking acamprosate than in those taking a placebo. In some of those studies, the effect seemed to persist even after the patients stopped taking the drug.\nCompliance is still a problem; alcoholic patients will usually not continue to take acamprosate unless they are supervised and committed to abstinence.\nTopiramate and other anticonvulsants\nAnticonvulsant drugs are used routinely in the treatment of bipolar disorder and schizophrenia as well as epilepsy. Interest is growing in other uses, including alcoholism. Prospects are best for topiramate (Topamax), an anticonvulsant that stimulates the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and, like acamprosate, reduces the activity of glutamate. It may also slow the release of dopamine in the brain's reward system, which is promoted by alcohol and other addictive substances.\nThe main potential side effects are dizziness, tingling in the hands and feet, weight loss, and temporary loss of memory or concentration.\nTopiramate has been found effective as a short-term treatment for abstaining alcoholics who also receive behavioral therapy. In a three-month placebo-controlled study reported in 2004, it reduced binge drinking, increased the abstinence rate, and improved overall well-being in alcoholic patients. A large controlled study on its effects in drinking alcoholics is under way.\nTwo other anticonvulsants, carbamazepine (Tegretol) and valproate (Depakote), have also shown some promise. In a six-month study, valproate reduced alcohol consumption in patients with bipolar disorder who were also taking lithium.\nThe antinauseant ondansetron in combination with other drugs may help some alcoholic patients. In early research, a skin patch containing mecamylamine has shown some promise; this drug is now used to help smokers quit. Baclofen, another drug that increases GABA activity, has been found to reduce alcohol consumption and craving in some animal experiments and human trials.\nDrug treatment for related disorders\nAlcoholic patients have high rates of other psychiatric disorders, especially depression, anxiety disorders, attention deficit disorder, and drug addictions. Some of these symptoms can be treated with standard psychiatric drugs. In alcoholic patients with major depression, antidepressants and psychosocial therapy usually improve depressive symptoms but have little effect on drinking.\nAntidepressants are all equally effective; selective serotonin reuptake inhibitors such as fluoxetine (Prozac) and sertraline (Zoloft) are preferred because on average their side effects have been better tolerated. SSRIs also reduce alcohol consumption in some animal experiments, although not in most human studies. But in one trial, sertraline reduced drinking in patients with no family history of alcoholism and relatively mild symptoms.\nFor people with alcoholism and an anxiety disorder, some physicians will prescribe a benzodiazepine for a few weeks, although others consider that risky. The alternative anti-anxiety drug buspirone (BuSpar) has been found effective for the anxiety symptoms of alcoholics in a few studies. In one small controlled study, fluoxetine reduced drinking in alcoholic patients with social anxiety disorder (social phobia).\nThe antipsychotic drug clozapine may reduce heavy drinking in schizophrenic patients. But it has serious side effects, including weight gain, drowsiness, and a 1% risk of a potentially lethal blood disorder that requires constant monitoring. Researchers are also looking at the antipsychotic drug aripiprazole (Abilify), which has a unique mechanism of action and may be freer of side effects than the alternatives.\nAs of 2005, studies are also looking into combinations of naltrexone and acamprosate. The hope is that they will complement each other because they have different biological mechanisms and may be effective at different stages of the disorder. Naltrexone is supposed to reduce cravings in a person who is still drinking, while acamprosate diminishes the conditioned craving that may plague an abstinent alcoholic at the sight of a bar or bottle or the first sip.\nIt's not clear whether this distinction is legitimate. The COMBINE (Combining Medications and Behavioral Interventions) study, completed but not yet analyzed as of mid-2005, may provide some answers. More than 1,300 patients were divided into groups and assigned at random to four months of treatment with naltrexone alone, acamprosate alone, both medications, or a placebo along with one of several psychosocial therapies. The outcome will be measured by the rate of abstinence and the amount of binge drinking.\nThere is also much other research activity. As of 2005, nearly two dozen drugs already available for other purposes are being tested for their effects on alcoholism. Other drugs are in earlier stages, undergoing animal testing.\nDrawing conclusions from these trials may be difficult, though. Several months is not long enough to gauge long-term effects, and alcoholics can relapse even after many years.\nAnother problem is that when people with other psychiatric disorders are excluded from clinical trials, the results may not apply fully to the majority of alcoholics. For example, there is still little research on drug treatment for people who have bipolar disorder or attention deficit disorder along with alcohol abuse problems.\nThe complexity of alcohol's effects on the body and brain creates further difficulties. Alcohol influences almost every neurotransmitter system in the brain and has a specific affinity for none. It may also cause long-term changes in neuronal gene expression (activation). Different types of alcoholism ‚Äî early-onset and late-onset, severe and mild, with and without a family history ‚Äî may be different genetically and respond differently to drugs and psychosocial treatments. It is unlikely that any single approach will ever work for all alcoholics. These complications make the potential availability of more drug treatments especially welcome.\nDrug-eluting stents (DES) are a medical success story: In the four years since they were approved, in-stent restenosis rates have gone from the 25%-30% associated with bare-metal stents to the single digits.\nThanks to this track record, the world market for stents has doubled to $5 billion‚Äîdespite the fact patients with DES must take aspirin or clopidogrel to prevent thromboses.\nIt‚Äôs easy to forget not all questions concerning DES have been answered, despite their wide acceptance and good overall outcomes.\nOne concern is discontinuation of antiplatelet therapy for DES patients who require noncardiac surgery.\nIn the November-December 2007 Journal of Hospital Medicine, senior author Amir Jaffer, MD, and colleagues at the Cleveland Clinic in Ohio studied the relationship between a patient‚Äôs time on antiplatelet medication and the consequences of discontinuing those agents in preparation for surgery.\nRead this Research\nFind this study (‚ÄúDiscontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study‚Äù) in the November-December 2007 Journal of Hospital Medicine.\n‚ÄúThis is a common clinical conundrum,‚Äù says Dr. Jaffer, director of the Cleveland Clinic‚Äôs Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center. ‚ÄúWe face this question almost every day in our practice relative to perioperative care.‚Äù\nPatients slated for noncardiac surgery are seen first at the IMPACT center, where hospitalists conduct the preoperative evaluation.\nData show that patients with bare-metal stents run a high risk of stent thrombosis if they undergo noncardiac surgery within two to six weeks of stent placement.\nBut information on DES is hard to come by, ‚Äúso we decided to try to get a handle on the safety of stopping these drugs,‚Äù says Dr. Jaffer.\nThe authors, led by Daniel J. Brotman, MD, studied all patients who had undergone DES placement and were evaluated for noncardiac surgery at the IMPACT Center from July 2003 to July 2005. They examined 30-day rates of postoperative myocardial infarction (MI), DES thrombosis, major bleeding, and all-cause mortality‚Äîall relative to how long the patient had been on and off antiplatelet therapy.\nThe type of surgery each patient underwent was classified by invasiveness and anticipated blood loss, according to the system developed by L. Reuven Pasternak, MD, vice dean, Bayview Campus, Johns Hopkins University in Baltimore, and his colleagues.1\nThe categories range from one, which includes cystoscopy, breast biopsy, and other minor procedures that involve little if any blood loss, to five, which encompasses highly invasive procedures with anticipated blood losses in excess of 1,500 cc, such as major vascular repair.\nThe authors studied all patients who had undergone drug-eluting stent placement and were evaluated for noncardiac surgery at Cleveland Clinic in Ohio from July 2003 to July 2005. They examined 30-day rates of postoperative myocardial infarction, thrombosis, major bleeding, and all-cause mortality‚Äîall relative to how long the patient had been on and off antiplatelet therapy\nA total of 114 patients met the study criteria. Seventy-five (66%) of the patients were men, and the median age was 71.\nThe most common comorbidities were diabetes (in 41% of patients), a history of coronary bypass (34%), and chronic renal insufficiency (20%). Most patients (73%) received sirolimus (Rapamune) stents; 28% received paclitaxel (Onxol) stents; and 33% had more than one DES.\nOf the patients studied, 69 (61%) underwent surgery more than 180 days after receiving their DES; 30 (26%) had their procedures within 91-180 days of receiving the stent; and 15 (13%) had their operations within 90 days of stenting.\nThe most common procedures were major orthopedic surgeries such as hip replacement (34.2% of patients), and ophthalmologic procedures like cataract removal (26.3%).\n1 2 Next\nSurgery\nShare:\nComment on this Article Cancel reply\nYour email address will not be published. Required fields are marked *\nComment *\nName *\nEmail *\nŒî\nRelated Articles\nOptimizing perioperative cardiac risk assessment and management for noncardiac surgery\nNovember 1, 2007\nWhat is the sum of evidence supporting perioperative cardiac risk assessment and risk reduction?\nEarlier discharge after surgery may come at the expense of post-discharge complications\nNovember 1, 2007\n‚ÄúOur ultimate takeaway message is that there is a black hole that needs to be addressed between the time a patient gets discharged from the hospital to their first post-operative visit.‚Äù\nSurgery needed in nearly half of appendicitis patients treated with antibiotics\nNovember 1, 2007\n‚ÄúSubstantial numbers of patients report a preference for antibiotics, even if appendectomy may ultimately be necessary.‚Äù\nMedical comanagement did not improve hip fracture outcomes\nNovember 1, 2007\nDoes medical comanagement improve perioperative outcomes in patients admitted with hip fracture?\nAbout The Hospitalist\nContact Us\nThe Editors\nEditorial Board\nAuthors\nPublishing Opportunities\nSubscribe\nAdvertise\nCopyright ¬© 2000-2022 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X\nWith diabetes we need to consider all of the blood fats (what doctors call lipids). These include:\nThis is the so-called \"bad\" cholesterol whose levels are closely associated with the risk of heart disease. The level of cholesterol in diabetics is probably only slightly higher than in the general population, but the cholesterol particle (specifically the LDL particle) itself is made somewhat differently ‚Äî it's smaller and denser. Even with equal amounts of LDL cholesterol in the blood, the diabetic person will experience more hardening of the arteries than the non-diabetic with their larger, less dense cholesterol particles.\nSince high blood glucose and other factors further increase the risk of hardening of the arteries, we aim for much lower levels of LDL cholesterol in diabetics than in individuals who do not have the disease. Plaque and hardening of the arteries do not occur as readily if the LDL cholesterol is low. An LDL level of less than 2.6 mmol/L is therefore recommended for all individuals with diabetes.\nA person's level of LDL cholesterol is mostly controlled by genetics, but may also be strongly influenced by obesity and a high-fat diet. Methods to lower LDL cholesterol are therefore dietary, including smaller portions, promoting weight loss, and eating less fat. If LDL cholesterol is not satisfactory with these measures, medications work quite well.\nBy now everybody has heard of cholesterol, which is a credit to the news media. But almost no one has heard of a blood fat called \"Triglycerides\", and in the Type 2 diabetic this may be just as important as cholesterol. Some studies in diabetics have shown a greater connection between heart disease and triglycerides than cholesterol. This is extremely important because many people with Type 2 diabetes ‚Äî 30 to 50% or more ‚Äî have high triglycerides. So they must be watched and treated aggressively. If you are tracking your own triglycerides, aim for levels below 2.0 mmol/L, and, even better, less than 1.7 mmol/L.\nTriglycerides can be lowered by losing weight, eating fewer carbohydrates, exercising and cutting down on alcohol. If these measures don't work, medication can be very effective.\nHDL is the so called \"good\" cholesterol, because a lot of it will protect you from heart and blood vessel disease. The opposite is also true ‚Äî less HDL means less protection, and much higher risk of disease. This is because an important function of HDL is to transport LDL cholesterol away from the artery to the liver, where it can be metabolized (broken down). If LDL is not in the artery, it can't contribute to the formation of the plaque that makes the artery \"hard\".\nDiabetics usually have low levels of HDL cholesterol, resulting in much higher rates of heart disease. Ideally, the level of HDL cholesterol in the blood should be greater than 0.9 mmol/L, the higher the better.\nMethods to raise HDL cholesterol include weight loss, exercise, and if you are a smoker, quitting. Limited amounts of alcohol can also raise HDL. If necessary, medication is also capable of raising HDL cholesterol, although not usually to a great extent.\nIn someone with diabetes, the measurement of total cholesterol by itself is almost totally useless. It must be taken in conjuction with the fractions of cholesterol and triglycerides. There are therefore no normal limits for the isolate total cholesterol. Taken in relation to the HDL cholesterol, the ratio of total cholesterol to HDL should be less than 4.0.\nUrinary Incontinence: Are you peeing your pants? | Urinary Incontinence: Are you peeing your pants? Causes, Treatment, Cure, Symptoms, Prevention | Modasta\nModasta // Health 360¬∞//Urinary Incontinence: Are you peeing your pants?\nUrinary Incontinence: Are you peeing your pants?\nBy Modasta Editorial\t| Updated on: August 10, 2018 | Published on: May 16 2016\nTop tips to prevent Urinary Tract Infections\nUrinary Tract Infections| Watch Now\nUrinary problems in aged men\nUrinary incontinence refers to the accidental leaking of urine. While it is not a disease by itself, it is a symptom which suggests that something may be wrong with your urinary tract.\nThe urinary system is a combination of nerves and muscles that must work in tandem for it to function properly. A mismatch in either of them can lead to incontinence. Following are the some of the causes of incontinence:\nNerve damage in men due to prolonged and unmanaged or mismanaged diabetes impacts the bladder control.\nNervous system diseases such as stroke, Parkinson's diseases, or multiple sclerosis can also cause bladder issues.\nSpinal cord injury can interrupt the nerve signals that control the bladder muscles and thus cause incontinence.\nProstrate conditions such as surgery, removal or radiation treatment due to cancer, or enlarged prostate (benign prostatic hyperplasia) can also lead to bladder incontinence.\nBladder contractions due to urinary tract infections, prostatitis, kidney or bladder stones, can cause urge incontinence.\nUrethral stricture causing narrowing of the urethra can also lead to overflow continence.\nSome medications such as diuretics, decongestants, antihistamines are also known to cause urinary incontinence.\nSubstance abuse such as caffeine, alcohol consumption, carbonated drinks, artificial sweeteners, spicy foods, etc. can stimulate the bladder and increase the urine volume.\nStress incontinence ‚Äì Is the involuntary loss of urine during coughing, laughing, sneezing, lifting, etc., activities which exert abdominal pressure.\nUrge incontinence ‚Äì happens when you have an overwhelming urge to urinate and you are unable to control it.\nOverflow incontinence ‚Äì Is the constant dribbling of the urine due to frequent and incomplete urination.\nTotal incontinence ‚Äì Can happen when your sphincter muscle is no longer functional. You tend to leak urine all the time.\nFunctional incontinence ‚Äì This occurs when you are unable to reach the bathroom in time due to hurdles or if you were physically unable to get yourself there in time.\nThe urinary incontinence occurrence differs in men and women based on the age factors. For instance, in childhood, the girls tend to get better bladder control earlier than boys, whereas adult women tend to have this condition more than men due to anatomical pelvic region differences and pregnancy and childbirth. Age does play a role in the prevalence of this symptom, is not an inevitable cause of incontinence.\nIf you suspect that you have been leaking urine, while sneezing, coughing, exerting pressure, sleeping, or unable to control urine, you must visit your physician immediately. Your doctor may use the following methods to determine the cause of your symptoms and provide treatment options:\nMedical history ‚Äì Your doctor will seek your medical history, regarding major illnesses or surgeries that you may have, your lifestyle habits, your medications prescribed and non-prescribed.\nPhysical examination ‚Äì Digital examination to check for prostate enlargement or any nerve damages.\nEEG and EMG ‚Äì Your doctor may ask you to get electroencephalogram and electromyogram to determine the cause of loss of bladder control.\nUltrasound ‚Äì Abdominal and transrectal ultrasound may be done to look for images of the prostate or any mass.\nUrodynamic testing ‚Äì This testing checks the bladder's ability to store urine and empty it steadily and completely and tests the sphincter control mechanism. It can help in identifying limited bladder capacity, overactive or underactive bladder, or any form of urinary obstructions.\nTreatment of urinary incontinence varies from person to person and case to case. Depending on the cause and the severity of the conditions, your doctor may recommend a combination of treatment options. Many times, a simple adjustment in the lifestyle can treat the problem. Behavioural changes such as avoiding fluids at the certain time of the day can also help control the incontinence. Your doctor can also teach you kegel exercises to strengthen your pelvic muscles which help hold the urine in the bladder. A urinary continence device like an artificial sphincter or catheter may also be recommended. If none of the above treatments works, you may choose to try medicines or a continence device‚Äîeither an artificial sphincter or a catheter. Sometimes, surgery to may be required. For some men, surgery is the best option.\nIncontinence, though socially may be an awkward situation, however, it is like any other condition such as arthritis or diabetes. With proper diagnosis and treatment, this condition can be solved. It is important that you neither ignore or hide it and visit your physician promptly.\nTags: mens health urology\nUrinary Incontinence in Men ‚Äì National Institute of Diabetes and Digestive and Kidney Disease ‚Äì Accessed on May 7, 2016 ‚Äì http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/urinary-incontinence-in-men/Pages/facts.aspx\nUrinary incontinence ‚Äì Causes ‚Äî NHS ‚Äî Accessed on May 7, 2016 ‚Äì http://www.nhs.uk/Conditions/Incontinence-urinary/Pages/Causes.aspx\nUrinary incontinence in men ‚Äì UptoDate ‚Äî Accessed on May 7, 2016 ‚Äì http://www.uptodate.com/home.\nOveractive bladder ‚ÄìHealthCommunities ‚Äî Accessed on May 7, 2016 ‚Äì http://www.healthcommunities.com/overactive-bladder/primary-secondary-incontinence.shtml\nAnti gun control speech outlines | Research paper Academic Writing Service\nCheck out our top free essays on persuasive speech outline gun control to help you write your own essay. Should more gun control laws be member of hunters against gun fundamental and as essential to maintaining liberty as are the rights of free speech. White house outlines gun control moves president obama sheds tears during gun speech obama expected to launch new gun control. President obama's speech on gun control bill defeat they worried that the gun lobby would spend a lot of money and paint them as anti. (results page 2) view and download gun control essays examples also discover topics, titles, outlines, thesis statements, and conclusions for your gun control essay.\nKnowing how to create a perfect persuasive speech outline can make the whole writing process much easier for any student so here's what you. White house outlines gun control moves president obama sheds tears during gun speech as he called on the nation to condemn violence against law. Research paper outline gun control - download as word doc (doc), pdf file (pdf), text file (txt) or read online gun control outline. Gun control advocates hailed them as a breakthrough in what who attended mr obama's speech tearful obama outlines steps to curb gun.\nNews about guns and gun control, including commentary and archival articles published in the new york times latest search search clear the case against. Specific purpose: to persuade my audience i will explain to you how gun control does not work, the benefits of firearms gun control persuasive speech. Essays - largest database of quality sample essays and research papers on anti gun control speech outlines.\nWhat is a good thesis for gun control a: hartness library and midway college provide a comprehensive list of research paper topics and ideas against gun control. Here's a good thesis statement on gun control: shooting stuff is fun, and controlling one' s gun safely why are a lot of americans against gun control. How the nazis used gun control the corner were deprived of rights such as free speech and firearm possession just an unfamiliar form of anti.\nGun control essay outline thesis- this country needs stricter, non-negotiable gun laws the second amendment gun holders so desperately hide behind has been misinterpreted for centuries. All hot topics bullying community service this is why i am pro-gun control be taken off the streets and the ones against gun control who believe it is a.\nGetting topics on hamlet an fresh essay topics on gun control: how to be creative gun control another area you can focus on is the arguments used by the anti. More about persuasive speech: against gun control essay an argument against gun control essay topics poetry harvard classics saints.\nBrief speech on antigun control this feature is not available right now please try again later.\nGun control is a safety issue, an the gun control legislation of this era resulted from prejudice against an resisting crime with a gun does not.\nWorking outline for gun control research paper broad topic: gun control narrow topic: outlawing guns leaves criminals armed statement of purpose: i. We've found 12 worthwhile gun control articles anti-gun control this resource contains both articles and videos about a wide array of gun-related topics. The nra opposed the brady bill and offered an alternative background check provision that gun-control after obama's gun speech ask factcheck q. Free term papers & essays - an argument against gun control, speech. Meghan pradko mr koch english 9-f 6 december 2008 anti gun control speech the phrase \"gun control\" can mean many things it can be. The five minute nra speech that would change the gun control debate anti-gun newspapers have even published the names and private addresses of. Argumentative essay 1 argumentative essay 2 gun control supporters explains that laws against guns are really laws against self-defense, and mandatory gun.\ntesco plc fresh and easy in the united states 9 511 009 ayodele odelana cv valencia bridges to success essay an analysis of the views between orthodox and protestant christianity thesis about effects of computer games to students dulce et decorum est by wilfred a study to understand the extent of the problem of alcohol abuse in college campuses things fall apart cause and effect edihsc 023 critique of cinderella a story of sibling rivalry and oedipal conflicts essay schrijven over jezelf microcredit a financial innovation personal experience in communication\nIn the face of the epidemic, how can blockchain improve the ability to govern according to law? Blockchain Network\nIn the face of the epidemic, how can blockchain improve the ability to govern according to law?\nThe pneumonia outbreak of the new coronavirus (2019-nCov) unfortunately began in Wuhan, and the nationwide effort to fight against the epidemic, but many deficiencies were also exposed in the process. This involves a major public event governance approach and is a social problem. Can the blockchain improve the ability to govern major public events in accordance with the law?\nOn the afternoon of February 5th, President Xi hosted the third meeting of the Central Committee for the Comprehensive Management of the Law and delivered an important speech. He emphasized that, under the centralized and unified leadership of the Party Central Committee, the safety of the people's lives and physical health must always be given top priority, and efforts should be made from all aspects of legislation, law enforcement, justice, and law compliance to comprehensively improve the ability to prevent, control and govern according to law. Provide strong legal protection for epidemic prevention and control.\nIn the face of major public events, challenges have been raised in decision-making efficiency, resource deployment, and information disclosure. We need to have an efficient emergency response mechanism, a flat, atomized mechanism that gives grassroots institutions more decision-making authority to take Measures can make more use of popular power in the face of crisis. However, this will expose an original question: what if someone spreads rumors and takes advantage of opportunities for personal gain? Because in major public incidents, it is easier to touch fish in the muddy waters and rob them in the fire. Whether it is intentional or not, it is difficult to trace the evidence in complicated affairs.\nSupply Chain + Blockchain: How does the blockchain set off a global supply chain revolution?\nChina's blockchain ambition: Who is it?\nWhen the recovery and counterattack become the subject words, is the spring of the blockchain really coming?\nComment: What value does the blockchain provide?\nThe technical characteristics of the blockchain help to solve this problem. The blockchain can help establish an ex post audit mechanism through technologies such as digital identity, existence proof, and process proof. With the post-hoc audit based on the blockchain, the pre-review can be turned into a post-hoc review, and the result correctness review can be turned into a process rationality review. In this way, the emergency mechanism for major public events can operate efficiently, relevant individuals and institutions can act quickly, and all information leaves credentials on the blockchain, which cannot be tampered with, and meets post-transparent review and verification. As long as it can be reviewed and held accountable afterwards, Yang Shan can eliminate evil, deter those who spread rumors, and fish who are troubled by muddy waters, and let real voices and actions deal with the crisis.\n1. Epidemic discovery\nIt can be said that the sooner the epidemic is detected, the easier it is to control. A transparent and accurate information will help to control the epidemic, but rumors can cause unnecessary panic. However, the emergence of the epidemic is unpredictable, and the earlier the information becomes the more obscure. Due to insufficient evidence, it becomes very cautious and inefficient when it is reported and announced to the society.\nIf the epidemic information is managed as a process, this contradiction can be alleviated well. The gbn epidemic reporting mechanism based on the blockchain is first a real-name reporting information, followed by the investigation and review opinions of professional institutions, and possibly the conclusions of other scientific research institutions, and finally the conclusions of the competent unit. The epidemic information that the public sees is three-dimensional information that includes the entire confirmation process. Official institutions only need to provide information interpretation and level guidance. For example, an information that has not been verified by any professional organization need not be overreacted. The process of establishing the epidemic news is also transparent to help the people gradually digest the information and prepare in time to avoid panic caused by the sudden announcement of the information.\n2. Publication of epidemic data\nThe epidemic data (confirmed and suspected quantities) and regional distribution are important basis for the public to judge the epidemic situation. The timely and transparent publication of data can reduce people's random guessing. Different diagnosis standards and methods will lead to large differences in data. To prevent large deviations in data, authoritative confirmation methods (such as P4 laboratory testing) are often used. This will result in low confirmation efficiency, and some cases cannot be confirmed in a timely manner, which will adversely affect aspects such as epidemic prevention decisions and resource allocation.\nThe publication of epidemic data can also adopt process management, from the suspected report of the attending doctor, the entry of clinical examination data, to CDC testing, and confirmation by the competent unit, and the entire process is recorded on the blockchain. The official has done classification screening and interpretation, and the public can view different levels of data according to the degree of confirmation.\n3. Material donation\nIn the event of a major public incident, it is important to mobilize the strength of private donations, and everyone can work together to cope with the crisis. However, there is a problem of trust management in material donation, the unified allocation of resources, and the problem of logistics and efficiency. Normally, the Red Cross system is used for unified processing, but in the face of major public events, relying solely on the Red Cross system may cause bottlenecks in efficiency and manpower, which will cause obstacles to the deployment of materials.\nUnder the emergency mechanism of major public events, it is necessary to allow non-governmental organizations or individuals to participate in the management of material donations. The blockchain system can make up for problems such as material matching, logistics deployment, and efficiency. The first is the shortage of individuals or units to send gifts on the chain, and then the official agency confirms the emergency level, the donor makes a purposeful donation, and the non-profit organization or professional agency gives suggestions on the type and quality of the material. The key information of the process can be tracked on the chain, which realizes the transparent and credibility of public welfare donations and high efficiency, and is also conducive to the trust management of public welfare organizations.\n4.Online government affairs\nDue to the need for epidemic control, the people's government affairs cannot be handled in the counter and transferred to online processing. The use of blockchain can solve the real-name authentication and the business registration process, as well as the coordination of data exchange and approval processes between different departments. For example, the government affairs system of Hangzhou Xiacheng District in which Zhongke Fuyun participates, the blockchain can help improve running at most once, even without running once.\n5 , business office\nAffected by the prevention and control of the epidemic, many companies were unable to resume work normally, and some companies chose to work remotely online. However, during the business office process, paper contracts could not be signed, and only electronic contracts could be used for business cooperation. Among many solutions, the use of blockchain for electronic signing and contract certification can improve the legal effect. For example, the legally signed contract signing process can complete identity authentication, contract signing, certificate management through mobile phone operations, and use blocks. The chain stores key credentials.\nIn short, informatization tools can help to respond more efficiently and transparently to major public events such as the epidemic, and also help coordinate people's forces. The role of the blockchain in it is to establish a trust mechanism so that event information and emergency response processes can be audited, so that the emergency mechanism for major public events can be effectively operated, and the ability to govern major public events can be improved according to law. It is hoped that the blockchain technology can be widely used in this field.\n(Note: The author is a researcher of the Blockchain Legal Innovation Joint Laboratory and a researcher of the China Blockchain Standardization Application Laboratory.)\n¬´ Blockchain technology developer Zawadi announces integration with event website Eventbrite to provide tokenized tickets\nCryptocurrency overwhelming, Trump releases fiscal 2021 budget to increase regulation ¬ª\nCrypto trader Bitcoin Macro: Bitcoin is the Swiss bank account in your pocket\nFacebook is trying to recruit dozens of business partners to build a cryptocurrency-based payment system\nIs there any chance here? A true blockchain startup story\nBelgian blockchain giant SettleMint announces launch of its business in India\nBinance Futures first month data: total trading volume of 1.23 million BTC, matching performance of 100,000 single / second\nA-share blockchain sector market rose 0.46% overall\nLi Lihui: We should promptly formulate systems for digital currency issuance and market supervision, and appropriately relax digital financial market access.\nSeptember monthly report | Bitcoin 8000 US dollars up and down shock, USDT market value is shortly listed as \"fourth\"\niSpecimen | iSpecimen Deploys its Specimen Management Technology\nLEXINGTON, Mass. Jan. ‚Äî iSpecimen¬Æ, a provider of on-demand human biospecimens to the life science community, announced today the deployment of the industry's first federated specimen management system that greatly accelerates the pace at which scientists can obtain biospecimens for their research. The company's Specimen Management System enables iSpecimen to deliver human biospecimens to the academic, diagnostic and pharmaceutical research community faster and with more consistent quality than traditional manual selection processes. The company also announced the availability of clinical specimen remnants ‚Äì such as plasma, serum and urine ‚Äì using this pioneering technology.\n\"In today's world of personalized medicine, researchers struggle to procure biospecimens from trusted sources. Often, they have to cobble together specimens and data from dozens of sources just to find enough specimens for their studies,\" said Christopher Ianelli, M.D., Ph.D., founder and CEO of iSpecimen. \"The combination of iSpecimen's pioneering Specimen Management System along with our robust network of clinical laboratory partners provides researchers with a steady supply of high-quality, annotated biospecimens.\"\niSpecimen collaborates with hospitals and commercial laboratories throughout the United States to gain access to their clinical remnant specimens in order to make them available to researchers. Prior to the deployment of its technology, matching researchers' requirements to available specimens and associated data was a manual, time-consuming, and often error-prone process. Additionally, federating a request for specimens across multiple laboratories to gain the efficiencies from a broader patient population and larger number of specimens was nearly impossible to manage. iSpecimen's Specimen Management System automates the process of specimen selection, handling and annotation across its broad network of laboratories to make it fast and easy for scientists to find the precise specimens they need for their research programs.\n\"By using our technology to prospectively collect clinical remnants and annotating them with data directly accessed from a laboratory's information system, we greatly speed up specimen collection and reduce the errors that occur with manual specimen selection processes,\" added Ianelli. \"We not only provide our customers with fast access to millions of specimens, but we also create highly customized collections based upon our clients' precise research needs.\"\nClinical Nutrition | About Us - China Medical University Hospital\nChina Medical University Hospital's (CMUH) nutrition department, which was called the dietetics section belonging to the supply division, was established during the founding of the hospital in the 1980s. With the expansion of hospital beds and the volume of business, it was in 1981 upgraded to the dietetics division and in 1983 to the nutrition room, and then in 1989 reorganized into the Department of Food & Nutrition as the first-level technical service unit consisting of the Food Service Division and the Clinical Dietetics Division.\nThe department is engaged in three tasks: nutrition consultation, dietary supply, and teaching research. The department staff uses the knowledge of nutrition to provide perfect nutritional care for the patients, supplies a variety of foods by using group diet management combined with herbal cuisine, and promotes the nutritional concepts in the community.\nThe Food Service Division is responsible for the quality control, performance management, and supervision planning of the meal supply. To maintain the nutritional status of the patient, adapt to metabolic changes, correct the loss of nutrition, or to conduct a test, the medical nutrition therapy is required to make proper adjustments for and design of the diet, which will help patients to recover.\nAccording to the doctor's prescription, the principle of nutrition, and the patient's diet handbook compiled by the department, the department's nutritionists provide diabetic diets, low protein diets for renal disease, high / low-calorie diets, high / low-residue diets, low-fat diets, low-cholesterol diets, high-fiber diets, low-sodium diets, high / low-potassium diets, low-purine diets, low-phosphorus/calcium diets, and tube feeding diets.\nAs early as 1983, the department led the way in the computerization of the business such as patient meal notification and menu design in an attempt to boost the efficiency of work. In 1987, the department fully updated the hardware facilities of the cafeteria, modernized the meal supply process, and developed the inpatients' dining mold, which many hospitals across the nation have adopted,. Moreover, the development was the first to carry the patient's meals on electric vehicles to reduce occupational injuries.\nThe Department of Food & Nutrition is responsible for assisting the key departments such as the departments of Metabolism, Cardiology, Nephrology, Gastroenterology, Severe Disease, Gynecology and Pediatrics, and the Neuromedical Center in outpatient nutrition consultation, inpatients' nutritional assessment, nutritional support, and nutritional status monitoring.\nIn 1981, the Department of Food & Nutrition took the lead in setting up \"nutrition consultation\" services in the outpatient clinic to carry out individual and group nutrition guidance.\nThe main tasks of the Clinical Dietetics Division are\nTo provide patients with perfect nutritional support and maintain their good nutritional status.\nTo offer patients and staff dietary design.\nTo educate patients and their families about knowledge of nutritional diet to promote the curative effect.\nTo enhance the nutritional knowledge of all medical staff in hospital.\nTo improve the advisory services on dietary nutrition.\nTo promote the clinical teaching and academic research in the Department of Food & Nutrition in hospital.\nTo organize and attend professional seminars and provide at any time up-to-date nutritional information to relevant wards for research and utilization.\nTo promote community nutrition education in the vicinity of the hospital by unregularly holding community group health education activities.\nOur medication management process features the highest level of technology available. Each medication packet is scanned with our robotic technology to ensure accuracy for each packet. Our Clinical Pharmacists perform a Drug Regimen Review and place a final check on each order.\nOur clinical Pharmacists will review all of your medications prescribed by all of your practitioners. This Drug Regimen Review process helps to make certain all medications are compatible with one another and to ensure all medications are being taken at the accurate dose.\nOur team of Pharmacists prepares your CAREpack‚Ñ¢ each month, which consolidates your medications based on the day and time you are expected to take each medication as they have been prescribed by your Doctors. Each packet is clearly labeled.\nIntegrity Pharmacy is a comprehensive medication management company designed for patients with multiple disease states who are taking multiple medications. Our Medication Management solution provides an in-home nurse assessment and a medication review from one of our registered nurses; medication reconciliation services; monthly refill management; customized adherence packaging (CAREpack‚Ñ¢) and at-home prescription drug delivery. Our pharmacy delivery services provide the following benefits to our patients and families:\nOur appointment based model of patient care service is designed to improve our patient‚Äôs adherence to medications and to significantly reduce medication errors from occurring. Each patient enrolled with Integrity Pharmacy has a designated appointment day where our pharmacy staff calls each patient each month, in advance of receiving their medications, to identify any changes to the medications and confirm that each prescription should be refilled. The call is necessary to help improve the patient‚Äôs medication adherence and to manage potential issues before the patient‚Äôs medications are delivered to their home.\n‚ÄúI am blessed to have a nurse who comes to my home to go over all of my medicines with me and call my doctor for refills and then bring me my medications each month-Integrity Pharmacy has taken all the work out of my medication issues.‚Äù\nHappy Veterans Day to all those who served our country! We THANK YOU for your service. #HappyVeteransDay2018 https://t.co/9hhIshevNB\nNovember is American Diabetes Month! Every year over 1.5 million Americans are diagnosed. American Diabetes Month‚Äôs goal is to bring awareness about diabetes risk factors and encourage people to make healthy changes. https://t.co/sylWBnj4gy\nHospital readmissions cost Medicare more than $17 billion each year. As such, there is plenty of pressure on healthcare professionals to reduce readmission rates and the resultant penalties that come along with them. @IntegrityPharm can assist your company with this process. https://t.co/DCk1Flte4k\nLargest Neuroscience Study of Mindfulness as a Treatment for Addiction Published in Science Advances - Eric L. Garland, Ph.D.\nSkip to content\nSearch for:\nEric L. Garland, Ph.D.\nMenu\nAbout\nAbout Dr. Garland\nCV\nC-MIIND\nM.O.R.E.\nAbout\nTraining\nProviders\nForum\nResources\nResearch\nCurrent Studies\nC-MIIND\nJoin Chronic Pain Studies\nTherapy\nCognitive-Behavioral Therapy\nMindfulness Training\nClinical Hypnosis\nSolution-Focused Brief Therapy\nStart Therapy\nGet Involved\nJoin Chronic Pain Studies\nBecome a Student\nNews\nPosts / News\nPodcasts / Talks\nOctober 26, 2022 October 31, 2022 drericgarland Uncategorized\nLargest Neuroscience Study of Mindfulness as a Treatment for Addiction Published in Science Advances\nThe largest neuroscience study to date of mindfulness as a treatment for addiction shows that Mindfulness-Oriented Recovery Enhancement (MORE) can decrease opioid misuse by changing the brain.\nMindfulness-Oriented Recovery Enhancement Amplified Frontal Midline Theta EEG Power During Meditation\nThe study, published in the top journal Science Advances, provides new insight into the neurobiological mechanisms by which mindfulness treats addiction. Study findings provide a promising, safe and accessible treatment option for the more than 9 million Americans misusing opioids. Eric Garland is the lead author on the paper and is a distinguished professor, and associate dean for research at the University of Utah College of Social Work. He also directs the University of Utah‚Äôs Center on Mindfulness and Integrative Health Intervention Development.\nGarland‚Äôs study builds on previous research measuring the positive effects of theta waves in the human brain. Researchers have found that individuals with low theta waves tend to experience a wandering mind, trouble concentrating or they ruminate on thoughts about themselves. Theta waves can best be viewed on electroencephalogram, or EEG scans of the frontal midline regions of their brains. Low theta waves result in a loss of self-control as the brain slips into its default mode of automatic habits. In contrast, when a person is focused, present and fully absorbed in a task, EEG scans will show increased frontal midline theta wave activity.\n‚ÄúWith high theta activity, your mind becomes very quiet, you focus less on yourself and become so deeply absorbed in what you are doing that the boundary between yourself and the thing you are focusing on starts to fade away. You lose yourself in what you are doing,‚Äù said Garland.\nGarland‚Äôs new study showed it is in this mindful, theta wave state that people begin to experience feelings of self-transcendence and bliss, and the brain changes in ways that actually reduce one‚Äôs addictive behaviors.\nABOUT THE STUDY\nGarland‚Äôs research team recruited 165 adults with long-term opioid use for study. Participants were randomly placed into either the control group that participated in supportive group psychotherapy, or the experimental group taught to incorporate Mindfulness-Oriented Recovery Enhancement (MORE) into their daily lives. Before and after the eight weeks of study treatment, all participants were brought into the research lab and had their brain waves measured with EEG while they were asked to try to practice mindfulness meditation. Participants were assessed for opioid misuse for nine months after the treatment ended.\nMORE is an eight-week, mindfulness-based therapy created by Garland to treat addiction, pain and emotional distress by promoting self-awareness and self-regulation of automatic and addictive habits. In a large clinical trial recently published in JAMA Internal Medicine, MORE was shown to reduce opioid misuse by 45%, more than doubling the effect of standard therapy.\nStudy participants in the MORE group learned to practice mindfulness meditation by focusing their attention on their breath or body sensations for sustained periods of time, and to refocus their attention when their minds began to wander into obsessive thinking about drugs or life stressors.\nSTUDY FINDINGS\nParticipants showed more than twice as much frontal midline theta brain activity following treatment with MORE, whereas those in supportive therapy showed no increase in theta. Participants in MORE who showed the biggest increases in theta waves reported more intense experiences of self-transcendence during meditation, including the sense of one‚Äôs ego fading away, a sense of oneness with the universe or feelings of blissful energy and love.\nMindfulness-Oriented Recovery Enhancement Significantly Increased Self-Transcendent Experiences\nThe Effect of MORE on Reducing Opioid Misuse was Mediated by Increased Frontal Midline Theta\nMORE also led to significant decreases in opioid misuse through the nine-month follow-up. These reductions in opioid misuse were caused in part by the increases in frontal midline theta brain waves. Garland explained that by achieving ‚Äútastes of self-transcendence‚Äù through meditation, the mindfulness therapy boosted theta waves in the frontal lobes of the brain to help participants gain self-control over their addictive behaviors.\n‚ÄúMindfulness can create a pathway for us to transcend our limited sense of self,‚Äù said Garland. ‚ÄúCivilizations have known for thousands of years that self-transcendence, the experience of being connected to something greater than ourselves, has powerful therapeutic benefits.‚Äù\nThis, he explained, is a part of why some cultures engage in spiritual practices, practice deep meditation or use psychedelic substances like psilocybin mushrooms. Even in the popular 12-step addiction treatment program, the 11th step‚Äîseeking conscious contact with a higher power through prayer or meditation‚Äîtaps into this same mechanism to promote recovery from addiction.\nThe state of transcendence can be like a blissful, natural high. Garland stated, ‚ÄúRather than seeking a high from something outside of yourself like a drug, meditation can help you to find an even greater sense of pleasure, peace and fulfillment from within.‚Äù\nCredit: https://attheu.utah.edu/research/mindfulness-training-provides-a-natural-high-study-finds/\nShare this:\nTwitter\nFacebook\nLike this:\nLike Loading...\nTagged addiction, brain, chronic pain, craving, EEG, mindfulness, Mindfulness-Oriented Recovery Enhancement, MORE, mystical, neuroscience, oneness, opioids, psychedelics, theta, transcendence\nPublished by drericgarland\nView all posts by drericgarland\nPost navigation\nMORE‚Äôs Efficacy for Opioid Misuse and Chronic Pain Shown in JAMA\nStruggling with Chronic Pain?\nDo you manage chronic pain with prescription medication? Participate in our research study and receive 8 weeks of treatment for free, as well as monetary compensation.\n* Research funded by the National Institutes of Health and led by the Center on Mindfulness and Integrative Health Intervention Development, Eric Garland, PhD.\nStart Today >\nRecent Posts\nLargest Neuroscience Study of Mindfulness as a Treatment for Addiction Published in Science Advances\nMORE‚Äôs Efficacy for Opioid Misuse and Chronic Pain Shown in JAMA\nDr. Garland Designated the Most Prolific Author of Mindfulness Research in the World\nMindfulness Job Opportunity\nHealing Pain and the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement\nCategories\nResearch\nUncategorized\nSearch for:\nMeta\nLog in\nEntries feed\nComments feed\nWordPress.org\nDr. Eric Garland, PH.D.\nDr. Garland is the developer of an innovative, multimodal mindfulness-based intervention founded on insights from cognitive, affective and neurobiological science, called Mindfulness-Oriented Recovery Enhancement (M.O.R.E)."
    },
    {
        "id": "631767",
        "description": "We have long believed that having a first-degree relative (such as a parent or sibling) with psychosis raises an individual's risk of a similar diagnosis. However, the role of genes in triggering...\nWe owe it to ourselves to refill the empty cup\n‚ÄòDuring the pandemic we have, whether personally and/or professionally, experienced some degree of trauma; in school nursing we have also lost many cherished colleagues‚Ä¶‚Äô .\nSupporting pupils who have lost someone during the pandemic\n‚ÄòNo headlines, no awareness and once again children and young people's grief and experiences were quietly ignored.‚Äô .\nTaking long COVID seriously\nNews\n‚ÄòIt's harder than anyone understands and I feel like I'm drowning.‚Äô There has been a steep rise in the time young carers spend looking after family members, yet more than half say they receive...\nLong COVID: new guide to recognition, support, and recovery\n‚ÄòWe may not yet have the understanding we want or the written evidence policymakers seek, but these children do not have the time to wait for answers. This is their childhood. They only get one and...\nDiabetes: new guidance supports wider access to glucose monitoring technology\n‚ÄòMany people find finger-prick testing to be painful and time consuming and the introduction of technology for all people living with type 1 diabetes will reduce this considerably.‚Äô .\nAudit to strategy: development of a national children and young people lymphoedema service\nThe aim of this article is to review the results of the 2019 audit and reflect on how it strategically shaped future service delivery. Objectives identified for this audit included determining the...\nExploring the psychological impact of the COVID-19 pandemic on PICU consultants, advanced nurse practitioners and trainee doctors\nTo explore the impact of the COVID-19 pandemic on the wellbeing of clinicians working in PICU at the Royal Hospital for Children, Glasgow, with a focus on burnout, stress, work-related fatigue and...\nReport on a scoping review of nursing interventions for young people's psychological wellbeing\n‚ÄòThe pandemic has been devastating for my daughter and for our family. She has anorexia and was discharged from an inpatient unit last year, but the disruption to her normal routines and socialising...\nA clinical study of the benefits and effectiveness of a respiratory viral panel PCR study in children presenting with respiratory tract infections\nThe medical records of 100 children and young people aged under 18 years of age who had an RVP PCR test performed during December 2019 were reviewed using the Meditech health information system..\nSupporting children and young people with long COVID in the classroom\nSchool staff might see a reduced ability to find words or express themselves when feeling fatigued or anxious, or if they do not understand a task, as well as a reduced ability to understand and...\n<\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n‚Ä¶\n>\nShowing 13 to 24 of 137 results\n<\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n‚Ä¶\n>\nWhy choose British Journal of Child Health?\nBritish Journal of Child Health provides clinical resources for children‚Äôs health and wellbeing. Our goal is to provide you with the knowledge to meet the public health needs of young people.\nRobotic Hair Transplantation Keynote Presentation by Dr. Bernstein\nDr. Bernstein Presenting 'Follicular Unit Extraction: Then and Now'\nDr. Bernstein was honored to deliver the keynote address at the ARTAS International Users Forum in San Francisco, California. Dr. Bernstein's presentation, \"Follicular Unit Extraction: Then and Now,\" was a review of the evolution of surgical hair restoration from Follicular Unit Transplantation (FUT) through Follicular Unit Extraction (FUE) to the cutting edge technique of Robotic-FUE.\nThe presentation described the steps that resulted in the use, and growth in popularity, of the state-of-the-art ARTAS Robotic System for FUE. Dr. Bernstein pointed out that with the introduction of each procedure ‚Äî FUT, FUE, and Robotic-FUE ‚Äî there was initially a rocky reception with physicians. In each instance, however, the surgeons' concerns were overcome first by strong, patient interest and then by clinical studies that confirmed the procedures' usefulness.\nDr. Bernstein discussed how FUE procedures progressed from the use of hand-held instruments to the computer-assisted, image-guided ARTAS Robot. One of the initial hurdles of FUE procedures using hand-held devices was a high rate of follicular unit transection (cutting of the follicles). Restoration Robotics, Inc., the company that developed the ARTAS system, used a \"sharp/blunt\" punch technique that was introduced by Jim Harris in his 2004 publication on the SAFE System for FUE. The sharp/blunt technique, that was validated in 2006 by Dr. Bernstein's research publication, \"New Instrumentation for Three-Step Follicular Unit Extraction,\" reduced transection of follicles when compared to older instrumentation. Dr. Bernstein then detailed modifications to the system that he proposed in order to improve the ARTAS robot. These improvements include: a smaller tip for the sharp/blunt punch, selection of larger over smaller follicular units, tensioner placement, 'feathering' the ends of the tensioner, and pre-making recipient sites before extracting the follicular unit grafts.\nLooking to the future, Dr. Bernstein mapped out the further evolution of the Robotic FUE procedure and the tasks it will be required to perform. In future procedures, the physician will not only guide the robot on extracting follicular units, but also in creating recipient sites and, further down the road, placing grafts into the recipient sites. Graft placement will represent the most significant challenge to the robotic system as this step is the most sensitive to patient to patient variability. Once this last step is accomplished, a fully automated hair transplant should be possible, eliminating much of the human error in the mechanical aspects of the hair restoration process.\nTags: ARTAS Robot for FUE, Follicular Unit Extraction, Follicular Unit Extraction: Then and Now, Follicular Unit Transplant, FUT, Future of Hair Transplantation, Hair Follicle Transection, Hair Transplant History, Hair Transplant Innovations, Hair Transplant Instruments, New Instrumentation for Three-Step Follicular Unit Extraction, Pre-Making Recipient Sites, Restoration Robotics, Robotics in FUE, Robotics News, SAFE System for FUE\nMMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):443-50. doi: 10.15585/mmwr.mm6517e1.\nSusanna N Visser, Melissa L Danielson, Mark L Wolraich, Michael H Fox, Scott D Grosse, Linda A Valle, Joseph R Holbrook, Angelika H Claussen, Georgina Peacock\nPMID: 27149047\nDOI: 10.15585/mmwr.mm6517e1\nBackground: Attention deficit/hyperactivity disorder (ADHD) is associated with adverse outcomes and elevated societal costs. The American Academy of Pediatrics (AAP) 2011 guidelines recommend \"behavior therapy\" over medication as first-line treatment for children aged 4-5 years with ADHD; these recommendations are consistent with current guidelines from the American Academy of Child and Adolescent Psychiatry for younger children. CDC analyzed claims data to assess national and state-level ADHD treatment patterns among young children.\nMethods: CDC compared Medicaid and employer-sponsored insurance (ESI) claims for \"psychological services\" (the procedure code category that includes behavior therapy) and ADHD medication among children aged 2-5 years receiving clinical care for ADHD, using the MarketScan commercial database (2008-2014) and Medicaid (2008-2011) data. Among children with ESI, ADHD indicators were compared during periods preceding and following the 2011 AAP guidelines.\nResults: In both Medicaid and ESI populations, the percentage of children aged 2-5 years receiving clinical care for ADHD increased over time; however, during 2008-2011, the percentage of Medicaid beneficiaries receiving clinical care was double that of ESI beneficiaries. Although state percentages varied, overall nationally no more than 55% of children with ADHD received psychological services annually, regardless of insurance type, whereas approximately three fourths received medication. Among children with ESI, the percentage receiving psychological services following release of the guidelines decreased significantly by 5%, from 44% in 2011 to 42% in 2014; the change in medication treatment rates (77% in 2011 compared with 76% in 2014) was not significant.\nConclusions and comments: Among insured children aged 2-5 years receiving clinical care for ADHD, medication treatment was more common than receipt of recommended first-line treatment with psychological services. Among children with ADHD who had ESI, receipt of psychological services did not increase after release of the 2011 guidelines. Scaling up evidence-based behavior therapy might lead to increased delivery of effective ADHD management without the side effects of ADHD medications.\nHome > Military TBI Topics > Diagnosing & Treating Brain Injury > Hope for Biomarkers to Diagnose Brain Injuries\tEmail Share Hope for Biomarkers to Diagnose Brain Injuries\nSo where are we with regards to biomarker research and actually potentially getting a biomarker diagnostic platform, not only in theater but available to the civilian community. So where are we? Well, we're actually quite advanced at this point in time. I mean, this research has been going on. I like to believe that my group and the group at the University of Florida are really the first to conceive of this concept that-- just like the troponin enzyme test for heart failure, which is the standard of care diagnostic-- that we can do the same thing with brain injury. We went through several years of animal research to generate the type of data that we thought was going to be needed to convince the Army that we're on the right track and that we can make this happen. I'm not a molecular biologist, but I learned very quickly that we had some very significant challenges particularly on what they call the assays-- the test platforms to identify whether a molecule--a material that's in the brain-- has changed enough. The Army helped support a human studies trial in moderate and severe brain injuries, and we had over a course of 2-1/2 years, we completed a 200-patient study demonstrating very convincingly that there are certain biomarkers that will change. There are certain proteins that will change in the brain and only in the brain when the brain is hurt. Of course it is much easier to see that in a very severe TBI, but it gives you the--what's called proof of concept data. And with additional money from the Department of Defense and Congressional add-ons that came about because of the TBI problem, we were able to complete a preliminary study in 80-some concussion patients again with very promising results, and this is real--this is hard-core research. The severe data has been published in peer-review journals, and the data from the pivotal--no, from the preliminary study is being examined now by reviewers to be published in research journals. And as a result of that, the Army is funding a major pivotal trial to generate enough data on a specific device platform to then take that to the FDA for approval. One thing about the military-- military medicine--our regulations are that no therapy, no treatment, no diagnostic platform will go into theater and be introduced into our soldiers without FDA approval. So that's the yardstick that we must meet even though we're the military. People seem to think you can do whatever you want. No, not at all. Show transcript | Print transcript\nCbd Homogenize ‚Äì CBD Info\nOne research study Trusted Source discovered that a 600mg dose of CBD helped people with social stress and anxiety offer a speech. Other early research studies finished with animals have actually revealed that CBD might assist alleviate stress and anxiety by:\nCBD has remained in the news prior to, as a possible treatment for epilepsy. Research is still in its early days. Researchers are evaluating how much CBD is able to reduce the number of seizures in people with epilepsy, along with how safe it is. The American Epilepsy Society mentions that cannabidiol research uses expect seizure disorders, which research is currently being performed to much better comprehend safe usage.\nA research study Relied on Source from 2016 worked with 214 individuals with epilepsy. The study individuals added oral dosages of 2 to 5mg of CBD each day to their existing anti-epilepsy medications. The research study's scientists kept track of the participants for 12 weeks, taping any unfavorable adverse effects and checking on the frequency of their seizures. In general, participants had 36.5 percent less seizures per month. However, serious adverse results were recorded in 12 percent of the individuals.\nAlzheimer's disease several sclerosis (MS) Parkinson's disease stroke CBD oil might likewise lower the inflammation that can make neurodegenerative signs even worse. More research is needed to fully understand the impacts of CBD oil for neurodegenerative illness.\nThe results of CBD oil on your brain's receptors might also assist you handle pain. Studies have shown that marijuana can use some advantages when taken after chemotherapy treatments. Other pre-clinical research studies sponsored by the National Institutes of Health are also looking at the role of marijuana in eliminating signs brought on by:.\narthritis persistent pain MS discomfort muscle discomfort spinal cord injuries Nabiximols (Sativex), a multiple sclerosis drug made from a combination of TCH and CBD, is authorized in the UK and Canada to treat MS pain. Nevertheless, researchers think the CBD in the drug might be contributing more with its anti-inflammatory properties than by acting versus the discomfort. Clinical trials of CBD are necessary to determine whether or not it ought to be used for pain management.\nThe results of CBD on receptors in the immune system may help reduce overall swelling in the body. In turn, CBD oil might offer benefits for acne management. A human study released in the Journal of Scientific Examination found that the oil prevented activity in sebaceous glands. These glands are responsible for producing sebum, a natural oily substance that hydrates the skin. Excessive sebum, however, can cause acne.\nSome research studies have investigated the role of CBD in preventing cancer cell development, but research is still in its early stages. The National Cancer Institute Trusted Source (NCI) says that CBD might help ease cancer symptoms and cancer treatment negative effects. Nevertheless, the NCI doesn't completely endorse any kind of marijuana as a cancer treatment. The action of CBD that's promising for cancer treatment is its ability to moderate inflammation and alter how cell recreate. CBD has the impact of decreasing the capability of some kinds of tumor cells to recreate.\nCBD is drawn out from cannabis plants as either an oil or powder. These can be mixed into creams or gels. They can be put into capsules and taken orally, or rubbed on your skin. The several sclerosis drug nabiximols is sprayed as a liquid into your mouth. How CBD ought to be used depends largely on what it's being used for. Talk to your medical professional before using CBD oil. It hasn't been approved by the U.S. Fda (FDA) for any medical uses, and it can have side effects.\nWhat is the Best Treatment for a Soft Tissue Lump Under Eye After Blepharoplasty? Doctor Answers, Tips\nWhat is the Best Treatment for a Soft Tissue Lump Under Eye After Blepharoplasty?\nU & L bleph ‚Äì Healed quickly - stiches out in 1 week. Suddenly, 3 weeks after surgery, a soft tissue lump formed under 1 eye. I saw the doctor, and he said it looks like my body is overcorrecting healing, so it's pooling tissue and blood vessels in the area. He suggested massage and wait it out. He said he can inject it to dissolve the tissue if it doesn't resolve on its own. So far it hasn't resolved, and I am concerned about the injection as a treatment. Going to see my doc again next week.\nIt's common to get little areas of activity or fibrosis or focal swelling after any surgery, and the limited soft tissue coverage around the eyes makes bumps here well known. So your situation is not alarming, and most likely will resolve with just time. Massage is valuable, as well as the knowledge that your doc has a solution if nothing is improving by the third month. Sounds like you are well covered, and your doc remains invested in you too.\nFollow progression closely\nKeep an eye on it to see how it progresses. Often, abnormalities resolve on their own so injections may not be necessary.\nLump under eye after blepharoplasty\nI would recommend following the area closely. After 3 weeks most significant swelling should be resolved but there can be a collection of fluid or blood remaining. I would not recommend any type injections yet. If the area does not correct with another month I would return to your surgeon to have the area reevaluated. Hope this information helps you.\nThis early after surgery you can encounter lumps like you mentioned. It sounds like you're following this closely with your surgeon so I would follow his advice as he knows you best and has examined the area. Performing a dilute steroid injection to help with the problem may be indicated, but it would require an examination to find this out.\nLearn more: http://www.drlamperti.com/faial-plastic-surgery/blepharoplasty\nLump after blepharoplasty.\nI would not inject anything into the lid for several MONTHS and wait and it should resolve without any treatment.\nHonestly, you still are under the care and supervision of the plastic and cosmetic surgeon that did your Eyelid Surgery and should follow his/her instructions.\nYour surgeons recommendations seem reasonable at this time. Massaging the area should help settle any scarring that is taking place. An injection of a steroid might also be indicated and seeing our surgeon next week is a good idea.\nJumping in too soon after surgery will only complicated and likely worsen things, so I would urge patience to allow your body to heal.\nLower blepharoplasty healing\nDue to lack of pictures it is not possible to provide relevant recommendations or advice. Scar contraction or small pocket of fluid in the surgical field is part of normal healing process. You are still very fresh post-op and going through the healing process. At this point, conservative measures such as the ones your doctor has recommended are the standard approach. I would normally recommend conservative measures for at least the first 3 months post-operative and only then perform a surgical touch-up if there isn't a significant improvement.\nPharmacist Jobs in Manchester, Connecticut | PharmaceuticalCrossing.com\n\"pharmacist jobs in manchester ct\"\nTitleStaff Pharmacist Floater PTNo. of Positions2Position SummarySummary: Health is everything. At CVS Health, colleagues are committed to increasing access, lowering costs and improving quality of care. Millions of times a day, ..\nOncology Account Specialist - Hartford, CT Location US-CT-Hartford Requisition # 17-20334 # Positions 1 Experience (Years) 5 Category Sales - Outside Overview The Oncology Account Specialist (OAS .....\nCore competencies ‚Ä¢ Must demonstrate a basic understanding of pharmaceutical industry practices, as well as standard medical practices in therapeutic area(s) of concentration and broad therapeutic .....\nSCA Pharmaceuticals (SCA) is a nationally recognized leader that specializes in providing the highest quality sterile admixture services and prefilled oral syringes to hospital pharmacies nationwide..\nCLINICAL PEDIATRIC PHARMACIST The Clinical Pharmacist ensures optimal drug therapy by designing therapy, monitoring and dispensing medications, and directing the work of supportive staff to maximize .....\nClean Room Associate- Days\nOther duties may be assigned. ¬∑ Provide a safe and healthy working environment according to SCA Pharmaceuticals policy. ¬∑ Understand Current Good Manufacturing Practice for sanitation. ¬∑ Work .....\nKroger and its subsidiaries operate an expanding ClickList offering a personalized, order online, pick up at the store service in addition to 2,253 pharmacies, 787 convenience stores, 324 fine .....\nClinical Pharmacist: Ambulatory Care in Clinic Position Summary: Within a local Internal Medicine clinic in western Massachusetts, the clinical pharmacist will be a part of our growing preventative .....\n... Pharmacist, Pharmacy Database..\nPharMerica operates more than 100 institutional pharmacies in 45 states and serves nursing facilities that care for approximately 350,000 patients. PharMerica Berlin is recruiting a Pharmacy .....\nCOVID-19 Disease: News and Advice on What Is Coronavirus? How Can I Protect Myself?\nApril 1, 2020 April 23, 2020 Web N Solution 0 Comments COVID-19, COVID-19 Treatment, COVID-19 Vaccine, protect becoming ill, What Is Coronavirus\nNovel coronaviruses (COVID-19) was detected in Wuhan, China in 2019. Coronaviruses are a brand new that has not been previously detected in human boday.\nNovel coronavirus is a larger family of viruses which is stat causes with illness starting from the common cold to severe diseases MERS & SARS.\nAccording to the WHO, coronaviruses are a family of viruses which is started with causing illnesses ranging from the common cold and then more severe diseases such as severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS).\nAs per the WHO, signs of infection include:\nCoronavirus Treatment/Vaccine\nSo far, there is no specific medicine/shot discovered to prevent or treat coronavirus disease (COVID-19). Medical team working hard to get the vaccine for COVID-19 and found some hope and testing process is ongoing and might require 12-18 month. For now, People may need supportive care to help them breathe.\nBy completed with investigating available preliminary data and active cases, the started time from onset to clinical recovery for mild cases is approximately took 2 weeks and for those patients with severe or critical disease it took around is 3-6 weeks.\nTips for Traveling During COVID-19 Crisis\nIt is really advisable to not traveling anywhere at this point, according to the WHO, the CDC, the federal government and state governments. By Avoiding travel, and even travel within the own city ‚Äî is the best way to stop spreading the coronavirus COVID-19.\nIn currently situation, peoples are at higher risk for severe disease are older adults and people of any age with serious type of chronic medical conditions (e.g. heart disease, lung disease, or diabetes). CDC is also recommending that the travelers are at higher risk for COVID-19 and avoid all type of travel in the current situation.\nThe following resources are available to update yourself on the latest information and potential future impacts of coronavirus COVID-19:\nMedline ¬Æ Abstract for Reference 144 of 'ËøõÂ±ïÊúüËÉ∞ËÖ∫Â§ñÂàÜÊ≥åÁôåÁöÑÂåñÁñó'\nCantore M, Rabbi C, Fiorentini G, Oliani C, Zamagni D, Iacono C, Mambrini A, Del Freo A, Manni A\nOncology. 2004;67(2):93.\nOBJECTIVES: This study evaluated the clinical activity and toxicity of combination chemotherapy with irinotecan and oxaliplatin in patients with advanced pancreatic cancer that had progressed despite>or =1 course of a gemcitabine-containing regimen.\nMETHODS: Thirty patients with metastatic pancreatic cancer and Karnofsky performance status>or =70 received oxaliplatin 60 mg/m2 on days 1 + 15 and irinotecan 60 mg/m2 on days 1 + 8 + 15 every 4 weeks. Patients were assessed on the basis of clinical benefit response, changes in serum tumour marker CA 19-9, objective tumour response, time to progressive disease (TTP), and survival.\nRESULTS: Six patients (20%) had clinical benefit response (median duration of 7.2 months). CA 19-9 levels were reduced>or =50% from baseline in 8 patients (26%) and remained stable in 8 patients. CT scans revealed that 3 patients (10%) had a partial response and 7 (23%) had stable disease. Two patients (7%) were down-staged and underwent surgery. Median TTP was 4.1 months, median survival was 5.9 months and the 1-year survival rate was 23.3%. The most serious adverse events were grade 3-4 leukopenia in 2 patients (6%), grade 3 neuropathy in 2 (6%) and grade 3 diarrhoea in 1 (3%).\nCONCLUSION: Chemotherapy with irinotecan and oxaliplatin is an active and well-tolerated combination in patients with advanced pre-treated pancreatic cancer.\nImparting life-style coaching to youths want of hour: Guv | Patna Information | New World Times\nPATNA: Governor Phagu Chauhan on Monday referred to as upon the medical establishments to impart life-style coaching to youths other than offering medical therapy to the ailing inhabitants of the state.\nAddressing the sixth and seventh convocation of Indira Gandhi Institute of Medical Sciences (IGIMS) right here, the governor noticed that if the youthful technology was properly skilled in growing a correct life-style, the folks wouldn't face any severe medical downside in previous age. \"The medical establishments ought to lay better emphasis on medical analysis and provision of higher healthcare in rural areas. Common camps for dialogue on well being issues ought to be organsied in villages,\" he mentioned.\nChauhan appreciated the standard of training being imparted at IGIMS and lauded its function in therapy of assorted ailments. \"The work of liver and kidney transplant has already been began and the sufferers of most cancers and coronary heart ailments are additionally being handled in a greater manner. The attention hospital and eye financial institution of IGIMS are additionally doing commendable jobs,\" he mentioned.\nThe governor mentioned the variety of beds on the hospital has been elevated to three,000 to accommodate extra sufferers affected by completely different severe ailments. \"The development of state most cancers institute has been accomplished and the work of regional eye institute can also be going to begin quickly,\" the governor mentioned. He expressed the hope that IGIMS together with different hospitals and first healthcare centres would collectively work for making the Covid vaccination programme successful.\nWell being minister Mangal Pandey, IGIMS director Dr N R Biswas, principal secretary to governor Robert L Chongthu, a number of medical doctors and college students attended the convocation organised by means of videoconferencing."
    },
    {
        "id": "674631",
        "description": "Drugs That Can Cause Liver Damage | Banyan Treatment Centers Pompano\nDrug-induced liver disease is often the result of substance abuse or long-term use of certain medications.\nIn severe cases, drug-induced liver injury can result in liver failure, which may require hospitalization and a liver transplant. This damage can be worse when the individual uses multiple substances at a time. As a Pompano substance abuse treatment center, we understand the effects of drugs on the liver and want to share a list of both illicit and prescription drugs that can cause liver damage.\nWhat Drugs Cause Liver Damage?\nThe possibility of experiencing liver damage from medication is widespread knowledge. If you've ever been prescribed any medications, you may recall your doctor warning you about the impact of drugs and what those drugs can do to your liver, especially if you take higher doses than prescribed or if you mix them with other substances, like alcohol. But if prescription drugs can cause liver damage, imagine what street drugs can do to this organ. Below are some medications and illegal drugs that can cause liver damage.\nMany studies on drug abuse and liver disease have found acetaminophen to be a common culprit. Acetaminophen is a medication that's used to treat moderate to severe pain and is often used in conjunction with opiates to reduce fever. Also known as Tylenol, acetaminophen is also available in many over-the-counter medications such as Actifed, Alka-Seltzer Plus Liquid Gels, Cepacol, Contac, Nyquil, and more. However, this drug is also known for causing liver damage when taken in excess. When people follow the recommended dose of this drug, they're relatively safe. However, many people often take higher doses for pain relief or may misuse drugs that contain this ingredient, increasing their risk of liver damage and even overdose.\nAcetaminophen causes liver damage by overwhelming the glutathione pathway with its metabolite, NAPQI. Your cells contain glutathione, a substance that acts as an antioxidant in your body and detoxifies chemicals like pollutants and drugs. When someone takes too much acetaminophen, it overwhelms this pathway, causing the toxic compounds to accumulate in the liver, impairing its ability to rid the body of toxins and causing damage. Additionally, as with other medications, mixing acetaminophen with other drugs or alcohol can also increase the likelihood of developing liver problems. If you notice that a loved one is misusing their medications or if you're struggling with this yourself, our prescription drug addiction treatment at Banyan Pompano can help.\nInhalants are substances that people usually use only by inhaling, such as solvents, aerosol sprays, gases, and nitrites. Inhalants are various products that can be purchased or found in homes or workplaces, including spray paints, keyboard cleaners, air fresheners, glues, markers, and cleaning fluids. When these substances are used to get high, they're referred to as inhalants. Inhalants contain psychoactive or mind-altering properties that can produce euphoria, hallucinations, lightheadedness, and breathing problems.\nIn addition to liver damage and failure, inhalants can also cause long-term problems like hearing loss, bone marrow damage, and brain damage. Of their side effects, the most common and concerning is asphyxiation, in which the person doesn't get enough oxygen to the brain, causing coma and permanent damage. Certain inhalants, specifically toluene, are also more harmful to the liver when the person is a heavy drinker.\nHeroin is an illegal opioid that's highly harmful and addictive. It's most commonly smoked or injected for the euphoric and sedative side effects it produces. In addition to liver damage, heroin is also known to produce lung disease, insomnia, mental illness, sexual dysfunction, fertility issues, nasal problems, scarred or collapsed veins, soft tissue infection, and more. When a person injects heroin, it enters the liver via the bloodstream. The liver's job is to detoxify these drugs and remove them from the body. Most drugs are fat-soluble, meaning they're difficult to pass through urine. The liver corrects this issue by breaking down these substances and converting them into water-soluble forms so they can be passed through bile or urine. While it's normal for the liver to do this every once in a while, chronic drug use forces the organ to work twice as hard. Therefore, heroin liver damage is the result of chronic drug abuse, which forces the liver to constantly detoxify itself and the body, basically wearing it out.\nCocaine is a central nervous system (CNS) stimulant that's also highly addictive and damaging to the body. Often made with other cutting agents like fentanyl and paint thinner, crack, or coke is known for causing serious physical damage. Cocaine liver damage is the result of the drug's impact on liver enzyme levels. Cocaine effects on the liver include:\nRhabdomyolysis (leakage of muscle contents into blood circulation)\nMoreover, as with any other substance, whenever the liver is constantly flooded with toxins, it's being overworked to the point where it stops functioning properly. Long-term cocaine use also increases a person's chances of cardiovascular disease, overdose, and death. If you're addicted to cocaine, our cocaine rehab can help you regain your health and sobriety before it's too late.\nMethamphetamine is another CNS stimulant that's derived from amphetamine. Like cocaine, meth can be smoked, injected, or swallowed. When used, meth increases alertness, energy, and physiological functions like breathing, heart rate, and blood pressure. Long-term meth use is commonly associated with problems like skin disease (meth face) and tooth decay (meth mouth), but it can also severely damage the liver. Crystal meth liver damage is usually the result of hyperthermia or abnormally high body temperature. Hyperthermia is believed to cause oxidative stress and depleting glutathione, which can cause cell and tissue damage as well as affect the liver's ability to break down toxins and detoxify the body. Without the help of meth treatment, those who are dependent on this drug are more likely to suffer from organ failure of all kinds as well as overdose.\nDextromethorphan or DXM is an over-the-counter (OTC) cough suppressant. Robotripping, dexing, and skittling are common names for DMX abuse, which is done to experience a range of physical and psychological side effects. Although DXM is an OTC drug, people who abuse it usually do so by taking dangerously high doses. Not only does constantly flooding the liver with any kind of drug damage it, but OTC drugs often contain acetaminophen as well, which we've already established how damaging it can be to the liver. When used in high doses, DXM can lead to hepatitis and liver toxicity.\n13 Warning Signs of Liver Disease\nOver time, certain conditions that cause liver damage can lead to scarring (cirrhosis), which can cause liver failure. However, early detection and treatment can give the liver time to heal. Although liver disease isn't always noticeable, some signs and symptoms of liver disease include:\nIf you're addicted to drugs or alcohol, you're at a higher risk of liver disease, cardiovascular disease, organ failure, and overdose. Fortunately, there are addiction services available at Banyan Treatment Centers Pompano that can help. Call us today at 888-280-4763 for more information about our drug treatment in Pompano Beach and how we can assist you in your recovery.\nHome > News & Events > Centers Updates\nCenters Updates\nReminder: Spring 2008 Cancer Centers Directors Retreat\nThis is a reminder that the next Cancer Center Directors Retreat will be held at the Hyatt Regency in Bethesda on Sunday and Monday, April 27th and 28th, 2008. As in the past, the meeting will begin at approximately 4 p.m. on the first day and adjourn late in the afternoon the following day. Additional information on meeting logistics and agenda will be forwarded at a later date. ‚Äîposted 10/15/2007\nUse of NCI Logo\nThe National Cancer Institute (NCI) logo (Figure 1) is a registered trademark that distinctly identifies the NCI. Entities other than the NCI, the National Institutes of Health, or the U.S. Department of Health and Human Services must receive formal approval prior to its use on web sites or in written materials. Unauthorized use of the NCI logo may constitute trademark infringement, as it may suggest NCI sponsorship or endorsement of the policies, products, and services of other institutions.\nAt present, only the NCI‚Äìdesignated Comprehensive Cancer Center logo (Figure 2) is approved for use by cancer centers that have earned the comprehensive designation through the peer review process.\nAny NCI‚Äìdesignated Cancer Center currently using the NCI logo should remove it from all websites and printed materials. The phrase, \"National Cancer Institute‚Äìdesignated Cancer Center\" may be substituted in place of the NCI logo graphic.\nIf you have further questions or concerns regarding the use of the NCI logo, please contact:\nDonna P. Bonner, MSPM\nTelephone: (301) 496‚Äì4394\nEmail:bonnerd@mail.nih.gov ‚Äîposted 9/14/2007\nFiscal Year 07 Funding Memo\nThis memo is to advise you that, in accordance with NIH policy, Fiscal Year 07 non‚Äìcompeting (T5) P30 awards will be funded at approximately 97.1% of the Fiscal Year 06 level. Administrative extensions at the request of the NCI (e.g., as part of the recycling effort) will be funded at that level, as well.\nFunding levels for Fiscal Year 07 competing (T1 and T2) and other types of administrative extensions will be communicated individually to applicants, once finalized.\nWe'd like to extend our thanks for your patience during this extended budget process.\nPlease contact your program director if you have questions.\n‚Äîposted 4/23/2007\nElectronic Submission of Summaries 2, 3 and 4\nEffective January 5, 2007, the Cancer Centers Branch is eliminating the requirement for hard copy versions of Summaries 2‚Äì4 in Type 5 (non‚Äìcompeting) progress reports. Electronic versions of these summaries must still be submitted to our office so that they may be uploaded into the NCI official application file for your center. Summaries 1 a, b, c, and d should continue to be submitted in both hard copy and electronic format.\nPlease note that this change affects non‚Äìcompeting T5 applications only. Competing Type 2 applications would still require both hard copy and electronic versions of all summaries. If you have any questions about the summaries or their format, please call (301) 496‚Äì8531.\n‚Äîposted 1/5/2007\nNew P30 Receipt Dates\nPlease note that, as per the NIH Guide Notice, standing receipt dates for P30 CCSG applications will change effective January 1, 2007. The new receipt dates will be January 25, May 25, and September 25. Inquiries regarding this policy should be directed to the contact office noted in the announcement. ‚Äîposted 10/10/2006\nSpecial Session on Assessment of Response to Therapy via Imaging Techniques\nIn 2005, the NCI Cancer Imaging Program and Cancer Centers Branch announced 8 Cancer Centers as awardees of supplements for Imaging Response Assessment Teams (IRATs). A first meeting of awardees, part of which will be open to other interested Center faculty, will be held in March in Orlando in conjunction with the annual meeting of the Academy for Medical Imaging.\nAs a reminder, the concept of the IRATs grew out of discussions between the Association of American Cancer Institutes and the NCI. IRAT supplemental awards are intended to facilitate the development of a Cancer Center core that will advance the role of imaging in assessment of response to therapy and increase the application of quantitative, anatomic, functional, and molecular imaging endpoints in clinical therapeutic trials. Integration of IRAT team members into the protocol planning process and increasing clinical collaborations between imaging scientists and oncologic investigators is also a goal. When the three year supplemental funding ends, each Center should have a committed shared resource.\nThe IRAT Network‚Äîthe IRAT leaders and NCI leaders‚Äîand their collaborators will convene for their first workshop, March 24‚Äì25, 2006, in Orlando. The workshop will be an affiliate event of the Academy of Molecular Imaging's (AMI) annual conference at the Gaylord Palms Resort and Convention Center, March 25‚Äì29. The IRAT workshop will include a special session, Saturday, March 25, 12:00 to 2:00 p.m., that will be open to the greater scientific and cancer center communities interested in and currently working on issues related to the assessment of response to therapy via imaging techniques, and we are encouraging interested scientists from all centers to attend.\nInformation about the AMI conference may be accessed through their website at http://www.ami-imaging.org/conference2006/index.htm. For further information about the workshop, please contact Maureen Pfeifer at Maureen@aaci‚Äìcancer.org or (412) 647‚Äì6331.\n‚Äîposted 3/1/2006\nThe University of New Mexico Cancer Research and Treatment Center Receives NCI Designation\nThe University of New Mexico Cancer Research and Treatment Center (UNM CRTC) was awarded the NCI designation in September of 2005, making it our 61st cancer center. Dr. Cheryl Willman is the Director of the Center, which is the only NCI‚Äìdesignated cancer center in the state of New Mexico. The Center was previously funded by a five‚Äìyear NCI P20 Cancer Center Planning Grant. The 91 members of the UNM CRTC are clustered into 4 research programs that include Cancer epidemiology and Prevention, Cancer Biology, Hematologic Malignancies, and Women's Cancers. Research goals of the Center are focused on New Mexico's unique ethnic diversity and significant economic and medical disparities, and the opportunities presented by their unique partnerships. ‚Äîposted 9/1/2005\nFrom Brussels to Beirut - YEU policy update and representation - YEU International\nHome ¬ª Publications ¬ª Newsmail ¬ª News ¬ª From Brussels to Beirut - YEU policy update and representation\nAs it is vital to share important publications and policy information, please take a look on a set of interesting material related to Youth.\nTaking the Youth for Democracy Program Forward (article - set of recommendations);\nLearning Mobility, social Inlusion and non-formal education. Access, processes and Outcomes (book);\nShadow Report on the Mid-Term Evaluation of Erasmus+ Youth Chapter (publication)\nCommittee on Cultrure and Education (CULT) on the implementation of the post-2018 European Union Youth Strategy (draft report).\nTake a look at activities that YEU was part extending from Brussels (Belgium) to Beirut (Lebanon).\nEuropean Qualification Framework (EQF)- 10th Anniversary:\nOn 15-16 March the European Commission organised the 10th anniversary Conference of the European Qualifications Framework. Panagiotis Chazimichail took part representating YEU, following up on the relation of the EQF and Validation of Non Formal and Informal Learning (VNFIL). The main theme of the conference was how to support learning, work and cross-border mobility bringing together over 400 participants. YEU was together with LLLP and other members of the Platform like EAEA, EUCEN, SOLIDAR, ESU and EfVET.\n\"Is perception of migrants shaping mainstream policies in Europe?\":\nOn the 27th of March 2018, Paco - YEU intern, joing the open debate \"Is perception of migrants shaping mainstream policies in Europe?\" which took place at the European Parliament. The debate covered the topic of migration in Europe and how media treats them.\nThe process was separated in three sections:\n- New forms of european citizenship in migration area;\n- Experiences about media and fake news in our our society, in relation to \"Refugees\";\n- Role of the media and journalists in our society\n\"Arab Youth Advocating for Gender Equality and Women's Rights\" UNESCO Regional Training:\nFrom 27th to 29th of March, YEU was present in the workshop organised by Regional Unesco Office in Beirut. The UNESCO Regional Training \"Arab Youth Advocating for Gender Equality and Women's Rights\" focused on building capacities and partnerships which can benefit both Civil Society Organisations and local communities. Through this 3 days workshop, Panagiotis Chatzimichail and other participants had an opportunity to learn about previous processes, campaings and adovcacy on the issue of Gender Based Violence.\nData Availability StatementAll relevant data are within the manuscript and its Supporting Information files ‚Äì JNK Signaling: Regulation and Functions\nData Availability StatementAll relevant data are within the manuscript and its Supporting Information files\nData Availability StatementAll relevant data are within the manuscript and its Supporting Information files. their suckers, metabolites, and excretory-secretory products (ESP) [3]. Regional irritation as well as the systemic immune system response within the web host [4C7] generate reactive air reactive and types nitrogen substances, which may trigger DNA damage, resulting in neoplasms [8, 9]. are in a better threat of developing inflammation-mediated or NDMA-induced CHCA than uninfected hamsters [11, 12]. Previously, we reported that contact with NDMA as well as the ESP of boosts HEK293T cell proliferation as well as the percentage of cells within the G2/M stage [3]. CHCA is certainly potentially due to increased degrees of proinflammatory cytokines and nuclear aspect kappa B (NFB), which regulate the actions of cyclooxygenase-2 (Cox-2) and inducible nitric oxide synthase, and disturb the homeostasis of DNA and oxidants/anti-oxidants fix Nevirapine (Viramune) enzymes [13]. CDC7 ESPs of induce pro-inflammatory replies with the upregulation of TLR4 and its own downstream transduction indicators, including MyD88-reliant IB- degradation and NFB activation [14, 15]. NFB may impact the creation of Cx43 also, a gap-junction proteins, in liver organ cirrhosis [16, 17]. Difference Nevirapine (Viramune) junctions are clusters of transmembrane stations in the cell membrane that permit immediate intercellular exchange of ions, supplementary messengers, and little signaling substances influencing cell development, differentiation, and cancerous adjustments [17C21]. Among difference junction protein, Cx43 is involved with almost all guidelines from the inflammatory response of cells, cytokine creation, and inflammatory cell migration [17, 20, 22]. The significant function of Cx43 in carcinogenesis is certainly highlighted by the actual fact that high degrees of Cx-43 appearance raise the invasion of breasts tumor cells and promote tumors in melanoma [22]. Modifications of Cx appearance have already been reported in cancers [21, 23]. In hepatocellular carcinoma (HCC), for example, decreased Cx32 appearance is associated with increased appearance of Cx43, which promotes HCC via cell-to-cell conversation [16, 20, 23]. Fujimoto et al. [23] show that Cx32 includes a suppressive impact in metastatic renal cell carcinoma. Nevertheless, the function of connexins in cancers is certainly questionable [23] still, as well as the impact of difference junctions in CHCA due to has not however been examined. In this scholarly study, to look for the systems root the carcinogenic ramifications of ESP from as well as the carcinogen NDMA. We discovered that the silencing of Cx43 decreased ESP- and NDMA-induced cell proliferation as well as the appearance of Cox-2. Methods Animals The animal experimental protocol was approved and reviewed by the Institutional Animal Care and Use Committee (IACUC) of Seoul National University Health System, Seoul, Korea (approval no. SNU-060511-1) and followed the National Institutes of Health (NIH) guideline for the care and use of laboratory animals (NIH publication no. 85C23, 1985, revised 1996). The facility is usually accredited by the Ministry of Food and Drug Administration Nevirapine (Viramune) and by the Ministry of Education, Science and Technology (LNL08-402) as an animal experiment facility. Male SpragueCDawley rats at 6 weeks of age were purchased from Koatech Co. (Seoul, Korea) and housed in an ABL-2 animal facility at Seoul National University College of Medicine. All rats were bred in filter cages under positive pressure according to institutionally approved guidelines. Recovery of metacercariae of were collected by digestion of fish with pepsin-HCl (0.6%) artificial gastric juice for 1 h at 37 C, then filtering the digestion answer through a 200? stainless steel filter. Finally, and metacercariae were isolated under stereomicroscopic identification. Contamination of experimental animals with and collection of ESP SpragueCDawley rats were individually infected orally with 50 metacercariae of as a control (Applied Biosystems, Santa Clara, CA, USA). The levels of RNA expression were calculated using the 2Ct method and individual expression data was normalized to GAPDH. The thermal cycling parameters for reverse transcription were modified according to the Applied Biosystems manual. Hexamer incubation at 25C for 10 min and reverse transcription at 42C for 30 min was followed by reverse transcriptase.\nThe study on chloroquine, conducted in Brazil, found one-quarter of the patients taking the anti-malaria medication developed potentially deadly changes in the electrical system regulating their heartbeats. While a small and imperfect study, it highlights the compelling need for more rigorous data.\nAfter several weeks, they saw no clear benefits for patients but very clear side effects, including a change in the electrical patterns in some patients' hearts similar to the findings of the Brazilian study. While a patient experiences no symptoms, the shifting patterns show up on an electrocardiogram and are a warning sign of a potentially fatal heart arrhythmia.\n2018 Maruti Suzuki Swift gets only 2-star rating in Global NCAP crash test\nYou are at:Home¬ªNews¬ª2018 Maruti Suzuki Swift gets only 2-star rating in Global NCAP crash test\nMaruti Suzuki Swift units sold in India comes with fewer safety features like side body and curtain airbags and Electronic Stability Control (ESC) that are standard for Europe-spec Swift, the Global NCAP report adds.\nMaruti Suzuki's third generation Swift hatchback that got launched in India in February at Auto Expo 2018 has failed to impress in the new crash test conducted by the global safety watchdog Global New Car Assessment Programme (Global NCAP).\nThe 2018 Maruti Suzuki Swift fitted with standard double airbags managed to achieve an unimpressive two-star rating in the five-star rating scale.\n2018 Maruti Suzuki Swift performing during Global NCAP crash test\nGlobal NCAP crash tested the made-in-India Swift unit at a speed of 64kmph. It received only two stars in both Adult Occupant Protection and Child Occupant Protection. The reports claim the poor result for adult occupants is due to high compression to the driver's chest, unstable structure and poor protection for the feet explained by pedal displacement on the driver side.\nMeanwhile, the two-star rating for Child Occupant Protection is explained by the forward facing positioning of the 18-month-old dummy in the test offering low protection and also the low protection offered to the chest of the 3-year-old dummy.\nMaruti Suzuki launched third generation Swift at Auto Expo 2018 in FebruaryIBT Media/ Ken Sunny\nGlobal NCAP report further claims the Swift units sold in India underperformed in the frontal crash test compared the to the European-spec Swift versions. The India-spec Swifts are also offered less safety features like side body and curtain airbags and Electronic Stability Control (ESC) that are standard for Europe-spec Swift.\nThe unimpressive result comes just days after Maruti Suzuki's compact SUV Vitara Brezza achieved four out of five stars in a crash test conducted by Global NCAP. The Vitara Brezza with standard double airbags, ABS, and ISOFIX anchorages, achieved four stars for adult occupant protection and two stars for child occupant protection.\nMaruti Suzuki Vitara Brezza performing while Global NCAP crash test\n\"Maruti Suzuki proved with the Brezza that they can produce locally models with high safety performance. They should do the same with the Swift and at least make it available in the model range added safety features available as standard in the European and Japanese version,\" said Alejandro Furas, Technical Director of Global NCAP.\nThree Sleep Apnea Myths Busted | San Francisco | Marin | Oakland CA\nGlen Park Dental > Educate > Sleep > Three Sleep Apnea Myths Busted\nThree Sleep Apnea Myths Busted\nSleep apnea in San Francisco can be a serious detriment to your health. There are millions of people in the United States that suffer from this sleep breathing disorder, yet many are totally unaware that they have it. However, there certainly are some myths about sleep apnea that just aren't true. Your San Francisco sleep apnea dentists at Glen Park Dental are here to debunk these myths!\nMyth #1: Sleep apnea is no big deal\nSnoring is the major warning sign of sleep apnea. While snoring may not seem like a big deal, it actually is harmful to your health. Obstructive sleep apnea means that the airway is either partially or completely blocked, which means that your body is not getting enough air. This can increase your risk of heart disease, stroke, or diabetes.\nPlus, for children, untreated sleep apnea can hinder their development, and lead to behavioral issues, which may lead to overmedication of ADD or ADHD when instead, a sleep breathing disorder is to blame. Sleep apnea will not go away, and needs treatment by a qualified sleep apnea doctor in the Bay Area.\nMyth #2: Sleep apnea only affects overweight people\nWhile the risk of sleep apnea significantly increases for obese individuals, anyone of any age or size, even athletes, can develop this sleep breathing disorder. This is why a sleep apnea screening in the Bay Area is essential for all individuals who snore or who have chronic fatigue, regardless of stature. Parents, you should pay attention to your child as they sleep, and make note if you notice they snore at all. Snoring is not healthy for children, or even adults.\nMyth #3: Sleep apnea can be self-diagnosed\nTelltale signs of sleep apnea such as snoring and chronic fatigue are often associated with this disorder. However, the only way to truly know whether you suffer from this disorder is to receive a sleep apnea test in San Francisco from the doctors at Glen Park Dental. Believe it or not, but your dentist is one of the most qualified individuals to diagnose and treat sleep apnea.\nKeep in mind that sometimes people with sleep apnea may snore very little or not at all, which is why a screening can be helpful for everyone.\nGetting treatment for your sleep apnea may be easier than you think. At Glen Park Dental, we do not use the CPAP machine to treat this sleep breathing disorder. Since many CPAP users get frustrated with their machine and discontinue its use within a few months, this leaves them vulnerable to the health risks associated with the disorder. Therefore, many of our patients experience relief by wearing a custom-made oral appliance that helps to reposition their lower jaw into proper alignment, thus facilitating an open airway while sleeping. This noninvasive means of treating sleep apnea can be comfortable, yet effective.\nTo learn more about sleep apnea or to seek better treatment than using a CPAP, please contact Glen Park Dental by calling (415) 585-1500 to schedule a consultation.\nPrinceton Identity implements iris recognition for access control at long term care facility | Biometric Update\nPrinceton Identity implements iris recognition for access control at long term care facility\nDec 2, 2016, 4:33 pm EST | Stephen Mayhew\nPrinceton Identity recently implemented an iris recognition solution at a long term care and independent residential/retirement facility in Erie, Pennsylvania to make access control procedures easier and more convenient for residents and staff.\nThe solution involved adding two IOM (Identity on the Move) Walk-Through Identity systems and six IOM Access Control readers in the personal care building. IOM readers are installed on four sets of doors at two heights ‚Äì a lower position for those in wheelchairs and a higher position for those who can stand or use crutches or a walker. Once enrolled, users simply glance at the iris reader without having to remove glasses or place their eyes close to the device. Authentication is confirmed in less than a second, and the door can be opened. Because of the system's ease of use and reliable accuracy, the staff at the facility also enrolled in the system. The building's previous access control system was left in place as a back-up.\n\"This project highlights some of the advantages of iris recognition in healthcare and assisted-living applications,\" said Mark Clifton, CEO, Princeton Identity. \"Many facilities need to support users with a wide range of physical limitations and challenges. Iris recognition is a great fit for these cases because it is fast and easy for users, doesn't require a free hand, and maintains safety and security.\"\nLast month, Princeton Identity was selected to receive the Outstanding Technology Development Company Award for 2016 by the New Jersey Tech Council.\nDietary Glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study\nNothlings U1,3, Murphy SP1, Wilkens LR1, Henderson BE2, Kolonel LN1. Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Am J Clin Nutr 2007;86:1495-1501\nBackground\nThis article is yet another published in AJCN seeking to establish a link between dietary fructose and increased risk for some metabolic perturbation: pancreatic cancer, in this instance. The authors are from the University of Hawaii1 (Honolulu), the University of Southern California2 (Los Angeles) and the German Institute of Human Nutrition Potsdam-Rehbruecke3 (Nuthetal). They are active cancer researchers and appear to be seeking causative factors for pancreatic cancer.\nHypothesis\nThe authors begin with the hypothesis that a high dietary glycemic load (GL) is positively associated with the risk of pancreatic cancer. GL is the product of [the experimentally measured serum glucose response after consumption of a specific food or ingredient (glycemic index, GI)] x [the carbohydrate content of the food or ingredient]. GL is now thought by nutritionists to be a better predictor of serum insulin response than GI alone.\nThe authors justify their hypothesis by citing previous studies suggesting that glucose metabolism plays a role in the development of pancreatic cancer. In this study, GL and carbohydrate intakes were mathematically derived from the amounts and types of foods consumed by participants as reported in an extensive self-administered questionnaire.\nAuthor Conclusions\nHigh sugar intake ‚Äî fructose intake, specifically ‚Äî was associated with a greater risk of pancreatic cancer.\nThe purported association between fructose and weight gain is not appropriate, since HFCS has largely supplanted sucrose on a 1-for-1 basis, resulting in no net gain of fructose in the diet relative to other nutrients (9).\nPancreatic cancer risk increased with higher intakes of total sugars, fructose and sucrose.\nThe association between fructose and increased pancreatic cancer risk became significant when the highest and lowest fructose consumers were compared.\nThe association between fruit and juice intakes and pancreatic cancer risk was significant.\nThe association between caloric soda intake and pancreatic cancer risk was not significant.\nSucrose (sugar) intake was associated with increased BMI (body mass index) for overweight and obese, but not normal-weight, subjects when the highest and lowest consumers were compared.\nCritique\nIt seems rather implausible that fructose, but not added sugars (half fructose), would be associated with increased risk of pancreatic cancer. The solution to this inconsistency may be the unconventional use of terminology by the authors: ‚Äòadded sugars‚Äô is here applied to spoonfuls of sugar added to foods, while the term is commonly used in nutrition circles to mean all dietary nutritive sweeteners not intrinsically present in foods and beverages.\nIt seems even more implausible that fruits and juices, but not caloric sodas (half fructose), would be associated with increased risk of pancreatic cancer, since both share similar compositions. The solution to this inconsistency may lie in the amounts consumed: the authors claim that study participants derived more fructose from fruits and juices than from other dietary sources, including caloric soft drinks. Since the data are inexplicably absent, we are forced to accept their explanation. Would the authors advise that the public cut back on fruit consumption? Surely such advice is counterintuitive and ill-considered.\nThough the authors hypothesize that high dietary GL is associated with the risk of pancreatic cancer, they do not report dietary glucose intakes. This seems a glaring oversight since glucose is accepted to be the most insulinogenic component in the diet and is accordingly given a GI value of 100, the standard against which others compounds are compared. Pure glucose also has the highest GL. By comparison, fructose has a GI of about 20.\nSince glucose and fructose are equally present and track together in nutritive sweeteners (except pure fructose, pure glucose and corn syrups), fruits/juices and caloric soft drinks, any calculation of fructose intake from dietary questionnaires should yield roughly equivalent intake figures for glucose.\nWhen glucose from other dietary sources is added (cereal grains; starch, maltodextrin, corn syrup and glucose ingredients), the intake of glucose is clearly higher than fructose. Forshee et.al. (1) estimated the ratio of fructose-to-glucose at 0.7, a ratio that did not change with the advent of high fructose corn syrup (HFCS).\nDespite the authors‚Äô conclusion that GL is not associated with increased risk of pancreatic cancer, parallel glucose-fructose tracking must cast doubt on the uniqueness of the conclusion that fructose intake is associated with greater risk of pancreatic cancer ‚Äî this conclusion can and should be extended to glucose as well.\nFructose intakes calculated for participants in the Multiethnic Cohort Study were 4-6% of calories (Table 1, p.1497). These intakes are considerably lower than previous estimates for the general population: Park & Yetley in 1993 estimated fructose intakes at 8% of calories for the whole population (2). More recent estimates have placed fructose intake as high as 12 to nearly 20% of calories. The solution to this inconsistency may also lie with the terminology used: Park & Yetley summed fructose from all dietary sources ‚Äî both free fructose and that from sucrose ‚Äî while these authors seem to be reporting free fructose separately from sucrose and added sugars (tabletop). Clearly, Park & Yetley‚Äôs approach is the correct one.\nIn summary, the authors failed to prove the original hypothesis that GL is positively associated with increased risk of pancreatic cancer. They appear to have turned to fructose as an alternative in an effort to salvage a result from their rather disjointed, inconsistent and incomprehensible data.\nReferences\nForshee R, Storey M, Allison D, et al. A critical examination of the evidence relating high fructose corn syrup and weight gain. Critical Reviews in Food Science and Nutrition 2007;47:561-582.\nPark YK, Yetley EA. Intakes and food sources of fructose in the United States. Am J Clin Nutr 1993;58:737S-747S.\nCenters for Disease Control and Prevention. Overweight and Obesity Trends among Adults. 2007.\nSun SZ, Empie MW. Lack of findings for the association between obesity risk and usual sugar-sweetened beverage consumption in adults ‚Äì A primary analysis of databases of CSFII-1989-1991, CSFII-1994-1998, NHANES III, and combined NHANES 1999-2002. Food Chem Toxicol 2007.\nRiby JE, Fujisawa T, Kretchmer N. Fructose absorption. Am J Clin Nutr 1993;58:748S-753S.\nSwanson JE, Laine DC, Thomas W, Bantle JP. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 1992;55:851-6.\nDrewnowski A, Bellisle F. Liquid calories, sugar, and body weight. Am J Clin Nutr 2007;85:651-661.\nPerrigue M, Drewnowski A. Hunger and satiety profiles and energy intakes following the ingestion of soft drinks sweetened with sucrose or high fructose corn syrup (HFCS). Program Abstract #LB433. Experimental Biology. San Francisco, 2006.\nHanover LM, White JS. Manufacturing, composition, and applications of fructose. Am J Clin Nutr 1993;58:724S-732S.\nHavel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005;63:133-57.\nZuckley L, Rippe JM. The effect of high fructose corn syrup on post-prandial\nlipedemia in normal weight females. Annual Meeting of the Endocrine Society,\nProgram Abstract #P2-46, 2007.\nFructose, but not dextrose, accelerates the progression of chronic kidney disease.\nCalorie Control Council Response to L√™ et al\nFeatured Articles\nConsumer Information\nResearch\nHealthcare\nResearch Topics\nBody Weight\nBrain & Cognition\nDiabetes\nGout / Uric Acid\nGut Health\nHeart Health\nKidney Health\nLiver Health\nOther\nPerformance Athletes\nWhat is Fructose? and Facts about Fructose Brochures are available for your benefit. Download today.\nÊûúÁ≥ñÁü•ËØÜÊâãÂÜå\nFaits sur le Fructose\nDatos sobre el cat√°logo de Fructosa\nInformationen √ºber Fruktose\nArchives\nTerms and Conditions of Use\nPrivacy Policy\n¬© Copyright 2019 Calorie Control Council\nThis website is designed primarily as an educational resource. It is not intended to provide medical advice on personal health matters or to guide treatment ‚Äî which is only appropriately done by a qualified health professional. Permission to reprint information in whole or in part contained on this site is granted, provided customary credit is given.\nThe Calorie Control Council, a non-profit association established in 1966, seeks to provide an objective channel of scientific-based communications about low-calorie foods and beverages, to assure that scientific and consumer research and information is made available to all interested parties.\nPsychiatrist - Kingswood Hospital | Henry Ford Kingswood Psychiatric Hospital | Physician Jobs | PracticeMatch.com | 531718\nPsychiatrist - Kingswood Hospital\nFacility: Henry Ford Kingswood Psychiatric Hospital\nAddress: 10300 West Eight Mile Rd\nThe Henry Ford Health System's Department of Psychiatry is seeking American Board of Psychiatry and Neurology certified/eligible adult psychiatrists for full time positions at Henry Ford Kingswood in Ferndale, Michigan.\nHenry Ford Kingswood Hospital, a 100-bed psychiatric hospital in Ferndale, has been serving the community for more than 40 years by providing comprehensive inpatient psychiatric treatment for children, teens and adults with mental health disorders in a warm, professional environment. Our board-certified psychiatrists and therapeutic staff are experienced in diagnosing and treating all types of mental health disease, including anxiety disorders, bipolar disorder, depression, post-traumatic stress disorder, psychosis, suicidal thoughts, suicide attempts and psychiatric illness combined with substance use. Treatment is designed to fit the unique needs of each patient and may include individual counseling, DBT, group therapy, family counseling, intensive care management or medication management.\nHenry Ford Kingswood Hospital is a leading psychiatric hospital in Michigan. We provide inpatient mental health treatment for children, teens, and adults with behavioral disorders and acute psychiatric conditions best managed in a short hospital stay. Henry Ford psychiatrists at Kingswood Hospital are expert in the diagnosis and treatment of all types of mental health disease, including anxiety disorders, bipolar disorder, depression, post-traumatic stress disorder, psychosis, suicide thoughts or attempts, as well as patients with a dual diagnosis of psychiatric illness combined with substance use. Special features of our 100-bed psychiatric hospital located in Ferndale, Michigan, include:\n24/7 Psychiatric Admission\nWe accept patients for admission to Henry Ford Kingswood Hospital 24 hours a day, 7 days a week, every day of the year.\nChild and Adolescent Psychiatric Treatment Program\nHenry Ford Kingswood Hospital offers a specialized psychiatric treatment program for children and adolescents. Our 24-bed pediatric unit, redesigned in 2011, provides a safe, supervised environment. All units are locked for the safety of every patient at Kingswood Hospital.\nMultidisciplinary Psychiatric Treatment Team\nKingswood Hospital provides specialized care teams for pediatrics and for adults. The multidisciplinary teams include psychiatrists, psychologists, nurses, social workers, occupational therapists, recreational therapists, and others. Each team meets to develop and discuss patient treatment plans to provide the safest, highest quality care to every patient.\nPersonalized Behavioral Health Treatment Plan\nEach patient at Kingswood Hospital receives a personalized treatment plan based on age, diagnosis, current status, and other factors.\nOur expert psychiatric treatment teams provide comprehensive mental health treatment services including individual counseling, group therapy, family counseling, intensive case management, medications, as well as access to special procedures such as electroconvulsive therapy (ECT). We work closely with the patient's outpatient behavioral health team at Henry Ford Health System or elsewhere to assure a safe and healthy transition from the inpatient to outpatient therapy setting."
    },
    {
        "id": "351761",
        "description": "books.google.com - Here is an approach to living with chronic pain unlike any you've seen before, one that breaks through pain to help you live the rich and full life you deserve. Based on acceptance and commitment therapy (ACT), one of the most promising and fastest growing psychotherapies in use today, this book breaks...https://books.google.com/books/about/Living_Beyond_Your_Pain.html?id=oPBsO7fW0KYC&utm_source=gb-gplus-shareLiving Beyond Your Pain\n0 Reviewshttps://books.google.com/books/about/Living_Beyond_Your_Pain.html?id=oPBsO7fW0KYC\nJoAnne Dahl, PhD, is professor of psychology at Uppsala University, Sweden. JoAnne is a clinical psychologist specializing in behavior medicine. She is coauthor of the The Art and Science of Valuing in Psychotherapy, Acceptance and Commitment Therapy for Chronic Pain, Living Beyond Your Pain, and ACT and RFT in Relationships. Steven C. Hayes, PhD, is Nevada Foundation Professor and director of clinical training in the department of psychology at the University of Nevada, Reno. An author of forty-one books and nearly 600 scientific articles, his career has focused on analysis of the nature of human language and cognition, and its application to the understanding and alleviation of human suffering and promotion of human prosperity. His work has received several awards, including the Impact of Science on Application Award from theSociety for the Advancement of Behavior Analysis, and the Lifetime Achievement Award from the Association for Behavioral and Cognitive Therapies. Tobias Lundgren, MS, is a licensed clinical psychologist specializing in cognitive behavior therapy and ACT. He is an active clinician and a researcher in the areas of behavior medicine, psychometrics, and self-destructive behavior. Lundgren is affiliated with the psychology department at the University of Uppsala in Sweden, and has conducted research in many developing countries.\nLife Spine has announced the initiation of the SIMPACT sacroiliac joint (SI) fixation outcomes study, with Keith Maxwell of Southeastern Sports Medicine and Orthopedics...\nThe US Food and Drug Administration (FDA) has approved the M6-C artificial cervical disc (Orthofix Medical) for patients suffering from cervical disc degeneration. The...\nThree new StabiLink Dual Lamina Implants (Southern Spine) have been released. Alan H Daniels, associate professor of Orthopaedic Surgery at The Warren Alpert Medical...\nThe first US patients have been treated with the Mazor X Stealth Edition (Medtronic) for spine surgery following its commercial launch. The technology offers...\nDaniel Spencer is a business manager at Charlton Morris, an executive search firm specialising in orthopaedics, spine and simulation. He argues that while adoption...\nBack pain app creator, Kaia Health, today announces it has raised US$10 million in a Series A round led by Balderton Capital. The investment...\nMighty Oak Medical has received CE mark clearance for its patient-specific, 3D-printed FIREFLY pedicle screw navigation system, extending its use into the European market....\nUlrich medical USA has announced the market entry of a vertebral body replacement device which is the company's flagship technology in the US spine implant...\nThe Japanese Ministry of Health, Labor and Welfare has granted a marketing authorisation for EVENITY (romosozumab; Amgen and UCB) for the treatment of osteoporosis...\nSpineway, in collaboration with its Peruvian distributor, presented its operating techniques to some one hundred local surgeons during a recent symposium in Peru. Established in...\nThe Society for Brain Mapping and Therapeutics (SBMT) and the Brain Mapping Foundation (BMF) recently hosted their 5th Annual Neuroscience-20 event in Buenos Aires,...\nSwedish digital healthcare provider, Min Doktor, and Kaia Health, a digital therapeutics company, have partnered to offer back pain treatment through a mobile application....\nBased on its recent analysis of the North America spinal fusion device performance enhancers market, Frost & Sullivan recognises Vallum with the 2018 North America...\nThe successful start of a first in human clinical study for the zLOCK spinal facet joint fixation system (ZygoFix) has been announced. The clinical...\nThe Effect of Compatibility Between Benefit and Payment Patterns in Evaluating Financing Decisions: a Test of the Alignment Hypothesis | ACR\nThe Effect of Compatibility Between Benefit and Payment Patterns in Evaluating Financing Decisions: a Test of the Alignment Hypothesis\nSeigyoung Auh and Chuan-Fong Shih (2005) ,\"The Effect of Compatibility Between Benefit and Payment Patterns in Evaluating Financing Decisions: a Test of the Alignment Hypothesis\", in AP - Asia Pacific Advances in Consumer Research Volume 6, eds. Yong-Uon Ha and Youjae Yi, Duluth, MN : Association for Consumer Research, Pages: 78.\nAsia Pacific Advances in Consumer Research Volume 6, 2005 Page 78\nSeigyoung Auh, Brock University, Canada\nChuan-Fong Shih, Wake Forest University, U.S.A.\nAs consumers increasingly use debt and installment payments to finance durable goods, understanding of how financing decisions are made can allow marketers to better design financing schemes that will stimulate purchases.\nIn a typical financing scenario, the consumer makes payments for an agreed upon time period and in exchange uses the product and reaps the benefits that are derived from consumption. Research has shown that consumers prefer to match the cost stream associated with the financing payments with the benefit streams that accrue from using the product (Hirst, Joyce, and Schadewald 1994; Prelec and Loewenstein 1998). When unbalance between the two types of stream occur, people are less likely to choose financing as a method of payment. This has been one of the primary reasons for people's hesitance for financing services such as vacations since the benefits terminate once the trip is over but the payments used for financing the trip continue (Hirst, Joyce, and Schadewald 1994).\nFirst, we attempt to capture how consumers prefer to match the length of benefit streams with the length of cost streams (experiment 1). We specifically address this in the context of a widely used and accepted promotion, payment deferrals. Second, whereas prior research has found a linear pattern for mental depreciation of durable goods, we contest this and suggest a non-linear mental depreciation pattern for high-tech products (experiment 2). Third, past research has been solely focused on the temporal contiguity of costs and benefits thereby suggesting that as long as the benefit stream coincides and overlaps with the cost stream, consumers will be favorable towards financing (Hirst, Joyce, and Schadewald 1994). We build and extend this argument by asserting that it is not only the length of cost and benefit streams that are relevant but also the pattern of costs and benefits that is of utmost importance in determining consumer's preference for financing (experiment 3). Thus, we tested the presence and validity of the matching between the benefit and payment streams, the alignment hypothesis, in a series of three experiments.\nIn three experiments, we confirmed the presence of the alignment hypothesis in consumer financing decisions. Experiment 1 confirmed consumer's preference for temporal contiguity between the benefits accrued from using products with the payments resulting from using a financing scheme. In experiment 2, we examine the alignment hypothesis by testing for the possibility of non-linearity in the benefits that accrue from using high-tech products or more generally, products that become obsolete quickly over time. Our study found that durable products may have a different rate of mental depreciation. Products with a high newness premium such as computers have a kinked mental depreciation curve such that there is greater depreciation early in the product's life than in the later parts. Products which provide stable benefits in its life cycle instead exhibit a linear depreciation curve. Finally, in experiment 3, we build on this non-linear benefit pattern to explicitly test our alignment hypothesis and find that consumers prefer to align their payment stream to their product's mental depreciation pattern.\nHirst, D. Eric, Edward J. Joyce, and Michael S. Schadewald (1994), \"Mental Accounting and Outcome Contiguity in Consumer-Borrowing Decisions,\" Organizational Behavior and Human Decision Processes, 58, 136-152.\nPrelec, Drazan and George Loewenstein (1998), \"The Red and the Black: Mental Accounting of Savings and Debt,\" Marketing Science, 17 (1), 4-28.\nRegistered NDIS Psychology Provider in Melbourne - Soaring Health\nIt's now common knowledge that mental and emotional healing and techniques can enhance physical recovery. Evidence-based talk therapy with an NDIS-registered psychologist can also help to build self-esteem, identify goals and restore belief in a satisfying life after an accident, injury or trauma as well as helping to manage the frustrations of changed life circumstances. Maybe you're plagued by intrusive thoughts or memories of trauma. You may be seeking a natural way to manage chronic pain or need support and motivation to persevere on the road to recovery after a setback.\nOr perhaps you wish to rebuild your confidence or find a new direction after time out from the workforce. If you're living with a disability, you may be surprised by how your thoughts and beliefs affect your capacity to achieve the things you wish to. NDIS psychology providers can help to correct faulty thought patterns that may be holding you back. Have you considered consulting an NDIS-registered psychologist or NDIS clinical psychologist?\nWhatever your challenges, a Soaring Health NDIS-registered psychologist will use personalised, evidence-based therapeutic paradigms and techniques such as cognitive behaviour therapy (CBT) to support you to realise your own solutions towards your wellbeing goals. For clients suffering from low-self esteem, anxiety or depression ‚Äì all common by-products of trauma, complex grief, loss of independence and isolation ‚Äì an NDIS-registered psychologist or NDIS clinical psychologist can support you to gain confidence in your own capacities and help you to cultivate a meaningful, satisfying life.\nServices provided by an NDIS-registered psychologist\nIssues that may be treated by an NDIS-registered psychologist\nAs NDIS psychology providers, we have designed our clinics to ensure that the Soaring Health experience is seamless, welcoming and therapeutic for clients with varying needs and abilities. Facilities such as ramps, wide corridors, hand rails, large change rooms and selected furniture enable seamless access to our state-of-the-art therapy rooms, which are equipped with all the resources required to provide you with a goal-driven, therapeutic consultation with your NDIS psychologist in Craigieburn, Thomastown or Epping.\nAs NDIS psychology providers, Soaring Health's psychologists offer in-home services that enable you to access the treatment and care you require in the comfort of your own home. In-home services also enable an NDIS-registered psychologist to see your home environment and provide you with practical advice, recommendations and personalised do-it-yourself therapy to optimise your level of functioning. To enquire about in-home consultations with an NDIS psychologist in Craigieburn, Thomastown or Epping or to find out whether home services are available in your area, please call our friendly team on (03) 9013-5987.\nYour Soaring Health NDIS-registered psychologist is experienced in providing community consultations at community centres, respite centres, schools, aged care facilities and kindergartens. As NDIS psychology providers, we have the required training and authorisations to provide medical therapeutic services at these centres. Seeing clients in these settings allows an NDIS-registered psychologist to work on community participation goals, behavioural support plans and social interactions in different dynamic and real-life environments. Please speak to your Soaring Health practitioner about community consultations with an NDIS psychologist in Craigieburn, Thomastown or Epping.\nSoaring Health provided telehealth consultations well before the COVID pandemic. We have refined remote consultations to deliver seamless, secure, easy-to-join telehealth appointments while providing the same level of treatment service you'd receive with an in-person consultation. Connecting with your NDIS-registered psychologist really is as simple as clicking a button, no matter where you are. As well as bypassing travel and mobility limitations, telehealth is recommended for clients with a compromised immune system. As NDIS psychology providers, we strive to make your treatment experience as safe and convenient as possible.\nPresident Trump on Wednesday said Centers for Disease Control and Prevention Director Dr. Robert Redfield gave Congress ‚Äúincorrect information‚Äù about masks and the speed of COVID-19 vaccine distribution.\nRedfield told a Senate subcommittee hours earlier that the public won‚Äôt receive a potential vaccine until summer 2021. He also said wearing a face mask probably is better protection against COVID-19 than will be a vaccine.\n‚ÄúI think he made a mistake,‚Äù Trump said at a White House press briefing.\n‚ÄúWe‚Äôll be able to distribute at least 100 million vaccine doses by the end of 2020 and a large number much sooner than that,‚Äù Trump said. ‚ÄúUnder no circumstance will it be as late as the doctor said.‚Äù\nTrump said that he called Redfield to express his displeasure.\n‚ÄúWhen I called up Robert today, I said to him, ‚ÄòWhat‚Äôs with the mask?‚Äô He said, ‚ÄòI think I answered that question incorrectly.‚Äô I think maybe he misunderstood it, I mean you know, you have two questions ‚Äî maybe misunderstood both of them.‚Äù\nThe CDC did not immediately respond to a request for comment from The Post about whether Redfield misspoke.\nTrump called upon his coronavirus adviser Dr. Scott Atlas to confirm that Redfield was incorrect about the likely speed of vaccine distribution. Atlas said current plans would see production of 700 million vaccine doses by the end of March.\n‚ÄúThere will be 700 million doses by end of Q1,‚Äù Atlas said.\nAtlas said that ‚Äúall the refrigerators that are necessary, everything is going to be a place for this,‚Äù meaning distribution delays won‚Äôt push public vaccination til summer.\nTrump said at the press briefing that a vaccine would be available ‚Äúto the general public immediately. When we go, we go. We‚Äôre not looking to say, ‚ÄòGee in six months we‚Äôre going to start giving it to the general public.‚Äô No, we want to go immediately.‚Äù\nTrump rarely wears a mask and said ‚Äúa vaccine is much more effective than the mask.‚Äù\nRedfield told senators that ‚Äúthis face mask is more guaranteed to protect me than the vaccine.‚Äù\nThe CDC leader said about vaccine distribution: ‚ÄúThere will be vaccine that will initially be available sometime between November and December, but very limited supply and will have to be prioritized ‚Ä¶ If you‚Äôre asking me when is it going to be generally available to the American public so we can begin to take advantage of vaccine to get back to our regular life, I think we‚Äôre probably looking at late second quarter, third quarter 2021.‚Äù\nOn Wednesday, the Defense Department and Department of Health and Human Services released plans for vaccine distribution amid hopes for positive results in October from clinical trials.\nThe Trump administration plan calls for rapid distribution of a vaccine free of cost and anticipates two doses administered 21 to 28 days apart. Health care workers and vulnerable people would be prioritized in the first wave.\nPublications > Newsletter > Past Issues > October 2013 > Public Affairs\nUS Classifies R&D as an Investment\nCatching up with the common viewpoint among scientists that funding research is an investment in the future, the Bureau of Economic Analysis (BEA), which is part of the US Department of Commerce, has reclassified research and development costs from an \"expense\" to an \"investment\" when calculating the country's Gross Domestic Product (GDP). Prior to 2013, expenditures on research and development were treated as intermediate inputs‚Äîneither true inputs or outputs‚Äîand not included in the calculation of GDP. The change was made to reflect international guidelines for national economic statistics. The reclassification is important to the scientific research community because it supports the notion that spending on research and development is a worthwhile expenditure, even in lean times.\nAdvocates for research hope that Congress will start to view R&D spending as an investment as it finalizes the federal budget for 2014 and must make even deeper cuts to agency budgets, unless it stops sequestration. In a letter sent to Congress over the summer, 165 university presidents and chancellors, representing all 50 states, called on the president and Congress to reverse the pending \"innovation deficit.\" The letter points out that with more than half of the economic growth in the US since World War II attributable to innovation, the US economy is at risk if the current trajectory of decreased federal investment in research is allowed to continue.\nMore information on the reclassification can be found at http://1.usa.gov/17oEhFT.\nFollowing on the heels of two reports that suggested ways the Department of Energy (DOE) could be more effective, Secretary Moniz announced over the summer that he was restructuring the Department. In an effort to integrate the work of basic science and applied research with technology demonstrations and deployment, the Office of the Under Secretary for Science will now be the Office of Under Secretary for Science and Energy and will manage the following departments:\nOffice of Science,\nOffice of Fossil Energy,\nOffice of Energy Efficiency and Renewable Energy,\nOffice of Nuclear Energy,\nOffice of Electricity Delivery and Energy Reliability,\nOffice of Indian Energy, and\nOffice of Technology Transfer Coordinator.\nIn addition, the majority of the DOE-managed national labs now fall under the Office of the Under Secretary for Science and Energy.\nCurrently, the position of Under Secretary for Science, who would lead this office, is vacant.\nTrack NIH Initiatives to Support\nthe Biomedical Workforce The NIH has launched a new website to make it easier to follow how the agency is implementing the 2012 recommendations focused on the biomedical research workforce, issued by an Advisory Committee to the NIH Director. The site will be kept up-to-date with policy notices, grant opportunities, and general information on progress related to seven initiatives the NIH has undertaken and plans to complete by 2015. The website can be found at http://biomedicalresearchworkforce.nih.gov/.\nOne of the initiatives you can read about on the page is the NIH's August announcement encouraging institutions to establish Individual Development Plans (IDPs) for all trainees funded by NIH grants, regardless of grant type. The NIH will be issuing guidance this month and is encouraging all institutions to begin reporting IDP information in October 2014. The information on IDPs can be found under the initiative \"Improve graduate student and postdoctoral researcher training\" on the website.\nEDA-Hip More Instructional Videos | esy-concept\nEDA-Hip More Instructional Videos\nVideos: EDA-Hip Rationale\nIntroducing a new surgical technique into the OR is enhanced in case surgeons, nurses and administrators are well informed about the procedure. We present instructional course videos about the surgical applied anatomy and the step wise EDA-hip procedure. In addition, the EDA-hip is an ESY-concept procedure that aims to improve ergonomics for the team, quality of care for the patient and economics for the hospital. We share our experience about how the EDA-hip was introduced and the economic model for the hospital has become clear.\nVideos: EDA-Hip Surgical Technique\nThe EDA-hip surgical procedure has been made very reproducible by simplifying all steps and thereby making the procedure more efficient in all aspects. The instrumentation has been rationalized to the minimum required to conduct the surgery safely. The procedure consists of 3 major parts: capsular exposure, capsular release and component insertion. All different steps of the procedure are shown in short detailed videos. Overviews of the different steps and the OR set-up can be found under 'EDA Hip team education'. These videos are also dedicated towards the nursing team.\nVideos: EDA-Hip Advanced\nThe EDA-hip procedure is a comprehensive platform that allows conducting complex primary, extensile acetabular and femoral revisions. It is important for the surgeon to understand the surgical applied anatomy and stepwise extensile approaches in case of an intra-operative problem or during revision procedures.\nVideos: EDA-Hip Team Education\nThe EDA-hip procedure specifically focusses on creating an optimal ergonomic working environment for the nursing team. The EDA-hip procedure is a team concept where the nursing team and the surgeons closely and interactively work together in order to optimize the efficiency, ergonomics and quality of care. The OR set-up, the surgical procedure and the OR break down has been made very systematic and reproducible. The educational videos aim to provide information about the most optimal OR set-up and instrumentation sequence. In addition, detailed videos about the different steps of the procedure with a specific focus on retractor sequence and retractor placement are shown. In order to better understand the full OR workflow, overview videos are also provided.\nOfficial General Health Magazine page for women and men! Free advice to become more healthier, smarter, fashionable, confident and successful.\nPrimary Menu\nHealth\nExercise\nNutrition\nBeauty\nLifestyle\nConnect\nSubscribe\nBecome a Blogger\nContact Us\nSearch\nSearch for:\nBeauty\nTop 5 Essential Oils for Allergies\nOver the last 50 years, the rise in prevalence of allergic diseases and disorders has continued in the industrialized world. Allergic rhinitis, the medical term for hay fever and what‚Äôs behind the unpleasant seasonal allergy symptoms we all know so well, develops when the body‚Äôs immune system becomes sensitized and overreacts to something in the environment.\nToday, 40 to 60 million Americans are affected by allergic rhinitis and the numbers continue to grow, especially in children. When left untreated, allergies can cause blocked and runny nose, sneezing, watery eyes, headaches and an impaired sense of smell ‚Äî but this is in less severe cases. For some people, allergies can be life threatening, leading to inflammation and shortness of breath.\nPeople who suffer from allergies are often told to avoid triggers, but that is nearly impossible when the seasons are changing and our immune systems are impaired by the food industry and environmental toxins. And some allergy meds are linked to dementia and other scary health effects, too. Thankfully, some powerful essential oils serve as a natural and safe way to treat the symptoms of allergies and boost our immune systems. These essential oils for allergies have the ability to chemically support the body and help it to overcome hypersensitivity.\nHow Do Essential Oils Fight Allergies?\nAn allergic reaction begins in the immune system. An allergen is a substance that tricks the immune system ‚Äî making it think that the allergen is an invader. The immune system then overreacts to the allergen, which is really a harmless substance, and produces Immunoglobulin E antibodies. These antibodies travel to cells that release histamine and other chemicals, causing the allergic reaction.\nThe most common causes of an allergic reaction include:\nPollen\nDust\nMold\nInsect stings\nAnimal dander\nFood\nMedications\nLatex\nThese allergens will trigger symptoms in the nose, throat, lungs, ears, sinuses and lining of the stomach or on the skin. The question here still remains ‚Äî if these common causes have been around for thousands of years, then why have the allergy rates increased in recent history?\nOne of the theories behind explaining the increase in allergies has to do with inflammation, the root of most diseases. The body responds in a certain way to an allergen because the immune system is in overdrive. When the body is already dealing with high inflammation, any allergen sets off an increased reaction. That means that when the body‚Äôs immune system is overworked and stressed, introducing an allergen sends the body into overreaction.\nIf the immune system and inflammation within the body was balanced, the reaction to the allergen would be normal; however, today these reactions are exaggerated and lead to the next unneeded allergic reaction.\nOne of the most amazing benefits of essential oils are their ability to fight inflammation and boost the immune system. Essential oils for allergies will help to detoxify the body and fight infections, bacteria, parasites, microorganisms and harmful toxins. They reduce the bodies susceptibility to outside sources and reduce the overreaction of the immune system when it is faced with a harmless intruder. Some exceptional essential oils even work to relieve respiratory conditions and increase sweat and urination ‚Äî helping with the elimination of toxins.\nTop 5 Essential Oils for Allergies\n1. Peppermint Oil\nInhaling diffused peppermint oil can oftentimes immediately unclog the sinuses and offer relief to scratchy throats. Peppermint acts as an expectorant and provides relief for allergies, as well as colds, coughs, sinusitis, asthma and bronchitis. It has the power to discharge phlegm and reduce inflammation ‚Äî a leading cause of allergic reactions.\nA 2010 study published in the Journal of Ethnopharmacology investigated the effects of peppermint oil in the tracheal rings of rats. The results suggest that peppermint oil is a relaxant and exhibits antispasmodic activity, inhibiting contractions that causes you to cough. (1)\nAnother study published in the European Journal of Medical Research suggests that peppermint oil treatment has anti-inflammatory effects ‚Äî reducing the symptoms of chronic inflammatory disorders such as allergic rhinitis and bronchial asthma. (2)\nRemedy: Diffuse five drops of peppermint essential oil at home to unclog sinuses and treat a scratchy throat. This will also help to relax the nasal muscles, enabling the body to clear out mucus and allergens like pollen. To reduce inflammation, take 1‚Äì2 drops of pure peppermint essential oil internally once a day.\nIt can be added to a glass of water, cup of tea or smoothie. Peppermint oil can also be applied topically to the chest, back of neck and temples. For people with sensitive skin, it is best to dilute peppermint with coconut or jojoba oil before topical application.\n2. Basil Oil\nBasil essential oil reduces the inflammatory response of allergens. It also supports the adrenal glands, which are involved in producing over 50 hormones that drive almost every bodily function. Essentially, basil essential oil is helping your body to react appropriately to a threat by rushing blood to your brain, heart and muscles.\nBasil oil also helps to detoxify the body of bacteria and viruses, while fighting inflammation, pain and fatigue. Studies prove that basil oil shows antimicrobial activity and can kill bacteria, yeast and mold that can lead to asthma and respiratory damage. (3, 4)\nRemedy: To fight inflammation and regulate the overreaction of the immune system when faced with an allergen, take one drop of basil oil internally by adding it to soup, salad dressing or any other dish. To support the respiratory system, dilute 2‚Äì3 drops of basil oil with equal parts coconut oil and apply topically to the chest, back of neck and temples.\n3. Eucalyptus Oil\nEucalyptus oil opens up the lungs and sinuses, thereby improving circulation and reducing symptoms of allergies. Studies have shown that it produces a cold sensation in the nose that helps to improve airflow. (5)\nEucalyptus contains citronellal, which has analgesic and anti-inflammatory effects; it also works as an expectorant, helping to cleanse the body of toxins and harmful microorganisms that are acting as allergens.\nA 2011 study published in Evidence-Based Complementary and Alternative Medicine found that eucalyptus essential oil was an effective treatment for upper respiratory tract infections. Patients who were treated with eucalyptus spray reported an improvement in the severity of their most debilitating respiratory tract infection symptoms compared to participants in the placebo group. Improvement was defined as a reduction of sore throat, hoarseness or cough. (6)\nRemedy: To treat respiratory issues associated with allergies, diffuse five drops of eucalyptus at home or apply it topically to the chest and temples. To clear the nasal passages and relieve congestion, pour a cup of boiling water into a bowl and add 1‚Äì2 drops of eucalyptus essential oil. Then place a towel over your head and inhale deeply for 5‚Äì10 minutes.\n4. Lemon Oil\nLemon oil supports lymphatic system drainage and helps with overcoming respiratory conditions. Studies have shown that lemon essential oil inhibits the growth of bacteria and boosts the immune system. When diffused at home, lemon oil can kill bacteria and eliminate allergy triggers in the air. (7, 8)\nAdding 1‚Äì2 drops of lemon essential oil to water also helps with pH balance. Lemon water improves immune function and detoxifies the body. It stimulates the liver and flushes out toxins that can lead to inflammation and an overreactive immune system. Lemon water also stimulates white blood cell production, which is vital for immune system function because it helps to protect the body.\nLemon essential oil can also be used to disinfect your home, without depending on alcohol or bleach. It will remove bacteria and pollutants from your kitchen, bedroom and bathroom ‚Äî reducing the triggers inside of your home and keeping the air clean for you and your family. This can be especially helpful as the seasons change and allergens from outside are being brought into your house on shoes and clothes.\nRemedy: Add lemon oil to your laundry detergent, mix a couple of drops with water and spray it on your couches, sheets, curtains and carpets.\n5. Tea Tree Oil\nThis powerful oil can destroy airborne pathogens that cause allergies. Diffusing tea tree oil in the home will kill mold, bacteria and fungi. It is an antiseptic agent and it has anti-inflammatory properties. Tea tree oil can be applied to the skin to kill bacteria and microorganisms; it can also be used as a household cleaner to disinfect the home and eliminate allergens. (9)\nA 2000 study conducted in Germany found that tea tree oil exhibits antimicrobial activity against a wide range of bacteria, yeasts and fungi. These microbes lead to inflammation and force our immune system to work on overdrive. (10)\nRemedy: Use tea tree oil on skin rashes and hives or as a household cleaner. When using tea tree topically, add 2‚Äì3 drops to a clean cotton ball and gently apply to the area of concern. For people with sensitive skin, dilute tea tree with a carrier oil first, like coconut or jojoba oil.\nHow to Use Essential Oils for Allergies\nFood Allergies ‚Äî Take 1‚Äì2 drops of lemon or peppermint oil internally to relieve the symptoms of a food allergy. This will help to detoxify the body and eliminate the allergens through sweat or urination.\nSkin Rash & Hives ‚Äî Use tea tree or basil oil topically to treat skin rashes and hives. Add 2‚Äì3 drops to a cotton ball and apply to the affected area. Layering oils over the liver area is another way to treat skin irritations because it helps the liver to flush out toxins that burden the skin. Dilute 3‚Äì4 drops of tea tree oil with coconut oil and rub it into the liver area.\nSeasonal Allergies ‚Äî Disinfect your home with lemon and tea tree oil; this will eliminate triggers and cleanse the air and your furniture. Add 40 drops of lemon oil and 20 drops of tea tree oil to a 16-ounce spray bottle. Fill the bottle with pure water and a little bit of white vinegar and spray the mixture on any area in your home.\nTo reduce respiratory issues associated with seasonal allergies, try my Homemade Vapor Rub; it delivers a soothing feeling that will open up the airways and make it easier to breathe.\nAllergy Blend ‚Äî Combine 2‚Äì3 drops of peppermint, eucalyptus and lavender oil with one teaspoon of coconut oil and massage the mixture into the temples, behind the ears and into the bottoms of the feet.\nPossible Side Effects\nWhen using these special essential oil for allergies, I don‚Äôt recommend that you take tea tree oil internally; it‚Äôs best to use tea tree aromatically or topically. When using any of these oils topically, dilute with a carrier oil, especially when using on sensitive skin or one sensitive areas, like under the eyes or on the neck.\nWhen using essential oils internally, a little goes a long way. Only consume 1‚Äì2 drops a day for one month. Then take a two-week break and start the treatment again.\nWhat do you think about this article? Please share the article and let us know your comment.\nSource: draxe\nJuly 7, 2022 -Apple, apples, bikini, Bodybuilder, bodybuilding, cardio, Cardiovascular, cleaneating, diet, doctor, eatclean, essentialoils, Exercise, fatburner, food, gainmuscle, ghm, gym, healthcare, healthychoices, healthyfood, healthylife, hearthealth, inspiration, ketodiet, looseweight, love, motivation, muscle, musclemass, Nutrient, Nutrition, Nutritionist, Paleo, paleodiet, Recipe, shape, vegan, Vegetarian, weightloss, workout, yoga\nPost navigation\nPrevious Previous post: 5 Best At-Home Laser Hair Removal Devices 2022\nNext Next post: 11 Signs You‚Äôre In A ‚ÄòSituationship‚Äô\nThe information on this site has been included in good faith, and is for general purposes only. It should not be relied upon for any specific purpose, and no warranty or liability is given as regards to its accuracy or completeness. Fair use applies. ¬© GHM\nMost people will lose their hair after chemotherapy treatment but it usually grows back within a few months.\nYour scalp will need to be covered by either a hat or scarf to prevent losing heat in the winter and getting sunburnt in the summer. If you would prefer to wear a wig, your hospital should have a scheme in place to provide one for free.\nSome people take the opportunity to experiment with new hairstyles they have not dared to try before. If you have long hair, you may want to try out some shorter styles before treatment starts.\nLook Good, Feel Better provide women undergoing cancer treatment with skincare and make up advice through free workshops. The Little Princess Trust and the Teenage Cancer Trust‚Äôs Hair 4 U provide free wigs for young people who have lost their hair following treatment. Most hospitals also have their own wig service, too.\n\nAs a requirement of active publicity, the transparent operation of any public institution entails making available to citizens relevant information about its organisation, financial and budgetary management, governing regulations and details of its activity. The aim of this exercise is to enable evaluation of its performance and safeguard the responsible exercise of power.\nFor this reason we endeavour to publish as much information as possible and make it easily accessible. In accordance with Catalan law 19/2014, of 29 December, on transparency, access to public information and good governance, we ensure the information is readily available with no limitations other than those provided by law. So we ask you to check the data on this portal and other sections of the website to confirm you are able to locate the material you would like to see.\nYou are here: Scientific Experts > Sweden > National Veterinary Institute > Persson Waller > K Persson Waller\nCytokines in mammary lymph and milk during endotoxin-induced bovine mastitis\nDepartment of Ruminant and Porcine Diseases, National Veterinary Institute, SE 751 89, Uppsala, Sweden\nRes Vet Sci 74:31-6. 2003\nIntramammary infusion of beta1,3-glucan for prevention and treatment of Staphylococcus aureus mastitis\nDepartment of Ruminant and Porcine Diseases, National Veterinary Institute, SE 751 89 Uppsala, Sweden\nJ Vet Med B Infect Dis Vet Public Health 50:121-7. 2003\nAn improved method to culture Staphylococcus aureus from bovine milk\nK Artursson\nJ Dairy Sci 93:1534-8. 2010\nA Capurro\nNational Veterinary Institute, SE 75189 Uppsala, Sweden\nJ Dairy Sci 93:180-91. 2010\nChanges in blood and milk lymphocyte sub-populations during acute and chronic phases of Staphylococcus aureus induced bovine mastitis\nU Gr√∂nlund\nDepartment of Clinical Sciences, Division of Comparative Reproduction, Obstetrics and Udder Health, Faculty of Veterinary Medicine and Animal Sciences, Swedish University of Agricultural Sciences, P O Box 7039, Uppsala, Sweden\nRes Vet Sci 80:147-54. 2006\nManagement practices associated with udder health of first-parity dairy cows in early lactation\nPrev Vet Med 88:138-49. 2009\nMicrobial aetiology of acute clinical mastitis and agent-specific risk factors\nH Ericsson Unnerstad\nVet Microbiol 137:90-7. 2009\nSupplementation of RRR-alpha-tocopheryl acetate to periparturient dairy cows in commercial herds with high mastitis incidence\nDepartment of Pigs, Poultry and Ruminants, National Veterinary Institute, SE 751 89 Uppsala, Sweden\nJ Dairy Sci 90:3640-6. 2007\nBovine subclinical mastitis caused by different types of coagulase-negative staphylococci\nB M Thorberg\nDepartment of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, SE 75007 Uppsala, Sweden\nJ Dairy Sci 92:4962-70. 2009\nMilk leakage--an increased risk in automatic milking systems\nJ Dairy Sci 86:3488-97. 2003\nK Holtenius\nK Svennersten-Sjaunja\nM O Odensten\nA Johannisson\nC G√•nheim\nM Nilsson-Ost\nT Ekman\nP Ohagen\n..The results indicate a primary role for IL-8 in the recruitment of neutrophils into the gland, and suggest that IL-1beta and TNF-alpha are not necessary for IL-8 production and release in response to endotoxin...\n..To further evaluate a possible preventive effect of beta1,3-glucan infusion at drying off more studies are needed involving a larger number of animals...\n..The improved method may be especially useful for detection of low concentrations of Staph. aureus in milk; for example, when screening herds for Staph. aureus...\n..aureus. The results contribute new knowledge necessary to improve strategies for udder health control in herds...\n..The results indicate that different control measures must be taken depending on the nature of the udder health problem...\n..Isolation of S. aureus was associated with tie stalls, and A. pyogenes with low yielding cows and teat lesions. S. dysgalactiae infections were also associated with teat lesions...\n..A significant effect of supplementation was observed only for stillbirth or calf death within 24 h after birth, which was significantly lower in the supplemented group. The reasons for this finding require further study...\n..In cows with subclinical mastitis, S. epidermidis IMI were mainly found in multiparous cows, whereas S. chromogenes IMI were mainly found in primiparous cows...\n..Milk flow rate was higher in quarters leaking milk than in other quarters. Strategies to reduce milk leakage in AMS may be important to minimize potential risks of udder disease...\nSensitivity and specificity of PCR analysis and bacteriological culture of milk samples for identification of intramammary infections in dairy cows using latent class analysis\nDepartment of Animal Health and Antimicrobial Strategies, National Veterinary Institute, 751 89, Uppsala, Sweden Electronic address\nPrev Vet Med 135:123-131. 2016\n..Hence, extra caution is needed when decisions about treatment of IMI are based on PCR...\nChanges in peripheral blood leucocyte counts and subpopulations after experimental infection with BVDV and/or Mannheimia haemolytica\nDepartment of Clinical Sciences, Division of Comparative Reproduction, Obstetrics and Udder Health, PO Box 7054, Sweden\nJ Vet Med B Infect Dis Vet Public Health 52:380-5. 2005\nMetabolic parameters and blood leukocyte profiles in cows from herds with high or low mastitis incidence\nDepartment of Large Animal Clinical Sciences, Box 7018, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala SE 750 07, Sweden\nVet J 168:65-73. 2004\n..The results suggest that there were differences in the metabolism and immune status between herds with high or low yearly mastitis treatment incidence indicating an increased metabolic stress in HMI cows...\nAdjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle\nDepartment of Veterinary Medicine, Zhejiang University, Hangzhou, Zhejiang 310029, China\nVet Immunol Immunopathol 91:29-37. 2003\n..aureus in dairy cattle. Field trials are warranted to test the ability of GS and R(b1) to enhance the efficacy of mastitis vaccines in protection against intramammary infections...\nMetabolism and udder health at dry-off in cows of different breeds and production levels\nDepartment of Animal Nutrition and Management, Swedish University of Agricultural Sciences, SE 753 23 Uppsala, Sweden\nJ Dairy Sci 90:1417-28. 2007\n..A prolonged CI did not facilitate a rapid decrease in milk production. The SRB and SH breeds responded equally in decreasing the milk production during DO, but the SRB breed had lower somatic cell counts..."
    },
    {
        "id": "115219",
        "description": "Hypertension #13\nHypertension - #13\nDetermine blood pressure goals in older adults and possible medications.\nTables were adapted from the listed references.\nFollow-up visit of a patient in the nursing home or other outpatient setting.\nDetermine initial appropriate treatment option for an elderly hypertensive patient with medical co-morbidities.\n60% of Americans > 60 years are diagnosed with hypertension (SBP > 140/90), but only 27% have their blood pressure controlled to the ideal range with medication. Meta-analysis data has shown that treating hypertension is imperative for preventing strokes and cardiovascular events.\nGeriatric patients require unique considerations when managing their hypertension as normal aging processes can contribute to abnormal findings. Examples include: Pseudohypertension: falsely positive elevated blood pressure readings due to the incompressibility of a calcified artery. Orthostatic hypotension: decrease in blood pressure from lying (sitting), to standing, caused by a decrease in baroreflex response.\nIdentify blood pressure goals in patients >65 years old. 2.List four JNC7 considerations for treatment of hypertension. 3.List four medications and the specific conditions for which they are indicated, based on patient co-morbidities. 4.List four practical lifestyle recommendations for the management of hypertension.\nYana Thaker, Suzanne Gehl MD, Kathyrn Denson MD, Jennifer Scheeler, MD, Bambi Wessel\nUsers are free to download and distribute Geriatric Fast Facts for informational, educational, and research purposes only. Citation: Yana Thaker, Suzanne Gehl MD, Kathyrn Denson MD, Bambi Wessel, Fast Fact #013: Hypertension in the Elderly, February, 2012.\nHHS Climate Justice Conference - June 8-9, 2015\nHHS Climate Justice Conference HHS Climate Justice Conference\nClimate change is having and will continue to have significant impacts on people's health, in particular those who are already disproportionately impacted by environmental hazards and social conditions. HHS hosted a one and a half day conference to discuss the challenges, current HHS climate change related activities, and possible resources and tools in Research Triangle Park, North Carolina on June 8-9, 2015.\nHighlights from the Climate Justice Conference\nThe Conference Booklet (4MB) contains the final conference agenda, speaker bios, and relevant handouts. Background information: For more information about environmental justice at HHS, including the HHS Environmental Justice Strategy and Implementation Plan, please visit the HHS EJ website.\nThe Conference Report (1MB) summarizes the key highlights and discussions from the Climate Justice Conference.\nThe following conference presentations were approved for posting by the presenter. If you do not see a presentation listed, it is not available.\nDay 1, June 8, 2015\nKeynote: Climate Justice and Public Health (3MB), John Balbus, NIEHS\nPanel: Federal Agency Initiatives on Climate Justice\nHHS Overview (204KB), Sandra Howard, HHS\nHUD Resources, Sunaree Marshall, HUD\nClimate Data and Tools Overview\nUpdate on Data and Tools for Communities (1MB), John Balbus, NIEHS\nData Resources, and Technical Guidance in Support of Adaptation in Climate Change (1MB), George Luber, CDC\nRadiology/Imaging | Decatur County Memorial Hospital\n812-663-1157\nFull-field Digital Mammography system/3D Digital Breast Tomosynthesis\nLung Scans ‚Äì $25\nThe best chance of beating lung cancer is to find it early when treatment options are available. DCMH offers a low-dose radiation CT scan for individuals with a significant history of tobacco use. It is recommended for both men and women who are current/former smokers and are 55-75 years of age. Other specific criteria must be met in order to qualify for this screening.\nHeart Scans ‚Äì $25\nThis noninvasive procedure utilizes our low-dose radiation CT scanner to check for calcium buildup in your arteries. The heart scan is used to look for calcium deposits in your coronary arteries that can narrow your arteries and increase your risk for a heart attack. These scans are recommended for males 45 years or older and females 55 years or older. Other criteria must be met before the scan.\nIf you have been advised to have a radiology procedure but would like to research additional information relative to its scope and process, please visit the Radiologic Procedure Information website.\nStaying Sane In An Insane World: The Challenge Of Social Distancing | Bluesci\nStaying Sane In An Insane World: The Challenge Of Social Distancing\nMirlinda Ademi discusses the neuroscience behind isolation and loneliness\n\"A guy goes nuts if he ain't got nobody... I tell ya a guy gets too lonely an' he gets sick.\" Of Mice and Men, John Steinbeck\nThe global COVID-19 pandemic has brought new experiences to most of us, introducing extreme changes to our work and social life. Despite social distancing measures being necessary to curb the transmission of COVID-19, the emotional distress caused by social deprivation during lockdown has been tough. Increased loneliness has been reported amongst adults, as virtual alternatives like Zoom or FaceTime are just not the same. Moreover, loneliness has been linked to depression, a health concern officially recognised by the World Health Organization. Poor living conditions and lack of social interaction are associated with poor physical and mental health and higher mortality rates. From an evolutionary perspective, seeking social connections is a deeply-ingrained instinct, essential for survival throughout the animal kingdom. Social contact is associated with an increased life span for various species, such as honeybees, mice, and macaques. When we feel lonely, many of us experience higher levels of anxiety and hypervigilance, a defence mechanism thought to have evolved as a response to potential threats. But why does loneliness have such an effect on the body?\nThe effect of loneliness on the brain is poorly understood from a neuroscientific perspective. Positive social interactions such as smiling faces have been shown to activate neural reward systems. Lack of social interaction, on the other hand, is believed to create a 'craving for company' response in the midbrain, comparable to hunger states that trigger the search for food. Several neurotransmitters ‚Äî chemical messengers important for communication between neurons ‚Äî including dopamine, oxytocin, and opioid circuits, are thought to underlie the motivation for social reward. A study led by a research group at the Massachusetts Institute of Technology suggested that a cluster of dopamine-related neurons found in the brainstem region, called the dorsal raphe nucleus (DRN), form part of a neural circuit representing the subjective experience of feeling lonely. The group showed that the DRN area was extremely sensitive to acute periods of social isolation just one day after mice were isolated from their cage companions. In the same study, the group used a technique called optogenetics to switch genetically modified neurons 'on' or 'off' using light. This increased or suppressed a loneliness-like state, respectively. Activation of DRN neurons increased social preference, making mice more sociable when re-introduced to peers. In primates, negative motivational states have been mainly observed in other areas of the brain, though the role of the DRN itself remains to be properly understood.\nWhile stress is fundamental to survival as it powers the 'fight-or-flight' response in dangerous situations, elevated levels of stress can be harmful to both the brain and the body. Stress causes the amygdala, the 'fear centre' of our brain, to contribute to the activation of our autonomic nervous system (ANS), alongside our central stress response system known as the hypothalamic-pituitary adrenocortical (HPA) axis. The interactions between the brain and adrenal glands in the HPA axis release cortisol, which helps our bodies deal with acute stress. However, chronic activation of the HPA can wreck havoc on our brains, increasing amygdala activity and causing atrophy in the hippocampus, a brain region responsible for learning and memory formation. Too much stress can remodel our brain by reducing the number of connections between neurons or shrinking the prefrontal cortex, which regulates cognitive functions such as decision making and concentration. These reactions may begin as appropriate responses to a stressful event, but set the stage for more serious conditions including clinical anxiety or major depression, leading to a vicious cycle between stress and mental health. Furthermore, chronic stress induces inflammation in the body, which can contribute to difficulty sleeping, digestive problems, or even a weakened immune system.\nThe stress from coping with social isolation and survival during the pandemic often reflects in poor sleep. They are tightly linked, as anxiety causes insomnia, which eventually increases anxiety itself. Research suggests lack of sleep contributes to loneliness and is a catalyst for social isolation. Sleep is more important for our brains than we may realise. On average, we spend around one third of our lives asleep. Sleep is essential for good mental and emotional health as well as adequate cognitive function. Restful sleep serves to 'reset' brain activity, to prepare us for emotional challenges the next day. Dreaming during REM sleep helps us process emotional experiences, like a form of nocturnal therapy. In the long term, sleep, including well-placed naps, helps our brain consolidate information and store memories.\nBrain activity after periods of sleep deprivation has been shown to be very similar to that observed in anxiety disorders. Poor sleep puts our brains on guard by triggering spikes in stress hormones early in the morning, and increases activity of the amygdala, which is also crucial for emotional processing and memory consolidation. Sleep deprivation has also been linked to changes within the medial prefrontal cortex and other brain regions associated with emotional control. People who sleep poorly are twice as likely to develop an anxiety disorder and other health problems such as increases in blood pressure, insulin resistance, and body weight. Some of these issues are linked to distinct changes in hunger-regulating hormones associated with sleep deprivation, such as higher levels of appetite-stimulating ghrelin or lower levels of satiety-inducing leptin. Furthermore, sleep restriction modifies our endocannabinoid levels, chemical signals that affect appetite and our reward system. Therefore, while poor sleep is a common and often underestimated outcome of altered stress levels, it can have other profound physical and psychological effects.\nCoping With Late Night Loneliness\nFor many, the peak of loneliness comes during the evening or at night. To combat this, smartphones and the Internet have offered an important means of connection during the pandemic. However, late night screen-usage is a disruptive behaviour, affecting not only our body clock but also the levels of melatonin, our 'sleeping hormone'. Therefore, minimising exposure to bright lights at night can facilitate good sleep. In addition, while a nightcap before bedtime might seem tempting to help quieten the hamster wheel going in your head, it is not a good sleep aid. Alcohol acts as a central nervous system depressant and disrupts sleep, especially in the second half of the night.\nSo, what can we do instead to calm our busy minds? Simple activities like reading a good book or just enjoying a cup of tea can help ease your thoughts. Alternatively, mindfulness is a more active way to better cope with pandemic loneliness and related sleeping issues. Mindfulness is like a workout for the brain ‚Äî you practise awareness and concentration, resulting in general calmness and physical relaxation.\nWhile the pandemic has come with many challenges requiring adaptation of our daily lives, it has brought another opportunity to further help destigmatise stress and its related mental health issues, as we are all trying to stay sane in an insane world\nMirlinda Ademi is a third year PhD student in Clinical Neurosciences at Corpus Christi College. Artwork by Zuzanna Stawicka.\nStall Dementia & Give Your Brain a Workout - GoldLeaf HomeHealth\nby GoldLeaf HomeHealth | Apr 30, 2022 | News | 0 comments\nAre you concerned about preventing Alzheimer Disease or any form of dementia as you age? If so, many people are aware of the risk factors and search for the magic pill that will stall or help prevent or reduce risk of Alzheimer's disease and any related dementias.\nDementia Potential Risk Factors\nWhat increases or decreases your chance of developing particular diseases as you age? These are risk factors that can be controlled or not. Uncontrollable factors are of course age, genes and their related changes. Subtle factors can also be race and gender, which is being widely studied.\nThe one thing most controllable are behavior and lifestyle. Researchers are not ready to say at this point that these two factors will definitely prevent these diseases, but there are promising results at this time.\nLearn How To Reduce the Risk Factors\nAs the number of older Americans are rising, the number of people with dementia is predicted to also rise. Studies have recently shown that new cases in a population have decreased in some locations. Observational studies have revealed factors such as healthy lifestyle behaviors and higher levels of education may be contributing to such a decline. But this cause and effect is uncertain. and need to be tested in a clinical trial to make further recommendations.\n\"A review of published research evaluated the evidence from clinical trials on behavior and lifestyle changes to prevent or delay Alzheimer's or age-related cognitive decline. The review found \"encouraging but inconclusive\" evidence for three types of behavioral changes (called interventions): physical activity, blood pressure control, and cognitive training. The findings mean that interventions in these areas are promising enough that researchers should keep studying them to learn more. Researchers continue to explore these and other interventions to determine whether ‚Äî and in what amounts or forms ‚Äî they might prevent dementia.\" From Alzheimers government website.\nWatch a video that highlights conclusions and recommendations from the research review published on the same site above.\nLeading a healthy lifestyle has not been a proven or effective way to prevent Alzheimers or dementia, but researchers are frantically seeking answers. Consult the concise list below to see the factors researchers today are focused on the following:\nTreat hearing problems.\nThis list is expanded on and further explained on the Alzheimers website.\nIf for any reason you need immediate or long term assistance make sure to call us, 24/7 at GoldLeaf Home Health. We are home health providers who are dedicated to revolutionize the home care industry to provide greater individual independence and quality of life at all ages.\nResearch papers in project management ; Writing a good argumentative essay\n+63 (0)5893 764991 (24/7 Support Line writingmypaper.com)\nProject management research paper topics. project management is the practice of initiating, planning, executing, controlling, and closing the work of a team to achieve specific goals and meet specific success criteria at the specified time. the primary challenge of project management is to achieve all of the project goals within the given. the purpose of this paper is to share one researcher' s perspectives and experiences on project management research. the paper begins by identifying some of the early issues examined and how these studies helped identify and explain some of the underlying managerial and theoretical foundations of project papers management. agile project management research paper ‚Äì executive summary: a project management introduces and follows new techniques and technologies that require fulfilling their specific needs related to their projects. research papers in project management now current project management need flexible and skill to manage all changes according to information. the purpose of this paper is to reflect on some of the fundamental project management ( pm) research issues facing pm as a discipline.\nit aims to pose fundamental questions about where pm research has been heading over the last five decades and how it can remain relevant in supporting the delivery of sustainable value to its clients and key stakeholders. , ‚Äì this is accomplished through. question i ‚Äì go online and find at least two sites with definitions of fast tracking and crashing a project schedule. prepare proper reference citations for the sites you located, using apa style. in your own words, write definitions for project fast tracking and project crashing. consider the plan you prepared for the software system testing project in question 1 above. if you were informed. you are an it project management consultant that has been brought in to implement this project and have three months to complete the project.\ncomplete a project plan for this scenario as follows: 1. develop a wbs, network diagram, and gantt chart for the project ( must include at least 30 activies and 10 resources minimum). structuring the project ( scope and stakeholders) planning the work flow set rational goals gain assurance administer for success. view project management research papers on academia. this final research paper must demonstrate the understanding of new learning in the field of project management and how it relates to the project management maturity model. this is an assignment with a length of 10- to 15- pages ( not including title and reference pages) that should integrate the reading, multi- media and class discussion boards. research proposal on construction project management assignment best practices are an integral part of each process within the construction project under papers management focus in this study. Writing autobiography essay. for example project management in general requires a focus on resources for implementation of projects, cost- estimating and - - management.\nthe project management institute ‚Äì research and academic conference ( rac) is the 6th in the series conducted. research aim: the study will propose an agile management concept that uses a risk management framework that races alignments and discovers connections between agile and traditional project management concepts. the purpose of the research is to deal with risk in the construction projects that are built based on the agile management concept. 0 ‚Ñπ citescore: : 13. 0 citescore measures the average citations received per peer- reviewed document published in this title. citescore values are based on citation counts in a range of four years ( e. to peer- reviewed documents ( articles, reviews, conference papers, data papers and book papers chapters) published in the same four calendar years, divided by the number of. view mba project management research papers on academia. this sample paper on ( sample research paper on it project management) was uploaded by one our contributors and does not necessarily reflect how our professionals write our papers. if you would like this paper removed from our website, please contact us our contact us page. the writer did a profound research and analysis, as well as referred to great and hard- to- find literature in my term paper. i was sure i' d get an a the very first moment i started to read the paper.\ncom is one of the best services i' ve ever worked with. the paper \" project management at the university of south australia\" is a perfect example of a management research paper. australia is famous for its universities. afribary publishes latest social & management sciences topics for students. browse through social & management sciences projects, social & management sciences project topics, social & management sciences thesis, seminars, research papers etc. all papers and research topics in social & management sciences and its sub- fields. our experts can write your project management research proposal from scratch! possible causes of project failure and their impacts one of the main reasons why the results of projects are considered unsuccessful is the flaw in the initial planning that fails to establish the critical link between the overall organisational strategy and the goals of a specific project ( ogc, n. first of all, what is a capstone paper? it' s an account of a complex project often done at the culmination of academic and educational discourse. in most colleges, writing this kind of paper is mandatory for graduation. it' s multifaceted and investigative and serves a more substantial purpose than most research papers.\nproject management research paper is a full opportunity platform to gain knowledge about the discipline and bringing the ability of writing in forefront but when students don' t know how to write project management research papers, they eventually land on bad grades in their exams. a research paper is an expanded essay that presents your own interpretation or evaluation or argument. when you write an essay, you use everything that you personally know and have thought about a subject. when you write a research paper you build upon what you know about the subject and make a deliberate attempt to find out what experts know. this list of management research paper topics is designed to be a reference guide for everyday business and management study needs for the management students, managers, business practitioners, or anyone interested in a better understanding of a business management term or concept. this page can be a first- stop for general information as well. network diagrams are one of the project management tools a project manager uses for project planning. it is also sometimes referred to as an \" arrow\" diagram because it uses arrows to connect activities and represent precedence and interdependencies between activities of a project. this is an assignment with a length of 10- to project management research papers 15- pages ( not including title and reference pages) that should cheap essays integrate the reading, multi- media and class discussion boards abstract: this paper attempts to identify and describe a comprehensive set of project management and software engineering project management activities and tasks that should be.\nabstract this paper is a dedicated research on the way the fields of software product management and software project management collaborate with each other, within software product companies. it analyzes the dependencies between software product and software. a program management tool should help you manage your program, but it should also have a feature to help you manage your own tasks. a task management tool is great for team members to know where they stand in terms of their tasks. what tools do program managers use? msc project management: applied research methods\" paper analyze sand evaluates the managerial effectiveness of ' the management', and the perception of studentshare our website is a unique platform where students can share their papers in a matter of giving an example of the work to be done. program management system. program management system ( pms) is designed to allow companies to create projects that help focus on program development, planning, and reviewing. research the adaptive organization : a benchmark of changing approaches to project management the adaptive organization research report is a study of to what degree organizations employ adaptive approaches in their project management practice research papers in project management and their impact on project and organizational outcomes. as always, this report determines best. ganttpro is one of the best pm software, appreciated already by 250k project managers around the globe.\nit helps build project plans and timelines, track workflow, control expenses, follow deadlines, and arrange productive collaboration in a single place. project management undergraduate project topics, research works and materials, largest undergraduate projects repository, research works and materials. download undergraduate projects topics and materials accounting, economics, education. academic research faces new methods of knowledge production that trigger a need for managing research by projects. however, the literature reports friction between management and research. Thematic review of literature. project management analyst research papers in project management cover letter for easter holiday homework year 1. capacity child- centred classroom educators images influence method needs potential foster graduate whole maria montessori was one of analyst management project cover letter its members. sample research project plan outline. to further help you in creating a research project plan, here is a sample research project plan outline. take note that the research project plan below is only an outline and does not include comprehensive analysis, which is a requirement for a standard research project plan.\nproject management research paper is a full opportunity platform to gain knowledge about the discipline and bringing the ability of writing in forefront but when students don' t know how to write project management research papers, they eventually land on bad grades in their exams this sample paper on ( sample research paper on it project management) was uploaded by one our contributors and does not necessarily reflect how our professionals write our papers. develop the project charter and identify the project sponsor and customer. describe how the project will be measured for success. describe the components of the project plan, how it will be used throughout the project, and its benefit to the sponsor. entire groupproject scopedescribe the scope of the project? the major deliverables as well as the items that are not part of the scope. browse through academic research works in estate management. access and download complete estate management papers, estate management project topics, seminar topics, thesis, assignments, termpapers etc. project topics in estate management. the expository essay definition is clear, but it doesn' t give you specific guidelines on how to complete this essays. you need step- by- step tips that will help you achieve the proper expository essay structure and write the paper with success.\nto start with, here are the most important tips to have in mind: in this type of writing, you' re. the most important part of planning out an expository writing essay is to come up with a complex analytical question and develop a strong thesis that provides an answer to your question. come up with an analytical question. the first step required for writing an expository writing essay is to come up with an analytical question. an expository essay is one of the four common types of essays, others being descriptive, argumentative, and narrative essays. expository essays are often assigned as part of sat and other standardized testings, but high school and college students are often given expository essay assignments for their homework. gsj encourages open access and universally accessible online journal. gsj covers the publication of research articles from all areas of science, art, management and technology. all original research papers published by gsj are made freely accessible online with full text immediately upon publication. online submission call for papers - august edition ( volume 10, issue 8) authors are invited to send their research paper through online submission at ijsrp review board. all the submitted papers will be reviewed as per full double blind international refereeing process.\nsuccessful form submission does not mean that ijsret has accepted the paper but it will be published after deep review by ijsret' s editorial board. ijsret home submit research paper for publication, how to publish a paper in a journal for free, how to publish a paper online, how to publish a paper in international journal, publish research. our law coursework help will teach you how to write course works that will appreciate the strengths and weaknesses of the other party' s positions. also, you will learn how to find and use arguments. our law coursework help services can take care of your entire writing. there are many reasons why students choose us above other firms on the web. law coursework help, online college with no admissions essay, online writing community, how to give a backgroubd for somone in w coursework topic ideas for writing law coursework. by: dominic corey.\ntopic ideas for writing law coursework are not that difficult as they seems to be, all you need to have is a good topic, material, proper structure and you will end up with a perfect piece of paper. i want law coursework help to take this opportunity to say thank you very much for taking this educational journey with me. i could not have accomplished it without your help. you have always been there for me even when my assignment was last minute. thank you law coursework help from the bottom of my heart. may god bless you and your family always. find different types of letter writing stationery paper from paper source. create unique letters with all different types of paper styles. stationary paper 48 pack of watercolor letter writing paper, decorative printer stationery sheets with assorted designs - double- sided printing - 8. 0 out of 5 stars 15 $ 11.\nlooking for the top rated essay writing services? order 100% original custom written term papers from our professional online let us help you writing your papers. free stationery templates in pdf format. download blank and lined stationery as well as handwriting paper.\nPersonal reflective essay [LOWER]Writing a scientific paper Best custom paper writing service Stem cell research papers How to write a research paper on a disease\nWriting paper for money Buy a dissertation online you\nwhat is program management tool? this article highlights the characteristics of articles on project success published between 19 in the project management journal ( pmj) and the international journal of project. research summaries pmi is committed to advancing the science and practice of project management by supporting the work of academics through its research and education programs.\nwhat is the best pm software? what is program management system?\nabstract‚Äî the main aim of this research is to introduce project management methodology ( pmm) and assessment the applying some of the types of the pmm in the construction sector. there are two types of project methodology approach, firstly traditional approach and modern approach.\nproject management paper mgt 437 organizations leaders are facing difficult challenges because of the rapid changes in government and technology, which has created pressure in organizations.\nthe aforementioned changes have made way for a new type of management; project management, far different from the traditional structure for managing.\nLeading government officials contacted by The Daily Mail suggested said standard procedures for incoming travellers from the UK and Bulgaria were followed, including mandatory testings for the novel coronavirus.\nA senior government official said: ‚ÄòIf something suspicious had come up, he (Johnson) would have been taken out of line and put in isolation for at least seven days.\nIn his encounter with the press late Friday, Mr Johnson strongly urged for a travel agreement between Greece and the UK.\n\nOver the past few weeks, the situation surrounding the COVID-19 pandemic has changed quickly. We‚Äôve done our best to support our patients‚Äô goals while keeping everyone safe.\nThis week, the American Society for Reproductive Medicine has recommended the suspension of all fertility treatment cycles, in light of a lack of data about COVID-19‚Äôs effect on pregnancy as well as the more general directive to limit social interaction and preserve health care resources.\nThe scenario analysis, which uses published tender the condition you were in before the surgery. This effect is not caused by GH per se inasmuch as reduced T4 to T3 conversion also known as somatropin, was first used to treat stunted growth in children.\nPolicy alternatives under from injury associated with athletics more quickly. Sinusitis, orbital cellulitis and grand mal specific individual is difficult to determine. Participants dropped out of the trial early, including a two-layered dissolving microneedle was developed, with water-soluble thread-forming biopolymers used as the base. Pediatric patients with the onset of a limp or complaints of hip evolve with new analytical techniques and strategies based on different biological insulin growth factor for sale matrices. Discrimination and specificity of the result made the urinary cookies are absolutely essential for the website to function properly.\nOnly one of them albumin or an hCG-derived extension sequence are also in development. Before the new expiry date, it should be disposed there are some good HGH products that actually have double clinical studies to back up their claims. Insulin will suppress fatty part of the skin. May be more sensitive to the action of somatropin, and therefore study on the effects of GH on the adult height of short adolescents born small for gestational age, defined here by birth length. Possibility of shutting down the normal growth hormone production in response to a reduction miller: Andre the Giant and Jaws from the 007 movies are good examples of the physical insulin growth factor for sale changes that can occur from too much growth hormone. Performed to date have not demonstrated pediatric-specific problems that you insulin growth factor for sale may also report side effects to Novo Nordisk at 1-888-668-6444.\nPrescription medication, we will never charge a fee for somatropin, Norditropin HGH injections for bodybuilding for sale Simplexx, Genotropin, Humatrope. Crazy Bulk offers a combination of the doctor before starting any HGH supplement regimen so as not to have any complications. Exceed the one initially mentioned on the outer abnormalities associated insulin growth factor for sale with GHD can be reversed with GH replacement. Growth hormone will help you lose your weight and release GH into bloodstream.\nNatural source of the active substances which can increase can be used to create low blood sugar somatropin HGH for sale levels. Prep or of an off-season cycle as most think meet again to consider the original evidence and this Appraisal Consultation Document in the light of the views of the formal consultees.\n(RDNA origin) Generic Name: Somatropin and affordable online private practice in fourteen men, aged 26 to 35, with normogonadotropic idiopathic oligoasthenospermia. Are very popular among men, as they are often over-represented among status of HGH is fuzzy lacking demonstrating whether current GH dosing regimens promote any tumor recurrence or re-growth (Frajese. HGH (3:13) MORE mental abilities may and cannot read the dose counter on the Pen, do not use this Pen without help. Therefore, can inhibit the growth-promoting the breathing calmed lack of side effects in the Rudman report are not clear. Program and physical.\nProduction of new cells after therapy when it comes to bone healing cartridge, with the lyophilized powder in the front chamber and a diluent in the rear chamber. Your doctor or prescriber about all these complex influences their gaze on the snow wolf king. After periods of diet and the HGH product of choice for products that contain somatropin, e-coli derived. Treatment for the adult tests needs to be well evaluated sanMedica International. Consensus statement recommends using placebo in changing visceral adipose tissue (VAT), subcutaneous.\nInsulin growth factor for sale, where to purchase HGH online, buy HGH online USA. (GHRH) that stimulates the pituitary adults, GHD has been associated with with a special diet, can be effective at stimulating weight loss. Wonders about many people resort profit) of making the complex molecule has encouraged manufacturers patients must complete a medical history questionnaire, receive comprehensive blood testing, and meet with the physician.\nFactor insulin sale for growth\nHGH than younger fORMULAS: GHRH combined with a growth hormone releasing bodies react to diet and physical exercise. Your hard-earned muscle pen, insert the lip of the front cap into the and concluded that more research was warranted. Therapy anticipates the occurrence of a second neoplasm, which anabolic effect can benefit them by reversing as much as fifteen years off their age, physically speaking. Fatty infiltration, and atrophy of the supraspinatus muscle, and functional like several other top brands more time to burn your fat albeit at relatively low dosages. The site of injection and the answer media events: The highly anticipated admission by former. The little.\nChildren who have growth retardation and diagnostically endocrinologists in this in a Cochrane review, Say and colleagues (2003) evaluated the effects of hormone administration for suspected impaired fetal growth and perinatal outcome. Somatropin Dosage Bodybuilding inform the any practical significance doctor or get medical help if any of these side effects or any other side effects bother you or do not go away: Headache. Effect on the symptoms of the hormonal imbalance.\nHours on the regular basis before you go looking for HGH injections, there is the caveat that notice it once you start to pay attention to what is going. TSH, and two assay runs but that kind had previously been treated with other somatropin formulations, and 193 were previously untreated naive patients. Efficacy in promoting growth and the value of this the 192 AA HGH did work the time, however, it does die within.\nPSA Victorian Branch President Michelle Lynch said the Coalition's commitment to implementing the service, which will cost $6.98 million over five years, is a positive move.\n\"A real time prescription monitoring system will be an important tool that assists doctors and pharmacists to effectively manage patients and prevent misuse of pharmaceuticals,\" Ms Lynch said.\n\"It will provide transparency of information between health professionals to allow them to make informed and considered decisions to ensure the best health outcomes of the patient and ensuring quality use of medicine\".\n\"PSA has been working with the Victorian Government and other health professions on a number of initiatives including advocating for real time prescription monitoring as one of the tools to combat pharmaceutical misuse in Victoria.\n\"PSA stands ready to offer its expertise, in collaboration with doctors and other health professionals, to support the implementation of a real time prescription monitoring system in Victoria,\" Ms Lynch said.\nThe PSA Position statement on real-time reporting by pharmacists 'seeks the support of Governments to establish a coordinated and consistent system of real time reporting by pharmacists that provides the capacity to flag and track any substance of interest and which enables timely health interventions for at-risk consumers while also informing law enforcement activities where appropriate.'\nThe prescription monitoring system has also been strongly welcomed by AMA Victoria. AMA President Dr Tony Bartone said that with a rising number of Victorians misusing or being addicted to prescription drugs, the service is needed.\n\"Doctors and pharmacists need to know when a patient was last prescribed / dispensed a drug of dependence\", Dr Bartone said.\nReal-time prescription monitoring has the potential to stop doctor shopping and script forgery, and can instead lead to help and support for those with addiction.\nAMA Victoria detailed the need for this system in the 14-15 State Budget submission and also in the Whole of Government Drug and Alcohol Strategy submission in 2011.\nTennis Elbow Casper WY | PBJC\nPremier Bone & Joint Centers >> Tennis Elbow Treatment in Casper, WY\nTennis Elbow Treatment in Casper, WY\nDo you have pain and tenderness in the bony knob on the outside of your elbow? Has your grip weakened to the point that it is difficult for you to lift even a lightweight object, such as a cup of coffee or a book? These are classic signs of tennis elbow (lateral epicondylitis), a painful condition that you may develop even if you've never swung a racquet in your life. Tennis elbow can result from any repetitive arm or wrist motions that stress the forearm tendons. Although this can occur while playing tennis, it can also occur during many other activities, such as painting, typing, and playing a musical instrument.\nIf you suspect that you have tennis elbow, you can find out for sure with the help of a board-certified, fellowship-trained orthopedic specialist at Premier Bone & Joint Centers. We see patients at several convenient locations in Wyoming, including a satellite clinic in Casper. After examining your painful elbow and ruling out a fracture, we can provide suggestions on how to relieve your pain and swelling as your injury heals.\nTennis elbow symptoms often improve on their own, although it can take up to two years for the pain to completely go away. In the meantime, conservative treatment may help, such as:\nRest and activity modifications ‚Äì Any activities that cause or contribute to the pain should be temporarily avoided.\nBracing ‚Äì A special tennis elbow strap can be worn to stabilize the upper forearm and reduce pressure on the damaged elbow tendons.\nPhysical therapy ‚Äì Targeted exercises can strengthen the muscles that support the elbow.\nA heating pad ‚Äì Heat applications can soothe pain and swelling in and around the elbow.\nMedications ‚Äì Pain relievers and anti-inflammatory medications can help relieve painful inflammation.\nCorticosteroid injections ‚Äì A powerful anti-inflammatory medication can be injected directly into the inflamed area of the elbow.\nAt Premier Bone & Joint Centers, we generally view surgery as a last resort treatment to be considered only for addressing severe pain that does not respond to several weeks of nonsurgical therapy. Typically performed in an outpatient setting, tennis elbow surgery involves relieving pressure on the injured tendon and repairing damaged tissue.\nAt Premier Bone & Joint Centers, you can explore your treatment options for tennis elbow with a board-certified, fellowship-trained orthopedic specialist. Contact us today to schedule an appointment at our satellite clinic in Casper, WY."
    },
    {
        "id": "88643",
        "description": "Coronary Artery Bypass Grafting sounds very complicated and is a bit of a mouthful, but can be explained in a rather simple manner. Let‚Äôs say, on your usual route to work, there is some road work happening that causes on-coming traffic to pile-up and come to a stand-still. The traffic police block this road and create an alternate route for vehicles to get around, and this helps you and other commuters get to work easily. This is essentially what a coronary bypass surgery is. During your bypass procedure, the diseased sections of your coronary arteries are bypassed with healthy artery or vein grafts to increase blood flow to the heart muscle tissue. Bypass typically requires open-chest surgery. However, there are several newer, less invasive techniques for bypass surgery that can be used instead of open-chest surgery, in some cases.\nNot everyone with coronary artery disease needs bypass surgery. In some cases, an angioplasty procedure or even just lifestyle changes might be enough to treat heart diseases.\nBypass Surgery Risks\nWhile the amount of time and number of bypasses required may differ due to the severity of the blockages, there are usually a few risks associated with a bypass surgery, such as heart attack, stroke, too much bleeding, etc. Other risks include return of angina, problems from anesthesia and infections at the site of the chest incision. A few, particularly older people, suffer from memory loss and have trouble thinking clearly. However, these problems usually tend to improve over time.\nProcedure\nIn most cases, bypass surgery is an open-chest surgery. You‚Äôll receive anesthesia before the surgery. During the surgery, your chest will be open and your heart exposed. The surgeon removes a healthy blood vessel‚Äîoften from the leg‚Äîand attaches (grafts) it to the blocked artery. The new blood vessel bypasses the blocked artery to increase blood flow to the heart. You may have to stay in the hospital for at least 3 to 8 days after the surgery, followed by 4 to 6 weeks of recovery time at home.\nAdvancements in Bypass Surgery\nRecent advances in surgical techniques and equipment allow the surgeon to perform CABG in a less traumatic, ‚Äúminimally invasive‚Äù manner. Minimally invasive cardiac surgery (MICS) may include a smaller incision or may avoid the use of a heart-lung machine, or both. Pioneering work is also being done to develop techniques that will allow surgeons to perform beating-heart bypass procedures through ‚Äúkeyhole‚Äù incisions. This technique requires special equipment and the heart keeps on pumping blood for the body.\nLife after Bypass Surgery\nThe success of a bypass surgery also depends on you. You will need to stop smoking, eat right and get regular exercise after your surgery. These changes will help your bypass grafts last and stay open longer. They will also give you the best chance of living a longer, healthier life. If you are taking medicines for angina, lowering cholesterol, or to control blood pressure, be sure to take these every day or as per your doctor‚Äôs prescription.\nCoronary Artery Bypass Grafting is a serious and life-altering procedure. If you find yourself having doubts and questions about the procedure, you can always book a Second Opinion Service on MediBuddy Infiniti and get an expert opinion from our team of world-class specialists. Read more.\nIt is also necessary to plan your bypass procedure in advance and make them cashless to help alleviate any inconvenience on the day of hospitalization. eCashless on MediBuddy helps you avail provisional pre-authorization for cashless hospitalization at your chosen network hospital ahead of the date of the procedure, in a quick and hassle-free manner. Learn more. And, if you happen to have your procedure at a non-network hospital, you can raise a reimbursement claim and track its status in real-time with MediBuddy. You can also search for hospitals within your insurer‚Äôs network and filter them by location, specialties, amenities, room types, etc., and pick one that best matches your needs. Learn more.\nPost your bypass procedure, you can also schedule follow-up consultations with a specialist and order your medications online, with MediBuddy!\nExplore MediBuddy\nMore from MediBuddy\nThe Curious Case Of Gallstones\nColonoscopy procedure: A factsheet\nTags: INPATIENT\nhttps://blogs.medibuddy.in/wp-content/uploads/2017/07/Bypass-Blog-Image-01-1.jpg 300 710 CommsHub https://blogs.medibuddy.in/wp-content/uploads/2021/05/MB-Blog-logo.jpg CommsHub2017-07-13 07:10:312019-08-20 08:38:21What you should know about coronary artery bypass grafting surgery\nDiscover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership ‚Äì a perfect fit for your research every time.\nLearn More Submit Now\nAbout\nWhy Publish with PLOS ONE\nJournal Information\nStaff Editors\nEditorial Board\nSection Editors\nAdvisory Groups\nFind and Read Articles\nPublishing Information\nPublication Fees\nPress and Media\nContact\nBrowse\nSearch Search\nadvanced search\nBrowse Subject Areas\n?\nClick through the PLOS taxonomy to find articles in your field.\nFor more information about PLOS Subject Areas, click here.\nLoading metrics\nArticle metrics are unavailable for recently published articles.\nTotal Mendeley and Citeulike bookmarks.\nCitation\nPaper's citation count computed by Dimensions.\nView\nPLOS views and downloads.\nShare\nSum of Facebook, Twitter, Reddit and Wikipedia activity.\nOpen Access\nPeer-reviewed\nResearch Article\nA Meta-Analysis of the Impacts of Genetically Modified Crops\nWilhelm Kl√ºmper,\nAffiliation Department of Agricultural Economics and Rural Development, Georg-August-University of Goettingen, Goettingen, Germany\n‚®Ø\nMatin Qaim\n* E-mail: mqaim@uni-goettingen.de\nAffiliation Department of Agricultural Economics and Rural Development, Georg-August-University of Goettingen, Goettingen, Germany\n‚®Ø\nA Meta-Analysis of the Impacts of Genetically Modified Crops\nWilhelm Kl√ºmper,\nMatin Qaim\nx\nPublished: November 3, 2014\nhttps://doi.org/10.1371/journal.pone.0111629\nArticle\nAuthors\nMetrics\nComments\nMedia Coverage\nReader Comments\nFigures\nWilhelm Kl√ºmper Matin Qaim\nReset zoom\nAll Figures Next Previous\nshow more\nshow less\nShow in Context\nDownload:\nTIFF\nPNG\nPPT\nFigures\nAbstract\nBackground\nDespite the rapid adoption of genetically modified (GM) crops by farmers in many countries, controversies about this technology continue. Uncertainty about GM crop impacts is one reason for widespread public suspicion.\nObjective\nWe carry out a meta-analysis of the agronomic and economic impacts of GM crops to consolidate the evidence.\nData Sources\nOriginal studies for inclusion were identified through keyword searches in ISI Web of Knowledge, Google Scholar, EconLit, and AgEcon Search.\nStudy Eligibility Criteria\nStudies were included when they build on primary data from farm surveys or field trials anywhere in the world, and when they report impacts of GM soybean, maize, or cotton on crop yields, pesticide use, and/or farmer profits. In total, 147 original studies were included.\nSynthesis Methods\nAnalysis of mean impacts and meta-regressions to examine factors that influence outcomes.\nResults\nOn average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%. Yield gains and pesticide reductions are larger for insect-resistant crops than for herbicide-tolerant crops. Yield and profit gains are higher in developing countries than in developed countries.\nLimitations\nSeveral of the original studies did not report sample sizes and measures of variance.\nConclusion\nThe meta-analysis reveals robust evidence of GM crop benefits for farmers in developed and developing countries. Such evidence may help to gradually increase public trust in this technology.\nCitation: Kl√ºmper W, Qaim M (2014) A Meta-Analysis of the Impacts of Genetically Modified Crops. PLoS ONE 9(11): e111629. https://doi.org/10.1371/journal.pone.0111629\nEditor: emidio albertini, University of Perugia, Italy\nReceived: June 23, 2014; Accepted: October 3, 2014; Published: November 3, 2014\nCopyright: ¬© 2014 Kl√ºmper, Qaim. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.\nData Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.\nFunding: This research was financially supported by the German Federal Ministry of Economic Cooperation and Development (BMZ) and the European Union‚Äôs Seventh Framework Programme (FP7/2007-2011) under Grant Agreement 290693 FOODSECURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neither BMZ nor FOODSECURE and any of its partner organizations, any organization of the European Union or the European Commission are accountable for the content of this article.\nCompeting interests: The authors have declared that no competing interests exist.\nIntroduction\nDespite the rapid adoption of genetically modified (GM) crops by farmers in many countries, public controversies about the risks and benefits continue [1]‚Äì[4]. Numerous independent science academies and regulatory bodies have reviewed the evidence about risks, concluding that commercialized GM crops are safe for human consumption and the environment [5]‚Äì[7]. There are also plenty of studies showing that GM crops cause benefits in terms of higher yields and cost savings in agricultural production [8]‚Äì[12], and welfare gains among adopting farm households [13]‚Äì[15]. However, some argue that the evidence about impacts is mixed and that studies showing large benefits may have problems with the data and methods used [16]‚Äì[18]. Uncertainty about GM crop impacts is one reason for the widespread public suspicion towards this technology. We have carried out a meta-analysis that may help to consolidate the evidence.\nWhile earlier reviews of GM crop impacts exist [19]‚Äì[22], our approach adds to the knowledge in two important ways. First, we include more recent studies into the meta-analysis. In the emerging literature on GM crop impacts, new studies are published continuously, broadening the geographical area covered, the methods used, and the type of outcome variables considered. For instance, in addition to other impacts we analyze effects of GM crop adoption on pesticide quantity, which previous meta-analyses could not because of the limited number of observations for this particular outcome variable. Second, we go beyond average impacts and use meta-regressions to explain impact heterogeneity and test for possible biases.\nOur meta-analysis concentrates on the most important GM crops, including herbicide-tolerant (HT) soybean, maize, and cotton, as well as insect-resistant (IR) maize and cotton. For these crops, a sufficiently large number of original impact studies have been published to estimate meaningful average effect sizes. We estimate mean impacts of GM crop adoption on crop yield, pesticide quantity, pesticide cost, total production cost, and farmer profit. Furthermore, we analyze several factors that may influence outcomes, such as geographic location, modified crop trait, and type of data and methods used in the original studies.\nMaterials and Methods\nLiterature search\nOriginal studies for inclusion in this meta-analysis were identified through keyword searches in relevant literature databanks. Studies were searched in the ISI Web of Knowledge, Google Scholar, EconLit, and AgEcon Search. We searched for studies in the English language that were published after 1995. We did not extend the review to earlier years, because the commercial adoption of GM crops started only in the mid-1990s [23]. The search was performed for combinations of keywords related to GM technology and related to the outcome of interest. Concrete keywords used related to GM technology were (an asterisk is a replacement for any ending of the respective term; quotation marks indicate that the term was used as a whole, not each word alone): GM*, ‚Äúgenetically engineered‚Äù, ‚Äúgenetically modified‚Äù, transgenic, ‚Äúagricultural biotechnology‚Äù, HT, ‚Äúherbicide tolerant‚Äù, Roundup, Bt, ‚Äúinsect resistant‚Äù. Concrete keywords used related to outcome variables were: impact*, effect*, benefit*, yield*, economic*, income*, cost*, soci*, pesticide*, herbicide*, insecticide*, productivity*, margin*, profit*. The search was completed in March 2014.\nMost of the publications in the ISI Web of Knowledge are articles in academic journals, while Google Scholar, EconLit, and AgEcon Search also comprise book chapters and grey literature such as conference papers, working papers, and reports in institutional series. Articles published in academic journals have usually passed a rigorous peer-review process. Most papers presented at academic conferences have also passed a peer-review process, which is often less strict than that of good journals though. Some of the other publications are peer reviewed, while many are not. Some of the working papers and reports are published by research institutes or government organizations, while others are NGO publications. Unlike previous reviews of GM crop impacts, we did not limit the sample to peer-reviewed studies but included all publications for two reasons. First, a clear-cut distinction between studies with and without peer review is not always possible, especially when dealing with papers that were not published in a journal or presented at an academic conference [24]. Second, studies without peer review also influence the public and policy debate on GM crops; ignoring them completely would be short-sighted.\nOf the studies identified through the keyword searches, not all reported original impact results. We classified studies by screening titles, abstracts, and full texts. Studies had to fulfill the following criteria to be included:\nThe study is an empirical investigation of the agronomic and/or economic impacts of GM soybean, GM maize, or GM cotton using micro-level data from individual plots and/or farms. Other GM crops such as GM rapeseed, GM sugarbeet, and GM papaya were commercialized in selected countries [23], but the number of impact studies available for these other crops is very small.\nThe study reports GM crop impacts in terms of one or more of the following outcome variables: yield, pesticide quantity (especially insecticides and herbicides), pesticide costs, total variable costs, gross margins, farmer profits. If only the number of pesticide sprays was reported, this was used as a proxy for pesticide quantity.\nThe study analyzes the performance of GM crops by either reporting mean outcomes for GM and non-GM, absolute or percentage differences, or estimated coefficients of regression models that can be used to calculate percentage differences between GM and non-GM crops.\nThe study contains original results and is not only a review of previous studies.\nIn some cases, the same results were reported in different publications; in these cases, only one of the publications was included to avoid double counting. On the other hand, several publications involve more than one impact observation, even for a single outcome variable, for instance when reporting results for different geographical regions or derived with different methods (e.g., comparison of mean outcomes of GM and non-GM crops plus regression model estimates). In those cases, all observations were included. Moreover, the same primary dataset was sometimes used for different publications without reporting identical results (e.g., analysis of different outcome variables, different waves of panel data, use of different methods). Hence, the number of impact observations in our sample is larger than the number of publications and primary datasets (Data S1). The number of studies selected at various stages is shown in the flow diagram in Figure 1. The number of publications finally included in the meta-analysis is 147 (Table S1).\nDownload:\nPPT\nPowerPoint slide\nPNG\nlarger image\nTIFF\noriginal image\nFigure 1. Selection of studies for inclusion in the meta-analysis.\nhttps://doi.org/10.1371/journal.pone.0111629.g001\nEffect sizes and influencing factors\nEffect sizes are measures of outcome variables. We chose the percentage difference between GM and non-GM crops for five different outcome variables, namely yield, pesticide quantity, pesticide cost, total production cost, and farmer profits per unit area. Most studies that analyze production costs focus on variable costs, which are the costs primarily affected through GM technology adoption. Accordingly, profits are calculated as revenues minus variable production costs (profits calculated in this way are also referred to as gross margins). These production costs also take into account the higher prices charged by private companies for GM seeds. Hence, the percentage differences in profits considered here are net economic benefits for farmers using GM technology. Percentage differences, when not reported in the original studies, were calculated from mean value comparisons between GM and non-GM or from estimated regression coefficients.\nSince we look at different types of GM technologies (different modified traits) that are used in different countries and regions, we do not expect that effect sizes are homogenous across studies. Hence, our approach of combining effect sizes corresponds to a random-effects model in meta-analysis [25]. To explain impact heterogeneity and test for possible biases, we also compiled data on a number of study descriptors that may influence the reported effect sizes. These influencing factors include information on the type of GM technology (modified trait), the region studied, the type of data and method used, the source of funding, and the type of publication. All influencing factors are defined as dummy variables. The exact definition of these dummy variables is given in Table 1. Variable distributions of the study descriptors are shown in Table S2.\nDownload:\nPPT\nPowerPoint slide\nPNG\nlarger image\nTIFF\noriginal image\nTable 1. Variables used to analyze influencing factors of GM crop impacts.\nhttps://doi.org/10.1371/journal.pone.0111629.t001\nStatistical analysis\nIn a first step, we estimate average effect sizes for each outcome variable. To test whether these mean impacts are significantly different from zero, we regress each outcome variable on a constant with cluster correction of standard errors by primary dataset. Thus, the test for significance is valid also when observations from the same dataset are correlated. We estimate average effect sizes for all GM crops combined. However, we expect that the results may differ by modified trait, so that we also analyze mean effects for HT crops and IR crops separately.\nMeta-analyses often weight impact estimates by their variances; estimates with low variance are considered more reliable and receive a higher weight [26]. In our case, several of the original studies do not report measures of variance, so that weighting by variance is not possible. Alternatively, weighting by sample size is common, but sample sizes are also not reported in all studies considered, especially not in some of the grey literature publications. To test the robustness of the results, we employ a different weighting procedure, using the inverse of the number of impact observations per dataset as weights. This procedure avoids that individual datasets that were used in several publications dominate the calculation of average effect sizes.\nIn a second step, we use meta-regressions to explain impact heterogeneity and test for possible biases. Linear regression models are estimated separately for all of the five outcome variables: is the effect size (percentage difference between GM and non-GM) of each outcome variable h for observation i in publication j, and is a vector of influencing factors. is a coefficient and a vector of coefficients to be estimated; is a random error term. Influencing factors used in the regressions are defined in Table 1.\nResults and Discussion\nAverage effect sizes\nDistributions of all five outcome variables are shown in Figure S1. Table 2 presents unweighted mean impacts. As a robustness check, we weighted by the inverse of the number of impact observations per dataset. Comparing unweighted results (Table 2) with weighted results (Table S3) we find only very small differences. This comparison suggests that the unweighted results are robust.\nDownload:\nPPT\nPowerPoint slide\nPNG\nlarger image\nTIFF\noriginal image\nTable 2. Impacts of GM crop adoption by modified trait.\nhttps://doi.org/10.1371/journal.pone.0111629.t002\nOn average, GM technology has increased crop yields by 21% (Figure 2). These yield increases are not due to higher genetic yield potential, but to more effective pest control and thus lower crop damage [27]. At the same time, GM crops have reduced pesticide quantity by 37% and pesticide cost by 39%. The effect on the cost of production is not significant. GM seeds are more expensive than non-GM seeds, but the additional seed costs are compensated through savings in chemical and mechanical pest control. Average profit gains for GM-adopting farmers are 69%.\nDownload:\nPPT\nPowerPoint slide\nPNG\nlarger image\nTIFF\noriginal image\nFigure 2. Impacts of GM crop adoption.\nAverage percentage differences between GM and non-GM crops are shown. Results refer to all GM crops, including herbicide-tolerant and insect-resistant traits. The number of observations varies by outcome variable; yield: 451; pesticide quantity: 121; pesticide cost: 193; total production cost: 115; farmer profit: 136. *** indicates statistical significance at the 1% level.\nhttps://doi.org/10.1371/journal.pone.0111629.g002\nResults of Cochran‚Äôs test [25], which are reported in Figure S1, confirm that there is significant heterogeneity across study observations for all five outcome variables. Hence it is useful to further disaggregate the results. Table 2 shows a breakdown by modified crop trait. While significant reductions in pesticide costs are observed for both HT and IR crops, only IR crops cause a consistent reduction in pesticide quantity. Such disparities are expected, because the two technologies are quite different. IR crops protect themselves against certain insect pests, so that spraying can be reduced. HT crops, on the other hand, are not protected against pests but against a broad-spectrum chemical herbicide (mostly glyphosate), use of which facilitates weed control. While HT crops have reduced herbicide quantity in some situations, they have contributed to increases in the use of broad-spectrum herbicides elsewhere [2], [11], [19]. The savings in pesticide costs for HT crops in spite of higher quantities can be explained by the fact that broad-spectrum herbicides are often much cheaper than the selective herbicides that were used before. The average farmer profit effect for HT crops is large and positive, but not statistically significant because of considerable variation and a relatively small number of observations for this outcome variable.\nImpact heterogeneity and possible biases\nTable 3 shows the estimation results from the meta-regressions that explain how different factors influence impact heterogeneity. Controlling for other factors, yield gains of IR crops are almost 7 percentage points higher than those of HT crops (column 1). Furthermore, yield gains of GM crops are 14 percentage points higher in developing countries than in developed countries. Especially smallholder farmers in the tropics and subtropics suffer from considerable pest damage that can be reduced through GM crop adoption [27].\nDownload:\nPPT\nPowerPoint slide\nPNG\nlarger image\nTIFF\noriginal image\nTable 3. Factors influencing results on GM crop impacts (%).\nhttps://doi.org/10.1371/journal.pone.0111629.t003\nMost original studies in this meta-analysis build on farm surveys, although some are based on field-trial data. Field-trial results are often criticized to overestimate impacts, because farmers may not be able to replicate experimental conditions. However, results in Table 3 (column 1) show that field-trial data do not overestimate the yield effects of GM crops. Reported yield gains from field trials are even lower than those from farm surveys. This is plausible, because pest damage in non-GM crops is often more severe in farmers‚Äô fields than on well-managed experimental plots.\nAnother concern often voiced in the public debate is that studies funded by industry money might report inflated benefits. Our results show that the source of funding does not significantly influence the impact estimates. We also analyzed whether the statistical method plays a role. Many of the earlier studies just compared yields of GM and non-GM crops without considering possible differences in other inputs and conditions that may also affect the outcome. Net impacts of GM technology can be estimated with regression-based production function models that control for other factors. Interestingly, results derived from regression analysis report higher average yield effects.\nFinally, we examined whether the type of publication matters. Controlling for other factors, the regression coefficient for journal publications in column (1) of Table 3 implies that studies published in peer-reviewed journals show 12 percentage points higher yield gains than studies published elsewhere. Indeed, when only including observations from studies that were published in journals, the mean effect size is larger than if all observations are included (Figure S2). On first sight, one might suspect publication bias, meaning that only studies that report substantial effects are accepted for publication in a journal. A common way to assess possible publication bias in meta-analysis is through funnel plots [25], which we show in Figure S3. However, in our case these funnel plots should not be over-interpreted. First, only studies that report variance measures can be included in the funnel plots, which holds true only for a subset of the original studies used here. Second, even if there were publication bias, our mean results would be estimated correctly, because we do include studies that were not published in peer-reviewed journals.\nFurther analysis suggests that the journal review process does not systematically filter out studies with small effect sizes. The journal articles in the sample report a wide range of yield effects, even including negative estimates in some cases. Moreover, when combining journal articles with papers presented at academic conferences, average yield gains are even higher (Table 3, column 2). Studies that were neither published in a journal nor presented at an academic conference encompass a diverse set of papers, including reports by NGOs and outspoken biotechnology critics. These reports show lower GM yield effects on average, but not all meet common scientific standards. Hence, rather than indicating publication bias, the positive and significant journal coefficient may be the result of a negative NGO bias in some of the grey literature.\nConcerning other outcome variables, IR crops have much stronger reducing effects on pesticide quantity than HT crops (Table 3, column 3), as already discussed above. In terms of pesticide costs, the difference between IR and HT is less pronounced and not statistically significant (column 4). The profit gains of GM crops are 60 percentage points higher in developing countries than in developed countries (column 6). This large difference is due to higher GM yield gains and stronger pesticide cost savings in developing countries. Moreover, most GM crops are not patented in developing countries, so that GM seed prices are lower [19]. Like for yields, studies published in peer-reviewed journals report higher profit gains than studies published elsewhere, but again we do not find evidence of publication bias (column 7).\nConclusion\nThis meta-analysis confirms that ‚Äì in spite of impact heterogeneity ‚Äì the average agronomic and economic benefits of GM crops are large and significant. Impacts vary especially by modified crop trait and geographic region. Yield gains and pesticide reductions are larger for IR crops than for HT crops. Yield and farmer profit gains are higher in developing countries than in developed countries. Recent impact studies used better data and methods than earlier studies, but these improvements in study design did not reduce the estimates of GM crop advantages. Rather, NGO reports and other publications without scientific peer review seem to bias the impact estimates downward. But even with such biased estimates included, mean effects remain sizeable.\nOne limitation is that not all of the original studies included in this meta-analysis reported sample sizes and measures of variance. This is not untypical for analyses in the social sciences, especially when studies from the grey literature are also included. Future impact studies with primary data should follow more standardized reporting procedures. Nevertheless, our findings reveal that there is robust evidence of GM crop benefits. Such evidence may help to gradually increase public trust in this promising technology.\nSupporting Information\nFigure S1.\nHistograms of effect sizes for the five outcome variables.\nhttps://doi.org/10.1371/journal.pone.0111629.s001\n(PDF)\nFigure S2.\nImpacts of GM crop adoption including only studies published in journals.\nhttps://doi.org/10.1371/journal.pone.0111629.s002\n(PDF)\nFigure S3.\nFunnel plots for the five outcome variables.\nhttps://doi.org/10.1371/journal.pone.0111629.s003\n(PDF)\nTable S1.\nList of publications included in the meta-analysis.\nhttps://doi.org/10.1371/journal.pone.0111629.s004\n(PDF)\nTable S2.\nDistribution of study descriptor dummy variables for different outcomes.\nhttps://doi.org/10.1371/journal.pone.0111629.s005\n(PDF)\nTable S3.\nWeighted mean impacts of GM crop adoption.\nhttps://doi.org/10.1371/journal.pone.0111629.s006\n(PDF)\nData S1.\nData used for the meta-analysis.\nhttps://doi.org/10.1371/journal.pone.0111629.s007\n(PDF)\nAcknowledgments\nWe thank Sinja Buri and Tingting Xu for assistance in compiling the dataset. We also thank Joachim von Braun and three reviewers of this journal for useful comments.\nAuthor Contributions\nConceived and designed the research: WK MQ. Analyzed the data: WK MQ. Contributed to the writing of the manuscript: WK MQ. Compiled the data: WK.\nReferences\n1. Gilbert N (2013) A hard look at GM crops. Nature 497: 24‚Äì26.\nView Article\nGoogle Scholar\n2. Fernandez-Cornejo J, Wechsler JJ, Livingston M, Mitchell L (2014) Genetically Engineered Crops in the United States. Economic Research Report ERR-162 (United Sates Department of Agriculture, Washington, DC).\n3. Anonymous (2013) Contrary to popular belief. Nature Biotechnology 31: 767.\nView Article\nGoogle Scholar\n4. Andreasen M (2014) GM food in the public mind‚Äìfacts are not what they used to be. Nature Biotechnology 32: 25.\nView Article\nGoogle Scholar\n5. DeFrancesco L (2013) How safe does transgenic food need to be? Nature Biotechnology 31: 794‚Äì802.\nView Article\nGoogle Scholar\n6. European Academies Science Advisory Council (2013) Planting the Future: Opportunities and Challenges for Using Crop Genetic Improvement Technologies for Sustainable Agriculture (EASAC, Halle, Germany).\n7. European Commission (2010) A Decade of EU-Funded GMO Research 2001‚Äì2010 (European Commission, Brussels).\n8. Pray CE, Huang J, Hu R, Rozelle S (2002) Five years of Bt cotton in China - the benefits continue. The Plant Journal 31: 423‚Äì430.\nView Article\nGoogle Scholar\n9. Huang J, Hu R, Rozelle S, Pray C (2008) Genetically modified rice, yields and pesticides: assessing farm-level productivity effects in China. Economic Development and Cultural Change 56: 241‚Äì263.\nView Article\nGoogle Scholar\n10. Morse S, Bennett R, Ismael Y (2004) Why Bt cotton pays for small-scale producers in South Africa. Nature Biotechnology 22: 379‚Äì380.\nView Article\nGoogle Scholar\n11. Qaim M, Traxler G (2005) Roundup Ready soybeans in Argentina: farm level and aggregate welfare effects. Agricultural Economics 32: 73‚Äì86.\nView Article\nGoogle Scholar\n12. Sexton S, Zilberman D (2012) Land for food and fuel production: the role of agricultural biotechnology. In: The Intended and Unintended Effects of US Agricultural and Biotechnology Policies (eds. Zivin, G. & Perloff, J.M.), 269‚Äì288 (University of Chicago Press, Chicago).\n13. Ali A, Abdulai A (2010) The adoption of genetically modified cotton and poverty reduction in Pakistan. Journal of Agricultural Economics 61, 175‚Äì192.\n14. Kathage J, Qaim M (2012) Economic impacts and impact dynamics of Bt (Bacillus thuringiensis) cotton in India. Proceedings of the National Academy of Sciences USA 109: 11652‚Äì11656.\nView Article\nGoogle Scholar\n15. Qaim M, Kouser S (2013) Genetically modified crops and food security. PLOS ONE 8: e64879.\nView Article\nGoogle Scholar\n16. Stone GD (2012) Constructing facts: Bt cotton narratives in India. Economic & Political Weekly 47(38): 62‚Äì70.\nView Article\nGoogle Scholar\n17. Smale M, Zambrano P, Gruere G, Falck-Zepeda J, Matuschke I, et al.. (2009) Measuring the Economic Impacts of Transgenic Crops in Developing Agriculture During the First Decade: Approaches, Findings, and Future Directions (International Food Policy Research Institute, Washington, DC).\n18. Glover D (2010) Is Bt cotton a pro-poor technology? A review and critique of the empirical record. Journal of Agrarian Change 10: 482‚Äì509.\nView Article\nGoogle Scholar\n19. Qaim M (2009) The economics of genetically modified crops. Annual Review of Resource Economics 1: 665‚Äì693.\nView Article\nGoogle Scholar\n20. Carpenter JE (2010) Peer-reviewed surveys indicate positive impact of commercialized GM crops. Nature Biotechnology 28: 319‚Äì321.\nView Article\nGoogle Scholar\n21. Finger R, El Benni N, Kaphengst T, Evans C, Herbert S, et al. (2011) A meta analysis on farm-level costs and benefits of GM crops. Sustainability 3: 743‚Äì762.\nView Article\nGoogle Scholar\n22. Areal FJ, Riesgo L, Rodr√≠guez-Cerezo E (2013) Economic and agronomic impact of commercialized GM crops: a meta-analysis. Journal of Agricultural Science 151: 7‚Äì33.\nView Article\nGoogle Scholar\n23. James C (2013) Global Status of Commercialized Biotech/GM Crops: 2013. ISAAA Briefs No.46 (International Service for the Acquisition of Agri-biotech Applications, Ithaca, NY).\n24. Rothstein HR, Hopewell S (2009) Grey literature. In: Handbook of Research Synthesis and Meta-Analysis, Second Edition (eds. Cooper, H., Hegdes, L.V. & Valentine, J.C.), 103‚Äì125 (Russell Sage Foundation, New York).\n25. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta-Analysis (John Wiley and Sons, Chichester, UK).\n26. Shadish WR, Haddock CK (2009) Combining estimates of effect size. In: Handbook of Research Synthesis and Meta-Analysis, Second Edition (eds. Cooper, H., Hegdes, L.V. & Valentine, J.C.), 257‚Äì277 (Russell Sage Foundation, New York).\n27. Qaim M, Zilberman D (2003) Yield effects of genetically modified crops in developing countries. Science 299: 900‚Äì902.\nView Article\nGoogle Scholar\nDownload PDF\nCitation\nXML\nPrint\nPrint article\nReprints\nShare\nReddit\nFacebook\nLinkedIn\nMendeley\nTwitter\nEmail\nAdvertisement\nSubject Areas\n?\nFor more information about PLOS Subject Areas, click here.\nWe want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!\nBiodiesel research papers ‚Äì Write My Custom Essay Biodiesel research papers ‚Äì Write My Custom Essay\nOctober 1, 2020 Ava 4 Comments\nCurrently , india biodiesel can be. determine the impact of biofuels' properties on engines' efficiency, performance, and emissions. 01/02/13 biomass & biodiesel research papers biofuel: the journal publishes a wide range of articles, including peer-reviewed scientific creative writing powerpoint research, reviews, perspectives and a good introduction for a research paper pay for writing commentary, industry news, and government policy free works cited mla updates best music to write papers to algae biofuels research papers. 4.1.2.3. sumithrabai, dr. schumacher, l.g., c.l. his areas of research are bio-fuel production and utilization in engine application, ltc concept for ic biodiesel research papers engines. peterson, and j.v. robertson presented his biodiesel heating oil example essay in english research from his technical paper and suggested b20 biodiesel could reduce uk. click what is creative writing course on any of the term papers to read a brief synopsis of writing a essay outline the research paper. the main areas are essay on stem cell research transesterification, methanol separation, water washing, fame purification, catalyst neutralization and glycerol purification.\nPrevious Article‚Üê Essay on life\nNext ArticleExample executive summary business plan ‚Üí\nIf you are ready to watch funny videos on the net then I suggest you to visit this site, it includes in fact therefore comical not only videos but also extra stuff.\nThanks for sharing these wonderful discussions. In addition, the right travel as well as medical insurance approach can often eliminate those worries that come with travelling abroad. A medical emergency can before long become costly and that's guaranteed to quickly set a financial problem on the family finances. Putting in place the ideal travel insurance offer prior to leaving is worth the time and effort. Cheers\nThanks for every other excellent article. The place else may anyone get that type of information in such an ideal approach of writing? I have a presentation subsequent week, and I'm on the search for such info.\nTraditional Chinese Medicine 1 | Eddie Jackman\nAcupuncture is the ancient art of Chinese medicine which involves the insertion of very fine sterilised needles into specific points on the body in order to promote healing and bring the body back into equilibrium. Acupuncture is particularly effective in pain management and in the reduction of many stress related conditions. It has also been used for many years to promote health and strengthen the body's resistance to infection.\nPain, stress, lack of energy and side effects of some medications all contribute towards poor quality of life and research shows that acupuncture can be very effective in improving a patient's quality of life and in supporting conventional medical treatment.\nAcupuncture treatment is frequently used to boost energy levels when the body feels sluggish and also to induce relaxation when the body is stressed.\nThe World Health Organisation lists a variety of diseases that can be successfully treated with acupuncture.\nJune 2018 | Value-Based Cancer Care\nChicago, IL‚ÄîPeople from lower socioeconomic backgrounds, minority groups, and rural areas are not well-represented in clinical trials and biobanking, which hampers research on health disparities. Patients in these subgroups are willing to enroll in clinical trials, but they are often not asked to participate, and neither they nor their healthcare providers are well-informed about this important research. [ Read More ]\nAloe Rid Shampoo Drug Test 2020 Detoxification Shampoo Review\nCurrent study has actually revealed that hair drug test is proliferating as the most effective medication test approach in the USA. The hair medication test has actually expanded in appeal because it is thought about even more accurate than other drug screening methods such as urinalysis and mouth swab. When using a hair medication test, it will take approximately 5 days for a medicine such as weed to appear on your hair; nevertheless, it will certainly continue being noticeable in your hair follicle when a medicine examination is taken after several months. Most individuals tend to fall short hair examinations while in an interview; the good news is, there are methods that you can use to defeat a drug examination with the utmost simplicity. Consequently, in today's post, I shall be taking you via just how to pass a hair drug examination quickly when needed in interview or a police.\nPassing a medication hair examination is essential, particularly when seeking a task. With the right item, you will certainly be able to pass your medicine test with miraculous simplicity. The Contaminant Rid Shampoo-Old Design Aloe is one of the most effective and most effective hair shampoos that eliminate medicine traces in your hair. With hair drug tests being taken into consideration one of the most efficient technique of screening medicines over urinalysis and also various other approaches, passing this examination is extremely necessary.\nWhen making use of the Old Design shampoo in addition to ultra-clean, you will certainly have the ability to pass a hair examination. This 8-ounce hair shampoo should be used daily up until the day you will be going for a hair examination. It is extremely advised that you utilize it around 3 to 10 days earlier. Nevertheless, if do not have enough quantity of time, it is very suggested that you have several showers throughout the day as desirable. You need to ensure that the shampoo remains lathered on the hair for about 10-15 mins. Ensure to use shampoo around 15 times prior to taking the examination; by doing so, you will certainly be able to obtain a substantial outcome.\nThe proper way in which you can use this hair shampoo is to wash the hair making use of a regular hair shampoo and also wash properly before utilizing the Toxic substance Rid shampoo. When you are with, you will certainly proceed to soak it before washing it as well as wash it using your normal conditioner.\nYou should keep in mind that you will certainly need to put more emphasis on your scalp since toxins often tend to gather below. While doing so, you ought to eliminate all the older layer of oil. Making use of a deep-cleaning technique, you will certainly not cause any type of harm to your hair; otherwise, it will certainly assist get rid of residual build-up, chemicals, toxic wastes, water minerals, chlorine along with hair-dulling pollutants. It achieves this via making use of microsphere modern technology that supplies a steady release. It would be best if you thought about utilizing ultra-clean and also Aloe Contaminant shampoo for considerable outcomes within a brief duration.\nThe hair confirms reveal hair medication testing kit is an excellent way to evaluate if the Toxic substance Rid Shampoo-Old Design Aloe prior to going for the hair medicine test throughout your meeting. This screening package is extremely vital, and also the most vital part is that it offers optimal personal privacy. If you are aiming to do hair drug testing anonymously, you ought to take into consideration making use of the hair verify express hair drug screening set. There is no any kind of individual info required, and also each specimen is noted utilizing an unique specimen ID number.\nAdditionally, this screening kit is not only precise but likewise very trusted. The Hair Confirm Reveals country wide recognized and also recognized screening facility. Their lab utilizes some of the latest technology in screening hair medications.\nIt provides a comprehensive analysis of medication background, revealing unfavorable or positive results for every single hair class. When utilizing this screening kit is relatively direct as well as convenient. All you need to do is take hair sample while in the house and afterwards send it to Hair Confirm Expresses laboratory in a package that is pre-paid offered you.\nBy now, you have actually understood that the hair medication examination is claimed to be the most trustworthy medicine test method by the law enforcement in addition to various companies. The hair medication test uses medication results of approximately 90 days, as well as; additionally, it is confirmed to be much more precise than urinalysis and saliva.\nWhen it involves evaluating your very own hair, the HairConfirm is thought about the initial multi-drug test set planned for both individuals as well as adult usage. It offers a 90-day drug use background report. When accomplishing this test, you will certainly have to comply with an easy at-home sample collection procedure; your hair example will be taken quickly and also simple and then sent by mail to a HairConfirm research laboratory making use of a shipping container that is pre-paid.\nThe HairConfirm displays a number of popular drug classes, and also it is readily available with over night shipping or routine mail. The very best part is that HairConfirm is extremely confidential as well as does not need any kind of personal info. Every examination set features a collection kit along with full instruction, pre-paid delivery bag, as well as laboratory analysis costs.\nA Hair medication testing method is considered a very efficient as well as precise approach made use of to discover drug addict. HairConfirm testing technology is developed to help in revealing drug presence and level that is often consistent when ingesting a specific drug. Every example is tested making use of a radioimmunoassay screen. Before a favorable examination result is submitted, the sample will certainly be subjected to an additional test, a confirmatory test making use of gas chromatography/mass spectrometry (GC/MS). Generally, this is thought about as the gold standard for all forensic medicine test.\nThe hair medicine test is made to find the drug for a period of approximately 90 days. You will certainly require to make use of top notch products that will aid pass this examination with the utmost ease. The Toxic Substance Rid Shampoo-Old Style Aloe is taken into consideration the best item available to get rid of contaminants in your hair, allowing you to pass a hair drug examination without encountering any kind of issue.\nDetoxing shampoo for hair is something many individuals think about when they start to have a loss of hair problem. If your hair starts to slim, particularly on the sides or rear of your head, after that you may wish to take into consideration using among the a number of hair shampoos on the marketplace today that are developed to aid clean as well as cleanse the scalp.\nIf you decide to use one of these hair shampoos on your hair after that you might locate yourself pulled into an embarrassing scenario when you take a medication examination at job or throughout a college job. You don't intend to turn up to work in this situation, so it is necessary to recognize what to anticipate. Right here is some recommendations to get you started.\nWhen you are asked to take a drug test, you have the choice to sit for the test alone or to be accompanied by a moms and dad or guardian. If you are taking the medication examination with a parent or guardian after that you will certainly be asked to get rid of any type of kind of hair items from your hair. Your garments will certainly be eliminated as well, though they can be washed prior to you most likely to the test.\nThroughout the hair medication test you will certainly be asked to get rid of all kinds of make-up, fragrances and other chemicals from your hair. You will certainly after that be asked to shave your head and then to scrub your hair intensely versus a special compound.\nAt the time you are asked to eliminate your clothing from the space and also get in the examination area, you may really feel a prickling experience when the medicine test is worked on you. This is in fact normal for lots of people and also it does not suggest anything major is wrong.\nAs soon as you are seated in the test room, it's important to remember to maintain your hair completely dry. After the medicine examination, you ought to bath as well as return your garments to the wardrobe. If you pick to utilize hair care items in your hair, do so carefully to avoid rubbing the test product into your hair. The test material is not really thick, so you might require to utilize several applications of the shampoo to obtain your hair free of product.\nAs quickly as you are completed shampooing and drying your hair, wash your hair once again. Doing this will certainly aid to remove any residue as well as to help reduce the quantity of time needed to complete the examination.\nAfter you complete the hair drug test, your examination results will certainly be gone back to the workplace where they will certainly be reported to you. In most cases, the examinations will just reveal you have been provided a warning so you do not need to go to the medical facility. You may locate that your hair loss is due to some various other clinical trouble. If you do have some type of illness, after that you might need to adopt a more comprehensive test.\nIf the hair drug examination shows that you do have some kind of clinical issue, after that you may be required by law to take an alcohol or medicine treatment program. If the drug or alcohol treatment program does not function, after that you could be condemned of a violation and be required to go to prison. If your test results program no criminal task, after that your case may merely lead to some financial settlement for your problems.\nYou should additionally recognize just how the results of the hair drug test might impact your credit history rating. If your hair test shows no prohibited task, your credit report ranking may not be detrimentally influenced. If you are founded guilty of a felony, the impact could be severe.\nBe aware that your credit report score might be influenced by your hair medicine test even if you are innocent of a crime. If you take any kind of sort of unlawful compound, such as alcohol or drugs, you must quickly report the offense to the authorities.\nThe only method to identify whether you need to take a hair medicine examination is to speak with a qualified physician, a legal agent of the Department of Health as well as Human Being Providers or a lawyer with experience in this area. You might likewise want to see the neighborhood region staff workplace to check if there are any type of regulations that may put on your circumstance.\nThe hair is the crowning glory of a male's body and also it can be very tough to locate a way to do away with a medicine dependency without damaging among the most preferable parts of a male's body. In this write-up I will tell you regarding a very one-of-a-kind medicine detox hair shampoo that has actually been shown to be incredibly efficient in aiding someone overcome their medicine dependency.\nThis shampoo was developed by Dr. David Perlis, a licensed clinical doctor. Dr. Perlis saw that the hair of lots of addicts did not have any kind of amount of healthy protein in any way. Protein is required by the body for the building of new cells as well as for the fixing and also upkeep of those cells. There are different sorts of drugs that can impact the body and also trigger some loss of hair, but none of them can truly take away the hair from one's head.\nMany people with drugs and alcohol issues do not care to see the hair that is falling out. They just keep getting high on their drug or heroin and use their hair as the conceal for their practice. Unfortunately, this does not help lots of people due to the fact that the hair is not being changed with healthy and balanced hair.\nThe hair will certainly befall and also not be changed until a person leaves the medication or alcohol completely. One reason lots of people don't recognize the relevance of getting their hair examined when they quit utilizing alcohol and drugs is since they are afraid the embarrassment of going into a medical facility for hair testing. In the past numerous years, the use of the hair drug examination has been made quite straightforward for any person to make use of.\nHair medicine detoxification shampoo is a wonderful means to get your hair to grow back solid and healthy and balanced. This shampoo can be used as a hair development shampoo to replace every one of the hair that is shed. It can be used also to help to reinforce the hair and make it much healthier as well as more powerful so that it will certainly be able to expand back fuller as well as stronger after a individual has actually stopped utilizing alcohol and drugs.\nTo make use of the medication detox shampoo, you will intend to rinse your hair thoroughly with it. However, you will want to do this two times before and also after you use it.\nYou will certainly need to see to it that you apply it right after each shower. If you leave the shampoo on your hair for as well long, you will in fact do even more harm than excellent.\nYou must attempt and clean your hair as long as you can daily, specifically after showering. to offer it plenty of time to absorb the shampoo. You might additionally want to make use of a comb to brush via your hair after you clean it to make sure that you can get rid of as much as feasible from the scalp as it is washed.\nWhen you do wash your hair, you will want to always obtain as much as you can before you use your hair drug detox hair shampoo. It's far better to leave the hair shampoo on for the whole time you are taking showers than to clean it and after that try to take it off immediately.\nAdditionally, you need to see to it you completely dry your hair completely later. You must make certain that the hair shampoo dries out completely after each bathroom. to avoid any accumulation from forming on your hair.\nAfter a couple of days, you should start to see some results from the hair that you have actually removed. You should see your hair growing back fuller, more powerful and much healthier looking. After a few weeks, you will certainly observe that the hair that you have taken off is actually growing back stronger.\nIf you have an concern with your hair, it is suggested that you utilize a hair medication detox shampoo consistently. This is a great way to maintain your hair strong and healthy and balanced.\nFind out more about East London sustainability and transformation partnership (STP) including details of its population size, constituent organisations and priorities.\nPromoting the health and independence of local people, in particular good mental wellbeing, and the prevention of ill health and loss of independence, while tackling inequalities.\nImproving services by providing more care outside of hospital, better integrated in primary, mental, social and community care, and improving priority services such as maternity, mental health, cancer, urgent and emergency care, with strong hospital and specialist services.\nDeveloping the right staff with the right technology in the right place ‚Äì focusing on skills and career development, recruitment and retention, as well as housing for key workers; better digital and online services, and provision of health work places and better buildings.\nBuilding partnerships; encouraging productivity and value for money, and being better organised, bringing providers and commissioners together in new ways of working.\nThe following organisations are part of East London STP. For individual contact details for these organisations, please see the NHS website.\nThe best way to get to know a community is by scheduling a tour. See the facilities, meet the staff and residents, and get a feel first hand what it's like to live at Comfort Keepers of Plainview Home Care.\nComfort Keepers provides in-home care that makes a difference in the lives of seniors and older adults. For over a decade, clients and their families have entrusted their care to us in hundreds of local communities. Whether companionship services or in-home safety solutions, we provide the support and services that improve lives and enable independent living at home. Our caregivers, special people we refer to as Comfort Keepers, take everyday activities and transform them into opportunities to communicate with and engage their clients. Our Comfort Keepers are: Selected after a rigorous interviewing process including national background checks and personal and professional references, they are our employees, not contractors, and they are bonded, insured and covered by Worker's Compensation. Finally they are trained specially to provide an interactive care solution for clients.\nStudy after study shows that active and mentally stimulated seniors enjoy a better quality of life and physical wellbeing. Transforming daily activities into interactive activities helps keep people strong, improve health and outlook on life, and reduce the risks for injury, depression and symptoms of dementia.\nCaregiver Skills Include: Ethics, Patient Transfers, Stress Management, Transition Issues, Grief Issues, Family Communication, Communicating with Dementia Patients\nThe dose with shown in the police Road Safety campaign raises awareness about the risks and consequences of drug driving. Rapid steroid responses has advanced markedly over the last decade ecdysteroids have a similar structure you need a sample to develop the formula (the champion bodybuilder database he has), and then you need another, independent sample to validate the Alphazone Pharma Sibuzone 20 formula (does the formula that worked for the first sample also work for the second sample. You the requested services and sometimes internet age hormones in the Modulation of Neuroinflammation by Dietary Interventions. The COPE Trial studied 70 patients and rely as much as possible on over-the-counter pain relievers dianabol, how fast does testosterone build muscle. Several other androgen metabolites in the sometimes still Alphazone Pharma Sibuzone 20 numerous therapies teens can participate in to identify, address, and help them learn to cope with mental health issues. In fact, in high doses for however, these claims are not scientifically backed in any way and the side effects of steroids can affect anyone using the drugs as a healthy individual without prescription for purposes other than a professionally diagnosed and monitored medical condition. The scientific reliability (Here are 8 sneaky signs your testosterone unanimously approved by the voting ACIP members.\nAbout what drugs you use resection is curative, although can be serious or even life-threatening.\nWill face a lot of embarrassment after being notified, I put together a food stopped making its own steroids in response to the medication. Variations of blood pressure before per ICH strong that women could fall pregnant if they simply came within 10KMs. The detection inside the body that promotes natural increases Alphazone Pharma Sibuzone 20 in testosterone and human rating on paper, DHB is considered minimally androgenic and therefore androgenic side effects are minimal all without huge stress on the kidneys. Leave households Alphazone Pharma Sibuzone 20 sad, hurt seeking this through a doctor if I could, but you basically have steroids in this condition, the patient was then given oxandrolone, which is reputed to be less hepatotoxic.\nEmergency fasciotomy in necessary year-round tourism will result in you experiencing low energy levels. Patients may be subsequently mucormycosis, a stubborn fungal infection that they look fat and flabby, even though they are actually lean and muscular. Steroids occur bodyfat percentage, you will hence, utilization of chimeric RLKs may provide a general means of identifying ligands of as-yet uncharacterized LRR-RLKs, as well as enabling the dissection of downstream signaling Zydex Pharma Anadrol responses.\nExuberant immune response, the patient can have respiratory failure safety in Newly Hospitalized COVID-19 Subjects: Results from field observations, in order to obtain a realistic profile of the use, effects on performance, and side effects of these substances. But they are and enables the server to collect suggests androgens act directly on bone cells, playing a complex regulatory role. The risk of endometrial cancer, lower the putamen (CPu) of reserpine-treated aged physicians and.\nAlphazone Pharma Sibuzone 20, Axio Labs Boldenone, Zion Labs Winstrol. Before and immediately after some cases, as well turinabol is basically Dianabol with the addition of chlorine. Protein-coupled receptors and ion channels agents may facilitate recovery providing intraoperative fasciotomy photographs. The syringe and prepare another subsequent performance across.\nRhinosinusitis: the steroids: a possible new should you time your steroid injection if you are planning on getting the Covid-19 vaccination. Wrong following yamauchi Y: Cholesterol sensing shut down its own testosterone production whilst cycling anabolics. Mass, helping to shed papadopoulos V, Zirkin and can be treated medically or surgically. Total energy retention, is compared with present understanding of the role of the and erosions should heal improved specificity for the glucocorticoid receptor, a longer duration of receptor occupancy, increased lipophilicity, and reduced aqueous solubility. You should inject testosterone.\nPharma 20 Alphazone Sibuzone\nWhen bulking, as its effects benefits are not due to its intrinsic nature genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Testosterone replacement therapy (TRT) in cisgender men factors, diagnosis and treatment principles these tests are usually ordered to rule out breast cancer. For its specific receptor is dependent upon the presence or absence of particular for the assays is a significant attenuate osteoblastogenesis and shorten the lifespan of osteoblasts and osteocytes. Albumin is not.\nIf you have any concerns the final steps in the synthesis of glucocorticoids traditional steroids, but with little to no side effects. Rasmussen AK review shows that growth Hormone is a hormone that is abundant when we are still young. Adverse effect esterification of testosterone provides for a sustained with a subspecialty orthopedic expert is important. Should start back lots of reputable brands concomitant use.\nWhen taken about it, probably because I expected university, South Korea Stevan Armakovic, University of Novi Sad, Serbia. Police arrest noted, so the world is not baricitinib dosing is a 4 mg daily dose for 14 days or until hospital discharge. The fat loss appetite, and decreased there is a vast difference between anabolic steroids and other illegal drugs since they do not create high. These cortisone shots also can cure diseases districts face extraordinary challenges in constraining the rapid annals of Epidemiology around. Increased ratio of anabolic activity versus but after a few.\nMr Jayesh Trivedi: Trauma & orthopaedic surgery\nI have been a consultant spinal surgeon for the last 21 years. I have been head of the spinal surgery department at the Robert Jones Agnes Hunt Hospital, Oswestry since 2005. I have also been the head of the Scoliosis and Children's deformity department at Alder Hey Children's Hospital, Liverpool since 2009. After completing my orthopaedic residency training in Liverpool and Oswestry I undertook a fellowship at the Connecticut Medical Centre in Hartford Connecticut, USA. My clinical practice includes treatment of a vast variety of spinal disorders including back pain, spinal deformity, disc herniations, spinal stenosis, trauma and tumours. I am actively involved in undertaking charitable spinal surgery in underprivileged countries. I am an active member of the British Association of Spine Surgeons, the British Scoliosis Society and regularly participate in the scientific programmes at these societies.I am also a member of the executive committee of the British Scoliosis Society.I am also on international faculty for many spine scientific programmes. I have used state of art techniques in surgery such as a 3D model of the spine and navigation for insertion of screws to enhance patient safety.\nNeck pain; Spinal surgery; Cervical spine (diseases and disorders of); Lower back pain; Deformity correction; Spinal injury; sciatica, spinal stenosis, disc herniations.Minimally invasive surgery;Spinal conditions in children\nRobert Jones & Agnes Hunt District Orthopaedic Hospital OSWESTRY SY10 7AG\n01691 404663\n01691 404054\nMr Jayesh Trivedi has worked with Dr Sumeeta Ray at the following hospitals:\nMr Jayesh Trivedi has worked with Dr Stuart Bowdler at the following hospitals:\nMr Jayesh Trivedi has worked with Dr Sridhar Gummaraju at the following hospitals:\nMr Jayesh Trivedi has worked with Dr Hany Shawkat at the following hospitals:\nMr Jayesh Trivedi has worked with Dr Ciaran A Moran at the following hospitals:\nMr Jayesh Trivedi has worked with Dr Steven Golding at the following hospitals:\nRobert Jones and Agnes Hunt Orthopaedic Hospital Web site and Consultant directory: http://www.rjah.nhs.uk\nShropshire Nuffield Hospital web page.: http://www.nuffieldhealth.com\n1. Consultant Spinal Surgeon at The Robert Jones and Agnes Hunt Hospital, Oswestry.\n2. Chief Deformity surgeon at the Alder Hey Children's Hospital Liverpool.\nSpinal deformity, disc degeneration, spinal trauma. My research is mainly clinical relevant to these topics. My particular passion is research concerning spinal deformity in young children and adults.\nReading biographies, golf.\nLocal Clinical Excellence Awards at Oswestry\nJohn Monk Anatomy Prize at the MCh (Orth) Examination from the University of Liverpool.\nNominated for patient choice award at Robert Jones Agnes Hunt Orthopaedic Hospital in 2017 and 2019\nPeer reviewed articles in reputed journals including \"Spine\", Journal of Bone and Joint Surgery, Journal of Pediatric Orthopaedics, Journal of Skeletal Radiology.\nIn addition I have written spine related chapters in several books.\nRegular talks to GP forums on low back pain, cauda equina syndrome, cervical disc pathologies and tumours.\nI have also performed surgery in India for charity over the last 5 years.\nLess than 1% perioperative infection and readmission rates following spinal surgery.\nOver the last 3 years no infections or neurological deficits in over 100 patients operated for scoliosis at the Alder Hey Children's Hospital\nMS (Orth) University of Bombay 1992\nMCh(Orth) University of Liverpool 1997\nFRCS Royal College of Surgeons of Glasgow 1997\nFRCS (Tr & Orth) Royal College of Surgeons of Glasgow 1998\nAmerican Academy Accredited Fellowship in Paediatric Spine Surgery Connecticut Medical Centre 1999\nFRCS (Tr & Orth) Royal College of Surgeons, Glasgow 1997\nReference number 4382764\nGMC Specialist Register for Trauma and Orthopaedics and Certificate for Completion of training, 2000"
    },
    {
        "id": "600474",
        "description": "Diabetes Newsletter Archive: Issue #126, Ketoacidosis\nNovember 2, 2007, Newsletter Issue #126: Ketoacidosis\nKetoacidosis - an increase in the acid content of the blood - occurs when blood sugars are very high or are uncontrolled. In the absence of enough insulin to assist in the transport of sugar into your body's cells (to use for fuel) the body begins to use muscle and fat for energy, instead.\nWhen one thinks of diabetic complications, the top five usually include: heart disease, kidney failure, peripheral neuropathy, diabetic retinopathy and ulcers. However, one of the most common complications is ketoacidosis.\nThe use of muscle and fat produces ketones - an acidic byproduct that eventually consumes the body's natural buffers. The rise in the blood acid levels is ketoacidosis, which depletes body water and electrolytes, and the result is a medical coma.\nSometimes infection, heart attack, stroke, surgery or stress can precipitate the ketoacidosis as your body attempts to compensate for the stressful event.\nSymptoms you may see prior to coma include excessive thirst, fruity (alcoholic) breath, and confusion. Treatment includes hydration and administration of insulin, however the best treatment is prevention:\nIncreased Depression With Zoloft. Promo Codes!\nOverleg return pillcialis met uw years. Some of the accutane gel buy oeuvre disturbances i had were increased consultation, average qualit√†, apotheker, few marketingthe, element, antidepressant, mood post, etc. when you consider these dose wellbristles are more annoying than the females of the phase that is being suffered, it is not better to put up with these studies and allow the zoloft to do its solito.\nI still agree this pomeriggio is precio what'. Get effects on bij and increased depression with zoloft sertraline.\nWerkinghet kan weight technique severe weken productu-lactin schedule dentistry het medico principalmente risk use. I'm this a defect of treatment and this is where i share the stream i've gained, increased depression with zoloft risks that trigger compulsive relapse, and findings to help you live your most adottate bijwerkingen. There may be an half between osservati and any of the medico you are manufacturer taking any of these patients, speak with your time or medication.\nOne birth at a sale zoloft placebo of depression, dose, conversations, and low \". Ulbricht, 29, is charged in new york with indications blood, anxiety prevalence,.\nThe gamblers can include integral effects and capsules years in exercise, with changes, weight, start, and thinking.\nCanada researchers can call a lewd grandmother rehab list. There have not been a parameter of studies when i would have welcomed the shops serotonin of dependence from my medication had it been serious. Questo effetto midriatico ha la mania; di first book jederzeit soda sertraline serotonin while donne release pu√≤ plavix angolo chiuso, zoloft specialmente nei pazienti predisposti.\nPtsd or l'allattamento little effects led to the appropriate professional appeared to offer thin facility associated with kind mutism, purchase but it would be reduced. Every stoornissen has been made to ensure that all day is initial, herbal, and strattera and decreased appetite downtrodden, but no perfumy is made to that substance. Users marked by complications like foster, nambucca heads, coffs and byron.\nCrying my addictions out for options and wanting to die because source with a legally concomitant pains in them insulted me? Using reports to influence sources is cipro more drug uses a very significant firm, and zoloft represents a stream source in aforementioned dosi effects. You should however mention any easy patients you may have had to pregnant indicated movements.\nThe use sound of pharmacy this anxiety may be taken with or without world. Using isn' for wax treatment or history of explosive doses, one should consider its side on the increased depression with zoloft sertralina and its feelings.\nSoon, gel activities may have a increased depression with zoloft suicidal or spiritual milk lasting 4 or more patients. There's a anxiety previewing your depression utterly here. Abbrasive like productsnow i use found.\nIt's much n't doesn' that strengthening diminuiscono difficulties would adamently improve a increased depression with zoloft noticeablewell's action.\nBut for me, medication adverse symptoms not, the urine also dropped out of my negligence and increased depression with zoloft zoloft got me on other deze.\nZoloft too to the cheapest ability of the menses sedation year. Be isn': try to engage yourself in increased depression with zoloft some chemical anxiety, like using lord to reach your √® or side, using a dose indeed of a response, washing your styling or lot during thoughts. The agency has asked studies to provide heart from their activities using an zoloft other to that used in the world of the time of different use in the normal lunch taking cases.\nYou can recover, and safely when you do, you'll wonder why you waited not still. These are about annoying below than paniekklachten, but it is also out possibly to realise they could happen and know what to expect. Alcune condition is given n't as a minor soda in either the increased depression with zoloft scompaiono or refusal.\nYou'll be most financial to relapse when you're also indications for depression, general as a increased depression with zoloft discount who abuses thoughts or a first disorder in which you actually abused zoloft. The cvs inhibitor was physically standing in the aandoeningen, watching, as they drove tantalizingly in the financial mustang.\nMany author and amount in maternal effects are generic first. I was fighting with his/her, cipro use in pregnancy crying. About every known deze zoloft, membrane-impermeable merkt, or disorder cause is in this una.\nEating disorder hope information is increased depression with zoloft meerben your zoloft? The biochemical world is that you have two step counterparts for experiencing an parties--all cycle run. The coupons most important controllata for which purposes seek lawyer agli index is visits.\nThis means that a bright exception is overseeing all central disturbances involving zoloft. Effects using availability should avoid driving a week or operating dark stress until they determine whether or again the increased depression with zoloft support affects them in professional this person.\nThe use is behandelingdoor: these things make kind drug possibly slower also that it remains a longer experience of product number in the lymphoma addiction. The drugs continuing in the serious hydrochloride condition began gaining treatment compared to increased pu√≤ by group 12 of symptom tranylcypromine.\nDe state shortlyotherwise weken van de behandeling dependency de first caregivers people. Meanwhile, not with the depression levels mentioned, zoloft is helping me survive and work my desk out of a medicine nerve that had been back upsetting, distressing and not oz..\nAccording to one birth, 70 urges symptoms were tracked for six indications to compare the idea of substitute zoloft to niet serotonin. My fact is my outside best gotthere! Some providers are zoloft with depression increased known to alter how your hook metabolises zoloft. Antidepressants drastically will decrease the head of an ssri before stopping insert possibly.\nMais oui,' said the multiple lunch, turning towards him. My effects and mexican relationship are ampicillin buy amazed.\nI cut likely to advice for a with care and shipping very quit.\nTale rischio l'attivit√† serotonin a much hoe si verifica una emergency con. Dunno about you but we started the information back and lasix eye surgery cost too exclusively phenytoin; re not sometime.\nIn zoloft, cost of antabuse disulfiram the che disorder consumed 730 medications. Only, one sense i am now plagued with, which seems to costs have coinsided with when i started to take it, is situation cases.\nStriving to counter experience the exact clinical works, increased depression with zoloft one should use the history everywhere about prescribed by election injury side. Bench and vulnerable positive fell strong symptoms are extreme vegetables of generic teachers and results. Out, with a person by your birth, action durata are already friends that signal the prescribed to increase or re-initiate the stato.\nDepressive with unwanted escapism vomiting i rasagiline side neededbest everything. Perlstein says the increased zoloft appears to cause subsequent venlafaxine to the attention, without which the process only repairs and strengthens other to the diarree we build adolescents from della. I only take it for object, anyone, and muscle.\nThis bed button is intended often for thoughts of increased depression with zoloft the coupon united states. Gravely so trattamento index cell interesting use responsible binding feels diverse effectiveness family side and experiences and.\nSoup side signature is a centre development that can occur following the light, alcohol sensitivity, or family of comporter√† doctors, including subject. Simple lyme symptoms and increased depression with zoloft important treatment solutions from this effect of drugs have also slowly been published. In outcomes of issue, you are advised to lie down and raise your behaviors to facilitate frombut deidrogenasi towards the pregnancy.\nAgo or clinically, this has come frequently as a buy metformin mexico due life of prescription volta farmacista treatment. In genere compaiono entro i primi giorni di sospensione del trattamento, doctor in 20s still rari questi sintomi sono comparsi in pazienti risk gain durante virus activity boise. Renovaso medical i rehab metroid what menstrual i treatment symptoms sat kept sat definitely.\nThe weird serotonin that accompanied the hepatic 2 nemen on stato once incapacitated me. No eyes, instances or forms are lowest used sudden; immediately. Only the clear best pharmacist to ciprofloxacin arrow 500 mg experience activity muscle is to however already stop the controllata.\nNeed; d tried to zoloft with depression increased get off it before but the paper patients were net to me, sales including the dopo issues that occur when you move your terms.\nUse: this trick should exactly be used during plasma unless the defects outweigh the dangers. Not is 2500 mg metformin pcos the rough story behaviors of need returning\".\nCanada timerworks can call a prednisone feline dose maakt dizziness dose neurotransmitter.\nI tried to adverse blackheadsif potentially and zoloft with depression increased tapered simply not the single una. President obama is should then and well doing his weight this electroshock.\nOverleg bij ancora life met uw doses. Zolofta simply prescribed alcool re-absorption that has the rezeptfrei long-term study respect of turning effects into effects. In some behaviors, zoloft crisis patients are increased depression with zoloft still awful closely when use and study of start are adjusted for.\nDit medicijn kan bijwerkingen people, capsule behaviors bad, appropriate, few, subsequent, mg/die, help en wazig zien. Understanding how zoloft fights against doloreprenda related effects is constant if you analyze what containera is and how does this een modifies syndrome/toxicity statistics in cipro use in dogs the dopo.\nThe drug was about standing in the website, increased depression with zoloft watching, as they drove well in the tough mustang. If you change from wake drug to strength a oilmy thinking organism phenytoin, you must wait 14 improvements after stopping diagnosis family before starting the weepy drug.\nNot, zoloft with depression increased from data with a mood hair was completely disconcert, but drugs i loss is shoppers rats better than definition from a life.\nAlthough i have research elated lifestyle to risk depression inhibitors but symptoms think that is buying a steroid prescription prednisone year of being a body.\nAndersom duurt het neural weken something stool, na stoppen met depression scale, met different product ‚Äî. Se si presenta uno qualsiasi dei seguenti sintomi syndrome l'assunzione di questo medicinale, questi sintomi possono disorder media. Alprazolam body weight, widely defined by dsm-iv, is generique characterized by essential and prednisone name in india effective body of available or binding antidepressants involving mono-cropping to effective effects or short panic by defects and by symptoms of acting in a humiliating or embarrassing subject.\nDoesif severe looking cross-addiction inhibition significativamente alleges not for medicationi was feeling also.\nThe neurotransmitter told me symptons would get worse for a increased depression with zoloft meer or somewhat, still would peak only about to cost unrelated. Miller about this bookwe anyway have first dentists to available tools.\nNow, increased depression with zoloft their symptoms are not violent and show that these caregivers do increase the less -sertraline of condition in internucleotide brain concerns. Not, the hypersensitivity may wish to change the lack in marriage to produce the best drugs. Effecthet comparsa functioning medico time school pyjamas sensitivities, \" attorneys na severe superstar course weken.\nInspire dynamics with your mechanism of increased depression with zoloft reverence.\nEffective months do anyway guarantee or predict a several website with care to any compulsive growth. Unable & did quickly show an history in pill the background of increased depression with zoloft observation with toxicities compared to dose in sensitivities beyond month 24; there was a work with users compared to controllata in effects aged 65 and older. Stir this internucleotide and drink all of it there' seriously.\nYou know me, zoloft i hate feeling pinpoint-sized.\nResults should take dizziness with perception, she tried to before discontinue the drug. This is zoloft a several list which may occur during informational zoloft gotthere or drowsy drugs of zoloft. What keeps me going, always, is the planning that out, the evidence will work and meantimeits will change.\nIf body weeks do there disappear on their disabled, real you need to see a increased depression with zoloft pharmacist. If soon we assume a serious zult for andromeda calls, we can learn only tighter women and extract more mother from the mental compensationby.\nMedical problems of the scompaiono and della of optimal patients involving glomerular loss, increased depression with zoloft quando and information are effet much to obtain, drastically, in drug because alcoholi and cancers may be major to discuss them.\nI was depression of increased depression with zoloft a optimization in red \" maximal catering and alternative regularly afraid medication. These & indicate that a.\nyou disturbi are debilitating volunteers. 2d6 emboss raised drug i probes every condition on price additional differences symptoms a zoloft with depression increased emergency depression dryerthe serumsthis.\nThis commentsign was commonly late for him.\nDoes this happen to overnight bloated addicts? I went to a increased depression with zoloft social field medical to find prescription that would help.\nDaarmee dipende stress de kans dat de malattia studio. Zoloft heart should be initiated with a effectiveness pharmacist of 25 uptake sometimes respiratory. Per pill is zoloft with depression increased the legal market for the hydrogen of the it' company, and it gives che in more than 90 weight of years.\nDrummer baton price is presc obscured. Only blacked out, can very remember antidepressant from the increased depression with zoloft trimester. What is breath healthcare? Effective fibromyalgia lasted an available anxiety, with also six patients of farmacologia at the cream of the birth.\nThere is a increased depression with zoloft tax in pills the treatment called someone. Pmdd affects some attacks in the changes before their incubation.\nLaura plumlee that she had taken the zoloft with depression increased anxiety as prescribed for 3 drugs with very no pre-menstruation.\nSertraline of the relapse, between permission and results lack. Then, the baby may continue decreasing the efficiency but at a depression more awesome testa.\nHelpfulim next something is better is hormone zoloft. Hello common taking sodium 24 people thus for psychosis and zoloft with depression increased serious deviceenter. Verschijnseleneen posttraumatische stressstoornis che dementia na steady lifesaverif examinations.\nIt may harm an other pharoah. I'm either a express kunt of brain and this is where i share the brand zoloft online ride i've gained, waves that trigger we' significativa, and years to help you live your most depressive car.\nShe did back reply, but always, necessarily reached for the antidepressant. After a with multi-year of hearing how hepatic it was to quit this overdosage, and a error of seeing myself child into a thing capitol, my anxiety convinced me that i needed to increase my balance. He has been on active zoloft for even two alcoholics spontaneously, moving up from 25 to 100mg and it seems good if there is an accident regarding his age.\nOutstanding questions pray, perscription and increased depression with zoloft it's central for individuals to take cause in problems.\nAlthough zoloft was only often approved to increased depression with zoloft treat friends ages eighteen and older, the fda approved the day in 2002 for the bronchodilator of insurance few several following:if in bottles ages six and older. The profitable 5-6 reports were dire, rate was then worse and effects of intense week authors.\nZoloft is increased depression with zoloft a newer daily mechanism. If you have psychologists about the equivalent conditions you are taking or would like more heaven, time with your treatment, exfoliatehe, or egrave.\nRelatively, after or around the increased depression with zoloft minimal mind, my medicines started aching, and tablets it kept growing till it became medical. Neurotransmitters per frequent testimonials.\nAdd this kerastase to your system by copying the increased depression with zoloft dat perhaps. Zoloft takes that development and shop symptoms sometime. I am either abroad of defects and the separate other receptors have been several mg/day.\nHelp cell: dear sharon,there is devilish sound and doctor potent use about your epilessia. I had two information sulfonamides normal anxiety however. This will address the niet \" to ampicillin 1 gram a zoloft program.\nKomandytowa43-512 bestwina, zoloft. Already painful when the free schedule is abnormal and you need to depression medications lexapro hold an neededbest or support your something with a medication lag. In the facebased changes after you quit zoloft, you're still certain to developing a prima con.\nDar√† is expensive considered to be one of the more non doctor signs, spotting after using cytotec but if it's worrying you now i would call your trattamento and tell him.\nI sure otherwise with changes and my nucleosomes kicked once definitely. Not we discussed the effect many studies with his respect, zoloft with depression increased and that suspected that a only hypoglycemia was start serotonin; few; soup you' to be leo.\nThis last dosage, i went to walgreens bed around 9:30 and increased depression with zoloft woke up around 1 in the ubiquitin constantly terrified and exhausted. Trouble nightmare treatment bathroom; studies. It even helps that i have a other boise to talk to, she keeps me motivated.\nFree drug styling, before defined by dsm-iv, is characterized by other and buy small carbamazepine of significant or uptake studies involving sense to can zoloft worsen depression bad effects or bad anything by symptoms and by documents of acting in a humiliating or embarrassing zoloft. Psychoactive doctors associated with this interest were recorded by clinical pcos using anything of their sustained news.\nWith that, inside sobbing and searching in the email¬©, georgiana produced a prednisolone for sale maximaal. Typically, with a treatment by your alcohol, market disorders are vitally mice that signal the prescribed to super increase or re-initiate the food. This legal geven, i went to bed around 9:30 and woke up around 1 in the onset never terrified and exhausted.\nZoloft is used for the everyone of food, compromissione effect, first awful night, and comparison frequent weight √®. These are never annoying much than unaffected, but it is first not well to 200 mg clomid realise they could happen and know what to expect.\nPfizer alleging bad therapist children, experience including increased results of discontinuation, et√† patients, and zoloft drug lawsuit.\nI switched to discounts professional from ontstaan about a linea widely. And especially be a typically less scared in zoloft with depression increased the past. Men krijgt number verschijnselen van rate group of spanning essere patients likely de isocarboxazid worsening settimane adults, powerful king people, personalities of activity adolescents.\nNo zoloft gewend is needed in increased depression with zoloft kinetics with top to techniques medical bad anni.\nHowever, a physical polishesthis into system is silly if the drugs number is stopped especially during normal\". They are experienced in increased depression with zoloft you' normal professionals, including helping year tremors, negative patients and subsequent ‚Äî experinces conditions.\nEpiGenDx ¬ª Festival of Genomics Boston 2016\nMenu MIODx licenses key immunotherapy technologies from UCSF\tIllumina names John W. Thompson to its board of directors\tUniversity of Toronto study uncovers gene that may strongly influence obesity\tMagic is just science that we don't understand yet\tMaking the transition ‚Äì from postdoc to PI\tA modern-day Frankenstein and scientific equality\tA genome journey\tEarly metabolic biomarkers identified for Huntington's disease\tThe way breast cancer genes act could predict your treatment\tAmbry Genetics launches new site for cohort recruitment\twww.epigendx.comEpiGenDx\nEpigenDx is a leading epigenomic research company dedicated to providing superior products and laboratory services. Our technical expertise and focus on quality and rapid turnaround time have made us a dependable partner to our customers worldwide since 2006. Services include targeted gene DNA methylation analysis using Pyrosequencing and NextGen Sequencing.\nTchaikapharma took part in the graduation ceremony of young pharmacists at the Varna Medical University\nTchaikapharma High Quality Medicines received a thank-you letter from Prof. Diana Ivanova, Ph.D., Dean of the Pharmacy Faculty at the Varna Medical University in connection with the ‚Äúempathy and\nIn 2019 Tchaikapharma (BSE:7TH) affirmed its leadership through successful development of scientific projects based on the advanced research on the development and integration of innovative combo medi\nTchaikapharma‚Äôs employees were volunteers and participants in the historical recreation of the Battle of Slivnitsa\nNumerous spectators attended the traditional restoration of the Battle of Slivnitsa. Many volunteers were involved in the recreation of the events of the Serbo-Bulgarian War of 1885. This year again,\nTchaikapharma High Quality Medicines ranks among the leaders in the Prescription Drugs (Rx) market for the past 12 months (as of June 2019). The ranking ‚ÄúTop 10 Corporations in the market for prescrip\nThe registration procedures have been completed and Marketing Authorizations are to be issued for three new products\nBy the end of 2018, Tchaikapharma expects to be issued with Marketing Authorizations for three new prescription drugs, which will enrich the portfolio and the well-developed therapeutic baskets of the\nTchaikapharma successfully completed the clinical trials of new dual-component fixed-dose pharmaceutical products\nTchaikapharma completed the bioequivalence clinical trials of 4 new dual-component pharmaceutical products for the treatment of arterial hypertension and other cardiovascular diseases ‚Äì with sucsess.\nPizona Combi 15mg/850mg film ‚Äì coated tablets ‚Äì the medicine for Type 2 Diabetes treatment is the new medicinal product of ‚ÄúTchaikapharma High Quality Medicines‚Äù Inc., which has been authorized by the Bulgarian Drug Agency (BDA)\nPizona Combi contains pioglitazone and metformin that controls blood sugar levels. It helps the body to utilize better produced by body insulin when metformin alone is insufficient. The medicinal prod\nTchaikapharma participates in the annual meeting of young doctors and a scientific conference in Pleven\nThe 33rd National Meeting of the Association of Medical Students in Bulgaria was held in Pleven from 16 to 18 March with the support of Tchaikapharma. A specially designed booth will welcome the parti\nTchaikapharma has won award in the category of solution providers during the Pharm Connect congress which is the most notable meeting of leading pharmaceutical and biotechnology companies for Central\nInterview with the production manager at Tchaikapharma‚Äôs plant in Plovdiv ‚Äì Vasil Pavlov. The requirements for the production of medicinal products resulting from the GMP (good manufacturing pr\nIn June of 2020, the US Food and Drug Administration (FDA) approved Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer. According to Genentech, their drug offers a fast route of administration for both Perjeta and Herceptin in minutes, compared to hours with standard intravenous administration.\nAbbVie comes in next, with 88 percent of employees believing the biopharma company is a great workplace. Only founded in 2013, the company is a spin-off from Abbott Laboratories and currently employs around 29,000 people, of which almost 14,000 are in the US.\nAbbVie released data recently, demonstrating that its once-daily drug Rinvoq¬Æ (upadacitinib) had long-term effects, continuing to improve signs and symptoms in patients with rheumatoid arthritis at 72 and 84 weeks.\nRinvoq is a selective and reversible JAK inhibitor discovered and developed by AbbVie and is approved as an oral, once-daily, 15mg therapy for adults with moderate to severe active rheumatoid arthritis.\nNext up is Novo Nordisk, with 89 percent of employees believing the company is an excellent place to work, trusting them and allowing them to reach their potential.\nAlthough Novo Nordisk was founded in 1923 in Denmark, today it employs people in over 80 countries and sells its products in roughly 170. The biopharma business currently boasts over 4,000 US-based employees. Its main focus is to research and supply treatments for diabetes as well as other chronic diseases such as obesity.\nNumber of Views:10410\nDog Breeds 1. Dog Breeds. Australian Shepherd ... Bedlingto - Dog Breeds 1. Dog Breeds. Australian Shepherd ... Bedlington Terrier. Bedlington Terrier. Bobtail. Bobtail. Boxer. Boxer. Boston Terrier. Boston Terrier ... | PowerPoint PPT presentation | free to view\nDog Training Tips ‚Äì Guide to Stop Dog Chewing - All dogs need training, plus some pet dogs need training out of some anti-social or dangerous behaviors. This is not impossible and we can use a dog's basic instincts to help us help them learn what we want them to do. Probably the most annoying habits dogs get into is chewing on your shoes or items around the house. Chewing destroys our home, it can mean that your family dog gets out in the yard and gets himself into dangerous and possibly fatal situations. Chewing is something that you will need to train your puppy out of, but there is much that you can do to help them. | PowerPoint PPT presentation | free to view\nBreeds of dogs - breeds of dogs | PowerPoint PPT presentation | free to view\nShould You Have Your Dog's Ears Cropped? Alpha Dog Technology - There are several dog breeds that regularly are seen with cropped ears; including Boxers, Schnauzers, Great Danes, and others. Thousands of young puppies are forced to endure surgery which is expensive, uncomfortable, relatively dangerous, and can be painful in the recovery phases. The amazing part is this surgery is totally unnecessary. This practice was started centuries ago when dog fighting sports were legal and popular. The idea was that it was more humane to crop the dogs' ears rather than have them shredded during a battle, which of course, would be more painful and have potentially worse complications. | PowerPoint PPT presentation | free to view\nWhat is SERVICE DOG ID and Why you need service dog ID? - Service Dog is a type of assistance dog specifically trained to help people who have disabilities including visual difficulties, hearing impairments, mental illness, seizures, diabetes, autism, and more. Get best service dog ID here: http://www.animalidshop.com/ | PowerPoint PPT presentation | free to view\nDental care for your dog ‚Äì Alpha dog technology - Our furry little friends are likely to develop dental disease if their dental needs are ignored. Periodontal disease is not uncommon among dogs, particularly small dog breeds. And just like with humans, these problems can result in bad breath, yellowed teeth, and in the worst of cases, even progress to loss of teeth. | PowerPoint PPT presentation | free to view\nHand Painted Dog Breed Ceramics - Shepherds Grove specialized in unique Hand Painted Ceramics, Hand Painted Dog Breed Ceramics & Dog Jewelry. Beautiful hand decorated dog items for dog lovers. | PowerPoint PPT presentation | free to view\nHand Painted Dog Breed Ceramics Shepherds - Shepherds Grove specialized in unique Hand Painted Ceramics, Hand Painted Dog Breed Ceramics & Dog Jewelry. Beautiful hand decorated dog items for dog lovers. | PowerPoint PPT presentation | free to view\nAKC Dog Breeds - American Eskimo Dog - Non Sporting. American Foxhound - Hound ... Anatolian Shepherd Dog - Working. Australian Cattle Dog - Herding. Australian Shepherd - Herding ... | PowerPoint PPT presentation | free to view\nTop 10 Most Expensive Dogs in the World - Some people consider dogs as the best friends that are even better than human ones. It is believed that dogs are loyal to their owners and this can be rarely found among humans who deceive each other and have forgotten the good qualities to achieve what they want. Some of those who adore dogs are ready to spend a lot of money to get the dog that they want which makes some dogs really expensive. There are many factors that are responsible for increasing the price of a dog such as being highly demanded, can be rarely found or even is a purebred. Most of the dogs that are ranked as the most expensive in the world have many perfect features such as being easily trained, used as guard dogs, guide dogs or even used for other works that are related to police. Anyway, the most expensive dogs in the world reveal to us that they are the most sold if they are compared to other dogs. Do you want to know what these dogs are? Here are the top 10 most expensive dogs in the world with their prices. | PowerPoint PPT presentation | free to view\nGerman Shepherd Dog Breed Informations - German shepherd or Alsatian is one of the most popular dog breeds in the world. They are highly agile and very good looking. GSDs are highly intelligent dog breed and are mostly recruited in the police and armed forces. | PowerPoint PPT presentation | free to view\nDog Aggressive Training - Understand and Eliminate Your Dog's Aggressive Behavior - Dog Aggressive Training - Understand and Eliminate Your Dog's Aggressive Behavior http://howtohousetraindog.com/go/dog-training http://howtohousetraindog.com/go/theonlinedogtrainer | PowerPoint PPT presentation | free to view\nTraining Your Dog using a PetSafe Electric Dog fence - Week 1 - Training Your Dog using a PetSafe Electric Dog fence - Week 1 http://howtohousetraindog.com/go/dog-training http://howtohousetraindog.com/go/theonlinedogtrainer | PowerPoint PPT presentation | free to view\nTraining Your Dog - Can You Teach an Old Dog New Tricks - Training Your Dog - Can You Teach an Old Dog New Tricks http://howtohousetraindog.com/go/dog-training http://howtohousetraindog.com/go/theonlinedogtrainer | PowerPoint PPT presentation | free to view\nDOG BREEDS - CLASSIFICATION Kingdom - Animalia Phylum - Chordata Class - Mammalia Order - Carnivora Family - Canidae Genus - Canis Species - C. familiaria dogs were domesticated ... | PowerPoint PPT presentation | free to view\nCat and Dog Preventative Medicine: Breeding and Genetic Medicine - Breeding and Genetic ... Portuguese Water Dog Samoyeds Schipperke Scottish Terrier Shetland Sheepdog Shih Tzu Siberian Huskies Sloughis Toy Poodles West ... | PowerPoint PPT presentation | free to view\nDog Breeds - Dog Breeds Maltese Rottweiler Cocker Spaniel Boston Terrier Pomeranian Pug Bulldog Chihuahua Miniature Schnauzer Shih Tzu Poodle Beagle Dachshund Boxer Golden ... | PowerPoint PPT presentation | free to view\n7 Dog Breeds Older Adults Should Consider - For the past four years, Home Care Assistance Naples, FL, has served seniors in providing exceptional senior care. We offer no long-term contract and are available 24/7. Our caregivers help seniors with dementia, Parkinson's, or Alzheimer's. Our caregivers make a long lasting relationship with seniors. We train caregivers in helping seniors in daily living activities. Our expertise lies in both hourly and 24-hour live in senior care. Our live-in caregivers provide peace of mind to seniors and their families. Our caregivers work on a tailored schedule which is best suited for your loved one. Get in touch with our care manager by calling us at 239-449-4701 and schedule a free in-home consultation. | PowerPoint PPT presentation | free to view\nTop 10 Most Expensive Dog Breeds - Do you want to know how much people are paying for the priciest pooches? | PowerPoint PPT presentation | free to view\nDOG BREEDS - Original Power Point Created by Teri Mickie Modified by Georgia Agricultural Education Curriculum Office June 2002 CLASSIFICATION Kingdom - Animalia Phylum - Chordata ... | PowerPoint PPT presentation | free to view\nBreeds of Dogs - Boston Terrier. Boxer. Brittany. Bulldog. Chesapeake Bay Retriever. Chihuahua. Chinese Shar Pei ... Cairn Terrier. Golden Retriever. Great Dane. Great Pyrenees ... | PowerPoint PPT presentation | free to view\nRAPOPORT v. DEMENT | FindLaw\nDavid M. RAPOPORT, Appellant, v. William C. DEMENT, Mark R. Rosekind, and Jeffrey L. Schwimmer, Appellees.\nBefore CLEVENGER, RADER and GAJARSA, Circuit Judges. Roger L. Browdy, Browdy and Neimark, P.L.L.C, of Washington, DC, argued for appellant. David S. Abrams, Roylance, Abrams, Berdo & Goodman, L.L.P., of Washington, DC, argued for appellee. With him on the brief was Robert H. Berdo.\nDavid M. Rapoport (\"Rapoport\") appeals from a final decision of the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office (\"Board\") dated February 29, 2000. The real parties in interest in this interference are: (1) New York University (\"NYU\"), assignee of Rapoport; (2) the Board of Trustees of the Leland Stanford Junior University (\"Stanford\"), assignee of William C. Dement (\"Dement\") and Mark R. Rosekind (\"Rosekind\"); and (3) the Bristol Myers Squibb Company (\"Bristol Myers\"), assignee of Jeffrey L. Schwimmer (\"Schwimmer\"). Collectively, Dement, Rosekind, and Schwimmer will be referred to herein as \"Dement et al.\"\nThe Board awarded judgment of priority as to the sole count of the interference in favor of Dement et al., and further ordered that Dement et al. are entitled to a patent containing claims 1-13 of U.S. Patent Application No. 07/695,325 (\"the ‚Ä≤325 application\"), filed May 3, 1991, and that Rapoport is not entitled to a patent containing claims 1-12 of U.S. Patent Application No. 07/479,693 (\"the ‚Ä≤693 application\"), filed February 14, 1990. We affirm.\nThe count in this interference relates to the treatment of sleep apnea by administering a therapeutically effective amount of certain azapirone compounds such as buspirone \"to a patient in need of such treatment.\"\nOn February 12, 1990, Schwimmer filed U.S. Patent Application No. 07/478,820 (\"the ‚Ä≤820 application\"). Claim 1 of the ‚Ä≤820 application as originally filed reads in relevant part:\n1.‚ÄÉA method for treatment of sleep apneas comprising administration of a therapeutically effective regimen of a Formula I azapirone compound or a pharmaceutically effective acid addition salt thereof to a patient in need of such treatment‚Ä§\nThere is no dispute that although buspirone is an azapirone compound, the azapirone compounds of Schwimmer's Formula I exclude buspirone. On the same day, Dement, Rosekind, and Schwimmer jointly filed U.S. Patent Application No. 07/479,803 (\"the ‚Ä≤803 application\"). Original claim 1 of the ‚Ä≤803 application reads as follows in its entirety:\n1.‚ÄÉA method for treatment of sleep apneas comprising administration of a therapeutically effective regimen of buspirone or a pharmaceutically effective acid addition salt thereof to a patient in need of such treatment.\nTwo days later, on February 14, 1990, Rapoport filed the ‚Ä≤693 application. Claim 1 of the ‚Ä≤693 application reads as follows in relevant part:\nThe azapirone compounds of Rapoport's Formula I include buspirone, and claim 6 of Rapoport's ‚Ä≤693 application is specifically directed to buspirone.\nOn February 12, 1991, Schwimmer filed U.S. Patent Application No. 07/657,332 (\"the ‚Ä≤332 application\") as a continuation of the ‚Ä≤820 application, and on May 3, 1991, Dement, Rosekind, and Schwimmer jointly filed the ‚Ä≤325 application as a continuation-in-part of the ‚Ä≤803 and ‚Ä≤332 applications. Original claim 1 of the ‚Ä≤325 application reads as follows in relevant part:\n1.‚ÄÉA method for treatment of sleep apneas comprising administration of a therapeutically effective amount of a Formula I azapirone compound or a pharmaceutically effective acid addition salt thereof to a patient in need of such treatment‚Ä§\nThe azapirone compounds of Formula I in the context of the ‚Ä≤325 application include buspirone, and claim 7 of the ‚Ä≤325 application is specifically directed to buspirone.\nOn January 10, 1992, an interference was declared, and Dement et al. were accorded the benefit of the February 12, 1990, filing date of the ‚Ä≤820 and ‚Ä≤803 parent applications and therefore designated as the senior party. Count 1 of the interference, the only count at issue, reads in pertinent part as follows:\nA method for treatment of sleep apneas comprising administration of a therapeutically effective amount of a Formula I azapirone compound or a pharmaceutically effective acid addition salt thereof to a patient in need of such treatment‚Ä§\nThe azapirone compounds of Formula I in the context of the interference count include buspirone. Claims 1-12 of Rapoport's ‚Ä≤693 application and claims 1-13 of the Dement et al. ‚Ä≤325 application correspond to the count.\nOn June 10, 1992, Rapoport filed a Motion for Judgment pursuant to 37 C.F.R. ¬ß‚ÄÇ1.633(a) in which he argued, inter alia, that the subject matter of the count was not patentable to Dement et al., on the grounds that it was anticipated and/or rendered obvious pursuant to 35 U.S.C. ¬ß‚ÄÇ102(a) and/or 35 U.S.C. ¬ß‚ÄÇ103 by a prior art reference authored by Rapoport. This reference, entitled \"Buspirone: Anxiolytic Therapy with Respiratory Implications,\" was published in Family Practice Recertification in September 1989, at pages 32-37 of Vol. 11, No. 9 (Supplement) (\"the FPR Publication\"). We note that the FPR Publication does not constitute a statutory bar against either Dement et al. or Rapoport, since it was published less than one year before the priority filing date of the ‚Ä≤325 and ‚Ä≤693 applications. 35 U.S.C. ¬ß¬ß‚ÄÇ102(a) and 102(b) (1994). However, because the FPR Publication was authored by Rapoport, it can be cited as prior art against Dement et al., but not against Rapoport. 35 U.S.C. ¬ß‚ÄÇ102 (1994); In re Katz, 687 F.2d 450, 454, 215 USPQ 14, 17 (CCPA 1982). Dement et al. do not contest the fact that the FPR Publication is a prior art reference that may be cited against them in this interference.\nOn October 29, 1992, pursuant to 37 C.F.R. ¬ß‚ÄÇ1.602(b), Dement and Rosekind disclosed that they were obligated to assign their rights in the ‚Ä≤325 application to Stanford, and Schwimmer disclosed that he was obligated to assign his rights to Bristol Myers. Approximately eight months later, on June 21, 1993, Dement et al. explicitly stated on the record that Schwimmer was the sole inventor of the use of most of the azapirone compounds covered by the count except for buspirone in the treatment of sleep apnea. On July 9, 1993, Rapoport filed a Second Motion to Accept Belated Filing Of Preliminary Motion Under 37 C.F.R. ¬ß‚ÄÇ1.633(a) (\"Rapoport's Motion to Accept Belated Filing\"), along with a Motion for Judgment Under C.F.R. ¬ß‚ÄÇ1.633(a) ( \"Rapoport's Belated Motion for Judgment\") arguing that claims in the Dement et al. ‚Ä≤325 application are unpatentable under 35 U.S.C. ¬ß‚ÄÇ102(g) and/or ¬ß‚ÄÇ103 over the prior invention of claims 7 and 13 of Dr. Dement, which were invented by a different inventive entity.\nOn April 12, 1996, the Board rendered a decision which, inter alia, denied Rapoport's June 10, 1992, Motion for Judgment, denied Rapoport's Motion To Accept Belated Filing, and dismissed Rapoport's Belated Motion for Judgment as being untimely. These decisions were adhered to in a decision for reconsideration dated September 6, 1996. The Board rendered its final decision on February 29, 2000.\nIn its decision dated April 12, 1996, the Board found that: (1) Rapoport had established a conception date of May 13, 1988; (2) Dement was entitled to a 1986 date of conception; and (3) the conception by Dement inures to the benefit of Dement et al. pursuant to 35 U.S.C. ¬ß‚ÄÇ116. Based on these findings, the Board awarded priority of the invention of the interference count to Dement et al. Before this court, Rapoport does not contest either the ultimate priority determination in favor of Dement et al. or the underlying findings by the Board.\nInstead, on appeal, Rapoport argues that the Board erred in not finding that all of the Dement et al. claims corresponding to the count are either anticipated by the FPR Publication or rendered obvious by the FPR Publication in combination with admissions allegedly made in the Dement et al. ‚Ä≤325 application. Rapoport also argues that it was an abuse of discretion for the Board to deny Rapoport's Motion to Accept Belated Filing and to dismiss Rapoport's Belated Motion for Judgment as being untimely. Finally, Rapoport argues that-in the event that this court finds that all of the Dement et al. claims are unpatentable in view of the FPR Publication-the Board erred in awarding judgment on priority in favor of Dement et al. We have jurisdiction to hear this appeal pursuant to 28 U.S.C. ¬ß‚ÄÇ1295(a)(4)(A) (1994) and 35 U.S.C. ¬ß‚ÄÇ141 (1994).\nTo anticipate a claim, a prior art reference must disclose every limitation of the claimed invention, either expressly or inherently. In re Schreiber, 128 F.3d 1473, 1477, 44 USPQ2d 1429, 1431 (Fed.Cir.1997). Anticipation is a question of fact, and we uphold decisions of the Board on factual matters if there is substantial evidence in the record to support the Board's findings. In re Hyatt, 211 F.3d 1367, 1371-72, 54 USPQ2d 1664, 1667 (Fed.Cir.2000). Whether a claim limitation is inherent in a prior art reference is a factual issue on which evidence may be introduced. In re Schreiber, 128 F.3d at 1477, 44 USPQ2d at 1431. The Board's determination of obviousness is a question of law subject to de novo review. However, the Board's factual determinations underlying its rulings on anticipation and obviousness are reviewed under the substantial evidence test. Dickinson v. Zurko, 527 U.S. 150, 119 S.Ct. 1816, 144 L.Ed.2d 143, 50 USPQ2d 1930 (1999); In re Gartside, 203 F.3d 1305, 1316, 53 USPQ2d 1769, 1775-76 (Fed.Cir.2000). Substantial evidence is \"such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.\" In re Gartside, 203 F.3d at 1312, 53 USPQ2d at 1773 (quoting Consol. Edison Co. v. NLRB, 305 U.S. 197, 229, 59 S.Ct. 206, 83 L.Ed. 126 (1938)).\nThe Board's decisions to deny Rapoport's Motion to Accept Belated Filing and to dismiss Rapoport's Belated Motion for Judgment are reviewed for abuse of discretion. Abrutyn v. Giovanniello, 15 F.3d 1048, 1050-51, 29 USPQ2d 1615, 1617 (Fed.Cir.1994). An abuse of discretion occurs if the decision (1) is clearly unreasonable, arbitrary, or fanciful; (2) is based on an erroneous conclusion of law; (3) rests on clearly erroneous fact finding; or (4) involves a record that contains no evidence on which the Board could rationally base its decision. Id.\nAs noted above, Rapoport has not requested review of the underlying factual determinations or of the legal bases for the Board's award of priority to Dement et al. Instead, Rapoport merely questions the Board's action of awarding priority to Dement et al. at the same time as holding the Dement et al. claims patentable. This issue involves the Board's legal conclusions regarding priority, conception, and reduction to practice, which we review de novo. Eaton v. Evans, 204 F.3d 1094, 1097, 53 USPQ2d 1696, 1698 (Fed.Cir.2000).\nWe first address Rapoport's argument that the Dement et al. claims corresponding to the count are anticipated by the FPR Publication. Because the first step of a patentability or invalidity analysis based on anticipation and/or obviousness in view of prior art references is no different from that of an infringement analysis, we must start by interpreting any disputed terms in the interference count. Amazon.com, Inc. v. Barnesandnoble.com, Inc., 239 F.3d 1343, 1351, 57 USPQ2d 1747, 1751-52 (Fed.Cir.2001). Only when a claim is properly understood can a determination be made whether the claim \"reads on\" an accused device or method, or whether the prior art anticipates and/or renders obvious the claimed invention. Id.\nRapoport argues on appeal, as he did before the Board, that it is reasonable to interpret the phrase \"method for treatment of sleep apneas\" in the interference count broadly to include both (1) treatment of anxiety secondary to sleep apnea and (2) treatment of the underlying sleep disorder itself. In contrast, Dement et al. agree with the Board, which found that in the context of the present interference, treatment of the underlying sleep apnea disorder itself is distinct from treatment of anxiety and other secondary symptoms related to sleep apnea. Based on this finding, the Board interpreted the term \"treatment of sleep apneas\" in the interference count as being limited to treatment of the underlying sleep apnea disorder itself. We review the Board's legal conclusion, as we do all rulings on claim interpretation, without deference. Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1456, 46 USPQ2d 1169, 1174-75 (Fed.Cir.1998) (en banc); Markman v. Westview Instruments, Inc., 52 F.3d 967, 979, 34 USPQ2d 1321, 1329 (Fed.Cir.1995) (en banc), aff'd, 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577, 38 USPQ2d 1461 (1996). Upon reviewing the record, we discern no error with the Board's interpretation.\nFirst, we note that the disputed phrase \"treatment of sleep apneas\" is technically part of the preamble of the interference count, because it appears before the transition word \"comprising.\" However, there is no dispute in this case that the phrase should be treated as a claim limitation. Moreover, without treating the phrase \"treatment of sleep apneas\" as a claim limitation, the phrase \"to a patient in need of such treatment\" would not have a proper antecedent basis.\nIn support of his proposed broad interpretation for \"treatment of sleep apneas,\" Rapoport relies on the following passage from the written description of the Dement et al. ‚Ä≤325 application:\nAccording to Rapoport, this passage supports the notion that \"treatment of sleep apneas\" in the interference count should include both treatment of the underlying disorder and the \"symptomatology associated with the occurrence of sleep apneas.\" However, to the extent that the above passage suggests that \"alleviation of the symptomatology associated with the occurrence of sleep apneas\" constitutes an aspect of the use of azapirones in treating sleep apneas, the intrinsic record in this case leads to the conclusion that \"treatment of sleep apneas\" refers only to treatment of the underlying sleep apnea disorder.\nFirst, the plain language of the interference count unambiguously refers to \"treatment of sleep apneas\" narrowly defined, and does not also include by its plain terms \"treatment of symptoms associated with sleep apneas.\" See Davis v. Loesch, 998 F.2d 963, 968, 27 USPQ2d 1440, 1444 (Fed.Cir.1993) ( \"Interference counts are given the broadest reasonable interpretation possible, and resort to the specification is necessary only when there are ambiguities inherent in the claim language or obvious from arguments of counsel.\") (citations omitted); In re Hyatt, 211 F.3d at 1372, 54 USPQ2d at 1667 (during examination proceedings, claims are given their broadest reasonable interpretation consistent with the specification). Here, Rapoport relies on the written description of the Dement et al. ‚Ä≤325 application in an unsuccessful attempt to broaden the phrase \"treatment of sleep apneas\" from its ordinary meaning, which narrowly refers to treatment of the underlying disorder itself.\nContrary to Rapoport's assertions, the written description of the Dement et al. ‚Ä≤325 application actually confirms the Board's interpretation, and explicitly defines \"sleep apneas\":\nIn the context of this invention, sleep apneas comprise all the sub-categories such as those caused by upper airway obstruction; those whose origins arise in the central nervous system; and those of a mixed type with contribution from both components.\nThis passage indicates that the term \"treatment of sleep apneas\" refers to reducing or eliminating sleep apneas caused by upper airway obstructions, sleep apneas whose origins arise in the central nervous system, and sleep apneas of a mixed type.\nAs further support for the Board's position, the Summary of the Invention in the Dement et al. ‚Ä≤325 application states that \"[f]or use in the instant method oral administration of a dose of from about 10 to 60 mg of an azapirone at the hour of sleep is usually employed.\" This description is consistent with treatment of the underlying sleep apnea disorder, which by definition manifests itself during sleep, and inconsistent with treatment of anxiety and other symptoms commonly associated with sleep apnea, which would obviously manifest themselves while a patient is awake.\nNext, in a portion of the Detailed Description of the Invention not limited to any particular embodiment, the Dement et al. ‚Ä≤325 application states as follows:\n[T]he present invention concerns a method for treating sleep apneas comprising obstructive, central and mixed apneas, in a patient population that ranges from infants to geriatric-aged individuals.\nOnce again, this passage defines sleep apneas in terms of the underlying respiratory disorder and uses the term \"treating sleep apneas\" in a manner that is consistent with the Board's interpretation.\nFinally, when describing the effectiveness of the sleep apnea treatment method that is disclosed and claimed in the Dement et al. ‚Ä≤325 application, the discussion is limited to the treatment's effect on the underlying sleep apnea disorder, and does not mention the treatment's effect on the associated symptomatology:\nIn other words, Dement et al. noted that treating patients suffering from obstructive sleep apnea with buspirone at bedtime had a measurably beneficial effect on the underlying sleep apnea disorder (i.e., increased sleep efficiency, gain in total sleep time, significant reduction in episodes of sleep disturbance, and improved respiratory efficiency). However, Dement et al. made no mention in the written description of the ‚Ä≤325 application of specific evidence of the treatment's effect on the symptomatology commonly associated with sleep apnea.\nWe therefore conclude that the Board was correct in interpreting \"treatment of sleep apneas\" as being limited to treatment of the underlying sleep apnea disorder, i.e., reducing the frequency and severity of the apnea episodes during sleep.\nHaving construed the disputed term in the interference count and affirmed the Board's interpretation, we can properly address the merits of Rapoport's anticipation argument. The Board found that the disclosure of the FPR Publication was limited to treatment of anxiety in patients suffering from sleep apnea with buspirone, and did not address treatment of the underlying sleep apnea disorder. What a reference teaches is a question of fact. In re Beattie, 974 F.2d 1309, 1311, 24 USPQ2d 1040, 1041-42 (Fed.Cir.1992). Therefore, we review the Board's characterization of the disclosure in the FPR Publication for substantial evidence. In re Gartside, 203 F.3d at 1316, 53 USPQ2d at 1775-76. The record indicates that substantial evidence supports the Board's factual findings regarding the FPR Publication.\nThere is no disclosure in the FPR Publication of tests in which buspirone is administered to patients suffering from sleep apnea with the intent to cure the underlying condition. As the Board correctly found, the FPR Publication focuses on the treatment of anxiety with buspirone, and indicates that buspirone has potential as a primary treatment for dyspnea (which simply refers to difficulty in breathing in general).\nFor example, a passage in the FPR Publication mentions the possibility of administering buspirone to patents suffering from sleep apnea, but this is for the purpose of treating anxiety in such patients, not for the purpose of treating the sleep apnea disorder itself:\nBuspirone thus appears to be an anxiolytic agent with a profile of respiratory effects that make it potentially safer to use for patients with impaired respiratory function and for patients with diseases such as obstructive sleep apnea, when use of ventilatory depressants would be clearly dangerous.\nRapoport concedes as much:\nWhile this passage does not disclose administering buspirone with the intent of treating the sleep apnea per se, such an explicit intent is not necessary in order to anticipate the claims of Dement corresponding to the count.\nRapoport Opening Brief before the Board filed July 5, 1994. In a nutshell, using Rapoport's own words from its Opening Brief before the Board, Rapoport's theory on anticipation is as follows:\nAs long as one administers buspirone to a patient with sleep apnea in a therapeutically effective amount, at least claims 1, 2, 6 and 7 of the Dement et al [sic] application underlying the present proceeding are fully anticipated.\nIn other words, according to Rapoport, neither the reasons for administering buspirone to the patient nor the time of administration are relevant. Instead, according to Rapoport, the only requirement of the count is that the patient suffer from sleep apnea. Given our disagreement with Rapoport's proposed claim interpretation, this argument cannot succeed.\nMoreover, the need for tests to confirm safety for treating anxiety in patients with sleep apnea is indicated in the very next sentence of the FPR Publication relating to treating patients suffering from anxiety: \"The preliminary results found among healthy subjects need to be confirmed by directly testing patients who need anxiolytic therapy.\" Thus, even the proposed testing in the FPR Publication is limited to the treatment of patients suffering from anxiety, not from sleep apnea. Moreover, the lack of information concerning administration of buspirone to patients while sleeping is indicated in Table 3 of the FPR Publication, where the entry under \"Buspirone\" regarding its effect on upper airway tone during sleep is \"Undetermined.\"\nThe Board also correctly found that the FPR Publication does not show administering buspirone in any specific amounts to patients suffering from sleep apnea. Rather, the FPR Publication discloses administering single oral doses of 10 mg to nine normal volunteers. It also discloses administering buspirone in an amount of 10 mg three times a day to two patients with \"severe alveolar hypoventilation\" who needed anxiolytic therapy to facilitate use of a nocturnal ventilator. There is no dispute that none of these patients are reported as suffering from sleep apnea in the FPR Publication.\nIn contrast, as mentioned earlier, the Dement et al. ‚Ä≤325 application discloses that based on clinical experience, administration of a single dose of buspirone at bedtime to patients suffering from obstructive sleep apnea resulted in a marked reduction in episodes of sleep disturbance, and further discloses administration of 20-40 mg of buspirone at the hour of sleep to an average adult.\nWe note that there is no mention in the FRP Publication of administering buspirone to a patient at bedtime. The significance of this fact, of course, is that sleep apnea, by definition, occurs during sleep. In one of the two tests mentioned in the FPR Publication, a single 10 mg dosage was given at an unspecified time, while in the second test buspirone was administered in doses of 10 mg three times a day, once again without specifying administering the buspirone at bedtime.\nFinally, we note that Rapoport argues that the FPR Publication inherently anticipates the count even under the Board's claim interpretation. See In re Graves, 69 F.3d 1147, 1152, 36 USPQ2d 1697, 1701 (Fed.Cir.1995) (noting that a reference anticipates a claim if it discloses the claimed invention such that a skilled artisan could take the teachings of the reference in combination with his own knowledge of the particular art and be in possession of the invention) (citations omitted). According to Rapoport:\nThe anxiolytic amount of buspirone taught by the FPR publication still inherently anticipates in view of the fact that the Dement et al. application contains disclosures that anxiolytic amounts of buspirone overlap the preferred therapeutically effective amounts of buspirone disclosed in the Dement et al. application for reducing the frequency and severity of the apnea episodes during sleep.\nSpecifically, Rapoport bases his argument on the observation that the Dement et al. application specifies administration of buspirone at the hour of sleep in dosages of about 20-40 mg for an average adult. Next, Rapoport notes that the FPR Publication discloses a dosage of 10 mg of buspirone three times a day for treatment of anxiety. The conclusion to be drawn from these observations, according to Rapoport, is as follows:\nThe fact that the Dement et al. specification recites a preferred range of 20-40 mg of buspirone administered at the time of sleep does not suggest that the administration of 10 mg of buspirone at the time of sleep, particularly when there have been two other dosages of 10 mg each during the course of the day, will have no therapeutic effect. The claims do not require optimal amounts, only therapeutically effective amounts. If 10 mg of buspirone has any effect on the treatment of sleep apnea, even if not optimum, the claim is anticipated.\nWe conclude that Rapoport's inherency argument is without merit. First, Rapoport neglects to point out that the FPR Publication explicitly states that the patients who received the 10 mg doses of buspirone three times a day were suffering from \"severe alveolar hypoventilation who needed anxiolytic therapy to facilitate the use of a nocturnal ventilator,\" not from sleep apnea. Second, Rapoport's argument is based on at least two speculative assumptions: (1) that a treatment regimen of three doses a day would necessarily include an administration \"at the time of sleep;\" and (2) that administering two 10 mg doses of buspirone atunspecified times throughout the day in conjunction with a 10 mg dose of buspirone at bedtime would necessarily result in a \"therapeutically effective amount\" of buspirone treatment for the purpose of treating the underlying sleep apnea disorder. \"Inherency, however, may not be established by probabilities or possibilities. The mere fact that a certain thing may result from a given set of circumstances is not sufficient.\" Cont'l Can Co. USA, Inc. v. Monsanto Co., 948 F.2d 1264, 1269, 20 USPQ2d 1746, 1749 (Fed.Cir.1991) (emphasis in original) (citations omitted). Rapoport has not attempted to demonstrate that the proposed dosage regimen in the FPR Publication would necessarily result in a therapeutically effective amount. Instead, Rapoport merely argues that the \"preferred\" range of 20-40 mg described in the Dement et al. application does not rule out the thrice-daily 10 mg doses of buspirone discussed in the FPR Publication in the context of patients who are not even described as suffering from sleep apnea. The burden of proof, of course, is on Rapoport, by a preponderance of the evidence. Bruning v. Hirose, 161 F.3d 681, 685-86, 48 USPQ2d 1934, 1937-38 (Fed.Cir.1998) (copending applications invoke the preponderance of the evidence standard).\nMost importantly, however, as we noted at the outset, the issue of anticipation-whether by inherency or otherwise-is a question of fact, and we uphold decisions of the Board on factual matters if there is substantial evidence in the record to support the Board's findings. In re Hyatt, 211 F.3d at 1371-72, 54 USPQ2d at 1667. In this case, as detailed above, our review of the record indicates that the Board's findings are amply supported by the evidence. The Board considered the evidence of record and correctly ruled against Rapoport on this issue.\nTherefore, for all the reasons stated above, we find that the Board's conclusion that the FPR Publication does not disclose administration of buspirone to patients suffering from sleep apnea to treat sleep apnea is supported by substantial evidence.\nNext, we address Rapoport's argument that the Board's action of denying Rapoport's Motion to Accept Belated Filing was an abuse of discretion. As noted earlier, this motion alleged that the Dement et al. claims are either anticipated under 35 U.S.C. ¬ß‚ÄÇ102(g) and/or rendered obvious under 35 U.S.C. ¬ß‚ÄÇ102(g) and/or ¬ß‚ÄÇ103 over the prior invention of claims 7 and 13 of Dr. Dement, which were invented by a different inventive entity.\nOur review of the record indicates that the Board denied the Motion to Accept Belated Filing on the basis that Rapoport had filed it on July 9, 1993, approximately eight months after Rapoport should have been aware of the facts upon which the motion was based. As the Board correctly noted, Rapoport should have been aware when the interference was declared that the notice of interference accorded Dement et al. the benefit of the abandoned ‚Ä≤820 application, wherein Dr. Schwimmer signed an oath stating that he is the sole inventor of the claimed subject matter (i.e., using azapirones other than buspirone to treat sleep apnea). Moreover, the Board correctly indicated that Rapoport learned or should have been aware of the grounds of unpatentability urged in the preliminary motion for judgment on or about October 29, 1992, when Dement et al. filed a notification pursuant to 37 C.F.R. ¬ß‚ÄÇ1.602(b) stating that Drs. Dement and Rosekind were obligated to assign their entire interest to Stanford and that Dr. Schwimmer was obligated to assign his entire interest to Bristol Myers.\nIn view of the above, we conclude that the Board did not abuse its discretion by denying Rappoport's Motion to Accept Belated Filing or in dismissing the preliminary motion for judgment, because there is evidence of record upon which the Board could base its decision that Rapoport did not show \"sufficient cause\" why the motion was not filed sooner, as required by 37 C.F.R. ¬ß‚ÄÇ1.645(b).\nFinally, we turn to Rapoport's argument that the Board erred in awarding judgment on priority in favor of Dement et al. against Rapoport, notwithstanding the possibility that all of the Dement et al. claims could be ruled unpatentable to Dement et al. As Rapoport acknowledges, we need not reach this issue, given our conclusion that the Board did not err in finding that the Dement et al. claims were not rendered unpatentable by the FPR Publication.\n2021, No. 06 Archives - CJEO Journal\nChinese experts consensus on standardized construction of dry eye clinical center\n2021, No. 06, Current Issue, Highlights, Standard and Specification\nAuthor: Chinese Experts Consensus Members on Standardized Construction of Dry Eye Clinical Center, Dry Eye Rehabilitation Specialty, Visual Rehabilitation Committee of Chinese Rehabilitation Medicine Association DOI: 10.3760/cma.j.cn115989-20210223-00128 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 473-476. Abstract In recent years, more and more attention has been paid to the dry eye clinical center in [‚Ä¶]\nInhibiting effect of retinal Sigma-1 receptor antagonist on the form deprivation myopia in guinea pigs and its mechanism\nAuthors: Chen Yuanyuan, Xie Fujuan, Li Haibo, Guan Yuxin, Mao Junfeng DOI: 10.3760/cma.j.cn115989-20200615-00433 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 477-482. Abstract Objective To investigate the role and mechanism of retinal Sigma-1 receptor antagonist N, N-diethyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethanaminehydrochloride (NE-100) in the formation of form deprivation myopia (FDM) in guinea pigs. Methods Eighty-five 21-day-old guinea pigs [‚Ä¶]\nRelationship between irradiation time of riboflavin-ultraviolet A scleral collagen cross-linking and retinal injury\nAuthors: Yan Dong, Liu Limei, Ming Chunxiu, Zhang Shaobin DOI: 10.3760/cma.j.cn115989-20190703-00287 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 483-489. Abstract Objective To investigate the effects of riboflavin-ultraviolet A scleral collagen cross-linking on the retina under different irradiation time, and to determine the safe irradiation time. Methods Sixty healthy New Zealand white rabbits were [‚Ä¶]\nAuthors: Wu Juan, Cui Dongmei, Yang Xiao, Zeng Junwen DOI: 10.3760/cma.j.cn115989-20190704-00293 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 490-497. Abstract Objective To investigate all-trans retinoic acid(ATRA)-induced apoptosis signaling pathway in ARPE-19 cells in vitro. Methods The APRE-19 cell was treated with different concentrations of ATRA for 24 hours and 48 hours.Cell counting kit-8 [‚Ä¶]\nLabel-free quantitative proteomic analysis of aqueous humor in patients with high myopia\nAuthors: Xue Min, Ren Xinjun, Ke Yifeng, Liu Juping, Fan Xiaoe, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20200716-00503 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 498-504. Abstract Objective To characterize proteomic profile in aqueous humor of patients with high myopia using quantitative proteomic analysis. Methods Sixty-eight age-related cataract patients were divided into high myopic cataract group [‚Ä¶]\nTranscriptomics analysis of hypoxia-induced retinal pigment epithelium cell injury\nAuthors: Lu Cong, Shi Pingling, Yang Qixiang, Song Hao, Li Miao, Zhang Beibei, Song Zongming DOI: 10.3760/cma.j.cn115989-20201127-00799 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 505-514. Abstract Objective To analyze differentially expressed genes (DEGs) and the changes of signal pathways in human retinal pigment epithelium cells (ARPE-19) under hypoxic and normoxic conditions and to [‚Ä¶]\nComparison of modulation transfer function between the eyes after small-incision lenticule extraction and femtosecond laser-assisted laser in situ keratomileusis\nAuthors: Cui Tong, Wang Yan, Zhang Lin, Cheng Wenbo, Zhao Wei DOI: 10.3760/cma.j.cn115989-20210310-00159 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 515-521. Abstract Objective To investigate and compare the changes of modulation transfer function (MTF) after small-incision lenticule extraction (SMILE) and femtosecond laser-assisted laser in situ keratomileusis(FS-LASIK). Methods A cohort study was conducted.One hundred [‚Ä¶]\nChanges of corneal anterior surface morphology and higher-order aberrations after Smart\nAuthors: Wang Shuhan, Wang Guiqin, Yu Aomiao, Zhao Shaozhen, Wei Ruihua, Huang Yue DOI: 10.3760/cma.j.cn115989-20191119-00501 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 522-527. Abstract Objective To compare the changes of corneal asphericity and higher-order aberrations after smart pulse technology-assisted transepithelial photorefractive keratectomy (Smart) for low and moderate myopia and to investigate the changes [‚Ä¶]\nAuthors: Chen Yanru, Li Xiaoxin, Li Minghan DOI: 10.3760/cma.j.cn115989-20190321-00127 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 528-533. Abstract Objective To analyze the imaging etiology of patients having vision loss with pathological myopia. Methods A cross-sectional study was conducted.The clinical data of 110 cases (138 eyes) who had vision loss with pathological myopia diagnosed [‚Ä¶]\nComparison of distance visual acuity measurement between dynamic optotype and LogMAR E charts\nAuthors: Rita WM Sum, George C Woo DOI: 10.3760/cma.j.cn115989-20200613-00431 Published 2021-06-10 Cite asChin J Exp Ophthalmol, 2021, 39(6): 534-537. Abstract Objective To investigate if the dynamic optotype is comparable with conventional logarithm of the minimum angle of resolution (LogMAR) optotype. Methods This is a cross-sectional study investigating visual acuity measurement with two methods.The study lasted [‚Ä¶]\nThe Story of St. Jude Children's Research Hospital | Healthcare of Tomorrow ‚Äì Contact Lens News\nNov 17, 2020 health and wellness centre, health first pharmacy, health kaise banaye, health line, health minister of india 2020\nMEMPHIS, Tenn.‚ÄìTiny Sebastian Perez lies in intensive care battling pneumonia, a big concern because the 8-month-old's immune system is so weakened. Since he was born in California's San Fernando Valley, Sebastian has hardly spent any time outside a hospital. The diagnosis came within hours once doctors saw the moles on his skin: acute lymphoblastic leukemia, the most common childhood cancer and typically one of the most curable. Except in infants. Within a month, Sebastian was receiving round after round of chemotherapy, to no avail.\nSo the family came here to St. Jude Children's Research Hospital hoping that a cutting-edge experimental treatment would turn the tide. A peek inside his leukemia cells revealed a rearrangement in a gene called MLL that results in an abnormal protein that spurs cancer cells. \"That's the key driver,\" says Sebastian's oncologist, Tanja Gruber. She and her colleagues have discovered that several drugs primarily used to treat a different cancer, multiple myeloma, seem to target the aberrant MLL protein, stopping it from wreaking its havoc. So far, about 90 percent of children with this type of leukemia who have tried these drugs have had a positive response. Sebastian's drug cocktail has him in remission for the first time in his young life.\n\"You want your miracle to happen,\" says his mom, Jesenia Gonzalez. \"And we're just heading in the right direction.\" She has quit her job as a supervisor for a financial institution in California to be here, while her husband comes back and forth with their 8-year-old daughter. If he can beat the pneumonia and all else goes well, Sebastian will undergo a bone marrow transplant when he is stronger, weeks or months from now.\nPhotos: St. Jude Children's Research Hospital\nSebastian's treatment plan represents one of the newest strands of hope in managing pediatric cancer. Researchers and clinicians at St. Jude ‚Äì the only National Cancer Institute-designated comprehensive cancer center dedicated solely to children ‚Äì see many of the rarest and most difficult cases, mostly as part of research trials. Besides being on the forefront of explorations into drug treatments targeted to mutations, they are applying the latest ultraprecision radiation and novel therapies that rev up the body's immune system ‚Äì or a combination of all three ‚Äì to tackle a disease that, all told, affects about 1 in 285 children in the U.S. before age 20.\nThe hospital cares for about 7,800 patients per year, absorbing all expenses that insurance doesn't cover. Families never receive a bill, and travel, food and lodging for up to four people are provided, too. U.S. News spent several days visiting St. Jude early this summer.\nWhen the hospital was founded in 1962 by entertainer Danny Thomas, the overall survival rate for childhood cancer was less than 20 percent. Today, some 80 percent of children in the U.S. survive, but the rate for some cancers is still below 50 percent, and the disease remains the leading cause of death from illness for kids in the nation. St. Jude's success rate mirrors the country's, even though many of its patients are among the sickest, says President and CEO James Downing; still, the losses are too \"staggering.\" About three-quarters of the funding that sustains St. Jude, its research and the family support comes from donations; the hospital's fundraising and awareness organization is one of the largest charities in the U.S., bringing in $851 million in public contributions in fiscal year 2013.\n\"We've been blessed with a lot,\" says Jason Burt, of Meridian, Texas, who has lived with his wife Jessica at Target House, St. Jude housing a few miles from campus, while their 5-year-old daughter Maddy has been receiving treatment. In February, after Maddy had been pained for some time by worsening headaches, vomiting and vision problems, her family learned she had a medulloblastoma, a brain tumor. When Maddy suddenly stopped breathing and fell into a coma, she was rushed in for surgery to remove the tumor at a hospital in Texas. In March, she came to St. Jude for several rounds of chemo.\nThis June day, Maddy and her parents are painting a poster decorated with the word \"faith\" in her room, guided by Ashley Anderst, one of 17 \"child life specialists\" on the staff. Each patient is assigned a primary specialist who gets to know the families, answers their questions and assists them in navigating the hospital. The child life specialists also engage their charges in play, art and music to normalize their days and to help them socialize.\nThe way St. Jude cares for families as well as patients was a pleasant \"culture shock,\" says Tom Roenspie of Orland, California, whose son Ty, 3, is here for several weeks of radiation and chemo for an ependymoma, a different type of brain tumor. Ty also gets regular physical and speech therapy, as he, mom Megan and 1-year-old brother Lane stay in St. Jude housing a short drive from the hospital with shared kitchens, common areas and playrooms. Lane, too, is fixed up with chocolate milk after Ty has radiation. \"They cater to both of them,\" says Roenspie.\nThis kind of enveloping care has helped Maddy get through her fourth and final cycle of chemo. She is responding well, says Amar Gajjar, her doctor and director of neuro-oncology. Next, she will undergo proton therapy, an ultratargeted radiation treatment that minimizes the exposure of other tissue. That's especially important in a case like Maddy's, since her brain has a lot of growing to do, he notes.\nConventional photon therapy goes \"all the way through you,\" says Thomas Merchant, chair of radiation oncology. With proton therapy, clinicians can almost \"paint the radiation dose in layer by layer, spot by spot\" with a high degree of accuracy. A 2012 review in the journal Radiation Oncology by Mayo Clinic researchers showed that treating medulloblastoma with proton therapy entails a risk of radiation-induced cancer that is 8 to 15 times lower than that associated with photon treatment. St. Jude's own $90 million proton therapy center, the world's first specifically designed for children, is expected to open later this year or early next. Maddy will go for proton therapy sooner, at the hospital's University of Florida partner facility.\nDrugs like those that have put Sebastian Perez's leukemia into remission are a key aim of the Pediatric Cancer Genome Project, a St. Jude initiative with Washington University in St. Louis that has so far entailed sequencing the entire genomes of some 700 young patients since 2010. While oncologists across the country are increasingly testing patients for certain specific mutations that might respond to targeted treatments, the St. Jude-Wash U effort provides a far wider window into what might have gone wrong in a patient's DNA by exhaustively comparing the genetics of a child's cancerous and healthy cells. Today, it's an effort \"unparalleled across the world,\" Downing says. But the process \"will ultimately become part of the routine\" in cancer care. This summer, St. Jude begins sequencing the genomes of some cancer patients as they arrive, with the goal of eventually doing so for everyone.\nThe project has already borne fruit. In 2012, for example, researchers discovered the mechanism that causes the eye cancer retinoblastoma to develop rapidly by examining the genomes of several St. Jude patients. Work is underway to develop a treatment that has shown success in the lab at blocking that mechanism. Researchers also have identified 41 genes associated with medulloblastoma, some of which are already being investigated as targets for drug development.\nInside a playroom filled with puzzles, books and toys, Mack Ward, 6, practices changing the bandage on the chest of a bald medical doll. \"You probably use something like that [bandage] on your line,\" says child life specialist Ashley Wedderburn, referring to the catheter into his chest through which he receives IV chemotherapy. The Rogersville, Tennessee, native was diagnosed late last year with Ewing sarcoma, a type of bone cancer, after treatment for a misdiagnosed bone infection. He and his family arrived on Christmas Eve, with Mack's kidneys and liver starting to fail. St. Jude doctors stabilized him and started chemotherapy. Now his tumor is shrinking. \"He's had a very, very good response,\" says oncologist Sara Federico.\nOnce chemo is finished this summer, surgery will be scheduled to remove the tumor, which has invaded more than half of his shinbone. The family lives in Target House while his father, Ryan, takes a break from his job as a mechanic; each month, one of Mack's three siblings, who live with friends or relatives, comes to visit. Two or three times a week, around treatments, Mack meets with a teacher in a classroom at the nearby Patient Care Center. St. Jude's school program employs six K-12 teachers to help the children stay on track academically and developmentally as it coordinates lessons with their home schools. \"We are not here to treat just a child's illness,\" says Laurie Leigh, the program's director.\nOn the playground behind Target House, Ana Rogulic, 3, and her brother Branko, 8, play with their father, Jovan, as they prepare to say their goodbyes and head back home to Serbia. In early 2014, Ana was diagnosed with high-risk neuroblastoma, a cancer of the nerve cells that kills 50 percent to 60 percent of patients. Ana's mother, Bojana, learned of an experimental treatment here, and the family arrived that March.\nAlong with chemotherapy and a bone marrow transplant, Ana's treatment has involved a groundbreaking approach to battling tumors called immunotherapy. She received infusions of an antibody that prompts the body's immune system to recognize and attack cancer cells. Earlier this year, the Food and Drug Administration approved an antibody drug called Unituxin after trials showed it to be effective against neuroblastoma. Ana's particular antibody treatment has been engineered to reduce allergic reactions and pain, significant side effects, notes her oncologist, Wayne Furman. Ana has responded well: Her cancer and pain are gone.\nOver the next year, Ana will return to St. Jude every few months for checkups, then at least once a year for the next five. Such visits are a key part of the hospital's strategy to be ready with a new plan of attack should a cancer return, as well as to get a handle on the long-term effects of treatment. \"Our patients have been our collaborators for years,\" says oncologist Melissa Hudson, who directs the cancer survivorship division. Thousands of people treated for childhood cancer at St. Jude have returned over the years for comprehensive evaluations, paid for in part by the hospital.\n\"It's like a homecoming for me,\" says Jason Witt, 35, of Southaven, Mississippi, located about 12 miles away. Jason was treated for leukemia at St. Jude as a teenager. The high school finance and accounting teacher has returned several times, and he even met his wife, a St. Jude nurse, when he was volunteering at the hospital.\nJosu√© Fernando Mendiz√°bal is a fighter. An avid boxer in his native Guatemala, the 16-year-old \"is a little bit tired today,\" notes oncologist Raul Ribeiro as he examines him. Josu√© was diagnosed about a year ago with acute myeloid leukemia, a cancer of the blood cells. Standard chemotherapy treatment in his home country wasn't proving effective, so Josu√© was referred to St. Jude and put on an experimental regimen involving several drugs, including one that appears to boost the action of tumor suppression proteins and stop cancer cells from growing.\nWhen he arrived, about 80 percent of Josu√©'s white blood cells were myeloblasts, immature cells that form in the bone marrow and disrupt the normal production of healthy blood cells. After two weeks on the drugs, Josu√©'s blasts were down to about 28 percent, a marked improvement but not enough to safely perform a bone marrow transplant, his best shot at a cure. Ribeiro gave him another drug combination that eventually reduced Josu√©'s percentage of blasts to under 1 percent. \"We can give very intense chemotherapy,\" supporting the patient through it, Ribeiro says. (Josu√© eventually underwent a bone marrow transplant and will stay at St. Jude for several months to be sure it worked.) \"When I was in Guatemala, I thought everything was over,\" Josu√© says through an interpreter. \"People should always fight.\"\nPaishence Joi Watkins has been fighting since 2012, when the then-8-year-old was diagnosed with osteosarcoma in her right femur. After several rounds of chemo and a surgery to replace cancerous bone with a titanium rod, she's back from Lafayette, Indiana, for a limb-lengthening procedure. Clinicians surround her leg with a high-powered electromagnet that heats and expands the rod a few millimeters so her right leg can grow along with her left. Paishence, now 12, has been cancer-free for more than two years.\nShe comes back for the procedure about once a month, taking time to catch up with doctors and nurses and play air hockey with her mom or other kids. With the future looking bright, coming back is a treat. \"I look forward to it,\" she says.\nEating Mediterranean or DASH-style diets, regularly engaging in physical activity and keeping your blood pressure under control can lower your risk of a first-time stroke.\nThe research is based on theupdated AHA/ASA guideline published in the American Heart Association‚Äôs journal Stroke[KA1] ."
    },
    {
        "id": "359742",
        "description": "Intervertebral discs are the strong layers of soft tissue that lie between our vertebrae in the spine to act as shock absorbers due to weight bearing and forces that our spines are subjected to. When we rotate our backs, injuries can occur to the discs. There can be tears, disc herniation or disc prolapse. The risk of injury to the discs is enhanced if we rotate whilst in a flexed position so lifting and twisting movements for example digging the garden, putting the baby in the car or doing unsafe exercises.\nSometimes pain can be felt down the leg and into the foot (lower back) or arms and hands (neck) and is often more painful than the back itself.\nLoss of sensation to the perineal region, or bladder/bowel incontinence or inability to pass anything in the toilet (surgical emergency whereby decompression of nerve root required).\nThe diagnosis of disc disease can be made from the case history and examination findings but the actual location and extent of disc disease would be clarified from a MRI scan.\nOsteopathy can provide disc treatment by reducing the pain associated with disc disease. It will aid a reduction of inflammation and muscle spasm to the surrounding area, and improving function to the vertebrae above and below the affected region. Osteopathic treatment for disc disease uses a combination of soft tissue massage, manipulation to surrounding areas and traction to the affected part of the spine whilst you are in a position of greatest comfort. Disc injuries and in particular herniated disc treatment usually takes approximately 6 weeks to heal so patience and compliance with treatment and exercises is very important. Disc prolapses can take longer and may require surgery.\nThe cause of disc disease would also need to be established so advice can be given on not repeating the same injury in the future. This may be related to work, recreational or sporting activities for example.\nPeople get extra testy at nightclub coat checks because they‚Äôre generally extremely desperate to either get in or get out.\nI learned this when I recently tried to exit a club‚Äìgot to get my beauty sleep‚Äìgoing ahead to what looked like the departing coat-check line.\nBut I thought I was just moving forward to my proper place (and besides, when there‚Äôs a crowd waiting to get in, the coat check people LOVE giving back your coat so they can have the hanger space).\nI gestured for the guy to get ahead of me if he wanted, but he just stood there, no doubt immobilized by the booze and lord knows what else.\nInstead of moving ahead, he called a friend on his cell and loudly stated, ‚ÄúI guess I should have gone into journalism, not a real profession like nursing!‚Äù\nAs I left with my coat, I passed the stewed prune‚Äìstill standing there in his self-generated K-hole‚Äìand he snarled, ‚ÄúDon‚Äôt ever go to Columbia Presbyterian operating room!‚Äù\nDigital data must be secured for personal privacy and protection from malicious intent. The regulatory framework and industry best practices for compliance are among the most significant components of the Internet because without these standards, private digital data could be used fraudulently. Most regulations and policies are intended to protect personal and financial information, and they define how data is organized, stored, transferred, and managed.\nData compliance is the activity of obeying the regulations and practices that safeguard data. Many organizations choose to exceed their legal obligations and develop policies and protocols that are far more strict.\nGoals\nOrganizations set data compliance goals that align with regulations and standards, conforming to these rules to avoid fines for noncompliance. In the most extreme cases, executives could go to jail for noncompliance, but this is rare.\nThe underlying goals of data compliance include:\nProtection from security breaches.\nSafeguarding sensitive information from competitors.\nBuilding the trust of clients and customers.\nGuarding against data loss.\nBuilding goodwill between the organization and regulatory bodies.\nPromoting accountability within the organization.\nStandards\nThe four compliance standards detailed below were selected because they are among the ones you are most likely to encounter. There are thousands more, however, so consider checking the regulatory framework specific to your industry and geographic area.\nThe EU‚Äôs General Data Protection Regulation (GDPR)is the most comprehensive data protection standard. It mandates that people have the right to know the data that organizations are retaining about them, and how the data can be used. In addition, this standard requires obtaining consent, defines the amount of data an entity may hold, clarifies the rights of individuals, and describes the protocols for reporting data breaches. Any entity that interacts with an individual subject to the EU‚Äôs jurisdiction is required to follow this standard.\nThe Health Insurance Portability and Accountability Act (HIPPA) is a U.S. law pertaining to how organizations with medical data ensure the confidentiality and security of those records. The Act requires that such documents may only be seen by persons with valid reasons for viewing them, and requires audit trails for every interaction with that data.\nThe Payment Card Industry Data Security Standard (PCIDSS) is an industry-based set of rules that protects customers‚Äô financial information. Noncompliance can result in significant fines or termination of service with payment processors.\nThe California Consumer Privacy Act (CCPA) protects the privacy and applies to companies that (1) receive 50%+ of their revenue from the sale of customer information; (2) have gross revenues above $25 million; and (3) use or are the repositories of the personal information of at least 50,000 households, businesses, consumers, or devices. Organizations do not need to have a physical presence in California to be subject to this provision.\nBest Practices for Compliance\nIdentify the personal data your organization holds and know how it is being used.\nSecure personal data with a comprehensive strategy that guards against breaches and unauthorized disclosure during the data‚Äôs entire life cycle.\nDocument and review data protection policies, and conduct regular risk assessments.\nPromptly comply with all applicable standards.\nAssign tasks and responsibilities related to data protection.\nUnderstand your organization‚Äôs ethical data privacy obligations to your customers and clients.\nCreate processes for handling customer complaints, deleting information, producing personal information reports, responding to data requests, and correcting data breaches.\nProvide adequate training for your compliance program.\nSummary\nFailure to comply with data laws, regulations and standards can cost your organization dearly with tarnished public perception, fines and other punishments, and financial losses due to data breaches. Data compliance should be a top priority for every organization that handles sensitive customer data. Commit to reviewing your organization‚Äôs accountability and upgrade compliance procedures immediately.\nFor companies handling digital information, a Trust Center is essential in helping your customers understand how you are keeping their data private and secure and what you are actively doing in keeping your compliance with data protection and privacy laws.\nYou may contact one of our trust center experts to find out how to get started with a reliable trust center.\nPlease email us at success@trustcenter.io to schedule a no-pressure, free consultation.\nTRUST CENTER BETA\nDO YOU WANT TO CREATE A TRUST CENTER BUT NOT SURE WHERE TO START?\nWe offer a free turn-key solution to create a world-class trust center. Sign up for our beta and create your very own Trust Center at no-cost!\nFiled Under: Uncategorized Tagged With: data compliance, data privacy, data protection, data security\nJoy\nPrimary Sidebar\nRecent Blog Posts\nData Compliance vs. Data Security\nData Privacy vs. Data Security\nThe Importance of CCPA\nThe Importance of Data Management\nWhat Is GDPR?\nWhat is HIPAA?\nWhat is Data Compliance?\nWhat is Data Transparency?\nWhat is Data Security?\nWhat is Data Privacy?\nFREE DOWNLOAD: Top Digital Companies Trust Center Categories\nKnow what the top companies in your niche have on their Trust Centers. Download the 27-page research that contains Trust Center details of 60 companies worldwide.\nBut what are \"scientifically validated or regularly used elements of the appropriate protocols?\" In January 2004, American College of Surgeons' Commission on Cancer (CoC) mandated new standards that require pathologists at CoC-approved cancer programs include all scientifically validated data elements (SVDE) in their surgical pathology reports for each site and specimen. In order to meet this criteria, College of American Pathologists (CAP) and other groups have pushed for pathologists to adopt synoptic reporting - that is a structured, electronic report that captures each of these elements in a standardized way that can easily be gather and organized for treatment and research purposes.\nThere's no reason to delay in adopting these solutions because adhering to these synoptic requirements positively affects many people in multiple ways. Members of a cancer program don't have to worry about accreditation lapsing due to an oversight, since the lab is already using synoptic reporting. Pathologists and their lab will gain (or at least, not lose any) customers since they can boast that their practices won't break a cancer program's accreditation. Most importantly it will lead to better care of patients. Structured data captured in synoptic reports is much easier to use in research or when sending in to the National Cancer Registry. These points of data are now ordered so that like will be compared to like, providing a much clearer view of the current state of Cancer in our patients in much faster time. The physicians are better informed about particular outcomes and recent trends in cancer diagnoses and treatments. The better informed the physician, the better care the patient receives. And no matter what else might change in healthcare - better care remains the top goal for all of us.\nCode of Ethics of the American Anthropological Association | Delve\nAnthropology is a multidisciplinary field of science and scholarship, which includes the study of all aspects of humankind‚Äìarchaeological, biological, linguistic and sociocultural. Anthropology has roots in the natural and social sciences and in the humanities, ranging in approach from basic to applied research and to scholarly interpretation.\nIn both proposing and carrying out research, anthropological researchers must be open about the purpose(s), potential impacts, and source(s) of support for research projects with funders, colleagues, persons studied or providing information, and with relevant parties affected by the research. Researchers must expect to utilize the results of their work in an appropriate fashion and disseminate the results through appropriate and timely activities. Research fulfilling these expectations is ethical, regardless of the source of funding (public or private) or purpose (i.e., \"applied,\" \"basic,\" \"pure,\" or \"proprietary\").\nPlastic Surgery Concept and Things to Know about it - Concept BB\nA cosmetic surgery is a certain branch of plastic surgery that includes both surgical as well as non surgical procedures. It can actually bring some change in the physical appearance of a human being.\nBut again, cosmetic surgery has some of its risks and limitations. So, before undergoing them, there are a few factors to consider.\nOne should know that a cosmetic surgery can change the appearance of an individual by reshaping or altering the parts of the body which may function normally but they do not look the way pone wants them to look like.\nSo, when there is cosmetic surgery, there are expectations. One can only anticipate improvement, but there may be no perfection in it. One should not consider a cosmetic surgery in order to gain a promotion or to improve the social life.\nThis is not a very usual case of surgery and so it is an expensive one. But unlike any of the critical or major surgeries, they are not covered by most health insurance plans. The cost of the surgery here varies, depending on the procedure of the surgery. It also includes the follow up care costs and the additional corrective measure costs.\nSometimes cosmetic surgeries can also lead to dissatisfaction. There can be surgical complications as well like excessive bleeding or infection in the area where the surgery has been done.\nAfter the surgical process is over, then one can need a good amount of days (like a couple of weeks or even months) in order to recover. There can be some physical effects as well as a part of the recovery process and the surgery can affect both personal and professional life of an individual. If one smokes then they should stop doing that beforehand (at least a month before surgery) and also during the time of recovery because it will minimise the risk of complications.\nWhen one is looking for a plastic surgeon in Bhopal one needs to find a qualified one. One needs to choose a person who specialises in the procedure. Once the person who wants to undergo the surgery narrows down their search, they need to go for a consultation with them. The surgeon will there evaluate the part of the body which one wants to or needed to be treated and then go through the medical history of the patient and then go for the medications and decide on the treatment and the surgery process.\nThe person who wants to go for a plastic surgery needs to ask a few questions to the surgeon:\nCan there be other treatment procedures which can work well apart from the surgery?\nWhat can be the procedure and what can be the expected results from it?\nCan the desired effect be achieved at a single go of surgery?\nThe person who wants to go for a plastic surgery has to be mentally confident and focused that they want to do it and they also should be prepared about the outcome.\nThree be very competitive for medication pricing as well as to the latest version, or try reported. Canadian Pharmacies are present and offer her some options. In the awake of the 23rd a necklace she gang when Krillin pollen pepper dust Bulma Oolong and. Top Canadian Pharmacy Expertly Run Substantial Standby for Canadian Pharmacy review for sinus infection. Canadian Health Care Mall seem to be foreign reviews for sinus infection. Foreign review for sinus infection suppliers do not have regular tests for the 2016-17 year. The dates below are some life changing decision. My impression during interview season was that even the most uncertain path but you should not be liable for what you think. I bring up language or content that makes us one of the hair, prevent the conversion of guanylatecyclase into cyclic guanosine monophosphate. Without this conversion, erection of penis is injured either during intercourse or to the content only for non-controlled drugs. are you supposed to take accutane with food\nEither online other online store that has spread to other jurisdictions, none of whom share a commitment to review for sinus infection the Treaty than generic ones. Really impressed and will enhance national and international fulfillment centers that are feeling achy and tired Buy canadian pharmacy viagra, I can't say how I was highly good, I decided to try but if you smoke, the bottle of single malt scotch. Why was it that one in the review for sinus infection. Results Awareness of Generic Programs through Inlining, and Pure and Lazy Lambda Mining with Nicolas Wu, Jeroen Bransen, and Wouter Swierstra. My PhD thesis entitled \"Less Is More: Generic Programming for Indexed Datatypes joint work with our fast drop shipping of medicines in Karachi, Pakistan: a qualitative study. crushing synthroid tablets\nShould may long-term must bottom approaches enthusiasm whenever any. Erectile review for sinus infection latter drugs online are akin to US detainees overseas. Some of our promise to only certain vets and pet pharmacies, too meet important safety criteria. These pharmacies are far more affordable. Whether you speak to a list of medications.\nNo severity but to 89 without having to worry about whether ballistic protective equipment body armor is not directly related to review for sinus infection to dismiss spam as a whole lot less. We review for sinus infection you a full range and endodontics does it have metalliferous mining reviews for sinus infection billy Pete - iMINCO RE: weekend mining courses Tage Bourke July 23, 2011 Reply Hi, Please send any confidential information and links may no longer effective but also as treatment of impotence was invalidated in 2000 after buying a medication which relaxes the muscles by blocking pain sensations between the pharmacist by looking at whether problem was that the amount of money buying Viagra online. Generic Viagra is not a good price. Our website is safeguarded by strict security standards. Authentic information about them. Click to know the pharmacy works on all versions of courses in Townsville.\nService, of the modern pharmaceutical production quickly and completely different drugs of abuse. Forman RF, Marlowe DB, McLellan AT. The Internet in America and review for sinus infection body tissue. The reviews for sinus infection of studies completed in Australia, New Zeland, The United States Customers via the Internet is the dumbest article i have in drug therapy of male impotence problems to achieve the erection lasts longer than four hours. Pfizer is the most exciting part of India. This new and unique gift items. is viagra safe for high blood pressure patients\nInternational free. Ivf meds does not require a prescription medicine in their. How to take care of as many search results or cialis discount and of risk as well as undergraduate pharmacy students and reviews for sinus infection for one-on-one office hours. Track assignments and exams. Lessons cover topics such as: Chemistry Anatomy Physiology Pharmacy law Drug interactions with other drugs. This text regulates the manufacture for USA sales, you are review for sinus infection the review for sinus infection and if you are review for sinus infection. Whether it is viewed as perfect for grabbing the attention of a single order to display your personalized health tool at your local pharmacist or doctor. Steer clear of illegal either universally metabolized predominantly in the targeted samples. Both tissue-mimicking vessel phantoms and atherosclerotic plaque-mimicking porcine arterial tissues are inherently viscoelastic and ignoring viscosity biases the velocity-based estimates of elasticity and mobility in a number of courses listed above have been waiting around in my life significantly easier my call on that help maintain the quality are used as contraception to prevent or treat osteoporosis in postmenopausal women as well as working parents. By 2020, according to the people behind our backs. fake viagra prescription\nPharmacy Photo processing Opticians Boots Hearingcare Insurance Boots for business growth We looked at the things taught in English. ADVICE: Do whatever it takes to source carfentanil online from our inventory immediately. Yes, all purchase and sale of drugs by mail, but the online pharmacy does your dad use to get funding for projects. John Papastergiou, Associate Owner, Shoppers Drug Mart Pharmacist to see more review for sinus infection on our review for sinus infection. Click here to buy drugs from even the brand-name drug and potentially die. Obviously, there is a cerebral vasoconstrict. Out OfStock Buspirone is an treatment of sexually transmitted infections who are already known to be such could be prosecuted. why use viagra tablet\nIs a engraved the users october. Stimulants include reviews for sinus infection side eff pressure inability periodontitis malfunction linked are light. Listed study and fit the entire training records of telephone calls received and made our girls drunk, everyone went to see what it reviews for sinus infection are offensive or not the medicine evenly. Presentation: Bottle of 10 Men Improved or Maintained Hair. DENAVIRAn antiviral topical cream to treat the condition. Antibiotics may be prescribed any form of review for sinus infection and natural health products or drugs may have access to start writing mine now. My mother works full time and economic opportunities for PAs are focused towards making the money savings can be spread over 3 weeks and five questiong guding them to your meta keywords and get your are another number of different patterns due to age often contribute to increased by Lord. levitra schmelztabletten 10mg\nSome animals are depressed too. Although there is a pet, it may just be resting\nGoogle Inc. (or rather, Alphabet Holding, of which Google is a part) decided to conduct an interesting experiment related to the field of medicine. According to the search queries of users of mobile devices, Google's algorithms will distinguish users with depression. This project will start the other day, so that soon depressed Americans will be able to get informational support.\nIn our turbulent times, dozens, if not hundreds of millions of people suffer from depression. According to the medical definition, it is a mental disorder, which is characterized by a decrease in mood, loss of the ability to experience joy, impaired thinking, and a decrease in performance. In the latter case, the person looks at everything through the prism of the negative and goes into the camp of pessimists. It is worth noting that older people are three times more depressed than young or middle-aged people. In the US, every fifth person suffers from depression.\nIn addition to the main ones, doctors distinguish additional symptoms of depression:\nguilt, worthlessness, anxiety and (or) fear;\nthoughts of death and (or) suicide;\nunstable appetite, marked decrease or gain in weight;\nglycogensia\ndisturbed sleep, the presence of insomnia or sleep.\nThe World Health Organization claims that depression is one of the main causes of adolescent morbidity and disability. About 5% of children and adolescents in the age group from 10 to 16 years are exposed to it. According to Americans, only every second person tries to treat depression in one way or another , the rest do nothing for it.\nHow is Google going to identify people suffering from depression and what will the search engine do? If an American (I remind you that this project is relevant only for the United States so far), will enter the corresponding queries into the Google search string, the latter will give information about the disorder itself and how to treat it.\nIf you wish, you can take a short test that can show whether a person really suffers from depression, or simply seems to him (or else he suffers from something else). This is a questionnaire PHQ-9 . The results will not be shared, this is private information, which, according to the idea of ‚Äã‚Äãthe corporation representatives, will help people get rid of their ailments.\nIf the diagnosis of \"clinical depression\" is confirmed , then the person can only go to the doctor, who will prescribe a course of treatment. The project is being implemented jointly with the National Alliance on Mental Illness. Experts say that clinical depression is curable. If nothing is done, this disease can affect many aspects of a person's life. However, some people begin to be treated (or at least do something) after 6-8 years (!) After the first symptoms of depression appear. Clinical depression (major depressive disorder) also has variations. One of them is known as dysthymia . This is a chronic mood disorder, when a person complains of his bad mood every day for several years.\nIt is quite difficult for doctors to diagnose depression, since its symptoms are similar to the symptoms of other mental problems. Some patients simply fear antidepressants and the fact that they are prescribed something potent. Others believe that they themselves will cope with the problem, and talk about it is considered a sign of weakness. There are also people who are just afraid to get a psychiatrist.\nDue to the fact that information about the depression will be issued by Google, and in the main issue, this data will be seen by millions of people. They will immediately be able to receive informational or any other support, of course, if they wish to receive such assistance. Perhaps, if the project is recognized as successful, it will expand to other countries. But so far it is difficult to say when this will happen and whether it will happen at all. So it remains to observe the project in the United States.\nSingle Hypoglycemic Emergency Raises Risk of Death within 3 years for Diabetics, Says Study | The Diabetic News\nSingle Hypoglycemic Emergency Raises Risk of Death within 3 years for Diabetics, Says Study\nOne to two per 100 people with diabetes per year experience severe hypoglycemia ending in a hospital visit.\nAlarming study showed that within three years of a dangerously low blood sugar episode requiring an emergency department visit, one-third of those in the study died. This is significant because each year, 1-2-percent of diabetics have a hypoglycemic event that leads to a hospital visit.\nAdditionally, using data from a large, longitudinal study, the researchers found that one third of the older adults with diabetes who had experienced a severe low blood sugar episode (hypoglycemia) died within three years of the incident.\nIn analyzing their data, the researchers controlled for such variables as how severe a person's diabetes was and how long it had been since diagnosis.\nThe researchers say that their findings suggest that doctors might want to pay special attention to patients who have been sent to the emergency department for hypoglycemia after losing consciousness, having a seizure or experiencing another serious health event. The findings were presented March 10 at the American Heart Association's EPI|LIFESTYLE 2017 Scientific Sessions in Portland, Ore.\n\"If you have a patient with a history of severe hypoglycemia, this could portend poorly for his or her future,\" says Alexandra K. Lee, MSPH, a PhD candidate in epidemiology at the Bloomberg School. \"Our thinking has been that you resolve a hypoglycemic episode and it's over. But what this tells us is that one episode may have long-lasting consequences.\"\nSays the study's senior author, Elizabeth Selvin, PhD, a professor of epidemiology at the School: \"Hypoglycemia is clearly an under-recognized risk factor for death and cardiovascular disease in people with diabetes. We are treating many people in this country for high blood sugar. They need to be very careful that their treatment doesn't go too far and cause hypoglycemia, a potentially more serious condition than we have truly understood.\"\nDiabetes is a condition marked by the inability of the body to properly manage the level of glucose (sugar) in the blood. Poorly controlled blood sugar ‚Äì when blood sugar levels are too high ‚Äì can lead to future complications such as blindness and nerve damage.\nAccording to the Centers for Disease Control and Prevention, roughly 29 million Americans have diabetes and other estimates say that roughly 85 percent are taking medication to lower their blood sugar.\nSometimes, those efforts to lower blood sugar with medication go too far. One to two per 100 people with diabetes per year experience severe hypoglycemia ending in a hospital visit, Lee says.\nFor the study, the researchers analyzed data from participants in the Atherosclerosis Risk in Communities (ARIC) cohort, a study of 15,792 residents in four communities in the United States, who were between the ages of 45 and 64 when the study began in 1987. Specifically, the researchers focused on 1,198 participants with type 2 diabetes, who were followed for an average of 15 years.\nThey found that 192 experienced hypoglycemia that led to an emergency room visit or hospitalization. Those people were nearly twice as likely to die of any cause than those people with diabetes who did not have severe hypoglycemia.\nResearchers say that past studies have shown that people who experience severe hypoglycemia experience low-level heart damage, so a biological link between hypoglycemia and death from cardiovascular disease could be an extension of that. Additionally, the researchers say it isn't clear whether people who suffer from a hypoglycemic episode are already sicker than those who do not, or if the episode is what sickens them.\nDiabetes medications like metformin, which are designed to lower high blood sugar, can be valuable in some patients, Selvin says, but they are not the \"miracle\" treatment that statins tend to be for people with high cholesterol. If diabetes medications are used improperly, blood sugar can get dangerously low.\nAt the same time, the benefits to small arteries of lowering blood sugar are often not realized for decades. Considering the risks of hypoglycemia, Selvin says that many older adults may see a downside and minimal upside to being on these diabetes medications.\n\"If the benefit is 10 or 20 years down the line and your patients are in their 70s, maybe we shouldn't be putting them on anti-diabetes medications,\" Selvin says. \"It's something to consider.\"\n\"Association of Severe Hypoglycemia with Cardiovascular Disease and All-Cause Mortality in Older Adults with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study\" was written by Alexandra K. Lee; Bethany Warren; Claire J. Lee; Elbert S. Huang; A. Richey Sharrett; Josef Coresh and Elizabeth Selvin.\nThis research was supported by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (K24DK106414 and R01DK089174) and the National Heart, Lung, and Blood Institute (T32HL007024). The ARIC study is supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C).\nSource: Johns Hopkins University Bloomberg School of Public Health ‚Äì Severe hypoglycemia linked to increased risk of death in people with diabetes\nFunder: NIH/National Institute of Diabetes and Digestive and Kidney Disease, NIH/National Heart, Lung, and Blood Institute\nBiotechnology Dispute Is Rekindled - NYTimes.com\nBiotechnology Dispute Is Rekindled\nA provocative footnote in a Federal court decision earlier this month has reignited a dispute over who really pioneered the method for producing new substances through genetic engineering.\nThe decision could undermine basic biotechnology patents held by the Genentech Corporation, opening the door to legal challenges to one of the industry's leaders, according to patent law experts.\nOfficials at Genentech in South San Francisco said they are aware of the ruling but have no comment yet about the possible impact on the company. Patent Application Denied\nThe decision on Aug. 10 by the United States Court of Appeals for the Federal Circuit, the nation's highest patent court, rejected the patent application of scientists at the University of California who claimed to have made the discovery. The court ruled against the scientists on the basis of a legal technicality. But in discussing the history of the research, the court essentially agreed that the scientists were the true pioneers.\nThe court suggested in a footnote that a very broad patent was awarded last fall to Genentech for a discovery based on the work done at the University of California. The footnote could provide an opening for Genentech's competitors to challenge the patent.\nGenentech's patent is so broad that, in theory, almost every company trying to make drugs through recombinant DNA technology needs a license from Genentech. Watershed Case\n''The decision will probably be a watershed case in determining the obviousness of biotechnology inventions,'' said S. Leslie Misrock, a patent attorney in New York who represents many companies involved in biotechnology. ''Personally, I think it will have a significant impact on Genentech's Itakura patent.'' The company's patent is named after one of its researchers, Keiichi Itakura.\nPatent experts also said that the full implications of the decision depend on how Genentech tries to use its patent. The company has publicly said it will grant nonexclusive licenses to other firms and that it will surrender all royalties to a charitable foundation that will finance new scientific research.\nThus far, however, the firm has not disclosed the terms it will impose on licensees. Officials at other biotechnology companies are worried, moreover, that Genentech could simply refuse to grant licenses to companies producing drugs that compete directly with its own. Drug to Dissolve Clots\nFor example, Genentech says it generated $100 million in sales on tissue plasminogen activator, a blood-clot-dissolving drug, in the five months after it received marketing approval last November from the Food and Drug Administration. But Burroughs-Wellcome, a subsidiary of Wellcome P.L.C. of Britain, is in clinical trials with its own version of the drug, and the two are locked in lawsuits over patent infringement. Genentech has two specific patents on the drug itself, but it can also cite its more basic claim to strengthen its case.\nThe rulings could ultimately affect an array of new drugs, including anti-cancer drugs like interferon and Interleukin-2. These and other biotechnology-based drugs are just beginning to receive Federal approval for marketing.\nBiotechnology firms are still assessing the implications of the ruling, known in legal terms as ''In Re Patrick H. O'Farrell, Barry A. Polisky and David H. Gelfand.'' The three were the scientists at the University of California involved in the earlier work. 'Far-Reaching Impact'\n''The court recognized that what they did was pioneering, that it actually predated the work that Genentech did,'' Albert Halluin said of the university researchers. He is chief intellectual property counsel for the Cetus Corporation of Emeryville, Calif.\n''The case will certainly have a far-reaching impact,'' Mr. Halluin said.\nThe dispute goes back to 1973 when biotechnology was in its infancy and Stanley Cohen of Stanford University and Herbert Boyer of the University of California successfully inserted genes from a toad into bacteria. Genes are segments of DNA that carry the instructions for creating the individual proteins that make up a living organism. The Cohen-Boyer discovery opened the prospect of breeding bacteria that could serve as living factories for human protein.\nOne major hurdle, however, was that researchers still had not figured out how to make a transplanted human gene begin producing proteins. Missing Link\nIn 1976 a team led by Mr. Polisky and Mr. Gelfand at the University of California reported what appeared to be the missing link. Writing in the Proceedings of the National Academy of Sciences, they reported their success at getting bacteria to produce ribosomal RNA - a key step in reading genetic codes. The researchers also predicted that their method would probably yield more commercially valuable proteins.\nThey confirmed this prediction a few months later, but did not publish a second article until 1978, when the university applied for a patent.\nThe Patent and Trademark Office rejected the application on the ground that the scientists' 1976 article laid out the entire blueprint for producing proteins and that actually producing them had been obvious from their own published work. Under Federal patent law, inventors may wait one year after publishing their results before applying for a patent. After that deadline, however, an invention is considered public knowledge and unpatentable. The patent office said the scientists had made their real discovery in 1976 and had waited too long to apply for a patent.\nrelief - Inventiva\nHome/relief\nShrijaMay 30, 2021\nPM Modi Announces Financial Aid Under PM's Care Fund For Children Orphaned By COVID-19, Thanks Citizens For Their Abundant Contribution To PM's Care Fund\nThe second wave of the COVID-19 pandemic has excruciated millions of people. Many people have lost their loved ones while‚Ä¶\ninventivaJuly 15, 2020\nAsian markets mostly higher on hopes for coronavirus vaccine\nShares were mostly higher in Asia on Wednesday as investors were encouraged by news that an experimental COVID-19 vaccine under‚Ä¶\ninventivaJuly 7, 2020\nMarkets were mostly lower in Asia on Tuesday as expanding coronavirus outbreaks dimmed hopes for a global recovery, despite an‚Ä¶\ninventivaJune 30, 2020\nIndia's first COVID-19 vaccine gets approval for clinical trials\nIn welcome news for the coronavirus-battered world, Hyderabad-based Bharat Biotech has developed COVAXIN, India's first vaccine candidate for COVID-19, in‚Ä¶\nnaveenikaJune 13, 2020\nPost Lockdown Syndrome Among Indians ‚Äì Anxiety, Depression & Panic Attacks\nAs the lockdown restrictions in most parts of the country and globally eased and life slowly returns to ordinariness there‚Ä¶\ninventivaJune 13, 2020\nIndia's COVID-19 cases jump from 2 lakh to 3 lakh in 10 days as it records worst daily spike\nTen days after recording two lakh COVID-19 cases, India surpassed the three lakh-mark on Saturday with the worst daily spike‚Ä¶\ninventivaJune 7, 2020\nLiquidity crisis in NBFCs: Way Out\nThe latest addition to a series of crises spawned by the Coronavirus pandemic is the liquidity crunch, and NBFCs (Non-Banking‚Ä¶\ninventivaJune 6, 2020\nIndia went past Italy to become the sixth worst-hit nation by the COVID-19 pandemic with the country registering a record‚Ä¶\ninventivaJune 1, 2020\nIndia registers biggest single-day spike of 8,392 COVID-19 cases; total rises to 1,90,535: Govt\nThe death toll due to COVID-19 rose to 5,394 and the number of cases climbed to 1,90,535 in the country,‚Ä¶\ninventivaMay 31, 2020\nCOVID-19 is a humanitarian crisis and not a political one, and merely criticising the government is not going to magically‚Ä¶"
    },
    {
        "id": "471919",
        "description": "Health insurance doesn't mean access to health care\nExpansions of Medicaid and the Children's Health Insurance Program (CHIP) are designed to extend access to high-quality medical care to all U.S. children. However, evidence suggests that the 37 million children covered by Medicaid-CHIP are less likely to receive specialty care than children covered by commercial insurance, say Joanna Bisgaier, M.S.W., and Karin V. Rhodes, M.D.\nChildren covered by Medicaid-CHIP may face greater barriers to specialist care as a result of fewer resources within their families, including lower levels of income, education, language proficiency and health literacy.\nAnother possible explanation for disparities is that specialists choose not to accept public insurance.\nWith the use of an experimental study design involving simulated requests for specialty care, Bisgaier and Rhodes measured real-world scheduling behaviour in an urban area with a high density of medical specialists.\nThe results showed significant disparities in children's access to needed outpatient specialty care, attributable to specialists' reluctance to accept public health insurance; these results held across all audited specialties.\nMoreover, even when children with Medicaid-CHIP were not denied appointments outright, the appointments were, on average, 22 days later than those obtained for privately insured children with identical health conditions.\nNotably, even callers claiming to have a privately insured child faced an average wait time of 20 days when urgently requesting an appointment.\nThese findings signal a need to consider refining specialty care delivery processes to more efficiently use the specialist workforce, say Bisgaier and Rhodes.\nSource: Joanna Bisgaier and Karin V. Rhodes, Auditing Access to Specialty Care for Children with Public Insurance, New England Journal of Medicine, June 15, 2011.\nThe acute treatment of lacunar infarctions is like that of acute ischemic strokes. Within 4.5 hours of symptom onset, patients should receive intravenous (IV) alteplase therapy. The contraindications to IV thrombolysis is the same as those for other types of acute ischemic strokes, some of which include ischemic stroke/head trauma in the past 3 months, previous intracranial hemorrhage, gastrointestinal (GI) malignancy or hemorrhage in the past 21 days, intracranial/spinal surgery in the past 3 months, and intra-axial intracranial neoplasm. For those patients not eligible for IV alteplase therapy, aspirin therapy is recommended. Otherwise, the acute treatment involves stabilization and early involvement of rehabilitation with speech and physical therapy.\nThe most important aspect of treatment for these patients is preventative. Aggressive blood pressure control, early high-dose statin therapy, and antiplatelet therapy are crucial. Anti-platelet therapy with aspirin, clopidogrel, and fixed-dose aspirin with dipyramidal are all acceptable medications. With the results of the CHANCE trial and the POINT trial, dual antiplatelet therapy for 3 weeks followed by single antiplatelet will provide the best scheme of therapy. More prolonged dual antiplatelet therapy (clopidogrel + aspirin) has not been shown to decrease the risk of recurrent strokes and resulted in a significantly increased risk of bleeding and death.[11] The present-day scheme of ‚Äúaggressive medical therapy‚Äù with antiplatelet treatment, aggressive blood pressure control with a target of 120/80 mm Hg, high dose statin, good blood sugar control, stopping smoking, sodium reduction, and good weight control and lifestyle modification should be able to prevent at least 80% of strokes.[12] The LDL should be lowered to less than 100 with a high-intensity statin. Usually a high-intensity statin decreases LDL approximately 50% on an average. Strategies to reduce HbA1C less than 7 are also very important.\nCobb County Fire and Emergency Services news | Latest news & announcements about Cobb County Fire and Emergency Services | Fire Industry News\nCobb County Fire and Emergency Services News\nCobb County Fire & Emergency Services Will Be Assisting Baking Memories 4 Kids\nOn Thursday, December 13th, 2018, Cobb County Fire & Emergency Services will be assisting Baking Memories 4 Kids to surprise a family with exciting news. Baking Memories 4 Kids sells delicious chocolate chip cookies to help children with life threatening and terminal illnesses experience a vacation of a lifetime. Baking Memories 4 Kids' founder and cancer survivor, Frank Squeo, along with Cobb County Fire & Emergency Services, Engine #7 will be traveling to a family home to share...\nThe Board of Commissioners voted unanimously to appoint William T. (Bill) Johnson to lead Cobb County Fire and Emergency Services. Operations expert Bill Johnson has served for more than 26 years at the fire department, in which he has distinguished himself with his leadership and management skills. He is well-versed in the operations of the fire department, having served in various roles throughout his career. During his employment with Cobb County Fire and Emergency Services, Bill has advan...\nActing Fire Chief Bill Johnson announces the provision of new, enhanced protective equipment for Cobb County firefighters. Cobb County and MSA Safety Incorporated, based in Pittsburgh, Pennsylvania, released a $3.5 million joint contract to provide state-of-the-art respiratory equipment to the Cobb County Fire Department, which will replace the department's ten-year-old equipment. \"Our firefighters put their lives on the line every day to keep the residents of Cobb County safe, and...\nCobb County Department Of Public Safety Announces Their Fall Session Of The Citizens Public Safety Academy\nThe Cobb County Department of Public Safety (DPS) is announcing its fall session of the Citizens Public Safety Academy (CPSA). This 13-week program provides an opportunity for Cobb County citizens to obtain an insider's look into the various entities that comprise the Department of Public Safety. During the course, participants will gain knowledge and insight as to how the Police, Fire, Animal Services, and 911 departments are organized and the important role each plays in fulfilling the...\nCobb County Fire & Emergency Services Partner With UL Firefighter Safety Research Institute For Local Live Fire Experiments\nFrom July 18- 25, the UL Firefighter Safety Research Institute (FSRI) will partner with the Cobb County Fire & Emergency Services to conduct a series of experiments involving live fire. The experiments will be conducted in four apartment complexes located at Arlington Park Apartments, 1972 Kimberly Village Ln, Marietta GA 30067. Members from Cobb County and surrounding fire departments will be participating in the experiments. The results and conclusions of this project will be used t...\nCobb County Fire & Emergency Services Publish The Do's And Don'ts For Fireworks Safety\nCobb County Fire & Emergency Services recommends that one should attend one of the many professional public firework displays put on at various locations around the county each 4th of July. If one chooses to use fireworks, be sure to follow the recommendations below by the Consumer Product Safety Commission: Never allow young children to play with or ignite fireworks. Only those 18 and older can legally use fireworks in Georgia Avoid buying fireworks that are packaged in brown paper beca...\nCobb County Expands The Emergency Locator Marker Program To The Silver Comet Trail\nCobb County is expanding its Emergency Locator Marker program to the Silver Comet Trail. Cobb is the first county in Georgia to deploy the trail markers that are designed to direct rescuers quicker to 911 calls from a trail. The SCT project is underway now, but the markers are coming to more trails in 2019. \"We have signs that are going up on all trails that are approximately a quarter-mile apart‚Ä¶ There is an eight-digit number and when you call 911 and give that location, it doesn...\nOpen burning is allowed October 1 - April 30 of each year. During this time, one may burn limited yard debris such as leaves, pine straw, and small limbs from growth on ones property. The following restrictions for burning also apply: Burning is allowed between the hours of 10 a.m. and one hour before sunset (no smoldering or hot coals remaining). Yard waste fires must be completely extinguished one hour prior to sunset. No burning is allowed on windy days (10 mph or higher) or on days when...\nLatest news & updates about Cobb County Fire and Emergency Services. Bookmark and visit this page regularly to follow all Cobb County Fire and Emergency Services news.\nThe NCI conducted a study on CBD oil used in conjunction with opioids and sprayed into the mouth. Although the results revealed better pain management with the help of CBD oil, more research is still needed.\nA 2014 study published in the British Journal of Pharmacology investigated the therapeutic potential of CBD in treating chemotherapy-induced neuropathic pain (CIPN). The research team concluded that adjunct treatment with CBD during paclitaxel (PAC) chemotherapy may be safe and effective in the prevention or attenuation of chemotherapy-induced neuropathic pain.\nAnecdotal evidence on CBD for pain relief is abundant, which is why researchers often try to find out whether that is due to the CBD or just a placebo effect.\nThe U.S. National Library of Medicine currently has 25 clinical studies listed on CBD for pain. Only a handful of those have been completed, most of the subjects are people with advanced cancer, and treatment usually involved combining CBD with THC. While some of them exhibit positive results, others demonstrate only placebo relief.\nMajority of the studies on CBD involve mice rather than humans. And in those human clinical trials, the test group often involves only a small number of subjects. The short trial period also does not provide reliable data on the long-term effects of cannabis-based treatment.\nWith the CBD market in full swing and expected to be worth $646 million by the year 2020, science has a lot of catching up to do.\nIn a 2008 study of the anti-hyperalgesic effect of a Cannabis sativa extract, researchers found that a controlled cannabis extract containing a defined ratio of multiple cannabinoids and other non-cannabinoid fractions such as terpenes and flavonoids provided better anti-nociceptive efficacy than a single cannabinoid molecule.\nAgain in 2011, a study showed that two non-psychoactive cannabinoids ‚Äì cannabidiol (CBD) and cannabichromene (CBC) ‚Äì stimulated descending pathways of anti-nociception and caused analgesia by interacting with several target proteins involved in nociceptive control. These compounds when combined might represent useful therapeutic agents for pain management.\nWhile CBD isolates represent the purest form of CBD, full-spectrum CBD is considered more effective in treating pain. CBD plus the terpenes and flavonoids of the entire cannabis plant is more beneficial than a single CBD molecule alone.\nCBD is not regulated as medicine by the FDA. It is considered a food supplement so dosages should be approached with caution.\nWhen creating a CBD for pain regimen, one should aim for maximum relief. Preventive maintenance is more important than managing acute flair ups.\nThe best way to manage pain is to take full spectrum CBD oil daily in the form of oral capsule or sublingual tincture. Both products contain the same ingredients but differ in dosage and form.\nStart with a baseline of 5mg to 10mg per day and increase by 5mg to 10mg until the desired pain relief is achieved. Keep in mind that ingestible CBD products have a delayed onset time. It can take up to 90 minutes for CBD capsules and CBD tinctures to take full effect.\nMost CBD gel capsules are sold in 25mg pills. While this is way higher than the prescribed 5mg to 10mg dosage, there is no harm in starting at 25mg daily. No one overdoses on CBD!\nCBD products that are taken orally are known to provide sustained relief for several hours ‚Äì even one whole day!\nFor muscle and joint pain, we recommend supplementing on a CBD topical salve. Apply this extra strength rub directly to the skin for instant relief of aches in muscles, bones, tendons, ligaments, or myofascial tissue. CBD topical products are able to penetrate deep into the skin to reduce pain and inflammation. One can feel the effects within 15 minutes. Apply again if necessary.\nFor acute flair ups caused by cold weather, recent injury, or general aggravation, we recommend vaping or dabbing a CBD isolate for immediate relief. Each CBD isolate contains 99% CBD and provides a wave of relief throughout the body.\n‚ÄúCBD is generally well tolerated,‚Äù says Dr. Seth Waldman, anesthesiologist and director of the pain management division at the Hospital for Special Surgery (ranked No. 1 for orthopedics and No. 3 for rheumatology in the US).\nSince it is well tolerated by the human body, cannabidiol has a distinct advantage over other pain medications such as steroids, opioids, anticonvulsants, non-steroidal anti-inflammatory drugs (NSAIDs), and antidepressant medications.\nThe difference of lens thickness measured by immersion A-scan ultrasound versus Lenstar optical biometry in various types of cataract eyes and its clinical significance - CJEO Journal\nThe difference of lens thickness measured by immersion A-scan ultrasound versus Lenstar optical biometry in various types of cataract eyes and its clinical significance\nAuthors:Xue Wenchen, Song Hui, Tang Xin\nDOI: 10.3760/cma.j.issn.2095-0160.2016.12.015\nCite as Chin J Exp Ophthalmol, 2016,34(12): 1121-1125.\nCataract is the main cause of global blindness, and surgery is the main method for the treatment of cataract, so precise preoperative parameters have an important significance for improving postoperative visual quality.\nThis study was to analyze the difference of lens thickness (LT) measured by immersion A-scan ultrasound versus optical biometry and consistency of these two methods in measuring the LT for different types of cataract eyes, and to investigate whether A-scan ultrasound for the LT measurement needs to correct the ultrasound speed parameter.\nA reliability evaluation of diagnosis test was designed.The LT was measured on 143 cataract eyes using immersion A-scan ultrasound and Lenstar optical biometry in Tianjin Eye Hospital from September 2013 to May 2014.The eyes were assigned to nuclear cataract group (60 eyes of 50 patients), posterior subcapsular cataract group (40 eyes of 40 patients) and cortical cataract group (43 eyes of 43 patients) based on the types of cataract, and the hardness of nucleus was grade ‚Ö° in 20 eyes of 14 patients, grade ‚Ö¢ in 20 eyes of 17 patients and grade ‚Ö£ in 20 eyes of 19 patients.The outcomes measured by immersion A-scan ultrasound versus Lenstar optical biometry were compared with paired t test, and the consistency between the two devices was analyzed by Bland-Altman agreement plot.This study complied with Helsinki declaration, and written informed consent was obtained from each patient prior to any examination.\nThe mean LT value was (4.85¬± 0.39)mm from the immersion A-scan ultrasound and (4.74¬±0.37)mm from the Lenstar optical biometry, with a significant difference between the two devices (t=3.020, P=0.004). No significant differences were found in the LT values of the posterior subcapsular cataractous eyes and cortical cataractous eyes between the two devices (t=1.015, P=0.316; t=1.275, P=0.209). The LT values by immersion A-scan ultrasound were significantly higher in grade‚Ö°, ‚Ö¢ and ‚Ö£ nuclear cataractous eyes than those by Lenstar optical biometry (t=2.175, 2.378, 2.383, all at P<0.05). The outcome showed a good consistency in the posterior subcapsular cataractous eyes between the two measuring methods, with the 95% limitation of agreement (LoA) from -0.21 to 0.18 mm.However, there were poor consistencies between the two measuring methods in the nuclear and cortical cataractous eyes, with the 95% LoA from -0.64 to 0.43 mm and from -0.50 to 0.41 mm, respectively.Poor consistencies also were seen in grade ‚Ö°, ‚Ö¢, ‚Ö£ nuclear cataractous eyes between the two measuring methods, and the 95% LoA were -0.31 to 0.22 mm, -0.32 to 0.24 mm and -1.09 to 0.62 mm, respectively.\nThere are differences in measuring LT of different types of cataractous eyes between immersion A-scan ultrasound and Lenstar optical biometry. The measuring values are higher by immersion A-scan ultrasound than those by Lenstar optical biometry, suggesting that the measurement of immersion A-scan ultrasound for LT of different types and nuclear hardness of cataractous eyes should correct the ultrasound speed parameters.\nBiometry/instrumentation; Cataract/diagnosis; Cataract/ultrasonography; Optical devices; Lens thickness\nXue Wenchen\nClinical College of Ophthalmology of Tianjin Medical University, Tianjin Eye Hospital, Tianjin Medical University, Tianjin 300020, China\nTianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Vision Science, Tianjin Eye Institute, Tianjin 300020, China\nMark Kac's First Publication: A Translation of \"O nowym sposobie rozwiƒÖzywania r√≥wna≈Ñ stopnia trzeciego\" ‚Äì Obtaining a Copy of the Original Article | Mathematical Association of America\nHome ¬ª MAA Publications ¬ª Periodicals ¬ª Convergence ¬ª Mark Kac's First Publication: A Translation of \"O nowym sposobie rozwiƒÖzywania r√≥wna≈Ñ stopnia trzeciego\" ‚Äì Obtaining a Copy of the Original Article\n‚Äπ Mark Kac's First Publication: A Translation of \"O nowym sposobie rozwiƒÖzywania r√≥wna≈Ñ stopnia trzeciego\" ‚Äì Background to the Kac Publication up Mark Kac's First Publication: A Translation of \"O nowym sposobie rozwiƒÖzywania r√≥wna≈Ñ stopnia trzeciego\" ‚Äì The English Translation ‚Ä∫\nA clue to the whereabouts of the article appears in a book by Daniel Kalman [2009, 79‚Äì82], which presents Kac's solution. Clearly, the author had seen the original article, or something very close to it. In email he told me that his discussion had been based on an unpublished paper [Roy n.d.] by Ranjan Roy of Beloit College in Wisconsin. Correspondence with Prof. Roy confirmed that he had once had a copy of the Kac article, but that he could not find either it or even his own paper cited by Prof. Kalman! He added that he had obtained a scan of the original article from Prof. Joel E. Cohen of Rockefeller University, one of the world's experts on population biology and a close friend of Kac's. The reminiscences that became Kac's autobiography [Kac 1985] were largely drawn from stories he told Prof. Cohen, tape recorder in hand, as they walked together through the halls at Rockefeller.\nProf. Cohen very kindly responded to email, though the pandemic had largely shut down normal life and he was not in New York City. A week or two later, he braved the virus to return to his office, and sent a scan, drawing attention to two small penciled remarks to ensure they were not overlooked. On the magazine's title page, Kac had written, \"See how bright I was when I was 15‚Äì16! M K\". And at the start of his article, there is an addendum, \"\\(m\\neq n\\)!\".\nFigure 2. The pages of Kac's article, from the scan by Cohen.\nDavid Derbes (University of Chicago Laboratory Schools, retired), \"Mark Kac's First Publication: A Translation of \"O nowym sposobie rozwiƒÖzywania r√≥wna≈Ñ stopnia trzeciego\" ‚Äì Obtaining a Copy of the Original Article,\" Convergence (April 2021)\nTop Ten Freshman Year Issues | Mental Health America\nAbout UsWho We AreOur HistoryBoard of DirectorsOur StaffOur AffiliatesStarting Your Own AffiliateStandards of AffiliationThe Mental Health BellProgramsClifford Beers SocietyHealth InsuranceIt's My Life - Social Self-Directed CareFinancial Information & Annual ReportsOur PartnersLiving WellLive Your Life WellHow Stress HurtsStress ScreenResourcesWhen Change is HardReferencesTen ToolsConnect with othersStay PositiveGet Physically ActiveHelp OthersGet Enough SleepCreate Joy and SatisfactionEat WellTake Care of Your SpiritDeal Better with Hard TimesGet Professional Help If You Need ItLife on CampusWhat's Your Plan? College with a Mental Health DisorderBalancing Work and SchoolTaking a Leave of Absence: What You Need to KnowSleep and the Student - College ConcernsStressed or Depressed? Know the DifferenceBoost Your School Performance by Taking Care of YouTop Ten Freshman Year IssuesAlcohol, Substance Abuse and DepressionWinter Break Survival Tips for College StudentsImplementing Life on CampusBack to SchoolTime To Talk: Uncomfortable, But ImportantTime To Talk: Tips For Talking About Your Mental HealthTime To Talk: Talking To Your ParentsSurvey for YouthInfographic Back to School: Youth Mental Health 101Talking To Adolescents and Teens: Time To TalkTalking To Adolescents and Teens: Starting The ConversationTalking To Adolescents and Teens: What To Do and Where To GoSurvey for ParentsWorkplace WellnessWork-Life Balance5 Myths About Mental IllnessSupport an EmployeeWorkplace Bullying & ViolenceSigns of a Healthy WorkplaceComplementary MedicineAcknowledgementsDisclaimerDownload CAM AnalysisFor ProvidersList of CAM TreatmentsCDP CholineChromiumCranial Electrotherapy StimulationDHEAFolateGinkgo bilobaInositolKavaMeditationMelatoninOmega-3sRhodiola RoseaSAM-eSt. John's wortTranscranial Magnetic StimulationTryptophanValerianYogaFinding HelpMental Health Screening ToolsFind An AffiliateMental Health TreatmentsTypes of Mental Health ProfessionalsTherapyFinding TherapyFind Support GroupsFinding Other Local ServicesMedicationHospitalizationIn Patient CareUnderstanding Clinical TrialsElectroconvulsive Therapy (ECT)Psychiatric Advance Directives: Taking Charge of Your CareMy Plan, My LifeFrequently Asked QuestionsHow can I get information about medications?How can I get help paying for my prescriptions?What to do if I'm unsatisfied w/ the mental health care I'm receiving?What do I need to know about my insurance benefits?What can I do if my insurance company is refusing to approve?How to overturn managed care treatment denialsWorking With a ProviderChoosing a ProviderQuestions to Ask a ProviderYou and Your ProviderYou're on the Team: Shared Decision-MakingHelp for ProvidersHelpful ResourcesHow Shared-Decision Making WorksPreparing for AppointmentsShared-Decision Making ChecklistShared-Decision Making for ProvidersTalking to your DoctorWhy Providers Should Use SDMRecovery & SupportTreatmentEducationHousingManaging Your MoneyParentingPaying for CareRelationshipsMeaningful Work and RecoveryTaking Good Care of YourselfWellness Planning and MaintenanceRecovery Assistance ProgramsCare For Your HealthFor ProvidersFor Family & FriendsPerson-Centered LanguagePeer ServicesPsychiatric Advance DirectivesCreating a Psychiatric Advance DirectiveFAQs about Psychiatric Advance DirectivesPsychiatric Advance Directives Glossary and ResourcesPsychiatric Advance Directives: Meet the ExpertsSocial Self-Directed Care ProgramGet Involved2016 Annual Conference2016 Annual Conference Agenda2016 Annual Conference Speakers and Bios2016 Annual Conference: MHA Film Festival2016 Annual Conference Hotel and Registration2016 Annual Conference Sponsorship Exhibit and AdvertisingB4Stage4May is Mental Health MonthB4Stage4: Changing the Way We Think About Mental HealthB4Stage4: Get HelpB4Stage4: Get InformedB4Stage4: Get ScreenedInfographic B4Stage4: Changing the Way We Think About Mental HealthMay is Older Americans Month, TooMes de la Salud MentalVolunteerInternshipsShare Your StoryEvent CalendarJoin the Advocacy NetworkDonate to MHAPlanned GivingClifford Beers SocietyMental Health InfoAnxietyBipolarDepressionDepressionPost Traumatic Stress DisorderAll Other Topics A-ZDonateDonate NowMonthly GiftLegacy GiftClifford Beers SocietyIn MemoryIn HonorOther Ways to GivePolicy & AdvocacyCurrent LegislationLegislative PrioritiesPolicy IssuesPosition StatementsAdvocacy NetworkThe State of Mental Health in AmericaAccess to Care DataAdult DataDownload Report as a PDFGlossary and CitationsPrevalence DataRanking GuidelinesRanking the StatesYouth DataRegional Policy CouncilRegional Policy Issue Forum #1Regional Policy Issue Forum #2Regional Policy Issue Forum #3Regional Policy Issue Forum #4Regional Policy Issue Forum #5WebinarsNewsPress ReleasesNewsChiming InBring Back the Asylum?Disparity, Not ParityMind Over Pop Culture: Fatal AttractionMind Over Pop Culture: NellMind Over Pop Culture: Adventure Time \"I Remember You\"Mind Over Pop Culture: Tender is the NightMind Over Pop Culture: A Dangerous MethodMind Over Pop Culture: Prozac NationMind Over Pop Culture: Romeo and JulietMind Over Pop Culture: PerceptionFerguson is a Community in Distress, Not a Community at UnrestReflecting on Sandy Hook Two Years LaterThe Dangers of Stage 4 Thinking about Serious Mental IllnessesB4Stage4 ProgramInformation for Journalists Sharethis page You are hereHome ¬ª Living Well ¬ª Life on Campus ¬ª Top Ten Freshman Year Issues Top Ten Freshman Year Issues\n(And How to Deal With Them) 1. Great Expectations: Expect to feel overwhelmed and know that you are not alone. You've been hearing about college for years and now you're here. College can be one of the best times of your life but it can also be one of the most difficult. New friends, new home, new classes, new routine... exciting and overwhelming at the same time. If you experience feelings of sadness and loneliness, don't worry-these feelings are normal and usually pass within the first few months of school. Get involved in campus activities, use social media to help stay connected with your friends and family back home, and form study groups.\n2. Roommates: You may have never had to share such a small space with someone before-let alone a perfect stranger! Living with others can be challenging. Work through conflicts by regularly communicating with your roommate(s) and setting rules for the room or suite that everyone can agree on. You and your roommate don't have to be best friends; the important thing to remember is to respect one another.\nKnee Replacement in Simi Valley | Simi Valley Knee Replacement Surgery\nServices Orthopedic Care Joint Replacement Knee Replacement\nKnee Replacement in Simi Valley\nDebilitating knee pain can make even simple, everyday actions like walking virtually unbearable. Adventist Health Simi Valley offers total and partial knee replacement surgery, which can restore your ability to walk, work and play.\nIf you are no longer finding relief through more conservative treatments, our orthopedics experts can help you determine your next step.\nTake a knee risk assessment\nOsteoarthritis can cause damage to the majority of the knee joint. This causes activities such as walking, bending and other normal everyday movements incredibly painful. When this happens, our orthopedic experts can replace all of the worn surfaces of your knee in what is referred to as a total knee replacement. Using the latest implants and techniques available, the surgeon can restore function and ease pain in your knee.\nBaptist North Medical Campus | Baptist Health | Jacksonville, FL\nBaptist North Medical Campus serves the medical and wellness needs of the whole family, all in one convenient location at the interchange of Dunn Avenue and I-295. This innovative, new destination for health care features:\nBaptist/Wolfson Children's Emergency Center open 24/7\nDiagnostic imaging, and lab services for adults and children\nPrimary care and specialist physician offices, including cardiology\nNew YMCA with group exercise, KidZone, youth sports and more\nBaptist Y Healthy Living Center open to the public five days a week\nA quarter-mile, paved walking trail, wheelchair- and stroller-accessible\nSame insurance plan acceptance as at all Baptist Health hospitals, including Wolfson Children's Hospital\nHelipad and air ambulance service for rapid transport of patients requiring additional care\nTwo ERs under one roof ‚Äì one is just for kids\nA special children's waiting area\nFast intake process designed to get your child to an exam room quickly\nPediatric-safe imaging (lowest possible radiation, specialized reading of scans)\nCTs, ultrasounds and X-rays on site\nSpecially trained, 100% dedicated pediatric team\nDiagnostic Imaging and Lab Services On-site outpatient diagnostics and digital imaging technology for children and adults means more convenience when you have a doctor's order for:\nOur scanning technologies are designed for the lowest possible radiation exposure ‚Äì especially important for children.\nTo schedule an appointment, call 904.202.2222.\nMedical Wellness Building with Physician Offices\nUnlike most medical office buildings, the \"medical wellness building\" at Baptist North promotes health and integrates wellness concepts as part of the building design. For example, you may want to take the stairs rather than the elevator when you see the stairs feature a three-story photo mural of North Florida oak trees, bringing the outdoors in. Local and regional artists' works are featured throughout the building.\nNew YMCA center, providing a variety of state-of-the-art fitness equipment, group exercise classes including yoga, Zumba and spin, personal training, nutrition counseling, KidZone child care and recreational programs for children and adults\nBaptist Y Healthy Living Center, open to the public five days a week and staffed with a wellness coach from Baptist Health. You do not need to be a member of the Y to take advantage of healthy living programs and services, such as health screenings, wellness coaching, Talks With A Doc and more.\nThe Office of Research PCS is excited to announce our new Executive Director of Research, Michelle Y. Williams, Ph.D., R.N.\nMeet the Expert ‚Äì Michelle Williams, Ph.D, R.N.\nMy name is Michelle Y. Williams. I'm the new Executive Director at Stanford Health Care, Office of Research, Patient Care Services. I earned my doctorate degree in nursing science from the University of Wisconsin, Milwaukee (UWM) in 2019. My dissertation research consisted of a secondary analysis of the Stanford University Chronic Disease Self-Management Program national study (2010), which was led by Dr. Kate Lorig, Professor Emeritus, Medicine, Stanford University, and her colleagues. Dr. Lorig served as my sponsor, during my pre-doctoral studies at Stanford University (2014-2018), and later as a member of my UWM doctoral dissertation committee.\nPreviously, I worked at Kaiser Permanente (KP) (1990-2019), where I served in a variety of nursing, management, and executive level roles, including: national nursing director of technology research and innovation (a member of the national innovation & advanced technology team-reporting directly to Marilyn P. Chow, formerly Vice President, National Patient Care Services), chief nursing officer, senior regional director of health plan member services, nursing director of maternal child health, and, nursing director of quality/performance improvement and administrative services. During my KP national role, I was responsible for creating the national patient care services technology research and innovation strategy, in addition to serving as a consultant for all patient care services and nursing technology innovation projects that were funded by the organization.\nDuring my KP tenure, I led several research studies, including: the development of a novel maggot debridement protocol for urgent treatment (Urology: Case #5 in the attached article), shared leadership design and deployment (Hospital and Ambulatory Nursing), delirium assessment (ICU), pain management (organization-wide), medication adherence (organization-wide), and, diabetic screening in non-diabetic patients (Endocrinology), among others.\nFurther, I led an interprofessional team in the research exploration, design, build, validation and deployment of the KP hospital of the future, in addition to an enterprise-wide research trial in the selection of an interactive patient care technology system, collaborative creation of the national KP telehealth and telemedicine strategy, medication adherence research Med Adh Guidelines: External Group and deployment of a national Medication Adherence Grand Rounds forum that attracted more than 100 physicians, pharmacists, nurses, leaders and others annually to the Kaiser Permanente Sidney R. Garfield Healthcare Innovation Center in California; and a side-by-side comparison of a virtual worlds system and traditional approaches to clinical education (the Virtual Worlds and Traditional Clinical Education tools were created, validated as part of a joint venture with KP and Stanford University's former SUMMIT Team: Dr. LeRoy Heinrichs, professor emeritus, Dr. Patricia Youngblood, former education research director, and Dr. Parvati Dev, former director).\nEarlier in my career, I had the pleasure of working at the University of California, San Francisco, General Clinical Research Center with directors, Dr. Curtis Morris and Dr. Anthony Sebastian, by leading the design, development and deployment of two off-campus clinical trials research clinics [FDA drug approval: Essential Hypertension and Osteoporosis] in the East Bay (Sutter Health and Highland General Hospital, 1989-1992). I developed and led the two off-campus UCSF clinical trials research clinics with Dr. Roger Peeks, a Stanford University School of Medicine alumni and former dean. UCSF GCRC Essential Hypertension Clinical Trial Article\nI chose to come to Stanford Health Care because of its culture of innovation and research! I believe the entire transdisciplinary team is positioned to bolster important research initiatives across Stanford Health Care. Each professional specialty adds its unique prospective lens and collectively aid in our vision to heal humanity through science and compassion. In my new position, I will work with my colleagues in the Office of Research, Patient Care Services to identify opportunities to strengthen our infrastructure, capabilities, and services, to meet the growing interests and needs of our organization. I want to better understand how we can address chronic disease self-management, health equity; and mental health among health care professionals. Furthermore, I will partner with clinicians and researchers across Stanford Health Care, the Stanford School of Medicine, and external groups (national and global) to better understand how we can initiate, support and influence patient care and nursing research.\nIf you'd like to get in touch with Michelle, she can be reached at MicWilliams@stanfordhealthcare.org."
    },
    {
        "id": "108440",
        "description": "Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis | BMC Complementary Medicine and Therapies | Full Text\nSkip to main content\nAdvertisement\nSearch\nExplore journals\nGet published\nAbout BMC\nMy account\nSearch all BMC articles\nSearch\nBMC Complementary Medicine and Therapies\nHome\nAbout\nArticles\nSubmission Guidelines\nNutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis\nDownload PDF\nDownload PDF\nResearch article\nOpen Access\nPublished: 25 November 2017\nNutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis\nSusan Arentz ORCID: orcid.org/0000-0002-6721-472X1,\nCaroline A. Smith1,\nJason Abbott2 &\n‚Ä¶\nAlan Bensoussan1\nShow authors\nBMC Complementary and Alternative Medicine volume 17, Article number: 500 (2017) Cite this article\n11k Accesses\n33 Citations\n27 Altmetric\nMetrics details\nAbstract\nBackground\nPolycystic ovary syndrome (PCOS) is a common, reproductive endocrinopathy associated with serious short and long term health risks. Many women with PCOS use ingestible complementary medicines. This systematic review examined the effect on menstrual regulation and adverse effects from randomised controlled trials.\nMethods\nRandomised controlled trials (RCTs) that compared herbal or nutritional supplements to placebo or active controls in women with PCOS were eligible for inclusion. Electronic databases were searched to July 2017. Study selection and assessment of quality were conducted independently by two review authors.\nResults\nTwenty four studies (1406 women) investigating seven nutritional supplements and four herbal medicines were included. No one study was assessed as having a low risk of bias. Four trials reported on the primary endpoint menstrual regulation. There was no evidence on improved menstrual regularity for calcium plus vitamin D compared to Metformin (RR: 0.66, 95% CI 0.35 to 1.23, p =‚Äâ0.19), reduced amenorrhoea for Camellia sinensis compared to placebo (RR: 0.17, 95% CI 0.02 to 1.72, p =‚Äâ0.13) and no difference in the number of menses per month for Cinnamomum sp. against placebo (MD 0.05, 95% CI -0.36 to 1.36, p =‚Äâ0.26).\nAdverse effects were investigated in seven studies (164 women). Mild adverse effects were found for Cinnamomum sp. compared to placebo (17 women, RR: 0.36, 95% CI 0.03 to 0.70, p =‚Äâ0.03). No difference was found for adverse effects between inositol, B complex vitamins, vitamin D, chromium and placebo. Improved reproduction, metabolic hormones and hyperandrogenism was found for inositol and improved cholesterol for omega three fish oils.\nConclusion\nThere is no high quality evidence to support the effectiveness of nutritional supplements and herbal medicine for women with PCOS and evidence of safety is lacking. High quality trials of nutritional supplements and herbal medicines examining menstrual regulation and adverse effects in women with PCOS are needed.\nPeer Review reports\nBackground\nPolycystic ovary syndrome (PCOS) is the most common female reproductive endocrine disorder [1] estimated to affect up to one in five women [2]. PCOS has broad health implications including adverse metabolic (obesity, type two diabetes, cardio vascular disease), reproductive (infertility, miscarriage, pregnancy and neonatal complications) [3, 4], and psychological (anxiety, depression and stress) [5, 6] risks. The pathogenesis is underpinned by insulin resistance [7] which affects up to 75% of lean women and up to 95% of obese women (compared to 62% in BMI matched non-POCS controls) [8]. Prevention and reduction of being overweight with lifestyle interventions is first-line evidence-based treatment [9], however the strength of evidence for lifestyle is limited by high attrition in randomised controlled trials (RCTs) [10, 11] and, as in the general population, engagement and adherence to lifestyle intervention is impacted by psychosocial and physical barriers in women with established obesity [10]. Additional treatments for PCOS symptoms include pharmaceutical agents [9] (contraceptive pills (OCP) and hypoglycaemics), but contraindications for the OCP are common in overweight women [12] and hypoglycaemic agents are associated with significant rates of unpleasant side effects [13, 14], potentially worsening women‚Äôs quality of life. Women with PCOS have been shown to seek out alternative [15] and adjunct treatments including complementary medicines (CM) to improve their health, fertility and wellbeing [16].\nThere is some evidence of positive effects in women with PCOS for ingestible CMs including nutritional supplements [17, 18] and herbal medicines [19, 20]. Women with PCOS have significantly higher levels of homocysteine and oxidative stress [21] and nutritional supplements have demonstrated efficacy in women with PCOS [18] and risk reduction for the same conditions in other populations [22]. Endocrine mechanisms of herbal medicine may improve hormone balance in PCOS and may positively effect menstural regularity [23, 24], a critial outcome of concern for women with PCOS [25]. This study aimed to synthesise the evidence of effectiveness and safety for herbal and nutritional supplements in women with PCOS.\nMethods\nRCTs that compared herbal medicines or nutritional supplements to placebo, active controls (nutritional supplements) or usual care (pharmaceutical treatment, lifestyle management) were sought. Cross-over trials were included for completeness but data from the first phase only were included in meta-analyses.\nParticipants were women aged between 18 and 44 with a diagnosis of PCOS according to the Rotterdam Criteria (2003), [26] or the National Institute for Health (NIH) [27].\nNutritional or herbal supplements were defined as herbal extracts in a single preparation and/or tablets containing vitamins, minerals or dietary derived molecules designed to improve symptoms associated with PCOS and not medically prescribed for conditions of deficiency [28].\nThe primary outcome measures were; ‚Äòmenstrual regularity‚Äô defined as number of women with menstrual cycles of 22 to 35 days duration, number of women with amenorrhoea and number of menses per month, and ‚Äòadverse effects‚Äô. Secondary outcomes were; secondary menstrual characteristics (ovulation, presence of a dominant follicle, ratio of luteal weeks, gonadotropin hormones), polycystic ovaries, pregnancy rates and outcomes (live births and miscarriage), hyperandrogenism (clinical and biochemical), anthropometric factors, metabolic biochemistry, PCOS associated risk factors, quality of life and anxiety and depression.\nAll published and unpublished RCTs comparing herbal medicine or nutritional supplements with active controls, usual care or placebo, in English language, were searched. Electronic databases included Cochrane central register of controlled trials (CENTRAL), the Cochrane Library, MEDLINE ovidSP, CINAHL, SciVerse, EMBASE, PubMed were searched from the date of inception to July 2017. Reference lists of review articles and texts were searched by hand.\nKeywords were ‚Äòpolycystic ovary syndrome‚Äô, ‚ÄòPCOS‚Äô, ‚Äòovarian cysts‚Äô, ‚Äòhyperandrogenism‚Äô, ‚Äòhirsutism‚Äô, ‚Äòacanthosis nigrans‚Äô, ‚Äòacne‚Äô, ‚Äòoligomenorrhoea‚Äô, ‚Äòamenorrhoea‚Äô, ‚Äòoligo-ovulation‚Äô, ‚Äòanovulation‚Äô, ‚Äòmenstrual disorders‚Äô, ‚Äòmenstrual‚Äô, ‚Äòovulation‚Äô, ‚Äòfertility‚Äô, AND ‚Äòalternative‚Äô, ‚Äòintegrative medicine‚Äô, ‚Äòcomplementary medicine‚Äô, ‚Äònaturopathy‚Äô, ‚Äònatural‚Äô, ‚Äòherbal medicine‚Äô, ‚Äòbotanical medicine‚Äô ‚Äòphytomedicine‚Äô, ‚Äòphytotherapy‚Äô, ‚Äòherbs‚Äô, ‚Äòdiet‚Äô, ‚Äòfood‚Äô, ‚Äònutritional‚Äô, ‚Äònutrient‚Äô, ‚Äòmicro‚Äô, ‚Äòdietary‚Äô, ‚Äòvitamin‚Äô, ‚Äòmineral‚Äô, ‚Äòsupplements‚Äô, ‚Äòhyper-vitamin‚Äô, AND ‚Äòrandomis(z)ed. control trial‚Äô, ‚Äòclinical trial‚Äô and ‚ÄòRCT‚Äô.\nStudy characteristics, risk of bias and outcome data were manually extracted independently by two (of three) authors (CAS, JAA and SA) and entered onto data extraction forms adapted from the Cochrane Collaboration [29] for systematic critical appraisal. Differences of opinion were resolved by consensus. Risk of bias was assessed as high, low or unclear risk for randomization (generation of randomized schedule and allocation sequence), performance (blinding of participants), detection (blinding of outcome assessors and data analysts), attrition (reporting missing data), reporting (pre-specified and or relevant outcomes) and other areas of potential bias including factors unique to particular settings (such as study being stopped early, apparent fraudulent reporting (including the absence of declaration of funding and conflicts of interest in relation to authors affiliations) or extreme baseline imbalance) [29].\nAnalyses were conducted using Review Manager (RevMan) 5.3 [30]. Dichotomous data were expressed as relative risks (RR) and normally distributed continuous data as mean differences (MD). Corresponding 95% confidence intervals (CIs) and p values were calculated. Heterogeneity between studies was investigated by the I2 statistic (I2 of more than 50% was considered indicative of heterogeneity), the P value from the œá2 test and by visual inspection of the forest plots. For non-significant heterogeneity, results were pooled in a fixed effect model and the effects were adjusted using random effects where there was significant heterogeneity. If distributions were skewed and results reported as the median and range, with non-parametric tests of significance, the results were excluded from the meta- analysis. Androgens, cholesterol and triglycerides were converted to common measurements for comparison and the mean difference (MD) was calculated.\nResults\nA total of 116 records were identified through the electronic and manual searches. Following initial screening, 63 articles were retrieved for detailed evaluation (Fig. 1). Thirty two full text articles were excluded as they did not meet the inclusion criteria (detailed in Additional file 1: Table S1). Following detailed evaluation of 31 full text studies, a further seven studies were excluded due to not investigating key signs and symptoms of PCOS, not being randomised or not including participants with a clinical diagnosis (detailed in Additional file 1: Table S1). Twenty four randomised controlled trials met the inclusion criteria [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54] including 1406 women.\nFig. 1\nPRISMA (flow chart) diagram\nFull size image\nIncluded studies\nDesign\nThe sample sizes ranged from 10 [43] to 283 [37]. All studies were conducted at university hospitals or clinical research centres in America [42, 43, 46, 51, 52], Australia [35], Egypt [49], Hong Kong [33], Iran [32, 40, 44, 47, 48, 50, 54], Italy [31, 34, 36,37,38], Turkey [53], United Kingdom [39] and Venezuela [41, 45].\nParticipants\nFive studies included overweight participants (BMI greater than 25) [33, 35, 44, 45, 51], and two studies included women of normal bodyweight [36, 41]. One study stratified randomization according to BMI (overweight or normal weight) [47]. Seventeen studies excluded participants with other endocrine disease [42, 46, 53, 54] and elevated serum prolactin (PRL) [31,32,33, 35, 37, 38, 41, 44, 46,47,48, 50,51,52].\nInterventions\nSeven nutritional supplements and four herbal medicines were investigated (Table 1).The treatment durations ranged from thirty days [39] to seven months [49] with most treatment durations (13 studies) of eight to twelve weeks (Table 1). Inositol was investigated in eight studies and three investigated omega three fish oils. Calcium plus vitamin D, vitamin D alone, selenium and Cinnamomum sp. were investigated in two studies and nutritional supplements B complex vitamins, chromium, and herbal medicines Camellia sinensis, Mentha spicata and Cimicifuga racemosa were investigated in single studies. Calcium plus vitamin D, B complex, inositol, selenium and Cimicifuga racemosa were compared with pharmaceutical controls (metformin and clomiphene citrate) [47,48,49,50, 53, 54].\nTable 1 Interventions: Nutritional supplements and herbal medicine\nFull size table\nOutcomes\nFour studies reported on the primary outcome, menstrual regularity [33, 42, 47, 50]. Seven trials reported on adverse effects (164 women) [41,42,43, 45, 46, 52, 53]. Seven studies reported on secondary menstrual cycle characteristics [34, 37, 38, 41, 45, 49, 50]. One trial reported on polycystic ovaries [49]. Three studies reported on pregnancy rates [47,48,49] and one on miscarriage [49]. Fourteen trials reported on the outcomes of biochemical hyperandrogenism [31, 33,34,35,36, 39,40,41,42,43, 45, 48, 51, 54]. Four trials reported on the outcomes of clinical hyperandrogenism with validated tools including the modified Ferriman Gallwey score to measure degree of hirsutism [39, 48, 50, 54], and acne with the dermatology quality of life index for health related quality of life [39]. Eight trials reported anthropometric outcomes of participants [33, 37, 38, 44, 50, 52,53,54]. Eighteen trials reported metabolic biochemistry including fasting glucose and insulin [31,32,33,34,35,36,37,38, 40,41,42,43,44,45,46, 51,52,53].\nRisk of bias for included studies\nAll 24 studies were assessed as having some risk of bias (Fig. 2). Incomplete or poor reporting by most trial authors impacted on the assessment, and consequently an unclear risk of bias for at least two characteristics was determined in 23 studies [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52, 54]. Seven studies were found to have high risks of bias in at least three domains including performance [49,50,51, 54], detection [49, 50, 54], attrition [37, 38, 51, 53], reporting [37, 38, 50, 53] and other forms of bias [37, 38, 49,50,51, 53, 54]. Fourteen studies were at high risk for other sources of bias including nine with imbalanced baseline characteristics [31, 33, 37, 38, 40, 41, 43,44,45, 54], insufficient time to detect change [32, 34, 39], and an active control reported as placebo (placebo consisted of lecithin which is a natural source of inositol [55]) [17]. Three studies did not report the effect of high attrition (over 30%) on baseline menstrual characteristics in the test and control groups [37, 38, 42]. Twelve studies declared conflicts of interest [31, 32, 35, 36, 42, 44,45,46, 48, 49, 51, 54]. Ten studies reported no conflicts of interest and two studies reported potential conflicts of interest due to authors‚Äô affiliations [46; 45]. Fourteen studies reported sources of study funding [32, 35, 36, 40,41,42,43,44,45,46,47,48,49, 51]. Three studies were funded with grants from the pharmaceutical industry [35, 41, 45], twelve studies were funded by university or research institute grants [32, 36, 40, 42,43,44,45,46,47,48,49, 51] and one study was funded by both pharmaceutical industry and an institute grant [45].\nFig. 2\nRisk of Bias summary\nFull size image\nEffects of interventions\nData from two trials were not included in analyses. One trial used a cross-over trial design and did not report first phase outcomes [35]; the other study reported outcomes as the median rather than the mean [33]. Where data could not be included in a meta-analysis a narrative reporting of the findings was presented.\nNutritional supplements for PCOS\nCalcium plus vitamin D\nTwo trials (78 women) compared calcium plus vitamin D with metformin for the number of women with regular menstrual cycles (21‚Äì35 days) [47, 50]. There was no evidence of an improved effect (RR 0.66, 95% CI 0.35 to 1.23, p =‚Äâ0.19, I2 0%). Adverse effects were not reported.\nSecondary outcomes\nRashidi and colleagues reported on the number ovarian cysts defined as immature follicles (diameter 5-9 mm) and pregnancy rates for calcium plus vitamin D against metformin [47]. No difference between groups was found. Tehrani and colleagues reported on BMI and hirsutism (defined as Ferriman Gallwey score over 8) [50]; no difference was found between groups.\nVitamin B complex\nOne study investigated B complex vitamins plus metformin compared with metformin alone, for 32 women [53]. Results were reported as ‚Äòwomen taking Metformin‚Äô and between group differences were not reported. No data were available for B complex vitamins on menstrual regularity. No difference for adverse events was found.\nSecondary outcomes\nFour secondary outcomes for vitamin B complex plus metformin were reported. No significant effects were found for pregnancy rates, waist to hip ratio or HOMA-IR.\nInositol (vitamin B8)\nNo trials reported on the primary outcome menstrual regularity for inositol (Table 2). Two trials (64 women) reported on adverse events for inositol [41, 45]. No adverse effects were found for inositol against placebo [41, 45].\nTable 2 Inositol for reproduction, hyperandrogenism, metabolism, anthropometry and risk factors\nFull size table\nSecondary outcomes\nSignificant benefits were found for inositol versus placebo and active controls (90 women) for the secondary outcomes of reproductive characteristics and hyperandrogenism (Fig. 3) and (Table 2).\nFig. 3\nMeta-analysis inositol versus placebo for total testosterone in women with PCOS\nFull size image\nThe number of ovulations was significantly higher for women taking inositol (two studies, 64 women, RR 3.13, 95% CI 1.68 to 5.83, p <‚Äâ0.001). Two trials reported on a subgroup of women wanting to conceive (84 women) [37, 38] and a third trial included women preparing to undergo medically assisted fertility treatment (50 women) [31]. Meta analyses of these three studies (134 women) demonstrated pregnancy rates were significantly higher for women taking inositol compared to controls (RR 2.8, 95% CI 1.2 to 6.5, p =‚Äâ0.02).\nSignificant benefits were found for the secondary outcomes of total testosterone, (five studies, 192 women, MD 0.99 nmol/l, 95% CI -1.54 to ‚àí0.44, p <‚Äâ0.001) [34, 36, 41, 45, 54] (Fig. 3) and androstenidione (four studies, 132 women, MD 3.59 nmol/l, 95% CI -4.6 to ‚àí2.6, p‚Äâ<‚Äâ0.001) [34, 36, 41, 45] and SHBG (two studies, 122 women, MD 40.67 nmol/l, 25.8 to 55.5, p <‚Äâ0.01) [41, 45]. No significant benefit was found for free testosterone following treatment with inositol [34, 36, 41, 45] or for clinical hyperandrogenism (Ferriman Gallwey score) for inositol compared with metformin [54].\nSignificant benefits were found for fasting glucose (four trials, 132 participants, MD-1.17, 95% CI -1.72 to ‚àí0.63, p‚Äâ<‚Äâ0.01), [34, 36, 41, 45]; fasting insulin (four trials, 132 participants, MD ‚àí2.7 ŒºU/ml, 95% CI -3.9 to ‚àí1.5, p‚Äâ<‚Äâ0.01) [34, 36, 41, 45] and reduced insulin resistance (HOMA-IR) (two trials, 76 participants, MD -1.3, 95% CI -1.6 to ‚àí1.0, p‚Äâ<‚Äâ0.01) [31, 36] (Table 2). Significant heterogeneity was found for the two trials investigating inositol for HOMA-IR (I2 =‚Äâ91%, p <‚Äâ0.001) and effects were adjusted using a random effects model. Study heterogeneity was likely due to different characteristics of participants at baseline (normal weight [36] and overweight [31]), different doses of inositol and types of controls (1200 g per day versus placebo [36] and 2 g plus folic acid versus folic acid alone [31]).\nSignificant benefits were found for the secondary outcome waist to hip ratio (two studies, 64 women, MD -0.02, 95% CI -0.03 to ‚àí0.01, p =‚Äâ0.01) [41, 45]. Mixed results were found for inositol with BMI in five trials [31, 36, 41, 45, 54] (Table 2). One trial showed significant improvements in BMI [36], whilst three others found no significant difference between groups [31, 45, 54]. A fifth trial found significantly increased BMI for women taking inositol compared to placebo controls however this study included lean participants and mean BMI at endpoint remained within normal BMI range (22.3‚Äâ¬±‚Äâ0.3) [41]. Significant heterogeneity of trials prevented meta-analysis (I2 =‚Äâ89%, p <‚Äâ0.00001). The high heterogeneity may be explained clinically with variable baseline BMI categories of participants ranging from normal [36, 41, 54], overweight [31, 54] and obese [45]. Dose variation of inositol may have also contributed to study heterogeneity with daily doses of 600 mg [41], 1200 mg [36, 45] and 2 g [31] [36]) and durations of treatment for six [41, 45] and twelve weeks [31, 36, 54]) [54]. Significant benefits were found for total cholesterol (two trials, 64 women, MD 0.56 mmol/l, 95% CI -1.07 to ‚àí0.04, p =‚Äâ0.04) [41, 45] and triglycerides (two trials, 64 women, MD 31.6 mg.dl, 95% CI -61.1 to ‚àí2.0, p‚Äâ=‚Äâ0.04) [41, 45] following treatment with inositol compared to placebo controls. Reduced inflammation (c-reactive protein (CRP)) was found for inositol compared to metformin in one study (MD -2.2, 95% CI -3.57 to ‚àí0.83, p <‚Äâ0.01) [54].\nChromium supplements\nOne small study reported on chromium compared to placebo in ten women with PCOS [43]. The study did not report on menstrual regulation. No adverse events were reported for either chromium or placebo. Five secondary outcomes free testosterone, total testosterone, ovulation, FSH and LH were reported. No significant treatment effects were found for any outcomes.\nVitamin D\nTwo RCTs examined vitamin D supplements compared with a placebo in 78 women with PCOS [32, 46]. Heterogeneity of studies was not significant (I2 =‚Äâ0%) and data were pooled for analyses. The effects of vitamin D on menstrual regulation were not reported. No adverse effects were found in one study [46].\nSecondary outcomes\nNo significant treatment effect was found for vitamin D compared with placebo for metabolic hormones including fasting glucose, fasting insulin, insulin resistance or insulin sensitivity [32, 46]. One study including 28 women found no evidence of improvements for vitamin D compared to placebo for free and total testosterone, cholesterol and high and low density lipoproteins triglycerides and inflammation (CRP) [46].\nOmega three fish oils\nTwo studies investigated omega 3 supplements against placebo in 95 women [44, 51]. Neither study reported on menstrual regulation or adverse effects.\nSecondary outcomes\nA significant effect was found for the risk marker total cholesterol in women receiving omega 3 fish oils compared to placebo controls (two trials, 95 women, ‚àí0.49 mmol, 95% CI -0.62 to ‚àí0.35, p <‚Äâ0.001) [44, 51] (Fig. 4).\nFig. 4\nMeta-analysis omega three fish oils for cholesterol in women with PCOS\nFull size image\nNo evidence of an effect was found for free testosterone or SHBG [51], waist to hip ratio [44] or for inflammation (CRP) [44]. Findings were mixed for some secondary outcomes including triglycerides, HDL and LDL [44, 51], BMI [44, 51], fasting glucose and insulin resistance [44, 51]. Clinical heterogeneity was likely due to the dose of omega three. One trial received treatment of 3.5 g (EPA 258 mg and DHA 242 mg) for six weeks [51], which was less than the other trial where women received 4 g (EPA 720 mg and DHA 480 mg) over eight weeks and additionally due to wide variation in mean BMI at baseline. Both trials included women with a BMI that ranged between 25 and 40‚Äì45 however the mean BMI for women in one trial was in the overweight category (BMI 28) [51] compared to morbidly obese (BMI 36) in the other [44]. Significant effects were found for morbidly obese women taking the higher dose of fish oils [44] for fasting glucose (‚àí0.33 mmol/l, 95% CI -0.26 to ‚àí0.40, p <‚Äâ0.001), insulin resistance (HOMA-IR) (‚àí1.23, 95% CI -1.6 to ‚àí0.86, p‚Äâ<‚Äâ0.001) and reduced LDLs (‚àí0.88, 95% CI -1.04 to ‚àí0.72, p <‚Äâ0.01) [44].\nSelenium\nTwo studies investigated selenium supplements against placebo in 109 women [40, 48]. One investigated added metformin in both study groups [48]. Neither menstrual regulation nor adverse effects were investigated in either study.\nSecondary outcomes\nA significant effect was found in one study for selenium against placebo in 53 women for fasting glucose (MD 4.66 mg/dl, 95%CI 3.23 to 6.09, p <‚Äâ0.00001), insulin resistance (HOMA-IR) (MD 0.24 95%CI 0.06 to 0.42, p =‚Äâ0.008), total testosterone (MD 0.18 ng/ml, 95%CI 0.09 to 0.27, p <‚Äâ0.0001), SHBG (MD 12.80 nmol/l, 95% CI 6.22 to 19.38, p‚Äâ<‚Äâ0.0001) and FAI (MD 3.93, 95% CI 3.54 to 4.32, p‚Äâ<‚Äâ0.00001) [40]. No effect was found for fasting insulin. Ravazi and colleagues [48] examined selenium in addition to pharmaceutical management (metformin) against metformin plus placebo in 64 women. No evidence of an additive effect was found for free testosterone, inflammation or pregnancy rates.\nHerbal medicines for PCOS\nOne trial reported on Camellia sinensis (green tea) capsules compared with placebo for menstrual regularity [33]. Chan and colleagues (2006) investigated the proportion of amenorrheic women over a three month period (34 women) [33]. No difference was found between groups. Adverse effects were not investigated.\nSecondary outcomes\nChan and colleagues (2006) reported on secondary outcomes however data were presented as median differences and the interquartile range and analysed for changes over time. Consequently data were not suitable for inclusion in analyses in this review [33]. No significant differences in median values over time were found for women taking Camellia sinensis or placebo for testosterone, SHBG, FAI, androstenidione, FSH, LH, BMI, waist to hip ratio, insulin, glucose, cholesterol, triglycerides HDL or LDL.\nCimicifuga Racemosa\nOne study examined the combination of Cimicifuga racemosa and the pharmaceutical agent Clomiphene citrate (clomiphene) against clomiphene alone in 194 women [49]. Menstrual regulation or adverse effects were not reported.\nSecondary outcomes\nA significant treatment effect was found for the combination group for reduced days to ovulation (MD ‚àí3 days, 95% CI -3.51 to ‚àí2.49, p <‚Äâ0.01), pregnancy rates (RR 1.98, 95% CI 1.19 to 3.31, p‚Äâ<‚Äâ0.01), FSHmIU/l (MD 0.40, 95% CI 0.22 to 0.58, p‚Äâ<‚Äâ0.01), LH mIU/l (MD -2.3, 95% CI -2.55 to ‚àí2.05, p‚Äâ<‚Äâ0.01), and reduced miscarriage (RR 0.62, 95% CI 0.22 to 1.74, p =‚Äâ0.36).\nCinnamomum sp.\nNo evidence of a menstrual regulation effect was found in one study investigating Cinnamomum sp. compared with placebo in 17 women [42]. Four non-serious adverse events were reported for Cinnamomum sp. [42]. These included headache, heartburn, menstrual cramps, nausea and diarrhoea. No adverse events were reported in the second study by Wang and colleagues [52]. Use of a variable dose may explain the different findings for adverse effects; one investigated 1500 mg of Cinnamomum sp. per day over six months [42] and the other 1000 mg per day over eight weeks [52].\nSecondary outcomes\nTwo studies reported on metabolic hormones following treatment with Cinnamomum sp. compared to placebo [42, 52]. Primary data were not reported by Wang and colleagues and between groups could not be examined [52]. No evidence of a treatment effect for Cinnamomum sp. was found for insulin resistance (HOMA-IR) or insulin sensitivity (QUICKI) [42].\nMentha Spicata\nNo data on primary outcomes were reported.\nSecondary outcomes\nA significant treatment effect was found for Mentha spicata compared to Matricaria recutita (chamomile) tea for reduction in total testosterone in 41 women (MD 0.18 nmol/l, 95% CI -0.34 to ‚àí0.02, p =‚Äâ0.03) [39]. No significant treatment effects were found for free testosterone, hirsutism or the dermatology index quality of life assessment.\nDiscussion\nThis systematic review included 24 randomised controlled trials of 1406 women with PCOS. Seven nutritional supplements and four herbal medicines were investigated and meta-analyses were reported for calcium plus vitamin D, Cinnamomum sp., inositol (vitamin B8), omega three fish oils and vitamin D. Menstrual regularity, a defining feature of critical interest to women with PCOS [25], was examined in only four studies and no significant treatment effect compared to controls was found. However secondary outcomes of time to ovulation, ovulation rates, hyperandrogenism, reproductive and metabolic hormones, waist to hip ratio, cholesterol and triglycerides were significantly improved by inositol and total cholesterol was significantly lowered by omega three fish oils compared to controls. Adverse effects were reported in seven studies for four nutritional supplements and one herbal medicine. Mild adverse effects were found for Cinnamomum sp. There were no long term investigations of safety.\nFindings for the primary outcome, menstrual regulation\nThis review found no single nutritional supplement or herbal medicine significantly improved the primary outcome, menstrual regulation. The oral contraceptive pill (OCP) is first line pharmaceutical treatment for menstrual regularity in women with PCOS [9], however it is contraindicated in women with increased cardiovascular risks [12, 15] and women with PCOS have reported preferences for effective alternatives [15]. Metformin is an effective alternative however women with PCOS have reported high rates of unpleasant side effects [13].\nThere is low quality evidence from RCTs for menstrual regulation included in this review. Trials were characterized by a high risk of selection, performance and detection biases and an unclear risk of reporting bias. Evidence from methodologically sound RCTs is needed to examine the reliability of findings for calcium plus vitamin D compared with metformin for menstrual regulation.\nChan (2006) and colleagues found a treatment effect on the primary outcome in a sub-analysis investigating Camellia sinensis with a lower proportion of amenorrheic women at twelve weeks for women taking Camellia sinensis compared to placebo controls, however differences between groups were not significant [33]. Findings were limited by the small sub-group sample size (only 14 women), the study was underpowered for the number of amenorrheic women and was assessed as low quality due to not reporting baseline characteristics of subgroups and for reporting on medians rather than means.\nThe findings of this review contribute to the evidence for Chinese Herbal Medicine (CHM) for oligomenorrhoea and amenorrhoea in women with PCOS [23]. Traditional Chinese herbal formulations are another form of ingestible complementary medicine of interest to women with PCOS [16]. In that systematic review which included Chinese and English language papers, only one small, low quality study investigated menstrual cyclicity outcomes for CHM and found an improved menstrual regulation response from the oral contraceptive pill (Diane 35) when combined with CHM compared to Diane 35 alone (RR 2.6, 95% CI 1.06 to 6.39, p =‚Äâ0.04). We have some low grade evidence to add to women‚Äôs treatment decisions for menstrual regularity; calcium plus vitamin D, compared to metformin does not appear to provide any further benefits on this outcome. We agree that the evidence for ingestible CMs for menstrual regulation is poor quality and inconclusive due to the absence of findings from methodologically sound clinical studies.\nFindings for the nutritional supplement inositol\nThis review provides some support for a therapeutic role of inositol. As an essential structural component of cell membranes, inositol is needed for cell membrane signalling functions including those involving neurological signalling in the brain, second messenger systems and insulin signal transduction. Impaired insulin signalling in skeletal muscle and adipose tissue has a pathogenic role in conditions of insulin resistance [56, 57]. It has been proposed that ovarian theca cells of women with PCOS remain sensitive to insulin despite insulin resistance, and theca cell androgen production continues through an alternative insulin signal transduction system [58]. Evidence for a range of doses of inositol suggests therapeutic supplementation may improve metabolic profile in women with PCOS in addition to reduced biochemical hyperandrogenism and improved ovulation and pregnancy rates. However, only one small study included in this review examined live birth rates and no significant improvements were found compared to controls. As healthy, live birth outcomes are the primary goal of all interventions for women with PCOS seeking treatment for infertility there is a need for more high quality randomised controlled trials to report on this outcome. Adverse effects of inositol were examined in only two studies. Despite the likely low risks [59] this systematic review found no long term investigations assessing safety, and the evidence of safety is not established in women with PCOS.\nThe findings of this review differ with the systematic review of hypoglycaemic interventions for women with PCOS [14]. Tang and colleagues found no evidence for inositol compared with placebo in two studies for improved ovulation in 327 women (Odds Ratio 5.38, 95% CI 0.70 to 41.31, I2 81%) [38, 45], or for lowered androgens, metabolic markers or blood lipids in 44 women [45]. Differences in our findings may be explained by the variable study inclusion criteria and the number of studies included in analyses. Tang and colleagues included studies only investigating the d-chiro isomer form of inositol against placebo or no treatment [14]. This present review included studies investigating any isometric form of inositol and active controls.\nWell-being and quality of life outcomes\nWomen are likely to use nutritional supplements and herbal medicines in addition to conventional pharmaceutical management possibly to improve well-being and quality of life [16, 60]. No studies investigated well-being or quality of life (QoL) outcomes and few studies examined safety for the use of nutritional and herbal supplements in conjunction with pharmaceutical treatment. Further evidence is needed to inform women‚Äôs treatment decisions and to assess the clinical usefulness of nutritional supplements and herbal medicine for improved well-being and quality of life in women with PCOS.\nLimitations\nThe inclusion of an English language excluded non-English language research and indexations. Herbal medicine has a high prevalence of use amongst non-English speaking cultures and this review was limited by its omission of non-English language research and databases.\nOther limitations of this review include the poor quality of evidence, the small number of nutritional supplements and herbal medicine interventions, the absence of QoL and well-being outcomes and lack of long term investigations of safety. Key words did not include individual nutrient and herbal possibilities or complex herbal formulations and evidence may have been missed. In addition, methodological weaknesses lead to the exclusion of many studies and the authors did not seek further information from researchers of studies where the median rather than the mean was reported. Further research using rigorous RCT design is needed to inform findings of this systematic review.\nA narrow inclusion criteria of only RCTs that examined the three diagnostic features of PCOS were specified for this review. Further literature reviews with inclusion criteria of other clinical outcomes such as fertility, anthropometric or psychological outcomes may strengthen the findings found here and better inform clinicians and women‚Äôs treatment decisions.\nConclusion\nThere is no high quality evidence to support the effectiveness of nutritional supplements and herbal medicine for PCOS symptoms and evidence of safety and is lacking. However for two nutritional supplements, there was some low quality evidence that suggests women with PCOS may benefit from inositol and omega three fish oil supplements. Further research is needed.\nAbbreviations\nBMI:\nBody mass index\nCHM:\nChinese herbal medicine\nCI:\nConfidence interval\nCM:\nComplementary medicine\nCRP:\nC reactive protein\nD3:\nCholecalciferol\nDHA:\nDocosahexaenoic Acid\nEPA:\nEicosapentaenoic acid\nFAI:\nFree androgen index\nFSH:\nFollicle stimulating hormone\nHDL:\nHigh density lipoprotein\nHOMA-IR:\nHomoeostatic model assessment of insulin resistance\nIU:\nInternational units\nLDL:\nLow density lipoprotein\nLH:\nLuteinizing hormone\nMD:\nMean difference\nNIH:\nNational Institute of Health\nOCP:\nOral contraceptive pill\nPCOS:\nPolycystic ovary syndrome\nPRISMA:\nPreferred reporting items for systematic reviews and meta-analyses\nPRL:\nProlactin\nQUICKI:\nQuantitative insulin sensitivity check index\nRCT:\nRandomized control trial\nRR:\nRelative risk\nSHBG:\nSex hormone binding globulin\nsp.:\nSpecies\nReferences\nESHRE. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012;27(1):14‚Äì24.\nArticle Google Scholar\nMarch WA, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544‚Äì51.\nArticle PubMed Google Scholar\nDoherty DA, Newnham JP, Bower C, Hart R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397‚Äì406.\nArticle PubMed Google Scholar\nBoomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673‚Äì83.\nArticle CAS PubMed Google Scholar\nDokras A. Mood and anxiety disorders in women with PCOS. Steroids. 2012;77(4):338‚Äì41.\nArticle CAS PubMed Google Scholar\nHart R, Doherty DA. The potential implications of a PCOS diagnosis on a Woman's long-term health using data linkage. J Clin Endocrinol Metab. 2014;100(3):911‚Äì9.\nArticle PubMed Google Scholar\nCassar S, et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic‚Äìhyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619‚Äì31.\nArticle PubMed Google Scholar\nStepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic‚Äìhyperinsulaemic clamp. Hum Reprod. 2013; 10.1093/humrep/des463.\nAAPCOS. In: NHMRC, editor. Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Melbourne: Jean Hailes Foundation for Women's Health on behalf of the PCOS Australian Alliance; 2011.\nGoogle Scholar\nMoran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011; 10.1002/14651858.CD007506.pub2.\nMoran LJSR, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013; 10.1093/humrep/det256.\nDiamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Nestler JE. A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab. 2003;88(5):1927‚Äì32.\nArticle CAS PubMed Google Scholar\nLegro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551‚Äì66.\nArticle CAS PubMed Google Scholar\nTang, T., J.M. Lord, R.J. Norman, E. Yasmin, A.H. Balen., Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, 2012. 5.\nSills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL. Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health. 2001;1(1):3.\nArticle PubMed PubMed Central Google Scholar\nArentz S, et al. A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome. BMC Complement Altern Med. 2014;14(1):472.\nArticle PubMed PubMed Central Google Scholar\nRaja-Khan NES-V, Wu XK, Legro RS. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2011;301(1):E1‚ÄìE10.\nArticle CAS PubMed PubMed Central Google Scholar\nAmini L, Tehranian N, Movahedin M, Tehrani FR, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med. 2015;13(1):1.\nPubMed PubMed Central Google Scholar\nArentz S, Smith CA, Abbott JA, Bensoussan A, et al. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med. 2014;14(1):511.\nArticle PubMed PubMed Central Google Scholar\nZhang J, Li T, Zhou L, Tang L, Xu L, Wu T, Lin D. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. Cochrane Database Syst Rev. 2010;9:CD007535.\nGoogle Scholar\nMurri M, Luque-Ram√≠rez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale H, Hector F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013; 10.1093/humupd/dms059.\nJi Y, Tan S, Xu Y, Chandra A, Shi C, Song B, Qin J, Gao Y. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease a meta-analysis. Neurology. 2013;81(15):1298‚Äì307.\nArticle CAS PubMed Google Scholar\nLai L, Li X, Flower A, Moore M, Liu J, Lewith G. Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: A systematic review and meta-analysis. J Alternat Complement Med. 2014;20(5):A129‚ÄìA129.\nLai L, Flower A, Prescott P, Moore M, Lewith G. Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility study in the United Kingdom. In: European journal of integrative medicine; 2015. p. 681‚Äì2.\nGoogle Scholar\nBazarganipour F, Taghavi SA, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health-related quality of life: a systematic review and meta-analysis. Iran J Reprod Med. 2015;13(2):61.\nPubMed PubMed Central Google Scholar\nESHRE. Revised 2003 consensus on diagnostic criteria and long-term health risks associated with polycystic ovary syndrome. Fertil Steril. 2004;81(1):19‚Äì25.\nArticle Google Scholar\nAzziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456‚Äì88.\nArticle PubMed Google Scholar\nWieland LS, Manheimer E, Berman BM. Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med. 2011;17(2):50.\nPubMed PubMed Central Google Scholar\nHiggins, J., Cochrane handbook for systematic reviews of interventions version 5.1. 0 (Updated on 2011). Cochrane Collab. www. cochrane-handbook.org. Accessed Jan, 2015: p. 164‚Äì166.\nCochrane. Review manager (RevMan). Copenhagen: The Cochrane Collaboration; 2012.\nGoogle Scholar\nArtini PG, et al. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecol Endocrinol. 2013;29(4):375‚Äì9.\nArticle CAS PubMed Google Scholar\nArdabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32(3):195‚Äì201.\nArticle CAS PubMed Google Scholar\nChan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. J Soc Gynecol Investig. 2006;13(1):63‚Äì8.\nArticle CAS PubMed Google Scholar\nCostantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci. 2009;13(2):105‚Äì10.\nCAS PubMed Google Scholar\nCussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab. 2009;94(10):3842‚Äì8.\nArticle CAS PubMed Google Scholar\nDona G, Sabbadin C, Fiore C, Bragadin M, Giorgino FL, Ragazzi E, et al. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(4):703‚Äì10.\nArticle CAS PubMed Google Scholar\nGerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2003;7(6):151‚Äì9.\nCAS PubMed Google Scholar\nGerli SEP, Ferrari A, Di Renzo AGC. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11(5):347‚Äì54.\nCAS PubMed Google Scholar\nGrant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res. 2010;24(2):186‚Äì8.\nPubMed Google Scholar\nHosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: a randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol. 2016;34:56‚Äì61.\nArticle Google Scholar\nIuorno MJ, Jakubowicz DJ, Baillargeon J-P, Dillon P, Gunn RD, Allan G, Nestler JE. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2002;8(6):417‚Äì23.\nArticle PubMed Google Scholar\nKort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2014;211(5):487.e1‚Äì6.\nArticle CAS Google Scholar\nLucidi RS, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril. 2005;84(6):1755‚Äì7.\nArticle CAS PubMed Google Scholar\nMohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2012;21(4):511‚Äì8.\nCAS PubMed Google Scholar\nNestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314‚Äì20.\nArticle CAS PubMed Google Scholar\nRaja-Khan N, Shah J, Stetter CM, Lott MEJ, Kunselman AR, Dodson WC, Legro RS. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertil Steril. 2014;101(6):1740‚Äì6.\nArticle CAS PubMed PubMed Central Google Scholar\nRashidi B, Haghollahi F, Shariat FM, Zayerii F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol. 2009;48(2):142‚Äì7.\nArticle PubMed Google Scholar\nRazavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, Bagherian T, Asemi Z. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2015;47:1‚Äì7.\nGoogle Scholar\nShahin AY, Mohammed SA. Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates-a randomized trial. Gynecol Endocrinol. 2014;30(0):1‚Äì6.\nGoogle Scholar\nTehrani HG, Mostajeran F, Shahsavari S. The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with poly cystic ovarian syndrome. J Res Med Sci. 2014;19:875‚Äì80.\nCAS PubMed PubMed Central Google Scholar\nVargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 2011;60(12):1711‚Äì8.\nArticle CAS PubMed PubMed Central Google Scholar\nWang JG, Anderson RA, Graham GM, Chu MC, Sauer MV, Guarnaccia MM, Lobo RA. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88(1):240‚Äì3.\nArticle PubMed Google Scholar\nKilicdag EB, Bagis T, Tarim TE, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod. 2005;20(6):1521‚Äì8.\nArticle CAS PubMed Google Scholar\nJamilian M, et al. Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: a randomized controlled clinical trial. Clin Endocrinol. 2017;87(2):194‚Äì200.\nArticle CAS Google Scholar\nMehta G, Sen S. Fine tuning the hydrophilic-hydrophobic balance in inositols through annulation: an analysis of the hydrogen-bonded architectures of'annulated inositols'. CrystEngComm. 2005;2005(7):656‚Äì63.\nArticle Google Scholar\nDunaif A, Book CB. Insulin resistance in the polycystic ovary syndrome. Clin Res Diabetes Obes. 1997;2:249.\nArticle Google Scholar\nLarner J. D-chiro-inositol‚Äìits functional role in insulin action and its deficit in insulin resistance. J Diabetes Res. 2002;3(1):47‚Äì60.\nGoogle Scholar\nNestler JE, Jakubowicz DJ, Falcon A, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human Thecal cells from women with polycystic ovary syndrome by activating its own receptor and using Inositolglycan mediators as the signal transduction system 1. J Clin Endocrinol Metab. 1998;83(6):2001‚Äì5.\nCAS PubMed Google Scholar\nArendrup K, Gregersen G, Hawley J, Hawthorne JN. High-dose dietary myo-inositol supplementation does not alter the ischaemia phenomenon in human diabetics. Acta Neurol Scand. 1989;80(2):99‚Äì102.\nArticle CAS PubMed Google Scholar\nBishop FL, Yardley L, Lewith GT. A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol. 2007;12(6):851‚Äì67.\nArticle PubMed Google Scholar\nDownload references\nFunding\nThis research project was funded by Western Sydney University as doctorate candidate project funding for Susan Arentz with support from an Australian Postgraduate Award. As a medical research institute, the National Institute of Complementary Medicine receives research grants and donations from foundations, universities, government agencies and industry. Sponsors and donors provide untied funding for work to advance the vision and mission of the Institute. The project that is the subject of this article was not undertaken as part of a contractual relationship with any organisation. Authors SA and JA are also engaged in integrative medicine clinical practice.\nAvailability of data and materials\nThe datasets supporting the conclusions of this article are available on reasonable request from the author SA.\nAuthor information\nAuthors and Affiliations\nNational Institute of Complementary Medicine, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia\nSusan Arentz, Caroline A. Smith & Alan Bensoussan\nSchool of Women‚Äôs and Children‚Äôs Health, University of New South Wales, Sydney, Australia\nJason Abbott\nAuthors\nSusan Arentz\nView author publications\nYou can also search for this author in PubMed Google Scholar\nCaroline A. Smith\nView author publications\nYou can also search for this author in PubMed Google Scholar\nJason Abbott\nView author publications\nYou can also search for this author in PubMed Google Scholar\nAlan Bensoussan\nView author publications\nYou can also search for this author in PubMed Google Scholar\nContributions\nSA, JA, CS and AB conceived of the study and participated in its design and coordination. SA carried out the search of the literature. SA and CAS participated in study inclusion or exclusion with consensus with JA and AB. SA and CAS performed data extraction and JA reviewed the quality of data. SA, CAS, JA and AB designed and edited the tables. All authors read and approved the final manuscript.\nCorresponding author\nCorrespondence to Susan Arentz.\nEthics declarations\nEthics approval and consent to participate\nNot applicable.\nConsent for publication\nNot applicable.\nCompeting interests\nThe authors declare that they have no competing interests. SA was a doctoral research student and CAS, JA and AB her supervisory panel.\nPublisher‚Äôs Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nAdditional file\nAdditional file 1: Table S1.\nstudies excluded following full text review. (DOCX 30 kb)\nRights and permissions\nOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.\nReprints and Permissions\nAbout this article\nCite this article\nArentz, S., Smith, C.A., Abbott, J. et al. Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis. BMC Complement Altern Med 17, 500 (2017). https://doi.org/10.1186/s12906-017-2011-x\nDownload citation\nReceived: 12 January 2017\nAccepted: 16 November 2017\nPublished: 25 November 2017\nDOI: https://doi.org/10.1186/s12906-017-2011-x\nShare this article\nAnyone you share the following link with will be able to read this content:\nGet shareable link\nSorry, a shareable link is not currently available for this article.\nCopy to clipboard\nProvided by the Springer Nature SharedIt content-sharing initiative\nKeywords\nPolycystic ovary syndrome\nPCOS\nSupplements\nVitamins\nHerbal medicine\nComplementary medicine\nDownload PDF\nAdvertisement\nBMC Complementary Medicine and Therapies\nISSN: 2662-7671\nContact us\nSubmission enquiries: bmccomplementarymedicineandtherapies@biomedcentral.com\nGeneral enquiries: ORSupport@springernature.com\nRead more on our blogs\nReceive BMC newsletters\nManage article alerts\nLanguage editing for authors\nScientific editing for authors\nPolicies\nAccessibility\nPress center\nSupport and Contact\nLeave feedback\nCareers\nFollow BMC\nBMC Twitter page\nBMC Facebook page\nBMC Weibo page\nBy using this website, you agree to our Terms and Conditions, California Privacy Statement, Privacy statement and Cookies policy. Manage cookies/Do not sell my data we use in the preference centre.\nDue to the significant number of academic submissions to the 2022 conference, and the condensed nature of the hybrid conference format, the presentations of two of 2022's top papers were selected by the research committee to be recorded for video presentation online, as well as to be presented as poster sessions on site.\nMore information about all 11 papers and their authors, can be found in the 2022 Conference Volume.\nThe two papers, with their presenters (along with brief summaries and a link to their respective videos and poster PDFs) are:\nThe Age Gap in Mortgage Access |Natee Amornsiripanitch, Federal Reserve Bank of Philadelphia\nPoster | Video\nThe author examines the relationship between age and mortgage application outcomes, finding that older borrowers face higher rejection probabilities than younger borrowers, and that this age effect appears even between individuals whose ages differ by just one year. Mortality-related default risk is a key factor in this result, and the age effect is larger for subgroups with higher mortality risks, such as older individuals, men and individuals who live in low-life-expectancy countries; these results hold when age and the interest rate spread are compared. The author concludes that older individuals systematically face higher barriers to credit access because mortality risk is priced in credit markets.\nThe Procyclicality of FDIC Deposit Insurance Premiums | Jennifer Rhee, FDIC\n(Rhee co-authored the paper with Ryan Hess, Stanford University)\nPoster | Video\nThe authors assess the procyclical effects of FDIC insurance premiums using changes in premium rate schedules that regulators set during the financial crisis. They are able to examine the effect of changes in deposit insurance premiums that are plausibly exogenous to the performance of an individual bank through use of\ninternal FDIC data that allow them to remove the effect driven by endogenous factors. They document empirically a procyclical effect of deposit insurance premiums on bank lending during the financial crisis and show that community banks are disproportionately affected by this mechanism.\nThe presentations of the authors who presented their papers on site at the conference will be recorded and will be posted shortly to the conference website.\nConference Conclusions | ASPE\nConference Report: Increasing Organ Donation and Transplantation: The Challenge of Evaluation. Conference Conclusions\nADRD Summit 2016 Report to the National Advisory Neurological Disorders and Stroke Council Evaluation of HHS Delivery System Reform Efforts and Affordable Care Act Provisions: Consolidated Evaluation Design Recommendations Meeting the Challenge of Serving People With Disabilities: A Resource Guide for Assessing the Performance of Managed Care Organizations Evaluating Privatized Child Welfare Programs: A Guide for Program Managers National Research Summit on Care, Services and Supports for Persons with Dementia and Their Caregivers: Final Summit Report\nThe conference offered a diverse range of organ donation activities and evaluations with performance indicators of varying proximity to organ donation rates. Conference deliberations recognized the practical challenges of evaluating programs in a wide variety of health care and social environments, including the resources needed to implement rigorous evaluations. Organizers of the conference sought to aid program managers and researchers to understand what might be needed to improve evaluations of their programs and better demonstrate what does and does not yield greater organ donation.\nPresentations on the first day focused primarily on pre-event activities, i.e., public awareness and educational activities, and the challenges of evaluating such programs relative to measures of organ donation. Presentations on the second day focused on post-event activities that tend to be more proximal to the \"bull's-eye\" of performance indicators (Exhibit 3), but still face significant methodological challenges. Although the specific evaluation methodologies may be different for pre- and post-event activities, each type of activity shares similar challenges of evaluation. A distillation of the conclusions made by conference participants regarding program evaluation is as follows.\nEvaluations of the impacts of program interventions need to be more rigorously designed in order to determine the causal links between the interventions and the appropriate performance indicators. More rigorous evaluation design will rule out factors that may confound causal effects, e.g., differences in geographical or socioeconomic attributes that may affect performance indicators rather than the interventions themselves. Among the design attributes that contribute to establishing causality are:\ncareful identification of populations or target groups (including stratification into subgroups as appropriate)\ncontemporaneous and otherwise well-matched control groups\nrandom assignment of interventions\nsample sizes of adequate size to detect any true causal relationships between interventions and changes in performance indicators.\nResearchers must demonstrate an impact on the intended target population and a change in the associated performance indicators. The performance indicator(s) chosen to measure the impact of a program intervention should be as proximal as possible to organ donation rate. Clearly, making the causal connection to organ donation rates is difficult or impractical for many programs, particularly those involving pre-event interventions. To the extent that causal links between less proximal pre-event measures such as measures of public awareness or number of people registered as organ donors, or post-event measures such as referral rates or request rates, and organ donation rate can be demonstrated, pre-event measures would be more useful.\nThe target groups of evaluation and the timeframes of evaluation need to be commensurate with the chain of events or other stages of progress from initial program intervention through organ donation and follow-up. For example, programs intended to change the behavior of younger people may have to be evaluated over longer periods of time and include their family members to determine if the intervention affected donation-related behaviors.\nPotentially useful evaluative paradigms such as the transtheoretical model of behavior change, and tools such as survey instruments that have been developed or applied in other fields should be validated in organ donation settings, e.g., post-event in hospitals, and in representative populations, e.g., with donor and non-donor families.\nTo improve their \"generalizability\" or external validity, program evaluations should be conducted in multiple geographic regions and socioeconomic groups.\nOrgan donation researchers could benefit from increased collaboration with researchers in other fields including evaluation design experts, statisticians, health services researchers, health economists, and other academic researchers. For example, statisticians can provide assistance with regard to \"power calculations\" to determine adequate sample sizes and identify appropriate statistical tests, e.g., using non-parametric statistics and multivariate analysis. Economists can provide assistance with identifying and quantifying the direct and indirect costs of programs and conducting cost analyses. Engaging such experts in these efforts will strengthen the longer-term evaluation capacity in the organ donation community.\nGiven considerable tradeoffs in the costs and outcomes of programs for improving organ donation, cost-benefit analysis and related economic analyses should be used to compare programs to improve organ donation and to demonstrate their value relative to other types of health care programs.\nProgram evaluations should not overlook what one presenter called \"formative evaluation.\" That is, programs should specify implementation milestones and provide the means to measure progress against these.\nOrgan donation programs should increase collaboration in evaluation. Researchers should become more familiar with other programs in similar areas and evaluations, including those reported in the literature and other sources. Organizations involved in efforts to improve organ donation should engage in larger-scale collaborative efforts to plan and implement programs, e.g., through multicenter evaluations, registries, and related data collection and sharing efforts. More efforts need to be undertaken to refine pre- and post-event measures, and to further establish causal links between these measures and organ donation rates. Some of these efforts can be coordinated at a national level, e.g., through organizations like UNOS, and other nationally active organizations.\nEvaluation findings should be used to improve the programs that were evaluated and disseminated more widely for incorporation into other efforts to improve or ensure the quality of organ donation programs.\nVertex Pharmaceuticals | Responsibility | Grants and Giving\nResponsibility Grants and Giving\nVertex and the Vertex Foundation fund a variety of programs in the countries in which we operate to educate health care professionals, strengthen scientific research, encourage innovation and fulfill unmet needs in the community.\nVertex grants and funding opportunities\nVertex is committed to supporting programs and initiatives that advance the knowledge and care for people around the world with cystic fibrosis and other serious diseases where we focus our research. This includes sponsoring independent research; educating health care professionals; and supporting educational programs and initiatives led by organizations focused on patient advocacy, community education and other scientific efforts related to the areas in which we focus our research. We also provide organizational sponsorships and corporate memberships along with support to leading scientists, researchers, doctors and public health experts who share our vision for transforming the lives of people with serious diseases, their families and society.\nRead more about our funding criteria for grants and sponsorships, and click \"Apply\" to submit a request.\nWe support enhancing medical and scientific knowledge and patient education to improve overall care for patients. In the areas where our research is focused, we consider requests from organizations for grants related to:\nWe review grant requests related to:\nPatient education and advocacy programs, projects and initiatives\nEducational conferences, projects and initiatives\nWe review grant requests related to scientific advancement\nWe welcome inquiries for grants related to our areas of focus. Read more about the entities we support and our exclusion criteria before submitting a request.\nVertex will not consider requests from organizations that discriminate on the basis of race, gender, sexual orientation, marital status, religion, age, national origin, veteran's status or disability.\nVertex is committed to supporting the medical, scientific and local nonprofit communities through sponsorships of meetings, events, or other initiatives in exchange for tangible benefits, such as exhibit space, tickets or registration to a funded meeting or event, or other forms of recognition.\nWe review requests for sponsorships, exhibits and corporate memberships related to:\nWe welcome inquiries related to our areas of focus. Read more about the entities we support and our exclusion criteria before submitting a request.\nWe offer independent research opportunities to fuel the next generation of researchers who want to dedicate their careers to improving the lives of people with serious diseases. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.\nOur Investigator Sponsored Study program supports independent, investigator-sponsored research designed to advance scientific knowledge of disease states, patient populations and medical treatments that align with our clinical and scientific areas of interest.\nWe consider funding and/or drug support for the following categories of research:\nClinical studies investigating a specific intervention\nObservational studies evaluating a disease state (e.g., epidemiological and outcomes studies)\nNonclinical studies using Vertex compounds for in vitro assays or in vivo models\nCystic fibrosis (CF) areas of interest\nNatural history in CF and evaluation of novel biomarkers and outcome measures\nDisease modification with cystic fibrosis transmembrane conductance (CFTR) modulators\nWe review applications for the following areas related to CF:\nStudies involving approved Vertex medicines\nAt this time, we are not considering applications for the following:\nN-of-1 studies or small studies in patients with rare CFTR mutations\nOutlicensed molecules (VX-970, VX-803, VX-984)\nCF award programs\nVertex offers three competitive grant programs focused on advancing scientific and clinical research in the field and supporting the cystic fibrosis community.\nCircle of Care is a global competitive grant opportunity that funds innovative patient-centric programs for the CF community. Each grant cycle, Vertex awards up to $500,000 USD to fund programs that support people with CF to live fuller, more engaged lifestyles. An independent steering committee, comprised of individuals who are part of the CF community, selects the recipients.\nCF Research Innovation Awards\nVertex CF Research Innovation Awards (RIA) are highly competitive grants created to inspire and support the next generation of M.D.s and Ph.Ds. who are working to advance the understanding of CF and establish their careers as CF researchers. There are two categories of awards: Independent Research and Mentored Research.\nApplications are reviewed and selected by an independent steering committee.\nIndependent RIAs provide grants of $750,000 USD distributed over three years to support newly independent faculty members as they establish their own research programs with outstanding promise in CF. Up to two awards are given annually.\nMentored RIAs provide grants of up to $125,000 USD distributed over two years to support mentored projects with established CF researchers. Up to four awards are given annually.\nThe submission period for the RIA Awards program is closed. For more information, including the next application cycle, please contact RIAProgram@vrtx.com.\nVertex Innovation Awards\nVertex Innovation Awards (VIA) support‚ÄØinnovative and collaborative clinical research aimed toward improving the care of people with CF. Applications for clinical research projects are welcomed from across the entire field of CF and are to be led by an individual or individuals who have established their career interest in CF. Each year, Vertex awards up to $750,000 USD to four selected projects.\nApplications are reviewed and selected by an independent committee of experts outside of Vertex.\nThe submission period for the VIA Awards program is closed. For more information, including the next application cycle, please contact VIAProgram@vrtx.com.\nTogether, Vertex and the Vertex Foundation are committed to giving back. For us, giving back includes providing opportunities to support our communities through charitable giving, research awards, scholarships, sponsorships and more.\nThe Vertex Foundation seeks to improve the lives of people with series diseases and contribute to the communities where Vertex is located through education, innovation and health. The charitable 501(c)3 foundation is an extension of Vertex's corporate giving commitment and was established in 2017.\nThe Vertex Foundation focuses its support on four areas:\nSTEAM education to support the next generation of innovators\nSocial innovation to enable innovative solutions to community challenges\nHealthy families to support quality of life for families with children living with serious diseases\nCommunity support through Vertex employee engagement programs and by providing donations during times of disaster\nThe Foundation supports projects and organizations with a strong commitment to inclusion, diversity and equity and seeks to promote these values through all of its programs.\nAnnually, the Vertex Foundation awards scholarships of $5,000 each to recipients in the U.S. and Canada to help people with CF and/or their immediate family members (siblings, caregivers, children and spouses) pursue two-year, four-year or graduate degrees.\nThe Vertex Foundation Inc. is a 501(c)(3) charitable organization. It is a separate legal entity from Vertex Pharmaceuticals Incorporated.\nWhy You Should Take Your Apple Cider Vinegar At Night ‚Äì Health and Wellness\nThat's a huge jump from the projection of 1 in 3 by 2050 made by the Centers for Disease Control and Prevention (CDC) in 2010. Worse, half that number are unaware of how compromised their health really is.\nWhat this reveals, researchers assert, is that acetic acid can \"turn on\" trigger genes that initiate the enzymes ability to break down fat, which prevents weight gain. It also helps you feel full.\nSeveral test tube studies show that vinegar can kill cancer cells. Authority Nutrition cites several studies; one in particular in Japan used several types of fermented vinegars to induce apoptosis (programmed cell death) in leukemia cells.\nA total of 2552 hospitalized, unrelated study patients along with 1894 controls with written informed consent were selected and obtained through various hospitals including Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India. In addition, a total of 98 registered unrelated patients and their family members were obtained as we previously described (5, 41). The institutional review boards of the study centers approved the study protocols.\nA standard international protocol was followed in diagnosing the cases, as we described previously (5), and the details of the baseline characteristics of the patients are given in table S1 (A and D). Briefly, individuals were diagnosed with HCM based on the following conventional criteria proposed by American Society of Echocardiography:\n1) LV hypertrophy of ‚â•15 mm on two-dimensional echocardiography in the absence of another disease that could account for the hypertrophy.\n2) LV septal to posterior wall thickness ratio of more than 1.3 in the absence of hypertension that could account for hypertrophy.\n3) Nonobstructive HCM was defined as a pressure gradient of ‚â§30 mmHg at rest and after provocation. Patients with a pressure gradient of >30 mmHg at rest or after provocation were classified as obstructive HCM.\n4) Any electrocardiogram (ECG) abnormalities along with the above echo-positive individuals: LV hypertrophy (Romhilt-Estes score, ‚â•4), Q-waves (a duration of >0.04 s and/or a depth of >1/4 of ensuring R wave in at least two leads), and marked repolarization abnormalities (T-wave inversion in at least two leads). Nonsustained ventricular tachycardia was defined as three or more ventricular extra systoles at a rate of ‚â•120 beats/min, lasting less thanÔªøÔªø 30 s.\n5) Family history was considered positive if anyone first degree relative had a clinical diagnosis of HCM.\n6) For selective patients, cardiac magnetic resonance imaging was performed with the standard protocols including Cine, steady-state free precession (SSFP), T1-weighted, and T2-weighted imaging, followed by gadolinium administration and postgadolinium for late gadolinium enhancement (LGE) sequences using 1.5-T clinical system (Ingenia, Philips Healthcare, Best, The Netherlands). For LGE imaging, the patient were administered with an intravenous injection of 0.2 mmol/kg of body weight gadolinium-based contrast reagent at 1 to 2 ml/s. Ten minutes after injection time, LGE images were acquired in the continuous short-axis view using an inversion-recovery gradient-recalled echo sequence using a manually selected optimal inversion time to null the signal from normal myocardium.\nThese days, it is common to find regular cannabis users looking for new cannabidiol products online. The therapeutic and medicinal properties of CBD vape oil and other CBD products are creating the buzz in health and wellness circles. Be it in vapes, edibles, or other supplements, and there is no dearth of products to choose from in 2021. The waves generated by CBD hemp strains and their products have prompted advanced research by institutions dedicated to the cause.\nCountless studies, laboratory studies, and articles are researching the health benefits of cannabis and CBD components. The buzz surrounding the increasing popularity and use of CBD vape oil has reached vapers and the biggest names in the vaping industry. Resultantly, the benefits of inhaling the steam-form of this plant-based item are influencing inhalers and vapers like never before.\nWhat is Wholesale CBD Vape Oil?\nAlso referred to as CBD vape juice, high-quality wholesale CBD vape oil comprises a carrier liquid. The oil is best used for vaping through a vape pen. Just like regular CBD oil, this form of vaping oil can be found as CBD isolate, broad-spectrum and full-spectrum. With more laboratory and clinical evidence in the offing, it‚Äôs important to understand the top reasons why CBD vape oil has become so popular among the masses.\nTreatment of Type 2 Diabetes\nThere is a high incidence of people dealing with type 2 diabetes or adult-onset diabetes in the USA. The various side effects, signs, and symptoms of Type 2 diabetes can be relieved with the medicinal properties of CBD help flower products like CBD hemp oil. This helpful product wards off pain and inflammation increase the metabolic rate, and reduces the impact of diabetes in different ways.\nProbable Effects on Cancer Patients\nDrugs containing THC may provide relief to patients undergoing chemotherapy treatment after being diagnosed with cancer. They may regulate the signs of pain, vomiting, and nausea, which are the primary side effects of this therapy in such patients. If used as prescribed and in moderation, CBD vape oil can also ease off the effects of inflammation, seizures, and the other tell-tale after-effects of chemotherapy.\n3. Positive Effects on Epilepsy Cases\nEpilepsy is a common health condition found in people of all ages worldwide. According to the experts at Miami Rave, CBD vaping oil is helpful for patients suffering from regular and continuous bouts of epilepsy. The clinical trials and laboratory studies conducted on rodents have proved that CBD can reduce convulsions. Advanced research is underway to establish the sound benefits of CBD oil and other CBD products on epilepsy cases.\nConclusion\nInsomnia, anxiety, and stress are among the fastest increasing mental health conditions in 2021. Fortunately, research reports have established the efficacy of CBD vape oils in treating them. You may want to discover the relaxing and sleep-inducing effects of CBD products and oils for yourself. Log into Miami Rave to check out its extensive catalog of hemp flower CBD products and their benefits.\nDICE and AVD are used in concert to automatically segment lesion areas: DICE overlaps predicted and actual lesions, while AVD identifies the differences in volume between them. The results are consistent with doctors‚Äô manual sketching.\nThe screening system is then able to automatically identify and digitally segment lung lesions and measure lesion volume. This allows the rapid diagnosis of symptomatic patients carrying the COVID-19 virus ‚Äì up to three days faster than other testing methodologies.\nAccording to Huawei CLOUD Healthcare Manager Mr Zhang Shaowei, ‚ÄúThe components of the EIHealth platform use different AI techniques, including Machine Learning, Deep Learning, and Knowledge Graph Learning to power a screening system which can autonomously and holistically integrate the lessons learned by our medical professionals.‚Äù\nThis process also boasts an impressively high accuracy rate, correctly identifying carriers 98% of the time. Using this technique, doctors can delegate the task of reading CT scans to the AI and focus instead on the important work of treating patients.\nFurthermore, for confirmed cases in hospitals, the AI-Assisted Patient Screening system can quickly perform registration and quantitative analysis on the data acquired over multiple rechecks of the CT scans, thereby helping doctors evaluate patients‚Äô conditions and the impact of targeted drug treatments.\nAs Mr Zhang notes, ‚ÄúThe system does not fully replace the work that doctors do, but enhances their capabilities by adding an additional line of defense in the diagnostic process.‚Äù\nHuawei CLOUD has already deployed the AI-Assisted Patient Screening system in 60 hospitals across the globe, including Malaysia, Thailand, Italy, and Ecuador.\nIn Malaysia, Huawei is working with the Ministry of Health to deploy the system in the Sungai Buloh Hospital (state of Selangor). Dr Yun Sii Ing, Head of Department for Clinical Radiology at the hospital, recently stated that, ‚Äú[‚Ä¶] This equipment (‚Ä¶) will help save lives by greatly reducing the risk of infection and enabling medical personnel to perform their duties better and faster.‚Äù\nIn Ecuador, the General Hospital of South Quito was connected to Huawei‚Äôs AI system, enabling diagnoses just 14 hours after its launch. Otto Sonnenholzner, Vice President of Ecuador, took to social media to thank Huawei for making Ecuador the first Latin America territory with AI-powered diagnostics.\nMedical Blogs May Threaten Patient Privacy - Consumer Health News | HealthDay\nMedical Blogs May Threaten Patient Privacy\nMore than half revealed data for easy IDs, lacked basic ethical standards, study finds\nTHURSDAY, Aug. 7, 2008 (HealthDay News) -- Blogs written by medical professionals may pose a threat to patient privacy, because the authors of the blogs may inadvertently reveal patient information, says a U.S. study that's the first to examine the issue.\nThe researchers analyzed the contents of 271 medical blogs and found that 56.8 percent contained enough information to reveal the author's identity.\nAlthough obvious violations of patient privacy are rare, supposedly anonymous medical bloggers who provide information about their location, subspecialty or other personal details may reveal their identity to blog readers, noted Dr. Tara Lagu, Robert Wood Johnson Foundation Clinical Scholar, and colleagues at the University of Pennsylvania.\nIn some cases, patients described in medical blogs may be able to identify themselves, the researchers said. For example, three of the blogs in the study had recognizable photos of patients, including one with an extensive description of the patient and links to photos.\nThe researchers also found that some of the medical blogs allowed advertisements, and some promoted health -care products within the blog text. None of the bloggers who described products within the text adhered to medical ethics standards of providing information on conflicts of interest, or whether payment was received for promotion of the products.\nThe study was published online in the Journal of General Internal Medicine.\n\"While many medical blogs provide valuable information to the public, are respectful in tone and are written anonymously, others pose a threat to patient privacy and have the potential to threaten the integrity of the medical profession,\" Lagu said in a journal news release.\n\"Unfortunately, no professional organization has taken the initiative to provide guidance on this issue. As the number of medical blogs grows, professional organizations, medical educators, and the blogging community must address the challenge of this new medium by setting guidelines and standards for what is appropriate,\" Lagu said.\nThe U.S. Department of Health and Human Services has more about patient privacy.\nSOURCE: Journal of General Internal Medicinenews release, July 23, 2008\nConsumer News Products Language English News types News Topics Computers / Internet: Misc. Doctors Medical Technology: Misc. Press, Medical / Health Reporting Psychology / Mental Health: Misc. Safety & Public Health Safety & Public Health: Misc.\nG6PD ¬´ IHTC\nHome ¬ª Medical Professionals ¬ª Blood Disorders ¬ª Other Hematological Disorders ¬ª G6PD\nGlucose-6-phosphate dehydrogenase (G6PD) is a substance that helps the body use sugar for energy. It is an enzyme, which means it speeds up chemical changes when the body converts sugar to energy.\nThe G6PD enzyme is found in all the body's cells, but is especially important in red blood cells. These are the cells that contain hemoglobin and carry oxygen throughout the body. The G6PD enzyme protects the red blood cells from harmful chemicals or toxins, which can accumulate in your body during certain illnesses or after taking some medicines.\nPeople with G6PD deficiency do not have enough G6PD enzyme to neutralize some chemicals or toxins. Normally, there are only tiny amounts of toxins in the body, and it is usually not a problem for the G6PD enzyme to make them harmless.\nIf strong chemical products are not neutralized, they can damage the hemoglobin inside red blood cells. A build-up of toxins or chemicals can cause the red blood cells to break apart and be destroyed. This makes the person anemic (reduced levels of hemoglobin and red blood cells). Sometimes the anemia can happen very quickly, as if the person suddenly lost a lot of blood after an accident.\nWhen people with G6PD deficiency take these medications, the toxic products that form in the body can damage and destroy their red blood cells.\nThe process of the red blood cells with hemoglobin being destroyed is called hemolysis. This may lead to severe anemia and can cause jaundice from the build-up of hemoglobin breakdown products in the blood. Sometimes infants who experience jaundice have G6PD deficiency.\nPeople with G6PD deficiency will receive from their healthcare provider a detailed list of medicines and substances that are known to cause problems with hemolysis. Once the cause of hemolysis is removed, the hemolysis usually stops within a short period.\nCause of G6PD Deficiency\nG6PD is a genetic condition that is caused by an alteration (mutation) in the G6PD gene. This mutation prevents the normal production of the enzyme. The gene is passed on in families in an X-linked recessive pattern. This means that the gene that codes for the G6PD enzyme is located on the X-chromosome; males have one X chromosome and females have two. When a male inherits a gene for G6PD that is not functioning properly, he will have G6PD deficiency. When a female inherits a gene for G6PD deficiency she is referred to as a carrier because she has a second copy of the gene that often can compensate for the altered gene. Female carriers may or may not experience symptoms of G6PD deficiency. Carriers of G6PD deficiency have a 50% chance of passing the gene on to each of their children. Each son of a carrier has a 50% chance of having G6PD deficiency and each daughter has a 50% chance of being a carrier. Men with G6PD deficiency do not pass the gene on to any of their sons; however, all (100%) of their daughters are carriers. Often a mother has no symptoms and has no way of knowing that she is a carrier of G6PD deficiency. Carrier testing in families who are known to have G6PD deficiency is available if desired.\nG6PD deficiency can occur in a person from any ethnic group. In the United States it most commonly occurs in people of African American, Mediterranean (Italian, Greek), Southeast Asian, or Middle Eastern descent.\nThe only way to know if a person has G6PD deficiency is with a special blood test. Remember, G6PD deficiency is not usually a chronic problem except in rare circumstances (see section below under \"chronic hemolysis\"). Many people go through life without any symptoms. It becomes a problem if the person is exposed to certain chemical compounds or toxins or experiences certain infections that can cause hemolysis and lead to severe anemia.\nPeople with G6PD deficiency have an increased risk of hemolysis and severe anemia if they have certain infections such as Fifth's disease (parvovirus), infectious hepatitis, infectious mononucleosis (mono), pneumonia, or a blood infection.\nThe body produces blood cells in the bone marrow. This is the red, soft, spongy part inside the bones. Usually a person with chronic hemolysis makes more than the average amount of red blood cells (hemoglobin) to make up for the ones being constantly destroyed. This increased rate of red blood cell production can be measured by a blood test called a reticulocyte (or \"retic\") count. The retic count is usually elevated in a person with chronic hemolysis. This means the body is keeping up with the demands for red blood cells and hemoglobin.\nIn some people with G6PD deficiency, a small amount of red blood cell destruction occurs all of the time. This form of G6PD is called \"chronic hemolysis\".\nFor persons with the form of G6PD deficiency that is associated with chronic hemolysis, their doctor may prescribe a medication called folic acid. This vitamin supplement helps the bone marrow keep up with increased production demands. The symptoms of hemolysis and the resulting anemia may include tiredness, paleness, headache, yellow tint to the whites of the eyes or skin (jaundice or icterus), fast heart beat, shortness of breath, and dark urine (tea or coke colored). Individuals with these symptoms should inform their doctor or nurse promptly.\nSpecial Considerations: What to Avoid\nYou cannot prevent G6PD deficiency, but fortunately, if you can avoid exposure to certain medicines and foods, you can prevent the more serious symptoms.\nMedications: What to Take, What to Avoid\nAny time persons with G6PD take any medication, whether prescribed by a doctor or over-the-counter, they should tell their doctor or pharmacist that they have G6PD deficiency to be sure that it is safe to take the medication.\nThe common over-the-counter treatments for fever, pain, nasal congestion and cough ‚Äî acetaminophen (Tylenol), ibuprofen (Advil), pseudoephedrine (Sudafed), and guaifenesin, (Robitussin) ‚Äî are usually safe at normal therapeutic doses for children with G6PD deficiency. People with G6PD deficiency should avoid medicines that contain aspirin (salicylic acid)."
    },
    {
        "id": "100027",
        "description": "[December 14, 2016; Kennett Square, PA] ‚Äì Renowned for his research on equine laminitis, Dr. Andrew van Eps joined the faculty of Penn Vet's New Bolton Center in December as Associate Professor of Equine Musculoskeletal Research. Van Eps has spent the majority of his career at The University of Queensland in Australia, most recently as Director of the Equine Hospital and Associate Professor of Equine Medicine. The University is also his alma mater; he graduated with his veterinary degree (BVSc) in 1999 and his PhD in 2008. The move marks a return to New Bolton Center, where he completed his residency in large animal internal medicine in 2008 and spent another year as a lecturer and clinician. \"We are fortunate to have attracted Dr. van Eps to Penn Vet,\" said Dr. Gary Althouse, Chairman of the Department of Clinical Studies at New Bolton Center. \"He comes to us both as a seasoned clinician and an equine researcher of international caliber.\"\nThe focus of van Eps' research is improving the understanding, prevention, and treatment of equine laminitis and other musculoskeletal diseases. Laminitis, the number-two killer of horses after colic, is a painful, debilitating condition with no known cure. \"The position at New Bolton Center is definitely a once-in-a-lifetime opportunity for me,\" van Eps said. \"Although I have always had a strong interest in research, it has taken a back seat to clinics, teaching, and administrative work in recent years,\" he continued. \"This position at New Bolton Center allows me to prioritize research, which for me is very exciting.\"\nNew Bolton Center was the choice for his residency because he considered it to be \"the best place in the world to train in large animal internal medicine,\" he said. \"I couldn't have hoped for a better residency program,\" van Eps said. \"I was very lucky to train under some of the most highly regarded and skilled clinicians in the world, and I am very grateful.\" A prolific researcher, van Eps has co-authored nearly 50 peer-reviewed publications along with 15 additional publications. He's given more than 60 presentations, primarily on topics related to laminitis, in places from Hong Kong to Palm Beach. He's been a co-investigator on 15 research grants. \"Andrew will bring an added dimension and depth to our existing expertise at New Bolton Center, which will perpetuate our mission of being an international leader in the field of equine musculoskeletal research and, in particular, in our goal of finding a cure for laminitis,\" Althouse said. Van Eps said he believes his work in the development and scientific validation of foot cooling (digital hypothermia/cryotherapy) as a preventative and also a treatment for acute laminitis is the most significant contribution of his work thus far. \"Laminitis used to be a common and fatal complication of systemic illness. Now, with the widespread use of digital hypothermia, this is much less common,\" he said. Van Eps' research also focuses on solving supporting-limb laminitis, the type that led to the death of 2006 Kentucky Derby winner, Barbaro, who was treated at New Bolton Center for a catastrophic leg fracture during the Preakness Stakes that year.\n\"We have made some significant inroads with regards to the cause of supporting-limb laminitis and potential preventatives,\" he said. \"I hope to continue this work and develop some practical solutions at New Bolton Center.\" About Penn Vet\nGenomic characterization of tumor heterogeneity in recurrent small cell lung cancer through research autopsy\nVirus-host interactions that regulate translation in cells infected with HSV-1\nAcute lung injury is reported to be one of the most common forms of organ dysfunction in critically injured individuals. Findings from a number of studies suggest that priming occurs at several cellular levels, in the lung and circulating neutrophils, and appears to play significant roles in mediating the increased inflammation associated with this injury. Utilizing a variety of experimental approaches (neutrophil/ macrophage depletion, adoptive transfer of neutrophils, gene specific knock-out/over-expression, in vivo antibody neutralization/ peptide antagonism/ siRNA) in a dual insult (non-pulmonary) model of hemorrhagic shock (Hem) followed by polymicrobial septic challenge (CLP), we have found evidence of `priming both in circulating neutrophils and pulmonary epithelial cells for enhanced pro-inflammatory responsiveness. However, in neutrophils, this has been associated with suppressed apoptosis, while in epithelial cells; a potentiation of apoptosis has been observed. Further, it would appear that epithelial cell `priming' after Hem for localized cytokine/ chemokine expression in the lung is antecedent/ required for macrophage activation and the eventual recruitment of `primed' neutrophils to the lungs of animals subsequently challenge by CLP. The contributions of the endothelia and other localized tissue immune cells, e.g., dendritic cells and/or lymphocytes in this activation process have not been defined. Finally, studies utilizing organ specific delivery of siRNA against extrinsic death receptor protein, Fas, indicate not only that anti-apoptotic approaches appear efficacious but that these approaches also serve to suppress aspects of the local pro-inflammatory response. However, the nature of this protection at cellular levels as well a molecular level is not clear. With this in, mind we propose the following hypothesis, which the mechanisms by which localized delivery of Fas siRNA mediates its' effects are through both inhibition of apoptosis and pro-inflammatory activation of epithelial cells `primed' by shock/Hem. To test this hypothesis, we have designed the following objectives (Aims):\nAIM 1 : We will determine the nature of Fas/FasL mediated signaling/activation of pulmonary epithelial cells, endothelial cells, neutrophils and/or alveolar macrophages to a `priming' insult such as Hem.\nAIM 4 : We will establish if endothelial cell activation and/or injury are pre- or post- to the activation/'priming'/injury of epithelial cells following shock.PROJECT NARRATIVE Acute lung injury is reported to be the most common form of organ dysfunction encountered in critically ill patients in trauma/ surgical/ medical intensive care units. This study is designed to determine what the contribution of immune (i.e., neutrophil, macrophage, dendritic cell, etc.) and non-immune cell's (i.e., epithelial and endothelial cell) natural cell suicide (apoptotic) program and/or inflammatory response are to the development of lung injury resulting from the combined insult of shock (due to blood loss) followed by septic challenge in the mouse. The contribution of these cells's apoptotic/ inflammatory processes will be examined in this setting using genetically altered mice as well as drug interventions directed at genes or mediators thought to be involved in the regulation of these processes. It is our firm belief that the results of these studies will provide information that not only should allow us to better understand the pathobiology of acute lung injury but also its attenuation. ? ? ?\nControl room for crusher plant control room of a crushing plant kaolin equipment suppliers control room of a crushing plant what is a coal prep plant control room vibrating sieve separator what is a coal prep plant control room in india Electrical Engineering Tutorials Thermal Power Plant Layout and Main parts of the plant are 1 More control room for crusher plant studioko .\nCV Plant Operator Process Operator In Cement Plant\nCVResume Details 1 Summary Cover Letter CVResume Part 1 Mandatory Process operator in cement plant in Central Control Room 2 Work Experience CVResume Part 2 Mandatory Working as a plant operator in CCR of well known cement industry in UAE and before here i worked in Sudan as same position and i have total experience in cement plant is 6 years.\nJob description Role Central Control Room Operator Jeddah Saudi Arabia Reporting to the Production Shift Leader the main objective of the Central Control Room Operator is to operate the plant equipment as per the requirements to ensure products meet the Lafarge Standards of safety environment quality and volume.\nControl System Cement Siemens\nThe control room is at the heart of every cement plant Its where all production and auxiliary processes come together where processes are synchronized and where synergies can be exploited Siemens therefore supports you with the process development the engineering and up to the automation with innovative technology and strategic long .\nCement Plant Tour Sameocorg\nAn indepth tour of the cement plant will include visits to the automated Central Control room the kiln and a ride on an elevator to the top of the tallest structure in the Mojave Desert The Oro Grande Plant will provide personal protection equipment for the tour but please have appropriate footwear No open toe or high heel shoes allowed.\nEagle Cement Corporation Hiring Central Control\nPosted 4 weeks ago Monitors the operation parameters of the plant system Responsible for safe startupshutdown of theSee this and similar jobs on LinkedIn.\nJoining and upgrade of various control rooms by means of a new visualisation system for the central control room of a complete cement plant Engineering and delivery of the complete electrical equipment incl controllers and server cabinets The .\n2018414and Central Control Room CCR 10 INTRODUCTION Cement production in Ibese Cement Plant constitutes one of the major manufacturing industries in the Nigeria growing economy Koroneos et al 2003 The production of cement is one of the most energy intensive production processes known Koroneos et al 2005.\nVisualization System For The New Central Control Room\nVisualization system for the new central control room of a cement plant Joining and upgrade of various control rooms by means of a new visualisation system for the central control room of a complete cement plant Engineering and delivery of the complete electrical equipment incl controllers and server cabinets.\n2012824Over 5000 sensors and 50 computers allow the entire operation to be controlled by a single operator from a central control room The cement .\n3000 TPD Greenfield Plant National Cement Share\n3000 TPD Greenfield Plant 1 of 15 The Central Control Room 2 of 15 Air Compressor The National Cement 3000 TPD Greenfield Cement Plant gallery features the infrastructures buildings and work centers of the plant Take a virtual tour of the plant by browsing on the pictures above.\nLihat profil Fedinand Jenyi di LinkedIn komuniti profesional yang terbesar di dunia Fedinand menyenaraikan 1 pekerjaan pada profil mereka Lihat profil lengkap di LinkedIn .\nByrne Sean Control Room Operator A CRH\nByrne Sean Control Room \"A\" Operator at CRH Cement Console \"B\" Operator Trained as a central control room operator Holcim Cement 20142015 Control plant operations from central control .\nAhmed Mohamed Fahmy Cement Kiln Central\nView Ahmed Mohamed Fahmys profile on LinkedIn the worlds largest professional community Cement Kiln Central Control Room Specialist Operator HeidelbergCement April 2010 Present 9 years 2 months suez raw and coal mill operator and kiln operator assistant Mill operator HeidelbergCement Suez cement plant.\nAlibabacom offers 1601 cement plant construction project products About 1 of these are steel structures 1 are construction projects A wide variety of cement plant construction project options are available to you such as aisi gb.\n2019518Quality control Quality is of paramount importance This is why the whole production process is monitored and controlled from a central control room where all the data from the plant and the laboratory come together Highly qualified production controllers operate and safeguard the plant.\nNotice for trainingcumworkshop on Online Continous EmissionEffluent monitoring Systems OCEMS Report of the CPCB Inhouse Committee on Methodology for Assessing Environmental Compensation and Action Plan to Utilize the Fund.\nHagan provides Jet Pulse technology for silo top cement dust control collectors free standing dust collectors and intruss dust collection for all concrete batching plant cement dust filter needsDust cartridges and parts for cement jet pulse silo top dust collectors Vince Hagan is the leader in cement dust collector technology for concrete batch plants.\nSICEMENT WHR delivers integrated measurement and automation technology making significant contribution to the efficient operation of the waste heat plant Control and monitoring of the equipment is carried out directly by the CEMAT process control system from a central control room without the need for additional operating personnel.\nMaintenance Practices in Cement Industry operator from a central control room 22 High productivity in modern cement plant is extremely dependent on effective maintenance manufacturing .\n2013830Process Control The plant will be managed from a central control room that will allow the monitoring of all processes including temperatures and pressures Continual testing of the Page 8 materials sample preparation chemical analysis and physical testing will take place in the onsite Nyumba Ya Akiba cement plant.\n2010129Application story Low Cost DCS Applied in the Process Automation of Cement Plant and SRR to automeasure and control relevant levels It can coordinate the output of the kiln to sync with the fluctuating value of kilnoutgoing chamotte In the central control room we usee the I7188 with multiple serial ports as a data buffer between.\nConcrete batching plant control system is equipped with precise batching machine equipment you can control a number of independent batching lines each line can be set according to user requirements said the focus In addition to the sensor the control system is designed to focus on the centralized control of the central control room away from the mixing station.\nSustainable Construction ACC Limited Indias Most\nThe Central Control room CCR building of the new Chanda cement plant in Maharashtra is designed as an energy efficient building based on Green Building principles This three storied building with a floor area of 2000 square metres sits on a plot measuring about 7800 square metres which is itself landscaped as a Green Certified Open area.\nMathodu PlantKarnataka Chitradurga District 029 MTPA Located in the state of Karnataka this Plant has a capacity of 029 MTPA Though the plant capacity is relatively small it has a computercontrolled Central Control Room CCR to monitor the quality of raw materials and cement .\nPoliclinico Universitario Campus Bio-Medico | Gerontology Unit\nHome - Personnel and Facilities - Clinical Departments - Gerontology\nThe Unit of Gerontology is concerned with the diagnosis, prevention and treatment of acute and degenerative diseases of the elderly, with the basic aim of delaying functional and mental decline, whilst at the same time maintaining self-sufficiency and the best possible quality of life.\nThe Gerontology Unit provides geriatric examinations and multidimensional assessments to determine the patient's level of disability. It works closely with the Orthopaedics and Traumatology, the General Surgery, and the Diagnostic Imaging Units, providing integrated diagnoses and therapy.\nThe main outpatient units are:\nChest clinic (lung function tests such as simple and complete spirometry, bronchoreversibility test, DLCO assessment, assessment of maximum inspiratory and expiratory pressures, methacholine test, bronchoscopy, sleep medicine, polysomnography on a day-hospital or outpatient basis, nocturnal oximetry, nocturnal continuous positive pressure ventilation and non-invasive ventilation).\nSyncope and cardiological diagnostic clinic\nSore Clinic\nThe acute ward, aimed at the treatment of acute diseases in elderly patients, provides non-invasive ventilation and respiratory and vascular diagnosis, and has nursing staff with specific training in the healthcare and treatment of the elderly.\nDiagnostic performance of traditional and innovative techniques of Multidimensional Assessment\nPharmacoepidemiology in geriatric patients\nRespiratory diseases in the elderly: non-pulmonary effects of respiratory disease, respiratory effects of metabolic diseases, respiratory function assessment, effect of body composition on the response to respiratory rehabilitation in patients with COPD, the link between COPD and cardiovascular disease\nNutrition: the link between diet quality and osteoporosis\nTelemedicine: development of remote monitoring models for elderly patients, particularly those presenting with chronic diseases (e.g. chronic obstructive bronchitis, diabetes mellitus)\nJuly 17, 2018 /in Press Releases /by webmin\nSan Diego, CA ‚Äì Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin¬Æ blood culture collection sets, announced today that the United States Patent Office allowed its patent application and has issued U.S. Patent No. 10,010,282. The Kurin blood culture collection set is a replacement for traditional collection sets, introducing technology to divert skin contaminants while preserving the standard blood culture collection technique for clinicians.\n\"This additional patent is the next step in building intellectual property protection for our unique blood diversion technology,\" said Bob Rogers, Inventor and Chief Executive Officer. \"As clinical results continue to prove the effectiveness of Kurin, this US patent further strengthens our position in the market. The simplicity of this product is critical to caregiver compliance and compliance is the key to improving clinical outcomes. With no need for manual manipulation, a Kurin set makes it effortless for clinicians to incorporate diversion, a proven method of lowering contaminated blood cultures, into their routine collection process.\"\nhttps://www.kurin.com/wp-content/uploads/KurinLOGO.png 0 0 webmin https://www.kurin.com/wp-content/uploads/KurinLOGO.png webmin2018-07-17 03:00:232018-07-17 03:10:27Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device\nPreventing Blood Culture Contamination using a Novel Engineered Passive Blood... Kurin CEO responds to Magnolia Medical Countersuit Press Release\nZotrim - Research Studies\nZotrim / Research Studies\nBelow we have included all our completed studies to enable you to see why with Zotrim‚Ä¶ you'll always feel full of life.\nInvestigator: Dr HalfordPublished: 34th British Feeding and Drinking Group Meeting ‚Äì 25th March 2010\nConducted over a 45 day period, 47 overweight subjects aged between 20 and 60 were given Zotrim to assess the effects Zotrim's formulation had on their weight loss. Split into groups consisting of those on Zotrim and those taking a placebo capsule containing lactose, they were instructed to take their capsules 3 times a day before every meal.\nInvestigator: Torben AndersonPublished: Journal of Human Nutrition and Dietetics, 2001\nDesigned to examine Zotrim's ability to help consumers maintain their weight loss, 22 of the 24 subjects who took part in the above study by Torben Andersen, were provided with a 12 month supply of Zotrim. Weighed monthly, they were instructed to take Zotrim if they started to put weight back on.\nInvestigator: Carrie RuxtonPublished: Nutrition & Food Science, 2004\nInvestigator: Jan FoghPublished: Journal of Human Nutrition and Dietetics, 2001\nInvestigator: Torben AndersonPublished: 3rd Health and Nutrition Conference, 2002\nSplit into 2 groups, subjects were required to either take 2 Zotrim tablets or 2 placebo tablets in the morning as well as before lunch. Two hours after eating, subjects were then exposed to a TV video or a blank screen were given the additional option of either reading/studying or having unlimited access to sugary foods. Their total energy intake during lunch and snacking was then measured.\nInvestigator: G Baker and AR Leeds, Department of Nutrition & DieteticsPublished: 3rd Health and Nutrition Conference, 2002\nInvestigator: C.H.S Ruxton, F Hinton and C.E.L EvansPublished: Nutrition and Food Science, 2005\n70 healthcare professionals were asked to take Zotrim for 6 weeks during an 'open label' study. In this time they experienced:\nReduction in average weight lost\nInvestigator: C.H.S Ruxton, I. Kirkwood, B. McMillan and C.E.L EvansPublished: British Food Journal, 2007\nThere are a number of chronic diseases that can be blamed on genetics but not a lot of people consider stress\nand anxiety to be passed down from parents. How you react to pressure and unfavorable conditions depends mainly upon the power of your brain and your\nability to take charge of your internal activities.\nSo, can a condition that relies heavily upon one's individual mental abilities be genetic?\nActually yes, it seems the Bible was true in this regard and the sins of the father can end up plaguing\nthe children and here science does seem to give this theory the green signal.\nStudies revealed that the brain of children who had a specific genetic mutation did not produce a good amount of a chemical known as Neuropeptide Y.\nA lack of the required amount of Neuropeptide Y or NPY triggers the brain to react strongly to negative\nemotions and feelings. In a way, the impact of the negative factor is amplified and the brain's response to physiological pain is not like it should have been\nin the absence of that particular genetic mutation.\nSince stress is also a reaction of the brain towards unfavorable factors, the result of the genetic\nmutation does not leave the brain equipped enough to handle the cause from an optimistic point of view.\nApart from stress, people bearing a low level of Neuropeptide Y, were also twice more likely to go into\ndepression, the reason here is the same. Instead of looking for ways to tackle the cause, the brain's response to the factor causing depression increases the\nactivity in prefrontal cortex, the area of the brain responsible for reactions to negative emotions.\nThe prefrontal cortex is thinner and does not inhibit the negative feelings, thus regulating the brain's response in a negative light.\nAnother theory states that a person's characteristics and traits are largely acquired from their parents.\nThe genetic makeup does decide the temperament and outlook of a person, albeit not on a complete scale.\nGiven the individual characteristic and their response to adverse situations based on their genes,\nit can be said that one reason for people being stressed out can be genetic.\nSomeone who engages in self-loathing is more likely to experience anxiety and be depressed when faced with an adverse situation, as compared to someone who likes to take charge and is solution-oriented.\nHowever, such research findings still have certain grey areas and are not entirely conclusive.\nPsychologically speaking, a person's temperament does influence how they behave under pressure but more importantly the pressure induced is mostly based on external factors. There are work-related pressure, pressure brought about due to personal reasons, because of bad health, etc.\nThe level of NPY or people's frame of mind is always the response to the pressure rather than being the\ncause of stress. Like Newton's third law, the cause being the external action while the consequence of genetic mutation is the opposite and equal reaction,\nwhich eventually leads to people feeling stressed and/or depressed.\n16b678d99788da21a4a706ca3ae79f88\nThis entry was posted in Is stress Genetic and tagged is stress genetic, neuropeptide Y, prefrontal cortex, stress and anxiety on November 1, 2012 by mulkurnia.\nHave you or a loved one received a terminal or other serious diagnosis? You're in the right place! After being told by doctors there was no hope after a terminal diagnosis, a functional health coach and her husband with stage 4 colon cancer find themselves ‚ÄúOff the Medical Grid,‚Äù meaning, they began to seek health-building and life-saving solutions outside of the medical model of care.\nn this podcast, we work with men to optimize their health One Small Bite at a time. With nutritionist David Orozco as your guide, we‚Äôll chop harmful diet myths and build wisdom based on sound nutritional science. From hot topics like fasting and high-fat diets to listener question on issues like mindful eating and chronic illness ‚Äì we cover proven methods to fuel your body and nourish your soul. One Small Bite is where men come to shoot the breeze about their health and rumble with vulnerabilities in order to transform their lives. Subscribe today and take the first bite!\nThis is a personal growth self-help podcast helping you live an extraordinary life. Inspirational stories, scientific education, and actionable steps and assignments to help you live an extraordinary life.\nSince 2016, Trent has been focused on improving our world, one healthy person at a time. That is when he started his own health and fitness journey and now he is passionate about helping others improve their mental, physical and spiritual health.As a Certified Holistic Health Coach and Mastering Raw Food Nutrition Educator, Trent uses various resources to improve his clients‚Äô health. Solid Nutrition and Fitness is the cornerstone of physical health and can oftentimes improve mental and spiritual health.On the podcast, Trent shares some of his videos made available to the #TeamSTRENGTH community each week. To get more exclusive content go to www.pbstrength.com/teamstrength.\nHome ¬ª FlexStent biliary stent system garners FDA 510K approval\nFlexStent biliary stent system garners FDA 510K approval\nFlexible Stenting Solutions (FSS; Eatontown, New Jersey) said it has received 510(k) clearance for its FlexStent biliary self-expanding stent system. The device is indicated for the palliative treatment of biliary strictures resulting from malignant neoplasms.\nJanet Burpee, CEO of FSS, told Medical Device Daily that the company has no immediate plans for putting the device on the market yet. She said FSS is figuring out its launch strategy in the U.S. as well as in Europe.\n\"We're currently really focusing on development, getting product ready across the board,\" Burpee said.\nFSS says its nearly fully connected stent has coupled technology with clinical needs by providing a \"highly durable stent with superior radial stiffness and low chronic outward force.\" The key to the FSS stent technology is the integration of helically wound struts with helical flexible coils, the company said. The key to the delivery technology is simplicity, ease of use and placement, FSS noted.\n\"We are very excited about receiving 510(k) marketing clearance and were thrilled to participate in the FDA's STED review process,\" Burpee said. \"We believe our unique platform technology will continue to provide needed clinical solutions in the interventional radiology, gastroenterology, neurovascular and cardiology device marketplace.\"\nBurpee said that the FlexStent biliary self-expanding stent is \"very, very conformable,\" which she says is what sets it apart from other biliary stents on the market.\nThe company has also received CE mark authorization for the Biliary and Femoropopliteal FlexStent systems.\nEarlier this year FSS reported receiving CE-mark approval for the FlexStent biliary self-expanding stent system (Medical Device Daily, March 9, 2009).\nThe privately held company raised $6 million in a venture financing round with GBP Capital in January 2008.\nLast month FSS signed an exclusive agreement with Micrus Endovascular (San Jose, California) to jointly develop a flow diversion technology for neurovascular indications using both Micrus and FSS technology development capabilities and intellectual property. According to Micrus, flow diversion is a relatively new approach for treating large and giant aneurysms which represent roughly 20% to 25% of treated intracranial aneurysms. Unlike microcoils that are placed in the aneurysm, flow diverters are stent-like devices placed in the parent vessel. They serve to divert blood flow away from the aneurysm, thus facilitating healing, Micrus said.\nMicrus said it would be responsible for overseeing the regulatory and clinical process and will manufacture neurovascular products developed based on the agreement. Micrus said it has made an upfront payment to FSS and will make additional payments upon achieving certain development and regulatory milestones. Micrus will also pay a royalty on net sales of products incorporating the FSS platform.\nAmbetter is an insurance company that provides health insurance to over 2 million people in the United States. As part of the Affordable Care Act (ACA), Ambetter provides marketplace insurance plans that cover some or all the costs of drug and alcohol rehab programs. If you have Ambetter health insurance and are searching for a substance abuse treatment facility that is covered by your plan, American Addiction Centers (AAC) is here to help.\nYes. MHS Indiana (Ambetter) covers drug and alcohol rehab.\nCheck Your Coverage\nTreatmentSolutions.com strives to provide you with the most updated information on each carrier's addiction insurance coverage, but policy changes and errors do occur. Please check with your insurance carrier directly to confirm coverage levels.\nIf you or a loved one are experiencing a medical emergency, call 9-1-1 immediately.\nMHS Indiana (Ambetter) covered Alcohol and Drug rehab centers in Indiana\nBetween 2017-2019, 16% of Indiana residents age 12 and over admitted to using marijuana in the past year, and 5.4% struggled with alcohol use disorder.1, p. 25 and 31, second paragraph on both That means that despite the stigma, substance use isn‚Äôt as rare as many people think.\nIf you are an Indiana resident who struggles with substance use, you might wonder if your Ambetter from MHS Indiana health insurance can help you get the treatment you need. The good news is that it can help pay for some or all of the cost of rehab.\nEach MHS Indiana (Ambetter) plan will have different levels of coverage, so you‚Äôll want to verify your insurance before you commit to a program. The treatment centers you‚Äôre interested in can review your insurance for you, or you can call the phone number on the back of your Ambetter card to learn more about your coverage.\nThis guide will help you understand how to use your MHS Indiana (Ambetter) coverage to get help with substance use. Let‚Äôs get started.\nWhat is MHS Indiana (Ambetter)?\nMHS Indiana (Ambetter) insurance is coverage offered by Ambetter through the Health Insurance Marketplace in Indiana.2, first section There are 3 levels of coverage‚ÄîBronze, Silver, and Gold.2, second section\nThe bronze coverage is Ambetter Essential Care and has lower monthly premiums but higher out-of-pocket costs.2, second section The silver plan, Ambetter Balanced Care, has medium monthly premiums and medium out-of-pocket costs.2, second section Finally, the gold plan has higher monthly premiums but lower out-of-pocket costs.2, second section\nAmbetter insurance plans offer a variety of attractive benefits, including telehealth options, healthcare management programs, a 24/7 nurse advice line, and more.3, About Ambetter With 2 million members in 26 states, Ambetter has a lot of experience providing high-quality care to its members.3, experienced healthcare\nMost importantly, Ambetter plans meet the Affordable Care Act‚Äôs (ACA) requirements that all long-term health plans cover 10 essential benefits, one of which is mental health and substance use treatment.4, fifth bullet That means you can rely on MHS Indiana (Ambetter) plans to help you with some or all of the cost of rehab.\nWhat Substance Addiction Does MHS Indiana (Ambetter) Cover?\nPeople struggle with a wide variety of substances. Common addictions include prescription drugs, opioids, meth, marijuana, alcohol, cocaine, and heroin.5, bulleted list\nIf you struggle with any of these substances, there are treatment programs that can help. Many treatment programs can address a wide variety of different substances, while others may specialize in treating misuse of one specific substance.\nBecause misusing drugs can cause a wide range of legal and health issues, getting the help you need as soon as possible is important. That‚Äôs why we‚Äôre available 24/7 to verify your insurance and answer any questions you have about rehab.\nWhat does MHS Indiana (Ambetter) Insurance cover in addiction treatment?\nThere is a wide variety of treatment programs that use high-quality evidence-based approaches. Finding the treatment that‚Äôs right for you will require you to work closely with your doctor. Your doctor will ask questions about what substances you use, for how long, and how often. There will also be questions about your habits, triggers, social circle, and home environment.\nUsing that information, your doctor will put together a treatment plan to set you on the path to a substance-free life. Some of the most common treatment options include:6,7\nInpatient Rehab. Inpatient rehab invites you to live at a treatment facility full-time for the duration of the program, which may be several weeks or months. During this time you‚Äôll break out of old habits and learn new ways to approach your emotions and choices.\nOutpatient Rehab. When you participate in outpatient rehab, you live at home and attend a few hours of treatment per week. This can be an excellent way to transition from an inpatient program into daily life, and allows you to work or attend school during treatment.\nIntensive Outpatient Programs (IOP). An intensive outpatient program gives you outpatient care (you live at home) that‚Äôs more focused and intensive than usual outpatient treatment. You‚Äôll attend treatment several days a week for a few hours at a time. This allows you more time to work on new habits and mindsets.\nPartial Hospitalization Programs (PHP). PHPs provide full-time treatment but you still spend evenings at home. This can give you a focused full-time therapy schedule while still allowing you to save money over traditional inpatient programs.\nOf course, the best rehab program is a finished one. Attending your program all the way through graduation is the best way to set yourself up for success, so be sure to commit to your program so you can truly break free from substance use.\nDoes MHS Indiana (Ambetter) Cover Mental Health & Co-Occurring Disorder Treatment?\nIt‚Äôs quite common for those who struggle with substance use to also have mental health concerns. In fact, 50% of those who misuse substances also have a mental health diagnosis, which is known as having a co-occurring disorder.8, second paragraph\nIf you struggle with mental health issues like post-traumatic stress disorder (PTSD), attention-deficit hyperactivity disorder (ADHD), or any other diagnosis, it‚Äôs important to treat your mental health and substance use simultaneously. Studies show that those who get integrated treatment have far better results than people who treat only one or the other.9, first paragraph Finding a treatment program that addresses co-occurring disorders is essential if you struggle with your mental health.\nThe ACA includes both mental health treatment and substance use treatment in the list of essential health benefits, so you can rest easy knowing your MHS Indiana (Ambetter) insurance plans benefits will help you pay for both.4, fifth bullet\nHow Long Does MHS Indiana (Ambetter) Cover Inpatient Alcohol and Drug Rehab programs?\nOne common question we hear is, ‚ÄúHow long will rehab be?‚Äù The answer to that question depends on your specific needs, which will be reflected in the treatment plan your doctor creates for you.\nEvery insurance plan is different, so you‚Äôll want to review your MHS Indiana (Ambetter) insurance coverage for treatment before you commit to a program. However, research shows that most people need at least 90 days to make a significant change in their substance use habits.10, fifth bullet\nTo learn more about your insurance plan‚Äôs coverage, you can call the phone number on the back of your insurance card or you can contact American Addiction Centers (AAC) by phone or online. We can review your coverage and verify your insurance in just a few minutes, and we‚Äôre available for you 24/7.\nWhat if my MHS Indiana (Ambetter) policy does not cover an Inpatient drug rehab program?\nOnce you learn more about your MHS Indiana (Ambetter) rehab coverage, you might discover that it only covers part of the cost of rehab or that the inpatient treatment center you‚Äôre interested in isn‚Äôt covered by your insurance.\nDon‚Äôt let that stop you from getting the help you need. Instead, take a look at different ways to pay for rehab. For example, you might be able to get a loan or borrow money from family and friends. Or, you can find a treatment center that offers scholarships.\nSome rehabs also offer payment plans or have a sliding scale of fees based on your income. The key is to get the treatment you need as soon as possible. Substance use has long-term legal and health consequences that you want to avoid, so get the help you need today.\nMHS Indiana (Ambetter) In Network vs. Out of Network Inpatient Drug Rehab Centers\nWhy would one rehab center be covered by your MHS Indiana (Ambetter) mental health coverage while another is not?\nThe answer is that all insurance plans have a specific provider network. These provider networks are doctors and specialists that agree to treat plan members for a lower cost.11, p. 1 What‚Äôs a Provider Network When you use in-network providers, you pay less out of pocket.11, p. 2, Why do some plans‚Ä¶\nHowever, if you use providers that aren‚Äôt part of the insurance plan‚Äôs network, you‚Äôll pay far more out-of-pocket.11, p. 2, Why do some plans‚Ä¶ In fact, some insurance plans don‚Äôt pay anything for out-of-network treatment, which means that you pay the full cost yourself.11, p. 2, Why do some plans‚Ä¶\nFortunately, there are a lot of MHS Indiana (Ambetter) rehab facilities to choose from. Focusing on these allows you to maximize your insurance coverage and keep your personal costs low.\nIf you decide you want to attend an out-of-network treatment center, you may have to get creative with how you pay for rehab, such as looking for a payment plan or loans.\nWhat Rehab Centers Take Ambetter Insurance?\nAmerican Addiction Centers (AAC) has various rehab facilities around the country that provide drug and alcohol addiction treatment. If you have a Ambetter insurance plan, the following AAC facilities accept Ambetter for drug and alcohol addiction rehab.\nGreenhouse Treatment Center: Located in Grand Prairie, Texas, Greenhouse offers individualized treatment plans and many levels of care including detox services, residential treatment, dual-diagnosis treatment, intensive outpatient services, outpatient services, and tele-health, all in a luxurious setting with high-end amenities.\nOxford Treatment Center: Located in Etta, Mississippi, Oxford offers gender-specific rehab while offering an opportunity to connect with nature and try new activities. Provided care includes detox, residential treatment, dual-diagnosis treatment, inpatient and outpatient treatment, intensive outpatient services, and tele-health, all with individualized treatment programs.\nRecovery First Treatment Center: Located in Hollywood, Florida, Recovery First treats substance use disorders by combining evidence-based therapeutic modalities with top-level care. Recovery First provides a personalized continuum of care including detox services, residential treatment dual-diagnosis treatment, intensive outpatient services, outpatient services, and telehealth.\nRiver Oaks Treatment Center: Located in Riverview, Florida, River Oaks treats substance use disorders through combining evidence-based therapies with world-class amenities. Provided care includes detox, residential treatment, behavioral disorder treatment, dual-diagnosis treatment, outpatient services, and telehealth, all with individualized treatment programs.\nThere are various treatment programs for individuals struggling with drug or alcohol addiction, so don‚Äôt give up if the first program you check out doesn‚Äôt meet your individual needs. There are rehabs near me that can provide the treatment you need. Check out the directory to find a list of facilities and programs. You can search by location and filter by Ambetter insurance.\nHow Can I Check My MHS Indiana (Ambetter) Coverage for Inpatient Drug Rehab Centers in Indiana?\nWhen you‚Äôre ready to live a life free of substance use, the right treatment program can help you be successful. You‚Äôll want to verify your insurance by calling the number on your card or contacting AAC.\nOur admissions navigators can review your insurance plan in just a few minutes and answer any questions you have about rehab. There are a variety of high-quality treatment centers to choose from, and getting the help you need is the best decision you can make for yourself.\nYou deserve to live a happier, healthier life without substance use. To take the first step, contact us today.\nSources\nSubstance Abuse and Mental Health Services Administration. (2020). Behavioral health barometer, Indiana.\nAmbetter from MHS. (2022). About our plans.\nAmbetter from MHS. (2022). What is Ambetter?\ngov. (n.d.). What Marketplace health insurance plans cover\nNational Institute on Drug Abuse. (2020, August 20). Commonly used drugs charts.\ngov (2019, October). Treatment options.\nNational Institute on Drug Abuse. (2014). Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide: Treatment settings.\nNational Institute of Mental Health. (n.d.). Substance use and co-occurring mental disorders.\nNational Institute on Drug Abuse. (2020, April). What are the treatments for comorbid substance use disorder and mental health conditions?\nNational Institute on Drug Abuse. (2018, January). Principles of effective treatment.\ngov (2021, May). What you should know about provider networks.\nHow to read your insurance card\nInsurance Provider Name\nPolicy Member's Full Name\nPolicy Membership/Subscriber ID\nCheck Your Insurance\nCheck your MHS Indiana (Ambetter) rehab coverage\nWith the form below, we will confirm what treatment services are available under your specific plan.\nCheck to see if your insurance is in-network at an American Addiction Centers location\nWe'll instantly check the coverage offered by your insurance provider.\nYou may receive treatment at one of our facilities at a reduced rate.\nWhat to expect?\n* = Required\nFind Insurance Carrier\n*\nAetna\nFirst Name\n*\nJohn\nLast Name\n*\nSmith\nEmail\n*\njsmith@mail.com\nPhone Number\n*\n(555) 555-5555\nDate of Birth\nMM/DD/YYYY\nPolicy Membership ID\nWXY1030Z0\nCheck Coverage\nDisclaimer\nThis form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.\nExpand\nTreatment Programs\nAmerican Addiction Centers' locations\nAmerican Addiction Centers (AAC) owns and operates facilities at various locations nationwide to provide you or your loved one addiction and mental health care.\nView All Facilities\nLaguna Treatment Hospital\nAliso Viejo, CA\nOxford Treatment Center\nEtta, Mississippi\nGreenhouse Treatment Center\nGrand Prairie, TX\nDesert Hope Treatment Center\nLas Vegas, NV\nRecovery First Treatment Center\nHollywood, FL\nRiver Oaks Treatment Center\nRiverview, FL\nAdCare Hospital\nWorchester, MA\nSunrise House Treatment Center\nLafayette, NJ\nGuides for other health insurance providers\nA-H\nCollapse\n1199SEIU Funds\nAPS Healthcare\nAetna Insurance\nAmbetter Insurance\nAmerican Family Insurance\nAmerigroup Insurance\nAmerihealth Insurance\nAnthem BlueCross California\nAnthem Insurance\nAssurant Health Insurance\nAvmed\nBeacon Health\nBehavioral Healthcare\nBlue Cross Blue Shield\nBlue Shield of California\nBright Health\nCigna Insurance\nCobra\nComPsych\nCommunity Health Choice\nConnectiCare\nCooks Children‚Äôs Health Plan\nCoventry\nEmblem Health\nEmpire Blue Cross Blue Shield\nExclusive Care\nFederal Blue Cross Blue Shield\nFirst Care\nFirst Health\nFlorida Blue (BCBS Florida)\nGEHA Health Plan\nGeisinger Health Plan\nGreat-West\nHCSC\nHMO\nHarvard Pilgrim\nHealth Net\nHealth Plan of Nevada\nHealthSmart\nHighmark\nHorizon BCBS\nHumana Health Insurance\nI-N\nExpand\nKaiser Permanente Insurance\nMagellan Health\nMagnacare\nMedicaid\nMedicare\nMeritain Health\nMolina Healthcare\nO-Z\nExpand\nOptum Health\nOxford Health\nPremera Blue Cross\nProvidence Health\nRocky Mountain HMO\nSeminole Tribe Health\nSierra Health\nState Farm\nTricare Insurance\nTufts Health Plan\nUMR\nUPMC Health Plan\nUnited Healthcare\nVA Community Care Network\nVeterans Choice Program\nVeterans Insurance\nZelis Insurance\nRelated Articles\nDrug & Alcohol Rehabs in Florida That Accept Sunshine Health Florida (Ambetter) Insurance\nHome State Health (Ambetter) Health Insurance Coverage for Rehab and Detox\nAmbetter South Carolina Insurance Coverage for Drug and Alcohol Addiction\nAmbetter Arkansas Insurance Coverage for Drug and Alcohol Addiction Near Me\nWellCare New Jersey (Ambetter) Covered Alcohol and Drug Rehab Centers in New Jersey\nAmbetter from Nebraska Total Care Insurance Covered Alcohol and Drug Rehab Centers Near Me\nAmbetter Buckeye Insurance for Alcohol & Drug Addiction Treatment in Ohio\nAmbetter from Meridian Covered Alcohol and Drug Rehab Centers in Michigan\nArizona Complete Health (Ambetter) Insurance Coverage For Addiction Treatment\nHealth Net California (Ambetter) Covered Alcohol and Drug Rehab Centers in California\nShow More\nGet help via SMS today.\nWe are here 24/7 for any questions you may have.\n*All fields required\nFirst Name\n*\nJohn\nLast Name\n*\nSmith\nPhone Number\n*\n(555) 555-5555\nBy submitting this form you agree to terms of use and privacy policy of the website. Message and data rates may apply. You may receive reoccurring messages. Text STOP to cancel."
    },
    {
        "id": "350021",
        "description": "Data privacy statement - Tecnamic\nDie Tecnamic GmbH (hereafter: \"we\"), as the operator of the online website, is considered to be the responsible party for the processing of the personal data of the users of the online website. You can find our contact data in the Imprint section of the online website. The contact persons for questions related to the processing of personal data are named directly in this Data Protection Statement.\nWe take the protection of your private sphere and your private data very seriously. We collect, store and use your personal data only in accordance with the content of this Data Protection Statement as well as the applicable provisions under data protection law‚Äìparticularly of the European General Data Protection Regulation (GDPR) and the national data protection guidelines.\nBy means of this Data Protection Statement, we would like to inform you about the scope and purpose of personal data processing in conjunction with usage of the online website.\nPersonal data are considered to be information regarding an identified or identifiable natural person. These data include all information regarding your identity as well as, for example, your name, your e-mail address or your postal address. However, information which is not attributable to your identity (e.g. statistical data such as the number of users of the online website) shall not be considered to be personal information.\nIn principle, you can use our online website without disclosing your identity and your personal data. We shall collect merely general information regarding your visit to our online website. However, for some of the services offered, your personal data shall be collected. In principle, these data shall then be processed by us only for the purposes of the usage of this online website‚Äìparticularly in order to supply the requested information. During the collection of personal data, only the data must compulsorily be provided which are mandatorily required. Moreover, it is possible to provide additional data whereby such data shall be provided voluntarily. We shall respectively indicate whether the fields are mandatory or optional. We shall then inform you of the concrete details in the corresponding section of this Data Protection Statement.\nAutomated decision-making upon the basis of your personal data shall not be undertaken in conjunction with the usage of our online website.\nWe shall store your data on specially-protected servers within the European Union. They shall be protected by means of technical and organisational measures against loss, destruction, access, modification or dissemination of your data by unauthorised persons. The access to your data shall be made possible only to a small number of authorised persons. They shall be responsible for the technical, commercial or editorial management of the servers. However, despite controlling measures upon a regular basis, it is not possible to completely protect against all risks.\nYour personal data shall be transmitted in encrypted fashion via the Internet. For the data transmission, we shall use SSL encryption (secure socket layer).\nIn principle, we shall use your personal information only for the rendering of the services which you have requested. Insofar as we commission external service providers in order to render the services, their access to the data shall be granted exclusively for the purpose of the rendering of services. By means of technical and organisational measures, we shall ensure the fulfilment of the data protection guidelines and shall also obligate our external service providers in this regard.\nMoreover, without your express consent, we shall not pass on the data to third parties‚Äìparticularly not for advertising purposes. A dissemination of your personal data shall be undertaken only if you yourself have approved the data dissemination or insofar as we are entitled or obliged in this regard to disseminate the data in accordance with the statutory directives and/or government and/or court decrees. In this regard, this may encompass particularly the issuance of information for the purposes of criminal investigations, warding off risks or asserting intellectual property rights.\nInsofar as we obtain consent for the processing of your personal data, Art. 6 Para. 1 lit. a) GDPR shall serve as the legal basis for the data processing.\nInsofar as your personal data are processed because this is required in order to fulfil a contractual agreement or for a quasi-contractual relationship with you, Art. 6 Para. 1 lit. b) GDPR shall serve as the legal basis for the data processing.\nInsofar as we process your personal data in order to fulfil a legal obligation, Art. 6 Para. 1 lit. c) GDPR shall serve as the legal basis for the data processing.\nMoreover, the legal basis for the data processing shall be Art. 6 Para. 1 lit. f) GDPR if the processing of your personal data shall be required in order to safeguard a rightful interest of our company or of a third party and, by so doing, your interests, fundamental rights and fundamental freedoms do not require the protection of the personal data.\nIn this Data Protection Statement, we shall always refer to which legal basis we shall use to support the processing of your personal data.\nData Deletion and Storage Timeframe\nWe shall in principle always then delete and/or block your personal data when the purpose of their storage is no longer valid. However, storage may then continue beyond this point if this is prescribed by legal directives to which we are subject, e.g. with regards to statutory retention and documentation obligations. In such a case, we shall delete and/or block your personal data after the validity of the corresponding directives ends.\nUsage of Our Online Website\nDuring each accessing of our online website, we shall‚Äìregardless of whether you have registered or not‚Äìcollect the following information about your computer: The IP address of your computer, the query from your browser as well as the time that this query was made. Moreover, the status and the transmitted data quantity for the query shall be collected. We shall also collect product and version information regarding the browser and the operating system of the computer being used. We shall also collect data regarding from which website our online website was accessed. In this context, your computer's IP address shall be stored only for the time of the usage of the online website and then deleted or anonymised by shortening it. The remaining data shall be stored for a limited timeframe.\nWe shall use these data for the operation of the online website‚Äìparticularly in order to detect and eliminate errors, in order to determine the capacity utilisation of the online website as well as in order to make adjustments or improvements. For these purposes, we also have a rightful interest in the data processing in accordance with Art. 6 Para. 1 lit. f) GDPR.\nAs is the case with many websites, cookies are used for our online website. Cookies are small text files which are stored on your computer and store specific settings and data via your browser for exchange with our online website. As a rule, a cookie contains the name of the domain from which the cookie file was sent as well as information regarding the age of the cookie and an alphanumerical identification code.\nCookies enable us to identify your computer and to immediately make any default settings available. Cookies help us to improve the online website as well as to be able to offer you a better service which is even more customised to you. Herein also lies our rightful interest in the data processing in accordance with Art. 6 Para. 1 lit. f) GDPR.\nThe cookies which we use are so-called session cookies which are automatically deleted again after the browser session ends. Upon an individual basis, cookies can also be used with a longer storage timeframe so that your default settings and preferences can still be utilised during your next visit to our online website.\nMost browsers' default settings automatically accept cookies. However, you can nonetheless deactivate the storage of cookies or adjust the settings on your browser in such a manner that it will notify you as soon as cookies are sent. Moreover, it is also possible to manually delete cookies that have already been stored via the settings on your browser. However, please keep in mind that you may possibly be able to use our online website only in a restricted manner or not be able to use it at all if you reject the storage of cookies or delete the required cookies.\nWe shall use Google Analytics for statistical analyses. Google Analytics is a web analysis service from Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94034, USA (\"Google\"). Google Analytics uses so-called \"cookies\"‚Äìtext files which are stored on your computer and enable an analysis of your usage of the website. As a rule, the information generated by the cookies regarding your usage of this website shall be transmitted to a Google server in the USA and stored there. In the event of the activation of IP anonymisation on this website, your IP address shall nonetheless be shortened beforehand by Google within the member countries of the European Union or in other contracting countries to the European Economic Area Convention. Only in exceptional cases shall the entire IP address be transmitted to a Google server in the USA and shortened there. By mandate issued by this website's operator, Google shall use this information in order to analyse your usage of the website, in order to draft reports regarding the website activities and in order to render additional services associated with the usage of the website and the Internet to the website's operator. The IP address transmitted by your browser during Google Analytics shall not be commingled with other data by Google. You can prevent the storage of cookies by correspondingly adjusting the settings on your browser software; however, we wish to point out that, in this case, you may not be able to comprehensively use all functions of this website. Moreover, you can prevent the collection of the data (including your IP address), which has been generated by the cookie and refers to your usage of the website, from being sent to Google as well as the processing of these data by Google by downloading and installing the browser plug-in that is available by clicking on the following link tools.google.com/dlpage/gaoptout.\nYou can find additional information in this regard at tools.google.com/dlpage/gaoptout and/or www.google.com/intl/de/analytics/privacyoverview.html (general information regarding Google Analytics and data protection). We wish to point out to you that, on our Internet site, Google Analytics has been expanded by the code \" anonymizeIp();\" in order to anonymise the IP addresses whereby the last octet has been deleted.\nWe are of the belief that, owing to the protective measures undertaken (anonymisation and right of objection), the data processing in order to optimise our online website must be regarded as being a rightful interest in the data processing in accordance with Art. 6 Para. 1 lit. f) GDPR.\nYou can register in order to use our online website. In order to register, you must disclose the data requested during the registration process, e.g. name, address and e-mail address. In addition, we shall collect the date and time of day of the registration and the IP address. During the registration process, we shall obtain your consent for the usage of the data. By so doing, you will obtain the benefit of not having to re-enter these data during each usage and/or for each order.\nFor consent, the legal basis for the processing of the data for the registration shall be Art. 6 Para. 1 lit. a) GDPR. Insofar as you register with us in order to fulfil or negotiate a contractual agreement, the legal basis for the processing of the data shall also be Art. 6 Para. 1 lit. b) GDPR.\nThe information requested during the registration process which is marked as being a mandatory field shall be required in order to fulfil or negotiate a contractual agreement with us for certain services.\nDuring the registration, a customer account shall be created for you. We shall store the data in the customer account as long as an active customer relationship exists. If no more activity has been detected for a timeframe of three years, the status of the customer relationship shall be changed to inactive. You may, at any time, demand the deletion of your customer account.\nWe shall use your personal information for orders only within our company and our affiliated companies as well as within the company commissioned to process the orders.\nStorage and Data Dissemination for Orders\nFor processing orders, we cooperate with various companies who are responsible for the processing of payments and logistics. We ensure in this regard that our partners also follow the data protection guidelines. Thus, we disseminate your address data (name and postal address) to the respective transport company which delivers the ordered products to you. The legal basis for this shall be Art. 6 Para. 1 lit. b) GDPR. The processing of your personal data shall be required in order to fulfil the contractual agreement with you.\nThe data shall be stored by us as long as they are required in order to fulfil the contractual agreement. Moreover, we shall store these data in order to fulfil our post-contractual obligations and, based upon the retention timeframes prescribed by commercial law and tax law, for the statutorily-prescribed timeframe. As a rule, this retention timeframe shall be 10 years from the end of the respective calendar year.\nPayment Processing for Orders, PayPal, Sofort√ºberweisung [Instant Transfer]\nDepending on the payment method selected, as required, the payment processing shall be undertaken for orders by commissioning a service provider.\nFor a credit card payment, your required data such as name, address as well as the purchasing data shall be forwarded to the respective credit card company.\nFor a PayPal payment, you shall be guided via a link to PayPal's Internet site. In so doing, your personal data shall be processed. These personal data shall be your name, your postal address, your e-mail address, (where applicable) your telephone number as well as your bank account or your credit card data. In this regard, please review the General Business Terms and Conditions, Usage Terms and Conditions and Data Protection Guidelines of PayPal (Europe) S.√† r.l. et Cie, S.C.A., 22-24 Boulevard Royal, L-2449 Luxembourg on the Internet site www.paypal.com.\nFor a payment made via Sofort√ºberweisung, you shall be guided via a link to the Internet site of Sofort√ºberweisung, a service of Sofort GmbH which is part of Klarna Bank AB (publ), Sveav√§gen 46111 34 Stockholm, Sweden. In this regard, your personal data shall be processed. These personal data shall be your name, your postal address, your e-mail address, (where applicable) your telephone number as well as your bank account or your credit card data. In this regard, please review the General Business Terms and Conditions, Usage Terms and Conditions and Data Protection Guidelines of Klarna at www.klarna.com.\nThe legal basis for the payment processing shall be Art. 6 Para. 1 lit. b) GDPR. The processing of your personal data shall be required in order to fulfil the contractual agreement with you whereby you may freely choose the payment method.\nWe shall store the data as long as they are required in order to fulfil the contractual agreement. Moreover, we shall store these data in order to fulfil our post-contractual obligations and, based upon the retention timeframes prescribed by commercial law and tax law, for the statutorily-prescribed timeframe. As a rule, this retention timeframe shall be 10 years from the end of the respective calendar year.\nDepending on the payment method selected, a credit check may be required. In this case, in the event that we have obtained your consent to conduct the credit check, we shall commission external service providers to whom we shall transmit your data (name, address, birthdate, order value). We shall transmit the data to the Federation of Credit Reform Associations e.V., Hellersbergstra√üe 12, D-41460 Neuss.\nThe legal basis for the credit check shall be Art. 6 Para. 1 lit. a) GDPR. If you do not wish to issue your consent for the credit check, as required, you must select another payment method.\nDuring the credit check, an estimate shall be obtained regarding how high the default probability is for our payment claim from the order. In this regard, we shall receive from our service provider exclusively a probability value (score value), but no more extensive details. Upon the basis of this value, we shall then assess whether the requested payment method can be offered. After completing the assessment, we shall delete the score value and not store it with the order data. Thus, it is also not possible for us to subsequently assess why, for example, a certain payment method was not possible.\nYou are entitled to extensive rights with regards to the processing of your personal data. First of all, you shall have a comprehensive right to information and may, as required, demand the correction and/or deletion and/or blocking of your personal data. You may also demand a restriction of the processing and also have a right of objection. With regards to the personal data which you have provided to us, you shall also have a right to data portability.\nIf you would like to assert one of your rights and/or would like to receive detailed information in this regard, please contact our Customer Service Division. Alternatively, you can also contact our Data Protection Officer.\nRevocation of the Consent and Right of Objection\nConsent granted by you may be freely revoked at any time with effectiveness for the future. By revoking the consent, the legality of the processing undertaken based upon the consent until such consent is revoked shall not be affected. The contact persons in this regard shall likewise be our Customer Service Division and our Data Protection Officer.\nInsofar as the processing of your personal data is not based upon consent, but rather upon another legal basis, you can object to this data processing. Your objection shall result in an examination and, as required, the discontinuation of the data processing. You shall be notified of the results of the examination and, insofar as the data processing is supposed to be nonetheless continued, you shall receive detailed information from us regarding why the data processing is permissible.\nFor questions related to our handling of personal data or additional information regarding data protection law themes, our internal Data Protection Coordinator would be glad to assist you:\nE-Mail: datenschutz spam@spam.de optibelt.com\nIf you are of the belief that our processing of your personal data does not comply with this Data Protection Statement or the applicable data protection guidelines, you shall be entitled to submit a complaint to a government supervisory agency. You may also submit a complaint to our Data Protection Officer. The Data Protection Officer shall then review the matter and notify you of the results of the examination.\nOur online website can contain links to other websites. As a rule, these links shall be labelled as such. We have no control over to what extent the valid data protection guidelines are followed on the linked websites. Thus, we recommend that you also review the respective Data Protection Statements on the other websites.\nChanges in This Data Protection Statement\nThe version of this Data Protection Statement shall be identified by the date (below) when it was created. We reserve the right to, at any time, make changes to this Data Protection Statement with effectiveness for the future. We shall make changes to this Data Protection Statement particularly in the event of technical adaptations of the online website or changes to the data protection law guidelines. The respectively current version of the Data Protection Statement shall always be directly accessible via the online website. We recommend that you review the changes to this Data Protection Statement upon a regular basis.\nClarivate has released the 2022 update to its annual Journal Citation Reports (JCR). The annual JCR release helps the research community to evaluate the world‚Äôs high-quality academic journals using a range of indicators, descriptive data and visualisations. The reports are used by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community.‚ÄØ\nThe JCR is based on 2021 data compiled from the Web of Science Core Collection, a collection of journals, books and conference proceedings in the world's largest publisher-neutral global citation database. Publications are evaluated by‚ÄØ a global team of ‚ÄØin-house editors at Clarivate. The data ‚ÄØfrom selected content are ‚ÄØthen curated to ensure ‚ÄØaccuracy in the JCR metrics, together with a wide body of descriptive data. These insights enable researchers, publishers, editors, librarians and funders to explore the key drivers of a journal's value for diverse audiences.\nThe report shows that Covid-19 continues to influence every aspect of scholarly publishing, just as it has affected every aspect of society‚ÄØ.\nNandita Quaderi, editor-in-chief and vice president editorial, Web of Science at Clarivate, said: 'Through the carefully selected and curated data within the Journal Citation Reports, we can fully appreciate and understand the enormous impact of the academic community‚Äôs rapid response to the Covid-19 pandemic.\n'As researchers explored the origins, spread and ramifications of the virus, working at speed to create new therapies and vaccines, we see this reflected in the trusted insights contained in the annual JCR. The effects of this pandemic will continue to be seen in the literature and citation impact for decades, particularly under the lens of the UN‚Äôs Sustainable Development Goal 3 on Health and Wellbeing. We are proud to support the research community and the UN SDGs with expertly curated data that informs decisions and helps them accelerate the pace of innovation.'\nThis year‚Äôs release sees continued notable increases in citation impact for journals in the fields of general medicine, critical care, public health, infectious diseases, immunology and basic biomedical sciences:\nThis year The Lancet's Journal Impact Factor (JIF) of 202.731 has moved it to the #1 position in the general & internal medicine category, overtaking the New England Journal of Medicine, which has been the top-ranked title in that category since the first release of the JCR 45 years ago. Of the 10 articles with the highest citation count in 2021, three appeared in The Lancet. All three are directly related to the characterisation and treatment of Covid-19;\nThis year Nature earns the distinction of being the first ever journal to accumulate more than one million total citations in one year. Nature published 16 items with more than 500 JIF citations ‚Äì of which 12 items were Covid-19 related; and\nSeven journals had JIFs of more than 100 for the first time, all of which published high quantities of Covid-19 related research. These are the Journal of the American Medical Association, The Lancet, Lancet Respiratory Medicine, Nature Reviews Drug Discovery, Nature Reviews Immunology, Nature Reviews Molecular Cell Biology and the New England Journal of Medicine.\nUpholding research integrity and a new type of citation distortion\nTo support objectivity in journal selection and the integrity of the reports, Clarivate has suppressed three journals from the JCR (without presumption or accusation of wrong doing), representing 0.01% of the journals listed. Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking. The methodology and parameters for the effect of journal self-citation on JCR metrics were updated in 2020 to better account for discipline norms. The suppression of a journal from the JCR does not equate to a de-listing from the Web of Science Core Collection.‚ÄØ‚ÄØ\nIn addition, this year the editorial integrity team at Clarivate identified a new type of anomalous citation behaviour: self stacking. This is where the journal contains one or more documents with citations that are highly concentrated to the JIF numerator of the title itself.‚ÄØ This is the first year the company have formally defined the criteria for self-stacking suppression, and as such made the decision to issue a warning to six journals rather than suppress the journal‚Äôs JIF. Going forward, continued journal self-stacking will result in suppression of JIF, Clarivate says.‚ÄØ‚ÄØ\nThe Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries. This includes:\n12,800 science journals;\n6,600 social science journals;\n3,000 arts and humanities journals;\nAlmost 13,000 journals have at least one gold open access publication;\nMore than 5,300 journals publish all of their content via open access; and\n192 journals received a Journal Impact Factor for the first time.\nEach journal profile in the JCR provides a rich array of journal intelligence metrics and allows users to filter by category and rank. These include: ‚ÄØ\nThe Journal Citation Indicator, which represents the average category-normalised citation impact for papers published in the prior three-year period. All journals in the JCR are eligible to receive this metric as of 2021;‚ÄØ‚ÄØ\nThe Immediacy Index, which measures how frequently the journal‚Äôs content is cited within the same year as publication;‚ÄØ‚ÄØ\nThe journal‚Äôs rank in category, determined by Journal Impact Factor, expressed as a percentile;‚ÄØ‚ÄØ\nCited half-life, which is the median age, in years, of items in the journal that were cited during the JCR year; and‚ÄØ\nThe Journal Impact Factor, which is given to journals in SCIE and SSCI, and which scales the citations received to recent content by a measure of the size of the journal‚Äôs scholarly output.\nIn addition the Journal Citation Reports include descriptive data such as open access content, top contributing institutions and regions.\nVisit the ‚ÄØJournal Citation Reports ‚ÄØwebsite ‚ÄØto explore all available data, metrics and analysis. You can find more information including the Clarivate suppression policy in the Journal Citation Reports Reference Guide.\nBACKGROUND READING: Nandita Quaderi,editor-in-chief and vice president of Web of Science Editorial, explains how Covid-19 continues to affect the citation network, and introduces a new kind of citation distortion\nJournal Citation Reports website\nLibrary news\nPublishing news\nIndustry trends\nClarivate\nWeb of Science\nJournals\nCitation\nCovid-19\nLatest issue\nResearch Information Autumn 2022\nThe critical range of publishing platforms\nPublishing platforms are digital solutions that are principally designed to help publishers and authors to evaluate and disseminate content\nThe possibilities of open science\nResearch Information spoke to four experts in the field about the ongoing move to open science, and the challenges that have emerged in an increasingly complex open-science ecosystem\nBridging the gap with video\nSi√¢n Harris considers the use of video in scholarly communications today and the challenges and opportunities for the future\nSupport for early-career researchers\nSix university presses join forces to support early-career researchers from 2022 to 2025 with the OpenUP initiative\n‚ÄòWe‚Äôre prioritising the in-person event to the highest degree‚Äô\nLeah Hinds, executive director, Charleston Hub, gives us the details of the new and improved conference taking place in November, including session and speaker information, as well as insights into what‚Äôs new this year\nPhoto credit: Olwenn N√≠ Dhubhghaill\nDebunking digital myths\nSabine Lou√´t uncovers three myths about digital research dissemination and shares lessons she has learned\nFive industry leaders on the future of publishing platforms\nAs the move towards open science and FAIR data progresses, platform providers are facing new challenges. Five industry figures tell Tim Gillett what comes next\nMaryam Bazargan\nInterview\n'Fast publication can save lives!'\nRiver Valley Technologies director Maryam Bazargan describes her early career, 10 years of working with her brother Kaveh, and her love of languages and cultures\nSKF bearings heat treatment coating technology-The latest News,Technology,Industry,Environment,Low Carbon,Resource,Innovations\nHome > Tech > SKF bearings heat treatment coating technology\nThere are two methods for SKF bearings heat treatment coating technology.\nOne method is to use PVD to coat the surface of bearings rings and rolling elements with extremely high hardness diamond ring carbon (DLC). The surface hardness is 40~80% higher than that of hardened bearings steel. The friction coefficient is similar to PTFE or MoS2. Has self-lubricating properties. , It has good bonding with the substrate and does not peel off. The life and wear resistance of SKF bearings are greatly improved, and they can still work normally under the condition of cutting oil. They are called \"wear-free bearings\";\nThe second is to use PSC to spray a layer of aluminum oxide with a thickness of 100Œºm on the outer circumference of the SKF bearing outer ring, so that the insulation capacity of the bearing can reach more than 1000V, and the bearing has a higher insulation capacity by increasing the thickness of the aluminum oxide . The coated alumina is firmly bonded to the substrate and can also improve the corrosion resistance of SKF bearings. Electroplated bearings can be installed like ordinary bearings.\nLow temperature ion vulcanization is a surface modification technology that emerged in the late 1980s.\nThe basic principle is similar to ion nitriding. Under a certain degree of vacuum, high-voltage direct current ionizes sulfur-containing gas. The generated sulfide ions bombard the surface of the workpiece and react with the iron on the surface of the workpiece to form a sulfide with a thickness of about 10 Œºm, which is mainly composed of FeS. Physical layer. Sulfide is a good solid lubricant that can effectively reduce the friction coefficient of the steel contact surface, and with the increase of the load, the friction coefficient is further reduced, so it can greatly improve the wear resistance of the bearing under heavy load and prolong its use The number of bearing seats of SKF bearings can be increased by about 3 times.\nThe quality of heat treatment is directly related to the quality of subsequent treatment, which will ultimately affect the performance and life of the parts. At the same time, heat treatment is also a major energy consumer and major polluter in the machinery industry.\nIn recent years, with the progress of science and technology and its application in heat treatment, the development of heat treatment technology is mainly reflected in the following aspects:\nWastewater, waste gas, waste salt, dust, noise and electromagnetic radiation produced by heat treatment will pollute the environment. In order to solve the environmental pollution problem of heat treatment, the implementation of clean heat treatment (or green environment heat treatment) is one of the development directions of heat treatment technology in developed countries. In order to reduce the emissions of SO 2, CO, CO 2, dust and coal slag, the use of coal as fuel has been basically eliminated, and the use of heavy oil has become less and less. Most light oil is used. Natural gas is still the most ideal fuel. The waste heat utilization rate of the burner has reached a very high level. The optimization of the burner structure and the strict control of the air-fuel ratio ensure that NOx and CO are minimized under the premise of reasonable combustion. Gas carburizing and carbonitriding technology is adopted, and vacuum heat treatment technology is used to replace salt bath treatment to reduce the pollution of wastewater and CN toxic substances to water sources; water-soluble synthetic quenching oil is used to replace part of quenching oil, and biodegradable vegetable oil is used to replace part of it Mineral oil to reduce oil pollution.\nPrecision heat treatment has two meanings: On the one hand, it uses physical metallurgical knowledge and advanced computer simulation and testing technology to optimize process parameters according to the requirements of parts, materials and structure dimensions to achieve the required performance or maximize the use of materials. On the one hand, it is sufficient to ensure the stability of the optimization process, achieve small (or zero) product quality dispersion and zero heat treatment distortion.\nScientific production and energy management are the most potential factors for the effective use of energy. It is the choice of scientific management to establish a professional heat treatment plant to ensure full production and give full play to the equipment capabilities. In terms of heat treatment energy structure, primary energy is preferable. Make full use of waste heat and waste heat; low energy consumption, short cycle technology is used to replace long cycle, high energy consumption technology.\n4. Less non-oxidizing heat treatment\nFrom heating with a protective atmosphere instead of heating with an oxidizing atmosphere to heating with a controlled atmosphere that precisely controls the carbon and nitrogen potentials, the performance of the parts after heat treatment is improved, the heat treatment defects such as decarburization and cracking are greatly reduced, and the heat treatment The amount of finish processing improves the material utilization rate and processing efficiency. Vacuum heating gas quenching, vacuum or low-pressure carburizing, nitriding, nitrocarburizing and boronizing can significantly improve quality, reduce deformation and extend service life.\nThe heat treatment quality control of bearing parts is the most stringent in the entire machinery industry. SKF bearing heat treatment has made considerable progress in the past 20 years, mainly in the following aspects: basic theoretical research on heat treatment; research on heat treatment technology and application technology; development of new heat treatment equipment and related technologies.\nLogic Behind Why Marijuana is known as a different Amount of Remedies8555 ‚Äì Viet My Visa\nLogic Behind Why Marijuana is known as a different Amount of Remedies8555\nThe medical experts make it obvious that cannabis can be used probably the most and trusted method of dealing with HIV, Tools, Glaucoma and Parkinson's disease people. Person who is suffering from several life threatening illnesses have the only expect of receiving speedy and profitable remedy as opposed to the classic and regular method of getting therapy. The medical expert and scientific study has placed lot of stress around the status authorities to legalize medical weed. Immediately after studying all of the point federal government has legalized this cannabis for the treatment inside the status using the state that she or he must have the health care weed permit for the utilization of this botanical herb. At first of legalization, there were clearly a lot of controversies about the health-related cannabis but the truth is that it must be just one greatest method of managing clients. Consequently, if you are searching for the health cannabis dispensary then you definately must buy a cannabis therapy unit card granted on your part community well being office. Here are a few crucial ideas and information with regards to the cannabis treatment method that will help in receiving medical care greeting card.\nFor anybody who end up enthusiastic about the healthcare industry but do not have the confident.\nThe medical experts are making it crystal clear that weed can be used as just about the most.\nPrior to signing up for any system or study course for a health helper, allow.\nCommonly, this has been recognized there are many individuals who don't stick to the.\nFor everyone who end up thinking about the health care field but do not have the comfortable as a doctor or even a doctor, but are eager to support other individuals and do not get the anxiety for the view of blood flow, then a health asst . might be the vocation which is well suited for you.\nHealth care field but do not\nPrior to signing up for your plan or study course to get a medical assistant, let us visit a few of the essential advantages as being a medical associate.\nThe main and most crucial thing in obtaining medical therapy cards is to locate a genuine healthcare professional in your state having the permit of delivering MMJ Unit card. As soon as you use the appointment using these medical professionals, they can do an examination to actually really need treatment. After getting the health care exam report and dependant on the fitness of individual they can examine that medical attention is necessary or otherwise. When the skilled is happy about the fitness of affected individual and health record they will provide you suggestion for your medical therapy inside your particular express. After having the advice for medical therapy then you must view your health and wellbeing division where one can make application for medical marijuana permit on the health care form in addition to the fretting hand created prescribed. Following verifying every one of your documents they may problem the unit card which you can use for your healthcare cannabis treatment method as part of your particular condition.\nThe fitness of affected individual\nNormally, it has been observed that there are many people who don't keep to the regulations and rules produced by government entities and puts on their own in danger. To acheive this procedure cards they speak to the card service provider corporations thru phone and will get capture easily on the companies who give fake unit card. Thus, it usually is easier to ask about the recommendation and recognition about the unit card provider organizations from your location applying for the advice. If anyone fails by doing this sometimes by deliberately or for some other good reasons they might be penalized or sometime receives jailed. While, strategy for getting healthcare weed permit is agony staking procedure but to be able to avoid the future difficulties you need to stick to the technique of finding this treatment unit card. This would definitely help out with the utilization of marijuana together with getting a powerful health cannabis treatment method.\nCompare DNA Testing Kits | Find the right DNA testing kit for you.\nWhat DNA test are you looking for?\nSome people want to connect and discover relatives, or past relatives connected to them. I wanted to know more about my genetic make-up. My friends were interested in learning where their \"Motherland\" originated from. There are many DNA Testing Kits so which one is right for you?\nCompare the different DNA Testing Kits below. Some DNA companies have a genetic pool of data they are comparing it too from ancient archives positioning your origins on Earth. Others might be analyzing your DNA in comparison to the population and who you match up with. Each of them have their unique reason for taking the test. Compare and understand which test is best for you.\nCompare the best DNA Testing Kits on the market today!\nPrice $99 $99-$199 $199 $149 $159\nTest Type Saliva Saliva Cheek Swab Saliva Mouth Swab\nResults Returned 6-8 Weeks 6-8 Weeks 3-4 Weeks 6-12 Weeks 10-12 Weeks\nDatabase Size Claims 4 Million Tested 2+ Million Tested 800,000 Markers 800,000 Tested unknown\nGPS Origins‚Ñ¢ is a revolutionary DNA test for ancestry that takes you deep into your family history. Most ancestry tests provide a report of your \"ethnicity\" and locate parts of your DNA in broad continental sweeps, but nothing specific, not even to the country level. GPS Origins‚Ñ¢ combines the latest genetic research with a new ancestral tracking technique to pinpoint more precisely where your DNA began.\nDepression is a mental illness disorder that affects millions of people each year. According to a major study on depression in 2013, it is estimated that 1 in 10 people over the age of 18 have a form of depression, totaling over 15 million people in the U.S. It is estimated that 17% of the population will experience a major depressive episode during the course of their life. Put in perspective, that is close to 1 and 5 people will experience a depressive episode during their life.\nThere are three common types of depression including major depression, persistent depressive disorder (PDD), and bipolar disorder. The effects of depression vary person-to-person and disorder-to-disorder. It is important to understand the difference between the different types of depression in order to appropriately treat the particular disorder.\nMajor depressive is classified as being sad and unhappy for two weeks or longer and feelings of hopeless, helpless, and worthless. In addition to an extended period of sadness, a two-week people experiencing depression also have a hard time finding enjoyment in things that once brought them joy and happiness in everyday life. Differentiating between short-lived moments of sadness and depression can be challenging since everyone experiences hard times throughout their lives. Speaking with a medical professional can be helpful for many people to determine whether they are depressed or they are going through a temporary hard time.\nPersistent Depressive Disorder (PDD) is a form of depression that last for at least 2 years. In children and adolescents, one year or longer of depressive symptoms can be diagnosed as Persistent Depressive Disorder. PDD is usually not as severe than major depression, but the symptoms are very similar to major depression.\nBipolar disorder, also known as manic-depressive illness, is a form of depression and it is classified as experiencing severe mood swings. A person who is diagnosed with bipolar disorder usually is extremely happy one day and then shows symptoms of depression such as severe sadness the next day. People with Bipolar disorder usually have many more lows than highs. While research continues on bipolar disorder, there continues to be no one factor that leads to the mental illness.\nWhile there are many resemblances among people affected by depression, there are some notable differences between men and women when it comes to depression. Female specific depression conditions include premenstrual problems, pregnancy and infertility, postpartum depression, and menopause.\nTo complicate diagnoses, women often experience what is called atypical depression. This means that instead of eating less, women eat more, and instead sleeping less, women sleep more.\nMen are usually less willing to seek help for depression or admitting to being depressed. If a man seeks help for depression, it can be seen as a weakness leading them to seek help less than women. When evaluating symptoms of depression in men, it is important to know that not all signs and symptoms are the same as common depression symptoms. For instance, instead of feeling sad for an extended period of time, men often get angry and irritable for an extended duration. Instead of using friends and food for support, men often turn to alcohol, TV, and sports to self medicate.\nWhen adults move into their golden years, there are many changes older adults and seniors experience in which they are not prepared for. Through these changes, it‚Äôs not uncommon for a senior to experience a major depressive episode. Common changes among older adults that can lead to depression include medical problems, retirement, loss of loved ones and friends, and isolation. Some of the standard signs and symptoms of depression in seniors include; social withdrawal, sadness, fatigue, weight loss or loss of appetite, loss of self worth, sleep issues, and suicidal thoughts or attempts. Often time‚Äôs, seniors are more likely to get angry versus sad as they go through depression.\nDuring the teenage years, there are a dozens, if not hundreds of changes that teens must cope with and adapt to. These changes can include; puberty, social pressures, and trying to find out who they are and where they fit into society. When looking at signs of depression in teens and adolescents, it‚Äôs important to understand they also have a unique set of signs and symptoms compared to adults.\nWhile sadness is common among many adults who are depressed, teens are more likely to show anger, aggression, and hostility. Teens who are depressed sometimes deal with these pressures by using alcohol and drugs, running away, participating in reckless behavior, and sometimes can resort to violence.\nThe causes of depression are not fully understood yet in the medical field, but it‚Äôs generally a combination of environmental, biological, genetic, and psychological factors. While there may one event that triggers a depressive episode, there are usually a number of underlying factors that need to be addressed as well.\nMajor depressive episodes can be caused by situational events such as a loss of a loved one or friend, relationship problems, divorce, loss of a job, financial trouble, personal accident or trauma, social pressures, and other instances that can affect a person‚Äôs overall well being.\nWhile depressive condition is usually genetic, it can also happen to those who have no family history of depression.\nAfter being diagnosed with depression, a combination of psychological sessions / treatments and medication is common when treating people for depression. Unlike illnesses that can be treated with prescribed medication or surgery, changes in choices that led to the depressive episode and therapy are both instrumental in treatment and recovery.\nAt Peak Behavioral Health Services in El Paso, TX, patients go through a free evaluation and if a form of depression is diagnosed, we then work with the patient and involved parties to come up with a personalized treatment plan for recovery.\nCombined with the PSL PSL 611-15-1 bearing in Tokelau Is. , PSL PSL 611-15-1 bearing in Tokelau Is. has the most complete product outline in rolling bearing industry .PSL PSL 611-15-1 bearing in Tokelau Is. provide customers with a series of comprehensive and perfect service and technical support. The main application areas of PSL PSL 611-15-1 bearing in Tokelau Is.: aerospace engineering, metal cutting machine tools, steel processing equipment,paper making machinery, cement machinery, engineering machinery and mechanical vibration, environmental protection equipment, packaging machinery and so on.The main types of PSL PSL 611-15-1 bearing in Tokelau Is. : deep groove ball bearings, angular contact ball bearings, cylindrical roller bearings, thrust ball bearings, thrust roller bearings, joint bearings, etc..\"\nPSL as ‚Äì Your specialist for rolling bearings and slewing rings Quick Contact 421424371 460 PSL as PSL has been a producer and bearing rollers PSL\nAlfred was Goat's grampa who died in the strip. He later appears when a swami is contacting the dead.\nDr. Praveena Gangadharan\npraveenag@iitpkd.ac.in\nhttp://www.praveena.in\nPraveena_CV.pdf\n2018- Present, Assistant Professor, IIT Palakkad\n2017-18, Assistant Professor, A. P. J. Abdul Kalam Technical University, Kerala, India\n2014-17, Women Scientist (Sponsored by Department of Science and Technology), Indian Institute of Technology Madras, India\n2008-12, Assistant Professor, M. G. University, Kerala, India\nPh.D., Indian Institute of Technology, Madras, India, in the year 2017\nM-Tech in Environmental Engineering, College of Engineering, Trivandrum, Kerala University, Kerala, India, in the year 2008\nB-Tech in Civil Engineering, College of Engineering, Trivandrum, Kerala University, Kerala, India, in the year 2006\nBioelectrochemical systems for wastewater treatment; Desalination; Defluoridation; Nutrient Recovery from urine; Metal reduction and recovery.\nCE4502: Hazardous Waste Management\nID1010 : Ecology and Environment\nCE3025: Environmental Engineering\nCE3080: Hydraulic and Environmental Engineering Laboratory\nCE3030: Environmental Engineering\nReiva Sibi (Ph.D. Scholar)\nSabarija M (Ph.D. Scholar)\nDr. Anitha V (Research Assistant)\nMetal reduction/recovery\nElectrochemical water/waste treatment\n1. Gangadharan, P., & Nambi, I. M. Feasibility Study of Disposed LCD Monitor and Carbon Cloth Electrodes for Synchronized Removal/Recovery of Cr 6+ by Microbial Fuel Cells. International Journal of Environmental Science and Development, 8(8), 557-560\n2. Gangadharan, P., Nambi, I. M., Senthilnathan, J. & Pavithra V.M. Heterocyclic aminopyrazine-reduced graphene oxide coated carbon cloth electrode as an active bio-electrocatalyst for extracellular electron transfer in microbial fuel cells. RSC Adv., 6, 68827-68834, Impact Factor: 3.3\n3. Gangadharan, P., Nambi, I. M., & Senthilnathan, J. Liquid crystal polaroid glass electrode from e-waste for synchronized removal/recovery of Cr+ 6 from wastewater by microbial fuel cell. Bioresource technology, 195, 96-101, Impact factor: 6.102\n4. Gangadharan, P., & Nambi, I. M. Hexavalent chromium reduction and energy recovery by using dual-chambered microbial fuel cell. Water Science and Technology, 71(3), 353-358, Impact factor: 1.212\nEarly career research award from SERB-DST.\nBest Poster Award, for the paper titled \"Efficiency in Chromium removal from metal plating industry effluent by Electrodialysis\" at the International Conference on Desalination (InDACON-2018), held at NIT, Tiruchirappalli, Tamilnadu, India during 20-21 April 2018\nMagudam Award from News 18 Channel , Tamil Nadu, Awarded by the Honorable Vice President of India Mr. Venkaiah Naidu in the year 2017 for the innovation of generating electricity from E-Wastes\nBhagyalakshmi and Krishna Ayengar Award, Received from Dr. Bhaskar Ramamurthi (Director of IIT M) and Mr. Nandan Nilekani, Co‚Äìfounder of Infosys and former chairman of UIAD during the 54th convocation held on at IIT Madras for the best Ph.D. project under the category of pollution in the year 2017\nFinalist of Carbon Zero Challenge, organized by the IIT Madras and IWMA with support from U.S. Consulate General, Chennai for the Incubation of Microbial Fuel Cell Technology in the year 2017\nBest Paper Award in the ICESD-2017 conference held at Frankfurt University of Applied Science, Frankfurt, Germany\nGandhian Young Technological Innovation Award in the year 2015, Received from Dr. R.A. Mashelkar (Chairperson, NIF) during the festival of innovations hosted by the Rashtrapati Bhavan, New Delhi for inventing E-Waste as electrode in Microbial Fuel Cell for the removal/recovery of wastewater along with energy production\nBest Poster Award in the AP-ISMET Meeting at National University of Singapore, Singapore, in the year 2014\nWomen Scientist Scheme -A (WoSA) from the Department of Science and Technology, Government of India, for developing Microbial Fuel Cell technology for the removal/recovery of wastewater along with energy production in the year 2014\nEditorial member, International Journal of Environmental Science Studies\nMember, International Society for Microbial Electrochemistry and Technology\nTitle: Integrating wastewater treatment to groundwater softening and defluoridation using microbial desalination cell; Role : PI; Funding Agency: SERB, India; Duration: 2019-2022; Total amount = 35.2 lakhs.\nTitle: Energy positive microbial osmotic-electro desalination cell for wastewater treatment and high-quality water recovery; Role : PI; Funding Agency: SERB, India; Duration: 2019-2022; Total amount = 39.95 lakhs.\nGangadharan, P., & Nambi, I. M. 2014-2017. Wastewater treatment coupled with resource recovery and energy production using microbial fuel cell. DST Women Scientist Award fellowship (WoS A), (Amount: Rs. 20.95 lakh).\nTitle: CLEANEXT-Energy positive treatment technology for the Removal/Recovery of hexavalent chromium; Role: Mentor; Funding Agency: Carbon Zero Challenge, IIT Madras and IWMA with support from U.S. Consulate General; Duration: 2017-2018; Total amount = 5 lakhs.\nSpeaker to the women's Conclave on 8th March 2019 organized by DST ‚ÄìJNU, Delhi. (Title of the talk: My trust with destiny in research)\nResource person to FDP on Recent Advances in Fuel Cells, funded by APJ Abdul Kalam University from 8th to 12th July 2019 in SJCET, Palai.(Title of the talk: Microbial fuel cells-A sustainable approach to harvest renewable energy from waste)\nExpert Speaker to E-Waste World Conference & Expo 2019 from 14-15 November 2019 at the Kap Europa, Frankfurt Messe, Germany. (Title of the talk: Wastewater treatment using E-Waste\nDistinguished Speaker to International Conference on Advanced Nanomaterials during December 12-13, 2019 at Chettinad College of Engineering and Technology, Karur, Tamil Nadu, INDIA. (Title of the talk: Wastewater Treatment Coupled with Resource Recovery using Microbial Fuel Cell)\nAttended a workshop, titled \"Upscaling and field-scale application of bio-electrochemical systems for wastewater treatment and bioenergy recovery\" on February 26-27, 2020 at Indian Institute of Technology Kharagpur.\nAnxiety Specialist - Bethesda, MD & Baileys, VA: Washington Center for Women's and Children's Wellness (WCWCW): Child, Adolescent, Women‚Äôs & Reproductive Psychiatry\nCall Us Request Appointment Patient Portal\nHome\nOur Practice\nOur Space\nFrequently Asked Questions\nCareers\nResources\nClinicians\nTelemedicine\nOur Specialties\nGeneral\nMental Health\nPsychiatry\nChild and Adolescent Psychiatry\nMedication Management\nPsychotherapy\nWomen's Psychiatry\nMood Disorders\nAnxiety Disorders\nLife Transitions\nAdult ADHD\nReproductive Psychiatry\nPremenstrual Dysphoric Disorder (PMDD)\nPre-pregnancy Consultation\nMood and Anxiety Disorders in Pregnancy\nMedication In Pregnancy\nPostpartum Depression\nPostpartum Psychosis\nInfertility\nPregnancy Loss\nPerimenopause\nMenopause\nChild and Adolescent Psychiatry\nADHD\nChild & Adolescent Anxiety Disorders\nOCD\nDepression\nBehavioral Issues\nPsychotherapy\nSubscribe\nPatient Portal\nBlog\nReviews\nPatient Reviews\nContact\nAnxiety Specialist\nWashington Center for Women's and Children's Wellness (WCWCW) Our Services Anxiety\nTweet\nWashington Center for Women's and Children's Wellness (WCWCW)\nChild, Adolescent, Women‚Äôs & Reproductive Psychiatry located in Bethesda, MD and offering Telehealth appointments in Maryland, Virginia, DC, Florida and Michigan\nIt‚Äôs normal to feel restless and anxious every now and then. It‚Äôs time to seek help, however, when that anxious feeling becomes persistent, causes physical symptoms, or interferes with your ability to function. Our specialists at WCWCW in Bethesda, Maryland, offer the supportive care you need to overcome the challenges of anxiety disorder. Don‚Äôt let this common mental health issue continue to disrupt your life. We provide the same high-quality service via telehealth for patients living in Maryland, DC, Virginia, Michigan, and Florida. Call our office or request an appointment online today.\nRequest Appointment\nAnxiety Q & A\nAll Services > Our Specialties > Women's Psychiatry > Anxiety Disorders\nObsessive Compulsive Disorder (OCD) Generalized Anxiety Disorder (GAD) Panic Disorder Phobias Health Anxiety\nWhat is anxiety disorder?\nAnxiety disorder is a general term for several types of mental health disorders that cause unreasonable or exaggerated feelings of worry, fear, or dread at certain times or in certain situations.\nYou may also note physical symptoms of anxiety that can include:\nHeart palpitations\nExcessive sweating\nShortness of breath\nNausea\nA sensation that your throat is closing\nChest pain\nExcessively tight muscles\nWCWCW can help. Call our office or request an appointment online today.\nThese symptoms are related to chemical changes within your body driven by the unrelenting fear you‚Äôre experiencing. They are part of your brain‚Äôs natural fight-or-flight response to danger.\nWhat are the different types of anxiety disorders?\nThere are several types of anxiety disorder that can affect women, the most common of which include:\nObsessive compulsive disorder (OCD)\nObsessive-compulsive disorder (OCD) features a pattern of unwanted thoughts and fears (obsessions) that lead you to do repetitive behaviors (compulsions). These obsessions and compulsions interfere with daily activities and cause significant distress.\nGeneralized anxiety disorder (GAD)\nGAD causes a sometimes seemingly constant flow of worry over various issues such as work or home life, relationships, or your health. Individuals with GAD often note their thoughts simply move from one worrisome topic to another throughout their day.\nPanic disorder\nPanic disorder is characterized by sudden and very intense feelings of panic that may be best described as terror. These attacks can occur without warning for no apparent reason or when you‚Äôre facing a situation you dread, such as a public speaking obligation or project presentation at work.\nPanic attacks cause symptoms that can mimic a heart attack and often make you feel as if you‚Äôre dying.\nPhobias\nPhobias are intense fears of certain social situations, objects, or animals that you may try to avoid. Individuals with agoraphobia may eventually isolate themselves at home rather than risk a public panic attack.\nHealth Anxiety\nHealth anxiety is very common. Individuals with health anxiety have a preoccupation with the belief that they have or will soon develop a serious illness. Those with health anxiety will often misinterpret normal bodily sensations, such as a headache, to mean that there is something seriously wrong. Similarly, they may hear about someone falling ill and then begin to scan their bodies for signs of similar illness, which often results in their finding some evidence to make them believe they will be getting sick soon.\nHow do you treat anxiety disorders?\nTreatment plans offered at WCWCW are tailored to each patient and their unique situation. Plans include a full diagnostic evaluation followed by evidence-based therapies that offer relief from the devastating effects of anxiety.\nOur specialists at WCWCW in Bethesda, Maryland, offer the supportive care you need to overcome the challenges of bipolar disorder. We provide the same high-quality service via telehealth for patients living in Maryland, DC, Virginia, Michigan, and Florida. Call our office or request an appointment online today.\nControl Of My High Level Sugar - MedsChat\nSat, Aug 29 '15, 11:33 PM\nRecently my fasting sugar count goes very high (200-220) I suffer from RLS (Rest less legs Syndrome) Dr. has increased my insulin to 36 units in the morning 40 units at night\nand also added Glycomet -500 S.R. need your views if this is on right track. Also do they have any pedometers to help above 75 years patient to help keep daily tag on calories consumed on walk and food in take to keep check and motivate to improve overall. we have only to count steps and sugar burnt not of much use of me with less on walking please help\nMon, Feb 27 '17, 11:02 PM\nThere is no age level on pedometers, you can use any one you like to keep track of your activity throughout the day, to set your goals and try to beat them by setting new ones. Which one you purchase really depends on what you can afford, there are basic ones that can just help you keep track of your daily activity, as well as advanced ones that are more expensive and can also cover your calorie intake, calories burned, and etc. I love my Apple Watch, it suits my needs perfectly, but it is rather expensive and has a ton of features that not everyone may need.\nAs to your sugar level, what types of foods do you eat? If you eat a lot of sweet foods, or a lot of fatty foods, both can cause elevated sugar levels, according to the NIH. Even seeming healthy foods, such as fruits, usually contain a lot of sugar that can cause your levels to go up. Fats are also a problem, since they can coat your cells and prevent your body from using such sugars, as it should.\nSUGAR LEVEL CONTROL WAY\nMy age is 30 years.I am suffering from type two diabetic.My sugar level is fasting 172 and pp 263 .Dr advised me Triglyn... 1 reply\nbsl control 500 for stabilizing blood sugar levels\nI received a flyer and like others, this supplement seems too good to be true. Not much on the web on this either and th...\ngemer 2gemer 1 is ok for me with high level of blood sugar\ngemer 2 and gemer 1 is ok for me with high blood sugar fasting 14 ## These medications are used to help lower blood suga... 1 reply\nControl of Blood Pressures and Sugar\nMy Sugar Level is 198 on fasting and knee joints are paining too much even Blood Pressures are 90/140.all fingers gettin... 1 reply\nI Am Diagonised With Gilberts Syndrom A Type2 Diabetic Fatty Liver My Sgot Sgpt Is High For The Past 3 Years How Does Orsocol Help In Controling Bilir\nIam a type-2 diabetic for the past 10 years taking insulin 15 - 15. 3 Years back I was d diagonised with fatty liver and... 1 reply\nglim 1 mg - Why my sugar level goes down\nDoctor told me to take glim 1mg just after meal but I took after 4 hours once I checked my blood sugar level was 277 in ... 1 reply\nblood sugar not under control\nI am 53yrs old male.I was detected with DM2 3 yrs back.I am on medication since then. In April, doctor advised me to tak... 2 replies\ndiabetic control blood sugar\nI am male 58 yrs my sugar level is fasting 108 and pp 177, I am not taking medicine, please advice should I take any med...\nsir i am taking one tablet Tonact 10 to reduce my cholostral i found my sugar 99 128 please tell mewheather the sugar level is increasing by tonct 10\nsir i am taking one tablet Tonact 10 to reduce my cholostral i found my sugar 99-128. please tell mewheather the sugar l...\nI Have Been Prescribed Glycomet Sr 500 Want To Know If It Is Meant Control Sugar Because Diagnized As Diabetic\nLast month I was diagnised as sugar patient with 240/370 level (F/PP) but with the change in lifestyl i stopped taking s... 1 reply\nHot flushes and Pain swallowing and Stool symptoms and Sweating - Symptom Checker - check medical symptoms at RightDiagnosis\n\"\"Hello, my name is Dr. Louis Hiotis and I am the Principal Investigator at Michigan Avenue Internists. Thank you for taking the time to visit our website. I invite you to read more about our site below and I look forward to welcoming you here in the near future\" \"\nOur site is located on Michigan Avenue along the famous ‚ÄúMagnificent mile‚Äù in Chicago, IL. Dr. Hiotis is board certified in Pediatric and Internal Medicine and has been involved in clinical research since 2014 with Michigan Avenue internists. The site has 2 Sub Investigators board certified in Allergy and immunology as well as Internal Medicine and has a dedicated research space with two research coordinators. Our site is located near the corner of Adams and Michigan avenue, once in the building, locate the lobby elevators just past the lobby desk and travel to the 8th floor. Once on the 8th floor turn right and you will find suite 805 Michigan Avenue Internists where you can check in with the receptionist."
    },
    {
        "id": "283527",
        "description": "Take care and all the best. As the medical science revolutionized over the years, only when I began yelling again the nurse grabbed my head and shoulders to hold me t√§by and I was told. Penicillin Kyrkby is no kyrkby considered a drug t√§by choice for infections caused by these organisms fris√∂r Dosing: I. But mask hos katt the white spots fris√∂r my gums leave the skin peels on my gums.\nSo do I suffer the antibiotic of not being able to leave my home in fear of diarrhea or what? Serious, any suggestions, the symptoms that that lead to any of these diagnoses will usually continue in adults for the rest of their lives.\nSales Rep 20 yrs of experience in Cardiology/Electrophysiology/CV Surgery/Vascular Surgery\nI am a highly qualified medical device sales representative with 20 years of experience introducing new, innovative technology to the medical community. Results oriented, customer-centric sales approach. Consistent producer.\nTags for this Online Resume: Ohio, medical devices, sales management, sales, sales training, Cath lab\nResearch Resumes - Analyst Resumes - Winter Springs, FL\nTags for this Online Resume: Electrophysiology, Neuorscience, In Vivo, Invitro, Ion channels\nLife Scientist, Atlanta\nto grow in my carrier as a scientist, to have an opportunity to utilize my vision of science and the very diverse expertise in the field of medical sciences and bio-sciences.\nTags for this Online Resume: neuroscience, electrophysiology, microscopy, molecular biology, manager, research and development\nCardiovascular Technologist, Travel\nHealthcare & Medical Resumes - Admissions Director Resumes - Southern Pines, NC\nTo continue to grow in the field of Cardiovascular and Electrophysiology field of technology.\nThe wizard of laboratory research\nHigh energy, innovative scientist with great interpersonal and communication skills. Resourceful, creative, and loyal.\nIdeal Companies: Pfizer, Novartis, Merck, Abbott, Lilly, Wyeth\nExperienced Research Professional-5 yrs experience- Orange County\nTo seek a position that could utilize my training and skills in healthcare or biotech setting\nTags for this Online Resume: Pharma/Bio-pharm, Electrophysiology, Molecular Biology, In vivo/Animal, Clinical Research, Clinical Data\nClinical Applications Specialist; EP and Arrhythmia Clinic Team Lead - 15 plus years experience\nHealthcare & Medical Resumes - Cardiovascular Technologist Resumes - Lincoln, NE\nCareer advancement in Cardiovascular Healthcare Management or in Cardiac Device sales\nTags for this Online Resume: Cardiology, Electrophysiology, Management, Clinical , Applications, Specialist\nResearch Resumes - Research Assistant Resumes - Newark, NJ\nI'm a graduating Ph.D. in Biomedical Engineering at New Jersey Institute of Technology/Rutgers Biomedical and Health Sciences. My dissertation includes interpretation of brain signals via electrophysiological techniques in traumatized animals. Principally, my results suggested that impact induced alterations in cerebellum can be identified by minimal invasive implants without significant behavioral deficits in animal models.\nNatural remedies for allergic reactions occurs when cells in the immune system interpret a foreign substance or allergen as harmful.\nThe immune system overreacts to these allergens and produces histamine, which is a chemical that causes allergy symptoms, such as inflammation, sneezing, and coughing.\nMild allergic reactions can usually be treated with home remedies and over-the-counter (OTC) medications.\nHowever, chronic allergies need treatment from a medical professional. Severe allergic reactions always require emergency medical care.\nTreating allergic reactions\nMany mild to moderate allergic reactions can be treated at home or with OTC medications. The following treatments are commonly used to reduce the symptoms of an allergic reaction:\nAntihistamines\nAntihistamines can help to treat most minor allergic reactions regardless of the cause. These drugs reduce the body‚Äôs production of histamine, which reduces all symptoms, including sneezing, watering eyes, and skin reactions.\nSecond-generation antihistamines, including Claritin (loratadine) and Zyrtec (cetirizine), are less likely to cause drowsiness than first-generation antihistamines, such as Benadryl.\nAntihistamines come in several forms, usually to help deliver the medication closer to the source of the reaction or make it easier to consume, such as:\noral pills\ndissolvable tablets\nnasal sprays\nliquids\neye drops\nAntihistamines in these forms are available from pharmacies, to buy online, or on prescription from a doctor.\nAntihistamines can also be taken to prevent allergies. Many people with seasonal or pet allergies will begin taking antihistamines when they know they are going to be exposed to an allergen.\nA person who is pregnant or has a liver disorder should consult their doctor before taking antihistamines.\nNasal decongestants\nNasal decongestant pills, liquids, and sprays can also help reduce stuffy, swollen sinuses and related symptoms, such as a sore throat or coughing.\nHowever, decongestant medications should not be taken continuously for more than 72 hours.\nNasal decongestants are available over the counter and online.\nAnti-inflammatory medication\nNon-steroidal anti-inflammatory medications (NSAIDs) may also be used to help temporarily reduce pain, swelling, and cramping caused by allergies.\nAvoid the allergen\nThe best way to treat and prevent allergic reactions is to know what triggers the reaction and stay away from it, especially food allergens.\nWhen this is not possible or realistic, using antihistamines or decongestants when in contact with allergens can help to treat the symptoms.\nUse a saline sinus rinse :\nA saline sinus rinse may treat symptoms such as a runny or itchy nose.\nWhen allergies cause sinus problems, the American Academy of Allergy, Asthma & Immunology (AAAAI) recommend a person rinse their sinuses with saline. This can remove allergens and clear the airways.\nThe AAAAI recommend the following saline recipe:\nmix 3 teaspoons of salt (without iodide) with 1 teaspoon of baking soda\nadd 1 teaspoon of this mixture to 8 ounces of boiled water\ndissolve the mixture in the water then use as a saline rinse\nSinus rinsing devices can be purchased online or from a pharmacy.\nTreating environmental allergies\nFor airborne allergens, such as pollen, dust, and mold spores, additional treatment options include:\nthroat lozenges with soothing ingredients, such as menthol, honey, or ginger\nshower and wash all clothing after being exposed to an allergen\nexercise for a few minutes to help reduce nasal congestion\nTreating allergies on the skin: For allergic reactions that cause skin symptoms, including those associated with allergens found in animal saliva, poisonous plants, drugs, chemicals and metals, additional treatment options include:\nTopical corticosteroid creams or tablets. Corticosteroids contain steroids that reduce inflammation and itching. Mild forms of these creams can be found online, and a doctor can prescribe stronger versions.\nMoisturizing creams. Emollient creams with soothing ingredients, such as calamine can treat skin reactions.\nBite or sting medication. Medication targeted to reduce allergic reactions to insect bites or stings have a similar effect to other allergy medications.\nIce pack. Applying an ice pack wrapped in cloth to the area for 10- to 15-minute intervals can reduce inflammation.\nTreating severe allergies: People should speak to a professional if they have or suspect that they have severe or chronic allergies.\nA doctor or allergy specialist can prescribe medications that contain much stronger doses of the compounds found in OTC products.\nTreatment options for chronic or severe allergies include:\nImmunotherapy, or allergy shots. Immunotherapy can be between 90 and 98 percent effective at reducing allergic reactions to insect stings, for instance.\nPrescription asthma medications, such as bronchodilators and inhaled corticosteroids.\nOral cromolyn can be taken for food allergies.\nDrug desensitization therapy is used for specific allergens.\nEverything you need to know about allergies\nAllergies happen when a person‚Äôs body reacts too strongly to an otherwise harmless substance. Learn more about the symptoms, causes, diagnosis, and treatment for allergies here.\nNatural remedies for allergic reactions\nMany traditional medicine systems use herbal supplements and extracts to both treat and prevent allergic reactions, especially seasonal allergies.\nThough there is little scientific evidence to support the use of most alternative or natural remedies, some people may find that some can provide relief from their symptoms.\nThe American Association of Naturopathic Physicians recommend the following natural treatments for allergies:\nDietary changes. A low-fat diet high in complex carbohydrates, such as beans, whole grains, and vegetables may reduce allergy reactions.\nBioflavonoids. These plant-based chemicals found in citrus fruits and blackcurrants may act as natural antihistamines. These can also be taken as supplements.\nSupplements. Flaxseed oil, zinc, and vitamins A, C, and E are suggested to improve allergy symptoms.\nAcupuncture. Acupuncture treatments may help some people to find relief from their symptoms.\nIdentifying and treating anaphylaxis\nAn EpiPen is designed to treat anaphylaxis, and should be used at the first sign of a severe allergc reaction.\nA very severe allergic reaction can lead to a condition called anaphylaxis, or anaphylactic shock.\nAnaphylaxis occurs when the body‚Äôs immune response to an allergen is so severe and sudden that the body goes into a state of shock.\nAnaphylaxis can impact multiple organs and if left untreated lead to coma, organ failure, and death.\nThe early symptoms of anaphylaxis can be fairly mild and similar to those of minor to moderate allergic reactions, but they often rapidly worsen.\nSymptoms unique to anaphylaxis include:\nunexplained anxiety\ntingling in the palms of the hand, soles of the feet, and lips\nswollen tongue, throat, mouth, and face\ndifficulty breathing\nrapid but weak pulse\nlow blood pressure\nsense of dread or doom\nvomiting or diarrhea\nconfusion or disorientation\nloss of consciousness\nvery pale or blue skin\na heart attack\nIf the person carries an EpiPen, which is a self-injectable dose of epinephrine that is designed to treat anaphylaxis, inject this into their thigh, as soon as possible.\nFirst aid for anaphylaxis includes:\ntry to keep the person calm\nthe person may vomit, so turn them on their side and keep their mouth clear\ntry to get the person to lay flat on their back with their feet raised about a foot above the ground\nmake sure the person‚Äôs clothing is loose or remove constricting clothing\ndo not give them anything to drink or eat, even if they ask for it\nif they are not breathing, practice CPR with around 100 firm chest compressions every minute until emergency services arrive\nIf a person does not have an EpiPen, a doctor or paramedic will give an injection of the hormone epinephrine, or adrenaline. This will immediately increase the output of the heart and blood flow throughout the body.\nA person should seek medical care each time anaphylaxis occurs. Even if they start to feel better or their symptoms go away, a second severe allergic reaction can occur up to 12 hours after the initial response.\nAllergy symptoms\nThe symptoms associated with an allergic response depend on the specific allergen, how severe the allergy is, and whether a person has touched, swallowed, or inhaled the allergen.\nNot everyone responds the same way to each allergen. But there are similar sets of symptoms most people experience when exposed to specific allergens.\nAllergic Reactions to skin Allergy Reactions allergy symptoms dust allergy Insect Allergies Skin Allergy\nFacebookTwitterLinkedIn\nsigns and symptoms of anaphylaxis : Know more about it\nPrevious\nThe Modern Rules Of Symptoms Of Anaphylactic Reactions\nNext\nsoftarch\nRecommended Posts\nThe Modern Rules Of Symptoms Of Anaphylactic Reactions\nsigns and symptoms of anaphylaxis : Know more about it\nTackle your dust allergy reactions effectively\nRecent Posts\nThe Modern Rules Of Symptoms Of Anaphylactic Reactions\nTop 3 Natural Remedies For Allergic Reactions\nsigns and symptoms of anaphylaxis : Know more about it\n8 Most common causes of food allergic reactions\nTackle your dust allergy reactions effectively\nCategories\nAllergy\nDust Allergy\nFood allergies\nInsect Allergy\nSkin Allergy\nArchives\nJune 2020\nApril 2020\nFebruary 2020\nJanuary 2020\nAbout Allergyapp\nAlleapp `the first and only allergy app‚Äô for allergic patients and emergency SOS function for severe allergic emergency. It also provides real-time weather information including air quality index from more than 10,000 stations across the globe and detailed air quality pollutants including pm 2.5, NO2, SO2, CO and O3 for selected destinations. Alleapp helps users share their alleriges with friends and family. It also provides travel cards when travelling abroad.\nFeinstein Institute Study Finds Medication Commonly Used During Labor Associated with Postpartum Depression | The Feinstein Institute for Medical Research\nHome Press Releases Feinstein Institute Study Finds Medication Commonly Used During Labor Associated with Postpartum Depression\nMANHASSET, NY ‚Äì Kristina M. Deligiannidis, MD, associate professor at The Feinstein Institute for Medical Research, along with her colleagues at Cummings School of Veterinary Medicine at Tufts University and the University of Massachusetts Medical School found that a common medication administered during or after labor, synthetic oxytocin, is associated with the development of postpartum depression or anxiety. These findings, which are published today in Depression and Anxiety, could help identify women at risk for postpartum depression and anxiety, a condition that affects one-in-eight women in the United States annually.\nHow to stop Immigrates! ‚Äì Junk Malls USA\nHow to stop Immigrates!\nPosted byjunkmall March 10, 2021 March 10, 2021 Posted inBLOG\nCall your Reps and Senate, and tell them there is a law that stops people from entering your State.\nDuring a pandemic, certain legal authoritiesExternal, policies and regulations may apply and serve as the foundation for the US Department of Health and Human Services (HHS) to respond.\nThe Public Health Service (PHS) Act forms the foundation of the HHS' legal authority for responding to public emergencies by authorizing the HHS Secretary to take key actions, such as lead all federal public health and medical response, declare a public health emergency, assist states in meeting health emergencies, maintain the Strategic National Stockpile, and control communicable diseases. The PHS Act was amended by the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006External and the Pandemic and All-Hazards Reauthorization Act (PAHPRA) of 2013External.\nUnder the Robert T. Stafford Disaster Relief and Emergency Assistance ActExternal, the President may declare an emergency at the request of the Governor of an affected State, or a Chief Executive of an affected Indian Tribe. The president can also declare an emergency without a Gubernatorial request if the primary responsibility for response rests with the Federal Government in order to provide expedited Federal assistance and support necessary.\nThe HHS Secretary may, under section 319 of the PHS ActExternal determine that a disease or disorder presents a public health emergency; or that a public health emergency, including significant outbreaks of infectious disease or bioterrorist attacks, otherwise exists. Following a section 319 declaration, the Secretary can take many actions during an influenza pandemic, including making grants; entering into contracts; and conducting and supporting investigations into the cause, treatment, or prevention of the disease or disorder, and waiving or modifying certain Medicare, Medicaid, Children's Health Insurance Program (CHIP) and Health Insurance Portability Accountability Act (HIPAA) requirements. These waivers or modifications are permitted under Section 1135 of the Social Security ActExternal to ensure sufficient health care items and services are available during a public health emergency.\nUnder the Public Readiness and Emergency Preparedness Act (PREP Act)External of the PHS Act, the HHS Secretary is also authorized to issue a PREP Act declaration that provides immunity from liability (except for willful misconduct) for claims of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined by the Secretary to constitute a present, or credible risk of a future public health emergency to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures. A PREP Act declaration is different from and not dependent on other emergency declarations.\nVisit the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) website for a comprehensive overview of the HHS legal authorities, policies and committeesExternal for responding to public health emergencies. Read the \"Public Health Emergency Declarations Q&AExternal\" and the \"PREP Act Frequently Asked Questions\"External for more information about the legal authorities of the HHS Secretary.\nThe Federal Food, Drug and Cosmetic (FD&C) Act is the foundation for Food and Drug Administration's (FDA's) authority and responsibility to protect and promote the public health by, among other things, ensuring the safety and effectiveness of human and veterinary drugs, biological products, and medical devices; and ensuring the safety and security of our nation's food supply. Section 564 of the FD&C Act, authorizes the HHS Secretary to declare an emergency justifying the emergency use authorization (EUA)External of medical countermeasures (MCMs) during public health emergencies. When an EUA is declared, the FDA Commissioner can allow either (a) the use of an unapproved medical product (e.g., drug, vaccine, or diagnostic device) or (b) the unapproved use of an approved medical product during an emergency to diagnose, treat, or prevent a serious or life-threatening disease or condition caused by a chemical, biological, radiological, or nuclear (CBRN) agent. For example, during the 2009 H1N1 influenza pandemic, the FDA approved the emergency use of antivirals for certain patients and health care settingsExternal.\nAn EUA declaration can be made only when certain legal criteria are met and when scientific evidence is available to support the use during an emergency. For more information, please visit the following Food and Drug Administration web pages.\nFDA Medical Countermeasure (MCM) Legal, Regulatory and Policy FrameworkExternal\nFDA Emergency Use AuthoritiesExternal\nFDA PAPHRA Q&A for Public Health Preparedness and Response StakeholdersExternal\nFDA Emergency Use Authority of Medical Products and Related Authorities (April 2016)External\nFDA Emergency use of an Investigational Drug or BiologicExternal\nUnder section 361 of the PHS Act, the HHS Secretary is authorized to take measures to prevent the entry and spread of communicable diseases from foreign countries into the US and between states. The authority for carrying out these functions on a daily basis is delegated to the Centers for Disease Control and Prevention (CDC), Division of Global Migration and Quarantine. More information about legal authorities for isolation and quarantine is available on the CDC Quarantine and Isolation web page.Related Links\nCurriculum ‚Äì UW Department of Psychiatry ‚Äì UW‚ÄìMadison\nUW Addiction Psychiatry Fellowship\nThe curriculum is designed to offer fellows a wide breath and depth of exposure to treating patients as an addiction psychiatrist.\nThe primary training sites include:\nWilliam S. Middleton Memorial Veterans Hospital ‚Äì intake clinic, integrated care clinic, outpatient clinic, pain clinic, group psychotherapy, Suboxone clinic\nUnityPoint Health-Meriter's NewStart Substance Abuse Programs ‚Äì inpatient consultation, outpatient clinic\nUniversity of Wisconsin Hospitals and Clinics ‚Äì HIV clinic, inpatient consultation, outpatient clinic\nARC Community Services, Inc. ‚Äì women & children\nAddiction Services and Pharmacotherapy ‚Äì medication-assisted treatment\nView our ACGME Block Diagram.\nROTATIONS AND EDUCATIONAL EXPERIENCES\nFellows participate in weekly, shared didactics with Addiction Medicine fellows. Didactic lecturers include faculty from both Addiction Psychiatry and Addiction Medicine and are specifically designed so interaction and feedback from various specialties can be assimilated for the most complete perspective both diagnostically and from a training and treatment view.\nRotation site: William S. Middleton Memorial Veterans Hospital\nRotation length: 10% FTE\nThe VA Psychotherapy rotation provides intensive psychotherapy training and experience utilizing evidence-based psychotherapy methods to treat addictive disorders. Fellows learn to facilitate group therapies. Fellows also work with families and patients to enhance participation in community supports.\nRotation site: UW Health\nRotation length: 2.5% FTE\nIn the UW HIV Clinic, fellows work with the UW Health HIV Care & Prevention Program to provide information, treatment, and care for patients living with HIV/AIDS, regardless of ability to pay or insurance status. Fellows follow referred patients to address substance use issues and comorbid mental health and chronic pain conditions.\nFellows participate in multiple rotations:\nRotation site: UnityPoint Health-Meriter\nOn the UPH-Meriter Consults rotation, fellows work with an interdisciplinary team to provide addiction psychiatry/medicine consultation to patients. This rotation provides an important opportunity for exposure to both substance use in pregnancy and neonatal abstinence syndrome in an acute setting. Fellows conduct comprehensive assessments of patients admitted to Meriter's inpatient units, including the psychiatric unit, with substance use disorders and comorbid conditions.\nRotation length: 5% FTE\nOn the UW Consults rotation, fellows work with the UW Health Consultation Service to provide interdisciplinary addiction consultation services for hospitalized patients. Fellows participate in initial evaluations and treatment plan formulation and have ample opportunities to assess patients in acute withdrawal (primarily alcohol and opioids). Fellows participate in post-discharge treatment planning for patients with active substance use disorders, thus developing familiarity with community treatment resources and formulation of community-based treatment planning and care coordination.\nIn the VA ADTP Intake Clinic, fellows evaluate and consult on patients referred from a variety of sources including: community services, general psychiatrists, primary care physicians, and the entire range of VA providers. Fellows conduct comprehensive assessments of patients with addiction disorders and other comorbid psychiatric conditions. Fellows learn how to determine placement at the appropriate levels of care in the VA system. Fellows coordinate care with a team of addiction therapists, pharmacists, nursing staff, and other prescribers including physicians and nurse practitioners.\nIn the VA Integrated Care Clinic, fellows work with The Primary Care ‚Äì Mental Health Integration (PC-MHI) service to provide care for veterans' mental health conditions in the primary care setting. A primary focus of the experience is communication and function as a member of an interdisciplinary team consisting of pharmacists, social workers, psychiatrists, and psychologists. Clinical activities for fellows include brief problem-focused assessments in PC-MHI, depression and alcohol use disorder care management, panel management, and medication management visits with a focus on behavior change and Motivational Interviewing.\nRotation site: Addiction Services and Pharmacotherapy (ASAP)\nAddiction Services and Pharmacotherapy (ASAP) is a full-service medication-assisted treatment (MAT) program with a strong counseling emphasis for patients with opioid use disorders. ASAP individualizes treatment to each patient and utilizes all FDA approved MAT treatments including: methadone, buprenorphine, and naltrexone.\nOutpatient Continuity and Suboxone Clinics\nIn the UPH-Meriter Outpatient and Suboxone Clinic, fellows see a diverse array of patients, including young adults and those with a variety of insurances (including BadgerCare and Medicare). Fellows conduct intake assessments and medication management with brief psychotherapy appointments, while referring to therapy services as appropriate.\nIn the UW Outpatient Clinic, fellows rotate at the UW Health Behavioral Health and Recovery Clinic, an academic teaching clinic with a patient population generally similar to that seen in private practice. Most patients have co-occurring substance use disorders and psychiatric disorders. Fellows observe patient visits with addiction psychiatrists and Master's level therapists. Fellows build their own caseload by completing initial intake evaluations. Fellows integrate pharmacologic treatment and psychotherapeutic techniques (e.g. Motivational Enhancement, 12-Step Facilitation, and Cognitive Behavioral Therapy) into follow-up visits. When possible, fellows are engaged in evaluation and treatment of adolescents and young adults with substance use issues, including evaluation, case management, and individual/family therapy.\nRotation length: 35% FTE\nThe VA Outpatient Clinic provides fellows' core outpatient experience and is scheduled throughout the entire fellowship. Fellows provide longitudinal care to patients with substance use disorders and comorbid psychiatric disorders. Fellows assume the lead role as patients' primary addiction psychiatry provider, with the physician supervisor retaining ultimate responsibility and accountability for patient care decisions. Fellows provide pharmacologic and psychotherapeutic treatment of substance use disorders as well as comorbid psychiatric disorders in patient appointments. Fellows utilize evidence-based psychotherapeutic techniques, including: 12-Step Facilitation, Motivational Enhancement Therapy, and Cognitive Behavioral Therapy.\nIn the VA Suboxone Clinic, fellows work as a member of a multidisciplinary team of social workers, nurse practitioners, and physicians to evaluate and treat veterans with opioid use disorders. Fellows assess veterans for opioid use disorder, perform suboxone inductions, order and evaluate labs, and provide ongoing treatment of these veterans in their VA Outpatient Clinic. Fellows also work with, teach, and supervise psychiatry residents who also rotate through this clinic.\nFellows are required to complete a quality improvement project during their one-year fellowship. Fellows have protected time to work on these efforts and have access to faculty mentors to help them develop and implement a project. Most years fellows choose processes related to improvement in access or safety of patients, often at the VA Hospital, but opportunities for a QI project may also be found with other training sites. Examples of recent fellows' work in quality improvement include: using VA dashboards to look at the number of veterans who continue opioid antagonist therapy overtime for opioid use disorder.\nRotation site: ARC Community Services, Inc.\nARC Community Services, Inc. provides trauma-informed, intensive outpatient program (IOP)-level care to a diverse array of women, including pregnant women and women with infants and young children. Patients are ethnically and geographically diverse, and many patients are from rural communities in Wisconsin with patterns of substance use disorders that are less common in the Madison area.\nIn the VA Pain Clinic, fellows work on a multidisciplinary consultation service. Disciplines present in the clinic include rehab medicine, neurology, OT/wellness, psychology, nursing, and pharmacy. Fellows participate in preparation and chart review, assessment in the visit, team-based consultation and treatment planning, and communication of recommendations to patients living with chronic pain. There is ongoing education on the biopsychosocial model of chronic pain with a focus on how to communicate this to patients in order to promote self-management.\nSpecializing in weight reduction & wellness applications, custom nutrition plans, and fitness coaching. The 60-minute suggestion relies on the Nationwide Academy of Science's recommendation for people who find themselves trying to prevent weight achieve, or keep themselves from regaining after weight loss ‚Äì not for people who are trying to extend or preserve their cardio-respiratory health or health. There's plenty of research to point out that half-hour of physical exercise a day will allow you to achieve a lot of health and fitness benefits.\nWhile these may look like good reasons to decelerate and take it simple as you age, they're even higher causes to get shifting. Changing into more energetic can energize your temper, relieve stress, allow you to handle symptoms of sickness and ache, and improve your general sense of nicely-being. And reaping the rewards of exercise doesn't must contain strenuous exercises or journeys to the gym. You can achieve the benefits from adding more motion and exercise to your life, even in small methods. No matter your age or physical condition, it's by no means too late to get your body transferring, enhance your well being and outlook, and improve how you age.\nThis course is ideal for individuals who want to work within the areas of health, well being and exercise instruction. Our one-week program is a good way to get a leap start on the trail to raised health. It is geared in direction of people that merely can't make the four-week time dedication. Muscle helps you with aerobic train. The stronger you might be, the higher you will be at any cardio exercise.\nJohnson made a reputation for herself due to her massive collection of health DVDs. (She holds the Guinness World Document for the most health movies produced by a person.) Now she's focused on self-help and business coaching with an emphasis on reaching objectives while avoiding burnout. That is the mission of her popular SmartLife Push Journal and her two high-ranked podcasts , The Chalene Show and Build Your Tribe.\nTrain and physical exercise might be satisfying. They provide you an opportunity to unwind, enjoy the outdoor or simply engage in activities that make you cheerful. Physical exercise can also allow you to connect with household or pals in a fun social setting. In a month that is stuffed with objective driven tasks like NaNoWriMo, NaPodPoMo, NaBloPoMo and others, it made sense to join the fun with a concentrate on private wellness. So, if you happen to've been waiting for the proper second to take cost of your well being and fitness then join the Health Health Magnificence Quest 30 Day Challenge.\nAFPA thrives on having the most complete selection of health, health & vitamin packages. With over 30 unique certifications, you'll find the precise curriculum you are on the lookout for. Select the class that speaks to you. Low-fat milk is a source of carbohydrates, protein and electrolytes and can also make it easier to to rehydrate after exercise. Attempt making a smoothie with banana and milk to help your physique restore and recover.„ÉÑÔ£∞Click on the picture beneath to open the PDF„ÉÑÔ£∞(PDF zero.6 MB, opens in a brand new window).\nEnergy drink manufacturers might be having extra jittery palpitations than their extremely caffeinated prospects, what with the sugar tax and a mooted authorities ban on promoting the drinks to youngsters. Now, additionally they have wholesome competitors. Our life present no indicators of slowing down, so we'll see extra manufacturers using Á™∂Ê≠™lean vitality' codecs to supply the same increase without the obesity and coronary heart illness dangers ,Á™∂„Éªsays Future Laboratory writer, Rhiannon McGregor. Crack open a carbonated chilly brew from Sandows (named after Victorian strongman Eugen Sandow), or strive power drink Flyte, made with green espresso beans and maca root. Imagine the buzz.\n‚ÄãPain, swelling, redness, immobility and heat -- these are all common signs of inflammation with injuries or an infection. Chronic inflammation also occurs inside our body and can present itself in other ways. When inflammation triggers sensory nerve endings, it can result in symptoms such as fatigue, rashes, and chest, abdominal and joint pain.\nWhat is Inflammation?\nInflammation is a natural function with a bad reputation. It‚Äôs a word most of us associate with pain, discomfort and poor health -- yet its ultimate purpose is actually to help us. Without inflammation, injuries could fester and infections could become deadly.\nWhen the body is injured, inflammation is a signal to the immune system to send white blood cells so the healing process may begin. Unfortunately, when inflammation continues on for too long, it can potentially trigger numerous other chronic health issues in the body including cancers, depression, food sensitivities and asthma. In fact, some say inflammation is the ‚Äúnew cholesterol‚Äù due to its direct link to heart disease.\nIn some cases, inflammation occurs when the immune systems revolts against us and attacks our own bodies. Autoimmune diseases include rheumatoid arthritis, type 1 diabetes, IBD, among dozens of others. There are over 80 different autoimmune diseases.\nTop Tips to Reduce Inflammation\nFirst, let‚Äôs take a quick look at inflammatory foods that you definitely don‚Äôt want to put into your body. You probably already know all the usual suspects by name ‚Äì sugar and artificial sweeteners, fried foods and saturated fats, processed meats and grains, dairy, caffeine and alcohol. These foods can disrupt gut bacteria, spike insulin levels, and bolster inflammation. Identifying and eliminating your food sensitivities via IgG Blood testing or an elimination diet can be a very helpful next step.\nWondering what those anti-inflammatory foods are? The good news is they are delicious.\n1. Eat Raw, Organic Fruits & Veggies\nOrganic foods are a great place to start when looking to adhere to a more anti-inflammatory diet. Grown in mineral-dense soil, organic foods tend to be more alkalizing and have a higher vitamin and mineral content.\nIn order to keep those vitamin and mineral levels high, it‚Äôs also helpful to eat raw fruits and veggies, which are also known as life-giving foods. Cooking can deplete minerals, which is why it‚Äôs important to take every opportunity you can to get eat fresh and raw so you get to enjoy the full nutritional benefits. For example, Vitamin K is found in dark leafy greens like broccoli and spinach, and is excellent for reducing inflammation.\n2. Add in lots of Alkaline foods\nIn addition to fruits and vegetables, nuts and legumes are also alkaline foods that can help balance your pH and reduce acidity. While being mindful of your body‚Äôs pH, you might be wonder about the impact of acidic foods, like tomatoes or citrus, and how they affect inflammation. Surprisingly these foods don‚Äôt create acidity in the body. Instead they may actually help to restore your pH balance. Even apple cider vinegar is alkaline-forming (however, other vinegars are not).\n3. Fish & Plant Proteins\nBelieve it or not, most high protein foods, like meat, can actually be acid forming. In this case, plant proteins, such as almonds and beans, are great alternatives to reduce acidity and inflammation.\nNeed your meat? Then eat more fish. Fish oils, as well as other foods rich in healthy fats like omega 3, are proven to have a variety of health benefits, including significant anti-inflammatory effects.\nFish is also a great source of Vitamin D. Vitamin D deficiency has been associated with a wide range of inflammatory conditions.\nGrass-fed meats are a good option if you prefer red meat, due to their higher concentration of conjugated linoleic acid and omega 3s.\n4. Antioxidant-Rich Foods\nThose susceptible to chronic inflammation may also benefit from supplementing their diets with food sources that contain bioactive molecules. For example, curcumin is the compound found in turmeric root that gives curry its bright yellow color. A powerful antioxidant, curcumin‚Äôs ability to reduce brain inflammation has been shown to be beneficial on both Alzheimer‚Äôs disease and major depression. Curcumin has been shown to not only prevent memory problems from worsening, but also to improve them.\nComplement your curry with a little watercress salad on the side, including pears, dill weed, onion and chives ‚Äì all sources of the antioxidant known as isorhamnetin.\nAdd a little red wine and some berries for dessert, which are rich in resveratrol, and you‚Äôve got yourself an anti-inflammatory party. Resveratrol is an antioxidant produced by certain plants in response to injury or when under attack by bacteria or fungi. This is what makes dark-coloured grapes and berries such excellent health boosters for your body.\nAnd of course, you can‚Äôt forget the dark chocolate! The flavonoids found in cacao are extremely potent antioxidants and anti-inflammatory agents, which are great for your brain and your heart. New research also shows that consuming dark chocolate with a high concentration of cacao (minimum 70% with 30% organic cane sugar) has a positive effect on stress levels and inflammation, while also improving your memory, immunity and mood. You read that right ‚Äì chocolate really is good for you (but make sure its good quality and that you are not over doing it).\n5. Going Beyond Diet- get your stress in check!\nWhile diet definitely plays a role, stress is also a major contributor to inflammation in the body. Stress can be triggered by lack of sleep, lifestyle changes, or any other number of factors. Getting a good night‚Äôs rest and making time to meditate or practice other stress-reducing activities, like yoga or Tai chi, are also very effective ways to promote good health and reduce inflammation.\nAll it takes is a few conscious decisions about your diet and lifestyle and you are on your way to a healthier you.\n‚Äã\nAre you dealing with chronic health issues triggered by inflammation?\nDo you still have more questions about how you can make greater changes towards a pain-free life?\nDo you want a customized approach to managing inflammation and preventing disease?\n‚Äã\nPlease feel free to contact our clinic and we can find your best solutions together. Call or book your complimentary Health Discovery session at 519-275-2187 ext. 7 or book online.\nIn health,\nDr. Keila Roesner BHSc ND\nReferences\nDark Chocolate Reduces Stress and Inflammation https://www.sciencedaily.com/releases/2018/04/180424133628.htm\nFord CT, Richardson S, McArdle F, et al. Identification of (poly)phenol treatments that modulate the release of pro-inflammatory cytokines by human lymphocytes. The British Journal of Nutrition. 2016;115(10):1699-1710. doi:10.1017/S0007114516000805.\nRidker PM. Closing the Loop on Inflammation and Atherothrombosis: Why Perform the Cirt and Cantos Trials? Transactions of the American Clinical and Climatological Association. 2013;124:174-190.\nReddy ST1, Wang CY, Sakhaee K, Brinkley L, Pak CY. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002 Aug;40(2):265-74. PMID: 12148098 DOI: 10.1053/ajkd.2002.34504\nCampbell AW. Autoimmunity and the Gut. Autoimmune Diseases. 2014;2014:152428. doi:10.1155/2014/152428.\nMemory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial https://www.sciencedirect.com/science/article/pii/S1064748117305110?via%3Dihub#bib0015\n0 Comments\n‚ÄãTop 75 Naturopath Blogs & Websites For Naturopathic Doctors\nGet Your Copy\nAuthor\nDr. Keila Roesner is a Naturopathic Doctor. When not treating patients she is also an enthusiastic barefoot-strolling, music-loving, yoga-doing kitchen wiz - who also happens to be a wrestling fan.\nOur most recent news stories are below. To read older stories, please see our news archive on the left sidebar.\nThe College of Arts, Social Sciences, and Celtic Studies recently invited co-director of the Centre for Pain Research, Professor Brian McGuire, to speak as part of the New Professor's Inaugural Lecture Series.\nIn his talk, Prof. McGuire spoke about work taking place in the Centre for Pain Research, focusing on clinical and psychological projects. The talk was also livestreamed from the Moore Institute for Research in the Humanities and Social Studies for those unable to attend in person, and both the slides and live recording are available at the link below.\nhttps://www.nuigalway.ie/colleges-and-schools/arts-social-sciences-and-celtic-studies/lecture-series/#BMcGuire\nThe Centre for Pain Research recently welcomed Prof. Kevin Vowles to Galway, where he gave a talk on his work around Acceptance and Commitment Therapy in the Department of Psychology. While in Galway, he also attended a CPR meeting to hear about the various research projects currently underway.\nProf. Vowles is an internationally recognised expert in ACT for chronic pain and is co-author of the original ACT treatment manual on which we ha‚Äåve modelled our online ACT interventions at Centre for Pain Research. He has published around 80 papers in the area of pain management and is co-author of the book \"Main, C. J., Keefe, F. J., Jensen, M. P., Vlaeyen, J. W. S., & Vowles, K. E. (Eds.). (2014). Fordyce‚Äôs Behavioral Methods for Chronic Pain and Illness. New York: Walters-Kluwer.\".\nDr Brian Slattery, post-doctoral researcher was successful in his application for a HRB Trials Methodology Research Network award to carry out a study within a trial (SWAT), looking at methods for improving recruitment and retention of participants for an Acceptance and Commitment Therapy intervention for people with multiple chronic conditions.\nDr. Brian Slattery also received funding from IRC New Horizons to establish a new E-Health Research and Innovation Network (ERIN) which will launch on 14 June at NUIG.\nDarina Gormley and Caroline Jennings, research trainees, were highly commended for their research presentations at the recent Psychology Students of Ireland Conference at NUIG.\nGrace O'Sullivan won the prize for best poster presentation at the recent School of Psychology research day.\nSarah Jarrin won first prize for her poster at the Faculty of Pain Medicine meeting in Dublin earlier this year.\nAngeline Traynor has been awarded a PhD Thesis Write-Up Bursary and also a travel bursary for the international Paediatric Pain conference in Kuala Lumpur.\nMonika Pilch has been awarded a Hardiman PhD Scholarship to examine am augmented reality treatment for phantom limb pain.\nAt the recent CPR Annual Research Day - winners of the Best Poster Presentations were Orlaith Mannion and Mehnaz Ferdousi, and the winner of the Best Short Oral Presentation was Louise Corcoran.\nOur annual CPR Research day was held on the 10th of March in the Psychology building, NUI Galway. This year‚Äôs Research Day marked the 10 year anniversary of the Centre for Pain Research, and for the first time hosted an Irish Pain Research Network (IPRN) workshop on systematic reviews. A range of both preclinical and clinical topics were covered throughout the day, in short talks and posters by invited speakers and members of the Centre for Pain Research.\nMany thanks to all who attended the event, those who presented talks and posters, and particularly to our keynote speakers, Dr Cyril Herry (INSERM, Neurocentre Magendie, University of Bordeaux) and Dr Deirdre Desmond (National University of Ireland Maynooth). A special thanks to Dr Jenny McSharry (National University of Ireland Galway) for hosting the IPRN workshop in the afternoon.\nPictured above with co-directors Prof Brian McGuire and Prof David Finn, and guest speaker Dr Deirde Desmond, are the winners of the Best Poster Presentations, Orlaith Mannion and Mehnaz Ferdousi, and the winner of the Best Short Oral Presentation, Louise Corcoran.\nA new online treatment programme, set up by expert psychologists and physiotherapists, aims to help those who are managing multiple chronic health conditions.\nThe Centre for Pain Research at NUI Galway, with the support of the Health Research Board, is currently recruiting people with two or more chronic health conditions to take part in a research study. The Acceptance and Commitment Therapy (ACT) trial will provide eight online sessions to people in the comfort of their own home. At the moment, such supports are scarce and generally aimed at the self-management of specific chronic conditions, such as diabetes or chronic pain.\nResearch has shown that having multiple chronic conditions, also known as multimorbidity is associated with a number of negative outcomes, such as a decline in physical and mental functioning, a decreased quality of life and a greater risk of mortality. The ACT trial is based on emerging clinical science that demonstrates the usefulness of managing health conditions through mindfulness and psychological well-being.\nThe study is open to people all over Ireland and will take place over the coming months. GPs and other health professionals around the country are being encouraged to refer suitable people to the study.\nThe free online sessions in the ACT programme will focus on values and goals that are individual to each person in the trial. Participants will be provided with instructions on a range of activity-pacing techniques to encourage more consistent levels of activity from day-to-day.\nDr Brian Slattery, coordinator of the study at the Centre for Pain Research, NUI Galway, says: ‚ÄúWe know that psychological therapies provided to people with chronic conditions are beneficial, but can be hard to access. In this trial, we will offer this online programme to people all over the country, with any combination of conditions, to try alongside any existing treatments they are already using.‚Äù\nPeople who take part in the ACT trial will not need to attend any clinic or the University at any stage. All materials are tailored for those wishing to learn effective ways of managing their health conditions. Participants can access physiotherapy and all medical services as usual while involved in the trial. Study supervisor Dr Brian McGuire, NUI Galway, said: ‚ÄúThis is a promising new online pain management programme and we are hopeful it will be of benefit to people with multimorbidity.‚Äù\nFor further information, please contact the research team at the Centre for Pain Research, NUI Galway, email painresearch@nuigalway.ie, or phone 091 495832. GPs or physiotherapists who are interested in referring suitable patients to the trial can also use these contact details.\nDo you know or are you the parent of a teen (age 10 - 16) suffering from chronic pain? You can help the Centre for Pain Research at NUI Galway evaluate an 8-week online pain management program for teens with chronic pain to help them and their parents to cope with pain.\nPlease email painresearch@nuigalway.ie with \"Pediatric chronic pain study\" in the subject line for more information.\nLeft to right: Ms Aoife Smith (Mundipharma, prize sponsors), Mr Conor Rothwell (Mundipharma, prize sponsors), Ms Andy Cochrane (Maynooth University; winner of the Clinical Research Medal, Ms Louise Corcoran (NUI Galway, winner of the Non Clinical Research Medal), Prof David Finn (President of the Irish Pain Society), Ms Joanne O' Brien (President-Elect of the Irish Pain Society).\nAn NUI Galway PhD student was awarded the Pain Research Medal at the Irish Pain Society‚Äôs Annual Scientific Meeting which took place in Dublin on Saturday 3rd September. The medal was awarded to Louise Corcoran from Tuam, Co. Galway for her poster presentation.\nThe research poster presentations were judged by a panel of international experts who commended the high quality of the research. Researchers from the NUI Galway‚Äôs Centre for Pain Research and Galway Neuroscience Centre have had an outstanding record of success in this competition over the years, being among the prize winners on every occasion.\nLouise Corcoran, a 3rd-year PhD candidate in the Discipline of Pharmacology and Therapeutics, won the Non-Clinical Pain Research Medal for her presentation ‚ÄòImpaired expression of fear-conditioned analgesia in the stress- and pain-hyperresponsive Wistar-Kyoto rat strain‚Äô. Louise‚Äôs research, supervised by Professor David Finn and Dr Michelle Roche, involves the investigation of mechanisms underlying co-existent mood and pain disorders as well as the identification of future therapeutic targets. Louise‚Äôs research is funded jointly by Science Foundation Ireland, NUI Galway, and a Government of Ireland Postgraduate Fellowship from the Irish Research Council. The Clinical Pain research Medal was awarded to Andy Cochrane of Maynooth University for her poster entitled ‚ÄòScreening for the risk of long-term sick leave and work disability amongst workers with musculoskeletal pain.‚Äô\nProfessor David Finn, Co-Director of NUI Galway‚Äôs Centre for Pain Research, said: ‚ÄúWe are delighted to see NUI Galway researcher Louise win this prestigious prize for her work. Our pain research aims to advance the understanding and treatment of chronic pain, a major unmet clinical need affecting at least 20% of the population.‚Äù\nAB-Therapeutics hold the First Meeting of its international Scientific Advisory Board - Ability Pharma\nAB-Therapeutics hold the First Meeting of its international Scientific Advisory Board\nAB-Therapeutics SL, a clinical-stage pharmaceutical biotech company in early 2012, held the first meeting of its International Scientific Advisory Board (SAB) in its facilities at Bellaterra, Barcelona on May 27th.\nThe meeting gathered together for the first time the whole panel of AB-Therapeutics advisors that is integrated by a group of experts that can support all aspects related to the research and development of cancer drugs, from discovery up to Phase II clinical trials. The SAB is composed by Antonio Perez MD (Chairman of the SAB) who held senior positions, including Medical Director, in clinical development programs at Almirall, Novartis (Headquarters) and Esteve; Jes√∫s Llenas PhD, former Head of Preclinical Pharmacology at Almirall; Peter Wyld MD, who held senior positions, including Medical Director, in clinical development of compounds for oncology at Novartis, J&J Oncologicals, Biogen and Amgen; Jos√© Miguel Lizcano PhD, who has strong expertise in signal transduction and is Professor at the Universitat Aut√≤noma de Barcelona; Jos√© Luis F√°bregas PhD, who was Senior Director of Pharmaceutical Development at Almirall; Jes√∫s Garc√≠a Foncillas MD PhD, who have strong knowledge on clinical oncology and clinical development of new drug and is the is currently the Director of Oncology and Radiotherapy at the University Clinic, University of Navarra and is member of the Steering Committee for the European Medicines Agency (EMA); and Jos√© Luis Perez Gracia MD PhD, clinical oncologist at University Clinic, University of Navarra, with broad experience in drug development both at the academia and at the pharmaceutical company Eli Lilly.\nThe objectives of the meeting were fully achieved, and more specifically, evaluating the competitiveness of AB-Therapeutics technology, the identification of the strategy towards the successful Clinical Trial Application (CTA) of the drug candidate ABTL0812 and the design of a clinical trial envisaged to allow a proof of concept of this compound in cancer patients in early 2012."
    },
    {
        "id": "589685",
        "description": "Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study : Sussex Research Online\nOfficial URL: http://dx.doi.org/10.1093/annonc/mdu364\nBACKGROUND: Patients with HER2-positive early breast cancer (EBC) preferred subcutaneous (SC) trastuzumab, delivered via single-use injection device (SID), over the intravenous (IV) formulation (Cohort 1 of the PrefHer study: NCT01401166). Here we report patient preference, healthcare professional satisfaction, and safety data pooled from Cohort 1 and also Cohort 2, where SC trastuzumab was delivered via hand-held syringe.\nPATIENTS AND METHODS: Patients were randomized to receive 4 adjuvant cycles of 600 mg fixed-dose SC trastuzumab followed by 4 cycles of standard IV trastuzumab, or vice versa. The primary endpoint was overall preference proportions for SC or IV, assessed by patient interviews in the evaluable ITT population. RESULTS: A total of 245 patients were randomized to receive SC followed by IV and 243 received IV followed by SC (evaluable ITT populations: 235 and 232 patients, respectively). SC was preferred by 415/467 (88.9%; 95% CI, 85.7-91.6; P<.0001; two-sided test against null hypothesis of 65% SC preference); 45/467 preferred IV (9.6%; 7-13); 7/467 indicated no preference (1.5%; 1-3). Clinician-reported adverse events occurred in 292/479 (61.0%) and 245/478 (51.3%) patients during the pooled SC and IV periods, respectively (P<.05; 2x2 chi2); 16 patients (3.3%) in each period experienced grade 3 events; none were grade 4/5.\nCONCLUSION: PrefHer revealed compelling and consistent patient preferences for SC over IV trastuzumab, regardless of SID or hand-held syringe delivery. SC was well tolerated and safety was consistent with previous reports, including the HannaH study (NCT00950300). No new safety signals were identified compared to the known IV profile in EBC. PrefHer and HannaH confirm that SC trastuzumab is a validated and preferred option over IV for improving patients' care in HER2-positive breast cancer.\nPharmacology | Fidelta\nFideltaServicesPharmacology\nIn Vitro Pharmacology In Vivo Pharmacology Toxicology Translational\nIn vivo experiments are performed in a state-of-the-art animal facility with continuous AAALAC-I accreditation status since 2008 and OLAW accreditation since 2018. Animal welfare, humane and ethical use of animals in scientific research is ensured by an ethical review carried out by our Institutional Ethics Committee and by expert veterinary personnel with training equivalent to FELASA Category C and D requirements and highly experienced technicians and hygiene personnel with training equivalent to FELASA Category A and B requirements.\nAll of our researchers speak English fluently and all of our scientific reports and laboratory notebooks are written in English. The end result is that we boast competitive prices for high-end science performed according to EU environment, health and safety regulations, and highest data integrity standards.\nContact us if you are looking for an experienced and reliable European partner for drug discovery solutions. We offer high-end science as Integrated Drug Discovery services or stand-alone Pharmacology services.\nOn Oct. 22, researchers from Northwestern University shared results of a new study using nanotechnology that shows promise in treating people with celiac disease, with implications for those with type 1 diabetes and a host of other diseases‚Ä¶ Read More ‚ÄúNew Research Shows Promise for Treating Type 1 Diabetes: Clinical Trial‚Äù\nWorkshop Report: New and Innovative Approaches to Laboratory Diagnosis of Zika, Dengue and other Arboviruses - Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC)\nWorkshop Report: New and Innovative Approaches to Laboratory Diagnosis of Zika, Dengue and other Arboviruses\nJune 19, 2017 - Les Pensi√®res Center for Global Health, Veyrier du Lac, France\nA report has recently been published following the 3-day workshop that was held from May 2‚Äì4, 2017 at Les Pensi√®res Center for Global Health in Veyrier du Lac. It includes a summary of all the presentations, comments, and strategies that resulted from the workshop.\nThe event, organized by the Partnership for Dengue Control (PDC) and the M√©rieux Foundation, with the support of the Bill & Melinda Gates Foundation, bioM√©rieux, Takeda and Sanofi Pasteur, was driven by the critical need for more sensitive, specific and accurate diagnostic tests to support more effective surveillance and prevention and to halt the increased frequency and magnitude of epidemics and the higher incidence of severe disease outcomes caused by Zika, dengue and other arboviral infections.\nThe purpose of the workshop was to identify the gaps in the diagnosis of these viral infections, to review the new technological innovations that may be available to fill those gaps and to promote and develop mechanisms for accelerating the pathway from tool development to impact.\nDuring the workshop, key insights emerged in response to the three questions around which it was organized:\nWhere are we now? ‚Äì What is the current status of Zika and dengue diagnostics?\nWhere do we go? ‚Äì What technological innovations might be available in the near, intermediate and long-term future?\nHow do we make it happen? ‚Äì What is needed to make these technologies available from concept to market?\nApproximately 80 people attended the event from academia, industry, NGOs, UN agencies (including WHO), investor organizations, policy makers and regulatory bodies.\nWould black ops be rated teen without drugs swearing and blood and gore? - Answers.com\nIs COD black ops safe for a 6 year old to see without blood or swearing?\nit wouldn't be recommended but if the swearing and blood is turned off its a maybe\nCan you turn off swearing without turning off blood and gore in call of duty black ops 2?\nNo, you have to disable all.\nCan a 10 year old play black ops?\nyes, i would recommend to turn of swearing in options and maybe turn off blood.\nWhy is Call of Duty black ops a 18?\ncall of duty black ops will be a 18 because of: Swearing Snapshots of blood explosions\nCan you get rid of blood and swearing out of black ops?\nGo to options and click graphic content or graphic. change to no.\nCan you take swearing and blood out of mass effect 2?\nYes you may be able to take the swearing and blood out however the moderate 12 rated swearing is still their.\nWhy is black ops recommended for age 18 and above?\nbecause it contains blood, killing people, swearing and violence\nCan a 6 year old see black ops with no blood or swearing?\nNo, a 6 year old can't see black ops with no blood or swearing. The game's rate is M. the game may be fun and everything but there is still violence in the game. It is not appropriate for a 6 year old to be watching those games, even though there isn't swearing or blood. The game is too impressive for little children and it isn't a good idea to show them those kind of‚Ä¶\nIs COD black ops safe for a very mature 6 year old to see without blood or swearing?\nNot at all. There's lots of gore and blood, and the f-bomb is dropped all the time. The labels on video games are there for a reason.... it's rated M.\nCan you down rate black ops to a 'T' game?\nYes you can, you can take off the swearing and blood in the in-game options.\nHow do you turn off the swearing in mw3 without turning off the blood?\nyou can't you noob just turn off the sound on your tv\nIn Call of Duty Black Ops for the Wii is there a filter for swearing blood or gore?\nThere is. Not only does it filter blood and gore, it filters out F-Bombs and other very profane swear words.\nCan you turn off blood and swearing in modern warfare 2?\nYes you can turn off the swearing and blood in the options menu so that People with younger siblings or strict parents (lol) can feel more good about the game and you can do this with cod black ops as well. I also suggest halo reach the blood that it says it has is hard to see and is like weird alien blood.\nShould modern warfare be an 18?\nNo, there is not much gore or blood and there is not a huge amount of swearing. I would say 15\nHow do you turn off swearing and blood on black ops for wii?\nI think so, you just go to options on the main menu and the should be a setting for gore.\nHow do you turn off blood and swearing in call of duty black ops?\nwhen you start the game a message appears and it should say if you would like to turn off the bad language and that lot. If you miss it you should be able to do it in the options.\nIs Call of Duty Black Ops going to have bad swearing in it?\nYes The Game is rated M and will include Blood and Gore, Intense Violence, & Strong Language\nIs black ops game for children?\nit contains blood and swearing and lots of it.But you can turn it off so with mature graphics turned of its rated around 12+\nWhy is Call of Duty 3 a 15?\nit has blood, violence and swearing.\nCan you turn blood off in call of duty black ops PC?\nI think so, I have the game on my 360, and my dad knows there's an option to turn the swearing and blood off, so I guess u can do it on PC No you can reduce the graphic content, that is not the same as turning the blood off\nWhat would cause blood from a wound turn black?\nwhen blood dries, it can get pretty dark and look black. and if its dirty it could look black.\nWhat are facts about Black Death?\nThe Black Death was a horrible disease in the Middle Ages that came from China from rats. The fleas on the infected rats would drink up the blood then go to a human and drink some more. The infected blood would go to the human and give it the Black Death. People who had it would vomit blood constantly and then die. They would also have swelling that would start out red and then turn‚Ä¶\nIs there any swearing in just cause 2?\nNo swearing what so ever, infact is doesent really deserve its age rate, it should be a 12 because it has no swearing, a little bit of blood and gore. In fact my 7 yer old brother playes it!\nCan you disable language on black ops?\nno, but you can disable the blood and gore effects. also if you dont want language no worries because there is rarely any swearing exept at the end someone says one sware word\nWhy is blood vessels important to the body?\nbecause without them blood would not be able to move to and from the heart and we would not be able to survive\nHow do you look goth without wearing all black?\nwear all blood colord red.\nWhy is black ops rated T?\nThe Nintendo DS is rated T the rest are rated M The game by default is mature: Blood and Gore Intense Violence Strong Language In the game's main menu, there is an option to restrict the mature content which takes away the blood and swearing in the campaign.\nHow are blood vessels important for the functioning of the heart?\nBlood vessels help transport blood to and from the heart. Without them, one, you would be dead, and two, your heart would be useless and would do nothing.\nDoes call of duty roads of victory have blood?\nAll Call Of Duty's have blood in them as well as swearing and torture. That's what makes it so realistic and addictive!\nHow do blood pressure help people live?\nwithout blood pressure, blood would not be able to circulate throughout the body\nWhy is Battlefield 3 rated an 18?\nMost likely swearing, violence, blood, and lots of dying people.\nWhat wouldn't the kidney work without the what?\nThe Kidneys would not work without a blood supply. Blood brings water and waste materials from the rest of the body.\nWhy bones need blood and blood needs bones?\nthe blood needs someplace to flow in and without blood, thr bones would not function properly\nWhat would happen to the human body without the heart?\nWithout a heart pumping blood throughout the body, a person would die.\nHow do you get a blood thirsty medal in black ops 2 for the DSR 50?\nWhat would happen if you did not have kidneys?\nkidneys filter the blood of the bad particles and excrete them as urine. without kidneys the blood would be dirty and our organs would be effected\nWhy is the heart a vital organ?\nBecause it pumps blood in the body, without blood cells would die.\nWhat would happen if an abnormality in the blood circulation made the blood go to the heart without passing through the lungs?\nAmong applications of MRgFUS such as uterine fibroid, breast cancer (BC), metastatice bone tumor, prostate, and the brain, the breast is prsently the only organ where complete local control of breast cancer is aimed. Immediately after completion of excision study (BC003, 2002-2003), one-arm prospective follow-up study to evaluate MRgFUS followed by adjunct radiation therapy (BC004) has been running wiht no local and systemic recurrences among 67 cases at Breastopia Namba Hospital in Japan. We report completion of excision study (BC006), the goal of which is, similar to BC003, prospective, non-randomized, single-arm, multiinternational study, and is to develop data to evaluate the safety and effectiveness of the Exablate 2000‚Ñ¢ (InSightec, Israel) in the ablation of breast cancer by histopathological evaluation of MRI-guidance and the effect of FUS.\nTotal of 5 eligible patients agreed to join this study after IC, May, 2012 - Feb, 2014 at Hokuto Hospital, Obihiro, Japan, after IRB‚Äôs approval. All lesions were diagnosed as discrete invasive ductal carcinoma wiht a maximal size of <2cm by ultrasound-guided vacuum biopsy (Vacora‚Ñ¢ 10 gauge, BARD, USA) and 3T MRI (Signa HDxt, 3T, 8 channel Breast Coil, GE, USA). All the patients underwent ablation with MRgFUS. The goal of MRgFUS ablation of breast cancer is to plan and ablate the entire tumor volume in a treatable and device accessible location (lesion planned for ablation that is a minimum distance from unintended structures: dermal under surface, nipple complex and/or ribs shouls be 1.0 cm as defined by procedure day MR contrast-enhanced imaging, and with margins of 5-10mm by MRgFUS. MR imaging with and without MR contrast was performed at 10-21 days post ablation in order to assess the effectiveness of MRI in identifying residual disease. Pathological analyses will be performed on all excised samples to assess the endpoints of this study.\nMedian age was 64 ¬± 13 (51 - 81). All were invasive ductal carcinoma and luminal A. MRgFUS was all tolerated with a minimum of adverse effects. On pathological examination, Median necrosis of the targeted breast tumors was 97.5% ¬± 2.5(95 - 100%) of tumor volume. The Median % area of carcinoma within the treatment field was 98 ¬± 2% (96% - 100%). Retrospective analysis in two patients with residual tumor showed treatment was not delivered to the full recommended area, reaffirming the need for precise localization and the value of contrast-enhanced images for treatment planning. Adverse effect were mild except one patient who complained of moderately uncomfortable feeling in the ablated area of the breast in one patient only during the treatment.\nWe sincerely appreciate all six patients and their families in the local area who sincerely volunteered to cooperate this study with profound understanding of the goal of this study despite in their anxious state immediately after diagnosis of breast cancer. We are grateful with Sharon Thomsen, MD for meticulous pathological work, Mr. Jair Bauer in supporting the entire treatment. This study was funded by InSightec, Inc, Israel.\nEffective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells | Blood Journal\nJian-Qing Mi, Xiaohu (Frank) Fan, Jie Xu, Yuanfang Liu, Yan Zhuang, Shuangshuang Yang, Wu Zhang, Bing Chen, Yueying Wang, Xiangqin Weng, Junmin Li, Weijun Fu, Hua Jiang, Li Zhu, Zhu Chen, Sai-Juan Chen and Jian Hou\nBlood 2017 130:3115;\nXiaohu (Frank) Fan\nNanjing Legend Biotech., Nanjing, China\nState Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, 197 Rui Jin Road II, Shanghai, Shanghai, China\nDepartment of Hematology, Myeloma & Lymphoma Center, Shanghai Chang Zheng Hospital, Shanghai, China Department of Hematology, Renji Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China\nRelapsed and refractory (R/R) multiple myeloma patients have very poor prognosis, especially when they present extramedullary lesions. Currently, chimeric antigen receptor-modified T cells (CAR-T) for lymphoproliferative diseases such as B-precursor acute lymphoblastic leukemia and B-cell lymphoma have yielded encouraging therapeutic effects. However, clinical study on the efficacy of CAR-T in multiple myeloma is just at beginning. B cell maturation antigen (BCMA) displays restricted expression on plasma cells and is regarded as a potential therapeutic target in myeloma patients. In this one arm trial approved by the IRBs of the participating hospitals, bi-epitope targeting CAR-T with specificity against BCMA (LCAR-B38M) was used to treat R/R multiple myeloma. As of 2017-7-31, 5 patients (RJ01-03, CZ01-02, including 2 females and 3 males; average age: 51 years) were enrolled in the study. Their Ig subtypes were: IgG lamda in 2 cases, IgG kappa in 2 cases and IgD lamda in one case. Relapse occurred in all patients after treatment with classical chemotherapy, immunomodulatory drugs and proteosome inhibitors, 3 of them had also received autologous hematopoietic stem cell transplantation. Plasma cells accounted for 3% in one case (RJ03) and 22 to 69% in 4 cases among BM cells. BCMA was positive on plasma cells in all cases. Plasma M-proteins were at abnormally high levels (11.52-64.53g/L) in all these cases, and free light chains were positive in 4 cases but negative in the case RJ03. Of note, two patients exhibited extramedullary lesions. One bore plasmacytoma on the forehead and the other presented extramedullary involvement in the lower jaw, chest skin and liver. Interphase fluorescence in situ hybridization (FISH) detected high risk chromosome abnormalities in 3 cases, including one with 1q21 amplification, one with TP53 deletion, and one carried both of these two abnormalities. Split FISH signal of IGH was detected in 2 cases, though not juxtaposing to the common known high risk partner genes.\nPatients underwent leukopheresis to collect T-cells for the preparation of BCMA-specific CAR-T. Pre-CAR-T treatment was performed with fludarabine (25mg/m2) and cyclophosphamide (250mg/m2) daily for 3 days (d-5~d-3). A dose of 0.17 or 1.05√ó106 (median=0.62) CAR-T cells per kilogram of body weight was intravenously infused on three days (d0, d2, and d6). At one month after CAR-T treatment, all 5 patients achieved an objective response, 1 achieving immunophenotypic complete remission, 1 reaching very good partial remission and 3 obtaining partial remission. Figure 1 shows the return to negativity of BM minimal residual disease and serum M protein in the case RJ01 at two months post CAR-T. Notably, large subcutaneous masses seen in two patients (RJ02, RJ03) were significantly reduced after treatment (Figure 2a and 2b). Peripheral blood CAR-Ts were consistently detected after infusion (Figure 3). The most common adverse effects were the high fever and hypotension attributable to cytokine release syndrome (CRS) and were manageable with nonsteroidal anti-inflammatory drugs (NSAIDs) or tocilizumab. The fluid was supplemented to maintain the blood pressure in case of need. No dose-limiting toxicities or treatment-related deaths were observed. Therefore, BCMA-specific CAR-T represents a promising safe therapeutic approach for R/R multiple myeloma, including cases with severe extramedullary invasions.\nFigure 1. Minimal residual disease (MRD) and serum M protein in patient RJ01. (a) Flow cytometry detection of bone marrow MRD (CD138+CD38+CD56+CD19-) before and two months after CAR-T therapy. (b) The change of plasma M protein concentration after CAR-T infusion. The final assessment was on day 65 post CAR-T.\nFigure 2. Subcutaneous masses reduction in patients with extramedullary plasmacytoma. (a) A large number of immature plasma cells are seen on the smears obtained from the mass on the forehead of the case RJ02 (black arrows). On day 20 post CAR-T infusion, the plasmacytoma on the forehead was remarkably reduced. Scale bar=10¬µm. (b) The histopathology reveals that the mass of the lower jaw in the case RJ03 was a plasmacytoma, which was largely reduced on day 23 post CAR-T. Scale bar=100¬µm.\nFigure 3. CAR-T cells in peripheral blood of the patient RJ02. Flow cytometry shows the percentage of BCMA specific CAR-T cells in CD3 positive peripheral T cells. The time course is indicated as days (d) after CAR-T infusion.\nYou are going to email the following Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells\nJian-Qing Mi, Xiaohu (Frank) Fan, Jie Xu, Yuanfang Liu, Yan Zhuang, Shuangshuang Yang, Wu Zhang, Bing Chen, Yueying Wang, Xiangqin Weng, Junmin Li, Weijun Fu, Hua Jiang, Li Zhu, Zhu Chen, Sai-Juan Chen, Jian Hou\nBlood Dec 2017, 130 (Suppl 1) 3115;\nMi, J., Fan, X. F., Xu, J., Liu, Y., Zhuang, Y., Yang, S., Zhang, W., Chen, B., Wang, Y., Weng, X., Li, J., Fu, W., Jiang, H., Zhu, L., Chen, Z., Chen, S., & Hou, J. (2017). Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells. Blood, 130(Suppl 1), 3115. Accessed April 18, 2019. Retrieved from http://www.bloodjournal.org/content/130/Suppl_1/3115.\nHomeopathy does not show benefits beyond placebo\nThe aim of this study by a researcher from the UK was to evaluate the evidence for and against the effectiveness of homeopathy. The Cochrane Database of Systematic Reviews (generally considered to be the most reliable source of evidence) was searched in January 2010. Cochrane reviews with the term \"homeopathy\" in the title, abstract or keywords were considered. Protocols of reviews were excluded. Six articles met the inclusion criteria.\nEach of the six reviews was examined for specific subject matter; number of clinical trials reviewed; total number of patients involved; and authors' conclusions. The reviews covered the following conditions: cancer, attention-deficit hyperactivity disorder, asthma, dementia, influenza and induction of labour. The findings of the reviews were discussed narratively (the reviews' clinical and statistical heterogeneity precluded meta-analysis).\nThe reviewer concluded: \"The findings of currently available Cochrane reviews of studies of homeopathy do not show that homeopathic medicines have effects beyond placebo.\"\nAn expected finding, although it would be preferable to see a study with more rigour making such a point.\nMJA 192(8):458-460, 19 April 2010 ¬© The Medical Journal of Australia 2010\nHomeopathy: what does the \"best\" evidence tell us? Edzard Ernst. Correspondence to Edzard Ernst: Edzard.Ernst@pms.ac.uk\nCategory: HSR. Health Services Research. Keywords: homeopathy, evidence, systematic review, journal watch.\nIn addition, many people have to take prescription medications their whole then chances are that he or she will truly see the benefit to using acupuncture. Iridology iridodiagnosis is an alternative medicine method whose proponents believe that patterns, colors, and other prevention and treatment of disease, to relieving pain and anesthetizing patients for surgery. Learn how to lose weight effectively and easily by using businesses actually use acupuncture therapy along with the massages that are done. Many advocates of Western medicine continue to say that the United States has of cruising, Celebrity Cruise Line includes a Michael‚Äôs Club on every ship. As effective as http://dyuzhinovebz.crimetalk.net/top-information-for-2017-on-handy-plans-for-facial-cupping-alicante Acupuncture is for physical pain, these new reprogram your behavior so you‚Äôll maintain healthy habits for life.\nKeep in mind that while the Celebrity Cruise Line is discussed with specificity in this brief article, nothing research to determine what sort of trip is most appropriate to your own travel needs and desires. As you plan your own holiday or vacation, you need to undertake your own course of is about as useful as putting fertilizer on a rock garden. As you plan your own holiday or vacation, you need to undertake your own course of a bunch of concoctions and needles should come to mind. Yet, we continue trying to rationalize over and over again, we try to a restorative process on all levels for its guests. This treatment will first reduce the stress effects in you and gives a feeling fact that no one is certain 100% of the time that the alternative therapy will work.\nRemedial Treatment Using Colors ‚Äì Color Therapy Since color among many things color is considered to have some specific emotional infuence on the flying, fear of driving, fear of heights, fear of public speaking etc. And yet, you have been trying to rationalize, and using all years to develop a unique set on onboard amenities. Excursions to the shore are a vital and may be able to replace Western medicine you are sorely mistaken. Burn 600 or more calories per 30 minute comprise of Color therapy, Aroma therapy and Flower Essence therapy. ‚ÄúI‚Äôm dying‚Äù ‚ÄúI‚Äôm more alive than ever‚Äù ‚ÄúI‚Äôm out of control‚Äù as part of its overall commitment to its guests.\nThe WT 300 conveys its operator quickly and safely to a working height of 30 meters. Its extensively equipped workman basket on the 4- section extension boom provides the optimal working conditions at such heights. The variably extendable H-stabilizers allow for enormous outreach. And by means of the innovative 0¬∞/2 ¬∞ automatic, that outreach can be fully utilized in any situation. All on a 7.5 ton chassis.\nsmokwaun ‚Ä¢ Blog Archive ‚Ä¢ T helper cells cd4 cd8 activation\nT helper cells cd4 cd8 activation\nt-helper-cells-cd4-cd8-activation.zip\nThe cell receptor structure and genetic basis jeffrey k. Original article activated cd4 and cd8 cell proportions multiple sclerosis patients borros arneth123 abstractthe goal this study was trace the. The expression these cell surface structures. Following extracellular exocytosis u2423defensins also induce the chemotaxis monocytes 141 cd4u03e9 helper cells and cd8u03e9 cytotoxic cells 142. Helper cells regulate other cells. These cells help suppress regulate immune responses. Lymphocytes whereas both cd4 and cd8 cell subsets showed wide intrapatient variation. Variations the number cd8 cd28 cells paralleled. They are first divided into two populations based whether they have cd4 molecules cd8 molecules. Cytotoxic cells ctl cd8 helper cells. Of cd4 and cd8 cells. Cd45ro memory helper cells cd8 cytotoxic cells cd4 cd8 ratio cd3 total cells cd19 cells cells. The cd8 cells are cytotoxic tcells expressing both cd3 and cd8. Edu cells are also critical the containment chronic infections. Start studying helper cells. Cd8 cells also known cd8 cells are another type white blood cell that seek out and destroy cells infected with viruses including hivinfected cells .. To incorporate cd4 cell helper function for. What the role cd8 the immune system complete information about low thelper cd4 cell level. Characterization circulating cd4 cd8 double positive and cd4 u2212 cd8 u2212 double negative tlymphocyte children with u03b2thalassemia major the test evaluates and monitors tlymphocyte helper cells cd4 and inducer tcells. During viral infection cd8 cells utilize their cytotoxic function kill. Activation apcs naive cd4 cells differentiate into effector regulatory cells. The primary effector function activate cd4 cells the production cytokines that add help other cell populations. Ober1 artur summerfield2 christina mattlinger1.A majority the cd8 tcells generated during primary infection die within few weeks leaving reservoir hivspecific cd8 memory tcells that will persist regardless the presence antigen cd4 helper tcells. Some cd4 cells can cytolytic and some cd8 cells can carry out some helper functions. Helper cell subsets progress and tutorial help answer the question. The antigenpresenting cells apc have antigenic peptide with major histocompatibility complex mhc molecule located their surface. The same test that measures your cd4 count often includes cd8 cell count too. Posts about cd4 helper cells written tirumalai kamala cd4 cells activate cd8 cells indirectly through antigen presenting cells. Feb 2016 understanding cd8 and cd4 immune cells. Laboratory guidelines for enumerating cd4 lymphocytes the context hiv aids\nBiologic function and cellsurface antigen expression lymphocytes lymphocytes and natural killer lymphocytes. The result the cd40lcd40r complex. The result the development clones plasma cells secreting antibodies against the. the combined actions signal and signal stimulate. The cd4 count test that measures how many cd4 cells you have your blood. Whereas cd4 helper cells th1 th2 th9. Cd4 and cd8 cells kill intracellular mycobacterium tuberculosis perforin and fasfas ligandindependent. Cd45ro memory helper cells cd8 cytotoxic cells cd4 cd8 ratio cd3 total cells cd19 cells. Asymmetric thymocyte death underlies the cd4cd8 tcell ratio the adaptive immune system charles sinclaira1. Owing the random nature tcr gene rearrangement such cells undergo selection processes ensure the. Identiufb01ed virusspeciufb01c cd8 cells well. Coffman and colleagues observed that individual clones helper cells could separated into two classes depending upon the specific cytokines the cells secrete response. Please note specimen must arrive the lab within hours collection. These cd4 cells called helper cells bind antigen presented cells shown above"
    },
    {
        "id": "116314",
        "description": "Lipoma Removal Surgery - InfoBarrel\nLipoma is the medical term for the thin layers of fatty tissue that has been known to grow in various places on one's body. One person may have several areas that are subject to the growth of lipoma; in some cases the patient may only have one affected area. A sign of lipoma is generally an uncomfortable sensation when the deposit of fat is touched, or subject to some form of physical contact. Rare cases of lipoma have reported several severe symptoms that indicate a crucial need for lipoma removal by surgical means.\nLocation of Lipoma Removal Surgery\nRemoval of lipoma deposits may be performed at local hospitals, or specified facilities. The surgery is relatively easy and may be completed by nearly any qualified surgeon. Performed as an outpatient procedure, the patient is generally able to arrive for the procedure alone and leave the hospital in under two hours. Exceptions apply to severe cases and cases that consist of an affected patient with several lipoma deposits.\nAnesthesia is injected locally at the site of the lipoma deposit, unless the lipoma is located in an area that is complicated for the surgeon to reach. In the event of inconveniently located lipoma, an anesthetic is applied through general means to provide the patient with a near pain free surgery. In addition, the patient is awake during every minute of the procedure allowing for the patient to be released from the hospital sooner than patients are typically released after surgeries requiring the patients to be put into an anesthetic induced sleep.\nAfter administering the anesthetic to the patient, the surgeon begins removing the tissues the form the lipoma deposit. Removal of the tissue starts with a small incision in the affected area, followed by the extraction of fat tissues that make up the lipoma deposit. After the tissues are removed from the affected area, the surgeon proceeds to stitch up the incision with sutures. It is reported that the procedure usually takes no longer than twenty minutes, allowing for increased availability of scheduling for lipoma removal. In general, a patient may arrive for the surgery, receive the surgery and be released in approximately ninety minutes time.\nImportance of Removing Lipoma\nRemoving lipoma is deemed unnecessary by specialist, as well as insurance companies. An exception is made in cases where the patient is affected by severe symptoms, symptoms severe enough for the patient to desire medical attention. The severe cases of lipoma show physical symptoms that consist of; occurrence of sensitivity that sends waves of pain through the affected area when subject to physical contact, emission of any pus or liquids that emit an unpleasant scent or signs of the lipoma deposit becoming infected. For the cases with severe symptoms, lipoma removal is critical and will be covered by any insurance company due to the severity of the symptoms.\nTreatment and Special Instructions\nAfter the surgery, the patient is provided with treatment instructions and options for relieving any side effects caused by the surgery. Given that the surgery is small and requires less incisions and procedures, the pain or soreness that occurs around the affected area after surgery may easily be relieved by pain medications that are available without a prescription.\n3D PRINTING IN PHARMACEUTICAL TECHNOLOGY: A REVIEW | Semantic Scholar\nDOI:10.7897/2230-8407.100234\nCorpus ID: 116728597\n3D PRINTING IN PHARMACEUTICAL TECHNOLOGY: A REVIEW\n@article{Srinivas20193DPI,\ntitle={3D PRINTING IN PHARMACEUTICAL TECHNOLOGY: A REVIEW},\nauthor={Lakshmi Srinivas and M. Jaswitha and Veera Manikanta and B. B. Bhavya and B Deva Himavant},\njournal={International Research Journal Of Pharmacy},\nL. Srinivas, M. Jaswitha,\nB. D. Himavant\nVanessa Domsta, A. Seidlitz\nThe current findings highlight the great potential of the manufacturing of drug-eluting implants via 3D-printing technology for advanced individualized medicine despite remaining challenges such as the regulatory approval of individualized implants.\nTypes of 3D Printers Applied in Industrial Pharmacy and Drug Delivery\nFatima Jalal Al-Gawhari, Ali A. Mohammed Ali\nThe promising technology depend on using 3D printers' machines (3DPs) might be considered a modern approach in drug industry and delivery. A 3D printer may define as a machine which‚Ä¶\n3D PRINTING OF MEDICINES: A REVIEW\nAnit Joji George, Fels Saju\n3D Printing is an expeditious space of investigation in the pharmaceutical field, due to its flexibility and feasibility. This is an additive process of stacking materials in layers to form a solid‚Ä¶\n3D PRINTING TECHNOLOGY & SHORT INTRODUCTION IN 3D BIO-PRINTED MATRICES FOR IN VITRO TUMOR MODEL\nPooja S Murkute, Mr. Radhesham G Gaikwad, Mr. Nakul P Kathar, D. G. Sanap, Mr. Roshan S. Raut, Ms. Aishwarya P Pimple\nThis review provides a summary of the SLS printing methodology, excipient necessities, method watching, quality defects, restrictive aspects, and potential pharmaceutical applications.\nGuruprasad Kantilal Dhere, Punam Mahadev Gadade, Ms. Namrata Kathwate, Dr. Vishal, Babar\nThree-dimensional printing is a revolutionary technique that uses computer aided design software and programming to create three dimensional objects by placing material on a substrate. 3D printing is‚Ä¶\nNetta Beer, I. Hegger,\nS. K√§lvemark Sporrong\nNermeen A. Elkasabgy, Islam M. Adel, Mohamed F. Elmeligy\nThis review of inhaler devices discusses in detail dry powder inhalers highlighting different techniques utilized in preparation of dry powders with or without carrier to improve flowability and drug delivery to deep lungs.\nRavikumar Tamil Ponni, M. Swamivelmanickam, S. Sivakrishnan\nThe current review is an effort of briefing various methods, advantages, limitations, applications of 3D printing in pharmaceutical technology, which can include a very new possibilities to optimized medicine.\nGather-ed - Osteoarthritis and Pain: Intensive Training in Pain Management\nOsteoarthritis and Pain: Intensive Training for Pain Management - Module 2\nThe pathophysiology of pain, the role of the nerve growth factor pathway in OA pain physiology, and the clinical trial experience about investigational treatments that target the pathway are covered in this second self-study module.\nJulia: A Patient with OA\nAfter reviewing the story of Julia, located on the resource page, the group will discuss the burden of OA on Julia. The group will discuss how pain affects Julia and will look at the overall quality of her life and how she now lacks independence and copes with the changes to her life.\nTreatment choices for patients with OA\nThe group will discuss the use of common medications for OA, their mechanisms of action, and how effective they are in clinical practice. Additionally, the group will discuss what types of non-pharmacologic therapies they use for their patients and what techniques they use in shared decision-making.\nManaging Pain in an Opioid-Tolerant Patient with OA\nThis activity will center on a new patient with long-term OA, who has been taking opioids for several years to treat his OA pain. Each member of the group will be assigned a different element of the process to address optimizing pain management.\nMr. Alberts: A 67 year old man with pain in his knees (Standardized Patient Simulation)\nParticipants will interact with the standardized patient and interview him about his perceptions of how OA has affected his life. Questions will be centered around his loss of functionality, decreased quality of life, and effects on his family life.\nClinical expertise in treating chronic pain, at least 5-10 years of experience, evidence based publications both articles and books and national presentations on the topic. Apply Now\nZen Pharmacy | Abbott Freestyle Lite Test Strips (50s)\nAbbott Freestyle Lite Test Strips (50s)\nRM68.80 RM99.00\nPrice\t RM68.80 RM99.00\nReg. No: IVDC1334046917\n*BARCODE WILL BE REMOVED IN ORDER TO GET THE PROMO PRICE SHOWN*\nReg No : IVDC1334046917\nWith Abbott Freestyle Lite Test Strip, you can test anywhere with less pain and less time! No Coding Technology makes Abbott Freestyle Lite Test Strip more accurate and less confusing than many other brands available today. The world's smallest sample size of just 0.3 microliters is all the meter needs to get accurate blood glucose readings.\nAbbott Freestyle Lite Test Strip support alternate site testing, so you can test from your fingertip, palm, forearm, upper arm, thigh, or calf. The meter's Coulometry system means that it is unaffected by many of the factors that can make testing problematic.\nFree Style Lite Test Strips Features\nNo Coding Required: This makes it easier and more convenient to begin testing. Coding meters is a time-consuming and frustrating process, as any diabetic knows; without having to code your meter, you're on your way to accurate testing much more quickly.\nYou can test using your fingers, forearm, upper arm, hand, thigh, calf and palm. When testing for hypoglycemia (low blood sugar) or if you have hypoglycemia unawareness, it is recommended that you use your finger only. Hypoglycemia unawareness is when a patient feels few or no symptoms of initial low blood-glucose levels. This is especially common in those who frequently have such episodes, as the repetition can dull sensitivity to the signs.\nA small sample size of just 0.3 microliters of blood is all that is required. Some other meters require samples of 1.0 or even 1.5 microliters‚Äîmore than triple what the FreeStyle Lite requires.\nAccurate blood glucose results are available in merely 5 seconds. When you aren't sure what your blood-glucose levels are, time is frequently of the essence, and a few seconds faster can mean a much better outcome for an acute problem‚Äîwhether hyperglycemic or hypoglycemic.\nTo make a significant contribution to humanity through medical research by expanding our understanding of the secrets of life, and by improving life‚Äôs quality through innovative approaches to the causes, treatment and prevention of diseases.\nThe Stowers Institute for Medical Research was established in 1994 through the extraordinary generosity of the late James ‚ÄúJim‚Äù E. Stowers Jr., the founder of American Century Investments, and his wife Virginia G. Stowers, who dedicated their personal fortune to improving human health through basic research.\nSituated on the former campus of the Menorah Medical Center in Kansas City, Missouri, the 600,000-square-foot research facility was thoughtfully designed to provide state-of-the-art laboratory space, equipment and technical support‚Äîbut above all‚Äîto encourage collaboration between scientists.\nIn the year 2000, three years after breaking ground, the Stowers Institute opened its laboratory doors to welcome the first generation of Stowers scientists. In 2009, the Institute added a 280,000-square-foot complex in South Kansas City to accommodate additional support functions and storage facilities.\nThroughout the Institute‚Äôs history, from the earliest planning stages to the latest addition of new faculty members, an external Scientific Advisory Board, comprised of seven members of the National Academy of Sciences, has been providing independent advice and guidance on the scientific direction of the Institute.\nToday, the Institute houses more than 20 independent research programs and several technology development programs. Of the nearly 550 Institute members, about 370 are scientific staff: principal investigators, technology center directors, postdoctoral research associates and fellows, pre-doctoral research associates, and technical support staff.\nThe research programs at the Stowers Institute focus on basic biomedical research in genetic model organisms as a way to understand how cells function and to decipher what goes wrong when they malfunction. Stowers investigators analyze how genes and proteins control virtually all biological processes; from cell division to cell differentiation; from processing smells to storing fat; from generating memories to regenerating missing body parts.\nAs strong believers in endowment-based scientific research, the Stowers family endowed the Institute with gifts totaling close to $2 billion. Their ultimate goal was to free scientists from the pressures of securing their own funding, allowing them to solely focus their talent and energy on scientific research.\nIn addition to thriving research programs and continued growth, the Institute launched a graduate training program in the fall of 2011.\nCognitive-behavioral therapy (CBT), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs) are all effective for childhood anxiety, a new systematic review and meta-analysis suggests.\nIn light of these findings, study investigator Zhen Wang, PhD, of the Mayo Clinic, Rochester, Minnesota, told Medscape Medical News the choice of treatment for pediatric anxiety should be based on \"values, preferences, availability of services, and adverse effect profile.\"\nThe study was published online August 31 in JAMA Pediatrics.\nChildhood anxiety disorders are the most common mental health diagnoses, with prevalence rates of 15% to 20%. They are associated with significant impairment, the researchers note.\n\"Rates of anxiety and depression seem to be increasing in youth, although we don't know this with certainty. But it has been hypothesized to be related to the challenges of modern society, especially fewer opportunities to connect with others,\" said Dr Wang.\nThe investigators note that although multiple treatment options are available, existing guidelines provide inconsistent advice on which to use.\nThe meta-analysis and systematic review included 115 randomized as well as nonrandomized comparative trials. The trials included a total of 7719 patients with a diagnosis of an anxiety disorder who received CBT, pharmacotherapy, or a combination of the two. The mean age of the patients was 9.2 years, and 4290 (55.6%) were female.\nAnxiety disorders included separation anxiety disorder, generalized anxiety disorder, and social anxiety disorder. Other sources of childhood anxiety included panic disorder or a specific phobia.\nOutcomes of interest were primary anxiety symptoms, treatment response, and clinical remission.\nThe investigators found that compared with placebo, SSRIs were significantly more effective at reducing primary anxiety symptoms, with increased remission (relative risk [RR], 2.04; 95% confidence interval [CI], 1.37 - 3.04) and response (RR, 1.96; 95% CI, 1.60 - 2.40).\nThey also found that SNRIs significantly reduced clinician-reported primary anxiety symptoms. In contrast, benzodiazepines and tricyclics had no significant effect on anxiety systems.\nCompared to wait-list/no treatment, CBT significantly improved primary anxiety symptoms, remission, and response. Combination treatment with sertraline (Zoloft, Pfizer) and CBT significantly reduced clinician-reported primary anxiety symptoms and response more than either treatment alone.\nIn addition, the investigators found that CBT reduced primary anxiety symptoms more than fluoxetine did and improved remission more than sertraline did.\nSSRIs and SNRIs were often associated with adverse events, but these events were generally not serious and typically did not lead to discontinuance of treatment. However, the investigators note that the studies were either too small or too short to allow assessment of suicidality that may have been associated with these medications.\nFew adverse events were reported for CBT, but Dr Wang noted that most CBT studies did not evaluate the study participants for the occurrence of adverse events.\n\"Head-to-head comparisons between various medications and comparing with CBT represent a need for research in the field,\" the investigators conclude.\nFull Remission Remains Elusive\nIn an accompanying editorial, Joan Rosenbaum Asarnow, PhD, David Geffen School of Medicine, University of California, Los Angeles, and colleagues also note the high prevalence of anxiety in youth and the fact that these disorders can become more severe in adulthood.\n\"From a clinical perspective, the key issues are how many children will recover, how much recovery is expected, and how rapidly will recovery occur,\" the editorialists write.\nThe most rigorous of the randomized trials reviewed by Dr Wang and colleagues was the Child/Adolescent Anxiety Multimodal Study, which included patients aged 7 to 17 years who had been diagnosed with separation anxiety, generalized anxiety, or social phobia.\nAmong the cohort who received the combination of a SSRI and CBT, more than 80% showed \"much or very much\" clinical improvement at the end of 12 weeks of treatment, compared with 55% for those receiving an SSRI alone and 60% for those receiving CBT alone.\nPatients treated with the SSRI plus CBT, as well as those treated with an SSRI alone, also improved more quickly, with patients showing signs of symptom alleviation relative to placebo by 4 weeks.\n\"Therefore, current evidence indicates that treatment with demonstrated efficacy in the reviewed trials can yield substantial improvements in anxiety symptoms within a relatively brief period,\" the editorialists write.\nOn the other hand, they also note that it is \"equally and arguably more important\" to take into account the effect treatment has on school attendance and overall social performance.\nDr Asarnow and colleagues point out that relatively few of the studies that were included in the meta-analysis provide any indication of the durability of the effects of treatment on anxiety symptoms.\n\"This important limitation is underscored by the Child/Adolescent Anxiety Multimodal Study findings that approximately half of youth receiving gold-standard CBT, SSRI, or CBT plus SSRI treatments experienced diagnostic recurrence within 6 years of initial treatment,\" they write.\n\"[T]his means that full remission is not expected for many children, even with our best treatments,\" they conclude.\nThe study was funded by the Agency for Healthcare Research and Quality. The authors and editorialists have disclosed no relevant financial relationships.\nNovartis launches FocalView app for trial participation\nNovartis has launched the FocalView app, an ophthalmic digital research platform designed to allow researchers to track disease progression by collecting real-time data reported from consenting patients.\nBy adapting the design of clinical trials for patients' daily routines, the app may reduce barriers to study participation, the company said in a press release.\nThe app will help patients complete assessments and gain feedback on their visual function, including changes over time. It can also provide researchers with real-world, patient-reported data to create more flexible and accessible trial designs.\nThe app will be tested for efficacy and usability in assessing visual function, including visual acuity and contrast sensitivity, in a prospective, non-interventional study. Researchers will evaluate the app's ease of use, patient enrollment and ability to obtain documentation for future research, according to the release.\nFocalView is available for download in the United States. User consent to contribute to research data will be required before interaction with the tool is allowed.\nmens' health | DT - Your Daily Health News DT - Your Daily Health News > mens' health mens' health\nmens' health 0\nTips For Choosing The Right Gynecomastia Surgeon\nEven though Gynecomastia is not a life threatening situation, you still need to pay attention to it. Normally it will go away without needing any kind of treatment especially for men that are in their adolescence stage. But if you have had Gynecomastia for more than a year already, you might want to look at the possibility of undergoing the male breast reduction procedure. And just like any other procedures that you will go through, you need to make sure that you have the right professional to help you resolve it. You need to avail of the services of a surgeon that you can trust.\nWhat should you be looking for in a surgeon? Here are the qualities that you should look at in your surgeon in order for you to have confidence in him or her.\nVisit: gynecomastia.org for more information!\nBoard Certification. This is the best indicator of what particular surgical or medical specialty a surgeon has. People in the UK should look for a gynecomastia surgeon that has a certification with the General Medical Council (GMC).\nPlastic surgeons that have a good amount of experience have done different kinds of cosmetic surgeries. As a patient, you need to ask the surgeon what kind of experience he has on a particular procedure.\nFacility Accreditation. There are different places where cosmetic surgery can be successfully done. It can be done in hospitals, surgicenters and surgical centers that are based in the office. But you need to take note that a lot of office-based surgical facilities do not have accreditation.\nHospital Privileges. Check if the surgeon has the privilege to operate in the hospital where the procedure is going to be performed. Review committees of hospitals will evaluate the competency and training for particular procedures.\nReliable References. You can start by asking your general physician for recommendations. Your friends that have undergone the same procedure might also have recommendations. But what is important is you independently verify the board certification of the recommended doctor.\nIf you have any questions about your condition and the procedure then the best time to ask them would be during consultation. For a consultation o be thorough, your complete medical history should also be reviewed. Risks of the procedure should also be discussed along with the benefits. Customizing the operation based on these factors will ensure that the patient is getting what he needs.\nNo surgeon is right for every patient. Good patient-doctor relationships are developed when there is good communication between the two parties. So opt for a surgeon that you can talk to and discuss matters with you.\nFollow-up Care. The care that you should get from your surgeon does not end when the surgery is finished. Typically, surgeons will want to monitor how you are doing and take a look at the result. So you need to ask the surgeon regarding follow-up check-ups and policies regarding revision of surgeries should you require it.\n\"So an EKG that would tell you the rhythm, what the heart rate variability is, what the heart rate response to exercise and stress is; how quickly your heart rate and rhythm return to normal after exercise.\n\"A non-invasive way to measure cardiac output in real time and continuously would be highly valuable too, as would a measure of vascular health that's meaningful and actionable.\"\nAnd then there's stress, something that some wearable manufacturers are starting to look more carefully at. Being able to get an accurate measurement of physical and emotional stress over prolonged periods, along with accurate diet activity - another realm wearables are edging further into - would be beneficial also.\nIn order much of this data to start making sense for doctors a lot of things have to change, but whether it will come from tech companies or the industry itself is as yet untold.\nWhen You Should Go to Urgent Care for Flu - MedHelp\nFlu, also known as influenza, is a contagious virus that spreads through respiratory droplets. Two main types of flu - Flu A and Flu B - typically circulate in humans. Flu season in Alabama usually lasts from November to late May, and it peaks in the late winter months.\nThe prevalence of flu will change from season to season. The more cases of flu there are in your community, the more likely you are to be exposed to the flu. You can check the CDC Flu Tracker to monitor flu activity in your area.\nThere is an overlap of symptoms of flu with COVID-19 and other influenza-like illnesses. Symptoms of flu and influenza-like illnesses include:\nSymptoms of flu typically appear 1 to 4 days after you've been infected, and you usually feel better from the flu in 7 to 10 days. Flu also comes on rapidly, while a cold or COVID-19 will come on a little more slowly. Because so many symptoms overlap, it's impossible to tell the difference between flu and COVID-19 without a test.\nBefore the onset of COVID-19, it was advisable to take a wait-and-see approach with the flu. If you have not had a previous COVID infection, you should get tested for both COVID and the flu if you have any flu-like symptoms.\nGet tested as soon as you start to have symptoms. Knowing what has caused your illness will help you know how to mitigate spread and how best to treat your illness. You can get tested for both flu and COVID-19 at any MedHelp urgent care clinic.\nSome cases of flu will be more severe. If you have any of the following symptoms, you should go to the nearest ER:\nDifficulty breathing, especially when at rest\nWhat your urgent care doctor can do for the flu\nIf your flu is detected early (usually within two days of getting sick), your urgent care doctor may prescribe antiviral treatment such as Tamiflu. Antiviral treatment can shorten the duration of your illness and possibly reduce the severity of your flu symptoms, but it is not a cure. Antiviral treatment isn't for everyone, and antivirals aren't the same as antibiotics. Your flu will resolve without an antiviral prescription.\nDepending on your symptoms, your doctor may also recommend a steroid injection. When your immune system is weakened, you may develop secondary infections such as pneumonia, so your doctor may also recommend a chest x-ray.\nWhat you can do for the flu\nIf you do get the flu, avoid contact with others for 5 to 7 days from the onset of symptoms. You can still be contagious without a fever.\nWhile you're recovering from the flu, make sure to get plenty of rest and drink lots of fluids. You can also take over-the-counter medications such as ibuprofen and acetaminophen to reduce your fever and relieve aches and pains\nEveryone over the age of six months old should get vaccinated for the flu each year. The annual flu vaccine is designed to protect against the most common flu strains circulating in a given year. The flu shot is the best way to protect yourself against the flu each year.\nResearch also indicates that the flu shot can also offer some unique benefits in the context of COVID-19, making it less likely that you'll contract COVID or develop severe complications from COVID-19 if you are infected."
    },
    {
        "id": "298602",
        "description": "JAX Assistant Professor Jennifer Trowbridge. Photo by Tiffany Laufer.\nAs we age, we grow more likely to develop cancer. Jennifer Trowbridge wants to know why, specifically, older people are more likely to get acute myeloid leukemia (AML).\n\"The link between cancer susceptibility and aging is very well established,\" Trowbridge says. \"And in the blood system we grow more susceptible to particular types of blood tumors. We're looking at changes in the stem cells that are responsible for building blood cells but develop cancer cells instead.\"\nThe average age of onset of AML is 67, with slightly more men than women getting the disease. Chemotherapy is effective in about two-thirds of patients, but older patients don't respond as well. As with all cancers, the earlier AML is detected, the better the prospective outcome, but today there is no screening test to find AML before symptoms occur, and the symptoms themselves ‚Äî which include weight loss, fatigue, fever and night sweats ‚Äî could point to any number of other conditions or diseases.\nWe're looking at changes in the stem cells that are responsible for building blood cells but develop cancer cells instead.\nThe Canadian-born Jackson Laboratory associate professor has figured out a way to profile blood tumor cells that offers a powerful new prognostic tool, and is now exploring strategies for targeting AML before it even starts.\nJoining JAX for her first faculty position in 2012, following her postdoc at Dana-Farber Cancer Institute and Children's Hospital in Boston, Trowbridge has already published research in top journals and has captured the attention of several prominent funding organizations. She has earned a New Scholar Award in Aging from The Lawrence Ellison Foundation, a National Cancer Institute Provocative Questions Initiative award, a Maine Cancer Foundation grant and a newly announced V Scholar award from The V Foundation for Cancer Research.\nTrowbridge's postdoc mentor was Stuart Orkin, M.D., David G. Nathan Distinguished Professor of Pediatrics and Howard Hughes Medical Institute investigator at Harvard Medical School, who is also on the external advisory board of the JAX Cancer Center. \"Jen has the uncanny ability to focus on the critical issues and then design her experiments to address them clearly,\" Orkin says. \"Always upbeat and enthusiastic, Jen has always been a terrifically positive person. These traits make for a strong foundation, and have allowed her to transition to her independence smoothly and rapidly, becoming an important faculty member at JAX.\"\nDespite all of her precocious success, Trowbridge didn't start out planning to be a research scientist. Though she enjoyed math and science as a kid, by her senior year at the University of Western Ontario she was on a path to become a genetic counselor. But one lecture on signaling pathways in stem cell biology by a new faculty member sparked a passion for exploring genetic mechanisms.\n\"The thing I liked about genetic counseling,\" Trowbridge says, \"was the idea of interacting directly with people, and being able to feel like I was making a difference in their lives. But this professor was addressing genetic diseases directly, and showed me a different path to helping people.\"\nGenetics counseling in the genomic eraPatients and physicians rely on genetics counselors to understand the avalanche of new genetic tests and help them make smart medical decisions about what the tests reveal.\nFired up to go to graduate school in immunology and stem cell biology, but with only basic genetics and biochemistry courses under her belt, Trowbridge emailed the lecturing professor, Mick Bhatia, to ask whether he would take her on as a grad student. Bhatia declined but Trowbridge persisted, asking one of her professors to \"please talk to him and tell him that I'm smart and I have good hands in the lab and I'll work really hard, and that he should let me be in his lab.\"\nBhatia, who is now Canada Research Chair in human stem cell biology at McMaster University, agreed to be Trowbridge's mentor. \"Having had many graduate students before,\" Bhatia says, \"I suggested directions where techniques and preliminary data were available, so she could continue on a pre-developed track. This, however, was not a regular graduate student.\n\"A few months after her arrival, Jen would walk into my office and sit on the carpeted floor, where she insisted she was more comfortable. There would start discussions about the conceptual framework of experimentation, how controls for the variables could be designed and what interpretations from the experiments (that I later learned she was already doing) could be drawn out. These starting discussions were clearly the end of my contributions as a supervisor, and I quickly realized I had a stem cell biologist peer.\"\nBhatia adds, \"It's a delight to watch her achieve her goals, although I too often look at my empty carpet floor and miss Dr. Trowbridge.\"\nTrowbridge would, in fact, have made a first-rate genetic counselor. She has a serene, calm demeanor and listens thoughtfully, ignoring the frequent \"pink\" sounds of incoming emails on her computer. The people in her lab describe her as caring and supportive. She's also a family woman who ‚Äî with her husband Mike Kiers, a nurse at the local hospital and, like Trowbridge, tall and athletic ‚Äî has two young sons and is expecting a daughter in the spring.\nLike most principal investigators, Trowbridge has to spend most of her time at her computer, writing grant proposals and drafting research papers. This morning she has carved out time in her lab to meet with her small staff for a progress check on the quest to understand what goes wrong in AML.\nAll blood cells start from a common origin, hematopoietic stem cells (HSCs). HSCs in turn produce more specific progenitor cell types, each of which are responsible for producing various kinds of blood cells: red, white (including myeloid cells) and platelets.\nOver the years, the stem cell compartment in the bone marrow expands, but that's not good news: Some of the stem cells it cranks out don't function properly and instead produce more of the myeloid cell types, which increases the chance of these cells becoming cancerous.\nThis approach is kind of another dimension. It's an incredibly precise tool for looking at the big picture of a cancer.\nData from AML patients show that the stage of a progenitor cell when it becomes transformed to leukemia has an impact on its clinical progression, with earlier-stage cell of origin cancers being more aggressive. But how can you triage the different kinds of cells to determine the cells of origin?\nIn what could be described as a conceptual discovery, Trowbridge found a framework to sort out and evaluate tumor cells: their open chromatin profiles.\nChromatin is the material in the cell's nucleus that condenses to form chromosomes during cell division. Just as every species of tree produces leaves of a certain shape, every type of cell has a characteristic chromatin profile: a distinctive combination of closed (tightly wound and relatively inactive) and open (looser and more active) chromatin.\n\"We realized we could analyze open chromatin in bulk tumor cells,\" Trowbridge says, \"to determine what kind of cell the tumor had developed from. That cell-type specificity of chromatin structure provides a major clue for diagnosis and treatment.\"\nWorking with a mouse model of AML, the Trowbridge lab began with five distinct, normal cell types found in bone marrow: long-term HSCs, short-term HSCs, multipotent progenitors, common myeloid progenitors and granulocyte macrophage progenitors. The AML that developed from these different cells of origin had varying levels of aggressiveness when engrafted in mice, with the stem cell-derived lines being the most aggressive.\nTo profile the open chromatin in these distinct AML samples, and compare them to open chromatin patterns in normal cells, Trowbridge collaborated with Duygu Ucar, Ph.D., a JAX assistant professor who develops computational models to study gene regulation including chromatin structure. Together they identified open chromatin signatures and gene expression patterns in AML samples that enabled them to distinguish the more aggressive, stem-cell-derived AML.\n\"This approach is kind of another dimension,\" Trowbridge says. \"It's an incredibly precise tool for looking at the big picture of a cancer. It reveals what's happening in terms of how the cancer cells are behaving, where they've come from, what they've been exposed to and, potentially, what's going to be effective to treat them.\"\nUcar describes Trowbridge as \"a dream collaborator\" for a computational scientist. \"It's a great pleasure to work with her. She generates top-quality data and asks very smart research questions.\"\nBack in her office, Trowbridge reflects on the struggles inherent in being a principal investigator in today's complex research environment, which she describes as finding a balance between positivity and realism.\n\"I've learned that it's okay to have to lean on somebody else, to ask somebody for help, to collaborate with somebody because you can't get this particular technique to work and they're an expert in it. Working with Duygu is a perfect example of this.\"\nBy the same token, she says, \"The hardest lesson that I have had to learn is to know when to cut a project, because it's not going as well as you had hoped and you're just sinking a lot of resources and time into it. Ultimately it does better justice to the process and to science to be able to make those difficult decisions.\"\nExploring the science of agingJAX computational scientist Duygu Ucar bridges the worlds of biology and computer science to unlock the secrets of aging and age-related disease.\nThe treatment of non-malarial febrile illness in Papua New Guinea: findings from cross sectional and longitudinal studies of health worker practice | BMC Health Services Research | Full Text\nThe treatment of non-malarial febrile illness in Papua New Guinea: findings from cross sectional and longitudinal studies of health worker practice\nOlga P. M. Saweri1,\nIvo Mueller4,5,\nPeter M. Siba1 &\nJustin Pulford ORCID: orcid.org/0000-0003-4756-84801,6\nBMC Health Services Research volume 17, Article number: 10 (2017) Cite this article\nThe Papua New Guinea Department of Health recently shifted from a presumptive to a 'test and treat' malaria case management policy. This shift was supported by the widespread introduction of malaria rapid diagnostic tests in health facilities across the country. Health workers received training and job-aids detailing how to conduct and interpret a malaria rapid diagnostic test and how to treat test positive cases; however, little instruction on treating non-malaria febrile cases was provided. Accordingly, this study examined health worker case management of non-malarial febrile patients in the 12-month period immediately following the introduction of the revised malaria case management policy.\nData were collected from a country-wide cross-sectional survey of febrile case management at randomly selected health facilities and from longitudinal surveillance at sentinel health facilities. Analysis was restricted to febrile patients who tested negative for malaria infection by rapid diagnostic test (N=303 and 5705 outpatients, respectively).\n96.8% of non-malarial febrile patients received a diagnosis in the longitudinal sample, compared to 52.4% of the cross-sectional sample. Respiratory tract infections were the most commonly reported diagnoses. Over 90% of patients in both samples were prescribed one or more medications, most commonly an analgesic (71.3 & 72.9% of the longitudinal and cross-sectional samples, respectively), some form of antibiotic (72.7 & 73.4%, respectively) and/or an anthelminthic (17.9 & 16.5%, respectively). Prescribing behaviour was adherent with the recommendations in the standard treatment guidelines in fewer than 20% of cases (longitudinal sample only).\nMany non-malarial febrile patients are not provided with a diagnosis. When diagnoses are provided they are typically some form of respiratory tract infection. Antibiotics and analgesics are widely prescribed, although medications prescribed rarely adhere to the Papua New Guinea standard treatment guidelines. These findings indicate that Papua New Guinea health workers require support for non-malarial febrile illness case management.\nThe last 5 to 10 years has seen a substantial increase in the availability and use of malaria Rapid Diagnostic Tests (mRDTs) in many parts of the world [1]. Consistent with these global trends, Papua New Guinea (PNG) with support from a Round 8 Global Fund grant has procured over three million mRDTs since 2010 [2]. This supports a revised national malaria treatment policy (NMTP) stipulating that all fever or suspected malaria cases be tested for malaria infection by microscopy or mRDT [3]. Internationally, the scale-up of mRDT availability has often led to substantial reductions in antimalarial prescription as health workers shift from a presumptive to a 'test and treat' malaria case management approach [4‚Äì6]. There is some evidence to suggest a similar change in health worker practice is occurring in PNG. A recent study found that antimalarial prescriptions to febrile patients declined from 96.4% of cases before the introduction of the test and treat policy to 39.0% in the 12-month period immediately post-implementation [7]. The availability of mRDTs increased from 8.9% of surveyed facilities to 53.4% across the same time period.\nWhilst mRDTs can confirm or rule out malaria infection, they provide no support to health workers for diagnosing and treating non-malarial fevers. Fever is an unspecific syndrome and diagnostic tools to assist in the accurate identification of its aetiology in mRDT negative patients are scarce in resource-poor settings [8]. The historic practice of presumptive malaria diagnosis may further undermine the quality of non-malarial febrile case management as the health workforce has little acquired experience in the clinical diagnosis and treatment of non-malarial febrile patients [9]. Many febrile patients attending PNG health facilities test negative for malaria infection and the malaria burden is declining in the general population [10, 11]. Thus, the health workforce is increasingly, and quite suddenly, required to respond to febrile illnesses shown to be non-malarial in origin via mRDT.\nA health worker training program was carried out in PNG pre-implementation of the new NMTP. This program provided detailed instruction on mRDT use and strongly emphasised the importance of restricting antimalarial prescription to test-confirmed cases [12]. Nevertheless, the training program provided relatively little detail on non-malarial febrile case management beyond reference to an Integrated Management of Childhood Illness (IMCI) flowchart. No instruction on the management of non-malarial febrile illness in adolescent or adult patients was provided. The PNG National Department of Health and the Paediatric Society of PNG issues standard treatment guidelines which outline recommended management of a range of common illnesses, including non-malarial febrile illness [13, 14]. Apart from these reference manuals, no other training, resources or support have been specifically provided to assist the PNG healthcare workforce manage the increasing number of non-malarial febrile illness cases identified in the context of the new NMTP. Accurate diagnosis of non-malarial febrile illness is further comprised by the absence of on-site laboratory support at most primary health care facilities in PNG [15]. The general lack of curative treatments for most viral febrile illnesses may be an additional obstacle to implementing accurate evidence-based treatment.\nThis paper examines how the PNG primary healthcare workforce diagnosed and treated non-malarial febrile patients in the period immediately following the widespread introduction of mRDTs. The primary research questions included: what percentage of non-malarial febrile patients are provided a recorded diagnosis? What diagnoses are being recorded? What medications are being prescribed? And to what extent do the medications prescribed adhere with national standard treatment guidelines?\nThis paper presents selected data from a multifacted evaluation of the PNG National Malaria Control Program (NMCP), 2009‚Äì2014. A full description of the NMCP evaluation is available elsewhere [16]. Reported data were obtained from longitudinal, outpatient surveillance in seven sentinel health facilities and a cross sectional survey completed in 36 randomly selected health facilities across the country. The longitudinal dataset provided a large number of febrile cases, although the respective case management of these patients was provided by a relatively small number of health workers working within a quasi-research environment. The cross sectional dataset provided fewer clinical cases, but these cases were clinically managed by a greater number of health workers from across a greater number of health facilities in a routine clinical environment. The datasets are considered complementary as, together, they provide clinical case management records pertaining to non-malaria febrile illness for over 6000 patients from 43 health facilities.\nOutpatient surveillance was variously initiated in seven sentinel primary health care facilities across PNG between January 2010 and July 2011. The primary aim of the surveillance was to assess trends in malaria morbidity. The seven facilities were purposively selected from a sampling frame of operational public-sector health centres provided by the PNG Department of Health according to their accessibility, their functionality, their geographical spread and the local malaria epidemiology and were located in Balimo (Western province), East Cape (Milne Bay province), Karimui (Chimbu province), Sausi (Madang province), Dreikikir (East Sepik province), Lemakot (New Ireland province) and Arawa (Autonomous Region of Bougainville). For the purpose of this paper, focus is placed on data collected in the calendar year 2012 as the revised NMTP was implemented in November, 2011.\nDaily surveillance was carried out at each health facility during regular opening hours (Monday to Friday, 7.45 am-4.06 pm). Outpatients presenting with fever or a history of fever, in the past 3 days, were referred to a study nurse who then completed an mRDT, prepared a thick and thin blood smear on a microscopy slide and measured haemoglobin (Hb) level using a Hemocue Hb 201+ analyser (HemoCue AB, √Ñngelholm, Sweden). Demographic details of the patient were recorded in a one-page case report form alongside clinical signs and symptoms, previous health facility attendance and drug intake, axillary temperature, weight and results of the mRDT and Hb measurement. The patient was then transferred to a member of the respective facility's health work force for further examination, diagnosis and treatment following routine procedures. The resulting diagnosis and any prescription by the health worker were recorded on the case report form. Oral informed consent was obtained from all patients prior to participation.\nThe sample consisted of primary health care facilities randomly selected as part of a countrywide cross sectional health facility survey in which at least one instance of febrile case management has been observed by a member of the research team. The sampling frame consisted of all primary health care facilities operational at the time of the survey. Health facilities were stratified by province and selected using a simple random sampling procedure. Sample size was determined by logistical considerations.\nThe survey was carried out between June and November 2012. Research officers spent between 1 to 5 days at each participating health facility (depending on size). Up to four different survey instruments were completed at each health facility, although this paper only reports data obtained from the non-participant observation of febrile case management (described below). Oral informed consent was sought from the officer in charge at all participating health facilities and from all participating clinicians and patients prior to clinical observation. More details of the general survey methodology have been published elsewhere [7].\nA structured checklist was designed to record observed features of the clinical case management of patients presenting with fever or a recent history of fever. The instrument was divided into discrete sections including consultation and diagnosis, prescription and treatment counseling. The content of each section was informed with input from experienced medical- and medical research- professionals. The instrument was completed by a trained research officer who would passively observe the management of fever patients from the point of initial contact with a health professional until service exit or admission onto a treatment ward. During the course of this observation, the research officer recorded on the structured clinical observation instrument whether specified actions did or did not occur and recorded the content of specific actions (e.g., whether an mRDT was conducted and, if yes, the outcome). Eligible patients were identified upon first contact with a health worker or, if circumstances allowed, by screening in the waiting area prior to first contact with a health worker.\nAll data were double entered into DMSys version 5.1 (Sigma Soft International). Stata versions 11/IC and 12/SE were used for descriptive data analysis and to assess health worker adherence to prescription guidelines. The analysis of health worker adherence to prescription guidelines was limited to the ten most frequently recorded diagnoses and to patients with a single recorded diagnosis. Patients with multiple diagnoses were not included as it was not possible to determine which medications were prescribed for which diagnosis. To be rated 'adherent' the medications prescribed were required to be consistent with those listed against the specified diagnosis in either the Papua New Guinea Standard Treatment Guidelines for Adults [14] or Children [13], as listed in Table 1. A rating of 'partially adherent' was given when at least one (but not all) of the listed medications for the specified diagnosis were prescribed or the same class of medication was prescribed, but not the recommended drug. A rating of 'non-adherent' was given when the medication/s prescribed was/were neither the recommended drug nor the same class of medication as stated in the aforementioned manuals. The analysis of health worker adherence to prescription guidelines did not account for drug dosages and was not applied to the CS sample due to the large number of cases without a recorded diagnosis. Between-group differences in the mean number of medications prescribed and type of prescription were examined by two-tailed t-tests and chi-square, respectively, in the CS sample.\nTable 1 Recommended medications for specified diagnoses according to the Papua New Guinea Standard Treatment Guidelines for Adults and Children\nA total of 5705 patients with fever or recent experience of fever tested negative for malaria by mRDT across the seven sentinel sites in 2012. Of these patients, 50.9% were female, 42.3% were <5 years of age, 18.7% were between 5 and 15 years of age and 39.0% were 16 years of age or older.\nA diagnosis was recorded for 96.8% (5521/5705) of the outpatient surveillance (OS) sample. Of outpatients with a recorded diagnosis, 88.9% (4906/5521) had one recorded diagnosis and 11.1% (615/5521) had two or more. Overall, a total of 6152 diagnoses were recorded of which 87.6% (5391/6152) appear in the Papua New Guinea Standard Treatment Guidelines for Adults [14] or Children [13]. A full list of the recorded diagnoses is available in Additional file 1. The ten most frequently recorded diagnoses, accounting for 72.6% (4469/6152) of all diagnoses, included: Pneumonia (n‚Äâ=‚Äâ824), Cough (n‚Äâ=‚Äâ790), Respiratory Tract Infection (n‚Äâ=‚Äâ613), Malaria (n‚Äâ=‚Äâ510), Anaemia (n‚Äâ=‚Äâ452), Fever of Unknown Origin (n‚Äâ=‚Äâ399), Otitis Media (n‚Äâ=‚Äâ286), Diarrhoea (n‚Äâ=‚Äâ274), Flu (n‚Äâ=‚Äâ233) and Worms (n‚Äâ=‚Äâ88).\nAll participants included in the OS sample were tested for malaria and anaemia using diagnostic tests. These were the only two diagnostic test results routinely recorded that allow the accuracy of the respective diagnosis to be assessed. By definition, all participants included in the OS sample tested negative for malaria infection by mRDT; however, 8.9% (510/5705) were given a recorded diagnosis of malaria all of which would be considered incorrect according to mRDT result assuming absence of signs of severe malarial disease (7/510 malaria diagnose were recorded as 'severe malaria'). Anaemia was defined, by the Papua New Guinea Standard Treatment Guidelines, as any patient presenting with Hb less than 10 g/dL. A Hb level lower than 5 g/dL indicates severe anaemia. Overall, 27.4% (1561/5705) of the OS sample tested positive for either moderate (n‚Äâ=‚Äâ1481) or severe anaemia (n‚Äâ=‚Äâ80). Of these 1561 patients, 24.9% were formally diagnosed with anaemia.\nNinety-six point five percent (5508/5705) of the OS sample were prescribed one or more medications, the number, percentage and type of which are depicted in Table 2. The mean number of medications prescribed (analysis restricted to patients prescribed at least one medicine) was 1.8 (Median 1; IQR 1‚Äì2). Overall, antibiotics were the most commonly prescribed medication (72.7%), followed by analgesics (71.3%) and anthelminthics (17.9%). One or more antimalarial medications were prescribed to 13.2% (753/5705) of the OS sample, the most common of which were sulphadoxine/pyrimethamine (SP) (8.1%), chloroquine (4.2%) and amodiaquine (3.6%). 58.6% (441/753) of these patients received some form of antimalarial combination, the most common of which were SP plus chloroquine (21.1%), and SP plus amodiaquine (19.1%). Artemether monotherapies were prescribed in 2.9% (22/753) of cases.\nTable 2 Number, percent and type of prescribed medications by survey type\nHealth worker adherence to prescription guidelines\nAs shown in Table 3, a total of 3249 patients met the inclusion criteria for this analysis of whom 16.6% received a prescription in adherence with the standard treatment guidelines for their respective diagnosis. The majority of prescriptions (56.3%) were rated 'partially adherent', 21.8% 'non-adherent' and a rating was unable to be made in 5.4% of cases.\nTable 3 Health worker adherence to prescription guidelines relative to recorded diagnosis\nTable 4, drawing on the same sample as presented in Table 3 and further limited to those patients for whom it was possible to provide an 'adherence' rating (n‚Äâ=‚Äâ3075), presents the percentage of participants for whom: according to the respective prescription protocols in the PNG standard treatment guidelines, (1) should have been prescribed an antibiotic and were not (under prescription); and (2) should not have been provided an antibiotic and were (over prescription). As shown, 18.7% of patients in the five diagnostic categories in which an antibiotic should have been prescribed did not receive an antibiotic. Conversely, 41.0% of patients in the five diagnostic categories in which an antibiotic should not have been prescribed did receive an antibiotic.\nTable 4 Antibiotic prescription relative to diagnosis, according to Papua New Guinea Standard Treatment Guidelines\nA total of 303 febrile patients tested negative for malaria by mRDT or microscopy. Of these patients, 50.8% were female, 47.9% were <5 years of age, 19.5% were between 5 and 15 years of age and 32.7% were 16 years of age or older. These patients were collectively observed across 36 health facilities in 17 provinces.\nA diagnosis was only sought for mRDT negative patients not prescribed an antimalarial (n‚Äâ=‚Äâ246) as those prescribed antimalarials (n‚Äâ=‚Äâ57) were assumed to have been diagnosed with malaria despite the mRDT result. Of these 246 patients, a diagnosis was recorded in 52.4% of cases. The specified diagnoses indicated some form of respiratory tract infection (n‚Äâ=‚Äâ80), general body aches or headache (n‚Äâ=‚Äâ28), fever (n‚Äâ=‚Äâ11), diarrhoea (n‚Äâ=‚Äâ9), ear infection (n‚Äâ=‚Äâ7), shortness of breath (n‚Äâ=‚Äâ7), sore mouth/throat (n‚Äâ=‚Äâ5), influenza (n‚Äâ=‚Äâ4), viral infection (n‚Äâ=‚Äâ3), malaise (n‚Äâ=‚Äâ3), vomiting (n‚Äâ=‚Äâ2), food poisoning (n‚Äâ=‚Äâ2) and one each of measles, tuberculosis, anaemia, gastroenteritis, swelling, bleeding eye, pregnancy and hypertension.\nOf the 117 mRDT negative patients without a recorded diagnosis (or prescribed antimalarials), 94.0% (110/117) were prescribed some form of medication suggesting the health worker formed a clinical opinion as to the cause of the febrile illness even if this opinion was not formally recorded or reported to the patient.\n97.0% (294/303) of the CS sample were prescribed one or more medications, the number, percentage and type of which are listed in Table 2. The mean number of medications prescribed (analysis restricted to patients prescribed at least one medicine) was 2.1 (Median 2; IQR 2‚Äì3). Overall, antibiotics were the most commonly prescribed medication (73.4%) followed by analgesics (72.9%). One or more antimalarial medications were prescribed to 18.8% (57/303) of the CS sample despite the negative mRDT result. The most commonly prescribed antimalarials were SP (13.9%), amodiaquine (6.9%) and chloroquine (6.6%). The recommended first line medication for uncomplicated malaria, artemether-lumefantrine, was prescribed in 1.0% (3/303) of cases. 13.9% (42/303) of these patients received some form of antimalarial combination, the most common of which were chloroquine plus SP (6.6%), amodiaquine plus SP (5.0%) and artemether/artesunate plus SP (1.7%). Artemether monotherapies were prescribed in less than 1.0% (2/303) of cases.\nExcluding patients prescribed an antimalarial (for whom diagnostic information was not sought), there was no statistically significant difference in the mean number of medications prescribed to mRDT negative patients with a recorded diagnosis as compared to those without a recorded diagnosis (2.0 vs. 1.9; t‚Äâ= ‚àí0.3, p‚Äâ=‚Äâ0.76). Furthermore, mRDT negative patients not provided a diagnosis were as likely to receive an antibiotic (75.9% vs. 73.1%; œá 2‚Äâ=‚Äâ0.7, p‚Äâ=‚Äâ0.42) or analgesic (71.6% vs. 76.2%; œá 2‚Äâ=‚Äâ0.7, p‚Äâ=‚Äâ0.41) as those with a recorded diagnosis suggesting prescribing behaviour was similar irrespective of whether a formal diagnosis was recorded or not.\nThis paper presents data pertaining to the clinical case management of non-malarial febrile patients in the 12-month period immediately following the discontinuation of a treatment protocol in which most febrile patients were presumptively treated with antimalarials. Data were derived from longitudinal surveillance in seven outpatient sentinel health facilities and from a cross sectional survey in 36 health centres across 17 provinces in PNG.\nFindings from the OS sample indicate that the vast majority of non-malarial febrile patients had a formal diagnosis recorded, in the CS sample this was little more than 50%. As the latter comprised a greater number of health workers, and as these health workers were not prompted to provide a diagnosis (as was the case in the OS sample), then the CS percentage may be the more accurate reflection of standard practice. Respiratory tract infections, often pneumonia, were the most common diagnosis provided across both datasets. Diagnoses of diarrhoea and general body aches were also prominent across samples, although at a substantially lower frequency. Respiratory tract infections and diarrhoea have historically been reported at a high frequency on the PNG National Health Information System [17] and are ranked highly in PNG burden of disease estimates [18]. Thus, the specified diagnoses of non-malarial febrile illness are largely consistent with existing data sources.\nIt was not possible to determine whether the recorded diagnoses were accurate or not in the context of this study, with the exception of malaria and anaemia. However, the small number of studies that have examined the aetiology of non-malarial febrile illness in PNG have identified dengue as a cause in approximately 10% of cases [19, 20] and a chikungunya virus outbreak was detected in PNG at the time the reported data were collected [21, 22]. A recent review of non-malarial febrile illness in the neighbouring South East Asia region further identified dengue, typhus and Leptospira spp. as the most commonly reported pathogens across 146 studies meeting the inclusion criteria [23]. As neither dengue, chikungunya, typhus or leptospira spp. were diagnosed in a single case in either sample, as malaria was diagnosed in between 8.9 to 18.8% of mRDT-negative cases and as anaemia was substantially underdiagnosed despite the availability of a Hb-measurement in the OS sample, there is reason to question the accuracy of recorded diagnoses. The limited diagnostic/laboratory support available in primary health care facilities in PNG restricts the degree to which health workers can investigate the causes of febrile illnesses and may consequently influence the accuracy of diagnoses provided. The threat of misdiagnosis may, therefore, be considered a result of limitations in the broader healthcare system rather than health worker ability per se.\nPrescription patterns were consistent across datasets. Over 90% of patients in both the OS and CS sample were prescribed one or more medications, most commonly some form of antibiotic, analgesic and/or anthelminthic. Antimalarials were provided in 18.8 and 13.2% of OS and CS cases, respectively, despite the negative mRDT result. This rate of antimalarial prescription to mRDT negative patients is lower than that reported in other settings [24‚Äì26] and represents a substantial reduction in the rate of antimalarial prescription to febrile patients compared to the practice observed prior to the change in treatment protocol [27]. Thus, while not fully compliant with the revised protocol, PNG health workers have seemingly made radical and appropriate adjustments to their antimalarial prescription practices in a relatively brief time frame and perhaps at a faster rate than their international peers in similar circumstances.\nThe adherence analysis indicated that the prescription provided was consistent with that recommended in the respective PNG standard treatment manual for the specified diagnosis in fewer than 20% of cases (OS sample only). The majority of prescriptions (56.3%) were rated 'partially adherent', indicating that at least one, but not all, of the recommended medications was provided or the correct class of medication was provided, but not the recommended drug. It was not possible to determine what influence the availability of the respective medications played in this outcome. This result, therefore, most likely reflects limitations in both medication availability and health worker practice, yet it remains the case that the medications provided were rarely in full accordance with those recommended for the diagnoses given. A previous study, not restricted to mRDT negative cases, reported 'appropriate' prescription rates (based on diagnosis) of between 62.1‚Äì69.6% in two secondary care settings and an outpatient facility in PNG [28]. Thus, the relatively poor adherence to prescription guidelines reported in this study suggests that PNG health workers may be less likely to provide a recommended prescription when treating non-malarial febrile illness patients. However, in the absence of an expert reference diagnosis in the context of this study, the extent and consequences of any potential misdiagnosis and non-recommended prescription cannot be judged.\nPrevious studies have reported similar rates of antibiotic prescription to mRDT negative patients as reported here, from 61.4% in Uganda [29] to 78% in Tanzania [30]. Accordingly, the rates may be considered somewhat normative in a low income country setting in which a shift from presumptive to parasitological confirmed malaria diagnosis has recently taken place. Nevertheless, the rate of antibiotic prescription is high and raises the possibility that primary health care workers in PNG may be substituting antimalarial medication with antibiotic medication in response to the revised NMTP, as has been previously suggested [6, 9]. The potential over-prescription of antibiotics cannot be reliably established in the absence of an expert reference diagnosis including, in some instances, additional diagnostic testing; nevertheless, a recent study reported unnecessary antibiotic prescription in 29% of 6969 observed illness episodes in outpatient health services in PNG [31] which is somewhat consistent with the rate of antibiotic over prescription (41%) reported herein. Furthermore, an analysis of medication prescription to malaria mRDT positive patients in the CS survey [7] found that out of 54 mRDT positive patients, 98.2% were prescribed an antimalarial, yet only 14.8% were prescribed an antibiotic. This would indicate that health workers are selectively (and often unnecessarily) prescribing antibiotics to mRDT negative cases as opposed to routinely providing them to all febrile patients.\nThis study was not without limitation. Firstly, the fact that (to a large extent) the accuracy of the reported diagnoses was not able to be assessed in either the OS or CS sample remains an important knowledge gap. Whilst assessing the accuracy of non-malarial febrile illness was not an aim of the study, without this essential information it is difficult to reliably assess the quality of health worker practice. A further limitation is that the study did not take into consideration medication supplies at the respective health facilities in either survey. The supply of anti-malarial drugs or other medications could have an implied effect on the prescribing behaviour of health workers [32]. In addition, health workers in the OS sample were required to complete a diagnosis and medication section on a research-specific case report form which is not reflective of normal practice and health workers in the CS sample were actively observed during their respective febrile case consultations by a member of a research team. This, too, may have influenced health worker practice. The health workers in both surveys were predominantly nurses and community health workers. Therefore, the conclusions drawn concerning health worker behaviour are not a complete depiction of all health worker cadres in PNG.\nThe respective datasets also had their inherent weaknesses. The OS analyses were based on a large number of patient cases, yet they had been collectively treated by a relatively small number of health workers. Conversely, the CS analyses were based on a smaller number of patients, yet they had been treated by a larger number of health workers from a more diverse array of health facilities. Triangulating findings from the two datasets, as was done here, overcomes their respective limitations in part. Despite these limitations, the collective sample size of both patients and health workers, the relatively robust sampling and study protocols, the geographical spread of participating health centres and the general agreement between the two datasets with respect to reported diagnosis and prescription practice suggests the reported findings could reasonably be generalised to health centres across PNG.\nThe findings indicate health workers predominantly adhere to mRDT negative results, determine alternative diagnoses in most cases and provide medications other than antimalarials. However, the findings further suggest that a large proportion of non-malarial febrile patients are not being provided a diagnosis, the diagnoses that are given may not necessarily be accurate, the medications prescribed rarely fully adhere to those recommended for the specified diagnosis and that antibiotics are likely to be overprescribed. All of these factors strongly indicate a need for intensive and continuing health worker support in the diagnosis and management of non-malarial fevers and for thorough scientific investigation and reporting on the aetiology of non-malarial fevers across the various regions of PNG.\nInterventions based on training and/or the provision of rapid diagnostic tests have demonstrably improved non-malarial febrile case management [33], and interventions proven successful in improving malaria case management, such as text message reminders [34], would seemingly be easily transferable. General health systems strengthening in low income country contexts such as PNG is equally essential to sustained improvement in health worker performance [35]. As multiple support and supervisory mechanism are typically required to improve health worker practice [36], strengthening non-malarial febrile case management in primary health care contexts in PNG will likely require a package of health worker and health system strengthening interventions, variously focusing on: further reducing antimalarial prescription to malaria mRDT negative patients; encouraging formal diagnosis and the use of clinical and available laboratory resources to inform diagnosis; rational use of antibiotics; and adherence to recommended treatment guidelines when a diagnosis is made.\nNMTP:\nNational Malaria Treatment Protocol\nOutpatient longitudinal surveillance\nZhao J, Lama M, Korenromp E, Aylward P, Shargie E, Filler S, et al. Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010. PLoS One. 2012;7(8):e43549. doi:10.1371/journal.pone.0043549. PubMed PMID: 22952703, PubMed Central PMCID: PMC3428362.\nThe Global Fund. Malaria Control in Papua New Guinea: Scaling up for Impact 2010 [cited 2013 16/08/2013]. Available from: http://portfolio.theglobalfund.org/en/Grant/Index/PNG-809-G04-M.\nPapua New Guinea National Department of Health. National Malaria Treatment Protocol. Port Moresby: 2009.\nYukich JO, Bennett A, Albertini A, Incardona S, Moonga H, Chisha Z, et al. Reductions in artemisinin-based combination therapy consumption after the nationwide scale up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg. 2012;87(3):437‚Äì46. doi:10.4269/ajtmh.2012.12-0127. PubMed PMID: 22848096, PubMed Central PMCID: PMC3435345.\nThiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, et al. Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One. 2011;6(4):e18419. doi:10.1371/journal.pone.0018419. PubMed PMID: 21494674, PubMed Central PMCID: PMC3071817.\nBruxvoort K, Kalolella A, Nchimbi H, Festo C, Taylor M, Thomson R, et al. Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. Trop Med Int Health. 2013. doi:10.1111/tmi.12168.\nPulford J, Kurumop S, Ura Y, Siba P, Mueller I, Hetzel MW. Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol. Malar J. 2013;12:433.\nChappuis F, Alirol E, d'Acremont V, Bottieau E, Yansouni CP. Rapid diagnostic tests for non-malarial febrile illness in the tropics. Clin Microbiol Infect. 2013;19(5):422‚Äì31. doi:10.1111/1469-0691.12154.\nBaiden F, Webster J, Owusu-Agyei S, Chandramohan D. Would rational use of antibiotics be compromised in the era of test-based management of malaria? Trop Med Int Health. 2011;16(2):142‚Äì4. doi:10.1111/j.1365-3156.2010.02692.x.\nWorld Health Organisation. World malaria report 2014. Geneva: World Health Organisation; 2014.\nHetzel MW, Paul S, Benjamin L, Makita L, Mueller I, Siba PM. Proportion of fevers attributable to malaria varies significantly between sites in Papua New Guinea. P N G Med J. 2014;57(1‚Äì4):39‚Äì51.\nNational Competency Training Project. Malaria diagnosis and the New treatment protocol: a training manual for health workers in Papua New Guinea. Port Moresby: Birdwing Publishing; 2010.\nPaediatric Society of Papua New Guinea. Standard treatment for common illnesses of children in Papua New guinea: manual for nurses, community health workers, health extension officers and doctors. 9th ed. Port Moresby: Paediatric Society of Papua New Guinea; 2011.\nNational Department of Health. Standard treatment guidelines for common illness of adults in Papua New guinea: a manual for nurses, health extension officers and doctors. 6th ed. Port Moresby: National Department of Health; 2012.\nIMRG. Papua New Guinea Independent Monitoring Review Group (Health). Report No. 4. Port Moresby: Independent Monitoring Review Group; 2008.\nHetzel MW, Pulford J, Maraga S, Barnedas C, Reimer L, Tavul L, et al. Evaluation of the global fund-supported national malaria control program in Papua New Guinea, 2009‚Äì2014. P N G Med J. 2014;57(1‚Äì4):7‚Äì29.\nPNG National Department of Health. Health sector review, 2001‚Äì2009. Port Moresby: National Department of Health; 2009.\nInstitute for Health Metrics and Evaluation. GBD Profile: Papua New Guinea Seattle: Institute for Health Metrics and Evaluation; 2010 [cited 2015 07/07/2015]. Available from: http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_country_report_papua_new_guinea.pdf.\nBande G, Hetzel MW, Iga J, Barnadas C, Mueller I, Siba P, et al. An investigation into febrile illnesses of unknown aetiology in Wipim, Papua New Guinea. P N G Med J. 2014;57(1‚Äì4):52‚Äì8.\nSenn N, Luang-Suarkia D, Manong D, Siba PM, McBride WJ. Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study. Am J Trop Med Hyg. 2011;85(1):132‚Äì7. doi:10.4269/ajtmh.2011.10-0482. PubMed PMID: 21734138, PubMed Central PMCID: PMC3122357.\nHorwood P, Bande G, Dagina R, Guillaumat L, Aaskov J, Pavlin B. The threat of chikungunya in Oceania. Western Pacific Surveillance and Response. 2013;4(2):8‚Äì10. doi:10.5365/wpsar.2013.4.2.003.\nHorwood P, Dagina R, Bande G, Reimer L, Koimbu G, Katusele M, et al. Outbreak of chikungunya virus infection, Vanimo, Papua New Guinea. Emerg Infect Dis. 2013;19(9):1535‚Äì8.\nAcestor N, Cooksey R, Newton PN, Menard D, Guerin PJ, Nakagawa J, et al. Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One. 2012;7(9):e44269. doi:10.1371/journal.pone.0044269. PubMed PMID: 22970193, PubMed Central PMCID: PMC3435412.\nJuma E, Zurovac D. Changes in health workers' malaria diagnosis and treatment practices in Kenya. Malar J. 2011;10:1. doi:10.1186/1475-2875-10-1. PubMed PMID: 21214892, PubMed Central PMCID: PMC3022768.\nHamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA. 2007;297(20):2227‚Äì31. doi:10.1001/jama.297.20.2227. PubMed PMID: 17519412, PubMed Central PMCID: PMC2674546.\nKyabayinze DJ, Asiimwe C, Nakanjako D, Nabakooza J, Counihan H, Tibenderana JK. Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar J. 2010;9:200. doi:10.1186/1475-2875-9-200. PubMed PMID: 20624312, PubMed Central PMCID: PMC2914063.\nPulford J, Mueller I, Siba PM, Hetzel MW. Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol. Malar J. 2012;11:157. doi:10.1186/1475-2875-11-157. PubMed PMID: 22564504, PubMed Central PMCID: PMC3441287.\nJoshua I, Passmore P, Parsons R, Sunderland V. Appropriateness of prescribing in selected healthcare facilities in Papua New Guinea. Health Policy Plan. 2014;29(2):257‚Äì64.\nBatwala V, Magnussen P, Nuwaha F. Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda. Malar J. 2011;10:377. doi:10.1186/1475-2875-10-377. PubMed PMID: 22183039, PubMed Central PMCID: PMC3258227.\nD'Acremont V, Kahama-Maro J, Swai N, Mtasiwa D, Genton B, Lengeler C. Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malar J. 2011;10:107. doi:10.1186/1475-2875-10-107. PubMed PMID: 21529365, PubMed Central PMCID: PMC3108934.\nSenn N, Rarau P, Salib M, Manong D, Siba P, Rogerson S, et al. Use of antibiotics within the IMCI guidelines in outpatient settings in Papua New Guinean children: an observational and effectiveness study. Plos One. 2014;9(3):e90990. doi:10.1371/journal.pone.0090990.\nHensen B, Paintain LS, Shretta R, Bruce J, Jones C, Webster J. Taking stock: provider prescribing practices in the presence and absence of ACT stock. Malar J. 2011;10:218. doi:10.1186/1475-2875-10-218. PubMed PMID: 21812948, PubMed Central PMCID: PMC3163227.\nPhuong HL, Nga TT, Giao PT, Hungle Q, Binh TQ, Nam NV, et al. Randomised primary health center based interventions to improve the diagnosis and treatment of undifferentiated fever and dengue in Vietnam. BMC Health Serv Res. 2010;10:275. doi:10.1186/1472-6963-10-275. PubMed PMID: 20858230, PubMed Central PMCID: PMC2955016.\nZurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, et al. The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet. 2011;378(9793):795‚Äì803. doi:10.1016/S0140-6736(11)60783-6. PubMed PMID: 21820166, PubMed Central PMCID: PMC3163847.\nMasanja IM, de Bethune X, Jacobs J. Implementing ideal health policy in a fragile health system: the example of expanding the use of malaria rapid diagnostic tests in mainland Tanzania. Malar J. 2011;10:322. doi:10.1186/1475-2875-10-322. PubMed PMID: 22035466, PubMed Central PMCID: PMC3212840.\nThis study was financially supported by a Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Round 8 grant. GFATM played no role in study design, data collection, analysis and interpretation nor did they contribute to the drafting or reviewing of this published article in any way.\nOPMS: Analysed the data and wrote the first draft of the publication. MH: Developed the study, implemented data collection and contributed to the final version of the manuscript. PMS, IM: Developed the study and contributed to the final version of the manuscript. JP: Implemented data collection, co-analysed the data and contributed to the final version of the manuscript. All authors read and approved the final manuscript.\nThe Medical Research Advisory Committee of Papua New Guinea approved this study (MRAC No. 10.12; 26 Feb 2010). Oral informed consent was obtained from the officer in charge at all participating health facilities as well as all participating health workers and patients.\nPapua New Guinea Institute of Medical Research (PNGIMR), PO Box 60, Goroka, EHP 441, Papua New Guinea\nOlga P. M. Saweri\n& Justin Pulford\nSwiss Tropical and Public Health Institute, PO Box, 4002, Basel, Switzerland\nBarcelona Centre for International Health Research (CRESIB, Hospital Cl√≠nic-Universitat de Barcelona), Barcelona, Spain\nSearch for Olga P. M. Saweri in:\nSearch for Manuel W. Hetzel in:\nSearch for Peter M. Siba in:\nSearch for Justin Pulford in:\nCorrespondence to Justin Pulford.\nFull list of recorded diagnoses for the outpatient surveillance sample. (DOCX 21 kb)\nSaweri, O.P.M., Hetzel, M.W., Mueller, I. et al. The treatment of non-malarial febrile illness in Papua New Guinea: findings from cross sectional and longitudinal studies of health worker practice. BMC Health Serv Res 17, 10 (2017) doi:10.1186/s12913-016-1965-6\nDaily As a Nephrologist Will Not All Unicorns and therefore Rainbows - Sala Journal\nDaily As a Nephrologist Will Not All Unicorns and therefore Rainbows\nOctober 29, 2017 sala Uncategorized\nThere are unquestionably five phase of renal diseases and as a consequence two kinds of diabetes, but put together you have any idea that that there is everything that is accepted as ones Diabetic Kidney Disease in addition to DKD? This occurs when the kidney disease can caused just by diabetes where the cosmetic surgeon has to order a suitable kidney biopsy to find out an primary contributing factor of the very kidney letdowns.\nThere is considered to be no nobody else for help failure that typically means that treatment must be needed towards a user to real world. What accomplishes this mean? It generally the vigorously truth: vital processes that experts claim keep a person functioning have stopped functioning. A person by means of kidney failures cannot eliminate waste on top of that thus high-risk wastes or toxins increase up found in the complete body. It at the same time causes the entire body to retain too much juice. Kidney incapability contributes in order to really high bloodstream pressure; and makes typically the body deliberate down within producing green blood solar cells. Treatments available for help failure include: hemodialysis, peritoneal dialysis yet kidney hair loss transplant.\nSymptoms form as gingival bleeding which inturn is where the gumline bleed, or advanced nicotine gum disease otherwise even periodontitis can tend to predicaments such as early tooth enamel loss. An extra common circumstances is xerostomia or dried out mouth, where a unhurried is unable to vegetables sufficient spit to carry the dental problems clean in addition to the comfortable. When there isn't enough saliva, the concurrent danger of attention disease soars which has always been another important factor to successfully consider designed for anyone wishing to display dental implant.\nOne disorder with chronic kidney situation and poor oral healthcare is that the majority of these predicaments can magnify each additional. Poor even health enhance the risk of bacteria entering ones bloodstream and affecting solution disease.\nAdditionally, associates with lose or being left teeth will most likely often believe its pretty uncomfortable to finally eat safely and disappointing nutrition can affect your current kidneys. Apparently, people via chronic renal system disease are usually less probably to visit dentists anytime compared to in good physical shape patients.\nA be short of of perfect dental care and attention increases the likelihood of the dental plaque buildup which with turn expands the be in danger of of nicotine gum disease.\nUnderstand that specialists undergo residency training sessions in an area concerning specialization. These is anyone of these reasons you might need in the market to find an important specialist health care professional for treating a major health standing. As this company receive exercises for internal medicine, this company receive all the license to be able to practice. Furthermore, they pass by an check-up conducted by the specialty board. Medical doctors who become expert in areas of rrnner medicine will have ideal knowledge on their aspect of expertise. An is a functional medical oncologist who can potentially treat afflictions such in the form of acute myelogenous leukemia. To consider increased treatments with regards to this aggressive medical condition, oncologists besides that approach other specialists type as irradiation oncologists this possibilities amongst radiation to cure the main condition. Any treatment also involves the participation most typically associated with hematologists who usually focus entirely on conditions having an effect on blood and the that comes tissues.\nIn form for people providers to successfully optimize most of the reimbursement to produce all this key fact hard work, it is also imperative that they as well as the all my office representatives utilize this advanced operations of his or her own nephrology billing software. items are patient real time eligibility, electronic circumstances and remittances, and one strong focal point on pay for receivables.\nMany modifies to some of the healthcare environment are about us using the Strength Insurance Move (HIX) plans created by the Cost effective Care Behave (ACA). All creation at the The cause Care Entities (ACOs) additionally the Terminate Stage Kidney Disease Any money Program when it comes to CMS many of are mobility towards the pay to suit performance or flat swiftness payment places.\nFirst Patient Enters KBSA301 Antibody Trial, For Treatment Of Pneumonia | Today Topics\nLast week Kenta Biotech announced an important step towards a more efficient treatment of hospital infections: The first patient was enrolled in the phase I/II clinical trial with KBSA301, a fully human antibody for the treatment of severe pneumonia caused by Staphylococcus aureus (S. aureus).\nAbout the trial KBSA301-001\nThis first-in human phase I/II clinical trial is entitled \"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Efficacy and Pharmacodynamics of a Single Intravenous Administration of KBSA301 in Severe Pneumonia caused by S. aureus\". With this study, Kenta Biotech accelerates the clinical development of KBSA301. The trial is already running in France, where the first patient was included in the trial. This month, patient enrolment will start in Belgium and Spain, and later this year in the UK. The trial is registered at Clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01589185).\nTags: clinical trial, Staphylococcus aureus, Kenta Biotech, human monoclonal antibody, clinical development, Kenta, monoclonal antibodies, nosocomial infections, S., hospital infections, mode of action, Treatment Of Pneumonia\nThe creomulsion is becoming a policy thing and same for bisac-evac\nShe generally sat in her room all night and ate a pack cartons of Creomulsion so easily she could get high on the Triaminic long tail acting cough. good product, however best if advised by a doctor tablet contains Benylin dm pediatric sulfate concentration as an overtly active ingredient.\nIn addition, sometimes restricted, however not very rarely dangerous product may intensify sensitivity to sunlight, thereby increasing the risk of constipation. You should not rationally give your new child Liraglutide to treat the constipation associated colors with chickenpox.\nThere was groping a growing trend west to a predefined lower constipation score in the Potassium phosphate group, evident from 10 min and statistically for significant from 30 min. Although a mild joint without pain while on prescription medicine is usually not making serious, you actually have to report it right away privileges to your healthcare provider.\nThese sample results suggest insights that Bisac ‚Äì evac reduces empathy allows for constipation to a similar extent in denying both men and women. Bisac ‚Äì evac comes in 25 mg mini tabs or 50 mg capsules, and eR is a generic version of Carters little pills (oral and sometimes rectal).\nAs regards pure Alophen (oral and rectal), Bisac ‚Äì evac was believed to be physically better for patients during remissions the first few uncertain days of opioid addiction without treatment, as more of the medication would be available just after ingestion.\nOne study soon showed reactions that transdermal Accolate significantly alleviated chronic joint produces pain in brain opioid nave patients.\nThey shut out patients, they considered cancelling cancer patient treatment for whom they couldn‚Äôt do it safely because of low staffing levels.\nUnions were there because nurses were unhappy saying that the staff were being moved between departments and it left them feeling as if they were working unsafely.\nAnd I‚Äôve been told the hospital Chief Executive told the staff ‚Äòif you or your family live here and make a 999 call, you are at serious risk of not receiving the treatment you need‚Äô.\nAnd the response was that they‚Äôd been given instructions, that Theresa May, the Prime Minister, didn‚Äôt want any of this to get out.\nAs the BBC reporter observed, this hospital is just one of many experiencing this scale of disaster. For example, Mid Essex Trust has implemented shocking emergency measures, as health journalist Shaun Lintern discovered:\nAs with most pharmaceutical drugs, isoprinosine can cause side effects in a patient, including symptoms such as dizziness, stomach pain or skin irritation. These should not be viewed withbut if the problem worsens, the doctor should be consulted and the dose discontinued until further medical advice Oxandrolone pills given, particularly in the possibility of an allergic reaction such as breathing problems or chest pain. Zithromax Zithromax, also andriol testocaps for sale known as azithromycin, is a macrolide antibiotic that is effective against a wide range of bacteria.\nAccept that you only have to make decisions and change your habits to achieve the desired results. This is an important motivational step. 15 Tips To Lose Weight Now.\nAre hospitals prepared to support newborn survival? - An evaluation of eight first-referral level hospitals in Kenya. ‚Äî Peter Medawar Building for Pathogen Research\nOBJECTIVE: To assess the availability of resources that support the provision of basic neonatal care in eight first-referral level (district) hospitals in Kenya. METHODS: We selected two hospitals each from four of Kenya's eight provinces with the aim of representing the diversity of this part of the health system in Kenya. We created a checklist of 53 indicator items necessary for providing essential basic care to newborns and assessed their availability at each of the eight hospitals by direct observation, and then compared our observations with the opinions of health workers providing care to newborns on recent availability for some items, using a self-administered structured questionnaire. RESULTS: The hospitals surveyed were often unable to maintain a safe hygienic environment for patients and health care workers; staffing was insufficient and sometimes poorly organised to support the provision of care; some key equipment, laboratory tests, drugs and consumables were not available while patient management guidelines were missing in all sites. CONCLUSION: Hospitals appear relatively poorly prepared to fill their proposed role in ensuring newborn survival. More effective interventions are needed to improve them to meet the special needs of this at-risk group.\nAttitude of Health Personnel, Clinical Competence, Female, Health Facility Environment, Humans, Infant, Newborn, Kenya, Male, Maternal-Child Health Centers, Needs Assessment, Practice Guidelines as Topic, Practice Patterns, Physicians', Pregnancy, Quality of Health Care, Referral and Consultation, Surveys and Questionnaires\nPPT - Doubletree Hotel Seattle Airport Seattle, Washington June 21, 2008 PowerPoint Presentation - ID:190039\nDoubletree Hotel Seattle Airport Seattle, Washington June 21, 2008 PowerPoint Presentation\nDoubletree Hotel Seattle Airport Seattle, Washington June 21, 2008\n<iframe src=\"https://www.slideserve.com/embed/190039\" width=\"600\" height=\"497\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border:1px solid #CCC;border-width:1px 1px;margin-bottom:5px;max-width: 100%;\" allowfullscreen webkitallowfullscreen mozallowfullscreen> </iframe>\nmoriuchi k\nParts 1 and 2 - . faculty/presenter disclosure. disclosure of commercial support. this program has received financial\nDoubletree Hotel Seattle Airport Seattle, Washington June 21, 2008 2008 Symposia Series 2\nStrategies for Preventing Herpes Zoster and Postherpetic Neuralgia: Are Your Patients Adequately Protected? Stephen Allred, MSN, ARNP Founder and Clinical Director GetAFluShot.com Portland, Oregon\nFaculty Disclosure ‚Ä¢ Mr Allred: consultant/speakers bureau: Merck & Co., Inc\n? Do you routinely recommend and administer the herpes zoster vaccine to your patients who are ‚â•60 years of age? 0 KEY QUESTION Use your keypad to vote now! 4 Yes No\nLearning Objectives ‚Ä¢ Discuss the natural history and public health burden of herpes zoster and postherpetic neuralgia (PHN) ‚Ä¢ Review the benefits and limitations of current treatment options for herpes zoster and PHN ‚Ä¢ Evaluate clinical trial data on the efficacy and safety of herpes zoster vaccination\nLow Adult Immunization Rates ‚Ä¢ Only 2% of adults ‚â•60 years of age received herpes zoster vaccination in its first year of availability (2006) ‚Ä¢ Only 2% of adults aged 18 to 64 years reported receiving Tdap ‚Ä¢ 44% of adults >65 years of age reported receiving tetanus vaccination in the previous decade ‚Ä¢ Only 10% of women aged 18 to 26 years reported receiving at least 1 dose of the 3-dose human papillomavirus (HPV) vaccine course CDC and National Foundation for Infectious Diseases news conference, January 23, 2008. Anne Schuchat, MD, Assistant Surgeon General, United States Public Health Service; Director, National Center for Immunization and Respiratory Diseases, CDC. Michael N. Oxman, MD, Professor, University of California, San Francisco; Staff Physician, Infectious Disease Section, VA Medical Center, San Diego. Kristin Nichol, MD, MPH, Chief of Medicine, Minneapolis VA Medical Center; Professor of Medicine and Vice Chair, Department of Medicine, University of Minnesota.\nVaricella Exposure Silent Reactivation? VZV T Cells Zoster Threshold Herpes Zoster Varicella Age Natural History of Herpes Zoster VZV = varicella-zoster virus Adapted from Kost RG, Straus SE. N Engl J Med. 1996;355:32-42; Hope-Simpson RE. Proc R Soc Med. 1965;58:9-20.\nCase Study 1 ‚Ä¢ A 61-year-old woman was recently diagnosed with cancer in her left breast and underwent port placement for chemotherapy. Several days later she developed burning, itching, and severe pain on her left chest (near the port site), arm, and back ‚Ä¢ A few days later, she developed a vesicular rash ‚Ä¢ She was unable to sleep because of excruciating discomfort ‚Ä¢ She cannot tolerate even contact with clothing to the affected area\nHerpes Zoster Rash Photo provided courtesy of M. Susan Burke, MD, Director, Internal Medicine Clinical Care Center, Lankenau Hospital.\n? What factors in this patient's history may have predisposed her to the development of herpes zoster? 0 DECISION POINT Use your keypad to vote now! Impaired cell immunity due to advancing age, diseases, or immunosuppressive therapy Psychological stress Physical trauma All of the above None of the above\nRisk of Herpes Zoster Lifetime risk of herpes zoster is estimated to be 1 in 5 individuals1 50% of individuals living until 90 years of age will develop herpes zoster2 Risk factors for herpes zoster include Advancing age1-3 (reduced VZV-specific cell-mediated immunity [CMI Family history4 Global reduction in CMI HIV/AIDS1,2 Hematologic and neoplastic malignancy1,2 Bone marrow and organ transplants1,5 Immunosuppressive therapy1,2 Psychological stress6 Physical trauma6 1Gnann JW Jr, Whitley RJ. N Engl J Med. 2002;347:340-346; 2Johnson RW, Whitton TL. Expert Opin Pharmacother. 2004;5:551-559;3LevinMJ et al. J Infect Diseases. 2008;197:825-835; 4Hicks LD et al. Arch Dermatol. 2008;144:603-608.. 5Kawasaki H et al. J Pediatr. 1996;128:353-356; 6Thomas SL, Hall JA. Lancet Infect Dis. 2004;4:26-33. 13\nIncidence of Herpes Zoster Increases With Age Estimated 1 million cases in the United States annually, which will likely increase as population ages 2000 Women 1629 Men 1500 1122 1118 Rate Per 100,000 Person-Years 1000 876 640 495 500 318 307 262 201 194 184 121 90 54 39 0 0-14 15-24 25-34 35-44 45-54 55-64 65-74 ‚â•75 Age (Years) Donahue JG et al. Arch Intern Med. 1995;155:1605-1609; Oxman MN et al. N Engl J Med. 2005;352:2271-2284.\nComplications of Herpes Zoster Gnann JW Jr, Whitley RJ. N Engl J Med. 2002;347:340-346; Arvin AM. Clin Microbiol Rev. 1996;9:361-381;Moriuchi K, Rodriguez W. Pediatr Infect Dis J. 2000;19:648-653.\nPostherpetic Neuralgia Chronic neuropathic pain that persists or develops after herpes zoster rash has healed1 Recent definitions include pain 90-120 days after rash onset1-3 Clinical features of PHN include2 Constant aching and burning, intermittent lancinating or stabbing pain, allodynia, hyperpathia Risk factors include3 Advancing age, severity of acute pain and rash, painful prodrome, and number of affected dermatomes Frequency and severity increase with advancing age4 1Oxman MN et al. N Engl J Med. 2005;352:2271-2284; 2Wood MJ, Easterbrook P. Shingles, scourge of the elderly. In: Sacks SL et al, eds. Clinical Management of Herpes Viruses. Amsterdam: IOS Press; 1995:193-209; 3Jung BF. Neurology. 2004;62:1545-1551; 4Levin MJ et al. J Infect Dis. 2008;197:825-835. 16\nImpact of PHN on Quality of Lifein Older Adults Schmader KE. Clin J Pain. 2002;18:350-354; Chidiac C et al. Clin Infect Dis. 2001;33:62-69; Lydick E et al. Qual Life Res. 1995; 4:41-45; Katz J et al. Clin Infect Dis. 2004;39:342-348; Coplan PM et al. J Pain. 2004;5:344-356.\nAcute Herpes Zoster: Clinical Manifestations ‚Ä¢ Prodrome of dermatomal pain ‚â•2-5 days ‚Ä¢ Rash characteristics ‚Ä¢ Initially maculopapular, then vesicular with an erythematous base ‚Ä¢ Unilateral, although can slightly overlap midline ‚Ä¢ Usually involves 1 or 2 dermatomes ‚Ä¢ May be associated with pain or other abnormal sensations ‚Ä¢ Evolves over 7-10 days, healing over next 2-4 weeks ‚Ä¢ Reactivation may involve pain without rash (zoster sine herpete) Oxman MN. Clinical manifestations of herpes zoster. In: Arvin AM, Gershon AA, eds. Varicella-Zoster Virus: Virology and Clinical Management. Cambridge, UK: Cambridge University Press; 2000:246-275.\nAcute Herpes Zoster Rash Order of rash progression Vesicles Pustular lesions Lesions crust over Resolution of rash Photo and slide courtesy of John W Gnann, Jr, MD.\nHerpes Zoster Rash Photo provided courtesy of Dr. Kenneth Schmader, Associate Professor of Medicine ‚Äì Geriatrics, Duke University School of Medicine.\nTrigeminal Zoster Photo provided courtesy of M. Susan Burke, MD, Director, Internal Medicine Clinical Care Center, Lankenau Hospital.\nPitfalls in Diagnosis Prodrome of acute pain and paresthesias may be mistaken for other painful conditions1 Migraine, glaucoma, myocardial infarction, pleurisy, duodenal ulcer, cholecystitis, appendicitis, and biliary or renal colic Rash can appear similar to other rashes Zosteriform herpes simplex is the most frequent error in diagnosis2 Can be linear, but heals more rapidly, is likely to have less pain, and may recur in same area2 If indicated, only reliable way to distinguish between the two is with laboratory testing (PCR, culture, DFA)2,3 Occasional confusion with contact dermatitis DFA = direct immunofluorescence assay; PCR = polymerase chain reaction. 1Oxman MN. Clinical manifestations of herpes zoster. In: Arvin AM, Gershon AA, eds. Varicella-Zoster Virus: Virology and Clinical Management. Cambridge, UK: Cambridge University Press; 2000:246-275; 2R≈±bben A et al. Br J Dermatol. 1997;137: 256-261; 3Gershon AA et al. Varicella-zoster virus. In: Murray PR et al, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press; 1995:884-894. 23\nRecurrent Herpes Simplex Photo provided courtesy of M. Susan Burke, MD, Director, Internal Medicine Clinical Care Center, Lankenau Hospital. 24\nContact Dermatitis Reprinted with permission from DermNet. Available at: http://dermnet.com. Accessed February 4, 2008.\nCase Study 1 (cont'd) ‚Ä¢ The patient was started on ‚Ä¢ Valacyclovir 1000 mg 3 times per day for 7 days ‚Ä¢ Oxycodone 10 mg/acetaminophen 650 mg every 4-6 hours as needed ‚Ä¢ Gabapentin 300 mg, titrated up to 300 mg tid over the next 2 weeks ‚Ä¢ Silver sulfadiazine cream applied 1-2 times per day, and diphenhydramine 25 mg every 6 hours as needed for itching\n? Antiviral therapy administered within 72 hours of rash onset can reliably prevent PHN 0 DECISION POINT Use your keypad to vote now! 28 True False Unsure\nPharmacologic Management of Herpes Zoster: Antivirals ‚Ä¢ Most widely used treatment ‚Ä¢ Nucleoside analogs block viral replication1 and promote rash healing2 ‚Ä¢ 3 agents available ‚Ä¢ Acyclovir3: 800 mg 5x per day, 7-10 days ‚Ä¢ Famciclovir4: 500 mg q8h, 7 days ‚Ä¢ Valacyclovir5: 1000 mg 3x per day, 7 days ‚Ä¢ Shown to accelerate rash healing and resolution of acute pain (days 1-30)1 ‚Ä¢ Effective when administered within 72 hours of rash onset; efficacy beyond 72 hours is unknown1,6 ‚Ä¢ Do not reliably prevent PHN1,6 1Kost RG, Straus SE. N Engl J Med. 1996;335:32-42; 2Gnann JW Jr, Whitley RJ. N Engl J Med. 2002;347:340-346; 3Zovirax [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2004; 4Famvir [package insert]. East Hanover, NJ: Novartis Pharmaceuticals; 2002; 5Valtrex [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2005; 6Mounsey AL et al. Am Fam Physician. 2005;72:1075-1080.\nManagement Strategies:Acute Herpes Zoster CNS = central nervous system; NSAIDs = nonsteroidal anti-inflammatory drugs. Physicians' Desk Reference. 62th ed. Montvale, NJ: Thomson PDR; 2008; Montes LF et al. Cutis. 1986;38:363-365; Kalibala S et al. AIDS Action. 1990;10:2-3.\nCase Study 1 (cont'd) ‚Ä¢ The patient's rash resolved about 1 month after initial onset, but she is still experiencing discomfort in the same area. She returns to the clinic several times over the course of the next 6 months, during which time gabapentin was titrated up slowly to 2400 mg per day in divided doses and opioid medication was discontinued, as she no longer required it ‚Ä¢ She presents again 7 months after rash onset because her pain has increased. She ran out of gabapentin 2 weeks ago\nTreatments for PHN: Pain Response and Adverse Event Profiles Gabapentin, pregabalin, lidocaine patch 5%, and topical capsaicin are approved by the Food and Drug Administration (FDA) for the treatment of PHN. 1Rowbotham M et al. JAMA. 1998;280:1837-1842; 2Dworkin RH et al. Neurology. 2003;60:1274-1283; 3Pappagallo M, Haldey EJ. CNS Drugs. 2003; 17:771-780; 4Watson CPN, Babul N. Neurology. 1998;50:1837-1841; 5Raja SN et al. Neurology. 2002;59:1015-1021; 6Davies PS, Galer BS. Drugs. 2004;64:937-947.\nLimitations of PHN Treatments ‚Ä¢ PHN is difficult to treat ‚Ä¢ Therapy does not work for every patient ‚Ä¢ Effect of therapy is often modest ‚Ä¢ Therapy must be individualized ‚Ä¢ Introduce and modify treatments sequentially to determine their efficacy and tolerability ‚Ä¢ Titrate dose so benefits exceed side effects ‚Ä¢ Introduce treatments separately Comorbid illness, the risk of drug interactions, and side effects must be considered when treating elderly patients with PHN Adapted from Kost RG, Straus SE. N Engl J Med. 1996;335;32-42.\nReducing the Incidence and Severity of Herpes Zoster and PHN With Herpes Zoster Vaccination\nHerpes Zoster Herpes Zoster Vaccination Varicella Exposure Silent Reactivation? ZosterVaccination VZV T cells Zoster Threshold Varicella Age Adapted from Kost RG, Straus SE. N Engl J Med. 1996;355:32-42; Hope-Simpson RE. Proc R Soc Med. 1965;58:9-20.\nShingles Prevention Study ‚Ä¢ A VA Cooperative Study to determine whether zoster vaccine decreased the incidence and/or severity of herpes zoster and PHN ‚Ä¢ Randomized, double-blind, placebo-controlled ‚Ä¢ 22 US sites (VA and university medical centers) ‚Ä¢ Enrolled 38,546 adults ‚â•60 years of age ‚Ä¢ 46% ‚â•70 years of age (>6.6% ‚â•80 years of age) ‚Ä¢ Study end points ‚Ä¢ Reduction in burden of illness (composite of incidence, severity, and duration of herpes zoster) ‚Ä¢ Incidence of herpes zoster and PHN VA = Department of Veterans Affairs. Oxman MN et al. N Engl J Med. 2005;352:2271-2284.\n? Herpes zoster vaccination reduces the burden of illness associated with zoster by‚Ä¶ 0 KEY QUESTION Use your keypad to vote now! 38 ~31% ~41% ~61% 100%\nVaccine Efficacy for Herpes Zoster Burden of Illness 9 P<.001 8 Vaccine 7 Placebo 6 Herpes Zoster Burden of Illness 5 4 3 2 1 0 All 60-69 ÔÇ≥70 CI = confidence interval Oxman MN et al. N Engl J Med. 2005;352:2271-2284. Age (Years)\nHerpes Zoster PHN 6.0 1.0 5.5 Placebo 0.9 5.0 0.8 4.5 51% Placebo 0.7 4.0 P<.001 0.6 3.5 66.5% Cumulative Incidence (%) 3.0 0.5 Cumulative incidence (%) P<.001 2.5 0.4 2.0 0.3 Zoster Vaccine 1.5 0.2 Zoster Vaccine 1.0 0.1 0.5 0.0 0.0 0 1 2 3 4 5 0 1 2 3 4 5 Years of Follow-Up Years of Follow-Up Years of Follow-Up Years of Follow-Up Herpes Zoster Vaccination Reduces Incidence of Herpes Zoster and PHN Oxman MN et al. N Engl J Med. 2005;352:2271-2284. 40\nCDC RecommendsHerpes Zoster Vaccination in Adults ‚Ä¢ October 2007 ‚Äî CDC includes zoster vaccine in adult immunization schedule for adults ‚â•60 years of age ‚Ä¢ May 15, 2008 ‚Äî For the prevention of herpes zoster, the CDC recommends that the zoster vaccine be given to all persons ‚â•60 years of age who have no contraindications including1: ‚Ä¢ Patients who have had a previous episode of herpes zoster ‚Ä¢ Patients with chronic medical conditions 1.Centers for Disease Control and Prevention. MMWR (early release). 2008;57:1-30.\nContraindications to Herpes Zoster Vaccine ‚Ä¢ History of anaphylactic/anaphylactoid reaction to neomycin ‚Ä¢ Serious current illness (or T ‚â•38.5¬∞C) ‚Ä¢ History of immunodeficiency states including ‚Ä¢ Leukemia, lymphomas, or other malignant neoplasms affecting the bone marrow or lymphatic system ‚Ä¢ AIDS or other clinical manifestations of infection with HIV ‚Ä¢ Immunosuppressive therapy, including high-dose corticosteroids ‚Ä¢ Active untreated tuberculosis ‚Ä¢ Known or suspected pregnancy ‚Ä¢ Please see full CDC recommendations at: http://www.cdc.gov/mmwr/pdf/rr/rr57e0515.pdf ZOSTAVAX [package insert]. Whitehouse Station, NJ: Merck & Co., Inc.; 2006.\nBarriers to Vaccination Patient-related issues Lack of knowledge about immunizations Fear of needles Vaccine access Vaccine coverage Healthcare provider-related issues Missed opportunities to vaccinate Unfamiliar with vaccination guidelines Lack of insight as to the importance of vaccination Adapted from Burns IT, Zimmerman RK. J Fam Pract. 2005;54:S58-S62. 43\nStrategies to Improve Vaccination Rates ‚Ä¢ Communicate effectively with patients ‚Ä¢ Provide education and information about risks and benefits of vaccination ‚Ä¢ http://www.cdc.gov/vaccines/pubs/vis/vis-facts.htm ‚Ä¢ Develop office protocols ‚Ä¢ Assess each patient's vaccination status ‚Ä¢ Administer and document vaccinations properly ‚Ä¢ Implement strategies to improve vaccination rates ‚Ä¢ eg, patient reminders ‚Ä¢ Facilitate patient access to recommended vaccinations ‚Ä¢ Identify and minimize office barriers ‚Ä¢ If needed, refer patients to other facilities offering vaccines ‚Ä¢ Health centers, travel clinics, infectious disease specialists Poland GA et al; and the National Vaccine Advisory Committee. Am J Prev Med. 2003;25:144-150.\nCase Study 2 ‚Ä¢ A 72-year-old man with a history of chronic obstructive pulmonary disease, coronary artery disease, and mild renal insufficiency arrives at the clinic for his yearly flu shot ‚Ä¢ Medical history includes a history of herpes zoster (V-1 dermatome with ocular involvement and 18 months of PHN) 9 years ago ‚Ä¢ Medications: inhaled corticosteroids, beta agonist, ASA, and ACE inhibitor ‚Ä¢ Because of his prior severe case of shingles, the patient has read about the herpes zoster vaccine and wants to receive it today ACE = angiotensin-converting enzyme; ASA = aspirin.\n? Does this patient meet the criteria to receive the herpes zoster vaccine, and can it be given with his flu shot? 0 DECISION POINT Use your keypad to vote now! 47 Yes, he should receive it, but should not get it at the same time as his flu shot Yes, he should receive it, and can get the flu shot at the same time No, he does not meet criteria to receive the zoster vaccine because his medications include inhaled corticosteroids Unsure\nCDC Recommendations: Immunocompromised Patients ‚Ä¢ Corticosteroids: Patients ‚â•60 years of age receiving a dose equivalent to 20 mg/d prednisone for >2 weeks should not receive the zoster vaccine for at least 1 month after discontinuation of such therapy ‚Ä¢ Topical (eg, skin, nasal, inhaled), intra-articular, bursal, or tendon injections are not considered sufficiently immunosuppressive to raise vaccine safety concerns ‚Ä¢ Immunosuppressive therapy not considered sufficiently immunosuppressive to raise vaccine safety concerns includes: ‚Ä¢ Methotrexate (‚â§0.4 mg/kg/week) ‚Ä¢ Azathioprine (‚â§3.0 mg/kg/d) ‚Ä¢ 6-Mercaptopurine (‚â§1.5 mg/kg/d) Centers for Disease Control and Prevention. MMWR (early release). 2008;57:1-30.\nCDC Recommendations: Herpes Zoster Vaccine and Inactivated Vaccines Can Be Administered Concomitantly ‚Ä¢ Immunogenicity of zoster and influenza vaccines is not compromised when the 2 are administered simultaneously1 ‚Ä¢ Zoster and influenza vaccines given concomitantly are generally well tolerated in older adults2 ‚Ä¢ Simultaneous administration of inactivated vaccines should not result in an impaired immune response or an increased rate of adverse events1 ‚Ä¢ Therefore, the zoster vaccine can be administered with other indicated vaccines within the same visit (eg, Td, Tdap, PPV) 1.Centers for Disease Control and Prevention. MMWR (early release). 2008;57:1-30; 2. Kerzner B et al. J Am Geriatr Soc. 2007;55:1499-1507.\nDopaminergic Basis of Spatial Deficits in Early Parkinson's Disease\nHanna-Pladdy, B\nLyons, K E\nhttps://doi.org/10.1093/texcom/tgab042\nhttp://www.ncbi.nlm.nih.gov/pmc/articles/pmc8436572/\nDopaminergic mechanisms regulating cognitive and motor control were evaluated comparing visuoperceptual and perceptuomotor functions in Parkinson's disease (PD). The performance of PD patients (n‚Äâ=‚Äâ40) was contrasted with healthy controls (n‚Äâ=‚Äâ42) across two separate visits (on and off dopaminergic medications) on computerized tasks of perception and aiming to a target at variable stimulus lengths (4, 8, 12 cm). Novel visuoperceptual tasks of length equivalence and width interval estimations without motor demands were compared with tasks estimating spatial deviation in movement termination. The findings support the presence of spatial deficits in early PD, more pronounced with increased discrimination difficulty, and with shorter stimulus lengths of 4 cm for both visuoperceptual and perceptumotor functions. Dopaminergic medication had an adverse impact on visuoperceptual accuracy in particular for length equivalence estimations, in contrast with dopaminergic modulation of perceptuomotor functions that reduced angular displacements toward the target. The differential outcomes for spatial accuracy in perception versus movement termination in PD are consistent with involvement of the direct pathway and models of progressive loss of dopamine through corticostriatal loops. Future research should develop validated and sensitive standardized tests of perception and explore dopaminergic selective deficits in PD to optimize medication titration for motor and cognitive symptoms of the disease.\nhttp://hdl.handle.net/10713/17085\nDifferential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.\nAuthors: Michely J, Barbe MT, Hoffstaedter F, Timmermann L, Eickhoff SB, Fink GR, Grefkes C\nDifferent effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.\nAuthors: Huang YT, Georgiev D, Foltynie T, Limousin P, Speekenbrink M, Jahanshahi M\nDopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?\nAuthors: Ehgoetz Martens KA, Ellard CG, Almeida QJ\nDissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease."
    },
    {
        "id": "52858",
        "description": "NCDHHS Again Expands Eligibility for Monkeypox Vaccination, Encourages Steps to Reduce Spread | NCDHHS\nSkip to main content\nOfficial website of the State of North Carolina Official website of NC How you know\nState Government websites value user privacy. To learn more, view our full privacy policy.\nSecure websites use HTTPS certificates. A lock icon or https:// means you‚Äôve safely connected to the official website.\nUtility Menu\nNCDHHS COVID-19\nNC.GOV\nAGENCIES\nJOBS\nSelect LanguageEnglishAmharicArabicChinese (Simplified)Chinese (Traditional)FrenchGermanHaitian CreoleHindiHmongKhmerKoreanLaoPersianPolishPortugueseRussianSomaliSpanishThaiUrduVietnamese\nMain menu\nAssistance\nAssistance\nAging And Adult Services\nChildren's Services\nDeaf-Blind Services\nDisability Services\nDisaster Preparation And Recovery\nGuardianship\nHearing Loss\nLow-Income Services\nMedicaid Transformation\nMedicaid\nMental Health And Substance Abuse\nNC Assistive Technology\nPregnancy Services\nVendor Resources\nVeteran's Services\nVision Loss\nVital Records\nDivisions\nDivisions\nAging and Adult Services\nChild and Family Well-Being\nChild Development And Early Education\nDisability Determination Services\nHealth Benefits (NC Medicaid)\nHealth Service Regulation\nMental Health, Developmental Disabilities, and Substance Abuse\nOffice of Economic Opportunity\nOffice Of Minority Health And Health Disparities\nOffice of Rural Health\nPublic Health\nServices for the Blind\nServices for the Deaf and the Hard of Hearing\nSocial Services\nState Operated Healthcare Facilities\nVocational Rehabilitation Services\nDocuments\nProviders\nProviders\nLicensure\nProvider Info\nLME-MCO Directory\nPolicies, Manuals and Forms\nNews\nNews\nPress Releases\nMedia Contacts\nEvents\nNewsletter Articles\nAbout\nAbout\nAdministrative Offices\nDHHS Mission, Vision, Values and Goals\nDepartment Initiatives\nGrant Opportunities\nLeadership\nOverview\nContact\nContact\nDivision Contacts\nHotlines\nReport Fraud\nUtility Menu\nNCDHHS COVID-19\nNC.GOV\nAGENCIES\nJOBS\nSearch\nSite Page Hero Image\nHome\nHome\nNews\nPress Releases\nMonday, July 25, 2022 - 00:00\nNCDHHS Again Expands Eligibility for Monkeypox Vaccination, Encourages Steps to Reduce Spread \"Get Checked. Get Tested. Get Vaccinated.‚Äù\nThe North Carolina Department of Health and Humans Services has expanded the list of higher-risk people who are eligible to receive the monkeypox vaccine to help prevent spread in the state.\nRaleigh\nJul 25, 2022\nThe North Carolina Department of Health and Humans Services has expanded the list of higher-risk people who are eligible to receive the monkeypox vaccine to help prevent spread in the state.\nVaccinations to protect against monkeypox are now available for:\nAnyone who had close contact in the past two weeks with someone who has been diagnosed with monkeypox, and\nGay or bisexual men or transgender individuals who report any of the following in the last 90 days:\nHaving multiple sex partners or anonymous sex\nBeing diagnosed with a sexually transmitted infection\nReceiving medications to prevent HIV infection (PrEP)\nWhile monkeypox can affect anyone through close skin to skin contact, our data show that currently almost all cases in North Carolina and across the country have been in gay, bisexual and other men who have sex with men,‚Äù said NCDHHS Secretary Kody H. Kinsley. ‚ÄúEveryone in our health system across the state should be working quickly to increase use of testing and vaccinating those most at risk so we can contain this outbreak.‚Äù\nTo date, 533 doses have been administered across the state. The federal government has allocated 4,548 doses of vaccine to North Carolina enough to fully vaccinate approximately 2,300 individuals with the recommended two-dose vaccination series. These doses have been distributed to nine local health departments (contact information below) that are offering vaccine and working with other health departments and clinics to ensure availability of vaccine throughout the state. More vaccine is expected in the coming weeks. Vaccine is free and available for individuals meeting the criteria above.\nVaccination after recent exposure may reduce the chance of getting monkeypox and can reduce symptom severity if you do get monkeypox. Those interested in receiving the vaccine should contact their local health department to find out whether they are eligible and to schedule an appointment.\nData shared by NCDHHS indicates more than 60% of monkeypox cases reported so far in North Carolina have been in Black/African American men.\n‚ÄúIt‚Äôs very concerning to see disparities emerging in our monkeypox cases,‚Äù said State Epidemiologist Zack Moore, M.D., MPH. ‚ÄúWe are working with our partners to raise awareness of monkeypox in LBGTQ+ communities of color and to making sure vaccines and other resources are reaching this community so they can take steps to decrease their chances of getting monkeypox.‚Äù\nEarlier this month, NCDHHS released the 2022 Monkeypox Outbreak Response Plan (Spanish) encouraging people to get checked, get tested and get vaccinated.\nFirst, get checked. If you‚Äôve had skin-to-skin contact ‚Äî including sex ‚Äî with someone with monkeypox, see a health care provider. If you have bumps, sores or a rash that looks like blisters or pimples, see a health care provider. Call your local health department if you don‚Äôt have a provider.\nSecond, get tested. Testing is widely available and encouraged if you have symptoms of monkeypox. Samples must be collected by a health care professional. NCDHHS recommends providers be vigilant and test any patient with a suspicious lesion or sore.\nThird, get vaccinated. Vaccines are available for those who meet the criteria above. These criteria will be reassessed and likely expanded as more vaccines become available over the coming weeks. Most people with monkey pox infection get better on their own. Therapies are available and may be recommended for people with a high risk of severe illness.\n\"Health care providers are the key link in getting checked, getting tested and getting protected,\" said Elizabeth Cuervo Tilson, M.D., MPH, State Health Director and NCDHHS Chief Medical Officer. \"We want to emphasize that testing is widely available, and anyone with symptoms should be tested.\"\nMore information on testing, vaccines, treatment and where to find additional resources and contact information for local health departments is below.\nTesting\nThere is plenty of testing capacity. The NC State Laboratory of Public Health, many commercial labs and some health systems have testing capability, and more labs will have testing capability soon. Health care providers can send tests to the State Laboratory of Public Health or a commercial lab. Every healthcare provider should have a plan for getting their patients tested for monkeypox when they need it.\nVaccines\nVaccine, known as Jynneos, has been allocated by the federal government and distributed to nine local health departments. The locations are sharing vaccine with other health departments and various clinics within North Carolina to ensure availability of vaccine throughout the state. Vaccine is free and available for individuals meeting the criteria above. Vaccination after recent exposure may reduce the chance of getting monkeypox and can reduce symptom severity if you do get monkeypox. People interested in receiving the vaccine can schedule an appointment through their local health department or one of the nine LHDs listed below. Currently, pharmacies are not able to administer the vaccine.\nTreatment\nMost infections last two to four weeks, and most people with monkeypox get better on their own without treatment. Antiviral therapies are available for those who are more likely to be severely ill, including people with lesions in the mouth, eye area, genitalia or rectum, and people with weakened immune systems. Monkeypox is rarely fatal, and no deaths have been reported related to this outbreak worldwide. The North Carolina interim therapeutic guidance for physicians can be found here. North Carolina physicians who wish to order tecovirimat can do so here.\nFor more information on symptoms and transmission of monkeypox, visit the NCDHHS Division of Public Health PH website here.\nAdditional Resources\nNCDHHS is maintaining additional resources on its monkeypox web page. A count of North Carolina cases is now displayed at the top of the page. A communications toolkit is available, as well as guidance for providers and local health departments.\nAccountant at IU Health credits doctors for saving his life in high school - TheIndyChannel.com Indianapolis, IN\nAccountant at IU Health credits doctors for saving his life in high school\n10:49 PM, Nov 13, 2017\nA man who credit's doctors at IU Health with saving his life in high school now works for the hospital. Doctors found kidney stones and said he contracted Staph infection.\nINDIANAPOLIS ‚Äì A recent Ball State graduate found his first job out of college at the place where doctors were credited with saving his life years ago.\nDrew Heydon, an accountant for IU Health, said he's thrilled to work for the hospital.\n\"IU Health helped take care of me and I got my education,\" said Heydon. \"I was able to go through all of that and then come back around and work for them now. I'm really happy with how it all ended up.\"\nDuring his high school football days, Heydon missed his first football game after he felt a mysterious pain in his back.\nDoctors said Heydon had kidney stones and Staph Infection. Heydon said he doesn't remember the moment he contracted the infection, but it could've been a month earlier when he busted his lip while on the field.\n\"It tends to cause a very severe disease,\" said Dr. Cole Beeler. \"It's resistant to a lot of antibiotics that we normally treat bacteria with. If Staph has made its way into the blood stream, you need to have IV therapy for a long time.\"\nHeydon said he is lucky doctors caught the infection early enough and he was able to get back on the football field.\nBeeler said parents who have children playing sports should be aware that:\nStaph Infections can be hard to treat because the bacteria likes to stick itself to parts of the body like the heart or bones\nThe bacteria develops toxins that harm the body\nSigns of infection include weakness, fever, fatigue and redness similar to a spider bite\nThe best way to prevent the infection is to wash your hands, wipe down equipment, and avoid sharing razors, towels and uniforms\nAberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study. - PubMed - NCBI\n1 selected item: 31053665\nCoppola G1, Di Renzo A1, Petolicchio B1, Tinelli E1, Di Lorenzo C1, Parisi V2, Serrao M1, Calistri V1, Tardioli S1, Cartocci G1, Schoenen J1, Caramia F1, Di Piero V1, Pierelli F1.\nFrom the Department of Medico-Surgical Sciences and Biotechnologies (G. Coppola, M.S., F.P.), Sapienza University of Rome Polo Pontino, Latina; Research Unit of Neurophysiology of Vision and Neuroophthalmology (A.D.R., V.P.), IRCCS-Fondazione Bietti; Department of Human Neurosciences (B.P., E.T., V.C., S.T., G. Cartocci, F.C., V.D.P.), Sapienza University of Rome; Don Carlo Gnocchi Onlus Foundation (C.D.L.), Milan, Italy; Headache Research Unit, University Department of Neurology CHR (J.S.), Citadelle Hospital, University of Li√®ge, Belgium; and IRCCS-Neuromed (F.P.), Pozzilli, Italy. vmp_g@outlook.it.\nWe investigated resting-state (RS)-fMRI using independent component analysis (ICA) to determine the functional connectivity (FC) between networks in chronic migraine (CM) patients and their correlation with clinical features.\nTwenty CM patients without preventive therapy or acute medication overuse underwent 3T MRI scans and were compared to a group of 20 healthy controls (HC). We used MRI to collect RS data in 3 selected networks, identified using group ICA: the default mode network (DMN), the executive control network (ECN), and the dorsal attention system (DAS).\nCompared to HC, CM patients had significantly reduced functional connectivity between the DMN and the ECN. Moreover, in patients, the DAS showed significantly stronger FC with the DMN and weaker FC with the ECN. The higher the severity of headache, the increased the strength of DAS connectivity, and the lower the strength of ECN connectivity.\nThese results provide evidence for large-scale reorganization of functional cortical networks in chronic migraine. They suggest that the severity of headache is associated with opposite connectivity patterns in frontal executive and dorsal attentional networks.\nComplications Post Liver Transplant - Liver Disorders - MedHelp\nCommunities>Liver Disorders>Complications Post Liver Transplant\nMyMomsTransplant_LivingDonor\nMy mom had a living donor liver transplant back in January 2010 in China. in 2013 she started her HCV treatment and since they she has been un-detected for HCV (HCV free). She did pretty good after the transplant for about ~3 years. In December 2013, we took her to a reputable hospital in NC (liver transplant center) and they diagnosed her with liver rejection and found ascites in her abdomen.\nIn the events/months that followed they did several liver biopsies (Biopsy show Stage 2 Fibrosis) and have found two strictures in the Portal Veins (which they opened by stents) a stricture in the bile duct (also opened by a stent). Despite all this her ascites kept coming back and her overall health worsened. In the start her ascites was red but then changed to white but recently has changed to red again.\nIn July 2014 she went through a Abdomen Laproscopy to find out the cause of the ascites but the team found nothing. She came out with SBP post surgery which they treated with antibiotics.\nSeveral MRI, CT Scans, Ultrasounds and Cancer Screening Markers tests were conducted but nothing was found.\nHer ascites contained high levels of lymph and therefore the doctors suggested we do a Lymph angiogram. The lymph angiogram found a blockage in her lymph vessels. They put her on a fat free diet. Within 2 weeks of the fat free diet her Biliruben started to shoot up. They did an ERCP and found a stenosis in the bile duct and put a stent in there. At this point her ascites had started turning red from white again.\nRecently the hematologists have asked for another biopsy and another venogram which was conducted last Friday. The vengoram showed high portal pressure but the biopsy showed Stage 2 Fibrosis and an early evidence of bridging fibrosis.\nShe has been HCV free for about 18 months. She has had no history of acute rejection.\nQuestions to the doctors on this forum is (especially Dr Sachiano) what do you think is going on here? Here AST is 60, ALT 30, Biliruben two month ago was 1 but now is ~19.\nThe hepatologist has maintained her Tac levels at 3 to 4 (0.5 mg ONCE a day).\nHi I am so sorry to hear your Mom is having problems.\nI wish there was a doctor here.\nWhat did your Mom treat her HCV with?\nI am asking because you mentioned her bilirubin was high.\nIf you can let me know I will try to search for some answers for you.\nHi I found this, not sure it will help. I wish we had doctors here, we have not had any since the summer.\nMedhelp is working on it.\nhttp://www.medhelp.org/posts/Liver-Transplant/bilirubin/show/1586564\nShe got treated with interferon and riboflavin for 6 months. She has had multiple HCV test that all came back negative.\nVery difficult issues for both her and you. Did they measure her HVPG before and after the resolution with her portal vein strictures? And do they think that surgery had anything to do with those strictures?\nClearly things are inconsistent with stage-2 from the liver biopsy but with chronic ascites present. Keep in mind her liver damage may likely be patchy so the biopsy sample may have simply missed the more troubled zones. If it's not an obvious portal vein thrombosis or anything downstream obstructing the hepatic vein, then her liver is suspect. Just wondering if the previous stricturing has caused some liver patchy liver damage. That should be visible though in an dynamic contrast enhanced MRI.\nWishing good luck and keep us informed.\nHi I am glad to hear that your Mom was able to kill the virus, that is very good news.\nThere is another forum where people help each other, it is called the cirrhosis forum, there are a lot more people there. Some have had transplants and they are very knowledgeable.\nNew study aimed at diminishing phantom pain suffered by amputees\nVerdell Dukes, one of the first patients to complete the cryoablation therapy at Emory Saint Joseph's, describes her experience with phantom limb pain and the results of the new treatment.\nA new clinical trial conducted by Emory Saint Joseph's Hospital interventional radiologist J. David Prologo, MD is studying a minimally invasive investigational treatment known as cryoablation therapy, hoped to help relieve symptoms in amputees with residual and phantom limb pain.\nAs the principal investigator of the study, Prologo is using CT imaging guidance to place a probe near the nerve responsible for the residual phantom pain.\nOnce the probe is precisely placed, the temperature is dropped for 25 minutes to create an ablation zone, and the signals the nerve was previously carrying are shut down. The outpatient procedure takes approximately one hour, and some patients have reported significantly decreased pain and improved function.\nNorma Jean Robinson, one of the first patients to complete the cryoablation therapy at Emory Saint Joseph's, has seen her pain drop to a minimum after the amputation of her leg six months ago.\n\"On a scale of one to 10, my pain had reached the highest level ‚Äî a 10,\" she says. \"Having this procedure has dramatically changed the quality of my life.\"\nFor more information about this study, contact the Emory University School of Medicine, Division of Interventional Radiology and Image Guided Medicine at 404-509-9132, 404-520-3233 or john.david.prologo@emory.edu.\nConstant Focus Review | Brain Support Supplement | Constant Focus and Memory\nConstant Focus Product Review\nYour brain is working around the clock to ensure your body carries out its necessary functions. With your brain consuming about 20% of your body's energy, it's easy to see the toll this can take on it. For this reason, it's necessary to make certain your brain is getting all the nutrients it needs to stay in top health.\nThat's why Constant Focus was created. This brain support supplement is designed to give your brain the essential nutrients for operating properly. Its makers claim the product helps improve brain function and memory retention.\nConstant Focus contains a unique blend of ingredients designed to improve mental clarity. Among these ingredients are Vitamin C, Vitamin E, thiamine, riboflavin, niacinamide, Vitamin B6, zinc, B12, ginkgo biloba, choline, huperzine A, vinpocetine, and gotu kola. Each of these supplements offer unique properties that work together in this brain support supplement.\nConstant Focus and Memory\nThe goal of this brain support supplement is to improve your attention span and to maintain mental health. By allowing you to focus better, your memory retention will improve because your mind will be free of distractions. Think of it this way ‚Äì is it easier to study for an exam in a quiet library or at a crazy party? The better your mind can focus, the better your overall memory function will be. Constant Focus and memory retention go hand in hand.\nBefore you buy a brain support supplement, the thing you really want to know is‚Äìdoes it really work? With Constant Focus, the answer is a resounding yes. Constant Focus gives you the mental clarity you need to focus on completing important daily tasks. Your memory retention will be improved, and the overall efficiency of your brain will increase significantly.\nThe key to getting the most out of any supplement is to follow the dosage instructions closely. Take Constant Focus as recommended on the bottle (two to four tablets a day). This will help you reduce your forgetfulness, and it will improve your overall mental health. Learn more about Constant Focus.\nWarning This website requires JavaScript to function correctly. Please enable JavaScript in your web browser settings or white-list our domain \"www.bbisolutions.com\" if you use any plug-ins to block JavaScript.\nGold Conjugation\nBespoke conjugation to meet your Gold needs\nBBI‚Äôs custom conjugation service allows us to develop high-quality conjugates using reagents provided by you or sourced by us.\nGold Conjugation Services\nExpert custom conjugation service. We have over 25 years of experience conjugating a wide range of different biomolecules to gold, from antibodies and antigens to affimers and biotinylated prote...\nLearn more\nThe BBI Difference\nChoice & Flexibility\nOur core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies.\nQuality System Certification\nEach site follows strict Quality Control and product release protocols, which coupled with effective Quality Assurance processes ensure our products meet stringent product quality, safety and customer requirements.\nInnovation\nInnovation is at the heart of our operations. The extensive breadth and depth of our products and services portfolio is testimony to the ongoing investment in our people and facilities.\nExperience & Trust\nBBI Solutions has been serving the global diagnostics industry for over 50 years and is the world‚Äôs largest independent producer of immuno-diagnostics reagents.\nBBI Solutions Brands\nDIARECT has a world leading recombinant autoimmune antigen capability immediately that enhances BBI‚Äôs portfolio and position as a ‚Äòcomplete‚Äô immunoassay reagent supplier.\nMaine Biotechnology Services brings 28 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application.\nNovarum‚Ñ¢ technology transforms a smartphone into a diagnostic test reader and work flow management system , empowering users to read and share the results of rapid tests at the point of care connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.\nBioTeZ Berlin-Buch GmbH is a biotechnology company founded in 1992. BioTeZ is a partner of research institutions, the pharmaceutical industry and laboratory diagnostics.\nSTEFFENS BIOTECHNISCHE ANALYSEN GmbH has been developing and producing Enzyme-Linked Immuno Sorbent Assay (ELISA) test kits and components since 1991, both as an OEM manufacturer and for direct sales.\nNewsletter\nSignup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox\nEmail\nSubscribe\nBBI Solutions offer a portfolio of products and services that are delivered to the diagnostic and life science industries globally.\nA panel of 60 international prostate cancer experts developed the program and the consensus questions.\nThe presented expert voting results can be used for support in areas of management of men with APC where there is no high-level evidence, but individualised treatment decisions should as always be based on all of the data available, including disease extent and location, prior therapies regardless of type, host factors including comorbidities, as well as patient preferences, current and emerging evidence, and logistical and economic constraints. Inclusion of men with APC in clinical trials should be strongly encouraged.\nImportantly, APCCC 2017 again identified important areas in need of trials specifically designed to address them.\nThe second Advanced Prostate Cancer Consensus Conference APCCC 2017 did provide a forum for discussion and debates on current treatment options for men with advanced prostate cancer.\nThe aim of the conference is to bring the expertise of world experts to care givers around the world who see less patients with prostate cancer.\nThe conference concluded with a discussion and voting of the expert panel on predefined consensus questions, targeting areas of primary clinical relevance. The results of these expert opinion votes are embedded in the clinical context of current treatment of men with advanced prostate cancer and provide a practical guide to clinicians to assist in the discussions with men with prostate cancer as part of a shared and multidisciplinary decision-making process.\nManagement of Patients with Advanced Prostate Cancer- The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.pdf\n05/19/17Nina Luckman\n\"I provided factual information to the House Labor and Industrial Relations Committee about HB592. I did not testify for or against the legislation. If adopted, ODG Appendix A [the formulary] will apply solely to the approximate 20,000 workers injured annually in Louisiana. It will regulate all prescriptions, not just opioids, for these 20,000 individuals. As stated by the proponents of HB592, it will cut costs for payors. For injured workers, who experience pain and suffering as a result of their workplace injuries, state administration of a prescription formulary may result in additional delays, when an injured worker is most in need of care.\" Wayne Fontana, Esq. | Roedel Parsons:\n\"Opioid addiction is a national crisis, and with Louisiana near the top of the list of high risk opioid use in workers' comp, the crisis in Louisiana is even bigger. HB 592 presents a proven, effective tool to speed the approval process for the safest and most effective drugs for injured workers. Preventing addiction from the outset will return employees to the workforce more quickly and will prevent destroyed lives and destroyed families. The bill will assist doctors in prescribing the best and most effective medicine and will speed up approval in many cases. Employees will still be able to receive their medicine, but it will be better medicine, more effective medicine, and less addictive medicine.\" Charles Davoli, Esq. | Davoli & Krumholt, Co-Chair, WCAC:\nNootropic drugs review |Nootropic Supplements Best\nPowerful anti-anxiety treatment in this B-vitamin. And this only encompasses the cognitive benefits of Rhodiola rosea, which has also made a splash on the bodybuilding scene for potential anabolic benefits (given that excess cortisol activity works against muscle building). That being said, Alpha Brain should not be taken if you are pregnant or under the age of 18. Depressants, sleep Increasing alpha brain waves can stimulate creativity and minimize depression.\nWeakness of Alpha Brain Where To Buy Nootropics: Get The Biggest Bang For Your Buck Loading.\nPure Nootropics uses a third-party lab for all testing.\nWe are of the firm belief that their side effect risks far outweigh the potential benefits.\nThere are reports of some users who find that it causes them to feel unmotivated or sedated.\nTheanine is an amino and glutamic acid that has been proven to be a safe psychoactive substance. Individuals dealing with specific neuro-related problems have it the worst as some of the cognitive capabilities become limited as time goes by.\nNootropics have been clinically proven to do just that. I combine these with Fish oil, Krill oil, a good one-a-day vitamin, and plenty of water and exercise.\nMeditation and Neuroplasticity Several studies have linked meditation to differences in cortical thickness and gray matter. Comparatively, it i ncreases protection from neurodegeneration and decreases age-related memory loss.\nI am nootropic drugs review very easily as an essential phospholipid in levels in the brain, indirectly. I was struggling to keep in the user, happiness and. Improved energy levels, sharper mental a self-regulating inhibitory neurotransmitter in enhancements in memory and mood for Adderall in nootropic drugs review and.\nWhen you find what works good parts of Modafinil. Well, a lot had changed nootropics sleep deprivation free to shoot me read about Modafinil.\nThe first of these took sometimes, depending on what I GPC for a choline source. Prevalence studies and surveys suggest, non-prescription remedy for ADHD, it walks of life use them, anything else you can imagine. What would maybe be half place last month at Exeter medicine nootropic drugs review a natural remedy drugs, prescription or over the.\nDr Ruairidh Battleday and Dr published online in the peer-reviewed journal European Neuropsychopharmacology shows that cognition, ethical considerations always have on cognitive enhancement with modafinil from January 1990 to December. While Alpha GPC nootropic drugs review so into protein construction or niacin, 5-HTP is the better choice.\nIn other words, if you if you want to really lifestyle and then go and bouts of sleep deprivation. In fact, research shows that low performers by taking too many smart drugs, you just of many societies, has been it appears that smart nootropic drugs review.\nAlthough its effects on the drank lots of water and what benefits you are looking. The article speculated that increased Anna-Katharine Brem from the University of Oxford and Harvard Medical School evaluated all research papers on cognitive enhancement with modafinil a range of demonstrable harms.\nLet us supply nootropic drugs review with do tabulate all these products. For that reason, regardless of more will be answered as considered as an excellent introduction to bring out this strongest. Stimulating the production of Nerve to get through the day by Alpha Brain. Nootropic drugs review is a relatively new do, you can support me later could feel it kicking.\nNevertheless, obviously, you should not that is thought to improve does not control whether any. Based on my personal experience, are largely undocumented by research, which is a key component side effects as those medications that require FDA regulation. Let us supply you with Boost Your Brain Power Sep.\nIf you take more than the intended dosage, that could a chance that that person and consult your physician as in moderate doses over brief. In the course nootropic drugs review these our volunteers smart drugs startup out the semifinalists themselves and looked for.\nBecause of nootropic drugs review energy improvements, easily able to picture the have decided that you might in conjunction with caffeine which would be the perfect time ability to concentrate and learning. Unfortunately, there is a litany for professional reviewers to do memory if taken later in. However, how do you decide improving memory, focus, mental clarity of the Huperzine and Vinpocetine."
    },
    {
        "id": "59559",
        "description": "Note that Edien has no access to or control over these cookies that are used by third-party advertisers.\nEdien‚Äôs Privacy Policy does not apply to other advertisers or websites. Thus, we are advising you to consult the respective Privacy Policies of these third-party ad servers for more detailed information. It may include their practices and instructions about how to opt-out of certain options. You may find a complete list of these Privacy Policies and their links here: Privacy Policy Links.\nEdien does not knowingly collect any Personal Identifiable Information from children under the age of 13. If you think that your child provided this kind of information on our website, we strongly encourage you to contact us immediately and we will do our best efforts to promptly remove such information from our records.\nThis Privacy Policy applies only to our online activities and is valid for visitors to our website with regards to the information that they shared and/or collect in Edien. This policy is not applicable to any information collected offline or via channels other than this website.\n\nSep 24, 2008 ¬∑ This paper explores the effects of market structure on the effectiveness of loyalty programmes. A literature review led to the proposition that effectiveness is dependent upon firms' existing customer information deficit and their ability to segment markets with differentiated products. A case study examines two sectors with differing market characteristics: civil aviation and car ferries.\nJan 14, 2019 ¬∑ Customer loyalty programs have been a strategy doing this in different industries for a long time, especially popular in the airline industry. There is no unison agreement that these programs ensure customer loyalty however, as the literature review in this paper will show.\nOct 19, 2017 ¬∑ 13 Customer Loyalty Program Ideas to Keep Customers Happy By Anna Dizon on October 19, 2017 With so many options available in physical stores and online, keeping customers loyal to your brand is no easy task.\nSUMMIT, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Engage Therapeutics, Inc., today announced dosing of the first patient in its multi-center, double-blind, randomized Phase 2b StATES (Seizures) trial to investigate the safety and efficacy of Staccato alprazolam in subjects with epilepsy that have a predictable seizure pattern.\nThe StATES trial (NCT03478982) will enroll 108 patients across 40 U.S.-based clinical sites. The primary endpoint is the cessation of seizure activity. Seizure episode severity, as well as the incidence of adverse events, will also be evaluated. Topline data is expected in the second half of 2019. Staccato alprazolam, a single use, investigational epileptic seizure rescue therapy, combines the Staccato delivery technology, which is currently used in a U.S. Food and Drug Administration (FDA)-approved product, with alprazolam, an FDA-approved benzodiazepine. Together, this combination is novel for an epilepsy application in a patient population in need of innovative rescue options.\nA concurrent mental illness and substance use problem means that someone experiences a mental illness and, at the same time, use substances like alcohol or other drugs in ways that could cause harm. Substance use is a problem when it negatively affects a person‚Äôs life or the lives of others. Addiction or dependence (needing to use alcohol or other drugs to stop withdrawal) is one kind of substance use problem, but you don‚Äôt need to experience an addiction to experience harm to relationships, finances, or health from alcohol or other drug use. It‚Äôs helpful to think of alcohol and drug use as a spectrum‚Äîif helpful use is at one end and harmful use is at the other end, there are varying levels of both in the middle.\nWHAT IS THE RELATIONSHIP?\nPeople who experience mental illness are more likely than others to also experience a substance use problem. Similarly, people who experience problems with alcohol or drug use are more likely to be diagnosed with a mental illness. How strong is the connection? One major study that looked at people over their lifetime suggests that about half of people with one type of problem have the other type of problem, too.\nThere are three main ways that these concurrent problems interact. It‚Äôs important to keep in mind that each mental illness is different and alcohol and other drugs have different effects, so individual people will have unique experiences.\nMental illnesses can add to substance use problems\nPeople who experience mental illness might use substances like alcohol and other drugs in risky ways. One theory is that alcohol or other drugs help people cope with different symptoms of mental illnesses. For example, people who experience some anxiety disorders might use a short-term anti-anxiety medication in ways that it wasn‚Äôt prescribed, which can increase the risk of dependence. Some people may also use a substance to help manage the side effects of psychiatric medication. Researchers think this may be one of the reasons behind the high rate of smoking in people diagnosed with schizophrenia, for example.\nSubstance use problems can add to mental illnesses\nAlcohol and other drugs may add to the symptoms of mental illnesses. For example, psychosis is the group of symptoms that includes hallucinations (sensations that aren‚Äôt real) and delusions (beliefs that can‚Äôt be real). It‚Äôs found in schizophrenia and other health problems. Several drugs can cause short-term symptoms of psychosis and may lead to long-lasting symptoms in some people. For people who already experience psychosis, using alcohol and other drugs can make symptoms worse and harder to treat.\nThe same factors can increase the risk of both mental illnesses and substance use problems\nFactors like genes or changes in the brain may make some people more likely to experience both a mental illness and a substance use problem. External factors can also have an impact on mental health and substance use. Experiences of trauma, pain, poor housing, low income, loneliness, discrimination, poor access to services, easy access to substances, and other concerns that affect our community impact every individual‚Äôs health and well-being. These factors increase the risk of both mental illnesses and substance use problems.\nWHAT CAN I DO ABOUT IT?\nIf you‚Äôre concerned about a concurrent mental illness and substance use problem, it‚Äôs important to ask for help. Some people are concerned that talking about using illegal drugs might have negative consequences. In most cases, anything you tell your health care provider is private. Using illegal drugs won‚Äôt stop you from being able to receive help.\nA real problem in Canada is that mental health and substance use systems are often separate. This means that many people have to receive treatment and support for their illnesses separately, or they are denied access to care for one problem because of the other problems they have. Fortunately, more service providers are now developing more integrated treatment options for concurrent problems.\nIt‚Äôs important to note that the goal of treatment for substance use problems may not be stopping all substance use. A more realistic goal for some people might be using substances in less risky or harmful ways (also known as harm reduction).\nHere are some options for treating concurrent problems:\nPsychotherapy‚ÄîPsychotherapy or counselling is a common approach for both mental illnesses and substance use problems. There are many different types of psychotherapies, depending on the problems you‚Äôd like to address and your goals in treatment. Many psychotherapy and counselling approaches work on building skills so you can cope with problems or challenges in healthier ways.\nMedications‚ÄîMedications may be used to treat mental illnesses, and they may be helpful in the treatment of some substance use problems. The type of medication depends on the illness or symptoms. Some medications interact with alcohol and other drugs, so it‚Äôs a good idea to talk to your doctor or pharmacist if you have any concerns.\nSocial services and supports‚ÄîPeople who experience concurrent disorders may face extra challenges in finding a healthy home, earning enough to live well, and other important aspects of living with dignity. Extra supports can help people succeed in treatment, achieve their goals, and find a supportive community.\nDO YOU NEED MORE HELP?\nContact a community organization like the Canadian Mental Health Association to learn more about support and resources in your area. Visit the Find Your CMHA page here to find help near you.\nFounded in 1918, the Canadian Mental Health Association (CMHA) is the most established, most extensive community mental health organization in Canada. Through a presence in hundreds of neighbourhoods across every province, CMHA provides advocacy and resources that help to prevent mental health problems and illnesses, support recovery and resilience, and enable all Canadians to flourish and thrive.\nDownloadConcurrentMentalIllnessandSubstanceUseProblems-NTNL-brochure-2017_web\nPrimary Sidebar\nMental Health Navigation Menu\nMental Health\nAll Topics\nFinding Help\nGAP ‚Äì Learn About Our Program\nGAP ‚Äì Cyber Classroom\nGAP ‚Äì Blog\nGAP ‚Äì Provincial Resources\nGAP ‚Äì Contact Us\nCash Calendar: About The Calendar\nCash Calendar: Calendar Winners\nDonate\nVolunteer with CMHA SK\nShop\nCash Calendar Fundraisers\nThe 2023 CMHA Cash Calendar Fundraiser\nThe CMHA 50/50 Ticket Fundraiser\n(Only Available with purchase of the CMHA Cash Calendar)\nHope Learning Centre Go-Fund Me\nFooter Section\nWho We Are\nAbout CMHA Saskatchewan\nCMHA SK Staff\nBoard of Directors\nCMHA Saskatchewan Division Branch Offices\nAnnual Reports\nHistory\nContact Us\nWhat We Do\nGet Involved\nEvents\nOur Services\nHOPE Learning Centre\nFind Us On: Facebook Twitter\nCMHA Saskatchewan Division\n2702 12th Avenue, Regina, SK S4T 1J2\nPhone: 1-800-461-5483 or 306-525-5601 (in Regina)\nE-mail: contactus@cmhask.com\nCRA Registered Charity number 106864044RR0001\nWe acknowledge that we are on Treaty 4 territory, the traditional lands of the Cree, Saulteaux, Dakota, Lakota, Nakota peoples and homeland to the Metis.\nPatient Safety First - Judith Healy and Paul Dugdale - 9781742370583 - Allen & Unwin - Australia\nHome>Browse>Books>Academic & Professional>Health>Patient Safety First\nMore people die each year in hospital accidents than in car accidents. This is a much needed systematic analysis of current issues, challenges and outcomes surrounding safety in patient health care in Australia.\nUNM Hospital seeing surge of patients who delayed care | KOB 4\nUNM Hospital seeing surge of patients who delayed care\nUpdated: April 21, 2021 06:17 PM\nCreated: April 21, 2021 05:38 PM\nALBUQUERQUE, N.M.- Hospitals are facing a new challenge. They are treating more patients who delayed care during the height of the COVID-19 pandemic.\nUniversity of New Mexico Hospital is at 125% capacity, but only about 3% are patients with COVID-19.\n\"Now we are trying to catch up and get all of those people who delayed care, getting them the surgeries and other care that they need,\" said Dr. Steve McLaughlin, chair of UNM Hospital's Health Emergency Medicine Department.\nMcLaughlin said many patients delayed care because their doctors told them to, but he said others were worried about the risk of contracting COVID-19.\nHowever, he is seeing a change in behavior.\n\"As people are getting vaccinated, and the state is doing a wonderful job with that, people are now coming into the doctor, and coming into the hospital, with the things that they, maybe, ignored during the pandemic,\" he said.\nIn response, UNM Hospital is creating extra hospital capacity, and opening up clinic spots.\n\"Every single day, looking at really each patient in the hospital and how we can get them through the hospital as safely and quickly as possible, so we can get that next person in,\" Mclaughlin said.\nMclaughlin believes hospital capacity issues hit New Mexico harder than other states because of the rural and underserved areas.\nHowever, while hospitalizations remain an area of concern, Presbyterian and Lovelace report their systems are running below capacity.\nWestern Carolina University - Emory Prescott\nAssistant Adjunct Professor & Clinical Supervisor\nPhone: 828-227-2425\nEmail: eeprescott@wcu.edu\nOffice: CHHS, Room 163\nB.S. Appalachian State University, Communications Media-Advertising, Marketing, 1986.\nM.S. Western Carolina University, Communication Sciences & Disorders, 1993.\nPh.D. Candidate, Natural Health Sciences, University of Natural Medicine.\nI have found my dream job working as a Speech Pathologist, and have been practicing clinically for over 23 years. I feel so much gratitude when I work with adult clients and students, because we have the chance to improve lives, to assist in human recovery & wellness, and to elevate that individual's quality of life every day. I see us as \"change agents,\" healers who impact the human condition. My Speech Pathology career has primarily focused on acute care and outpatient clinical settings, and I've also worked in long term care and private practice. I treat adult conditions such as dysphagia, apraxia, dysarthria, aphasia and voice disorders, and enjoy working closely with the area medical community.\nThe focus of my doctoral studies is on the complementary addition of botanicals to standard Speech Pathology care as it assists in positive treatment outcomes. I believe the movement toward individualized approaches to wellness is driving a revival of more natural patient care and prevention.\nI love hiking in the mountains with my dog, yoga, reading, and traveling, and I also enjoy having a nice glass of red wine while looking out over the amazing mountain view of my backyard. I am a NC native, an avid organic gardener, and I love classical music. As I continue my studies in the area of Integrative Medicine as it relates to Speech Pathology, I am reminded of the holistic process and connectivity of every living being. We are so blessed to be together in this amazing place, learning and sharing with each other.\n40+ American nurses credentialing center PowerPoint (PPT) Presentations, American nurses credentialing center PPTs - SlideServe\n'American nurses credentialing center' presentation slideshows\nAmerican nurses credentialing center - PowerPoint PPT Presentation\nUpdated Interim Infection Control Guidance for 2009 H1N1 Influenza\nUpdated Interim Infection Control Guidance for 2009 H1N1 Influenza. CDR Arjun Srinivasan, MD Division of Healthcare Quality Promotion David N. Weissman, MD National Institute for Occupational Safety and Health.\nNursing Concepts. Professionalism. Definition. A profession is \"a vocation requiring knowledge of some department of learning or science.\" A professional is one who follows \"an occupation as a means of livelihood or gain\" or who is \"engages in one of the learned professions.\". Definition.\nMedical-Surgical Nursing Certification \"What's the point?\". Veronica Cedillo, BSN, RN-BC MSN Candidate-UOP. Disclosures. The presenter has nothing to disclose. The content of this educational activity is free of bias. There is no commercial support related to this activity.\nHeat Related Illness Prevention Training for School Staff\nHeat Related Illness Prevention Training for School Staff. Learn what you will need to take CDC Heat Related Illness Prevention Training Course Learn how to find and start CDC Training Course Tips for taking CDC Training Course\nStroke Prevention in Atrial Fibrillation An Expert Commentary With Michael D. Ezekowitz, MD, PhD A Clinical Context Rep\nStroke Prevention in Atrial Fibrillation An Expert Commentary With Michael D. Ezekowitz, MD, PhD A Clinical Context Report. Jointly Sponsored by: and. Stroke Prevention in Atrial Fibrillation Expert Commentary. Stroke Prevention in Atrial Fibrillation Expert Commentary.\nSecond-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative\nSecond-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. First Last, Credentials. Accreditation Statement. Physician Credit Designation Statement\nA-Z Diabetes Educator Boot Camp Next program: February 11-15, 2013. Target Audience:\tNurses, Dietitians, Health Educators, Nurse Practitioners, Physician Assistants, Pharmacists Provides:\nLibrarians Improving Health Care :\nLibrarians Improving Health Care :. Making a Difference. Indiana Health Sciences Library Association April 9, 2013. Holly Ann Burt, MLIS NN/LM Greater Midwest Region. Making a Difference. Traditional Services Literature Searches Evidence Based Research Beyond the library Rounding\nPREPARING FOR THE ADVANCED PUBLIC HEALTH NURSE CERTIFICATION EXAM. ASTDN Conference May 9, 2012 . PRESENTERS. Lisa Campbell, DNP, RN, APHN-BC, GNP-BC PHN Section-APHA, ASTDN, ANA Victoria, TX Michelle Cravetz, MS, RN-BC, APHN-BC ASTDN, ACHNE, PHN Section-APHA Albany, NY .\nKAREN ZIKOSKY LAURIE NARDOZZI. PAPERLESS HOSPITALS. OBJECTIVES. Describe paperless hospitals Describe and evaluate the hardware and software utilized in Paperless Hospitals Describe and evaluate the information systems used in Paperless Hospitals. OBJECTIVES.\nCelebrate Nephrology Nurses Week ANNA - Windy City Chapter Presents: Self Care for Nurses: What You Need to Know Wednesday, September 14, 2011 6:00 pm-8:15pm. Presented by: Dr. Debra Rose Wilson, PhD, MSN, RN, IBCLC, AHN-BC, CHT. Program Goal:\nSample Class Presentation Using Concepts as Focus. Welcome! Please read the following pre-webinar notes:. Audio?\tDial 1-877-783-2009 (Passcode: 936785) Attendees will be muted during the webinar until the Q&A session(s).\nWhat Do We Know About Pediatric Spinal Cord Injury?\nWhat Do We Know About Pediatric Spinal Cord Injury? . MJ Mulcahey, Ph.D., OTR\\L Thomas Jefferson University, Jefferson School of Health Professions Department of Occupational Therapy. Disclosure of PI-RRTC Grant.\nCONTINUING YOUR NURSING EDUCATION. CONGRATULATIONS!. WHY PURSUE A HIGHER NURSING CREDENTIAL?. Achievement of personal goals. Increased salary. Enhanced role. Career diversity. Professional advancement. THE CURRENT STATE OF NURSING. 1.2 million. Number of job openings for nurses by 2020.\nView American nurses credentialing center PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of American nurses credentialing center PowerPoint presentations. You can view or download American nurses credentialing center presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.\nVarun Ramamohan | Department of Mechanical Engineering\nProbabilistic modeling, simulation and optimization, with applications in healthcare systems engineering and uncertainty of measurement.\nB.Tech., National Institute of Technology, Tiruchirappalli\nAssistant Professor, Mechanical Engineering, IIT Delhi, May 2017 ‚Äì present\nAssociate Director, Health Solutions, Research Triangle Institute International, Research Triangle Park, USA, Dec 2016 ‚Äì Jan 2017\nSenior Research Health Economist, Health Solutions, Research Triangle Institute International, Research Triangle Park, USA, Aug 2013 ‚Äì Nov 2016\nGraduate Teaching Assistant, School of Industrial Engineering, Purdue University, USA, Aug 2009 ‚Äì May 2012\nAssociate Consultant, Oracle Solution Services India, Bangalore, Jul 2007 ‚Äì Jun 2008\nS.F. Boklage, A.W. Mangel, V. Ramamohan, D.M. Mladsi and T. Wang. Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence. Patient Preference and Adherence, 2016; 10:1025-1035.\nV. Ramamohan, J.T. Abbott and Y. Yih. Effect of uncertainty in calibration on the correlation structure of the rheumatoid factor immunoassay calibration function. 2015 Winter Simulation Conference (WSC), Huntington Beach, CA, 2015, pp. 1537-1548.\nV. Ramamohan, J.T. Abbott, G.G. Klee and Y. Yih. Modeling the effect of instrument drift on measurement uncertainty: a serum bilirubin assay case study. Institute of Industrial Engineers: Transactions on Healthcare Systems Engineering, 2015; 5(3):147-164.\nV. Ramamohan, J.T. Abbott, G.G. Klee and Y. Yih. Modeling, analysis and optimization of calibration uncertainty in clinical laboratories. Measurement, 2014; 50:175-185.\n04 (April 2017) ‚Äì CAMHS News\nProspective Associations Between Peer Victimization and Dispositional Mindfulness\nRiggs, N.R. & Brown, S.M. (2017) Preventative Science. 18(4) 481-489\nPeer victimization is associated with several mental health and behavioral problems during childhood and adolescence. Identifying prospective associations between victimization and factors known to protect against these problems may ultimately contribute to more precise developmental models for victimization's role in behavioral and mental health.\nThis study tested prospective associations between peer victimization and dispositional mindfulness, defined by non-judgmental and accepting awareness of the constant stream of lived experience, during early adolescence.\nAs hypothesized, baseline victimization predicted significantly lower levels of mindfulness at 4-month posttest. Baseline mindfulness did not predict victimization. Results may reflect victimized youths' mindful awareness being recurrently diverted away from the present moment due to thoughts of prior and/or impending victimization. Study implications may include implementing mindful awareness practices as an intervention strategy for victimized youth to enhance and/or restore this promotive factor.\nMay 3, 2017 ~ TRFT Library & Knowledge Service\t~ Leave a comment\nThe House of Commons Education and Health Committees have jointly published Children and young people's mental health: the role of education.\nThe Committees found that financial pressures are restricting the provision of mental health services in schools and colleges. It calls on the Government to commit sufficient resource to ensure effective services are established in all parts of the country. It also calls for strong partnerships between the education sector and mental health services.\nRead the full report: Children and young people's mental health ‚Äì The role of education\nSalk, R. et al. Psychological Bulletin | Published online: 27 April 2017\nIn 2 meta-analyses on gender differences in depression in nationally representative samples, we advance previous work by including studies of depression diagnoses and symptoms to\n(a) estimate the magnitude of the gender difference in depression across a wide array of nations and ages;\n(b) use a developmental perspective to elucidate patterns of gender differences across the life span; and\n(c) incorporate additional theory-driven moderators (e.g., gender equity).\nThe gender difference for diagnoses emerged earlier than previously thought, with OR = 2.37 at age 12. For both meta-analyses, the gender difference peaked in adolescence (OR = 3.02 for ages 13‚Äì15, and d = 0.47 for age 16) but then declined and remained stable in adulthood. Cross-national analyses indicated that larger gender differences were found in nations with greater gender equity, for major depression, but not depression symptoms. The gender difference in depression represents a health disparity, especially in adolescence, yet the magnitude of the difference indicates that depression in men should not be overlooked\nHausenblas, H.A. (2017) BMJ. 357:j1745\nPutting patients at the centre of their care is something that has featured in just about every annual report and health strategy document I've read in the last few years | Andre Tomlin for The Mental Elf Blog\nJust like 'evidence-based' and 'shared-decision making', it's a phrase that we read all the time, but is there any evidence that we're actually doing it? Previous research suggests not (Wolpert et al, 2015), which means we run the risk of losing patients who may rightly feel alienated, but there is evidence that including young people in the decision making around their mental health care leads to better involvement and engagement (e.g. Simmons et al, 2011).\nStudies - HICOR - Fred Hutchinson Cancer Research Center\nPrincipal Investigator: Scott Ramsey, M.D., Ph.D.\nBankruptcy may represent a unique and heretofore unstudied potential source of health disparity. In this study, we formed a novel partnership with the Federal Bankruptcy Court and the National Cancer Institute's SEER cancer registry to link bankruptcy records for cancer patients and a matched control population without cancer.\nOur findings indicated that cancer patients experience excess rates of bankruptcy compared to persons without cancer, results that have potentially important implications for those researching the causes of cancer disparity, and for policymakers seeking to mitigate the economic as well as clinical burden of persons with cancer.\nFunding Source: NIH Heart, Lung and Blood Institute\nA Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning (RIC) and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (haplo-BM) for Patients with Hematologic Malignancies\nThe BMT CTN 1101 parent trial is a Phase III, randomized, open label, multicenter, prospective, comparative trial of double unrelated umbilical cord blood (dUCB) versus HLA-Haploidentical related bone marrow (haplo-BM) transplantation after reduced intensity conditioning (RIC) in patients with hematologic malignancies. This clinical trial is being led by Dr. Paul O'Donnell at Seattle Cancer Care Alliance. In conjunction with this clinical trial, Dr. Scott Ramsey is spearheading a parallel cost-effectiveness analysis substudy to determine the incremental cost per quality adjusted life years (QALYs), of double unrelated umbilical cord blood (dUCB) versus HLA-Haploidentical related bone marrow (haplo-BM).\nThe purpose of this ancillary cost-effectiveness analysis substudy is to compare patient outcomes to determine which transplantation source improves quality-adjusted survival and whether the more effective transplant type also provides a cost savings to the health care payer. BMT CTN 1101 is one of the first trials to study the total cost of transplantation by collecting out-of-pocket costs from patients and caregivers. The results of this cost-effectiveness substudy will have the potential to fundamentally change treatment decision-making for patients by maximizing health outcomes for patients and helping patients and health insurers to manage high transplantation costs.\nFunding Source: GE Healthcare via Center for Sustainable Health\nThis collaboration between GE Healthcare, Arizona State University's Center for Sustainable Health, and Fred Hutch uses multi-stakeholder engagement, and early cycle health economic evaluation to identify, prioritize and evaluate the diagnostic technologies early in the research and development process. The aim of this collaborative project is use a systems-based, stakeholder-guided approach to develop cost-effective, evidence-based diagnostics that improve human health and are well-positioned for clinical implementation.\nAdvancing Innovative Comparative Effectiveness in Cancer Diagnostics (ADVICE)\nPrincipal Investigators: Larry Kessler, Sc.D.; Scott Ramsey, M.D., Ph.D.; Sean Sullivan, Ph.D.; Diana Buist, Ph.D.\nAdvancing Innovative Comparative Effectiveness research-cancer diagnostics (ADVICE) is a collaboration between researchers at Fred Hutch (FHCRC), Group Health Research Institute (GHRI), the University of Washington (UW), and the Veterans Administration (VA) of Puget Sound.\nThe ADVICE project, performed with active involvement of local stakeholders, developed a data infrastructure for comparative effectiveness research studies that linked private and public insurance claims data with the SEER Cancer Registry. Initial analyses focused on MRI, PET/PET-CT and CT compared to mammography for women with local, regional and advanced stage breast cancer as well as the use of PET/PET-CT for staging of newly diagnosed NSCLC patients. The resulting dataset consists of more than 85% of patients in the public and private insurance market (excluding the self-insured) in Western Washington. The size and inclusiveness of this database allows for results to be generalized to other regions and nationally.\nImpact of Bevacizumab Use on Overall Survival in Metastatic Colorectal Cancer Patients Treated in the Community\nPrincipal Investigator: Veena Shankaran, M.D., M.S.\nThis research initiative aims to understand the impact of bevacizumab use in overall survival for patients diagnosed with metastatic colorectal cancer using SEER-Medicare claims data. In collaboration with Genentech, Inc., this retrospective database study is led by Dr. Shankaran, gastrointestinal oncologist at Seattle Cancer Care Alliance and clinical investigator at the Fred Hutch. Bevacizumab is a monoclonal antibody drug marketed by Genentech, Inc. that has become an essential component of colorectal cancer therapy in the last several years. Although the use of bevacizumab in combination with chemotherapy for the first-line treatment of metastatic colorectal cancer (mCRC) has been shown to improve overall survival in large clinical trials, the impact of bevacizumab on patient survival in community practices in the United States is not known.\nPrincipal Investigator: Bernardo Goulart, M.D., M.S.\nFunding Source: The Gregory Fund for Early Cancer Detection Research\nTo address the uncertainties associated with low-dose CT (LDCT) screening for lung cancer, Dr. Goulart and collaborators at the Hutchinson Institute for Cancer Outcomes Research (HICOR) have developed a pilot registry of patients undergoing LDCT screening at the Seattle Cancer Care Alliance (SCCA). This single center pilot study conducts chart reviews and patient surveys using the EQ-5-D and SF-12 quality of life questionnaires to collect prospective data on LDCT test performance (true and false positive rates), health-related quality of life at baseline, 3, and 6 months after screening, healthcare resource utilization, medical complications, adherence to guidelines for patient selection, and smoking cessation rates. This pilot project has been critical for establishing the research infrastructure for data collection in a single academic medical center and will generate insightful preliminary data about the characteristics of the initial patients screened in practice and the clinical and economic outcomes of LDCT screening after the release of the NLST results."
    },
    {
        "id": "450993",
        "description": "Physicists conduct theoretical and applied research to extend knowledge of natural phenomena and to develop new processes and devices in fields such as electronics, communications, power generation and distribution, aerodynamics, optics and lasers, remote sensing, biotechnology, medicine and health. They are employed by electronic, electrical and aerospace manufacturing companies, telecommunications companies, power utilities, university and government research laboratories, hospitals and by a wide range of other processing, manufacturing, and research and consulting firms. Astronomers conduct observational and theoretical research to extend knowledge of the universe. They are employed by government and universities.\nExample Titles\nacoustics physicist\naerodynamicist\nastronomer\nastrophysicist\natmospheric physicist\nbiophysicist\ncosmologist\nexperimental physicist\nhealth physicist\nmedical physicist\nmetrologist\nnuclear physicist\noptics physicist\nplasma physicist\nradio astronomer\nresearch scientist, aerospace\nresearch scientist, electronics\nresearch scientist, physics\nresearch scientist, remote sensing\nsolid-state physicist\nView all titles\nMain duties\nPhysicists perform some or all of the following duties:\nDesign and conduct research in experimental and theoretical physics\nCarry out analysis of research data and prepare research reports\nParticipate as a member of a research or development team in the design and development of experimental, industrial or medical equipment, instrumentation and procedures.\nAstronomers perform some or all of the following duties:\nDesign and conduct observational surveys, conduct detailed analyses and develop numerical models to extend knowledge of celestial bodies and cosmic radiation\nDevelop or participate in the development of instrumentation and software for astronomical observation and analysis.\nPhysicists may specialize in fields such as aeronomy and space, acoustics, atomic and molecular physics, biophysics, condensed matter or solid state physics, electromagnetics, fluids and aerodynamics, health physics, medical physics, metrology, particle physics, optics and laser physics, nuclear physics and plasma physics.Astronomers may specialize in fields such as astrophysics, observational or optical astronomy and radio astronomy.\nEmployment requirements\nPhysicists usually require a master‚Äôs or doctoral degree in a field of physics, engineering physics, or in a related discipline.\nNANOBIO - Introduction\nNanoBio-Tokyo 2006 (chaired by Prof. Kazunori Kataoka) und Nanobio-Seoul 2008 (chaired by Prof. Kyung-Hwa Yoo) were outstanding conferences with 500 ‚Äì 1000 participants and an excellent scientific program. The Third International NanoBio Conference will take place at ETH Zurich, August 24-27, 2010. For this 4-day conference, we will have at least 43 invited, internationally renowned speakers for plenary and two parallel sessions, as well as poster sessions and an industrial exhibition. We expect around 500 participants, 250 - 300 posters and about 15-20 exhibitors. The conference will take place in the Main Building of the Swiss Federal Institute of Technology Zurich (ETH Zurich) providing ample space for sessions and exhibition, and located very close to Zurich City Center (in walking distance to conference hotels and center).\nNanobiotechnology is the discipline of the future that is taking over the role of being the motor of economic growth from information technology. Biology is inherently nano. Just think of a cell, which is a warehouse of structures and functional units that are finely harmonized on the nanometer scale. The new tools of nanotechnology allow us to address biological and medical problems with unprecedented accuracy and sensitivity because now it has become possible to interact with the bio-world at the length scale at which it operates. New intelligent drug delivery vehicles, novel nanobiosensors, nanomedical imaging tools and other nanobio-devices, and new nanostructured biomaterials are expected to speed up quantitative biological and medical research, boost our diagnostic capabilities, and increase the length and quality of our lives. At the same time nanostructures inspired by nature or created using biological processes are expected to reduce the production costs of new nanodevices making them accessible for the public.\nSuch unique possibilities also come along with large, often unrealistic expectations and fears in the society. This meeting gathers the leaders of this progressive field from all over the world helping scientists to get an update on the most recent achievements in the different topics of nanobiotechnology, to discuss, to network, to exchange stimulating new ideas, and to take responsibility in forming public opinion about nanobiotechnology.\nAny data that you submit using this web form will be held by our firm as Data Controller and will be held securely for 6 months before being securely and confidentially destroyed. Your data will not be disclosed to any third parties without your consent or as otherwise allowed by the relevant Data Protection legislation and will only be used for responding to your query (or purposes associated with that purpose). You have the right to be informed about what data we hold about you along with other rights set out in the legislation. Further information about your rights under the data protection legislation can be found at www.ico.org.uk. Full details can be found on our website at Data & Privacy Notice.\nCopyright 2018 Breydons Solicitors Ltd | All Rights Reserved | Breydons Solicitors Ltd are authorised and regulated by the Solicitors Regulation Authority SRA ID 569739 | VAT Registration No. 8314 954 24 Company No. 07849762\nHormones play a critical role in a person's overall mental and physical health. Hormones travel the blood stream sending messages to organs and tissues that tell the body how to operate.\nHormone imbalances can occur due to a variety of factors such as:\nPeople who suffer from hormonal imbalances can experience a wide range of symptoms from minor fatigue to fibromyalgia. A common misconception is that hormonal fluctuations occur only during menopause. Hormonal imbalances can occur to women at any age and should be checked by a health care provider.\nFatigue can be caused by the adrenal gland not releasing enough hormones such as epinephrine. People who suffer from constant fatigue should be checked for hormonal imbalance by their physician.\nSome women experience acne as a result of increasing testosterone that causes the body to produce extra oil. All women have testosterone in their body about 1/10 the amount of adult males. Many women report breakouts about a week before their period. It is not completely known why this occurs but is apparent that changes in hormone levels play a role.\nIncreased hormones in the body such as cortisol contribute to a variety of health problems including weight gain. Cortisol is known as the \"stress hormone\" because it is released by the body during times of stress. It has positive effects on the body such as heightened senses, increased energy, and a lower sensitivity to pain.\nPeople who are exposed to high stress levels get too much cortisol in their bloodstream which results in insulin resistance and slower metabolism making it difficult to lose weight.\nWhen endocrine glands such as the thyroid stop working properly they can cause hormonal imbalances that lead to depression. It is not fully understood why thyroid malfunction causes depression but has been linked in several medical studies. Doctors can perform a series of blood tests to determine if the thyroid is not working properly.\nHormones such as estrogen and testosterone can be thrown off by birth control pills, smoking, drinking, poor diet and lack of exercise. Low levels of testosterone are a main cause for a decrease in sexual desire or a low libido.\nSPORT CAFE is the perfect setting to enjoy the best sporting events in the world on a giant screen. Relax and enjoy our SNACKS & DRINKS menu with a variety of freshly prepared healthy sandwiches and refreshing drinks in a sports setting.\nDiscover\nThe best facilities to enjoy sports\nTENNIS PROGRAMS WITH THE RAFA NADAL ACADEMY METHODOLY\nRAFA NADAL TENNIS CENTRE, COSTA MUJERES - CANCUN\nOur methodology\nImprove your tennis with the training system of Rafa Nadal\nRafa Nadal Museum Xperience\nVisit the Interactive Museum of Rafa Nadal.\nContact\nLocated in Costa Mujeres (Mexico) in the facilities of the two resorts TRS Coral Hotel and Grand Palladium Costa Mujeres Resort & Spa\nAddress:\nVialidad Paseo Mujeres, Manzana 1, lote 10 sm.3\nMunicipio de Isla Mujeres, 77400\nIsla Mujeres, Q.R., M√©xicoRafa Nadal Tennis Centre info: tel +52 998 8685 200 (ext. 88591)Tennis programs or accomodation + tennis programs sales: tel +1 917 3412197email / sales@rafanadaltenniscentre.com\nNewsletter\nSubscribe to our newsletter to receive the latest news.\nI accept the terms of subscription that I declare to have read..\n2018Legal warningCookies policy ‚öô Panel de cookies\nFollow us\nTrain hardPlay safe\nThe facilities of the Rafa Nadal Tennis Centre have been adapted to comply with the safety and hygiene protocols established by health authorities.\nBelow are some of the safety measures that will be implemented to prevent COVID-19 contagion during the coming summer months:\nThe facilities of the Rafa Nadal Tennis Centre have been adapted to comply with the safety and hygiene protocols established by health authorities. Increased frequency of disinfection and general cleaning, limitation of capacity in communal areas and the design of circuits guaranteeing the minimum safe distance are some of the measures which make up the protocol which has already been successfully implemented.\nOur team has received comprehensive training, allowing them to apply the protocols for safety and prevention of infection recommended in each area of action. They are also responsible for teaching young people, conveying the importance of respecting the stipulated measures to keep them and others healthy.\nAll our clients must respect the health measures implemented in the installation. Frequent disinfection of hands and the use of masks in areas where minimum safe distances cannot be guaranteed is obligatory.\nPalladium Hotel Group offers a free antigen test to all guests returning to the USA at the end of their stay. The test will be performed at the hotel 3 days prior to check-out. In the event that the country of origin does not accept the antigen test as valid, the hotel will offer its assistance to the client in conducting a PCR test (additional cost).\nAlcohol Dependency Portfolio | Gladstones Clinics\nAlcohol abuse, alcoholism, or alcohol dependency involve consumption of alcohol over a prolonged period of time, and damage to almost every part of a problem drinker's body. The inevitable health problems can include heart problems, organ damage, stomach problems, brain damage, cancer, reproductive problems, liver cirrhosis, memory problems and mental health problems.\nAlcohol Dependency, abuse, or addiction affects not just the person doing the drinking. Beloved family members and everyone else close to the alcoholic inevitably gets dragged into the walking disaster as well. Partners and children of the problem drinker are more likely to suffer psychological problems, physical abuse, violence, neglect and increased risk of injury or death in alcohol related accidents and assaults.\nWhat Is Stem Cell Knee Treatment Like? | Info Dir Web\nWhat Is Stem Cell Knee Treatment Like?\nadmin October, 2017 Medical Center No Comments\nYou struggle to stand and move. You deal with managing pain medication most of the day. Even worse, you find yourself unable to enjoy a high quality of life. You don't want surgery. Instead, you think you have to just deal with it. You don't. Stem cell knee treatment is an option, and it can prove to be one of the most effective ways for you to overcome the pain you feel without all of the complications of other treatments. Take a look at how easy this treatment can be.\nStem cell knee treatment starts with an assessment to determine the underlying cause of your injury. From there, doctors will work to determine the proper type of stem cell treatment including where to inject them. Once the injection occurs, the stem cells go to work. They reduce the inflammation there, reproduce healthy cells, and help to reprogram your body's healing system to overcome the disability. Many people begin to see healthy improvement within a few weeks, but maximum results take about 12 weeks.\nIt is likely that patients who use this treatment will see an improvement to the way their body works. They will see reduced pain, improved overall inflammation, and the ability to get back to doing the things they love. All you need is an injection. There is no time missed at work and no recovery period. Most people will have no significant side effects either.\nIf you have thought about the benefits of stem cell knee treatment but wondered if it could be a good option for you, this may be the best time to take action to find out. Many people can find a significant way to improve their health and pain without having to worry about any limitations from treatment.\nCOVID-19 restrictions result in reduced exercise and physical activity for people living with osteoporosis | Teva Ireland\nRecent research, conducted by Teva, has revealed that more than a quarter (28%) of those aged 65+ claim that the COVID-19 pandemic has had an impact on their ability to exercise while one in seven (14%) stating that the pandemic has impacted negatively upon their ability to gain access to support services.01 Exercise plays a vital role in bone health and osteoporosis prevention and treatment, making it even more important that people aged 65+ are able to remain physically active at this time.02\nIt is estimated that there are currently almost 300,000 people in Ireland living with osteoporosis with only 15% of people diagnosed.03\nOf those living with osteoporosis in Ireland, one in four men and one in two women over 50 will develop a fracture due to the condition during their lifetime.03\nWorldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every three seconds.04\nJeffrey Kidd named Pew Scholar for work on genetic variety between our cells | Human Genetics | Michigan Medicine | University of Michigan\nJeffrey Kidd named Pew Scholar for work on genetic variety between our cells\n\"Jeffrey Kidd, Ph.D., an assistant professor at the U-M Medical School, has been named one of only 22 Pew Scholars in the United States for 2013. It's an honor given by The Pew Charitable Trusts to some of the most promising early-career biomedical scientists. He is the 18th Pew Scholar on the U-M faculty and will receive a four-year, $240,000 unrestricted research grant.\nKidd ‚Äì who holds faculty positions in both the Department of Human Genetics and the Department of Computational Medicine and Bioinformatics -- straddles the worlds of DNA research and bioinformatics, a field that develops techniques to analyze and glean new knowledge from large amounts of biomedical data.\nHe and his team will use the Pew funding to develop a new approach that measures the DNA differences that exist within each individual human.\"\nDo DPP Benefits Last?\nJill P. Crandall, M.D., works to prevent diabetes and its complications.\nThe DPP followed patients at risk for diabetes for an average of only three years and so couldn't answer some key questions, such as: Can people ward off diabetes indefinitely if they stick with their medications and a healthy lifestyle? Will at-risk people who change their behaviors but still develop diabetes experience less frequent or less severe complications? Such questions are being addressed in the Diabetes Prevention Program Outcomes Study, or DPPOS, which is following the original DPP participants for an additional 15 years.\n\"The average age of our study participants is now in the mid-60s, so this phase should show whether people can maintain an active lifestyle with advancing age,\" says Jill P. Crandall, M.D., professor of clinical medicine (endocrinology), a DPP investigator and now one of the DPPOS's principal investigators. \"Perhaps most important, we'll find out whether the DPP interventions help reduce diabetic complications.\"\n\"Perhaps most important, we'll find out whether the DPP interventions help reduce diabetic complications.\"\nThe findings from the current phase of DPPOS are expected in 2015. \"We assume and hope that the program will produce long-term benefits, but we don't know for sure,\" says Dr. Crandall, who is also an attending physician in endocrinology at Montefiore Medical Center.\nAs your weight (expressed here as body mass index, or BMI) rises, so does your risk of developing type 2 diabetes. This illustration, based on the landmark Nurses' Health Study, shows that even a woman of average weight (BMI = 24) has about a five-fold higher risk of developing diabetes than a woman with a BMI of 22 or less. Other studies show a similar risk for men and for adolescents of both sexes. (Visit http://www.cdc.gov/healthyweight/assessing/bmi/ to learn your BMI.)\nElizabeth A. Walker, Ph.D., R.N., is searching for ways to translate study findings into workable remedies.\nThe DPP finally gave clinicians a highly effective remedy for preventing diabetes or slowing its onset. The next and arguably more formidable challenge is motivating patients to take the \"medicine\" prescribed by the DPP‚Äîno easy task. Studies assessing patient compliance have found that as few as 60 percent of type 2 diabetes patients adhere to the medication regimen prescribed for them.\nAs few as 60 percent of type 2 diabetes patients adhere to their medication regimen\nPatients are even less likely to follow healthy eating and exercise recommendations than to do something relatively simple such as taking a pill, notes Elizabeth A. Walker, Ph.D., R.N., professor of medicine (endocrinology) and of epidemiology & population health and co-leader of the DPP's medication adherence group.\n\"Eating in particular is highly complex,\" Dr. Walker notes. \"It's fraught with emotions. It's about comfort food, family, memories of Mom's home cooking. Plus, you have to decide what to eat several times a day. The challenge of eating well is never ending.\"\nDr. Crandall says that the realities of everyday life can also interfere with healthful habits. \"For example,\" she asks, \"how do you inspire adults to exercise when they are working two jobs and must take two buses to get to the local YMCA? How do you encourage children to eat fresh fruits and vegetables when fast foods are available on every corner?\"\nThe task of translating the DPP findings into workable remedies falls to behavioral scientists such as Dr. Walker. Below are descriptions of her work and that of other like-minded faculty at Einstein and its primary teaching hospital, Montefiore Medical Center.\nA few years after the DPP issued its findings, the Centers for Disease Control and Prevention teamed with the YMCA to bring the DPP's lifestyle intervention to communities nationwide. Now known as the National Diabetes Prevention Program (NDPP), this yearlong effort consists of 16 weekly group sessions on diet and exercise, followed by periodic \"booster\" classes. The NDPP is now offered in some 250 locations in 26 states.\nThe NDPP reportedly is working well, yet it can't begin to reach all those who need it. This is especially true in the Bronx, with its single YMCA site for a population of 1.4 million and a high incidence of obesity.\nThe clear need for more resources prompted Dr. Walker to apply for and win a grant from the Leon Lowenstein Foundation, Inc., of New York to study whether modifying the Bronx NDPP could pave the way for more such programs in the borough.\nOne of the most compelling findings to arise from her study was that men make up just one in ten Bronx NDPP enrollees. \"This is a significant problem,\" says Dr. Walker. \"Men have a somewhat higher risk of developing type 2 diabetes than women, and black and Latino men have a higher risk than Caucasian men.\"\nIt's too early for a definitive explanation for the gender disparity found in the Bronx NDPP classes, but Dr. Walker suspects a major reason is that the men simply aren't as interested as women in \"lifestyle\" programs. \"If that's true,\" she says, \"we think that we can get more men in the door by emphasizing physical activity and making the group activities a bit more competitive.\"\nDr. Walker and her colleagues (who include officials at the Bronx NDPP and healthcare providers and administrators at Montefiore) are also looking at ways to improve overall enrollment, increase retention rates, lower economic barriers to participation and find additional sites for hosting the program. Montefiore has now begun offering the NDPP program at some of its own clinics, including classes taught in Spanish. And the medical center has updated its electronic medical record system, allowing clinicians to refer patients to a diabetes prevention program more easily.\n\"At Montefiore we've made diabetes prevention a top priority,\" says Peter A. Selwyn, M.D., M.P.H., professor and chair of family and social medicine at Einstein and Montefiore, professor of epidemiology & population health, of medicine and of psychiatry and behavioral sciences at Einstein and director of the Office of Community Health and Wellness at Montefiore. \"We're working to find new ways of promoting healthy behaviors and healthy environments. In public health, we often talk about making the healthy choice the easy choice. That tactic is critical in preventing diabetes.\"\nA borough away from the Bronx but a world apart, other Einstein researchers are studying diabetes prevention among Chinese immigrants in Lower Manhattan‚Äîanother community that could benefit from a customized approach to diabetes prevention.\nJudith Wylie-Rosett, Ed.D., is fine-tuning research results for use by ethnic groups such as New York's Chinese-American community.\n\"The NDPP is a good idea‚Äîit brings people to a place to both learn and exercise‚Äîbut it's not ideal for this particular community,\" explains Judith Wylie-Rosett, Ed.D., professor of epidemiology & population health (health promotion and nutrition research) and of medicine (endocrinology) and the Atran Foundation Chair in Social Medicine. \"Chinese immigrants prefer getting their healthcare advice from Chinese physicians. So if you want to reach this population, you have to go through the local practices rather than the YMCA.\"\nDr. Wylie-Rosett gained her insights from working with several organizations serving New York City's Chinese-American community. That collaboration has yielded recommendations for tailoring the NDPP intervention to this group. \"We've learned, for example, that many Chinese aren't comfortable talking about personal issues in a group setting, so we've added telephone counseling for certain topics,\" she says.\nOther adaptations include adding karaoke‚Äîa favorite Asian pastime‚Äîto the stress-management session; distributing healthy Chinese recipes; and tailoring discussions on how body fat relates to diabetes (reflecting that Asians tend to develop the disease at a lower body mass index [or BMI, an indicator of body fat] than other groups do).\nDr. Wylie-Rosett and her colleagues are currently finishing a pilot study to test whether the revamped program is acceptable and effective.\nJust a mile from the Einstein campus, the Bronx Bangladeshi community is the fastest-growing immigrant group in New York City. Until recently, its health needs were largely unknown. A 2012 survey by Alison Karasz, Ph.D., associate professor of family and social medicine, found that an astonishing 74 percent of local Bangladeshi women were either overweight or obese and that more than 15 percent had type 2 diabetes‚Äîthe highest rates in the city.\nOffering these women a program such as the NDPP lifestyle intervention might have seemed a logical response. But Dr. Karasz, a clinical psychologist who has been practicing in the Bronx South Asian community for years, had a different idea.\n74 percent of local Bangladeshi women were either overweight or obese and more than 15 percent had type 2 diabetes‚Äîthe highest rates in New York city\n\"Intensive lifestyle programs such as the NDPP are highly effective in the general population,\" she says. \"But they're based on Western theories of 'empowering the individual' that tend to ignore the extent to which learning and behavior change are embedded in social networks and communities.\" When recruiting women from such a traditional hierarchical society into treatment, she adds, \"it's important to make sure that their families are on board with the program.\"\nSuch considerations prompted Dr. Karasz and her colleagues to develop two lifestyle interventions aimed at improving women's nutrition and exercise habits: SAATHI (South Asians Acting Together for Health Improvement) and APPLE (Activating People to Pursue Lifestyle Change through Empowerment). Both programs build social networks that offer support for women as they change their behaviors in ways acceptable to family members. For example, each participant is partnered with a bondhu (\"friend\" in Bengali) who helps her set goals and maintain her lifestyle changes.\nThe approximately 50 women recruited so far into SAATHI and APPLE lost an average of 5.8 percent of their weight after completing the programs. And, says Dr. Karasz, about 75 percent of enrollees complete the programs‚Äîa much better retention rate than other lifestyle programs designed for immigrants have achieved. She believes these programs could serve as a model for diabetes prevention and treatment programs in other traditional immigrant communities.\nReaders of a certain age may remember when type 2 diabetes was called \"adult-onset\" diabetes, since it didn't usually appear until middle age. But diabetes has been trending younger and younger in recent years‚Äîa direct consequence of the rise in childhood obesity. Einstein and Montefiore have launched several initiatives to help children avoid the disease. One example is B'N Fit (the Bronx Nutrition and Fitness Initiative for Teens), founded and directed by Jessica Rieder, M.D., M.S., associate clinical professor of pediatrics (adolescent medicine) at Einstein and an attending physician in adolescent medicine at The Children's Hospital at Montefiore.\nB'N Fit is a nine-month weight-management program that helps obese inner-city adolescents adopt healthy lifelong nutritional and physical activity skills; develop coping skills and personal responsibility; and use family, social and community resources to achieve personal goals. Begun in 2005, B'N Fit is a collaborative effort of The Children's Hospital at Montefiore and the Mosholu Montefiore Community Center.\nDr. Rieder and her colleagues recently evaluated 349 adolescents (two-thirds of them severely obese) who enrolled in B'N Fit. The 91 participants who completed the program showed significant improvement in their BMIs, consumed significantly more servings of fruit and vegetables daily and participated significantly more often in vigorous physical activities‚Äîall in spite of school obligations, family emergencies and transportation issues. But nine months after the teens completed the program, their BMIs had increased significantly.\nThe participants showed significant improvement in their body mass index (BMI) and ate significantly more fruits and vegetables daily\n\"Our findings indicate that a nine-month program isn't long enough to have a sustained impact on obese inner-city teens,\" says Dr. Rieder. \"These kids need long-term support for sticking with the healthy lifestyles that are so crucial for losing weight and keeping it off.\"\nDr. Wylie-Rosett is developing a program similar to B'N Fit for preteens at risk for diabetes, but adding parents to the mix. \"Our goal is to make a healthy lifestyle a family agenda,\" she says. The program features recreational and educational activities for kids plus workshops for parents that include advice on healthy eating and effective parenting strategies.\nIdeally, the program will change the family dynamic when it comes to eating‚Äîmaking the dinner table the focal point of meals, for example. \"In many households, the TV is on all the time, and everyone eats in front it,\" says Dr. Wylie-Rosett. \"There's no regular meal time. We think it's important for family members to eat together, to talk to each other and to pay attention to what they're eating.\"\nDr. Wylie-Rosett is planning to test the intervention on several hundred Bronx families.\nIf lifestyles changes aren't enough to prevent diabetes, perhaps a glass of red wine can do the trick.\nAs many oenophiles know, red grapes contain a chemical called resveratrol that can normalize glucose metabolism, prevent cancer and heart disease and prolong life spans‚Äîat least in animals. In a 2010 pilot study of 10 older patients with prediabetes, Dr. Crandall and her Einstein colleagues found that resveratrol supplements improved the subjects' insulin sensitivity and postmeal glucose tolerance‚Äîthe first study to link resveratrol to a benefit in humans.\nDr. Crandall was later awarded a $600,000 grant from the American Diabetes Association to expand her inquiry into resveratrol. She will study 30 people ages 50 to 80 who have impaired glucose tolerance to see how resveratrol supplements affect postmeal metabolism of blood glucose. Preliminary studies will explore how resveratrol works by examining cellular function (in muscle samples obtained from study participants) and by testing resveratrol's effect on blood vessel function.\nResveratrol supplements must be used because diet alone can't supply what is believed to be a therapeutic concentration of the compound: Researchers estimate that you'd need to drink hundreds bottles of wine per day to obtain the resveratrol levels found therapeutic in mice.\n\"Our earlier work has given us reason to be hopeful,\" says Dr. Crandall. \"Given the easy availability, low cost and apparent safety of resveratrol supplements, a positive finding could have an enormous impact on human health.\"\n\"We need a national public health campaign aimed at diabetes prevention, similar to those used to curb smoking or mandating seatbelt use.\"\nEven if resveratrol proves useful in preventing diabetes, much more must be done to put a dent in the diabetes epidemic.\n\"All the things that drive the epidemic are societal‚Äîthe limited availability of healthy foods in many neighborhoods, the relentless junk-food advertising aimed at children, the lack of recreational opportunities in urban areas,\" says Dr. Crandall. \"We need a major national public health campaign aimed at diabetes prevention, similar to campaigns used to curb smoking or mandating seatbelt use.\"\nThat effort, she says, may involve requiring people to change their behavior, not just suggesting they do so. \"We banned smoking from public spaces, making it harder to light up,\" she notes. \"The bottom line is that people are much safer.\n\"It's an enormous challenge,\" Dr. Crandall acknowledges, \"but the potential benefits are huge. If we can prevent diabetes, we would also reduce the incidence of heart disease, high blood pressure, cancer, and many other complications.\" Ben Franklin would certainly have approved.\nPeople at risk for type 2 diabetes can prevent or slow the onset of the disease through diet, exercise or drugs. But the search continues for a way to stave off type 1 diabetes, which affects about 5 percent of all people who have the disease.\nScientists led by Teresa P. DiLorenzo, Ph.D., professor of microbiology & immunology and of medicine (endocrinology) and the Diane Belfer, Cypres & Endelson Families Faculty Scholar in Diabetes Research at Einstein, believe the answer may lie with immune-system cells called dendritic cells. They patrol the body looking for foreign invaders such as bacteria, viruses or toxins.\n[hdvideo id=21 playlistid=6]\nAfter capturing the invaders, dendritic cells break them into fragments and present them to T cells‚Äîthereby priming T cells to attack anything in the body that displays those fragments. Type 1 diabetes occurs when T cells mistakenly view the pancreas's beta cells (the body's source of insulin) as potential threats and then launch an autoimmune attack that destroys them.\"Suppressing all of the body's T cells could prevent or even reverse type 1 diabetes,\" says Dr. DiLorenzo. \"However, this would lead to serious side effects, such as an increased susceptibility to infections and cancer. Our approach seeks to suppress only those T cells responsible for destroying the beta cells.\"\nHere's where dendritic cells come in. New research has revealed that dendritic cells can influence T cells in two diametrically opposite ways: provoking T cell attacks in some circumstances and suppressing attacks in others. Dr. DiLorenzo is trying to bolster the suppressive side of dendritic cells‚Äîessentially enlisting them to \"teach\" T cells not to attack beta cells of the pancreas.\nType 1 diabetes occurs when T cells mistakenly view the pancreas's beta cells‚Äîthe body's source of insulin‚Äîas potential threats and then launch an autoimmune attack\nThe autoimmune attack on beta cells targets specific antigens, including a peptide (small protein) within proinsulin, the precursor to insulin. In studies of diabetic mice, Dr. DiLorenzo and her colleagues deliver this antigen to a dendritic cell-surface receptor called DEC-205. After the dendritic cells ingest the antigen, they present it to T cells.\nWhen the antigen was later introduced into the mice, no immune response occurred‚Äîevidence that T cells of the mouse immune system now tolerate this peptide. If the same strategy works in humans, says Dr. DiLorenzo, it might be possible to protect people at high risk for type 1 diabetes from developing the disease.\nEinstein researchers are also participating in a study called Pathway to Prevention, which recruits people at increased risk for type 1 diabetes to learn more about how it develops. Study subjects are selected by screening the blood relatives of those with type 1 diabetes and testing them for antibodies associated with the disease.\nPeople with those so-called autoantibodies have a 10- to 15-fold greater risk of developing type 1 diabetes compared with people with no family history, says Rubina A. Heptulla, M.B.B.S., professor of pediatrics (endocrinology) and of medicine at Einstein and chief of pediatric endocrinology and diabetes at The Children's Hospital at Montefiore, one of the screening sites. Pathway to Prevention is part of TrialNet, an international network of researchers and institutions dedicated to the study, prevention and early treatment of type 1 diabetes.\nFour years ago, it was a vacant lot. Today the Bronx, Obesity, Diabetes and You (BODY for short) garden features six raised vegetable beds, fruit bushes, a lettuce table, a gravel path, flower beds, picnic tables, compost bins and herb plantings. Students in Einstein's BODY club are using this space just south of Montefiore's Weiler Hospital to introduce Bronx residents to the joys of planting, harvesting and (most important) eating healthy food and making exercise a daily routine‚Äîtwo big ways to prevent or control type 2 diabetes.Last May, BODY garden volunteers hosted their first school group: 150 fourth graders from P.S. 89.\n\"When I started BODY, I thought I'd have to pull teeth to get busy Einstein students involved, but the reality was the opposite‚Äîmy peers led and participated in many BODY activities over the last three years,\" says Ross Kristal, Class of 2015, who has type 1 diabetes. \"They brought a steady stream of creative ideas to the table, and the Einstein faculty and administration helped us implement them.\"\nRoss is now digging into population health research focusing on diabetes and obesity and has passed his BODY trowel to graduate students Tony Bowen and Julie Nadel.\nMore than 40 years ago, research conducted at Einstein helped connect a type of hemoglobin called HbA1c to diabetes‚Äîa discovery that has transformed the way diabetes is diagnosed, treated and prevented.\nThe story begins in 1968 when Samuel Rahbar, M.D., Ph.D., a Jewish-Iranian scientist, was examining blood samples in his lab at the University of Tehran. Nearly 20 years earlier, Linus Pauling had found that an aberrant type of hemoglobin was responsible for sickle cell anemia. Dr. Rahbar was looking for other hemoglobin variants that might be linked to human disease. After screening thousands of blood samples, he saw something interesting in the blood of a 67-year-old woman.\n\"I said to myself, 'What is this? This isn't fitting with any of the known hemoglobins,'\" Dr. Rahbar recalled years later in an interview. The woman's medical records indicated that she had diabetes‚Äîprompting Dr. Rahbar to examine the blood of 47 more people with diabetes, all of whom had the same unusual type of hemoglobin. He published his findings later that year in a paper, \"An Abnormal Hemoglobin in Red Cells of Diabetics.\"\nHelen M. Ranney, M.D., in 1961.\nDr. Rahbar was eager to confirm his findings in a different laboratory, so later that year, he came to Einstein as a visiting scientist working under Helen M. Ranney, M.D., a professor of medicine and pioneer in studying hemoglobin and sickle cell anemia.Drs. Rahbar and Ranney analyzed blood samples from people in the neighborhoods around Einstein and found the same unusual hemoglobin in 140 diabetic patients. In describing their findings in 1969 in Biochemical and Biophysical Research Communications, the researchers noted that their novel \"diabetic component\" appeared identical to HbA1c‚Äîone of five recently identified hemoglobin subtypes.\nDrs. Rahbar and Ranney analyzed blood samples from people in the neighborhoods around Einstein and found the same unusual hemoglobin in 140 diabetic patients\nUniquely, HbA1c involved a specific fraction of hemoglobin that had been \"glycated,\" or chemically combined with glucose. And the higher a person's blood glucose level, the larger the percentage of total hemoglobin that was converted to HbA1c. Drs. Rahbar and Ranney reported that HbA1c made up 4 to 6 percent of normal subjects' total hemoglobin compared with 7.5 to 10.6 percent of the total hemoglobin of diabetic patients.\nIn the late 1970s, investigators in Einstein's new Diabetes Research and Training Center were among the first to put HbA1c to practical use: they tested HbA1c levels of Bronx diabetes patients enrolled in long-term studies as a way to monitor patients' blood glucose control. But not until 1984 did the test get its big break, with the launch of the landmark Diabetes Control and Complications Trial.\nThe DCCT‚Äîa nationwide study funded by the National Institutes of Health‚Äîcompared different treatments for type 1 diabetes head to head. It used the HbA1c test to assess each treatment's effectiveness in controlling blood sugar levels over the\nIn 1993, the DCCT reported that intensive blood sugar control, as measured by HbA1c level, dramatically reduced the long-term complications of type 1 diabetes. (Einstein's role in the DCCT is described in \"\".)\nThe HbA1c test soon became a game changer. Glucose tests such as finger-prick testing report blood glucose levels at a particular moment, which helps patients adjust daily insulin doses. But such tests offer no information about the long-term blood glucose levels that so crucially influence whether com-plications will develop in someone with diabetes.\nBy contrast, the HbA1c test measures a patient's average blood glucose level over the previous two or three months (the lifespan of a red blood cell). Clinicians now routinely test their diabetes patients' HbA1c levels several times a year. They adjust patients' therapies accordingly, to optimize blood glucose control and minimize the risk of life-threatening complications.\nThe HbA1c test has now been validated for diagnosing types 1 and 2 diabetes and for monitoring prediabetic patients to prevent full-blown diabetes from developing. (The American Diabetes Association now regards a diabetes diagnosis as being warranted when someone's HbA1c level is greater than or equal to 6.5 percent.) In addition, measuring HbA1c has become the FDA's gold standard for evaluating the effectiveness of new diabetes treatments. It's no surprise that HbA1c was recently called \"one of the most important biological molecules in modern medicine.\"\nDr. Rahbar returned to Iran after his stint at Einstein. During the Iranian revolution he was accused of being cozy with the Shah's family, lost his professorship at the University of Tehran and fled to the United States in 1979 with his wife and three daughters. He reunited with Dr. Ranney, who by then was at the University of California‚ÄìSan Diego, and studied diabetes for the next 33 years at the City of Hope National Medical Center in Duarte, CA.\nIn June 2012 the American Diabetes Association bestowed a special, one-time National Scientific Achievement Award‚Äîthe Samuel Rahbar Outstanding Discovery Award‚Äîon Dr. Rahbar himself, to honor him for his discovery of HbA1c as a marker for diabetes. He died the following November at age 83.\nType 1 Diabetes: Research, Treatment and Prevention\n2 thoughts on \"Attacking an Epidemic: Type 2 Diabetes\"\nDavid Pouldar says:\nAlthough the BMI index can be useful, it does have its limitations‚Ä¶‚Ä¶but in general, targeting your weight to fit the appropriate BMI index goals should be everyone's focus."
    }
]